Citrus Sinensis ID: 008648
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.919 | 0.655 | 0.492 | 1e-153 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.978 | 0.642 | 0.475 | 1e-153 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.982 | 0.646 | 0.457 | 1e-142 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.976 | 0.635 | 0.436 | 1e-141 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.935 | 0.640 | 0.511 | 1e-141 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.971 | 0.650 | 0.451 | 1e-139 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.969 | 0.641 | 0.453 | 1e-139 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.969 | 0.640 | 0.450 | 1e-137 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.969 | 0.634 | 0.446 | 1e-129 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.964 | 0.656 | 0.437 | 1e-127 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 543 bits (1400), Expect = e-153, Method: Compositional matrix adjust.
Identities = 274/556 (49%), Positives = 366/556 (65%), Gaps = 43/556 (7%)
Query: 3 VVWSASLSKEVQQTPV---VLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKL 59
++WS+S S Q+ + ++Q+LD+GNLV+R GD Y WQS DYP D LPGMK
Sbjct: 107 IIWSSSSSPSSQKASLRNPIVQILDTGNLVVR--NSGDDQDYIWQSLDYPGDMFLPGMKY 164
Query: 60 GWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA 119
G + TG R + SW++ DDPS G++ ++ P+ + K S + TGPWNGL F+
Sbjct: 165 GLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTG 224
Query: 120 -PTTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLY 178
P +PNPI+ + +V E+E+ YT+ +++ +V++R+ +N L QR+TW +N Q+W+ Y
Sbjct: 225 MPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGAL-QRYTWVDNLQSWNFY 283
Query: 179 SKAPRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSGGYM---DWHEGCVRSKALNYS 235
A D CD Y LCG+YG C I++SP C+CLKGF K+ DW EGCVR L+
Sbjct: 284 LSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCG 343
Query: 236 R-QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWF 294
+ +DGF+K ++LKLPD S K+++L EC++ CL N +C AY+ DIR GG GC +WF
Sbjct: 344 KGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWF 403
Query: 295 GDLIDMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYLIHKRR 354
GDLID+R + + GQD Y+R+++SE+ + +
Sbjct: 404 GDLIDIREYNENGQDLYVRLASSEIET----------------------------LQRES 435
Query: 355 RNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIA 414
++ QE E DLELP +L T+S AT+ FS NKLG+GGFGPVYKGTL GQE+A
Sbjct: 436 SRVSSRKQEEE----DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVA 491
Query: 415 VKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIF 474
VKRLS+ S QG++E KNE+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLD FIF
Sbjct: 492 VKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIF 551
Query: 475 DQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534
D+ + LDW KR II G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611
Query: 535 ARTCGGDKTEGNTNRV 550
ART GGD+TE NT RV
Sbjct: 612 ARTLGGDETEANTTRV 627
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 543 bits (1400), Expect = e-153, Method: Compositional matrix adjust.
Identities = 274/576 (47%), Positives = 366/576 (63%), Gaps = 30/576 (5%)
Query: 4 VWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDL 63
VWS +L+ ++P+V +LLD+GN VLR + WQSFD+P+DTLLP MKLGWD
Sbjct: 114 VWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDA 173
Query: 64 KTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFS-APTT 122
KTGF R + SWKS DDPS GDF + +E + PE+ +W S+ Y +GPWNG+ FS P
Sbjct: 174 KTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEM 233
Query: 123 RPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKAP 182
+P F+F +++E+ Y+F I V SR+ ++ + L QRFTW Q W+ + AP
Sbjct: 234 QPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLL-QRFTWIETAQNWNQFWYAP 292
Query: 183 RDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALNYSRQDG 239
+D+CD Y CG YG C + SPVC C+KGFK ++ G D +GCVR L+ DG
Sbjct: 293 KDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDG 352
Query: 240 FIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLID 299
F++ ++KLPD + V + + +KEC +KCL + +C A+ N+DIRG GSGC W G+L D
Sbjct: 353 FVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFD 412
Query: 300 MRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYL-IHKRRRNI- 357
+R++ GGQD Y+R++A++L K + KI+ I LL + I +L K++R+I
Sbjct: 413 IRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSIL 472
Query: 358 -----------------------AETDQENEDQNIDLELPLFELATISNATNNFSINNKL 394
+ E+ DLELPL E ++ ATNNFS NKL
Sbjct: 473 IETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKL 532
Query: 395 GEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG 454
G+GGFG VYKG L+DGQE+AVKRLSK S QG E KNEV L ++LQH NLV+LL CC+
Sbjct: 533 GQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDA 592
Query: 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 514
EK+LIYE++ N SLD +FD++ + L+W RF II G ARGLLYLHQDSR RIIHRDL
Sbjct: 593 GEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDL 652
Query: 515 KASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
KASN+LLD M PKISDFG+AR G D+TE NT +V
Sbjct: 653 KASNILLDKYMTPKISDFGMARIFGRDETEANTRKV 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 505 bits (1300), Expect = e-142, Method: Compositional matrix adjust.
Identities = 264/577 (45%), Positives = 356/577 (61%), Gaps = 29/577 (5%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGW 61
R VWS +++ ++PV +LLD GN VLR + + WQSFD+P+DTLL MK+GW
Sbjct: 110 RPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGW 169
Query: 62 DLKTG-FERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA- 119
D K+G F R + SWK+ DDPS GDF + PE ++ S Y +GPW G FS+
Sbjct: 170 DNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSV 229
Query: 120 PTTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYS 179
P +P + SF N ++ Y++ + + S + ++ T L QR TW Q+W
Sbjct: 230 PGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLL-QRLTWMEAAQSWKQLW 288
Query: 180 KAPRDECDTYGLCGAYGVCIISKSPVCQCLKGFK--TKSGGYMDWHEGCVRSKALNYSRQ 237
+P+D CD Y CG YG C + SP+C C+KGF+ + D GCVR L+ +
Sbjct: 289 YSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGR 348
Query: 238 DGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDL 297
DGF++ +++LPD + V K + LKEC E+CL+ +C A+ N+DIR GGSGC +W G L
Sbjct: 349 DGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGL 408
Query: 298 IDMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVIS-AVALLAVVLISGYLIHKRRRN 356
D+R++ GGQD Y+R++A +L K + KI+ I ++ LL +I + K++R+
Sbjct: 409 FDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRS 468
Query: 357 I-----------------------AETDQENEDQNIDLELPLFELATISNATNNFSINNK 393
I + + E++ LELPL E ++ ATNNFS +NK
Sbjct: 469 ITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNK 528
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453
LG+GGFG VYKG L+DG+EIAVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+
Sbjct: 529 LGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVD 588
Query: 454 GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 513
EK+LIYE++ N SLD +FDQT S L+W KRF II G ARGLLYLHQDSR RIIHRD
Sbjct: 589 KGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRD 648
Query: 514 LKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
LKASNVLLD +M PKISDFG+AR G ++TE NT RV
Sbjct: 649 LKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 685
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 252/577 (43%), Positives = 366/577 (63%), Gaps = 32/577 (5%)
Query: 4 VWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDL 63
VW +L++ +++PVV +LL +GN V+R D+ Y WQSFDYP+DTLLP MKLG++L
Sbjct: 116 VWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNL 175
Query: 64 KTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTT 122
KTG R + SW+S+DDPS G+F + +E Q PE + + + + +GPWNG+ FS P
Sbjct: 176 KTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPED 235
Query: 123 RPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKAP 182
+ ++F+ N +E+ YTF + + + SR+ + Y QR TW + + W+ + +P
Sbjct: 236 QKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYF-QRLTWYPSIRIWNRFWSSP 294
Query: 183 RD-ECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSGGYMD---WHEGCVRSKALNYSRQD 238
D +CDTY +CG Y C ++ SPVC C++GF ++ D W GC+R L+ S D
Sbjct: 295 VDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GD 353
Query: 239 GFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLI 298
GF + ++KLP+ + V +S+ +KEC+++C+ + +C A+ N+DIR GGSGC +W L
Sbjct: 354 GFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLE 413
Query: 299 DMRSFPDG---GQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYLIHKRRR 355
D+R++ GQD Y+R++A+++ K + KI+ L + LL +++ + ++R
Sbjct: 414 DIRNYATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRA 473
Query: 356 NIAETDQEN--EDQNI--------------------DLELPLFELATISNATNNFSINNK 393
+ N +QN+ +LELPL E+ T+ AT NFS NK
Sbjct: 474 KASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNK 533
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453
LG+GGFG VYKG L+DG+EIAVKRLSK S QG E NEV L ++LQH NLV++LGCCI
Sbjct: 534 LGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIE 593
Query: 454 GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 513
G+EK+LIYE++ N SLD ++F +T L+W++RF I G ARGLLYLHQDSR RIIHRD
Sbjct: 594 GDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRD 653
Query: 514 LKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
LK SN+LLD +M PKISDFG+AR D+TE NT +V
Sbjct: 654 LKVSNILLDKNMIPKISDFGMARIFERDETEANTMKV 690
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1291), Expect = e-141, Method: Compositional matrix adjust.
Identities = 279/545 (51%), Positives = 368/545 (67%), Gaps = 23/545 (4%)
Query: 19 VLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSAD 78
+L++ SGNL+ +E WQSFDYP +T+L GMKLG + KT E + SWK+
Sbjct: 128 LLKISCSGNLISSDGEEA----VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLK 183
Query: 79 DPSPGDFIWAVERQDNPEVVMWKG--SSKFYTTGPWNGLSFS-APTT-RPNPIFNFSFVA 134
DPSPGDF +++ + P++++ K SS Y G WNGLSF+ AP R N +F++ F +
Sbjct: 184 DPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTS 243
Query: 135 NEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKAPRDECDTYGLCGA 194
+ E+ Y+++ + + +VSR+V+N T L RF S Q W L + AP DECD Y +CGA
Sbjct: 244 SAQEVNYSWTPRHR-IVSRLVLNNTGKL-HRFIQSKQNQ-WILANTAPEDECDYYSICGA 300
Query: 195 YGVCIIS--KSPVCQCLKGFKTKSGGYMDWH-----EGCVRSKALNYSRQDGFIKFTELK 247
Y VC I+ +P C CL+GFK KSG W+ GCV N ++D F+KF LK
Sbjct: 301 YAVCGINSKNTPSCSCLQGFKPKSG--RKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLK 358
Query: 248 LPDANFS--RVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPD 305
LPD ++S + L++C+ KC N SC AY N+DIR GG GC +WFGDL+DMR +
Sbjct: 359 LPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSS 418
Query: 306 GGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYLIHKRRRNIAETDQENE 365
GQD YIRM +++ KG +VV + A+A++ VV+ + + +R E ++
Sbjct: 419 FGQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGI 478
Query: 366 DQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQG 425
++ DL+LP+F+ TIS AT++FS N LG GGFGPVYKG L DGQEIAVKRLS S QG
Sbjct: 479 EEE-DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQG 537
Query: 426 LKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWS 485
++E KNEV L +KLQHRNLV+LLGCCI GEE +LIYE+MPNKSLD+FIFD+ S LDW
Sbjct: 538 VEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWK 597
Query: 486 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEG 545
KR +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD+DMNPKISDFGLA++ GGD++E
Sbjct: 598 KRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSES 657
Query: 546 NTNRV 550
+TNRV
Sbjct: 658 STNRV 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 496 bits (1277), Expect = e-139, Method: Compositional matrix adjust.
Identities = 262/580 (45%), Positives = 372/580 (64%), Gaps = 38/580 (6%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
++WS ++S + + +V L D GNLVL G S FW+SFD+P+DT LP M+LG+
Sbjct: 104 LIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGRS---FWESFDHPTDTFLPFMRLGFT 160
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPTT 122
K G +R + SWKS DP GD I +ER+ P+++++KG + ++ G W G +S
Sbjct: 161 RKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHRWSGVPE 220
Query: 123 RP-NPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
P IFN SFV NEDE+ +T+ + D +V++R ++N+T + RFTW + W+ +
Sbjct: 221 MPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTM-HRFTWIARDKRWNDFWSV 279
Query: 182 PRDECDTYGLCGAYGVC--IISKSPVCQCLKGFKTKSGGY---MDWHEGCVRSKALNY-S 235
P+++CD Y CG G C SK+ C CL GF+ K + D GC + K + S
Sbjct: 280 PKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKKRASICS 339
Query: 236 RQDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNS--DIRGGGSGCAMW 293
+DGF+K +K+PD + + V ++ LKEC+++CL+N SC+AY ++ + + G GC W
Sbjct: 340 EKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKW 399
Query: 294 FGDLIDMRSFPDGGQDFYIRMSASEL------GMKGEPTTKIVVL-VISAVALLAVVLIS 346
G ++D R++ + GQDFYIR+ EL G+ G+ ++++ +I+AV LL V+L
Sbjct: 400 HGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRRVLLILISLIAAVMLLTVILFC 459
Query: 347 GYLIHKRRR----------------NIAETDQENEDQNIDLELPLFELATISNATNNFSI 390
++ +RR+ + E+ + +D+ + ELPLF+L TI ATNNFS
Sbjct: 460 --VVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSS 517
Query: 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGC 450
NKLG GGFGPVYKG L + EIAVKRLS+ S QG++E KNEV L SKLQHRNLV++LGC
Sbjct: 518 QNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGC 577
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRII 510
C+ EEK+L+YE++PNKSLDYFIF + LDW KR I+ G ARG+LYLHQDSRLRII
Sbjct: 578 CVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRII 637
Query: 511 HRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
HRDLKASN+LLD +M PKISDFG+AR GG++ EG T+RV
Sbjct: 638 HRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRV 677
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 495 bits (1274), Expect = e-139, Method: Compositional matrix adjust.
Identities = 263/580 (45%), Positives = 358/580 (61%), Gaps = 39/580 (6%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGW 61
R VWS +++ ++PV +LLD+GN +LR + WQSFD+P+DTLL MKLGW
Sbjct: 110 RPVWSTNITGGDVRSPVAAELLDNGNFLLRDS----NNRLLWQSFDFPTDTLLAEMKLGW 165
Query: 62 DLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-P 120
D KTGF R + SWK+ DDPS G+F +E + PE + S Y +GPWNG+ FS+ P
Sbjct: 166 DQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVP 225
Query: 121 TTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSK 180
T ++F A+++E+ Y++ I + SR+ +N L QR TW TQ+W
Sbjct: 226 GTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLL-QRLTWFETTQSWKQLWY 284
Query: 181 APRDECDTYGLCGAYGVCIISKSPVCQCLKGFK---TKSGGYMDWHEGCVRSKALNYSRQ 237
+P+D CD Y +CG +G C + P C C+KGFK ++ D GC+R L+ +
Sbjct: 285 SPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGR 344
Query: 238 DGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDL 297
DGF + +KLPD + V + + LK C+E+CLE+ +C A+ N+DIR GGSGC +W ++
Sbjct: 345 DGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREI 404
Query: 298 IDMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYLIH--KRRR 355
+DMR++ GGQD Y+R++A+EL K KI+ S++ + ++L+S + H KR++
Sbjct: 405 LDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIG---SSIGVSILLLLSFVIFHFWKRKQ 461
Query: 356 NIAETDQENEDQNIDLELPLFELATIS-------------------------NATNNFSI 390
+ T Q + + L +S ATNNFS
Sbjct: 462 KRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSN 521
Query: 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGC 450
+NKLG+GGFG VYKG L+DG+EIAVKRLSK+S QG E NEV L +KLQH NLV+LLGC
Sbjct: 522 DNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGC 581
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRII 510
C+ EK+LIYE++ N SLD +FDQT S L+W KRF II G ARGLLYLHQDSR RII
Sbjct: 582 CVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRII 641
Query: 511 HRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
HRDLKASNVLLD +M PKISDFG+AR G ++TE NT RV
Sbjct: 642 HRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 488 bits (1256), Expect = e-137, Method: Compositional matrix adjust.
Identities = 263/584 (45%), Positives = 374/584 (64%), Gaps = 43/584 (7%)
Query: 4 VWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDL 63
+WS + +Q+ +V +L D GNLVL G S FW+SF++P++TLLP MK G+
Sbjct: 108 IWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS---FWESFNHPTNTLLPFMKFGFTR 164
Query: 64 KTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTT 122
++G +R + SW+S DP G+ + +ER+ P+++M+KG + ++ TG W G +S P
Sbjct: 165 QSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMMYKGLTLWWRTGSWTGQRWSGVPEM 224
Query: 123 RPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKAP 182
IFN SFV N DE+ T+ + D +V +R+V+N+T L QRF W+ + W + AP
Sbjct: 225 TNKFIFNISFVNNPDEVSITYGVLDASVTTRMVLNETGTL-QRFRWNGRDKKWIGFWSAP 283
Query: 183 RDECDTYGLCGAYGVCIISKSPV--CQCLKGFKTKSGGYMDW-----HEGCVRSKALNYS 235
D+CD Y CG G C + + C CL G++ K+ DW +GC R KA +
Sbjct: 284 EDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKTP--RDWFLRDASDGCTRIKADSIC 341
Query: 236 R-QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNS--DIRGGGSGCAM 292
++GF K +K+P+ + V ++ LKEC ++CL+N SC+AY ++ + + G GC
Sbjct: 342 NGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKNCSCVAYASAYHESQDGAKGCLT 401
Query: 293 WFGDLIDMRSFPDGGQDFYIRMSASEL----GMKGEPTTKIVVLVISAVALLAVVLISGY 348
W G+++D R++ GQDFY+R+ SEL G ++V+++IS +A++ ++LIS +
Sbjct: 402 WHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGASGKKRLVLILISLIAVVMLLLISFH 461
Query: 349 LIHKRRRNIAETD----------------------QENEDQNIDLELPLFELATISNATN 386
++RR +++ +E ED++ ELPLFEL+TI+ ATN
Sbjct: 462 CYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRELPLFELSTIATATN 521
Query: 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVK 446
NF+ NKLG GGFGPVYKG L +G EIAVKRLSK S QG++E KNEV L SKLQHRNLV+
Sbjct: 522 NFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVR 581
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSR 506
+LGCC+ EEK+L+YE++PNKSLDYFIF + LDW KR II G RG+LYLHQDSR
Sbjct: 582 ILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSR 641
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
LRIIHRDLKASNVLLD++M PKI+DFGLAR GG++ EG+TNRV
Sbjct: 642 LRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRV 685
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-129, Method: Compositional matrix adjust.
Identities = 258/578 (44%), Positives = 345/578 (59%), Gaps = 37/578 (6%)
Query: 4 VWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDL 63
VWS +L+ V+ + VV +LLD+GN VLRG + +S + WQSFD+P+DTLLP MKLG D
Sbjct: 116 VWSTNLTGAVRSS-VVAELLDNGNFVLRGSKINESDEFLWQSFDFPTDTLLPQMKLGRDH 174
Query: 64 KTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPTTR 123
K G R V SWKS+ DPS G F++ +E PE + + Y +GPW+GL FS
Sbjct: 175 KRGLNRFVTSWKSSFDPSSGSFMFKLETLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEM 234
Query: 124 P---NPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSK 180
+ I+NF+ N +E+ YTF + D SR+ +N L + F W Q W+++
Sbjct: 235 QQWDDIIYNFT--ENREEVAYTFRVTDHNSYSRLTINTVGRL-EGFMWEPTQQEWNMFWF 291
Query: 181 APRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSGGYMDWHEGCV----RSKALNYSR 236
P+D CD YG+CG Y C +S SP C C+KGF+ S DW G V R K
Sbjct: 292 MPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQPLSP--QDWASGDVTGRCRRKTQLTCG 349
Query: 237 QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGD 296
+D F + +K+P + V K + LKEC EKC + +C AY NSDIR GGSGC +W G+
Sbjct: 350 EDRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKTHCNCTAYANSDIRNGGSGCIIWIGE 409
Query: 297 LIDMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYLIHKRRRN 356
D+R++ GQD ++R++A+E G + KI+ L+I +L + I K+++
Sbjct: 410 FRDIRNYAADGQDLFVRLAAAEFGERRTIRGKIIGLIIGISLMLVLSFIIYCFWKKKQKR 469
Query: 357 IAETDQENEDQNIDLELPL-----------------------FELATISNATNNFSINNK 393
T ++ EL + E T+ AT NFS +N
Sbjct: 470 ARATAAPIGYRDRIQELIITNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNI 529
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453
LG GGFG VYKG L+DGQEIAVKRLS++S QG E KNEV L ++LQH NLV+LL CCI+
Sbjct: 530 LGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIY 589
Query: 454 GEEKLLIYEFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
+EK+LIYE++ N SLD +F+ T +S L+W RF II G ARGLLYLHQDSR +IIHR
Sbjct: 590 ADEKILIYEYLENGSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHR 649
Query: 513 DLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
DLKASNVLLD +M PKISDFG+AR D+TE NT +V
Sbjct: 650 DLKASNVLLDKNMTPKISDFGMARIFERDETEANTRKV 687
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-127, Method: Compositional matrix adjust.
Identities = 251/574 (43%), Positives = 341/574 (59%), Gaps = 36/574 (6%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGW 61
RV+WS ++S + V +LLDSGNLVL+ E S Y W+SF YP+D+ LP M +G
Sbjct: 109 RVLWSTNVSTQASANSTVAELLDSGNLVLK---EASSDAYLWESFKYPTDSWLPNMLVGT 165
Query: 62 DLKTGFERRVI-SWKSADDPSPGDFIWAVERQDNPEVVMWKGS---SKFYTTGPWNGLSF 117
+ + G I SWKS DPSPG + A+ PE+ + + S + +GPWNG F
Sbjct: 166 NARIGGGNVTITSWKSPSDPSPGSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMF 225
Query: 118 SAPTTRPNPIFNFSFVANED-ELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWD 176
+ +F + F+ N+D T S + + + M+ + +R WS + W
Sbjct: 226 NGLPDVYAGVFLYRFIVNDDTNGSVTMSYANDSTLRYFYMDYRGSVIRR-DWSETRRNWT 284
Query: 177 LYSKAPRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKS---GGYMDWHEGCVRSKALN 233
+ + P ECD Y CG + C K+P+C C++GF+ ++ +W GC R L
Sbjct: 285 VGLQVPATECDNYRRCGEFATCNPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQ 344
Query: 234 YSRQ------DGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGG 287
RQ DGF++ +KLPD F+R S++ EC CL+ SC+A + G G
Sbjct: 345 CERQNNNGSADGFLRLRRMKLPD--FARRSEASE-PECLRTCLQTCSCIAAAH----GLG 397
Query: 288 SGCAMWFGDLIDMRSFPDGGQDFYIRMSASELGMKGE-PTTKIVVLVISAVALLAVVLIS 346
GC +W G L+D + G D YIR++ SE+ K + P +L + A VL++
Sbjct: 398 YGCMIWNGSLVDSQELSASGLDLYIRLAHSEIKTKDKRPILIGTILAGGIFVVAACVLLA 457
Query: 347 GYLIHKRRRNIAETDQENEDQNIDL----------ELPLFELATISNATNNFSINNKLGE 396
++ K+R D E + ++ ELPLFE ++ ATNNFS+ NKLG+
Sbjct: 458 RRIVMKKRAKKKGRDAEQIFERVEALAGGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQ 517
Query: 397 GGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456
GGFGPVYKG L +GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI GEE
Sbjct: 518 GGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEE 577
Query: 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 516
++L+YEFMP KSLDY++FD +KLLDW RF+II G RGLLYLH+DSRLRIIHRDLKA
Sbjct: 578 RMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKA 637
Query: 517 SNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
SN+LLD ++ PKISDFGLAR G++ E NT RV
Sbjct: 638 SNILLDENLIPKISDFGLARIFPGNEDEANTRRV 671
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | ||||||
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.973 | 0.662 | 0.629 | 0.0 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.971 | 0.660 | 0.613 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.976 | 0.651 | 0.601 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.910 | 0.646 | 0.615 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.915 | 0.650 | 0.619 | 0.0 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.976 | 0.646 | 0.600 | 0.0 | |
| 356514895 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.978 | 0.665 | 0.567 | 0.0 | |
| 356545297 | 824 | PREDICTED: G-type lectin S-receptor-like | 0.978 | 0.662 | 0.556 | 1e-180 | |
| 356514913 | 829 | PREDICTED: G-type lectin S-receptor-like | 0.976 | 0.657 | 0.555 | 1e-179 | |
| 356514897 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.978 | 0.665 | 0.558 | 1e-179 |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1838), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/559 (62%), Positives = 423/559 (75%), Gaps = 16/559 (2%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
VVWS++ K Q LQ DSGNLVLR E++ +SG Y WQSFDYPSDTLLPGMKLGWD
Sbjct: 111 VVWSSNSKKAAQSAMGELQ--DSGNLVLRDEKDDNSGIYLWQSFDYPSDTLLPGMKLGWD 168
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPTT 122
L+ G +RR+ +WKS DDPS GDF W + Q NPE+VMWKGS K+Y +GPWNG+ FS
Sbjct: 169 LRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPELVMWKGSKKYYRSGPWNGIGFSGGLA 228
Query: 123 -RPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
R NP+F F FV + +E+ YT+++K+K++++RIVMNQTTY QR+TW+ QTW LY+
Sbjct: 229 LRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIVMNQTTYFRQRYTWNEINQTWVLYATV 288
Query: 182 PRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALNYSRQD 238
PRD CDTY LCGAYG CI+S+SPVCQCL+ F +S MDW +GCVR+K L+ + D
Sbjct: 289 PRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGD 348
Query: 239 GFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLI 298
GF+K+ LKLPDA S V+K++NLKECR KCL+N SCMAYT ++I+ SGCA+WFGDLI
Sbjct: 349 GFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQNCSCMAYTATNIKER-SGCAVWFGDLI 407
Query: 299 DMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAV--VLISGYLIHKRRR- 355
D+R F GQ+ YIR++ASE + + +KI + V SA+++ +L+ Y I KR+
Sbjct: 408 DIRQFSAAGQEIYIRLNASE--SRAKAASKIKMTVGSALSIFVACGILLVAYYIFKRKAK 465
Query: 356 ----NIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQ 411
N E DQ + DLELPLF+ TI+ ATN FS NNKLGEGGFGPVYKGTL DGQ
Sbjct: 466 HIGGNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQ 525
Query: 412 EIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDY 471
EIA K LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCI GEEK+L+YE+MPNKSLD
Sbjct: 526 EIAAKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDS 585
Query: 472 FIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531
FIFDQT KLLDWSKRF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD DMNPKISD
Sbjct: 586 FIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISD 645
Query: 532 FGLARTCGGDKTEGNTNRV 550
FGLAR GGD+TEGNT RV
Sbjct: 646 FGLARMFGGDQTEGNTTRV 664
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1811), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/566 (61%), Positives = 421/566 (74%), Gaps = 24/566 (4%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
VVWS++ K Q + +LLDSGNLVLR E++ +SG Y WQSFDYPSDTLLPGMKLGWD
Sbjct: 105 VVWSSNSKKAAQS--AMGELLDSGNLVLRDEKDANSGIYLWQSFDYPSDTLLPGMKLGWD 162
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PT 121
L+ G +RR+ +WKS DDPS GDF W + Q NPE+VMWKGS ++Y +GPWNG+ FS P
Sbjct: 163 LRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPELVMWKGSKEYYRSGPWNGIGFSGGPE 222
Query: 122 TRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
R NP+F F FV + +E+ YT+++K+K++++RIVMNQ+TY QR+TW+ QTW LY+
Sbjct: 223 LRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIVMNQSTYFRQRYTWNEINQTWVLYANV 282
Query: 182 PRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALNYSRQD 238
PRD CDTY LCGAYG CIIS+SPVC+CL+ F KS MDW +GCVR+K L+ + D
Sbjct: 283 PRDYCDTYSLCGAYGNCIISQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGD 342
Query: 239 GFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLI 298
GF+K+ LKLPDA S V+K++NLKECR CLEN SCMAYT ++I+ SGCA+WFGDLI
Sbjct: 343 GFVKYVGLKLPDATNSWVNKTMNLKECRSICLENCSCMAYTATNIKER-SGCAIWFGDLI 401
Query: 299 DMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAV--VLISGYLIHKRR-- 354
D+ P GQ+ YIRM+ASE E + +++ V A+++ +L+ Y I KR+
Sbjct: 402 DITQLPAAGQEIYIRMNASE---SSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAK 458
Query: 355 ----------RNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYK 404
N E DQ + DLELPLF+ TI+ ATN FS NNKLGEGGFGPVYK
Sbjct: 459 LIGKVTLTAFSNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYK 518
Query: 405 GTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464
GTL DGQEIA K S+ S QG+ E KNEVIL +KLQHRNLVKLLGCCI GEEK+L+YE+M
Sbjct: 519 GTLEDGQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYM 578
Query: 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD 524
PNKSLD FIFDQT +LLDWSKRF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD D
Sbjct: 579 PNKSLDSFIFDQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKD 638
Query: 525 MNPKISDFGLARTCGGDKTEGNTNRV 550
MNPKISDFGLAR GGD+TEGNT RV
Sbjct: 639 MNPKISDFGLARMFGGDQTEGNTTRV 664
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1811), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/579 (60%), Positives = 426/579 (73%), Gaps = 34/579 (5%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
VVWS++ K Q + +LLDSGNLVLR E++ +SG+Y WQSFDYPSDT+LPGMKLGWD
Sbjct: 105 VVWSSNSKKAAQS--AMGELLDSGNLVLRDEKDVNSGSYLWQSFDYPSDTMLPGMKLGWD 162
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPTT 122
L+ G +RR+ +WKS DDPS GDF W + Q NPE+V+WKGS K++ +GPWNG+ FS
Sbjct: 163 LRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPELVIWKGSEKYFRSGPWNGIGFSGEAA 222
Query: 123 -RPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTT-YLGQRFTWSNNTQTWDLYSK 180
R NP+F F FV N +E+ YT+++K+K++++R+VMNQTT +L QR+TW+ +QTW+LY+
Sbjct: 223 LRINPVFYFDFVDNGEEVYYTYNLKNKSLITRLVMNQTTGFLRQRYTWNEISQTWELYAY 282
Query: 181 APRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALNYSRQ 237
PRD CD Y LCGAYG CIIS+SPVC+CL+ F KS M+W +GCVR+K L+ +
Sbjct: 283 VPRDYCDNYNLCGAYGNCIISQSPVCECLEKFTPKSPESWNSMNWSQGCVRNKPLDCQKG 342
Query: 238 DGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDL 297
DGF+K+ LKLPDA S V+K++NLKECR KCL+N SCMAYT +DI+ SGCA+WFGDL
Sbjct: 343 DGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQNCSCMAYTATDIKER-SGCAIWFGDL 401
Query: 298 IDMRSFPDGGQDFYIRMSASELG-----MKGEPTTKIVVLVISAVALLAVVLIS------ 346
ID+R FPDGGQ+ YIRM+ASE +K E + + V + L+A +
Sbjct: 402 IDIRQFPDGGQEIYIRMNASESSECLSLIKMEMGIALSIFVACGMLLVAYYIFKRTEKLK 461
Query: 347 ---------------GYLIHKRRRNIAETDQENEDQNIDLELPLFELATISNATNNFSIN 391
L K N E DQ + D+ELPLF+ TI+ ATN FS+N
Sbjct: 462 AHYSFLLVYHVCDSHSLLSEKTGGNREENDQIDSGPMEDMELPLFQFTTIAKATNGFSLN 521
Query: 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCC 451
NK+GEGGFGPVYKGTL DGQEIAVK LS+ S QGL E KNEVIL +KLQHRNLVKLLGCC
Sbjct: 522 NKIGEGGFGPVYKGTLEDGQEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCC 581
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 511
I GEEK+L+YE+MPN+SLD FIFDQT KLLDWSKRF IICG ARGLLYLHQDSRLRI+H
Sbjct: 582 IQGEEKILVYEYMPNRSLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVH 641
Query: 512 RDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
RDLKASNVLLD DMNPKISDFGLAR GGD+TEGNT RV
Sbjct: 642 RDLKASNVLLDKDMNPKISDFGLARMVGGDQTEGNTTRV 680
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/556 (61%), Positives = 415/556 (74%), Gaps = 48/556 (8%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
VVWS++ S V ++P+VLQLLDSGNLVLR E+ DSG Y WQSFD+PSDTL+PGMKLGWD
Sbjct: 116 VVWSSN-STIVAKSPIVLQLLDSGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWD 173
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFS-APT 121
L+TG ERR+ SW+S+DDPSPGD W ++ Q+NPE ++W+GS +++ +GPW G++F+ AP
Sbjct: 174 LRTGLERRLSSWRSSDDPSPGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPE 233
Query: 122 TRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
NP+F +FV++EDE+ ++++K+ + SRIV+NQTT + +TW+ TQTW LY+
Sbjct: 234 LVQNPVFKLNFVSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASV 293
Query: 182 PRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALNYSRQD 238
PRD CD Y CGA G CII+ P+C+CLK FK KS MDW +GCVR+K LN + D
Sbjct: 294 PRDSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGD 353
Query: 239 GFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLI 298
GF+K+ LK PDA S ++KS+NL ECR KCL+N SCMAY+NSD+RGGGSGC +W+GDLI
Sbjct: 354 GFVKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLI 413
Query: 299 DMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYLIHKRRRNIA 358
D+R FP GGQ+ YIRM+ SE A
Sbjct: 414 DIRQFPAGGQELYIRMNPSE--------------------------------------SA 435
Query: 359 ETDQENED----QNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIA 414
E DQ+N+ +N DLELP FE A I NATNNFSI NKLG+GGFGPVYKGTL DGQEIA
Sbjct: 436 EMDQQNDQITDGENEDLELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKGTLEDGQEIA 495
Query: 415 VKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIF 474
VKRLS S QG KE KNEVIL +KLQHRNLVKLLGC I EE+LL+YE+MPNKSLD F+F
Sbjct: 496 VKRLSMSSRQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLF 555
Query: 475 DQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534
DQT SKLLDWSKRF+IICG ARGLLYLHQDSRLRIIHRDLK+SNVLLD DMNPKISDFGL
Sbjct: 556 DQTKSKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGL 615
Query: 535 ARTCGGDKTEGNTNRV 550
ART GGD+TEGNT+RV
Sbjct: 616 ARTFGGDQTEGNTSRV 631
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 693 bits (1789), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/552 (61%), Positives = 414/552 (75%), Gaps = 41/552 (7%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
VVWS++ S V ++P+VLQLLDSGNLVLR E+ DSG Y WQSFD+PSDTL+PGMKLGWD
Sbjct: 116 VVWSSN-STIVAKSPIVLQLLDSGNLVLRDEKS-DSGRYLWQSFDHPSDTLIPGMKLGWD 173
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFS-APT 121
L+TG ERR+ SW+S+DDPSPGD W ++ Q+NPE ++W+GS +++ +GPW G++F+ AP
Sbjct: 174 LRTGLERRLSSWRSSDDPSPGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPE 233
Query: 122 TRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
NP+F +FV++EDE+ ++++K+ + SRIV+NQTT + +TW+ TQTW LY+
Sbjct: 234 LVQNPVFKLNFVSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASV 293
Query: 182 PRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALNYSRQD 238
PRD CD Y CGA G CII+ P+C+CLK FK KS MDW +GCVR+K LN + D
Sbjct: 294 PRDSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGD 353
Query: 239 GFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLI 298
GF+K+ LK PDA S ++KS+NL ECR KCL+N SCMAY+NSD+RGGGSGC +W+G LI
Sbjct: 354 GFVKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLI 413
Query: 299 DMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYLIHKRRRNIA 358
D+R FP GGQ+ YIRM+ SE M ++N
Sbjct: 414 DIRQFPAGGQELYIRMNPSESEMD-------------------------------QQNDQ 442
Query: 359 ETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 418
TD ENE DLELP FE A I NATNNFSI NKLG+GGFGPVYKGTL DGQEIAVKRL
Sbjct: 443 ITDGENE----DLELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRL 498
Query: 419 SKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTN 478
S S QG KE KNEVIL +KLQHRNLVKLLGC I EE+LL+YE+MPNKSLD F+FDQT
Sbjct: 499 SMSSGQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTK 558
Query: 479 SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538
SKLLDWSKRF+IICG ARGLLYLHQDSRLRIIHRDLK+SNVLLD DMNPKISDFGLART
Sbjct: 559 SKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTF 618
Query: 539 GGDKTEGNTNRV 550
GGD+TEGNT+RV
Sbjct: 619 GGDQTEGNTSRV 630
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1761), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/566 (60%), Positives = 412/566 (72%), Gaps = 21/566 (3%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
VVWS++ +K+ +LQLLDSGNLVLR + +G SG WQSFDYP DT+LPGMK+GWD
Sbjct: 107 VVWSSNSTKKASSP--ILQLLDSGNLVLRDKNDGRSG-LLWQSFDYPCDTMLPGMKIGWD 163
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPT- 121
L+ GF+ R+ SWKS+DDPSPGDF +ER+ NPEVV WKGS K Y +GPWNG+ FS T
Sbjct: 164 LRAGFDWRLSSWKSSDDPSPGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTE 223
Query: 122 TRPNPIFNFSFVANEDELCYTFSIKDKA-VVSRIVMNQTTYLGQRFTWSNNTQTWDLYSK 180
+PNP+F F+FV+N E+ Y F++K ++ V++R+V+N TT Q +TW+ TQTW L
Sbjct: 224 VKPNPVFYFTFVSNNIEVYYIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVS 283
Query: 181 APRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALNYSRQ 237
PRD CD YGLCGA CI + PVCQCL+ FK KS MDW +GCVR+K L+ +
Sbjct: 284 VPRDHCDNYGLCGANANCIFNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKG 343
Query: 238 DGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDL 297
DGFIKF LKLPDA S V+K +NLKEC+ KCL N SCMAY+N DIRGGGSGCA WFGDL
Sbjct: 344 DGFIKFDGLKLPDATHSWVNKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDL 403
Query: 298 IDMRSFPDGGQDFYIRMSASELG-MKGEPTTKIVVLVISAVALLAVVLISGYLIHKRRRN 356
+D+R P GGQ+ YIRM ASE+G + + KI + + V L+ L Y + K +
Sbjct: 404 MDIRLVPGGGQELYIRMHASEIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAK 463
Query: 357 IAET------------DQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYK 404
AE D N Q D+ELPLF + I++ATNNFS+NNKLGEGGFGPVY+
Sbjct: 464 SAENTSSERTENDWKNDTNNGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYR 523
Query: 405 GTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464
G L DG EIAVKRLS+ S QG E KNEVIL +KLQHRNLVKLLGCC EEK+LIYE+M
Sbjct: 524 GKLEDGLEIAVKRLSRCSGQGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYM 583
Query: 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD 524
PN+SLD+FIFD+T +LLDWS+RF+II G ARGLLYLHQDSRLRIIHRDLKASNVLLD
Sbjct: 584 PNRSLDFFIFDETKGRLLDWSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDH 643
Query: 525 MNPKISDFGLARTCGGDKTEGNTNRV 550
MNPKISDFGLAR D+TEG+T+RV
Sbjct: 644 MNPKISDFGLARMFVADQTEGDTSRV 669
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514895|ref|XP_003526137.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/559 (56%), Positives = 403/559 (72%), Gaps = 13/559 (2%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
V+WS + + + + VV QLLDSGNLVLR E++ + Y WQSFDYPSDT LPGMK GWD
Sbjct: 109 VIWSTNTT--TKASLVVAQLLDSGNLVLRDEKDNNPENYSWQSFDYPSDTFLPGMKAGWD 166
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFS-APT 121
LK G R + +WK+ DDPS GDF R + PE VMWKG+S++Y +GPW+G FS +P+
Sbjct: 167 LKKGLNRVLTAWKNWDDPSSGDFTANSSRTNFPEEVMWKGTSEYYRSGPWDGRKFSGSPS 226
Query: 122 TRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
N I N+S V+N+DE T+S+ DK+++SR+V+NQT Y+ QR TW+ ++QTW + S+
Sbjct: 227 VPTNSIVNYSVVSNKDEFYATYSMIDKSLISRVVVNQTLYVRQRLTWNEDSQTWRVSSEL 286
Query: 182 PRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALN--YSR 236
P D CD Y CGA+G+C+ ++PVC CL GFK KS M+W++GCV ++ +
Sbjct: 287 PGDLCDNYSTCGAFGICVAGQAPVCNCLDGFKPKSTRNWTQMNWNQGCVHNQTWSCMEKN 346
Query: 237 QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGD 296
+DGF KF+ LK PD S V+ S+ L EC+ KC EN SC AY N D+RG GSGCA+WFGD
Sbjct: 347 KDGFKKFSNLKAPDTERSWVNASMTLDECKNKCRENCSCTAYANFDMRGEGSGCAIWFGD 406
Query: 297 LIDMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVALLAVVLISGYLIHKRRRN 356
L+D+R P+ GQD YIR++ SE K + K+VV+ +++A +LI ++ +N
Sbjct: 407 LLDIRLIPNAGQDLYIRLAVSETDEKDDSKKKVVVIASIVSSVVATLLIFIFIYWSNAKN 466
Query: 357 IAETD-----QENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQ 411
I E + NE Q D ELPLF+L +I+ AT++FS +NKLGEGGFGPVYKGTL DG
Sbjct: 467 IKEIILGIEVKNNESQQEDFELPLFDLVSIAQATDHFSDHNKLGEGGFGPVYKGTLPDGL 526
Query: 412 EIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDY 471
E+AVKRLS+ S QGLKE KNEV+L +KLQHRNLVK+LGCCI EKLLIYE+M NKSLD
Sbjct: 527 EVAVKRLSQTSGQGLKEFKNEVMLCAKLQHRNLVKVLGCCIQENEKLLIYEYMANKSLDV 586
Query: 472 FIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531
F+FD SKLLDW KRF+II ARGLLYLHQDSRLRIIHRDLKASNVLLD++MNPKISD
Sbjct: 587 FLFDSDRSKLLDWPKRFYIINRIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD 646
Query: 532 FGLARTCGGDKTEGNTNRV 550
FGLAR CGGD+ EG T RV
Sbjct: 647 FGLARMCGGDQIEGKTRRV 665
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545297|ref|XP_003541080.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1647), Expect = e-180, Method: Compositional matrix adjust.
Identities = 314/564 (55%), Positives = 404/564 (71%), Gaps = 18/564 (3%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
V+WSA+ + + VV QLLDSGNLVLR E++ + Y WQSFD P+DT LPGMKLGWD
Sbjct: 108 VIWSANPT--TKGVVVVAQLLDSGNLVLRDEKDTNPENYLWQSFDNPTDTFLPGMKLGWD 165
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PT 121
LK G + +WK+ DDPSPGDF R + PE VMWKG++K++ +GPW+G FS P+
Sbjct: 166 LKKGLNTVLTAWKNWDDPSPGDFTDITLRTNYPEEVMWKGTTKYWRSGPWDGTKFSGNPS 225
Query: 122 TRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
N I N++ V+N+DE T+S+ DK+++SRIVMNQ+ Y+ QR TW+ ++QTW + S+
Sbjct: 226 VPSNAIVNYTIVSNKDEFYATYSMTDKSIISRIVMNQSLYVRQRLTWNTDSQTWRVSSEL 285
Query: 182 PRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSK--ALNYSR 236
P D CD Y CGA+G+C+ ++PVC+CL GFK KS M+W++GCV ++ +
Sbjct: 286 PGDLCDHYNTCGAFGICVAGQAPVCKCLDGFKPKSPRNWNQMNWNQGCVHNQTWSCREKN 345
Query: 237 QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGD 296
+DGF KF+ +K PD S V+ S+ L ECR KC EN SCMAY NS+IRG GSGCA+W GD
Sbjct: 346 KDGFTKFSNVKAPDTERSWVNASMTLGECRVKCWENCSCMAYANSNIRGEGSGCAIWIGD 405
Query: 297 LIDMRSFPDGGQDFYIRMSASELGM-----KGEPTTKIVVLVISAVALLAVVLISGYLIH 351
L+D+R P+ GQD YIR++ SE K K+VV+ + +++A++LI ++
Sbjct: 406 LLDIRLMPNAGQDLYIRLAVSETAQQSHDQKDNSNKKVVVIASTISSVIAMILIFIFIYW 465
Query: 352 KRRRNIAET-----DQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT 406
R E + NE Q D ELPLF+L I+ AT++FS + KLGEGGFGPVYKGT
Sbjct: 466 SYRNKNKEIITGIEGKSNESQQEDFELPLFDLVLIAQATDHFSDHKKLGEGGFGPVYKGT 525
Query: 407 LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466
L DGQE+AVKRLS+ S QGLKE KNEV+L ++LQHRNLVK+LGCC +EKLLIYE+M N
Sbjct: 526 LPDGQEVAVKRLSQTSRQGLKEFKNEVMLCAELQHRNLVKVLGCCFQDDEKLLIYEYMSN 585
Query: 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526
KSLD F+FD + SKLLDW KRF II G ARGLLYLHQDSRLRIIHRDLKASNVLLD++MN
Sbjct: 586 KSLDVFLFDSSRSKLLDWPKRFCIINGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 645
Query: 527 PKISDFGLARTCGGDKTEGNTNRV 550
PKISDFGLAR CGGD+ EG T+R+
Sbjct: 646 PKISDFGLARMCGGDQIEGETSRI 669
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514913|ref|XP_003526146.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1639), Expect = e-179, Method: Compositional matrix adjust.
Identities = 319/574 (55%), Positives = 405/574 (70%), Gaps = 29/574 (5%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGT-----------YFWQSFDYPS 50
+V WS + + + + +LQLL++GNLVLR + E + + WQSFDYPS
Sbjct: 105 KVQWSTNTTTKASRP--ILQLLNTGNLVLRNDNEDNKNNNKSSNNNNEDRFLWQSFDYPS 162
Query: 51 DTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTG 110
DTLLPGMKLGW KTG RRVI+WK+ DDPSPG+F W + NPE+V+WKGS K++ +G
Sbjct: 163 DTLLPGMKLGWYRKTGLNRRVIAWKNWDDPSPGNFSWGITFDSNPEMVLWKGSFKYHRSG 222
Query: 111 PWNGLSFSAPTTRPN-----PIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQR 165
PWNG+ FS N P+F + + N+DE+ Y++S+ +K+V+S +VMNQT QR
Sbjct: 223 PWNGIRFSGAFGGSNRLSTHPLFVYKLINNDDEVYYSYSLTNKSVISIVVMNQTLLRRQR 282
Query: 166 FTWSNNTQTWDLYSKAPRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSGGYMDWHEG 225
W TW L+ APRD CDTY CG+Y C++ SPVCQCL+GFK KS M+ +G
Sbjct: 283 NIWIPENGTWRLFQTAPRDICDTYNPCGSYANCMVDSSPVCQCLEGFKPKSLDTME--QG 340
Query: 226 CVRSK--ALNYSRQDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDI 283
CVRS+ + +DGF KF LK PD S ++KS+ L+EC+ KC EN SC AY N DI
Sbjct: 341 CVRSEPWSCKVEGRDGFRKFVGLKFPDTTHSWINKSMTLEECKVKCWENCSCTAYANLDI 400
Query: 284 RGGGSGCAMWFGDLIDMRSFPDGGQDFYIRMSASELGMKGEPTTKIVVLVISAVA-LLAV 342
RG GSGC++WFGDLID++ GQ YIRM+ S+ K K ++L+ + V ++ V
Sbjct: 401 RGAGSGCSIWFGDLIDLKVVSQSGQYLYIRMADSQTDAKDAHKKKELLLIGTIVPPIVLV 460
Query: 343 VLISGYLIHKRRRNIAETD------QENEDQNIDLELPLFELATISNATNNFSINNKLGE 396
+L++ + +KR+R E + E Q +ELPLF+LAT+ NATNNFS +NKLG+
Sbjct: 461 ILLAIFYSYKRKRKYEEENVSVVKKDEAGGQEHSMELPLFDLATLVNATNNFSTDNKLGQ 520
Query: 397 GGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456
GGFGPVYKG L GQEIAVKRLS+ S QGL E KNEVIL +KLQHRNLVK+LGCCI EE
Sbjct: 521 GGFGPVYKGVLAGGQEIAVKRLSRSSGQGLTEFKNEVILCAKLQHRNLVKVLGCCIEEEE 580
Query: 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 516
K+L+YE+MPNKSLD F+FD T SK+LDWSKRFHI+C TARGLLYLHQDSRLRIIHRDLKA
Sbjct: 581 KMLLYEYMPNKSLDSFLFDSTKSKILDWSKRFHILCATARGLLYLHQDSRLRIIHRDLKA 640
Query: 517 SNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
SN+LLD+++NPKISDFGLAR CGGD+ EGNTNRV
Sbjct: 641 SNILLDNNLNPKISDFGLARMCGGDQIEGNTNRV 674
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514897|ref|XP_003526138.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1637), Expect = e-179, Method: Compositional matrix adjust.
Identities = 313/560 (55%), Positives = 405/560 (72%), Gaps = 14/560 (2%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
V+WS + + + + VV QLLDSGNLVLR E++ D Y WQSFDYPSDT LPGMK GWD
Sbjct: 109 VIWSTNTT--TKASVVVAQLLDSGNLVLRDEKDTDPENYLWQSFDYPSDTFLPGMKAGWD 166
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PT 121
LK G R + +WK+ DDPS GDF + PE VM KG++K++ +GPW+G FS P+
Sbjct: 167 LKKGLNRVLTAWKNWDDPSSGDFRDIALHTNYPEEVMLKGTTKYWRSGPWDGTKFSGNPS 226
Query: 122 TRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
N I N++ V+N DE +S+ DK+V+SRI+MNQT Y+ QR TW+ ++Q W + S+
Sbjct: 227 VPSNAIVNYTVVSNNDEFYAMYSMTDKSVISRIIMNQTLYVRQRLTWNTDSQMWRVSSEL 286
Query: 182 PRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSK--ALNYSR 236
P D CD Y CGA+G+C +S++PVC+CL GFK KS M+W++GCV ++ +
Sbjct: 287 PGDLCDRYNTCGAFGICDLSEAPVCKCLDGFKPKSPRNWTQMNWNQGCVHNQTWSCREKN 346
Query: 237 QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGD 296
+DGF KF+ +K PD S V+ S+ L+EC+ KC EN SCMAY NSDIRG GSGCA+WFGD
Sbjct: 347 KDGFKKFSNVKAPDTERSWVNASMTLEECKHKCTENCSCMAYANSDIRGEGSGCAIWFGD 406
Query: 297 LIDMRSFPDGGQDFYIRMSASELGM-----KGEPTTKIVVLVISAVALLAVVLISGYLIH 351
L+D+R + GQD YIR++ SE K K+VV+ S +++A++LI ++
Sbjct: 407 LLDIRLMSNAGQDLYIRLAMSETAHQDQDEKDSSKKKVVVIASSISSVIAMLLIFIFIYW 466
Query: 352 KRRRNIAETD-QENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDG 410
+ E + +N+ Q D ELPLF+LA++++AT+NFS + KLGEGGFGPVYKGTL +G
Sbjct: 467 RYTNKNNEIEGTKNQSQQEDFELPLFDLASVAHATSNFSNDKKLGEGGFGPVYKGTLPNG 526
Query: 411 QEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 470
QE+AVKRLS+ S QGLKE KNEV+L ++LQHRNLVK+LGCCI +EKLLIYE+M NKSLD
Sbjct: 527 QEVAVKRLSQTSRQGLKEFKNEVMLCAELQHRNLVKVLGCCIQDDEKLLIYEYMANKSLD 586
Query: 471 YFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530
F+FD + SKLLDW RF II G ARGLLYLHQDSRLRIIHRDLKASNVLLD++MNPKIS
Sbjct: 587 VFLFDSSQSKLLDWPMRFGIINGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 646
Query: 531 DFGLARTCGGDKTEGNTNRV 550
DFGLAR CGGD+ EG T+RV
Sbjct: 647 DFGLARMCGGDQIEGETSRV 666
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.562 | 0.401 | 0.44 | 3.3e-147 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.580 | 0.381 | 0.443 | 5.5e-143 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.973 | 0.666 | 0.494 | 5.2e-136 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.560 | 0.371 | 0.413 | 2e-134 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.568 | 0.374 | 0.403 | 6e-133 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.327 | 0.215 | 0.690 | 1.3e-117 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.327 | 0.220 | 0.641 | 3.5e-109 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.949 | 0.659 | 0.428 | 8.1e-108 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.951 | 0.660 | 0.423 | 2.1e-107 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.919 | 0.635 | 0.431 | 1.2e-106 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 3.3e-147, Sum P(2) = 3.3e-147
Identities = 143/325 (44%), Positives = 213/325 (65%)
Query: 3 VVWSASLSKEVQQTPV---VLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKL 59
++WS+S S Q+ + ++Q+LD+GNLV+R GD Y WQS DYP D LPGMK
Sbjct: 107 IIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNS--GDDQDYIWQSLDYPGDMFLPGMKY 164
Query: 60 GWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA 119
G + TG R + SW++ DDPS G++ ++ P+ + K S + TGPWNGL F+
Sbjct: 165 GLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTG 224
Query: 120 -PTTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLY 178
P +PNPI+ + +V E+E+ YT+ +++ +V++R+ +N L QR+TW +N Q+W+ Y
Sbjct: 225 MPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGAL-QRYTWVDNLQSWNFY 283
Query: 179 SKAPRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG-GYM--DWHEGCVRSKALNYS 235
A D CD Y LCG+YG C I++SP C+CLKGF K+ ++ DW EGCVR L+
Sbjct: 284 LSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCG 343
Query: 236 R-QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWF 294
+ +DGF+K ++LKLPD S K+++L EC++ CL N +C AY+ DIR GG GC +WF
Sbjct: 344 KGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWF 403
Query: 295 GDLIDMRSFPDGGQDFYIRMSASEL 319
GDLID+R + + GQD Y+R+++SE+
Sbjct: 404 GDLIDIREYNENGQDLYVRLASSEI 428
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 5.5e-143, Sum P(2) = 5.5e-143
Identities = 146/329 (44%), Positives = 209/329 (63%)
Query: 4 VWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDL 63
VWS +L+ ++P+V +LLD+GN VLR + WQSFD+P+DTLLP MKLGWD
Sbjct: 114 VWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDA 173
Query: 64 KTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTT 122
KTGF R + SWKS DDPS GDF + +E + PE+ +W S+ Y +GPWNG+ FS P
Sbjct: 174 KTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEM 233
Query: 123 RPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKAP 182
+P F+F +++E+ Y+F I V SR+ ++ + L QRFTW Q W+ + AP
Sbjct: 234 QPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLL-QRFTWIETAQNWNQFWYAP 292
Query: 183 RDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSG---GYMDWHEGCVRSKALNYSRQDG 239
+D+CD Y CG YG C + SPVC C+KGFK ++ G D +GCVR L+ DG
Sbjct: 293 KDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDG 352
Query: 240 FIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLID 299
F++ ++KLPD + V + + +KEC +KCL + +C A+ N+DIRG GSGC W G+L D
Sbjct: 353 FVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFD 412
Query: 300 MRSFPDGGQDFYIRMSASELGMKGEPTTK 328
+R++ GGQD Y+R++A++L K + K
Sbjct: 413 IRNYAKGGQDLYVRLAATDLEDKRNRSAK 441
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1332 (473.9 bits), Expect = 5.2e-136, P = 5.2e-136
Identities = 282/570 (49%), Positives = 370/570 (64%)
Query: 2 RVVWSASLSK-EVQQTP--VVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMK 58
+ +WS+S S + +T +L++ SGNL+ +G+ WQSFDYP +T+L GMK
Sbjct: 108 KALWSSSSSSTKASKTANNPLLKISCSGNLI---SSDGEEAV-LWQSFDYPMNTILAGMK 163
Query: 59 LGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWK-GSSKF-YTTGPWNGLS 116
LG + KT E + SWK+ DPSPGDF +++ + P++++ K G S + Y G WNGLS
Sbjct: 164 LGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLS 223
Query: 117 FS-APTT-RPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQT 174
F+ AP R N +F++ F ++ E+ Y+++ + + +VSR+V+N T L RF S Q
Sbjct: 224 FTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHR-IVSRLVLNNTGKL-HRFIQSKQNQ- 280
Query: 175 WDLYSKAPRDECDTYGLCGAYGVC-IISKS-PVCQCLKGFKTKSGGYMDWH-----EGCV 227
W L + AP DECD Y +CGAY VC I SK+ P C CL+GFK KSG W+ GCV
Sbjct: 281 WILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSG--RKWNISRGAYGCV 338
Query: 228 RSKALNYSRQDGFIKFTELKLPDANFS--RVSKSVNLKECREKCLENSSCMAYTNSDIRG 285
N ++D F+KF LKLPD ++S + L++C+ KC N SC AY N+DIR
Sbjct: 339 HEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIRE 398
Query: 286 GGSGCAMWFGDLIDMRSFPDGGQDFYIRMSASELGMKGEPTTKXXXXXXXXXXXXXXXXX 345
GG GC +WFGDL+DMR + GQD YIRM +++ KG
Sbjct: 399 GGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVF 458
Query: 346 XGYLIHKRRRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKG 405
+ +R E ++ ++ DL+LP+F+ TIS AT++FS N LG GGFGPVYKG
Sbjct: 459 ACFRKKIMKRYRGENFRKGIEEE-DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKG 517
Query: 406 TLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465
L DGQEIAVKRLS S QG++E KNEV L +KLQHRNLV+LLGCCI GEE +LIYE+MP
Sbjct: 518 KLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMP 577
Query: 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM 525
NKSLD+FIFD+ S LDW KR +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD+DM
Sbjct: 578 NKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDM 637
Query: 526 NPKISDFGLARTCGGDKTEGNTNRV-WLYG 554
NPKISDFGLA++ GGD++E +TNRV YG
Sbjct: 638 NPKISDFGLAKSFGGDQSESSTNRVVGTYG 667
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 2.0e-134, Sum P(2) = 2.0e-134
Identities = 133/322 (41%), Positives = 197/322 (61%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGW 61
R VWS +++ ++PV +LLD+GN +LR + WQSFD+P+DTLL MKLGW
Sbjct: 110 RPVWSTNITGGDVRSPVAAELLDNGNFLLRDS----NNRLLWQSFDFPTDTLLAEMKLGW 165
Query: 62 DLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-P 120
D KTGF R + SWK+ DDPS G+F +E + PE + S Y +GPWNG+ FS+ P
Sbjct: 166 DQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVP 225
Query: 121 TTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSK 180
T ++F A+++E+ Y++ I + SR+ +N L QR TW TQ+W
Sbjct: 226 GTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLL-QRLTWFETTQSWKQLWY 284
Query: 181 APRDECDTYGLCGAYGVCIISKSPVCQCLKGFKT---KSGGYMDWHEGCVRSKALNYSRQ 237
+P+D CD Y +CG +G C + P C C+KGFK ++ D GC+R L+ +
Sbjct: 285 SPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGR 344
Query: 238 DGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDL 297
DGF + +KLPD + V + + LK C+E+CLE+ +C A+ N+DIR GGSGC +W ++
Sbjct: 345 DGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREI 404
Query: 298 IDMRSFPDGGQDFYIRMSASEL 319
+DMR++ GGQD Y+R++A+EL
Sbjct: 405 LDMRNYAKGGQDLYVRLAAAEL 426
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 699 (251.1 bits), Expect = 6.0e-133, Sum P(2) = 6.0e-133
Identities = 130/322 (40%), Positives = 190/322 (59%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGW 61
R VWS +++ ++PV +LLD GN VLR + + WQSFD+P+DTLL MK+GW
Sbjct: 110 RPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGW 169
Query: 62 DLKTG-FERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA- 119
D K+G F R + SWK+ DDPS GDF + PE ++ S Y +GPW G FS+
Sbjct: 170 DNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSV 229
Query: 120 PTTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYS 179
P +P + SF N ++ Y++ + + S + ++ T L QR TW Q+W
Sbjct: 230 PGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLL-QRLTWMEAAQSWKQLW 288
Query: 180 KAPRDECDTYGLCGAYGVCIISKSPVCQCLKGFK--TKSGGYMDWHEGCVRSKALNYSRQ 237
+P+D CD Y CG YG C + SP+C C+KGF+ + D GCVR L+ +
Sbjct: 289 YSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGR 348
Query: 238 DGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDL 297
DGF++ +++LPD + V K + LKEC E+CL+ +C A+ N+DIR GGSGC +W G L
Sbjct: 349 DGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGL 408
Query: 298 IDMRSFPDGGQDFYIRMSASEL 319
D+R++ GGQD Y+R++A +L
Sbjct: 409 FDIRNYAKGGQDLYVRVAAGDL 430
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 1.3e-117, Sum P(3) = 1.3e-117
Identities = 127/184 (69%), Positives = 148/184 (80%)
Query: 372 ELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKN 431
ELP+F L I+ ATN+F N+LG GGFGPVYKG L DG+EIAVKRLS S QG+ E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 432 EVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHII 491
E+IL +KLQHRNLV+LLGCC GEEK+L+YE+MPNKSLD+F+FD+T L+DW RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV- 550
G ARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFG+AR GG++ E NT RV
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 551 WLYG 554
YG
Sbjct: 693 GTYG 696
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 3.5e-109, Sum P(3) = 3.5e-109
Identities = 118/184 (64%), Positives = 145/184 (78%)
Query: 372 ELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKN 431
ELPLFE ++ ATNNFSI NKLG+GGFG VYKG L +G +IAVKRLS+ S QG++E N
Sbjct: 496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555
Query: 432 EVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHII 491
EV++ SKLQHRNLV+LLG CI GEE++L+YEFMP LD ++FD +LLDW RF+II
Sbjct: 556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNII 615
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV- 550
G RGL+YLH+DSRL+IIHRDLKASN+LLD ++NPKISDFGLAR G++ E +T RV
Sbjct: 616 DGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVV 675
Query: 551 WLYG 554
YG
Sbjct: 676 GTYG 679
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 8.1e-108, Sum P(2) = 8.1e-108
Identities = 241/563 (42%), Positives = 327/563 (58%)
Query: 4 VWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDL 63
VWS+ ++ + +L DSGNL + + S WQSFD+ DTLL L ++L
Sbjct: 108 VWSSGVT--FSSSGCRAELSDSGNLKVI---DNVSERALWQSFDHLGDTLLHTSSLTYNL 162
Query: 64 KTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTT 122
T +R + SWKS DPSPGDF+ + Q + + +GS+ ++ +GPW F+ P
Sbjct: 163 ATAEKRVLTSWKSYTDPSPGDFLGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFM 222
Query: 123 RPNPIFNFSFVANEDELCY-TFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKA 181
+ F+ + + Y T+ +D + SRI + T G + +N W+LY +A
Sbjct: 223 DESYTGPFTLHQDVNGSGYLTYFQRDYKL-SRITL---TSEGSIKMFRDNGMGWELYYEA 278
Query: 182 PRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKSGGYM---DWHEGCVRSKAL----NY 234
P+ CD YG CG +G+C++S SP+C+C +GF KS +W GCVR L N
Sbjct: 279 PKKLCDFYGACGPFGLCVMSPSPMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNS 338
Query: 235 SRQDG--FIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAM 292
+ +D F + +K PD F + SVN +EC ++C+ N SC+A+ I+G GC +
Sbjct: 339 TGEDADDFHQIANIKPPD--FYEFASSVNAEECHQRCVHNCSCLAFAY--IKG--IGCLV 392
Query: 293 WFGDLIDMRSFPDGGQDFYIRMSASELGMKGEPTTKXXXXXXXXXXXXXXXXXXGYLIHK 352
W DL+D F G+ IR++ SEL G K + + +
Sbjct: 393 WNQDLMDAVQFSATGELLSIRLARSELD--GNKRKKTIVASIVSLTLFMILGFTAFGVWR 450
Query: 353 RR-RNIAETDQE---NEDQNIDLE-LPLFELATISNATNNFSINNKLGEGGFGPVYKGTL 407
R +IA ++ N+ + D+ L F++ TI NATNNFS++NKLG+GGFG VYKG L
Sbjct: 451 CRVEHIAHISKDAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKL 510
Query: 408 VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467
DG+EIAVKRLS S QG +E NE++L SKLQHRNLV++LGCCI EEKLLIYEFM NK
Sbjct: 511 QDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNK 570
Query: 468 SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527
SLD F+FD +DW KRF II G ARGLLYLH DSRLR+IHRDLK SN+LLD MNP
Sbjct: 571 SLDTFLFDSRKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNP 630
Query: 528 KISDFGLARTCGGDKTEGNTNRV 550
KISDFGLAR G + + NT RV
Sbjct: 631 KISDFGLARMYQGTEYQDNTRRV 653
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 2.1e-107, Sum P(2) = 2.1e-107
Identities = 239/564 (42%), Positives = 331/564 (58%)
Query: 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWD 62
VVWS + + +L D+GNLV+ + SG W+SF++ DT+LP L ++
Sbjct: 106 VVWS--IGENFASNGSRAELTDNGNLVVI---DNASGRTLWESFEHFGDTMLPFSSLMYN 160
Query: 63 LKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PT 121
L TG +R + SWK+ DPSPG F+ + Q +V++ +GS+++Y TGPW F+ P
Sbjct: 161 LATGEKRVLTSWKTDTDPSPGVFVGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPL 220
Query: 122 TRPNPIFNFSFVANEDELCYTFSIKDKAV-VSRIVMNQTTYLGQRFTWSNNTQTWDLYSK 180
FS + + + F+ D++ +SRI+++ + +RF +N W+L
Sbjct: 221 MDDTYASPFSLQQDANGSGF-FTYFDRSFKLSRIIISSEGSM-KRFR--HNGTDWELSYM 276
Query: 181 APRDECDTYGLCGAYGVCIISKSPVCQCLKGF---KTKSGGYMDWHEGCVRSKAL----N 233
AP + CD YG+CG +G+CI+S C+CLKGF T+ +W GC R L N
Sbjct: 277 APANSCDIYGVCGPFGLCIVSVPLKCKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQGN 336
Query: 234 YSRQDG--FIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCA 291
+ +D F T +KLPD F SV+ +EC + CL N SC+A+ G GC
Sbjct: 337 STGKDVNIFHPVTNVKLPD--FYEYESSVDAEECHQSCLHNCSCLAFAYIH----GIGCL 390
Query: 292 MWFGDLIDMRSFPDGGQDFYIRMSASELGMKGEPTTKXXXXXXXXXXXXXXXXXXGYLIH 351
+W +L+D F GG+ IR++ SELG G K +
Sbjct: 391 IWNQNLMDAVQFSAGGEILSIRLAHSELG--GNKRNKIIVASTVSLSLFVILTSAAFGFW 448
Query: 352 KRR-RNIAETDQE---NEDQNIDLE-LPLFELATISNATNNFSINNKLGEGGFGPVYKGT 406
+ R ++ A T ++ N+ ++ ++ L FE+ TI ATNNFS++NKLG+GGFG VYKG
Sbjct: 449 RYRVKHKAYTLKDAWRNDLKSKEVPGLEFFEMNTIQTATNNFSLSNKLGQGGFGSVYKGK 508
Query: 407 LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466
L DG+EIAVK+LS S QG +E NE++L SKLQHRNLV++LGCCI GEEKLLIYEFM N
Sbjct: 509 LQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLN 568
Query: 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526
KSLD F+FD +DW KRF I+ G ARGLLYLH+DSRL++IHRDLK SN+LLD MN
Sbjct: 569 KSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMN 628
Query: 527 PKISDFGLARTCGGDKTEGNTNRV 550
PKISDFGLAR G + + T RV
Sbjct: 629 PKISDFGLARMYEGTQCQDKTRRV 652
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 1.2e-106, Sum P(2) = 1.2e-106
Identities = 238/552 (43%), Positives = 315/552 (57%)
Query: 21 QLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVIS-WKSADD 79
+L D+GNL++ + SG WQSFD+ DT+LP L ++L TG E++V+S WKS D
Sbjct: 122 ELSDTGNLIVI---DNFSGRTLWQSFDHLGDTMLPSSTLKYNLATG-EKQVLSSWKSYTD 177
Query: 80 PSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PT---TRPNPIFNFSFVAN 135
PS GDF+ + Q +V++ KGS+ +Y +GPW F+ P T P+
Sbjct: 178 PSVGDFVLQITPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGPVSVQQDTNG 237
Query: 136 EDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKAPRDECDTYGLCGAY 195
L Y + D+ + R ++ T+ Q +W N T W L AP CD YG+CG +
Sbjct: 238 SGSLTY-LNRNDR--LQRTML--TSKGTQELSWHNGTD-WVLNFVAPEHSCDYYGVCGPF 291
Query: 196 GVCIISKSPVCQCLKGFKTK---SGGYMDWHEGCVRSKALNYSRQDGFIKFTELKLPDA- 251
G+C+ S P C C KGF K +W GCVR L Y + + K+ + P A
Sbjct: 292 GLCVKSVPPKCTCFKGFVPKLIEEWKRGNWTGGCVRRTEL-YCQGNSTGKYANVFHPVAR 350
Query: 252 ----NFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGG 307
+F + VN++EC++ CL N SC+A+ D G GC MW DL+D F +GG
Sbjct: 351 IKPPDFYEFASFVNVEECQKSCLHNCSCLAFAYID----GIGCLMWNQDLMDAVQFSEGG 406
Query: 308 QDFYIRMSASELGMKGEPTTKXXXXXXXXXXXXXXXXXXGYLIHKRR-RNIAE--TDQEN 364
+ IR++ SELG G K + + R ++ A+ TD
Sbjct: 407 ELLSIRLARSELG--GNKRKKAITASIVSLSLVVIIAFVAFCFWRYRVKHNADITTDASQ 464
Query: 365 EDQNIDLE------LPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 418
DL+ L F++ TI ATNNFSI+NKLG+GGFGPVYKG L DG+EIAVKRL
Sbjct: 465 VSWRNDLKPQDVPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRL 524
Query: 419 SKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTN 478
S S QG +E NE++L SKLQH+NLV++LGCCI GEEKLLIYEFM N SLD F+FD
Sbjct: 525 SSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRK 584
Query: 479 SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538
+DW KR II G ARG+ YLH+DS L++IHRDLK SN+LLD MNPKISDFGLAR
Sbjct: 585 RLEIDWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMY 644
Query: 539 GGDKTEGNTNRV 550
G + + NT RV
Sbjct: 645 QGTEYQDNTRRV 656
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.254.15.1 | annotation not avaliable (816 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 558 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-39 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 3e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-21 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-06 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 0.004 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.004 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 58/154 (37%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 389 SINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISD-QGLKELKNEVILFSKLQHR 442
++ KLGEG FG VYKG L E+AVK L + + Q ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
N+VKLLG C E ++ E+M L ++ + N L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
IHRDL A N L+ ++ KISDFGL+R
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 7e-40
Identities = 60/154 (38%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 389 SINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKISD-QGLKELKNEVILFSKLQHR 442
++ KLGEG FG VYKGTL E+AVK L + + Q ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
N+VKLLG C E +++ E+MP L ++ K L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
IHRDL A N L+ ++ KISDFGL+R
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 3e-39
Identities = 56/156 (35%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 392 NKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVK 446
KLGEG FG VYKG L E+AVK L + S++ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFI------FDQTNSKLLDWSKRFHIICGTARGLLY 500
LLG C E L+ E+M L ++ F L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L + +HRDL A N L+ D+ KISDFGL+R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 44/111 (39%), Positives = 71/111 (63%), Gaps = 2/111 (1%)
Query: 107 YTTGPWNGLSFS-APTTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQR 165
+ +GPWNG+ FS P + + ++F N +E+ YT+ + + ++ SR+ ++ L +R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSL-ER 59
Query: 166 FTWSNNTQTWDLYSKAPRDECDTYGLCGAYGVCIISKSPVCQCLKGFKTKS 216
FTW N+Q W+L+ AP+D+CD YG CG YG C ++ SP C C+KGF K+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 55/156 (35%), Positives = 80/156 (51%), Gaps = 11/156 (7%)
Query: 388 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISD-QGLKELKNEVILFSKLQH 441
+ KLGEG FG VYKGTL ++AVK L + + + +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
N+V+LLG C GE ++ E+MP L F+ + + + L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
+HRDL A N L+ ++ KISDFGL+R
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRD 151
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 57/159 (35%), Positives = 77/159 (48%), Gaps = 8/159 (5%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNLVKLLGCC 451
LGEGGFG VY G+++A+K + K L E L E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 511
L+ E+ SL + + N L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 512 RDLKASNVLLDHD-MNPKISDFGLARTCGGDKTEGNTNR 549
RDLK N+LLD D K++DFGL++ DK+ T
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 9/160 (5%)
Query: 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNL 444
+ + KLG G FG VYK G+ +AVK L K + + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
V+L+ + L+ E+ L ++ L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH-- 115
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
IIHRDLK N+LLD + KI+DFGLA+ +
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS 154
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNLV 445
+ I KLGEG FG VY G+ +A+K + K + +E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L ++ L+ E+ L + + +L + RF + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
I+HRDLK N+LLD D + K++DFGLAR
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR 145
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 59/183 (32%), Positives = 88/183 (48%), Gaps = 31/183 (16%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVK--RLSKISDQGLKELKNEVILFSKLQHRN 443
++ LG G FG VY D G+ +AVK LS S++ L+ L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 444 LVKLLGCCIHGEEK-LLIY-EFMPNKSLDYFIFDQTNSKLLDWSKRF-----HIICGTAR 496
+V+ G E+ L I+ E++ SL + K+F +I R
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108
Query: 497 ----GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWL 552
GL YLH I+HRD+K +N+L+D D K++DFG A+ G +T T +
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG--SV 163
Query: 553 YGT 555
GT
Sbjct: 164 RGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 17/190 (8%)
Query: 370 DLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE 428
+L+ L ++ + + + K+GEG G VYK T G+E+A+K++ ++ Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61
Query: 429 LKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF 488
+ NE+++ +H N+V + G+E ++ E+M SL I Q ++
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRM----NEP 116
Query: 489 HI--ICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEG 545
I +C +GL YLH +IHRD+K+ N+LL D + K++DFG A T+
Sbjct: 117 QIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFA----AQLTKE 169
Query: 546 NTNRVWLYGT 555
+ R + GT
Sbjct: 170 KSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 54/162 (33%), Positives = 85/162 (52%), Gaps = 29/162 (17%)
Query: 387 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLS--KISDQGLKELKNEVILFSKLQHRN 443
N+ + + +G G FG VYKG L G +A+K++S KI ++ LK + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 444 LVKLLGCCIHGEEKLLIY-EFMPNKSLDYFIFDQTNSKLLDWSKRFH------IICGTA- 495
+VK +G I + L I E+ N SL +++ K+F +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSL---------RQII---KKFGPFPESLVAVYVYQ 107
Query: 496 --RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+GL YLH+ +IHRD+KA+N+L D K++DFG+A
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 52/149 (34%), Positives = 84/149 (56%), Gaps = 6/149 (4%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVK 446
F I K+G+GGFG VYK G+E+A+K + S + +++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSR 506
G + +E ++ EF SL + ++ ++ L S+ ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLA 535
IIHRD+KA+N+LL D K+ DFGL+
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 56/163 (34%), Positives = 81/163 (49%), Gaps = 21/163 (12%)
Query: 392 NKLGEGGFGPVYKGT---LVDGQ--EIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLV 445
+LGEG FG V L D ++AVK L+ +Q + + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 446 KLLGCC--IHGEEKLLIYEFMPNKSLDYFI----FDQTNSKLLDWSKRFHIICGTARGLL 499
K G C G LI E++P+ SL ++ +LL +S + IC +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ---IC---KGMD 123
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
YL R IHRDL A N+L++ + KISDFGLA+ DK
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 58/163 (35%), Positives = 85/163 (52%), Gaps = 25/163 (15%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSK----ISDQGLKELKNEVILFSKLQ 440
+ KLGEG +G VYK G+ +A+K RL I L+E+ L +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELK 56
Query: 441 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKL-LDWSKR--FHIICGTAR 496
H N+VKLL IH E KL L++E+ + L ++ D+ L + K + ++ G
Sbjct: 57 HPNIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLLRG--- 110
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
L Y H RI+HRDLK N+L++ D K++DFGLAR G
Sbjct: 111 -LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 6e-23
Identities = 49/149 (32%), Positives = 77/149 (51%), Gaps = 4/149 (2%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
F++ KLG G FG V++G + +A+K L ++ + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
C GE +I E M SL F+ ++L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLAR 536
IHRDL A N+L+ D+ K++DFGLAR
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVK 446
F I KLGEG +G VYK GQ +A+K + ++ L+E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 447 LLGCCIHGEEKLLIYEFMPNKS-LDYFIFDQTNSKLLDWSKRFHIIC-GTARGLLYLHQD 504
G + ++ E+ S D I TN L + + I T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTE--EEIAAILYQTLKGLEYLHS- 117
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ IHRD+KA N+LL+ + K++DFG++
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 51/173 (29%), Positives = 89/173 (51%), Gaps = 21/173 (12%)
Query: 388 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISD------QGLKELKNEVILFSKLQ 440
+ ++GEG +G VYK G+ +A+K++ ++ ++E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 441 HRNLVKLLGCCIHGEEK---LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARG 497
H N+V+L + + K +++E+M + L + D K + S+ + G
Sbjct: 57 HPNIVRLK-EIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTE-SQIKCYMKQLLEG 112
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
L YLH + I+HRD+K SN+L+++D K++DFGLAR + TNRV
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-21
Identities = 33/65 (50%), Positives = 45/65 (69%), Gaps = 1/65 (1%)
Query: 236 RQDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFG 295
DGF++ +KLPD + V +S+ LKEC ++CL N SC AY +DIR GGSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTG 61
Query: 296 DLIDM 300
+L+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 394 LGEGGFGPVYKGT---LVDGQE---IAVKRLSKISDQGLKE-LKNEVILFSKLQHRNLVK 446
LGEG FG V+ G L + +AVK L + + ++ + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYF---------IFDQTNSKL--LDWSKRFHIICGTA 495
G C G+ ++++E+M + L+ F +S + L S+ I A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR---TCGGDKTEGNT 547
G++YL + +HRDL N L+ +D+ KI DFG++R T + G+T
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 57/163 (34%), Positives = 80/163 (49%), Gaps = 23/163 (14%)
Query: 394 LGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVK 446
LGEG FG VYKG L +A+K L + ++ ++ E + E L S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIF-------------DQTNSKLLDWSKRFHIICG 493
LLG C + +++E++ + L F+ D+T LD S HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ YL S +HRDL A N L+ + KISDFGL+R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 54/161 (33%), Positives = 88/161 (54%), Gaps = 20/161 (12%)
Query: 394 LGEGGFGPVYKGT-LVDGQ----EIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKL 447
LG G FG VYKG + +G+ +A+K L + + + KE+ +E + + + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIF---DQTNSK-LLDWSKRFHIICGTARGLLYLHQ 503
LG C+ + LI + MP L ++ D S+ LL+W + A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
R++HRDL A NVL+ + KI+DFGLA+ D+ E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 3e-21
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISDQGLKELKNEVILFSKLQHRN 443
+ I ++G+G FG VY DG+ +K LS +S++ ++ NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNS-------KLLDWSKRFHIICGTAR 496
++K + ++ E+ L I Q ++LDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
L YLH SR +I+HRD+K N+ L + K+ DFG+++
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKV 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-21
Identities = 32/77 (41%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 237 QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGD 296
DGF+K ++KLPD + +++L+ECRE CL N SC AY ++ G GC +W G
Sbjct: 11 TDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGL 65
Query: 297 LIDMRSFPDGGQDFYIR 313
L ++RS GG Y+R
Sbjct: 66 LNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 393 KLGEGGFGPVYKG-TLVDGQEIAVKRLSK------ISDQGLKELKNEVILFSKLQHRNLV 445
K+GEG +G VYK + G+ +A+K++ I L+E+K L +L H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
KLL H + L++EFM D + + + L S + +GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
I+HRDLK N+L++ + K++DFGLAR+ G
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.0 bits (232), Expect = 9e-21
Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQH-R 442
++ I KLGEG FG VY D + +A+K L+K + ++ E+ + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
N+VKL L+ E++ SL+ + L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 503 QDSRLRIIHRDLKASNVLLDHDMN-PKISDFGLAR 536
IIHRD+K N+LLD D K+ DFGLA+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAK 150
|
Length = 384 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 62/160 (38%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 394 LGEGGFGPVYKGTLVD-------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLV 445
LG G FG VY+GT D +AVK L K + DQ KE E L S H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFD----QTNSKLLDWSKRFHIICGTARGLLYL 501
KLLG C+ E + +I E M L ++ D + LL + I A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 502 HQDSRLRIIHRDLKASNVLL-----DHDMNPKISDFGLAR 536
Q + IHRDL A N L+ D D KI DFGLAR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-20
Identities = 40/80 (50%), Positives = 50/80 (62%), Gaps = 7/80 (8%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGW 61
RVVWS++ S + + V L D GNLVL +SG WQSFD+P+DTLLPG K G
Sbjct: 37 RVVWSSNTSG--KGSGCVAVLQDDGNLVLYD----NSGKVLWQSFDHPTDTLLPGQKDG- 89
Query: 62 DLKTGFERRVISWKSADDPS 81
++ G RR+ SWKS DPS
Sbjct: 90 NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 5/151 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + KLG G FG V+ GT ++AVK L K + E + KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L C E ++ E+M SL F+ KL + + A G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE--- 120
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
IHRDL A N+L+ ++ KI+DFGLAR
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISDQGLKELKNEVILFSKL-Q 440
++F +GEG F V +E A+K L K I ++ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 441 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTAR 496
H ++KL EE L + E+ PN L +I + L + RF+ I+
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA--- 114
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
L YLH IIHRDLK N+LLD DM+ KI+DFG A+ + + +
Sbjct: 115 -LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 53/146 (36%), Positives = 75/146 (51%), Gaps = 8/146 (5%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVK--RLSKISDQGLKELKNEVILFSKLQHRNLVKLLGC 450
K+G+G FG VYKG L E+AVK R + D K L+ IL + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRII 510
C+ + ++ E +P SL F+ + L K + A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 511 HRDLKASNVLLDHDMNPKISDFGLAR 536
HRDL A N L+ + KISDFG++R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 19/160 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISDQGLKELKNEV-ILFSKLQHR 442
++ LG+G G VYK G+ A+K++ ++ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA-----RG 497
+VK G E ++ E+M SL + K+ + + +G
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP---VLAYIARQILKG 111
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
L YLH IIHRD+K SN+L++ KI+DFG+++
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKV 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 10/168 (5%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISDQGLKELKNEVILFSKLQ 440
+ +I +G G FG V +G L +EI A+K L + SD+ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H N+++L G ++I E+M N SLD F+ + N + ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
L S + +HRDL A N+L++ ++ K+SDFGL+R + T
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 54/161 (33%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 392 NKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVK 446
+LG G FG V KG + G+E+ AVK L + G KE E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ---TNSKLLDWSKRFHIICGTARGLLYLHQ 503
L+G C GE +L+ E P L ++ + S L + + H + A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA---HQV---AMGMAYLES 113
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+HRDL A NVLL + KISDFG++R G
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 52/151 (34%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 394 LGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVK 446
LG+G FG V LV G+ A+K L K I + ++ E + S++ H +VK
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 447 LLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
L EEKL L+ E+ P L + + + RF L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLH--- 110
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L II+RDLK N+LLD D + K++DFGLA+
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAK 141
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 16/148 (10%)
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRL---SKISDQGLKELKNEVILFSKLQHRNLVKLLGC 450
+G+G FG V G GQ++AVK L S + L E + + L+H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEAS----VMTTLRHPNLVQLLGV 68
Query: 451 CIHGEEKLLIYEFMPNKSL-DYFIFDQTNSKLLDWSKRFHIIC-GTARGLLYLHQDSRLR 508
+ G ++ E+M SL DY ++ + + + G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLAR 536
+HRDL A NVL+ D+ K+SDFGLA+
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 62/156 (39%), Positives = 80/156 (51%), Gaps = 25/156 (16%)
Query: 394 LGEGGFG--------PVYKGTLVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNL 444
LGEG FG P GT G+ +AVK L + Q K E+ + L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 445 VKLLGCCIHGEEK--LLIYEFMPNKSL-DYFIFDQTN-SKLLDWSKRFHIICGTARGLLY 500
VK GCC K LI E++P SL DY + N ++LL ++++ IC G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ---IC---EGMAY 122
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
LH IHRDL A NVLLD+D KI DFGLA+
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 28/167 (16%)
Query: 392 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKN-----EVILFSKLQHRNLV 445
KLGEG + VYK G+ +A+K++ + K+ N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 446 KLLGCCIHGEEKLLIYEFMP--------NKSLDYFIFDQTNSKLLDWSKRFHIICGTARG 497
LL H L++EFM +KS+ T + + + T RG
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL-----TPADIKSYMLM------TLRG 114
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
L YLH I+HRDLK +N+L+ D K++DFGLAR+ G +
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 18/165 (10%)
Query: 388 FSINNKLGEGGFGPVYKGTLV--DG--QEIAVK--RLSKISDQGLKELKNEVILFSKLQH 441
+ LGEG FG V +G L DG ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 442 RNLVKLLGCCIHGEEK------LLIYEFMPNKSLDYFIFD---QTNSKLLDWSKRFHIIC 492
N++KL+G C ++I FM + L F+ + L +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
A G+ YL S IHRDL A N +L DM ++DFGL++
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 393 KLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISDQGLKELKNEVILFSKLQHRNLVK 446
+LGEG FG V+ L+ Q+ +AVK L + S+ ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ-TNSKLLDWSK-----------RFHIICGT 494
G C G L+++E+M + L+ F+ ++K+L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G++YL + L +HRDL N L+ + KI DFG++R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 59/159 (37%), Positives = 85/159 (53%), Gaps = 32/159 (20%)
Query: 394 LGEGGFGPVYKG-TLVDGQEIAVKRLSKISD-----QGLKELKNEVILFSKLQHRNLVKL 447
LG G FG VY+G L DG AVK +S D + +K+L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 448 LGCCIHGEEKLLIY-EFMPNKSLDYFIFDQTNSKLLDWSKRFH------IICGTAR---G 497
LG E+ L I+ E +P SL +KLL K++ I T + G
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSL---------AKLL---KKYGSFPEPVIRLYTRQILLG 114
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L YLH +HRD+K +N+L+D + K++DFG+A+
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 54/149 (36%), Positives = 85/149 (57%), Gaps = 11/149 (7%)
Query: 394 LGEGGFGPVYKGTLVD--GQEI--AVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLL 448
+G+G FG VY GTL+D GQ+I AVK L++I+D + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 449 GCCIHGE-EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
G C+ E L++ +M + L FI +T++ + F + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ +HRDL A N +LD K++DFGLAR
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 56/165 (33%), Positives = 92/165 (55%), Gaps = 20/165 (12%)
Query: 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQ--GLK---ELKNEVILFSKLQHRNLVKL 447
LG G FG VYKG V +G+ + + KI ++ G K E +E ++ + + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNS----KLLDWSKRFHIICGTARGLLYLHQ 503
LG C+ +L + + MP+ L ++ + ++ LL+W + A+G++YL +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
R++HRDL A NVL+ + KI+DFGLAR GD+ E N +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 8/155 (5%)
Query: 389 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
++ +KLG G +G VY+G +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 448 LGCCIHGEEKLLIYEFMPNKS-LDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSR 506
LG C +I EFM + LDY + N + ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKKN- 124
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
IHRDL A N L+ + K++DFGL+R GD
Sbjct: 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISDQGLKELKNEVILFSKL 439
+N + +LGEG FG V+ L Q+ +AVK L SD K+ E L + L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL----------LDWSKRFH 489
QH ++VK G C+ G+ ++++E+M + L+ F+ + L S+ H
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
I A G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 29/177 (16%)
Query: 386 NNFSINNKLGEGGFGPVYKGT---LVDGQE---IAVKRLSK-ISDQGLKELKNEVILFSK 438
NN +G+G FG V++ L+ + +AVK L + S + + E L ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD----------QTNSKLLDWSKRF 488
H N+VKLLG C G+ L++E+M L+ F+ + S
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 489 HIICGT---------ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ T A G+ YL S + +HRDL N L+ +M KI+DFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKR--LSKISDQGLKELKNEVILFSKLQHRN 443
+F I NK+G+G FG V+K D + A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLD---WSKRFHIICGTARGLLY 500
+++ + + ++ E+ N L + Q L + W RF I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
LH +I+HRD+K+ N+ LD N KI D G+A+ + NT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 56/154 (36%), Positives = 84/154 (54%), Gaps = 15/154 (9%)
Query: 393 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKIS-DQGLKELK-NEVILFSKLQHRNLVKLLG 449
K+GEG +G VYKG GQ +A+K++ S ++G+ E+ L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 450 CCIHGEEKL-LIYEFMP---NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+ E +L LI+EF+ K LD Q L S + I+ +G+L+ H
Sbjct: 67 V-LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH--- 118
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
R++HRDLK N+L+D+ K++DFGLAR G
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 394 LGEGGFGPVYK---GTLVD--GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLL 448
LG+G FG V L D G+ +AVK+L + + L++ + E+ + LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 449 GCCIH-GEEKL-LIYEFMPNKSL-DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
G C G L L+ E++P SL DY Q + + LD K +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL---G 125
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
R +HRDL N+L++ + KI DFGL + DK
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 55/185 (29%), Positives = 91/185 (49%), Gaps = 28/185 (15%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS------KISDQGLKELKNEVILFSKL 439
+ I ++GEG G V+K G+ +A+K+++ I +Q L+E+K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF-HIICGTARGL 498
QH +VKLL HG +L+ E+MP+ L + D+ K + ++ +G+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGV 112
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV---W---- 551
Y+H I+HRDLK +N+L+ D KI+DFGLAR ++ +++V W
Sbjct: 113 AYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
Query: 552 --LYG 554
LYG
Sbjct: 170 ELLYG 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKR---LSKISDQGLKEL-----KNEVIL 435
++ I KLGEG FG VYK ++I R L KI K+ E+ +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA-----RQIKTGRVVALKKILMHNEKDGFPITALREIKI 60
Query: 436 FSKLQHRNLVKLLGCCI-----HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF-- 488
KL+H N+V L+ + ++ +Y P Y D S LL+ +
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP-----YMDHDL--SGLLE-NPSVKL 112
Query: 489 ---HIICGTAR---GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
I C + G+ YLH++ I+HRD+KA+N+L+D+ KI+DFGLAR G
Sbjct: 113 TESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 543 TEGNT 547
Sbjct: 170 PNPKG 174
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 54/156 (34%), Positives = 85/156 (54%), Gaps = 20/156 (12%)
Query: 393 KLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISDQGLKELK-NEVILFSKLQHRNLVKLL 448
K+GEG +G VYK + G+ +A+K RL D+G+ E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 449 GCCIHGEEKL-LIYEFMP---NKSLDYFIFDQTNSKLLDWSKRF-HIICGTARGLLYLHQ 503
+H E KL L++EF+ K +D + L+ K + + + +G+ Y H
Sbjct: 65 DV-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYLYQLL---QGIAYCHS 117
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
R++HRDLK N+L+D + K++DFGLAR G
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 28/165 (16%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKR-----LSKISDQGLKELKNEVILFSKL 439
N+ LG+G FG VY VD G+E+AVK+ S + + + L+ E+ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 440 QHRNLVKLLGCCIHGEEKLLIY-EFMPNKSLDYFIFDQ-------TNSKLLDWSKRFHII 491
QH +V+ GC + +E L I+ E+MP S + DQ T + ++++
Sbjct: 62 QHERIVQYYGC-LRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQI--- 113
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
G+ YLH + I+HRD+K +N+L D N K+ DFG ++
Sbjct: 114 ---LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 25/180 (13%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKL-Q 440
+ T F + +GEG +G VYK GQ +A+K + I D+ +E+K E + K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 441 HRNLVKLLGC------CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------ 488
H N+ G + ++ L+ E S + D L KR
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIA 116
Query: 489 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
+I+ T RGL YLH++ ++IHRD+K N+LL + K+ DFG++ D T G N
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRN 171
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 8/156 (5%)
Query: 387 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELK-NEVILFSKLQHRNL 444
NF KLGEG + VYKG G+ +A+K + +++G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 445 VKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
V+L IH E KL L++E+M +K L ++ LD + +G+ + H+
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
+ R++HRDLK N+L++ K++DFGLAR G
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 57/160 (35%), Positives = 87/160 (54%), Gaps = 16/160 (10%)
Query: 387 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISDQGLKELKNEVILFSKLQHRN 443
NF K+GEG +G VYK + G+ +A+K RL ++ E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 444 LVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKL---LDWSKRFHIICGTARGLL 499
+VKLL IH E KL L++EF+ ++ L F+ S + L S F ++ +GL
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLA 114
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
+ H R++HRDLK N+L++ + K++DFGLAR G
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 51/156 (32%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ KLG G FG V+ G ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSL-DYFIFDQ----TNSKLLDWSKRFHIICGTARGLLY 500
+L + E +I E+M N SL D+ + T +KL+D + + A G+ +
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAF 117
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ R IHRDL+A+N+L+ + KI+DFGLAR
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 49/149 (32%), Positives = 79/149 (53%), Gaps = 13/149 (8%)
Query: 392 NKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISDQGLKELKNEVILFSKLQHRNLVKLL 448
NK+G G FG VY L G+ +AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWS--KRFHIICGTARGLLYLHQDSR 506
G +H E+ + E+ +L+ + + ++LD + + + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTL--QLLEGLAYLHSH-- 118
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLA 535
I+HRD+K +N+ LDH+ K+ DFG A
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 54/162 (33%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 393 KLGEGGFGPVYKGTLVDGQ----EIAVK-----RLSKISDQGLKELKNEVILFSKLQHRN 443
KLG+G FG V +G +AVK +LS I D LKE + L H N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKE----AAIMHSLDHEN 57
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSL---------DYFIFDQTNSKLLDWSKRFHIICGT 494
L++L G + + + E P SL +F+ S L D++ +
Sbjct: 58 LIRLYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLI----STLCDYAVQI------ 106
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ YL R IHRDL A N+LL D KI DFGL R
Sbjct: 107 ANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 51/158 (32%), Positives = 86/158 (54%), Gaps = 18/158 (11%)
Query: 392 NKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISDQG--LKELKNEVILFSKLQ---HRNL 444
++GEG +G VYK L G+ +A+K++ +S++G L L+ E+ L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 445 VKLLGCC--IHGEEKL---LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLL 499
V+LL C + +L L++E + ++ L ++ + L ++ RG+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
+LH RI+HRDLK N+L+ D KI+DFGLAR
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 23/164 (14%)
Query: 393 KLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNLV 445
+LGE FG VYKG L Q +A+K L ++ L+E K+E ++ S+LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIF-------------DQTNSKLLDWSKRFHIIC 492
LLG + +I+ + + L F+ D+T L+ + HI+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ +L S ++H+DL NVL+ +N KISD GL R
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 52/144 (36%), Positives = 70/144 (48%), Gaps = 5/144 (3%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452
KLG G FG V+ G + ++AVK L K ++ E L LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
E +I E+M SL F+ K+L K A G+ Y+ R IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 513 DLKASNVLLDHDMNPKISDFGLAR 536
DL+A+NVL+ + KI+DFGLAR
Sbjct: 128 DLRAANVLVSESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 54/179 (30%), Positives = 86/179 (48%), Gaps = 28/179 (15%)
Query: 394 LGEGGFGPVYKG-TLVDGQEIAVKR--LSKISDQG-------LKELKNEVILFSKLQHRN 443
+G G FG VY G G+ +AVK+ L +S L L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSL-----DYFIFDQTNSKLLDWSKRFHIICGTARGL 498
+V+ LG + + + E++P S+ +Y F++T + + + +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEG--NTNRVWLYGT 555
YLH IIHRD+K +N+L+D+ KISDFG+++ + N R L G+
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 394 LGEGGFGPVYKGTLVDGQ-EIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452
LG+G +G VY + Q IA+K + + + ++ L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 453 HGEEKLLIYEFMPNKSLDYFI------FDQTNSKLLDWSKRFHIICGTARGLLYLHQDSR 506
+ E +P SL + ++ ++K+ GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHD--- 126
Query: 507 LRIIHRDLKASNVLLD-HDMNPKISDFGLARTCGG 540
+I+HRD+K NVL++ + KISDFG ++ G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 394 LGEGGFGPVY----KGTLVDGQE--IAVKRLSKISDQG-LKELKNEVILFSKLQHRNLVK 446
LG G FG V+ KG +G E + VK L K D+ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFI------FDQTNSKLLDWSKRFHIICGTARGLLY 500
LLG C E +I E+ L F+ ++ L ++ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
L S R +HRDL A N L+ K+S L++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 55/161 (34%), Positives = 88/161 (54%), Gaps = 20/161 (12%)
Query: 394 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKL 447
LG G FG VYKG + +G+++ A+K L + S + KE+ +E + + + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 448 LGCCIHGEEKLLIYEFMPNKSL-DYFIFDQTN---SKLLDWSKRFHIICGTARGLLYLHQ 503
LG C+ +L I + MP L DY + N LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
R++HRDL A NVL+ + KI+DFGLA+ G D+ E
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 49/144 (34%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 452
LG+G FG V+KGTL D +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
+ ++ E +P D+ F + L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 513 DLKASNVLLDHDMNPKISDFGLAR 536
DL A N L+ + KISDFG++R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 394 LGEGGFGPVYKGTLVD------GQEIAVKRL-SKISDQGLKELKNEVILFSKL-QHRNLV 445
LGEG FG V K V +AVK L +++ L +L +E+ + + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFD-----QTNSKLLDWSKRFHIIC-------- 492
LLG C ++ E+ + +L F+ + S +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
ARG+ +L + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 49/155 (31%), Positives = 70/155 (45%), Gaps = 5/155 (3%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452
KLG G FG V++G + +AVK L K K+ E + KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
E ++ E M SL ++ L + + A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 513 DLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
DL A NVL+ + K++DFGLAR D E
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVK--RLSKISDQGLKELKNEVILFSKLQHRNLVKLLGC 450
++G G FG V+ G ++ +++A+K R +S++ E E + KL H LV+L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYGV 67
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRII 510
C L++EFM + L ++ + + G+ YL + +I
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 511 HRDLKASNVLLDHDMNPKISDFGLAR 536
HRDL A N L+ + K+SDFG+ R
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 57/159 (35%), Positives = 74/159 (46%), Gaps = 12/159 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSKISDQGLKE-LKNEVILFSK 438
NN S LG G FG V + T L ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARG 497
L H N+V LLG C G L+I E+ L F+ + S L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-FLTLEDLLSFSYQVAKG 153
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ +L + IHRDL A NVLL H KI DFGLAR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 4e-15
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 41/178 (23%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISD------QGLKELKNEVILFSKLQ 440
+ + +G G +G V G+++A+K++S + D + L+E+K L L+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK----LLRHLR 57
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLD----YFIFD----------QTNSKLLDWSK 486
H N++ LL I P D Y + + ++ L D
Sbjct: 58 HENIIGLL----------DI--LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHI 105
Query: 487 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
++ + RGL YLH +IHRDLK SN+L++ + + KI DFGLAR D+ E
Sbjct: 106 QY-FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISDQGLKELKNEVILFSKLQHRNL 444
F++ +G+G FG VYK Q +A+K L + D+ +++++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
K G + G + +I E+ S D LD + I+ GL YLH++
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
IHRD+KA+N+LL + + K++DFG++
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 49/149 (32%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
++ +GEG FG V +G GQ++AVK + D + E + +KL H+NLV+L
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
LG +H ++ E M +L F+ + + L+ + A G+ YL
Sbjct: 65 LGVILH-NGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK--- 119
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+++HRDL A N+L+ D K+SDFGLAR
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 24/167 (14%)
Query: 390 INNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN 443
+ +LGEG FG V+ D +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD--------------QTNSKLLDWSKRFH 489
+VK G C G+ ++++E+M + L+ F+ Q + L S+ H
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLH 127
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
I A G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 54/148 (36%), Positives = 81/148 (54%), Gaps = 10/148 (6%)
Query: 393 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLGC 450
KLGEG + VYKG + ++GQ +A+K +S +++G+ E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70
Query: 451 CIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRI 509
IH +E L ++E+M Y I Q L ++ R + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMF-QLLRGLAYIH---GQHI 124
Query: 510 IHRDLKASNVLLDHDMNPKISDFGLART 537
+HRDLK N+L+ + K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 8/150 (5%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVK 446
+ + ++G G +G VYK + E+ ++ K+ + ++ E+ + + +H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 447 LLGCCIHGEEKLLI-YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
G +KL I E+ SL I+ T L + + ++ T +GL YLH+
Sbjct: 65 YFGS-YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-LQIAYVCRETLKGLAYLHE-- 119
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
IHRD+K +N+LL D + K++DFG++
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 56/157 (35%), Positives = 86/157 (54%), Gaps = 21/157 (13%)
Query: 393 KLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISDQGLKELK-NEVILFSKLQHRNLVKLL 448
K+GEG +G VYK V + IA+K RL + D+G+ E+ L ++QH N+V+L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 449 GCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHII----CGTARGLLYLHQ 503
+H E++L L++E+ LD + +S D++K +I RG+ Y H
Sbjct: 68 DV-VHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 504 DSRLRIIHRDLKASNVLLDHDMNP-KISDFGLARTCG 539
R++HRDLK N+L+D N K++DFGLAR G
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL-------SKISDQGLKELKNEVILF 436
NF I K+G+G F VYK L+DG+ +A+K++ +K LKE+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 437 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI-FDQTNSKLLD----WSKRFHII 491
+L H N++K L I E ++ E L I + +L+ W K F +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW-KYFVQL 115
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
C L ++H RI+HRD+K +NV + K+ D GL R
Sbjct: 116 C---SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 49/151 (32%), Positives = 84/151 (55%), Gaps = 11/151 (7%)
Query: 393 KLGEGGFGPVYKGTLVDGQEI-AVKRLS-KISDQGLKELK-NEVILFSKLQHRNLVKLLG 449
K+GEG +G V+K + EI A+KR+ D+G+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 450 CCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
+H ++KL L++E+ ++ L + FD N + D + +GL + H
Sbjct: 67 V-LHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
++HRDLK N+L++ + K++DFGLAR G
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 23/164 (14%)
Query: 393 KLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVK 446
+LGE FG +YKG L Q +A+K L I++ Q E + E L ++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIF--------------DQTNSKLLDWSKRFHIIC 492
LLG + +++E++ L F+ D T LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ YL S +H+DL A N+L+ ++ KISD GL+R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 35/163 (21%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRL---SKISDQG-------LKELKNEVILFSKLQHR 442
+G+G +G VY V G+ +AVK++ + I+ + +K L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 443 NLVKLLGCCIHGEEKLLIY----EFMPNKSL-----DYFIFDQTNSKLLDWSKRFHIICG 493
N+V+ LG E E++P S+ Y F++ +
Sbjct: 69 NIVQYLGF----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR--------FFTEQ 116
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
GL YLH I+HRDLKA N+L+D D KISDFG+++
Sbjct: 117 VLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 16/151 (10%)
Query: 393 KLGEGGFGPVYKGTLVDGQEI-AVKR----LSKISD-QGLKELKNEVILFSKLQ-HRNLV 445
+LG+G FG VY + E+ A+K+ + L+E+K+ KL H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNIV 61
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
KL +E ++E+M +L Y + K S II +GL ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ HRDLK N+L+ KI+DFGLAR
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 20/152 (13%)
Query: 393 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLGC 450
KLGEG + VYKG + + GQ +A+K + ++G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 451 CIHGEEKL-LIYEFMPNKSLDYF-----IFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
IH ++ L L++E++ Y N +L F ++ RGL Y HQ
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLF----LFQLL----RGLAYCHQR 122
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
R++HRDLK N+L+ K++DFGLAR
Sbjct: 123 ---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 55/178 (30%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 387 NFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISDQG-LKELKNEVILFSKL 439
N + LGEG FG V K T +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI-------------FDQTNSKLLDWSK 486
H +++KL G C LLI E+ SL F+ NS LD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 487 RFHIICG--------TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ G +RG+ YL + ++++HRDL A NVL+ KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 10/152 (6%)
Query: 390 INNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISDQGLKELKNEVILFSKLQHRNL 444
I +G G FG V +G L + G+ +A+K L S +++ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+ L G ++I EFM N +LD F+ + N + ++ G A G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
S + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 383 NATNNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH 441
N + + I +LG+G FG VYK G A K + S++ L++ E+ + S+ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 442 RNLVKLLGCCIHGEEKLLIY-EFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC-GTARGLL 499
N+V L + E KL I EF +LD I + L + R+ +C L
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY--VCRQMLEALN 117
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+LH ++IHRDLKA N+LL D + K++DFG++
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 20/154 (12%)
Query: 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRL-----SKISDQGLKELKNEVILFSKLQHRNLV 445
+LG G G V K G+ +AVK + I Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYF---IFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
G + + + E+M SLD + + ++L K I +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL--GK---IAVAVLKGLTYLH 117
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ +IIHRD+K SN+L++ K+ DFG++
Sbjct: 118 --EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVK 446
+ + KLG G FG V+ T ++AVK + K ++ E + LQH LVK
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 447 LLGCCIHGEEKLLIYEFMPNKSL-DYFIFDQTNS----KLLDWSKRFHIICGTARGLLYL 501
L + E +I EFM SL D+ D+ + KL+D+S + A G+ ++
Sbjct: 66 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFI 118
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
Q + IHRDL+A+N+L+ + KI+DFGLAR
Sbjct: 119 EQRN---YIHRDLRAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 46/144 (31%), Positives = 74/144 (51%), Gaps = 6/144 (4%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452
KLG+G FG V+ GT +A+K L K + E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
E ++ E+M SL F+ + K L + + A G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 513 DLKASNVLLDHDMNPKISDFGLAR 536
DL+A+N+L+ ++ K++DFGLAR
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTL-VDG--QEIAVKRLSKISDQG-LKELKNEVILFSKL-Q 440
N+ + +GEG FG V K + DG + A+KR+ + + + ++ E+ + KL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DY------------FIFDQTNSKLLDWSKR 487
H N++ LLG C H L E+ P+ +L D+ F + + L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 488 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H ARG+ YL Q + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 7/153 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE-IAVKR--LSKISDQGLKELKNEVILFSKLQHR 442
+++ + +G G VY + E +A+KR L K + EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHP 59
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
N+VK + G+E L+ ++ SL + LD + ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ + IHRD+KA N+LL D + KI+DFG++
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 386 NNFSINNKLGEGGFGPVY-------------KGTLVDGQE--IAVKRL-SKISDQGLKEL 429
+ KLGEG FG V+ DGQ +AVK L + ++ +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 430 KNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ---------TNSK 480
E+ + S+L++ N+++LLG C+ + +I E+M N L+ F+ + N
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 481 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ + ++ A G+ YL + L +HRDL N L+ + KI+DFG++R
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 387 NFSINNKLGEGGFGPVYKGTLV----DGQE--IAVKRLSKI-SDQGLKELKNEVILFSKL 439
+ ++ LG G FG VY+G D E +AVK L + S+Q + E ++ SK
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD----QTNSKLLDWSKRFHIICGTA 495
H+N+V+L+G + ++ E M L F+ + L A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGLAR 536
+G YL ++ IHRD+ A N LL KI+DFG+AR
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 30/160 (18%)
Query: 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISDQGLKE-----LKNEVILFSKLQHRNLV 445
LG+G +G VY G GQ IAVK++ S+ E L+ EV L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH-----IICGTAR---- 496
+ LG C+ + EF+P S+ + RF + C +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQILD 113
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
G+ YLH + ++HRD+K +NV+L + K+ DFG AR
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 38/173 (21%)
Query: 388 FSINNKLGEGGFGPVYKG---TLVDGQEIAVKRL--SKISDQGLKELK-NEVILFSKLQH 441
+ I +G G +G VYK DG+E A+K+ K G+ + E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDW------SKRFHIICGTA 495
N+V L+ + +K + Y +FD L +KR I
Sbjct: 62 ENVVSLVEVFLEHADKSV-----------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 496 R--------GLLYLHQDSRLRIIHRDLKASNVLLDHDMNP----KISDFGLAR 536
+ G+ YLH + ++HRDLK +N+L+ + KI D GLAR
Sbjct: 111 KSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 46/162 (28%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 375 LFELATISNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELK-NE 432
L + ++ + ++ K+G+G G VY V GQE+A+K+++ + Q KEL NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
+++ + +H N+V L + G+E ++ E++ SL D +D + +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534
+ L +LH + ++IHRD+K+ N+LL D + K++DFG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/161 (35%), Positives = 88/161 (54%), Gaps = 20/161 (12%)
Query: 394 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKL 447
LG G FG VYKG + DG+ + A+K L + S + KE+ +E + + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 448 LGCCIHGEEKLLIYEFMPNKSL-DYFI--FDQTNSK-LLDWSKRFHIICGTARGLLYLHQ 503
LG C+ +L + + MP L DY D+ S+ LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+R++HRDL A NVL+ + KI+DFGLAR D+TE
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 44/150 (29%), Positives = 85/150 (56%), Gaps = 14/150 (9%)
Query: 394 LGEGGFGPVYKGTL-VDGQE---IAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLL 448
+G G FG V++G L + G++ +A+K L +++ ++ +E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWS--KRFHIICGTARGLLYLHQDSR 506
G + ++I E+M N +LD ++ D ++S + ++ G A G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 48/175 (27%), Positives = 94/175 (53%), Gaps = 10/175 (5%)
Query: 375 LFELATISNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKEL-KNE 432
L + +I + ++ K+G+G G V+ V GQE+A+K+++ + Q KEL NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINE 66
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
+++ +L++ N+V L + G+E ++ E++ SL D +D ++ +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
+ L +LH + ++IHRD+K+ NVLL D + K++DFG ++++ +T
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 46/172 (26%)
Query: 388 FSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISDQGLKELKN---------EVIL 435
+ I KLG+G +G V+K +D + +A+K KI D +N E++
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KIFDA----FRNATDAQRTFREIMF 59
Query: 436 FSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSK---------LLDWS 485
+L H N+VKLL + + +K + Y +F+ + L D
Sbjct: 60 LQELGDHPNIVKLLN----------VIKAENDKDI-YLVFEYMETDLHAVIRANILEDVH 108
Query: 486 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
KR+ I+ + L Y+H S +IHRDLK SN+LL+ D K++DFGLAR+
Sbjct: 109 KRY-IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARS 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 52/170 (30%), Positives = 74/170 (43%), Gaps = 29/170 (17%)
Query: 393 KLGEGGFGPVYKGTLVDGQEI-----------------AVKRLSK-ISDQGLKELKNEVI 434
KLGEG FG V+ Q+ AVK L SD ++ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 435 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI--------FDQTNSKLLDWSK 486
+ S+L N+ +LLG C +I E+M N L+ F+ NSK L +S
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 487 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
++ A G+ YL L +HRDL N L+ + KI+DFG++R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKG---TLVDGQ---EIAVKRLSK-ISDQGLKELKNEVILFSK 438
++ +LG+G FG VY+G +V G+ +A+K +++ S + E NE + +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI------FDQTNSKLLDWSKRFHIIC 492
++V+LLG G+ L++ E M L ++ + ++F +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 493 G-TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ YL + +HRDL A N ++ D+ KI DFG+ R
Sbjct: 126 AEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 388 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVK 446
+ I +LG+G FG VYK + G A K + S++ L++ E+ + + H +VK
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLD---WSKRFHIICGTA-RGLLYLH 502
LLG + ++ EF P ++D + + LD + +IC L YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLH 127
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
++IIHRDLKA NVLL D + K++DFG++
Sbjct: 128 S---MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQHR 442
+F + +G+G FG V D +++ A+K ++K + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
LV L E L+ + + L Y + K + +F IC L YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKF-WICEIVLALEYLH 117
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
IIHRD+K N+LLD + I+DF +A
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIAT 148
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 392 NKLGEGGFGPVYKGTLV----DGQEIAVKRLS--KISDQGLKELKNEVILFSKLQHRNLV 445
+G+G FG V K V DG+ + K + ++++ ++L +EV + +L+H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 446 KLLGCCIHGEEKLLIY---EFMPNKSLDYFI--FDQTNSKLLDWSKRFHIICGTARGLLY 500
+ I +Y E+ L I + + + + I+ L
Sbjct: 63 RYYDR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI-EEEFIWRILTQLLLALYE 120
Query: 501 LH--QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
H D ++HRDLK +N+ LD + N K+ DFGLA+ G D
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 387 NFSINNKLGEGGFGPVYK-GTLVDGQEIAVKR--LSKISDQGLKELKNEVILFSKLQHRN 443
+F + KLG+G +G VYK L D Q A+K L +S + ++ NE+ + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD-QTNSKLLDWSKRFHIICGTARGLLYLH 502
++ + G + ++ E+ P L I + KL+ + + I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ +I+HRDLK++N+LL + KI D G+++
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISK 151
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 56/161 (34%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLG 449
LG+GGFG V + G+ A K+L K +G + NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 450 CCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQDS 505
++ L L+ M L Y I++ + F+ IICG L +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLA-RTCGGDKTEG 545
RI++RDLK NVLLD N +ISD GLA GG K +G
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 43/144 (29%), Positives = 78/144 (54%), Gaps = 10/144 (6%)
Query: 392 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGC 450
K+GEG G V T G+++AVK++ Q + L NEV++ QH N+V++
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC-GTARGLLYLHQDSRLRI 509
+ G+E ++ EF+ +L + T++++ + ++ +C + L +LH +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIV---THTRMNE--EQIATVCLAVLKALSFLHAQ---GV 136
Query: 510 IHRDLKASNVLLDHDMNPKISDFG 533
IHRD+K+ ++LL D K+SDFG
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 56/169 (33%), Positives = 81/169 (47%), Gaps = 33/169 (19%)
Query: 387 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISD----QGLKELKNEVILFSKL 439
F N++GEG +G VY+ G+ +A+K R+ D L+E+ L L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREIT----LLLNL 63
Query: 440 QHRNLVKLLGCCI--HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKR-FH------I 490
+H N+V+L + H + L+ E+ +Q + LLD F +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYC----------EQDLASLLDNMPTPFSESQVKCL 113
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
+ RGL YLH++ IIHRDLK SN+LL KI+DFGLART G
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 45/145 (31%), Positives = 66/145 (45%), Gaps = 10/145 (6%)
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCC 451
LG G FG V+ G ++A+K + + +S+ E E + KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 511
++ E+M N L ++ + L + + YL + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 512 RDLKASNVLLDHDMNPKISDFGLAR 536
RDL A N L+ D K+SDFGLAR
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 30/158 (18%)
Query: 394 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISDQG--LKELKNEVILFSKLQHRNLV 445
LG G F Y+ GTL+ +++ R + S+Q ++ L+ E+ L ++L H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPHII 66
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSL-----DYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
++LG L E+M S+ Y F + + RGL Y
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLL---RGLSY 118
Query: 501 LHQDSRLRIIHRDLKASNVLLD---HDMNPKISDFGLA 535
LH++ +IIHRD+K +N+L+D + +I+DFG A
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 386 NNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELKN----EVILFSKLQ 440
N + + +GEG +G V K G+ +A+K+ K S+ +++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H N+V L L++E++ L+ + + L I + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR--TCGGD 541
H IIHRD+K N+L+ K+ DFG AR
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452
KLG G FG V+ GT ++AVK L K + E + KL+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV-V 70
Query: 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
E ++ E+M SL F+ D + L + A G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 513 DLKASNVLLDHDMNPKISDFGLAR 536
DL+++N+L+ + KI+DFGLAR
Sbjct: 127 DLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 10/169 (5%)
Query: 386 NNFSINNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISDQGLKELKNEVILFSKLQ 440
+ I +G G FG V G L + G+ +A+K L + +++ ++ +E + +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H N++ L G + +++ E+M N SLD F+ + + + ++ G A G+ Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNR 549
L S + +HRDL A N+L++ ++ K+SDFGL+R D T R
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 50/151 (33%), Positives = 70/151 (46%), Gaps = 11/151 (7%)
Query: 392 NKLGEGGFGPVYKG---TLVDGQEIAVKRL--SKISDQGLKELKNEVILFSKLQHRNLVK 446
+++G G FG V G + + VK L S D+ L L+ EV + +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ-EVQPYRELNHPNVLQ 59
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF--HIICGTARGLLYLHQD 504
LG CI LL+ EF P L ++ K + C A GLL+LHQ
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
IH DL N L D++ KI D+GLA
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 49/144 (34%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452
KLG+G FG V+ GT ++A+K L K + E + KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
E ++ EFM SL F+ + + K L + + A G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 513 DLKASNVLLDHDMNPKISDFGLAR 536
DL+A+N+L+ ++ KI+DFGLAR
Sbjct: 127 DLRAANILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 49/174 (28%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQ-----GLKELKNEVILFSKLQ 440
+ + +GEG +G V T G ++A+K++S Q L+E+K + + +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61
Query: 441 HRNLVKLLGCCIHG-----EEKLLIYEFMP-------------NKSLDYFIFDQTNSKLL 482
H N++ +L + ++ E M N + YF++
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ------- 114
Query: 483 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 115 -----------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/160 (35%), Positives = 82/160 (51%), Gaps = 34/160 (21%)
Query: 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ--GLKELK------------NEVILFS 437
+KLGEG + VYKG SK++D LKE++ EV L
Sbjct: 12 DKLGEGTYATVYKGR------------SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK 59
Query: 438 KLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
L+H N+V L IH E+ L L++E++ +K L ++ D NS + K F + R
Sbjct: 60 DLKHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLR 115
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
GL Y H R +++HRDLK N+L++ K++DFGLAR
Sbjct: 116 GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 26/173 (15%)
Query: 396 EGGFGPVYKGTLVDG-----QEIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLG 449
EG FG ++ G L+D +E+ VK + S+ + L E L L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 450 CCIHGEEK-LLIYEFMPNKSLDYF-----IFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
CI E ++Y +M +L F + + N + L + H+ A G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLART-------CGGDKTEGNTNR 549
+ +IH+D+ A N ++D ++ KI+D L+R C GD N NR
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----NENR 181
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 15/158 (9%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELK-NEVI-------LFSKL 439
+ + +LG+G FG VY + D + +A +RL + + + EL NE + L SKL
Sbjct: 2 YILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD-QTNSKLLDWSKRFHIICGTARGL 498
H +VK + + +I E+ + LD + + + K L ++ G+
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
Y+HQ RI+HRDLKA N+ L +++ KI DFG++R
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSR 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 393 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKN----EVILFSKLQHRNLVKL 447
+GEG +G V K + GQ +A+K+ + D K +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
+ + L++EF+ + LD + LD S+ + RG+ + H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLART 537
IIHRD+K N+L+ K+ DFG ART
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFART 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 56/159 (35%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 394 LGEGGFGPVY------KGTLVDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVK 446
LGEG FG V +G G+++AVK L S + +LK E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 447 LLGCCIHGEEK--LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI-ICGTARGLLYLHQ 503
G C LI EF+P+ SL ++ N L ++ + IC +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC---KGMDYL-- 125
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
SR + +HRDL A NVL++ + KI DFGL + DK
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-12
Identities = 29/81 (35%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 235 SRQDGFIKFTELKLPDANFSRVSKSVNLKECREKCLE-NSSCMAYTNSDIRGGGSGCAMW 293
D F++ KLP + V +L+EC KCL N SC ++T ++ G GC +W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRI-VISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 294 -FGDLIDMRSFPDGGQDFYIR 313
L D R FP GG D Y +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 44/144 (30%), Positives = 78/144 (54%), Gaps = 10/144 (6%)
Query: 393 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCC 451
K+GEG G V T+ G+ +AVK++ Q + L NEV++ QH N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC-GTARGLLYLHQDSRLRII 510
+ G+E ++ EF+ +L + T++++ + ++ +C + L LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV---THTRMNE--EQIAAVCLAVLKALSVLHAQG---VI 138
Query: 511 HRDLKASNVLLDHDMNPKISDFGL 534
HRD+K+ ++LL HD K+SDFG
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 53/182 (29%), Positives = 93/182 (51%), Gaps = 31/182 (17%)
Query: 388 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQ------GLKELKNEVILFSKLQ 440
F I ++GEG +G VYK D G+ +A+K++ +++ ++E+K + +L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQLN 64
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTN--------SKLLDWSKRFHIIC 492
HRN+V L ++ L +F +K Y +F+ + S L+ +S+ I
Sbjct: 65 HRNIVNLKEIVTDKQDAL---DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH--IK 119
Query: 493 GTAR----GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
+ GL Y H+ + L HRD+K SN+LL++ K++DFGLAR +++ TN
Sbjct: 120 SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 549 RV 550
+V
Sbjct: 177 KV 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 57/174 (32%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 386 NNFSINNKLGEGGFGPVYK----GTLVDGQE----IAVKRLS-KISDQGLKELKNEVILF 436
+ + LGEG FG V + G + +AVK L +D+ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 437 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI-----------FDQTNS--KLL 482
+ +H+N++ LLG C +I E+ +L F+ FD T + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 483 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ ARG+ YL +SR R IHRDL A NVL+ D KI+DFGLAR
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 57/181 (31%), Positives = 90/181 (49%), Gaps = 27/181 (14%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISDQGLKELKNEVILFSKLQ 440
N+ + LG G FG VY D G+E+AVK++ S+ + + + L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 441 HRNLVKLLGCCI-HGEEKLLIY-EFMPNKSLDYFIFDQTNS--KLLDWSKRFHIICGTAR 496
H +V+ GC E+KL I+ E+MP S I DQ + L + R + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTR-QILQ 117
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYGTG 556
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ + + GTG
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK---------RIQTICMSGTG 165
Query: 557 I 557
I
Sbjct: 166 I 166
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 15/180 (8%)
Query: 377 ELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILF 436
+L+ + + F + +G G +G VYKG V ++A ++ +++ +E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 437 SKL-QHRNLVKLLGCCI------HGEEKLLIYEFMPNKSL-DYFIFDQTNSKLLDWSKRF 488
K HRN+ G I H ++ L+ EF S+ D + N+ DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124
Query: 489 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
+I RGL +LH ++IHRD+K NVLL + K+ DFG++ D+T G N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 28/158 (17%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISDQGLKELKNEVILFSKLQHRNLVKL 447
LG+G FG VY VD G+E+A K++ S + + + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 448 LGCCI-HGEEKLLIY-EFMPNKSLDYFIFDQ-------TNSKLLDWSKRFHIICGTARGL 498
GC E+ L I+ E+MP S+ DQ T S ++++ G+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQI------LEGM 119
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
YLH + I+HRD+K +N+L D N K+ DFG ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 20/152 (13%)
Query: 394 LGEGGFGPVYKGTLV-DGQEI----AVKRL-SKISDQGLKELKNEVILFSKLQHRNLVKL 447
LG G FG V+KG + +G I A+K + + Q +E+ + ++ L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNS----KLLDWSKRFHIICGTARGLLYLHQ 503
LG C G L+ + P SL + +S +LL+W + A+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLEE 127
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
R++HR+L A N+LL D +I+DFG+A
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 5e-12
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISDQGLKELKNEVILFSKLQHRN 443
F+ ++G G FG VY V E+ A+K++S K S++ +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
++ GC + L+ E+ + D + + K L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ +IHRD+KA N+LL K++DFG A
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 23/165 (13%)
Query: 389 SINNKLGEGGFGPVYKGTLVDGQEI---AVK--RLSKISDQGLKELKNEVILFSKLQHRN 443
++ LGEG FG V +G L I AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 444 LVKLLGCCIHGEEK------LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HII 491
+++L+G C+ E ++I FM + L F+ S+L D + +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFM 118
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ YL S IHRDL A N +L+ +MN ++DFGL++
Sbjct: 119 TDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISDQGLKELKNEVILFSKLQHRN 443
FS ++G G FG VY V E+ A+K++S K S++ +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
++ GC + L+ E+ + D + + K L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ +IHRD+KA N+LL K+ DFG A
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 394 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
+G G FG V+ LV ++I V++++K + NE + L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
+ + +++ E+ P +L +I + NS LLD H L ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 508 RIIHRDLKASNVLLD-HDMNPKISDFGLARTCG 539
I+HRDLK N+LLD H M KI DFG+++
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 392 NKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISDQGLKELKNEVILFSKLQHRNLVKL 447
+++G G FG VY T E+ AVK++S K +++ +++ EV +L+H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
GC + L+ E+ + D + + K L + I G +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLA 535
+IHRD+KA N+LL K++DFG A
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQEIAV-KRLSKISDQGLKELKNEVILFSKLQH 441
N + I +LG+G FG VYK + +A K + S++ L++ E+ + + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICG-TARGLLY 500
N+VKLL + ++ EF ++D + + + ++C T L Y
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNY 118
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
LH++ +IIHRDLKA N+L D + K++DFG++
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 45/175 (25%), Positives = 92/175 (52%), Gaps = 10/175 (5%)
Query: 375 LFELATISNATNNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELK-NE 432
L + ++ + ++ K+G+G G VY + GQE+A+K+++ + Q KEL NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
+++ + ++ N+V L + G+E ++ E++ SL D +D + +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 388 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQH 441
F++ LG+G FG V + L Q++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 442 RNLVKLLGCCIHGEEK------LLIYEFMPNKSLDYFIF-----DQTNSKLLDWSKRFHI 490
N++KL+G + K ++I FM + L F+ ++ + L RF I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ YL S IHRDL A N +L+ +M ++DFGL++
Sbjct: 121 --DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 11/178 (6%)
Query: 359 ETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 418
++ E++D + D +P + A A+ +++ L G G V+ T GQ V +
Sbjct: 39 DSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--V 95
Query: 419 SKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTN 478
KI +G + E +L + H +++++ + G ++ +P+ S D + +
Sbjct: 96 LKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR 150
Query: 479 SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
S+ L + I GL YLH RIIHRD+K N+ ++ I D G A+
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 394 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISDQGLKELKNEVILFSKL-QHRNLV 445
LG+G FG V KGT + AVK L K + D ++ E + + +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 446 KLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+L C +++L + E++ L + I Q + + + RF+ GL +LH+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHER 115
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR--TCGGDKT 543
II+RDLK NVLLD + + KI+DFG+ + GG T
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453
+G+G FG V G G ++AVK + +D + E + ++L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 454 GEEKLLIY-EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
+ L I E+M SL ++ + S +L + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 513 DLKASNVLLDHDMNPKISDFGLAR 536
DL A NVL+ D K+SDFGL +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 393 KLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISDQGLKELKNEVILFSKLQHRNLVKLL 448
++G G FG VY V E+ A+K++S K S++ +++ EV +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
GC + L+ E+ + D + + K L + I G +GL YLH R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLARTC 538
IHRD+KA N+LL K++DFG A
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLV 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 335 SAVALLAVVLISGYLIHKRRRNIAETDQ-ENEDQNIDLELPLFELATISNATNNFSIN-- 391
+ A L + L++ + R RN E + ENED EL F+ S + + +IN
Sbjct: 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT--WELQFFD----SKVSKSITINDI 688
Query: 392 -------NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN 443
N + G G YKG ++ +G + VK ++ ++ +E+ KLQH N
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPN 744
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+VKL+G C + LI+E++ K+L + + L W +R I G A+ L +LH
Sbjct: 745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHC 798
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKI 529
++ +L +++D P +
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISDQGLKELKNEVILFSKLQ 440
N+ + LG+G FG VY D G+E+AVK++ S + + + L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 441 HRNLVKLLGCCIHGEEKLL--IYEFMPNKSLDYFIFDQTNS--KLLDWSKRFHIICGTAR 496
H +V+ GC E+ L E MP S I DQ S L + R +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTR-QILE 117
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
G+ YLH + I+HRD+K +N+L D N K+ DFG ++
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 10/144 (6%)
Query: 393 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCC 451
K+GEG G V T G+++AVK++ Q + L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC-GTARGLLYLHQDSRLRII 510
+ G+E ++ EF+ +L + T++++ + ++ +C R L YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV---THTRMNE--EQIATVCLSVLRALSYLHNQG---VI 140
Query: 511 HRDLKASNVLLDHDMNPKISDFGL 534
HRD+K+ ++LL D K+SDFG
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 389 SINNKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISDQGLKEL-KNEVILFSKLQHRN 443
++ +GEG FG VY+G + + +AVK + ++E E + + H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+VKL+G ++ E P L ++ Q N LD + + L YL
Sbjct: 69 IVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
R +HRD+ A NVL+ K+ DFGL+R
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 43/162 (26%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 375 LFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELK-NE 432
L + ++ + ++ K+G+G G VY + GQE+A+++++ + Q KEL NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINE 67
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
+++ + ++ N+V L + G+E ++ E++ SL D +D + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 123
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534
+ L +LH + ++IHRD+K+ N+LL D + K++DFG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 29/149 (19%)
Query: 407 LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464
V GQ +A+K+LS+ + K E++L + H+N++ LL F
Sbjct: 38 TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FT 85
Query: 465 PNKSLDYF--------IFD----QTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512
P KSL+ F + D Q LD + +++ G+ +LH IIHR
Sbjct: 86 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHR 142
Query: 513 DLKASNVLLDHDMNPKISDFGLARTCGGD 541
DLK SN+++ D KI DFGLART G
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 37/179 (20%)
Query: 388 FSINNKLGEGGFGPVY------------KGTLVDGQE-----IAVKRLSKISDQG----- 425
+ KLGEG FG V+ K +D +AVK L + +++
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 426 LKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI--------FDQT 477
LKE+K + S+L+ N+++LL CI + +I E+M N L+ F+ ++
Sbjct: 67 LKEIK----IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 478 NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ + +S + A G+ YL S L +HRDL N L+ + KI+DFG++R
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 393 KLGEGGFGPVYKGTLVDG---QEIAVKRL-SKISDQGLKELKNEVILFSKLQHRNLVKLL 448
++G G FG V G + G ++ VK L S Q + E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLL--DWSKRFHIICGTARGLLYLHQDSR 506
G C LL+ EF P L ++ ++L+ D + + C A GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLA 535
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 59/166 (35%), Positives = 80/166 (48%), Gaps = 24/166 (14%)
Query: 394 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
LG+GGFG V G L +++ KRL K +G + E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 448 LGCCIHGEEKL-LIYEFMPNKSLDYFIF--DQTNSKLLDWSKRFH---IICGTARGLLYL 501
+ L L+ M L Y I+ D+ N + F+ II G L +L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHL 113
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC--GGDKTEG 545
HQ RII+RDLK NVLLD+D N +ISD GLA G KT+G
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 3e-11
Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 15/169 (8%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVK 446
F + +G G +G VYKG V ++A ++ ++ +E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 447 LLGCCIH------GEEKLLIYEFMPNKSLDYFIFDQTNSKLLD-WSKRFHIICGTARGLL 499
G I ++ L+ EF S+ I + + L + W +I RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLS 125
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
+LHQ ++IHRD+K NVLL + K+ DFG++ D+T G N
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 169
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 51/185 (27%)
Query: 393 KLGEGGFGPVYKGTLVDGQE-----------------IAVKRLSKISDQG-----LKELK 430
KLGEG FG V+ +V+ Q+ +AVK L +++ LKE+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 431 NEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLD------- 483
+ S+L+ N+++LLG C+ + +I E+M N L+ F+ ++ L D
Sbjct: 72 ----ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGND 124
Query: 484 ------------WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531
+S H+ A G+ YL S L +HRDL N L+ ++ KI+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 532 FGLAR 536
FG++R
Sbjct: 182 FGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 52/183 (28%)
Query: 378 LATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISDQGLKELK 430
T+ TN + +G G FG V + GQ +A+K++ K ++ + +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 431 NEVILFSKLQHRNLV-----------------KLLGCCIHGEEKLLIYEFMPNKSLDYFI 473
L L+H N++ +LLG +H +LL + + + YF+
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLH---RLLTSRPLEKQFIQYFL 114
Query: 474 FDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533
+ RGL Y+H ++HRDLK SN+L++ + + KI DFG
Sbjct: 115 YQ------------------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFG 153
Query: 534 LAR 536
LAR
Sbjct: 154 LAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 54/152 (35%), Positives = 78/152 (51%), Gaps = 20/152 (13%)
Query: 393 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLGC 450
KLGEG + VYKG + V+G+ +A+K + ++G E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLHD 70
Query: 451 CIHGEEKL-LIYEFMPNKSLDYFI-----FDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
IH +E L L++E++ Y N KL F ++ RGL Y+HQ
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLF----LFQLL----RGLSYIHQR 122
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
I+HRDLK N+L+ K++DFGLAR
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKN-----EVILFSKLQHRNLVKL 447
+G G FG V K G +AVKR+ D+ KE K +V++ S +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSS-DCPYIVKF 68
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYF---IFDQTNSKLLDWSKRF--HIICGTARGLLYLH 502
G + + E M + SLD F +++ S + + I T + L YL
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLK 124
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
++ L+IIHRD+K SN+LLD + N K+ DFG++
Sbjct: 125 EE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 20/151 (13%)
Query: 394 LGEGGFGPVYKGTLV-DGQEIAVKRLS-KISDQGLKELKNEVILFSKLQH---RNLVKLL 448
+G G +G VY+G V G+ +A+K ++ D + +++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLL----YLHQD 504
G + G +I E+ S+ +T K ++++ I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKY--ISVIIREVLVALKYIHKV 120
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+IHRD+KA+N+L+ + N K+ DFG+A
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 393 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLGC 450
++G G FG V+ G L D +AVK + LK + E + + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRII 510
C + ++ E + + D+ F +T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 511 HRDLKASNVLLDHDMNPKISDFGLAR 536
HRDL A N L+ KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISDQGLKE---LKNEVILFSKLQH 441
+F I ++G+GG+G V+ D EI A+KR+ K L E + E + + +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI---ICGTARGL 498
LVKLL E L E++P D+ L + RF++
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFEAVDA-- 116
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
LH L IHRDLK N L+D + K++DFGL+
Sbjct: 117 --LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 6e-11
Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQH 441
N +F + ++G G +G VYK V+ E+A ++ K+ + ++ E+I+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
N+V G + ++ + EF SL I+ T L S+ ++ T +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
H + +HRD+K +N+LL + + K++DFG++
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 387 NFSINNKLGEGGFGPVYK-------GTLVDGQEIAVKRLS-----KISDQGLKELKNEV- 433
+++ LG G FG VYK L+ +EI V + + D+ + ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 434 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DYFIFDQTNSKLLDWSKRFHIIC 492
I+ +L+H N+V+ + + ++ + + L ++F + + + ++I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L YLH++ R I+HRDL +N++L D I+DFGLA+
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 20/153 (13%)
Query: 392 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLG 449
+KLGEG + V+KG + + +A+K + ++G EV L L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 450 CCIHGEEKL-LIYEFMPNKSLDYF-----IFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
IH E L L++E++ + Y + N K+ F ++ RGL Y H
Sbjct: 71 I-IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIF----MFQLL----RGLSYCH- 120
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ +I+HRDLK N+L++ K++DFGLAR
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 49/148 (33%), Positives = 80/148 (54%), Gaps = 10/148 (6%)
Query: 392 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLG 449
KLGEG + V+KG + + +A+K + ++G EV L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 450 CCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
+H ++ L L++E++ +K L ++ D N + K F + RGL Y H R +
Sbjct: 72 I-VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRK 124
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLAR 536
++HRDLK N+L++ K++DFGLAR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452
+LG G FG V G ++A+K + + S E E + KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 453 HGEEKLLIYEFMPNKSLDYFIFDQ----TNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
++ E+M N L ++ + S+LL+ K +C G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD---VC---EGMAYLESK---Q 120
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLAR 536
IHRDL A N L+D K+SDFGL+R
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 44/177 (24%), Positives = 71/177 (40%), Gaps = 54/177 (30%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISD------QGLKELKNEVILFS 437
+ +G G +G V +D G+++A+K++ D + L+ELK +
Sbjct: 6 RYKPIENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILR 59
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD---YFIFDQTNSKLLDWSKRFHIICGT 494
+H N++ + P + Y + D S L HII
Sbjct: 60 HFKHDNIIAIRDI------------LRPPGADFKDVYVVMDLMESDL------HHIIHSD 101
Query: 495 A---------------RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
RGL Y+H + +IHRDLK SN+L++ D +I DFG+AR
Sbjct: 102 QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 20/151 (13%)
Query: 392 NKLGEGGFGPVYK----GTLVDGQEIAVKRL-SKISDQGLKELKNEVILFSKLQHRNLVK 446
N++G G G VYK T G+ A+K + D +++ E+ + + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLD-YFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
H E ++ EFM SL+ I D+ L D +++ I+ G A YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADE--QFLADVARQ--ILSGIA----YLH--- 185
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
R I+HRD+K SN+L++ N KI+DFG++R
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216
|
Length = 353 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 39/160 (24%), Positives = 75/160 (46%), Gaps = 13/160 (8%)
Query: 394 LGEGGFGP--VYK----GTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
LG+G FG +Y+ +LV +E+ + RLS ++ ++ NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
+ L+ E+ +L Y + +L + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
I+HRD+K N+ L K+ DFG+++ G + + T
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 56/181 (30%), Positives = 85/181 (46%), Gaps = 36/181 (19%)
Query: 392 NKLGEGGFGPVYKG-TLVDGQEIAVKR-LSKISDQG-----LKELKNEVILFSKLQHRNL 444
K+G+G FG V+K Q +A+K+ L + +G L+E+K IL L+H N+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENV 73
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD-----------QTNSKL-LDWSKRFHIIC 492
V L+ C + + K Y +F+ N K L K+ ++
Sbjct: 74 VNLIEIC-RTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMK 126
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG---GDKTEGNTNR 549
GL Y+H R +I+HRD+KA+N+L+ D K++DFGLAR K TNR
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 550 V 550
V
Sbjct: 184 V 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 13/170 (7%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLV 445
F+ ++G+G FG VYKG +E+ ++ + ++ +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+ G + G + +I E++ S D L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYGT 555
R IHRD+KA+NVLL + K++DFG+A G T+ R GT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 10/144 (6%)
Query: 393 KLGEGGFGPV-YKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCC 451
K+GEG G V G+++AVK + Q + L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA-RGLLYLHQDSRLRII 510
+ GEE ++ EF+ +L + S+ ++ +C + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 511 HRDLKASNVLLDHDMNPKISDFGL 534
HRD+K+ ++LL D K+SDFG
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 54/170 (31%), Positives = 73/170 (42%), Gaps = 40/170 (23%)
Query: 386 NNFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK--ISDQGLKE-LKNEVILFSK 438
++F LG G FG V +KG+ G+ A+K LSK I E + NE +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNS----KLLDWSKRFHIICGT 494
++H LV L G F + +L Y + + L S RF
Sbjct: 58 IRHPFLVNLYGS------------FQDDSNL-YLVMEYVPGGELFSHLRKSGRFPE--PV 102
Query: 495 AR--------GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
AR L YLH L I++RDLK N+LLD D KI+DFG A+
Sbjct: 103 ARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 387 NFSINNKLGEGGFGPVY--KGTLVDGQEIAVKR--LSKISDQGLKELKNEVILFSKLQHR 442
+ I K+GEG FG +Y K D + +K L+K+ + + K EVIL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ-----TNSKLLDWSKRFHIICGTARG 497
N+V ++ E+ L I Q + ++L W + G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLG 113
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLART 537
L ++H +I+HRD+K+ N+ L + M K+ DFG+AR
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 49/148 (33%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGC 450
+LG G FG V+ G ++A+K +++ +S++ E E + KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI-IC-GTARGLLYLHQDSRLR 508
C + ++ EFM N L ++ Q KL SK + +C G+ YL ++S
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL-RQRQGKL---SKDMLLSMCQDVCEGMEYLERNS--- 120
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLAR 536
IHRDL A N L+ K+SDFG+ R
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 51/170 (30%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISD------QGLKELKNEVILFSKLQHRNLVK 446
+G G +G V + +++A+K+++ D + L+E+K L L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVIA 68
Query: 447 LLGCC--IHGE---EKLLIYEFM---------PNKSL-----DYFIFDQTNSKLLDWSKR 487
+ H E + ++YE M +++L YF++ +LL
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY-----QLL----- 118
Query: 488 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGLART
Sbjct: 119 --------RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/185 (31%), Positives = 89/185 (48%), Gaps = 24/185 (12%)
Query: 378 LATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV-IL 435
L ++ + T+ + I +G+G +G VYK T DG AVK L ISD +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 436 FSKLQHRNLVKLLGC------CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF- 488
S H N+VK G + G+ L+ E S+ + LL +R
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELV-----KGLLICGQRLD 126
Query: 489 -----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG++ +
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 544 EGNTN 548
NT+
Sbjct: 184 RRNTS 188
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 13/170 (7%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLV 445
F+ K+G+G FG V+KG Q++ ++ + ++ +++++ E+ + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
K G + + +I E++ S D LD ++ I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYGT 555
+ IHRD+KA+NVLL K++DFG+A G T+ R GT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 393 KLGEGGFGPVYKG---TLVDGQEIAVKRLSKIS-DQGLK-ELKNEVILFSKLQHRNLVKL 447
+LG G FG V KG + +AVK L + D LK EL E + +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
+G C E +L+ E L+ F+ + + ++ H + + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
+HRDL A NVLL KISDFGL++ G D+
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 24/168 (14%)
Query: 397 GGFGPVY----KGTLVDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLG 449
G +G V+ K T G A+K + K I + ++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 450 CCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
G++ L L+ E++P L + + S D ++ I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVAR--IYIAEIVLALEYLHS---NG 113
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLA------RTCGGDKTEGNTNRV 550
IIHRDLK N+L+D + + K++DFGL+ R + E R+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISDQGLKELKNEVILFSKLQHR 442
NF I K+G G F VY+ T L+D + +A+K++ + + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLD-----WSKRFHIICGTARG 497
N++K L I E ++ E L I K L W K F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H SR R++HRD+K +NV + K+ D GL R
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 384 ATNNFSINNKLGEGGFGPVY----KGTLVDGQE--IAVKRLSKISDQGLK-ELKNEVILF 436
A +++ +LG+G FG VY KG + D E +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 437 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD-----QTNSKLL--DWSKRFH 489
+ ++V+LLG G+ L+I E M L ++ + N K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ A G+ YL+ + + +HRDL A N ++ D KI DFG+ R
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 50/164 (30%), Positives = 70/164 (42%), Gaps = 37/164 (22%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGC 450
+G G +G V G+++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 451 CIHGEEKLLIYEFMPNKSLDYF----------------IFDQTNSKLLDWSKRFHIICGT 494
F P SL+ F I KL D +F ++
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQF-LVYQI 127
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538
RGL Y+H IIHRDLK SN+ ++ D KI DFGLAR
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 49/165 (29%), Positives = 84/165 (50%), Gaps = 23/165 (13%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISDQG----LKELKNEVILFSKLQH 441
+ N++ EG +G VY+ EI A+K+L K+ + + L+ E+ + KLQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQH 63
Query: 442 RNLVKL----LGCCIHGEEKLLIYEFMPN--KSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
N+V + +G + + ++ E++ + KSL +T + S+ ++
Sbjct: 64 PNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLM-----ETMKQPFLQSEVKCLMLQLL 116
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540
G+ +LH + I+HRDLK SN+LL++ KI DFGLAR G
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 394 LGEGGFGPVYKGTLV--DGQE------IAVKRL-SKISDQGLKELKNEVILFSKL-QHRN 443
LGEG FG V + D ++ +AVK L S +++ L +L +E+ + + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFI-----------FDQTNSKLLDWSKRFHIIC 492
++ LLG C +I E+ +L ++ ++ T S + + C
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 493 G--TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
ARG+ YL + + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQG--LKELKNEVILFSKLQ 440
N +++ + ++G G +G VYK + E+A ++ K+ + G ++ E+ + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DYFIFDQTNSKLLDWSKRFHIIC-GTARGL 498
H N+V G + E+ + E+ SL D + S+L + +C T +GL
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-----QIAYVCRETLQGL 119
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
YLH ++ HRD+K +N+LL + + K++DFG+A
Sbjct: 120 AYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 21/160 (13%)
Query: 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQHRNLVKLLG 449
LG GGFG V + + A+K + K I + G +E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 450 CCIHG--EEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+ ++K IY E+ L + D +++ RF+I C YLH
Sbjct: 59 ---YRTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIACVV-LAFEYLH-- 110
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG-GDKT 543
II+RDLK N+LLD + K+ DFG A+ G KT
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT 149
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 15/171 (8%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQEI-AVK--RLSKISDQGLKELKNEVILFSKLQHRNL 444
F+ ++G+G FG V+KG Q++ A+K L + D+ +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
K G + G + +I E++ S D + D + ++ +GL YLH +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYGT 555
+ IHRD+KA+NVLL + K++DFG+A G T+ R GT
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 21/161 (13%)
Query: 394 LGEGGFGPVYKGTLV-DGQEI--AVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLL 448
+GEG FG V + + DG ++ A+K L + S+ ++ E+ + KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA-----RGLLYLHQ 503
G C + + E+ P +L F+ S++L+ F GTA + LL
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 504 D--------SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
D S + IHRDL A NVL+ ++ KI+DFGL+R
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 49/177 (27%)
Query: 393 KLGEGGFGPVYKGTLV----DGQEIAVKRL--SKISDQGLKELKNEVILFSKLQHRNLVK 446
K+GEG FG K LV DG++ +K + SK+S + +E + EV + S ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYF----IFDQTNSK---------LLDWSKRFHIICG 493
EE +Y M DY ++ + N++ +LDW F IC
Sbjct: 64 YQESF---EENGNLYIVM-----DYCEGGDLYKKINAQRGVLFPEDQILDW---FVQIC- 111
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG----------LARTCGG 540
L ++H +I+HRD+K+ N+ L D K+ DFG LARTC G
Sbjct: 112 --LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIG 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 53/161 (32%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 394 LGEGGFGPVYKGTLV-DGQEI--AVKRLSK-ISDQGLKELKNEVILFSKL-QHRNLVKLL 448
+GEG FG V K + DG + A+KR+ + S ++ E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA-----RGLLYLHQ 503
G C H L E+ P+ +L F+ S++L+ F I TA + LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 504 D--------SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
D S+ + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 10/154 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISDQGL-KELKNEVILFSKLQHRN 443
++LGEG G V K L + I A+K ++ + L K++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 444 LVKLLGCCI--HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF--HIICGTARGLL 499
+VK G + + E+ SLD I+ + + ++ I +GL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533
YLH +IIHRD+K SN+LL K+ DFG
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 43/177 (24%), Positives = 74/177 (41%), Gaps = 42/177 (23%)
Query: 390 INNKLGEGGFGPVYKG-TLVDGQEIAVKRL-------------SKISDQG-----LKELK 430
LGEG +G V K + G+ +A+K++ + G L+ELK
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 431 NEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF-- 488
+ ++++H N++ L+ + G+ L+ + M K++D R
Sbjct: 73 ----IMNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTE 118
Query: 489 -HIIC---GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
+ C GL LH+ +HRDL +N+ ++ KI+DFGLAR G
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
|
Length = 335 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 26/172 (15%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQE--------IAVKRLSK-ISDQGLKELKNEVILFSK 438
++ LGEG FG V + + +AVK L +D+ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI-----------FDQTNSKLLDWSK 486
+ +H+N++ LLG C ++ E+ +L ++ FD +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 487 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ + C ARG+ YL + + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 393 KLGEGGFGPVYKGT--LVDGQ-EIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLL 448
+LG G FG V KG + Q ++A+K L +++ ++ E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
G C E +L+ E L+ F+ + + + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
+HRDL A NVLL + KISDFGL++ G D
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 29/144 (20%)
Query: 408 VDGQEIAVKRLSK-ISDQG-LKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465
V G +AVK+LS+ +Q K E++L + H+N++ LL F P
Sbjct: 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTP 91
Query: 466 NKSLD-----YFIFDQTNSKL-------LDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 513
KSL+ Y + + ++ L LD + +++ G+ +LH IIHRD
Sbjct: 92 QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRD 148
Query: 514 LKASNVLLDHDMNPKISDFGLART 537
LK SN+++ D KI DFGLART
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLART 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 29/143 (20%)
Query: 411 QEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 468
+ +A+K+LS+ + K E++L + H+N++ LL F P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 469 LD-----YFIFDQTNSKL-------LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 516
L+ Y + + ++ L LD + +++ G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 517 SNVLLDHDMNPKISDFGLARTCG 539
SN+++ D KI DFGLART G
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 34/163 (20%)
Query: 394 LGEGGFGPV---YKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLL 448
+G G G V Y L + +A+K+LS+ + K E++L + H+N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 449 GCCIHGEEKLLIYEFMPNKSLD-----YFIFDQTNSKL-------LDWSKRFHIICGTAR 496
F P KSL+ Y + + ++ L LD + +++
Sbjct: 83 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
G+ +LH IIHRDLK SN+++ D KI DFGLART G
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 394 LGEGGFGPV------YKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
LG+GGFG V G + +++ KRL K S + + L+ E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
L+ M L Y I++ + L+ + H G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
I++RD+K NVLLD N ++SD GLA KT
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 28/155 (18%)
Query: 394 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISDQGLKELKNEVILF---SKLQHRN 443
LG G FG V YK T G+ A+K L K I+ ++ L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFI----FDQTNSKLLDWSKRFHIICGTARGLL 499
LV L C + + E+ L I F + + F+ C GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV-------FYAAC-VVLGLQ 115
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534
YLH++ +I++RDLK N+LLD + KI+DFGL
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 393 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGL--KELKNEVILFSKLQHRNLVKLLG 449
K+GEG +G V+K + GQ +A+K+ + D + K E+ + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 450 CCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRI 509
+ L++E+ + L+ + N + + II T + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNC 121
Query: 510 IHRDLKASNVLLDHDMNPKISDFGLARTCGG 540
IHRD+K N+L+ K+ DFG AR G
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISD----QGLKELKNEVILFSKLQH 441
NF I K+G G F VY+ T L+DG +A+K++ +I D + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLD-----WSKRFHIICGTAR 496
N++K I E ++ E L I K L W K F +C
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE 120
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H SR R++HRD+K +NV + K+ D GL R
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 30/163 (18%)
Query: 393 KLGEGGFGPVYKG-TLVDGQEIAVKR-LSKISDQGLKELK-NEVILFSKLQHRN-LVKLL 448
K+GEG +G VYK G+ +A+K+ ++ ++G+ E+ L L +V+LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA------------- 495
H EEK K Y +F+ +S L + G
Sbjct: 68 -DVEHVEEK-------NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 496 -RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP-KISDFGLAR 536
+G+ + H + ++HRDLK N+L+D KI+D GL R
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 15/145 (10%)
Query: 394 LGEGGFGPVYK----GTLVDGQEIAVKR--LSKISDQGLKELKNEVILFSKLQHRNLVKL 447
+ + K TLV AVK+ L S + LK L+ E+I +LQH N++
Sbjct: 10 FEDLMIVHLAKHKPTNTLV-----AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
+ I E ++ M S + + L + + F I+ L Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHS---K 120
Query: 508 RIIHRDLKASNVLLDHDMNPKISDF 532
IHR +KAS++LL D +S
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLS-KISDQGLKELKNEVILF 436
+ ++ LGEG FG V + + +AVK L +++ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 437 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI-----------FDQTNSKLLDW 484
+ +H+N++ LLG C +I E+ +L ++ +D
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 485 SKRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ + + C ARG+ YL + + IHRDL A NVL+ + KI+DFGLAR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 17/158 (10%)
Query: 393 KLGEGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLV 445
+LG+G FG VY+G ++ G+ +AVK +++ S + E NE + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIF-------DQTNSKLLDWSKRFHIICGTARGL 498
+LLG G+ L++ E M + L ++ + + + A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
YL+ + +HRDL A N ++ HD KI DFG+ R
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 394 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKE------LKNEVILFSKLQHRNLVK 446
LG+G FG V L G+ AVK L K D L++ + + IL H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKK--DVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 447 LLGCCIHGEEKLL-IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
L CC ++L + EF+ L + I Q + + + RF+ T+ L++LH
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITS-ALMFLHDKG 116
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
II+RDLK NVLLDH+ + K++DFG+ +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 389 SINNKLGEGGFGPVYKG--TLVDGQE--IAVKRL-SKISDQGLKELKNEVILFSKLQHRN 443
I LG G FG + +G L +E +A+ L + SD+ + E + + H N
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+V+L G G +++ E+M N +LD F+ + + L + ++ G A G+ YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL-- 123
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFG 533
S + +H+ L A VL++ D+ KIS F
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 48/156 (30%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLG- 449
+G G +G V G+++A+K+LS+ S+ K E+ L +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 450 --CCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
+ G+E Y MP D + L K +++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
IIHRDLK N+ ++ D KI DFGLAR + T
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 172
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 13/146 (8%)
Query: 397 GGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELKN----EVILFSKLQHRNLVKLLGCC 451
G FG VY G A+K L K ++ N I+ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKL-LDWSKRFHIICGTARGLLYLHQDSRLRII 510
+ L+ E++ I +T L DW+K++ I G+ LHQ II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119
Query: 511 HRDLKASNVLLDHDMNPKISDFGLAR 536
HRD+K N+L+D + K++DFGL+R
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 52/161 (32%), Positives = 74/161 (45%), Gaps = 35/161 (21%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGL---KELKNEVILFSKLQHRNLVKLLG 449
+G G +G V Q++AVK+LS+ Q L + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 450 CCIHGEEKLLIYEFMPNKSLDYF--IFDQTN------------SKLLDWSKRFHIICGTA 495
F P S++ F ++ TN KL D +F +I
Sbjct: 82 V------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLL 128
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
RGL Y+H IIHRDLK SNV ++ D +I DFGLAR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISDQGLKELKNEVILFSKLQHR 442
+ +G G FG V+ + A+K ++ I + + + NE + ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 443 NLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGL 498
+++L H + L ++ E++P L F + + + + + + F+ I+C L
Sbjct: 62 FIIRLF-WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCA----L 114
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
YLH I++RDLK N+LLD + + K++DFG A+
Sbjct: 115 EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 52/160 (32%), Positives = 73/160 (45%), Gaps = 33/160 (20%)
Query: 394 LGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGL--KELKNEVILFSKLQHRNLVKLLGC 450
+G G +G V G +AVK+LS+ + K E+ L ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 451 CIHGEEKLLIYEFMPNKSLDYF--IF--------DQTN----SKLLDWSKRFHIICGTAR 496
F P +SL+ F ++ D N KL D +F +I R
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 131
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
GL Y+H IIHRDLK SN+ ++ D KI DFGLAR
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 29/175 (16%)
Query: 387 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSKISDQ------GLKELKNEVILF 436
+ + +LG+G +G V T + + +A+K+++ + + L+ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 437 SKLQHRNLVKLLGCCI---HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--- 490
H+N+ L I +L +YE + L I ++ L D H
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTD----AHFQSF 110
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEG 545
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR + E
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 17/156 (10%)
Query: 393 KLGEGGFGPVYKGTLVD--GQEIAVKRLS-KISDQG--LKELKNEVIL--FSKLQHRNLV 445
++GEG +G V+K + G+ +A+KR+ + ++G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 446 KLLGCCIHG----EEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
+L C E KL L++E + Y D+ + ++ RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
LH R++HRDLK N+L+ K++DFGLAR
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 34/164 (20%)
Query: 394 LGEGGFGPVYKGTLVD---GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL--- 447
LG G G V+ VD + +AVK++ Q +K E+ + +L H N+VK+
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 448 -----------LGCCIHGEEKLLIYEFMPN---KSLDYFIFDQTNSKLLDWSKRFHIICG 493
+G ++ E+M L+ + +++L +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ-------- 122
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLAR 536
RGL Y+H + ++HRDLK +NV ++ D+ KI DFGLAR
Sbjct: 123 LLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 17/151 (11%)
Query: 394 LGEGGFGPVYKGTLV-DGQEIAVKRL-SKISDQGLKELKNEV-ILFSKLQHRNLVKLLGC 450
LG G +G V K V G +AVKR+ + ++ Q K L ++ I + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTARGLLYLHQD 504
+ + E M + SLD F K+ D I + L YLH
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH-- 120
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
S+L +IHRD+K SNVL++ + K+ DFG++
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 48/165 (29%), Positives = 74/165 (44%), Gaps = 15/165 (9%)
Query: 394 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLG 449
LG+GGFG V + G+ A KRL K +G NE + K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 450 CCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQDSR 506
+ L+ M L + I++ N + F+ I+CG L LH+++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN- 122
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLA-RTCGGDKTEGNTNRV 550
++RDLK N+LLD + +ISD GLA + G+ G V
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 393 KLGEGGFGPVYKGTLVD-GQEIAVKRLS-KISDQGLK-ELKNEVILFSKLQ---HRNLVK 446
++G G +G VYK G +A+K + + ++ GL EV L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 447 LLGCCIHG----EEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
L+ C E K+ L++E + Y D+ L ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H + I+HRDLK N+L+ K++DFGLAR
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 394 LGEGGFGPVYKGTLVD---------GQEIAVKRLSKISDQGLK---ELKNEVILFSKLQH 441
LG+G F +YKG L GQE++V K+ + L S+L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVL--KVLGSDHRDSLAFFETASLMSQLSH 60
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
++LVKL G C+ +E +++ E++ LD F+ + N+ L W + + A L YL
Sbjct: 61 KHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 502 HQDSRLRIIHRDLKASNVLL-DHDMNP------KISDFGLARTCG 539
+++H ++ N+L+ + +N K+SD G+ T
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 20/153 (13%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIA---VKRLSKISDQGLKELKNEVIL----FSKLQHRNLV 445
++G G FG V + +A VK L ++ KE +NE + + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNIL 58
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQT----NSKLLDWSKRFHIICGTARGLLYL 501
+ LG C+ LL++E+ L ++ + NS+LL + + C A G+ ++
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHM 115
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534
H + +H DL N L D+ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK----ISDQGLKELKNEVILFSKLQHRNLVKLL 448
LG+G FG V L E A+K L K D + +L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 449 GCCIHGEEKLL-IYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQD 504
C +E L + E++ L + I Q++ + + RF+ IICG L +LH+
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICG----LQFLHKK 115
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
II+RDLK NVLLD D + KI+DFG+ +
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 394 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELK------NEVILFSKLQHRNLVK 446
LG+GGFG V + G+ A K+L K + +K+ K NE + K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQ 503
L + L+ M L + I+ + + F+ I CG L LHQ
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQ 120
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ RI++RDLK N+LLD + +ISD GLA
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 40/169 (23%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISDQGLKELKNEVILFSKLQH 441
++F + +G G FG V+ LV GQ A+K L K SD +K I + +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRK-SDM----IKRNQIAHVRAE- 51
Query: 442 RN---------LVKLLGCCIHGEEKL-LIYEFMPNKSL-----DYFIFDQTNSKLLDWSK 486
R+ +VKL EE L L+ E+MP L +F + + +
Sbjct: 52 RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETA- 103
Query: 487 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
RF+I A +L L +L IHRD+K N+L+D D + K++DFGL
Sbjct: 104 RFYI----AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 31/159 (19%)
Query: 394 LGEGGFGPV-YKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGC 450
+G G +G V G ++A+K+L + S+ K E+ L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 451 CIHGEEKLLIYEFMPNKSLDYFI-------FDQTN-SKLLDWSK----RFH-IICGTARG 497
F P+ SLD F F T+ KL+ K R ++ +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L Y+H IIHRDLK N+ ++ D KI DFGLAR
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 50/159 (31%), Positives = 68/159 (42%), Gaps = 33/159 (20%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV----ILFSKLQHRNLVKLL 448
+G+G FG V DG+ AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNS-----------KLLDWSKRFHIICGTARG 497
H Y F L YF+ D N + RF+ A
Sbjct: 62 ----H-------YSFQTADKL-YFVLDYVNGGELFFHLQRERSFPEPRARFYA-AEIASA 108
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L YLH L II+RDLK N+LLD + ++DFGL +
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-07
Identities = 22/48 (45%), Positives = 27/48 (56%), Gaps = 6/48 (12%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYP 49
VVWS++ ++ VL LLD GNLVL G + WQSFDYP
Sbjct: 75 TVVWSSNTTRVNG--NYVLVLLDDGNLVLY----DSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 32/165 (19%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKN-----EVILFSKL 439
N+ ++G G G VYK G +AVK++ + ++ +E K +V+L S
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS-- 70
Query: 440 QHR--NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF-------HI 490
H +VK G I + + E M + LD KLL + +
Sbjct: 71 -HDCPYIVKCYGYFITDSDVFICMELM-STCLD---------KLLKRIQGPIPEDILGKM 119
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ L YL + +IHRD+K SN+LLD N K+ DFG++
Sbjct: 120 TVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 26/155 (16%)
Query: 394 LGEGGFGPVYKGTLV----DGQEIAVK--RLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
+GEG FG + LV Q+ A+K RL K S +++ + E +L +K++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 448 LGCCIHGEEKL-LIYEFMPNKSLDYFIFDQ-----TNSKLLDWSKRFHIICGTARGLLYL 501
+ L ++ E+ L I Q +L W F +C G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHI 116
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H+ R++HRD+K+ N+ L + K+ DFG AR
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 21/160 (13%)
Query: 394 LGEGGFGPVYKGT---LVDGQEIAVKR-LSKISDQGLKELKNEVI----LFSKLQHRNLV 445
LG+G F ++KG + D E+ L K+ D+ + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
G C+ G+E +++ E++ SLD ++ + N L++ S + + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 506 RLRIIHRDLKASNVLL-----DHDMNP---KISDFGLART 537
+ H ++ A NVLL NP K+SD G++ T
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 22/156 (14%)
Query: 392 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELKN--EVILFSKLQ-HRNLVKL 447
K+GEG F V K + G+ A+K + K L+++ N E+ +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQVNNLREIQALRRLSPHPNILRL 63
Query: 448 LGCCIHGEEKL----LIYEFMPNKSLDYFIFD--QTNSKLLDWSKRFHIICGTARGLLYL 501
+ + K L++E M D +++ + + L + + + L ++
Sbjct: 64 --IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
H++ I HRD+K N+L+ D K++DFG R
Sbjct: 117 HRNG---IFHRDIKPENILIKDD-ILKLADFGSCRG 148
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 16/151 (10%)
Query: 394 LGEGGFGPVYKGTLV----DGQEIAVKRLS--KISDQGLKELKNEVILFSKLQHRNLVKL 447
+G+G +G V +LV DG++ +K+L+ S + K + E L S+L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 448 LGCCIHGEEKLL--IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
GE+ LL + F L Y + KLL ++ A L YLH+
Sbjct: 65 RESW-EGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK- 121
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
I+HRDLK NV L K+ D G+AR
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 394 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELK------NEVILFSKLQHRNLVK 446
LG+GGFG V + G+ A K+L K + +K+ K NE + K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQ 503
L + L+ M L + I++ N + F+ I CG L LH
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLH- 119
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
R RI++RDLK N+LLD + +ISD GLA
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 27/158 (17%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI------SDQGLKELKNEVILFSKLQHRNLVK 446
+G G FG V+ T DG+ +A+K++ + + +ELK + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNVLS 63
Query: 447 LLGCCIHG-----EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF--HIICGTARGLL 499
L EE ++ E M + + Q S D K F I+ RGL
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSS--DHVKVFLYQIL----RGLK 117
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
YLH I+HRD+K N+L++ + KI DFGLAR
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 387 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSKISDQGLKELKN---EVILFSKL 439
+F + LG G FG V +KGT G+ A+K L K +K++++ E + +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 440 QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLL-DWSKRFHIICGTARG 497
H +V ++ C E ++ + EF+ L F + + D +K +H A
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYH-----AEL 127
Query: 498 LL---YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+L YLH II+RDLK N+LLD+ + K++DFG A+
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 46/152 (30%), Positives = 69/152 (45%), Gaps = 20/152 (13%)
Query: 394 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELK------NEVILFSKLQHRNLVK 446
LG+GGFG V + G+ A K+L K + +K+ K NE + K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQ 503
L + L+ M L + I++ N + F+ + CG L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LED 117
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
R RI++RDLK N+LLD + +ISD GLA
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 28/200 (14%)
Query: 355 RNIAETDQENEDQNIDLELPLFELATISNATN-----NFSINNKLGEGGFGPVYKGTLVD 409
N + D+E N + E I N N ++ + N +G G FG VY+ +D
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICID 89
Query: 410 GQE-IAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGC----CIHGEEKLL----I 460
E +A+K++ + D K E+++ L H N++ L C EK + +
Sbjct: 90 TSEKVAIKKV--LQDPQYK--NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 461 YEFMP---NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 517
EF+P +K + ++ + L + +C R L Y+H I HRDLK
Sbjct: 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC---RALAYIHSKF---ICHRDLKPQ 199
Query: 518 NVLLDHDMNP-KISDFGLAR 536
N+L+D + + K+ DFG A+
Sbjct: 200 NLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 19/150 (12%)
Query: 394 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
LG G G V K GT++ + + + S + Q L+EL+ + + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 448 LGCCIHGEEKLLIYEFMPNKSLD--YFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
G ++ + EFM SLD Y ++L I GL YL+ +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--N 121
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
RI+HRD+K SN+L++ K+ DFG++
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 39/123 (31%), Positives = 62/123 (50%), Gaps = 13/123 (10%)
Query: 405 GTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464
GTLV + + L +++ LK L+NEV+L +H N++ G +I FM
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 465 PNKSLDYFI---FDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 521
S + + F + S+ L + I+ G RGL YLHQ+ IHR++KAS++L+
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHILI 134
Query: 522 DHD 524
D
Sbjct: 135 SGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 42/168 (25%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL------SKISDQGLKELKNEVILFSK 438
N F + +GEG +G V K + +EI A+K+ ++ + L+ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
L+ N+V+L + L++E++ L+ + + N + + + I + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSY--IYQLIKAI 113
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGN 546
+ H++ I+HRD+K N+L+ H+ K+ DFG AR + +EG+
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR----NLSEGS 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLK-ELKNEVILFSKLQHRNLVKLL 448
LG+G FG V L E+ A+K L K + D + + + IL +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 449 GCCIHGEEKLL-IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
CC +++L + E++ L + I Q + K + RF+ T L++LH+
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTL-ALMFLHRHG-- 116
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
+I+RDLK N+LLD + + K++DFG+ C G T
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGM---CKEGILNGVT 152
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 21/47 (44%), Positives = 26/47 (55%), Gaps = 6/47 (12%)
Query: 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDY 48
RVVWS++ + VL LLD GNLV+ G + WQSFDY
Sbjct: 74 RVVWSSNTTGANG--NYVLVLLDDGNLVIY----DSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 383 NATNNFSINNKLGEGGFGPVYK-GTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ- 440
+ ++ + I +G+G +G V+K +G + AVK L I D +E++ E + L
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSD 73
Query: 441 HRNLVKLLGC-----CIHGEEKLLIYEFMPNKSLDYFIF------DQTNSKLLDWSKRFH 489
H N+VK G +G++ L+ E S+ + ++ ++ +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY----- 128
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
I+ GL +LH + + IHRD+K +N+LL + K+ DFG++ + NT+
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVDGQ--EIAVKRLSK---ISDQGLKELKNEVILFSKLQH 441
+F+ LG G FG V T + +A+KR K I + + + +E + + + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
V L G L+ EF+ ++F F + N + + F+ A+ +L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFY----AAQIVLIF 144
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L I++RDLK N+LLD D K++DFG A+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 25/155 (16%)
Query: 394 LGEGGFGPVY----KGTLVDGQEIAVKRLSK----ISDQGLKELKNEVILFSKLQHRNLV 445
LG+G FG V+ KGT Q A+K L K + D + + +L +H L
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 446 KLLGCCIHGEEKLL-IYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYL 501
L C +E L + E++ L + I Q+ K F+ IICG L +L
Sbjct: 60 HLY-CTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICG----LQFL 112
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H I++RDLK N+LLD D + KI+DFG+ +
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 50/152 (32%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSK----ISDQGLKELKNEVILFSKLQHRNLVKLL 448
LG+G FG V L G+ AVK L K I D + + +L ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 449 GCCIHGEEKLL-IYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQD 504
C +E L + EF+ L + I D+ L + F+ I+CG L +LH
Sbjct: 63 -CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSK 115
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
II+RDLK NV+LD D + KI+DFG+ +
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 53/160 (33%), Positives = 78/160 (48%), Gaps = 34/160 (21%)
Query: 394 LGEGGFGPVY---KGTLVD-GQEIAVKRLSKISDQGLK-----ELKNEVILFSKLQHRNL 444
LG+G FG V+ K T D GQ A+K L K + LK K E + +++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 445 VKLLGCCIHGEEKL-LIYEFMPNKSLDYF-------IFDQTNSKLLDWSKRFHIICGTAR 496
VKL E KL LI +F+ + D F +F + + K + A
Sbjct: 61 VKL-HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY--------LAELAL 109
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L +LH L II+RDLK N+LLD + + K++DFGL++
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 49/168 (29%), Positives = 74/168 (44%), Gaps = 14/168 (8%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQHR 442
+F+ LG+G FG V E+ A+K L K I D ++ E + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 443 NLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
+ L C ++L + E++ L Y I Q K + F+ A GL +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYA-AEIAIGLFFL 117
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNR 549
H II+RDLK NV+LD + + KI+DFG+ C + G T R
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTR 159
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 53/170 (31%), Positives = 77/170 (45%), Gaps = 37/170 (21%)
Query: 394 LGEGGFGPVYKGTLV----DGQEIAVKRLSKISDQGLKE----LKNEVILFSKLQHRNLV 445
+G G FG V LV G A+K+L K S+ KE ++ E + ++ + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 446 KLLGCCIHGEEKL-LIYEFMPNKSL-------DYFIFDQTNSKLLDWSKRFHIICGTARG 497
KL E L LI E++P + D F ++T RF+I A
Sbjct: 65 KLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---------RFYI----AET 110
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
+L + +L IHRD+K N+LLD + K+SDFGL C G K T
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL---CTGLKKSHRT 157
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 52/171 (30%), Positives = 72/171 (42%), Gaps = 35/171 (20%)
Query: 394 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEV----ILFSKLQHRNLVKLL 448
+G+G FG V DG AVK L K + KE + + +L L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNS-----------KLLDWSKRFHIICGTARG 497
Y F + L YF+ D N L+ RF+ A
Sbjct: 63 ------------YSFQTAEKL-YFVLDYVNGGELFFHLQRERCFLEPRARFYA-AEVASA 108
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
+ YLH L II+RDLK N+LLD + ++DFGL + G + E T+
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTS 154
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 21/160 (13%)
Query: 388 FSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISDQ---GLKELKNEVILFSKLQH 441
+ I +G+G +G V + +D G+++A+K+++ + + + L+ E+ L L+H
Sbjct: 2 YKIQEVIGKGSYGVV--CSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRH 58
Query: 442 RNLVKLLGCCIHGEEK-----LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
++V++ + + +++E M + D + N L +F + R
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLY-QLLR 114
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L Y+H + + HRDLK N+L + D KI DFGLAR
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 394 LGEGGFGPVYKGTLVDGQE----IAVKRLSKI----SDQGLKELKNEVILFSKLQHRNLV 445
LG+GG+G V++ V G + A+K L K + + K E + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
L+ G + LI E++ L F+ + ++ + F++ + L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYL-SEISLALEHLHQ-- 118
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
II+RDLK N+LLD + K++DFGL +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 32/86 (37%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD-GQE-----IAVKRLSKISDQGLKE-LKNEVILFSK 438
+N LG G FG V + T G+E +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEF 463
L QH+N+V LLG C HG L+I E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 49/165 (29%), Positives = 72/165 (43%), Gaps = 32/165 (19%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----DQGLKELKNEVILFS 437
+F +G+G FG V LV G+ A+K L K DQ L +K E + +
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQ-LAHVKAERDVLA 56
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-------DYFIFDQTNSKLLDWSKRFHI 490
+ +V L + LI EF+P L D F D T RF++
Sbjct: 57 ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---------RFYM 107
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
A +L + +L IHRD+K N+L+D + K+SDFGL+
Sbjct: 108 ----AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLG 449
LG+G FG V E+ A+K L K I D ++ E + + + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 450 CCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
C ++L + E++ L Y I Q K + F+ + GL +LH+
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYA-AEISVGLFFLHRRG--- 121
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVW 551
II+RDLK NV+LD + + KI+DFG+ C +G T R +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTF 161
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 48/166 (28%), Positives = 69/166 (41%), Gaps = 29/166 (17%)
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV--KLLGCC 451
LG+G FG V LV +E A + + K LK EVI+ L ++L
Sbjct: 3 LGKGTFGKV---ILV--REKATGKYYAM-----KILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR----------GLLYL 501
H L Y F + L F+ + N L + + R L YL
Sbjct: 53 RHPFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYL 111
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
H +++RDLK N++LD D + KI+DFGL C ++G T
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGL---CKEGISDGAT 151
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 48/181 (26%), Positives = 75/181 (41%), Gaps = 39/181 (21%)
Query: 388 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK-ISDQGL--KELKNEVILFSKLQHRN 443
+ I +G+GG G VY V + +A+K++ + +S+ L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLD--WSKR-------------- 487
+V + C G+ +Y MP +I T LL W K
Sbjct: 64 IVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 488 ----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
FH IC T Y+H S+ ++HRDLK N+LL I D+G A ++
Sbjct: 115 FLSIFHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 544 E 544
+
Sbjct: 169 D 169
|
Length = 932 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLGCC 451
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 452 I-HGEEKL-LIYEFMPNKSLDYFIF---DQTNSKLLDWSKRF--HIICGTARGLLYLHQD 504
+ H + K+ L++++ + F + N K + + ++ G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 505 SRLRIIHRDLKASNVLLDHDMNP-----KISDFGLAR 536
++HRDLK +N+L+ + P KI+D G AR
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 49/159 (30%), Positives = 70/159 (44%), Gaps = 33/159 (20%)
Query: 394 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEV----ILFSKLQHRNLVKLL 448
+G+G FG V +DG+ AVK L K KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLL-----------DWSKRFHIICGTARG 497
H Y F + L YF+ D N L + RF+ A
Sbjct: 62 ----H-------YSFQTTEKL-YFVLDFVNGGELFFHLQRERSFPEPRARFYA-AEIASA 108
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L YLH + I++RDLK N+LLD + ++DFGL +
Sbjct: 109 LGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 12/145 (8%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLS-KISDQGLKELKNEVILFSKLQHRNLVKLLGCC 451
LG G G VYK + + I AVK + I+ + K++ +E+ + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 511
+ EFM SLD ++ + +L I +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 512 RDLKASNVLLDHDMNPKISDFGLAR 536
RD+K SN+L++ K+ DFG++
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 47/152 (30%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRN--LVKL 447
+G GGFG VY D G+ A+K L K QG NE I+ S + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 448 LGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQ 503
+ H +KL I + M L Y + + + RF+ II G H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLE------HM 113
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+R +++RDLK +N+LLD + +ISD GLA
Sbjct: 114 HNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLK-ELKNEVILFSKLQHRNLVKLLGCC 451
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 452 I-HGEEKL-LIYEFMPNKSLDYFIF---DQTNSKLLDWSKRF--HIICGTARGLLYLHQD 504
+ H + K+ L++++ + F + N K + + ++ G+ YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 505 SRLRIIHRDLKASNVLLDHDMNP-----KISDFGLAR 536
++HRDLK +N+L+ + P KI+D G AR
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 38/167 (22%)
Query: 388 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELKNEVI------------ 434
F I + G FG VY G + + AVK + K +D K + ++V
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK-ADMINKNMVHQVQAERDALALSKSP 64
Query: 435 ----LFSKLQHRNLVKL-LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH 489
L+ LQ N V L + I G+ K L++ Y FD+ + +
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI--------YGYFDEEMA-------VKY 109
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
I A L YLH+ IIHRDLK N+L+ ++ + K++DFGL++
Sbjct: 110 I-SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 25/164 (15%)
Query: 394 LGEGGFGPVYKGTLVD---------GQEIAVKRLSKISDQGLKELK----NEVILFSKLQ 440
LG G +Y G L E +K + K+ D +++ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H+++V L G C+ E +++ EF+ LD F+ +++ W +F + A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 501 LHQDSRLRIIHRDLKASNVLL-----DHDMNP--KISDFGLART 537
L +D L +H ++ N+LL D + P K+SD G+ T
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLG 449
+G G + V L + I A+K + K D+ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 450 CCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--ICGTARGLLYLHQDSR 506
C E +L + EF+ L + + Q KL + RF+ I L +LH+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEIS---LALNFLHERG- 116
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
II+RDLK NVLLD + + K++D+G+ +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 41/152 (26%), Positives = 62/152 (40%), Gaps = 17/152 (11%)
Query: 388 FSINNKLGEGGFGPVYKGTL---VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
++I + L G G V+ T +++ VK ++ G K E+ + + HR +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAI 148
Query: 445 VKLLGCCIHG-EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+ L IH K + MP D F + + L + I L YLH
Sbjct: 149 INL----IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPL-PLEQAITIQRRLLEALAYLHG 203
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
IIHRD+K N+ LD N + DFG A
Sbjct: 204 RG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKIS----DQGLKELKNEVILFSKLQHRNLVKLLG 449
+G G + V L +I ++ K D+ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 450 CCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--ICGTARGLLYLHQDSR 506
C +L L+ E++ L + + Q KL + RF+ IC L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEIC---IALNFLHERG- 116
Query: 507 LRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
II+RDLK NVLLD D + K++D+G+ +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 54/213 (25%), Positives = 78/213 (36%), Gaps = 76/213 (35%)
Query: 394 LGEGGFGPVYKGTLVDGQE------IAVKRL---SKISDQG--LKELKNEVILFSKLQHR 442
LG G FG V + + ++ +AVK L + S+ + ELK IL H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---ILIHIGHHL 71
Query: 443 NLVKLLGCCIHGEEKLLI------------------YEFMPNKSLDY------------- 471
N+V LLG C L++ F P ++
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 472 ---------------FIFD------QTNSKLLDWSKRF----HIICGT---ARGLLYLHQ 503
FI D + + + + K +I + ARG+ +L
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL-- 189
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
SR + IHRDL A N+LL + KI DFGLAR
Sbjct: 190 ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 47/152 (30%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRN--LVKL 447
+G GGFG VY D G+ A+K L K QG NE I+ S + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 448 LGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQ 503
+ H +KL I + M L Y + + + RF+ II G H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLE------HM 113
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+R +++RDLK +N+LLD + +ISD GLA
Sbjct: 114 HNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 18/39 (46%), Positives = 28/39 (71%), Gaps = 3/39 (7%)
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L +LHQ L II+RD+K N+LLD + + ++DFGL++
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 33/171 (19%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSKISDQGLKEL--KNEVILFSKLQHRNLVKLLGC 450
+G+G FG VY+ D + I A+K LSK KE+ K EV + RN+ L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVA--HTIGERNI---LVR 49
Query: 451 CIHGEEKLLI---YEFMPNKSLDYFIFD-----------QTNSKLLDWSKRFHIICGTAR 496
+ E ++ + F + L Y + D Q + + +F+I A
Sbjct: 50 TLLDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYI----AE 104
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
+L L + I++RDLK N+LLD + + DFGL++ D NT
Sbjct: 105 LVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 44/195 (22%)
Query: 374 PLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKN-- 431
PL L S ++F + KLGEG FG VYK +LV+ K+ K LK+
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVN------KQSKKEGKYVLKKATEYG 173
Query: 432 --EVILFSKLQHRNLVKLLGCCIHG-------------------EEKLLIYEFMPNKSLD 470
E+ + +++ R ++G E + + + M +K
Sbjct: 174 AVEIWMNERVR-RACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFP 232
Query: 471 Y----FIFDQTNSKLLDWSKRFHIICGTA-RGLLY----LHQDSRLRIIHRDLKASNVLL 521
Y ++ + L +R + I T R +L+ LH I+HRD+K N++
Sbjct: 233 YNVEPYLLGKVQD-LPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIF 288
Query: 522 DHDMNP-KISDFGLA 535
KI D G A
Sbjct: 289 SEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 432 EVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIF--DQTNSKLLDWSKRFH 489
E + + H ++++L G + + LI +P D + + + N + D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
I R + YLH++ RIIHRD+KA N+ ++H + + DFG A
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 12/150 (8%)
Query: 392 NKLGEGGFGPVYK------GTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
++LG+G +G VYK G + +EI RL + + ++ E+ + K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKAVSPYIV 62
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
G + E+M SLD ++ + I +GL +L ++
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
IIHRD+K +NVL++ + K+ DFG++
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 43/157 (27%), Positives = 66/157 (42%), Gaps = 20/157 (12%)
Query: 393 KLGEGGFGPVY----KGTLVDGQEIAVKRLSKISDQGLKELKN---EVILFSKLQHRNLV 445
LG+G G V+ KGT G+ A+K L K ++K E + + L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLH 502
L L+ ++ P L + Q L + RF+ ++ L YLH
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLH 120
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
L I++RDLK N+LL + +SDF L++
Sbjct: 121 L---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 20/119 (16%)
Query: 428 ELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE---FMPNKSLDYFIFDQTNSKLLDW 484
+L+NE++ +L H N++K+ E++L E +M + D+ ++ + DW
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 485 SKR------FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
R I+ + Y+H ++IHRD+K N+ L+ D + DFG A
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
|
Length = 501 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV----ILFSKLQHRNLVKLL 448
+G+G FG V + + AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
++ + +++ L Y + Q L+ RF+ A L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYA-AEIASALGYLHS---LN 116
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLAR 536
I++RDLK N+LLD + ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 365 EDQNIDLELPLFE-----LATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL 418
+++NID L +E + + ++ + +G G FG V Q++ A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 419 SKI-----SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYF 472
SK SD + +++ F+ + V L C ++ L ++ E+MP L
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFA---NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 473 IFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532
+ + + W+K + TA +L L + +IHRD+K N+LLD + K++DF
Sbjct: 134 MSNYDVPE--KWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 533 GLARTC 538
G TC
Sbjct: 187 G---TC 189
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 32/115 (27%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 423 DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL-IYEFMPNKSLDYFIFDQTNSKL 481
D+ + ++ E +F + + + L C E +L + E++ L + + Q KL
Sbjct: 36 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKL 93
Query: 482 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ RF+ + L YLH+ II+RDLK NVLLD + + K++D+G+ +
Sbjct: 94 PEEHARFYS-AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 17/40 (42%), Positives = 28/40 (70%), Gaps = 2/40 (5%)
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
RGL YL + + +I+HRD+K SN+L++ K+ DFG++
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 19/32 (59%), Positives = 20/32 (62%)
Query: 510 IHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
IHRDL A N+LL H KI DFGLAR D
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRND 267
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 31/89 (34%), Positives = 42/89 (47%), Gaps = 9/89 (10%)
Query: 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518
LI EF+P D L + +F+I A +L + +L IHRD+K N
Sbjct: 78 LIMEFLPGG--DMMTLLMKKDTLTEEETQFYI----AETVLAIDSIHQLGFIHRDIKPDN 131
Query: 519 VLLDHDMNPKISDFGLARTCGGDKTEGNT 547
+LLD + K+SDFGL C G K T
Sbjct: 132 LLLDSKGHVKLSDFGL---CTGLKKAHRT 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 9e-04
Identities = 24/62 (38%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 475 DQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534
D +S LD A+G+ +L + IHRD+ A NVLL KI DFGL
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 535 AR 536
AR
Sbjct: 259 AR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 6/51 (11%)
Query: 489 HIICGT---ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+IC + A+G+ +L SR + IHRDL A N+LL + KI DFGLAR
Sbjct: 180 DLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 23/42 (54%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
ARG+ +L SR + IHRDL A N+LL + KI DFGLAR
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 31/146 (21%), Positives = 51/146 (34%), Gaps = 15/146 (10%)
Query: 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV--KLLGC 450
L G VY ++ +K S + + + EV + L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRII 510
L+ E++ ++LD ++ A L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLVLC 111
Query: 511 HRDLKASNVLLDHDMNPKISDFGLAR 536
H DL N+L+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 20/42 (47%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A GL +LH II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 13/158 (8%)
Query: 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKE----LKNEVILFSKLQHRNLVKLLG 449
+G G FG V D I ++ + +D KE ++ E + + +VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 450 CCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRI 509
LI EF+P D L + + +F+I A +L + +L
Sbjct: 69 SFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYI----AETVLAIDAIHQLGF 122
Query: 510 IHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
IHRD+K N+LLD + K+SDFGL C G K T
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGL---CTGLKKAHRT 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 13/132 (9%)
Query: 410 GQEIAVKRLSKISDQGLKE---LKNEVILFSKLQHRNLVKLLGCCIHGEEKLL-IYEFMP 465
G E+A+K L + + + + E L ++L H N+V LL L ++E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---D 522
++L + L + ++ L H I+HRDLK N+++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 523 HDMNPKISDFGL 534
+ K+ DFG+
Sbjct: 117 VRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.002
Identities = 54/186 (29%), Positives = 81/186 (43%), Gaps = 37/186 (19%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKE-----LKNEVILFSKLQ 440
N + + K+G G FG V+ QE + IS +GLKE L EV + +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 441 HRNLVKLLGCCIH-GEEKLLI-YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
H+N+V+ + ++ +KL I EF L I Q K+ + H I R L
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI--QKCYKMFGKIEE-HAIVDITRQL 127
Query: 499 L----YLHQ----DSRLRIIHRDLKASNVLLD-------------HDMN----PKISDFG 533
L Y H + R++HRDLK N+ L +++N KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 534 LARTCG 539
L++ G
Sbjct: 188 LSKNIG 193
|
Length = 1021 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 18/47 (38%), Positives = 30/47 (63%)
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+L L +L II+RD+K N+LLD + + ++DFGL++ D+ E
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 36/160 (22%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSKISDQGLKELKNEVILFSK----LQHRN---LV 445
+G G FG V +++ A+K LSK + +K +++ F + + H N +V
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSK--FEMIK--RSDSAFFWEERDIMAHANSEWIV 106
Query: 446 KLLGCCIHGEEKLL--IYEFMPNKSL-----DYFIFDQTNSKLLDWSKRFHIICGTARGL 498
+L ++K L + E+MP L +Y I + W+ RF+ TA +
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------KWA-RFY----TAEVV 152
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538
L L + IHRD+K N+LLD + K++DFG TC
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TC 189
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 20/54 (37%), Positives = 32/54 (59%), Gaps = 6/54 (11%)
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVW 551
L YLH +++RD+K N++LD D + KI+DFGL C ++G T + +
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL---CKEGISDGATMKTF 155
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 21/42 (50%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
ARG+ +L + +HRDL A NVLL KI DFGLAR
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLAR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 36.1 bits (83), Expect = 0.004
Identities = 17/82 (20%), Positives = 27/82 (32%), Gaps = 13/82 (15%)
Query: 236 RQDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENS---SCMAYTNSDIRGGGSGCAM 292
+ LK+ K+ EC +C +N SC A+ + R C
Sbjct: 7 SAGTTLIKIALKIKTT------KANTADECANRCEKNGLPFSCKAFVFAKARK---QCLW 57
Query: 293 W-FGDLIDMRSFPDGGQDFYIR 313
+ F + +R G D Y
Sbjct: 58 FPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLG 449
+G+G FG V + D Q I A+K + K +S + E + +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 450 CCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRI 509
E+ L+ F+ L + + Q + RF+ TA L L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFY----TAELLCALENLHKFNV 114
Query: 510 IHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
I+RDLK N+LLD+ + + DFGL + D + NT
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L YLH + +++RDLK N++LD D + KI+DFGL +
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.96 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.95 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.94 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.94 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.93 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.92 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.92 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.92 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.92 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.92 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.92 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.92 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.91 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.91 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.91 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.91 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.91 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.91 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.91 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.91 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.91 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.91 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.91 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.9 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.9 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.9 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.9 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.9 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.9 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.9 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.9 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.9 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.9 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.9 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.9 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.9 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.9 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.89 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.89 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.89 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.89 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.89 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.89 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.89 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.89 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.89 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.89 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.89 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.89 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.89 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.89 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.89 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.89 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.89 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.89 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.89 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.89 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.89 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.89 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.89 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.89 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.89 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.89 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.89 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.89 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.88 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.88 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.88 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.88 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.88 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.88 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.88 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.88 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.88 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.88 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.88 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.88 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.88 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.88 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.88 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.88 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.88 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.88 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.88 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.88 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.87 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.87 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.87 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.87 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.87 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.87 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.87 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.87 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.87 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.87 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.87 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.87 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.87 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.87 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.87 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.87 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.87 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.87 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.87 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.87 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.87 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.86 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.86 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.86 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.86 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.86 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.86 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.86 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.86 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.86 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.86 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.86 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.86 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.86 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.86 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.86 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.86 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.86 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.86 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.86 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.85 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.85 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.85 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.85 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.85 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.85 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.85 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.85 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.85 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.85 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.85 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.85 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.85 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.85 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.85 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.85 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.84 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.84 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.84 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.84 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.84 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.84 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.84 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.84 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.84 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.84 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.84 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.84 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.84 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.83 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.83 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.83 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.83 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.83 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.83 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.83 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.83 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.82 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.82 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.82 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.82 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.82 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.82 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.82 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.82 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.82 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.8 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.8 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.8 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.79 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.77 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.77 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.76 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.73 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.72 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.66 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.63 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.14 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.14 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.0 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.95 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.76 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.75 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.5 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.46 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.4 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.25 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.23 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.97 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.95 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.94 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.82 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.82 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.62 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.32 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.26 | |
| PLN02236 | 344 | choline kinase | 97.16 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.16 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.11 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.02 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.0 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.98 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.92 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.79 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.79 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.3 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.21 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.92 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.87 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.87 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.55 Aligned_cols=168 Identities=53% Similarity=0.866 Sum_probs=153.7
Q ss_pred CCCccchhhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEE
Q 008648 372 ELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCC 451 (558)
Q Consensus 372 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 451 (558)
....|++.++..++++|...+.||+|+||.||+|.+.++..||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988764433156699999999999999999999999
Q ss_pred EeCC-eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 452 IHGE-EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 452 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
.+.+ +++||||||++|+|.+.|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999775544 78999999999999999999999988899999999999999999999999
Q ss_pred ccccceeeCC
Q 008648 531 DFGLARTCGG 540 (558)
Q Consensus 531 DFGla~~~~~ 540 (558)
|||+|+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999977654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=266.71 Aligned_cols=153 Identities=31% Similarity=0.525 Sum_probs=137.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
...+|.+.++||+|+|+.||+|++. ++.+||||.+.+. .....+.+..|+++|+.++|||||++++++..++..+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467888899999999999999974 4789999998764 555677789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC------CCeEEecccc
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD------MNPKISDFGL 534 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~------~~~kl~DFGl 534 (558)
||||.||+|..+++.. +.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999654 36899999999999999999999999 9999999999999864 4589999999
Q ss_pred ceeeCCCc
Q 008648 535 ARTCGGDK 542 (558)
Q Consensus 535 a~~~~~~~ 542 (558)
||.+....
T Consensus 162 AR~L~~~~ 169 (429)
T KOG0595|consen 162 ARFLQPGS 169 (429)
T ss_pred hhhCCchh
Confidence 99987543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=252.13 Aligned_cols=153 Identities=28% Similarity=0.450 Sum_probs=132.1
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccc-------cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQ-------GLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
..+.|.+.+.||+|+||.|-+|.. .+++.||||++++.... .....++|+++|++|+|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445778889999999999999985 56999999999762211 2234679999999999999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CCeEEecc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD---MNPKISDF 532 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DF 532 (558)
..||||||++||+|.+.+.. .+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999988844 345777888899999999999999999 9999999999999755 67999999
Q ss_pred ccceeeCCCc
Q 008648 533 GLARTCGGDK 542 (558)
Q Consensus 533 Gla~~~~~~~ 542 (558)
|+|+..+...
T Consensus 324 GlAK~~g~~s 333 (475)
T KOG0615|consen 324 GLAKVSGEGS 333 (475)
T ss_pred chhhccccce
Confidence 9999886443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=255.74 Aligned_cols=162 Identities=28% Similarity=0.408 Sum_probs=140.5
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 458 (558)
..+.|+.+++||+|+||.||+|+. .+|+.||+|++.... +....-..+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345678889999999999999985 568999999987533 44556788999999999999999999999887 6899
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||+|||++ +|.-++.. ..-.+++.++..++.||+.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+.+
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999975 66666632 2346899999999999999999999999 999999999999999999999999999999
Q ss_pred CCCcCccccceEE
Q 008648 539 GGDKTEGNTNRVW 551 (558)
Q Consensus 539 ~~~~~~~~~~~~~ 551 (558)
........|++++
T Consensus 269 ~~~~~~~~T~rVv 281 (560)
T KOG0600|consen 269 TPSGSAPYTSRVV 281 (560)
T ss_pred cCCCCcccccceE
Confidence 8888777787764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=257.34 Aligned_cols=153 Identities=30% Similarity=0.431 Sum_probs=140.8
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecc---cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
.+|...+.||+|+|++||+++. ..|+.||+|++.+ ......+.+.+|++|.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 7799999999976 24456778999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+|+.++|..++. ..+.+++.++..++.||+.||.|||+++ |+|||||..|++|+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 4567999999999999999999999998 999999999999999999999999999999866
Q ss_pred cCc
Q 008648 542 KTE 544 (558)
Q Consensus 542 ~~~ 544 (558)
...
T Consensus 172 ~Er 174 (592)
T KOG0575|consen 172 GER 174 (592)
T ss_pred ccc
Confidence 443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=242.45 Aligned_cols=148 Identities=29% Similarity=0.355 Sum_probs=131.5
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecc-cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-eEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-EKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~ 463 (558)
+++..+.||+|..|+|||+.++ +++.+|+|++.. ..+...+++.+|++++++.+||+||+++|.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455679999999999999975 578899999853 34556788999999999999999999999999998 59999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|++|+|+.++... +.+++...-+|+.+|++||.|||+ ++ ||||||||+||||+..|+|||+|||.++.+.+
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999998443 568999999999999999999996 55 99999999999999999999999999987643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=240.88 Aligned_cols=152 Identities=30% Similarity=0.447 Sum_probs=136.0
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|+++++||+|+||+||+++..+ ++.+|+|++++. .....+...+|..+|.+++||.||+++..|.+.+..||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 34689999999999999999998654 789999999762 23456788999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+||+.||.|...|.+ ...+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999844 446888888888999999999999999 9999999999999999999999999999665
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
.+
T Consensus 177 ~~ 178 (357)
T KOG0598|consen 177 KD 178 (357)
T ss_pred cC
Confidence 44
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=253.50 Aligned_cols=157 Identities=34% Similarity=0.565 Sum_probs=140.1
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.....+.+.+.+.||+|-||.|+.|.+.....||+|.++.. ....+.|.+|+.+|++|+|+|||+++++|..++.++||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 34445567778999999999999999988889999999763 34557888999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||||+.|+|.++|.. .....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||.+++
T Consensus 280 tE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC
Confidence 999999999999976 34566889999999999999999999998 99999999999999999999999999997665
Q ss_pred Cc
Q 008648 541 DK 542 (558)
Q Consensus 541 ~~ 542 (558)
+.
T Consensus 356 ~~ 357 (468)
T KOG0197|consen 356 DE 357 (468)
T ss_pred Cc
Confidence 54
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=236.84 Aligned_cols=149 Identities=26% Similarity=0.411 Sum_probs=130.8
Q ss_pred CCcccceeecccCcccEEEEEEcC-CcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
+.|+.+.++|+|+||.||+++.++ |+.||||++..... .-.+-..+|+++|+.++|+|+|.|+++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467888899999999999999765 89999999865332 234557899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|++..-|+++- .....++.+.+..++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+.+
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99887776654 23445889999999999999999999998 99999999999999999999999999998863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=249.52 Aligned_cols=151 Identities=36% Similarity=0.596 Sum_probs=132.5
Q ss_pred CcccceeecccCcccEEEEEEcCCcEEEEEEecccccc--cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-eEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ--GLKELKNEVILFSKLQHRNLVKLLGCCIHGE-EKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~ 463 (558)
.+.+.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ...|||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34445679999999999999965555999999763322 2568999999999999999999999999888 78999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~ 540 (558)
+++|+|..+++.. ....+++..+++++.+||+||+|||++++ ||||||||+||||+.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999764 45679999999999999999999999873 99999999999999997 999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=226.93 Aligned_cols=152 Identities=34% Similarity=0.534 Sum_probs=134.4
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.+|...++||+|.||.||+|+. .+|+.||||+++.... .......+|++.|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999985 5699999999975322 223567899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
||+ .+|+..+.+ +...++..++..++.++++||+|+|++. |+||||||.|+||+++|.+||+|||+||.++...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 689999855 3457899999999999999999999998 9999999999999999999999999999997554
Q ss_pred C
Q 008648 543 T 543 (558)
Q Consensus 543 ~ 543 (558)
.
T Consensus 156 ~ 156 (318)
T KOG0659|consen 156 R 156 (318)
T ss_pred c
Confidence 3
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=240.12 Aligned_cols=160 Identities=33% Similarity=0.519 Sum_probs=136.6
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCeeeeeeeEEEeCC----eEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSK--LQHRNLVKLLGCCIHGE----EKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 459 (558)
...++.++||+|.||.||||.+. ++.||||++.. +..+.+++|-.|.+. ++|+||+++++.-.... +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 45567789999999999999984 59999999854 456778888887765 58999999999987666 7899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD------SRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~------~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
|+||.+.|+|.++|. ...++|....+|+..+++||+|||+. .+++|+|||||.+||||..|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999994 34689999999999999999999975 34579999999999999999999999999
Q ss_pred cceeeCCCcCccccceEEEe
Q 008648 534 LARTCGGDKTEGNTNRVWLY 553 (558)
Q Consensus 534 la~~~~~~~~~~~~~~~~~~ 553 (558)
+|.++........+...+|+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eeEEecCCCCCcchhhhhhh
Confidence 99999877766655544443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=238.27 Aligned_cols=153 Identities=27% Similarity=0.491 Sum_probs=138.5
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecc---cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++ .++++.-.+++|++||..|+||||+.++.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45789999999999999999985 6799999999876 3455667799999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||..+|.|.+|+.. ...|++.++.++++||..|+.|.|.++ ++|||||.+|||||.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999944 456999999999999999999999988 99999999999999999999999999987765
Q ss_pred CcC
Q 008648 541 DKT 543 (558)
Q Consensus 541 ~~~ 543 (558)
++.
T Consensus 206 ~kf 208 (668)
T KOG0611|consen 206 KKF 208 (668)
T ss_pred ccH
Confidence 543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-29 Score=245.07 Aligned_cols=153 Identities=30% Similarity=0.444 Sum_probs=133.8
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccH-HHHHHHHHHHhcCC-CCeeeeeeeEEEeCC-eEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGL-KELKNEVILFSKLQ-HRNLVKLLGCCIHGE-EKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 459 (558)
..++|.+.++||.|+||.||+|+. ..+..||||++++....-. -.-.+|++.|++|. |||||+|.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346899999999999999999985 5688999999976333222 22468999999998 999999999999988 8999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|||||+ .+|.+++.++ ...+++.++..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 6898888665 678999999999999999999999999 9999999999999988899999999999886
Q ss_pred CCc
Q 008648 540 GDK 542 (558)
Q Consensus 540 ~~~ 542 (558)
...
T Consensus 162 Skp 164 (538)
T KOG0661|consen 162 SKP 164 (538)
T ss_pred cCC
Confidence 544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=242.72 Aligned_cols=152 Identities=30% Similarity=0.510 Sum_probs=135.4
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
+.....+.++||+|-||.|.+++...+..||||+++..... ...+|..|+++|.+++|||||+|+|+|..++..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34566778999999999999999988899999999875444 45889999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||++|+|.+|+....... +......+|+.||+.||+||.+.+ +|||||.++|+|+|.++++||+|||++|.+-
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999997654333 566677889999999999999887 9999999999999999999999999999543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=202.36 Aligned_cols=109 Identities=43% Similarity=1.042 Sum_probs=104.1
Q ss_pred EEeccCCCCCccC-CCCCCCCceeeEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEEEEeCCCCCeEEEeeccCCC
Q 008648 107 YTTGPWNGLSFSA-PTTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKAPRDE 185 (558)
Q Consensus 107 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~~~~~~~~~W~~~~~~~~~~ 185 (558)
|++|+|+|..|++ |++.....+.+.|+.++++.+++|.+.+.+.++|++||.+| ++++|.|+++++.|...|.+|.++
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G-~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDG-QLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeee-EEEEEEEecCCCcEEEEEEecccC
Confidence 8999999999999 99988888999999999999999999999999999999999 999999999999999999999999
Q ss_pred CCcCccCCCcccccCCCCCcccccCCceecC
Q 008648 186 CDTYGLCGAYGVCIISKSPVCQCLKGFKTKS 216 (558)
Q Consensus 186 C~~~~~CG~~g~C~~~~~~~C~C~~gf~~~~ 216 (558)
||+|+.||+||+|+.+..+.|+||+||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988889999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=241.62 Aligned_cols=155 Identities=32% Similarity=0.447 Sum_probs=137.9
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecc---cccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 457 (558)
...++|.+.+.||+|+|++|++|+.. .++++|||++.+ ..+...+.+..|-.+|.+| .||.|++|+-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34568999999999999999999854 589999999876 3344556678899999999 899999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
|+|+||+++|+|.++|.+. +.+++.....++.+|+.||+|||++| ||||||||+|||||+++++||+|||-|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999553 56899999999999999999999999 99999999999999999999999999999
Q ss_pred eCCCcC
Q 008648 538 CGGDKT 543 (558)
Q Consensus 538 ~~~~~~ 543 (558)
+.+...
T Consensus 224 l~~~~~ 229 (604)
T KOG0592|consen 224 LSPSQK 229 (604)
T ss_pred CChhhc
Confidence 875543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=249.46 Aligned_cols=152 Identities=29% Similarity=0.506 Sum_probs=136.6
Q ss_pred CCcccceeecccCcccEEEEEEcC----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
...+|.++||.|.||.|++|+++- ...||||.++.. .+....+|+.|+.||.+++||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345678999999999999999743 457999999863 345667899999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+|||++|+|+.||+... ..+++.+...++++||.||+||.+.+ +|||||.++||||+.+..+|++||||+|.+.+
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999996543 45899999999999999999999988 99999999999999999999999999998876
Q ss_pred Cc
Q 008648 541 DK 542 (558)
Q Consensus 541 ~~ 542 (558)
+.
T Consensus 784 d~ 785 (996)
T KOG0196|consen 784 DP 785 (996)
T ss_pred CC
Confidence 65
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=221.21 Aligned_cols=150 Identities=30% Similarity=0.406 Sum_probs=134.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|+..+.||.|+||+|.+++.+ .+.-+|+|++++.. ....+...+|..+|+.+.||+++++++.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 47888899999999999999965 47889999997632 234566789999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||++||.|..++++ .+.+++..+.-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...+.
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999944 456899999999999999999999998 999999999999999999999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=230.65 Aligned_cols=159 Identities=27% Similarity=0.457 Sum_probs=136.7
Q ss_pred CCcccceeecccCcccEEEEE-EcCCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeee-EEEeCCe-EEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLG-CCIHGEE-KLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 460 (558)
..|+++++||+|.||.||++. ..++..||.|.+.- .+.+.......|+.+|+.|+|||||++++ -+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468899999999999999998 56899999998863 34456677899999999999999999998 4555555 7899
Q ss_pred EecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 461 YEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDS-RLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~-~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||+.+|+|..++... ...+.+++..+++++.|++.||.++|..- +..|+||||||.||+|+.+|.+||+|||++|.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998764 33567899999999999999999999832 123999999999999999999999999999999
Q ss_pred CCCcCc
Q 008648 539 GGDKTE 544 (558)
Q Consensus 539 ~~~~~~ 544 (558)
..+.+.
T Consensus 179 ~s~~tf 184 (375)
T KOG0591|consen 179 SSKTTF 184 (375)
T ss_pred cchhHH
Confidence 776543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=237.02 Aligned_cols=152 Identities=26% Similarity=0.360 Sum_probs=137.0
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
....++|+++..||+|+||.||+|+.+ +|..+|+|++++. .....+.++.|-.+|....+|.||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345578999999999999999999865 5899999999873 344567789999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
||||||++||++..+|. ....|++..+..++.+++.|++-||+.| +|||||||+|+|||..|++||+||||++-
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999994 4567999999999999999999999999 99999999999999999999999999965
Q ss_pred eC
Q 008648 538 CG 539 (558)
Q Consensus 538 ~~ 539 (558)
+.
T Consensus 291 l~ 292 (550)
T KOG0605|consen 291 LD 292 (550)
T ss_pred hh
Confidence 43
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=251.08 Aligned_cols=153 Identities=33% Similarity=0.588 Sum_probs=135.2
Q ss_pred hhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
..+.+.+..++||+|+||+||+|+.. +...||||.++..... ...+|++|++++..++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34456677799999999999999853 3467999999875544 7889999999999999999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTN-----------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD 524 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~ 524 (558)
..++|+|||..|+|.+||..... ...|+..+.+.|+.|||.||+||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 99999999999999999974311 223889999999999999999999987 9999999999999999
Q ss_pred CCeEEeccccceee
Q 008648 525 MNPKISDFGLARTC 538 (558)
Q Consensus 525 ~~~kl~DFGla~~~ 538 (558)
..|||+||||+|.+
T Consensus 640 l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 640 LVVKISDFGLSRDI 653 (774)
T ss_pred eEEEecccccchhh
Confidence 99999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=222.29 Aligned_cols=150 Identities=29% Similarity=0.464 Sum_probs=129.8
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCC------
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRN-LVKLLGCCIHGE------ 455 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 455 (558)
..|...++||+|+||.||+|+. .+|+.||+|++.-... .......+|+.++++++|+| ||.|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4567778999999999999985 5688999999875333 24456789999999999999 999999999877
Q ss_pred eEEEEEecCCCCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNS-KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
..++|+||+ ..+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 788999999 46899988664432 45777889999999999999999998 99999999999999999999999999
Q ss_pred ceeeC
Q 008648 535 ARTCG 539 (558)
Q Consensus 535 a~~~~ 539 (558)
|+.+.
T Consensus 167 Ara~~ 171 (323)
T KOG0594|consen 167 ARAFS 171 (323)
T ss_pred HHHhc
Confidence 99775
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=239.18 Aligned_cols=153 Identities=35% Similarity=0.556 Sum_probs=133.8
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEcC--C---cEEEEEEecc---cccccHHHHHHHHHHHhcCCCCeeeeeeeEEE
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLVD--G---QEIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 452 (558)
++...++..+.++||+|+||.||+|.+.. + ..||||..+. .......++.+|+++|+.++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34444556666899999999999998643 2 2389998874 34566788999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
...+++||||++.||+|+++|.+.. ..++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 9999999999999999999996543 35899999999999999999999998 999999999999999999999999
Q ss_pred ccceee
Q 008648 533 GLARTC 538 (558)
Q Consensus 533 Gla~~~ 538 (558)
|+++.-
T Consensus 307 GLs~~~ 312 (474)
T KOG0194|consen 307 GLSRAG 312 (474)
T ss_pred ccccCC
Confidence 999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=230.03 Aligned_cols=148 Identities=31% Similarity=0.483 Sum_probs=128.4
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--------------cccHHHHHHHHHHHhcCCCCeeeeee
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--------------DQGLKELKNEVILFSKLQHRNLVKLL 448 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l~ 448 (558)
..++|++.+.||+|.||.|-+|+. .+++.||||++.+.. ....+..++|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 457899999999999999999996 468999999986521 11235789999999999999999999
Q ss_pred eEEEeC--CeEEEEEecCCCCChhHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 008648 449 GCCIHG--EEKLLIYEFMPNKSLDYFIFDQTNSKL-LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM 525 (558)
Q Consensus 449 ~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~ 525 (558)
++..+. +..|||+||+..|.+...- .... +++.++..++++++.||+|||.++ ||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 998764 5689999999998885432 2334 899999999999999999999999 99999999999999999
Q ss_pred CeEEeccccceee
Q 008648 526 NPKISDFGLARTC 538 (558)
Q Consensus 526 ~~kl~DFGla~~~ 538 (558)
.+||+|||.+-.+
T Consensus 248 ~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 248 TVKISDFGVSNEF 260 (576)
T ss_pred cEEeeccceeeec
Confidence 9999999999876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=225.13 Aligned_cols=151 Identities=32% Similarity=0.476 Sum_probs=132.4
Q ss_pred cCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC--eEEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE--EKLLIY 461 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 461 (558)
..+|...+.||+|+||.||++...+ +...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778999999999999999754 8899999886543333677999999999999999999999855555 588999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~ 540 (558)
||+++|+|.+++.+... .+++..+.++..||++||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999966443 6999999999999999999999998 999999999999999 79999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=233.37 Aligned_cols=151 Identities=26% Similarity=0.444 Sum_probs=134.4
Q ss_pred hhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc----cc-ccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCC
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI----SD-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGE 455 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 455 (558)
...++|.+.+.||+|+||.|+.|.. .++..||+|.+.+. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999975 45799999977552 11 34556778999999999 999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CCeEEecccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGL 534 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGl 534 (558)
..++||||+.+|+|.+++.+ ...+.+.++..++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999955 456888999999999999999999998 9999999999999999 9999999999
Q ss_pred ceeeC
Q 008648 535 ARTCG 539 (558)
Q Consensus 535 a~~~~ 539 (558)
+....
T Consensus 168 s~~~~ 172 (370)
T KOG0583|consen 168 SAISP 172 (370)
T ss_pred ccccC
Confidence 99883
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=219.92 Aligned_cols=152 Identities=28% Similarity=0.421 Sum_probs=129.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccc--cHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQ--GLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 458 (558)
..+.|+.++.|++|+||.||+|++. +++.||+|+++...+. ..-...+|+.+|.+++|||||.+..+.+.. +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3457888999999999999999964 5789999998753221 223467899999999999999999987743 4689
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||||++ .+|..++..-. ..+...++..++.|+++||+|||.+. |+||||||+|+|+++.|.+||+|||+||.+
T Consensus 154 ~VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 9999996 58888885533 56888999999999999999999998 999999999999999999999999999999
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
+..
T Consensus 228 gsp 230 (419)
T KOG0663|consen 228 GSP 230 (419)
T ss_pred cCC
Confidence 765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=235.01 Aligned_cols=149 Identities=31% Similarity=0.499 Sum_probs=134.6
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. .+...+.+++|++|+++++|||||.+++.|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47888899999999999999864 5788999998763 33456779999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+.| +|..++.. ...++++.+..|+.+++.||.|||+++ |+|||+||+||||+..+.+|++|||+||.+..+
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99999944 445999999999999999999999998 999999999999999999999999999988654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=228.42 Aligned_cols=154 Identities=29% Similarity=0.482 Sum_probs=139.2
Q ss_pred hhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
.....|...++||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.+...++.++||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3456788888999999999999984 568899999998766666677899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|||+||+|.+.+. ...+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999883 345899999999999999999999999 999999999999999999999999999998766
Q ss_pred cC
Q 008648 542 KT 543 (558)
Q Consensus 542 ~~ 543 (558)
+.
T Consensus 423 ~~ 424 (550)
T KOG0578|consen 423 QS 424 (550)
T ss_pred cC
Confidence 54
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=228.19 Aligned_cols=148 Identities=26% Similarity=0.357 Sum_probs=132.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|... +++.+|+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36889999999999999999864 58899999986522 233456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999854 345899999999999999999999988 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=206.86 Aligned_cols=152 Identities=32% Similarity=0.432 Sum_probs=134.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|.||.||.|+.+ .+-.||+|++.+. ..+...++++|++|-+.|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4467899999999999999999864 5678999998762 23345679999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++||...|+|...|... ....+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999998653 3445788888999999999999999887 9999999999999999999999999987654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=226.54 Aligned_cols=153 Identities=31% Similarity=0.468 Sum_probs=129.4
Q ss_pred hcCCcccceeecccCcccEEEEEE------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 455 (558)
..++|++.++||+|+||.||+|.. ..+..||||++.... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456899999999999999999974 224679999986532 23456789999999999 8999999999987654
Q ss_pred -eEEEEEecCCCCChhHHHhhcCC--------------------------------------------------------
Q 008648 456 -EKLLIYEFMPNKSLDYFIFDQTN-------------------------------------------------------- 478 (558)
Q Consensus 456 -~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 478 (558)
..+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999998864311
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 479 ---SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 479 ---~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
...+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~ 225 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 225 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccc
Confidence 134778889999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-25 Score=215.42 Aligned_cols=155 Identities=26% Similarity=0.371 Sum_probs=137.8
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
....+.|++.++||.|.-+.||+|+. +.+..||||++.-. .....+.+++|+..++.++||||++++..|..+...|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 34557899999999999999999984 56899999998642 23347899999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||.||.+|++.+++...-.. .+++..+..|.+++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+-
T Consensus 102 VmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999765433 4899999999999999999999999 9999999999999999999999999887664
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 178 ~ 178 (516)
T KOG0582|consen 178 D 178 (516)
T ss_pred c
Confidence 4
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=220.87 Aligned_cols=152 Identities=30% Similarity=0.525 Sum_probs=130.9
Q ss_pred cCCcccceeecccCcccEEEEEEcC-----------------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeee
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVK 446 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 446 (558)
.++|++.++||+|+||.||+|...+ +..||+|.+.... .....++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 3369999886532 334567899999999999999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCChhHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 008648 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQT----------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRII 510 (558)
Q Consensus 447 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iv 510 (558)
+++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885421 1124678889999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 511 HRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 511 HrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||||+|||+++++.+||+|||+++.+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~ 189 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLY 189 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecc
Confidence 99999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=228.52 Aligned_cols=147 Identities=25% Similarity=0.339 Sum_probs=130.8
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.++||+|+||.||++.. .+++.||||++.+. .....+.+.+|+++++.++||||+++++++.+....+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999986 46889999998652 2234567889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999998854 345788899999999999999999998 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=227.66 Aligned_cols=149 Identities=25% Similarity=0.353 Sum_probs=132.9
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999975 58899999986522 234456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999998543 35899999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=223.28 Aligned_cols=150 Identities=25% Similarity=0.360 Sum_probs=133.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++.+.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357899999999999999999975 5789999998652 223456788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999988543 45788889999999999999999998 99999999999999999999999999987643
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=226.20 Aligned_cols=152 Identities=21% Similarity=0.260 Sum_probs=133.6
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
+....++|++.+.||+|+||.||++... +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445578999999999999999999975 4788999998642 22334568899999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998843 24788899999999999999999988 9999999999999999999999999998
Q ss_pred eeC
Q 008648 537 TCG 539 (558)
Q Consensus 537 ~~~ 539 (558)
.+.
T Consensus 191 ~~~ 193 (370)
T cd05621 191 KMD 193 (370)
T ss_pred ecc
Confidence 764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=227.51 Aligned_cols=146 Identities=23% Similarity=0.338 Sum_probs=130.1
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.|++.+.||+|+||.||+|... +++.+|+|++.+. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 5789999998652 22345678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999854 235788888999999999999999988 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=222.94 Aligned_cols=151 Identities=26% Similarity=0.346 Sum_probs=132.8
Q ss_pred hcCCcccceeecccCcccEEEEEEcC--CcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34579999999999999999998643 368999988642 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 108 lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999998543 35889999999999999999999998 999999999999999999999999999876
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 182 ~~ 183 (340)
T PTZ00426 182 DT 183 (340)
T ss_pred CC
Confidence 43
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=226.55 Aligned_cols=147 Identities=22% Similarity=0.339 Sum_probs=130.4
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 58899999986522 234566889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999854 345788888999999999999999988 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=220.36 Aligned_cols=149 Identities=22% Similarity=0.320 Sum_probs=132.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999975 58899999986422 234556889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999998543 35888999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=226.51 Aligned_cols=151 Identities=32% Similarity=0.568 Sum_probs=133.7
Q ss_pred hhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 379 ATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 379 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
+++....+.+.+.+.||+|.||+||+|++. ..||||++.. ......+.|++|+..+++-+|.||+-+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 455556667788899999999999999974 3699999864 334467889999999999999999999999998877
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.||+.+++|.+|..+++..+ ..++..+.+.|+.||++||.|||.++ |||||||..||+|.+++.|||+|||||.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999996644 45888999999999999999999998 9999999999999999999999999995
Q ss_pred e
Q 008648 537 T 537 (558)
Q Consensus 537 ~ 537 (558)
.
T Consensus 537 v 537 (678)
T KOG0193|consen 537 V 537 (678)
T ss_pred e
Confidence 3
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=216.67 Aligned_cols=149 Identities=31% Similarity=0.453 Sum_probs=121.7
Q ss_pred CcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe-----EEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE-----KLLI 460 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 460 (558)
.|...+++|.|+||.||+|.... +++||||++-...+ .-.+|+.+|++++|||||+|.-+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999999654 68999998854222 23468999999999999999998875432 2489
Q ss_pred EecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CCeEEeccccceee
Q 008648 461 YEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLARTC 538 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~~ 538 (558)
||||+ .+|..++... .....++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||+|||-|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99997 4787777542 22445777888889999999999999988 9999999999999965 89999999999998
Q ss_pred CCCcC
Q 008648 539 GGDKT 543 (558)
Q Consensus 539 ~~~~~ 543 (558)
..++.
T Consensus 177 ~~~ep 181 (364)
T KOG0658|consen 177 VKGEP 181 (364)
T ss_pred ccCCC
Confidence 66543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=216.74 Aligned_cols=151 Identities=25% Similarity=0.430 Sum_probs=130.1
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCeeeeeeeEEEeCC----eE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSK--LQHRNLVKLLGCCIHGE----EK 457 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~ 457 (558)
..++..+.+.||+|.||.||+|.+ .|+.||||++.. .+++.+.+|.+|.+. |+|+||+.+++.-..++ +.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345788889999999999999998 578999999965 344566777777765 59999999999876544 46
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-----DSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-----~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
+||++|.+.|||.+||.. ..++.+..++++..+|.||+|||- +|++.|.|||||..||||.+++...|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 899999999999999943 568999999999999999999995 47888999999999999999999999999
Q ss_pred ccceeeCCCc
Q 008648 533 GLARTCGGDK 542 (558)
Q Consensus 533 Gla~~~~~~~ 542 (558)
|||.....+.
T Consensus 361 GLAv~h~~~t 370 (513)
T KOG2052|consen 361 GLAVRHDSDT 370 (513)
T ss_pred eeeEEecccC
Confidence 9998876664
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=226.65 Aligned_cols=146 Identities=23% Similarity=0.342 Sum_probs=129.9
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.|++.++||+|+||.||+|+.. +++.+|+|++.+.. ......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 57899999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999988543 35788889999999999999999988 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=221.92 Aligned_cols=148 Identities=26% Similarity=0.398 Sum_probs=132.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|... +++.||+|++.+.. ....+.+..|+.++..++||||+++++++...+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999975 47899999987532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999843 345889999999999999999999998 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=214.17 Aligned_cols=150 Identities=29% Similarity=0.393 Sum_probs=130.8
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999986 468999999886422 2234467889999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++++|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999988875432 335889999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=232.88 Aligned_cols=155 Identities=32% Similarity=0.465 Sum_probs=135.6
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCC-cEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeE-EEe-----
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGC-CIH----- 453 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~----- 453 (558)
.....++++.+.|.+|||+.||.|....+ .++|+|++-..++...+.+.+|+++|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456788889999999999999998766 999999987778888999999999999997 9999999993 322
Q ss_pred -CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 454 -GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 454 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
.-+.+|+||||++|.|-+++..+.... |++.++++|+.++++|+.+||... ++|||||||.+||||+.+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 135689999999999999997654433 999999999999999999999985 78999999999999999999999999
Q ss_pred ccceee
Q 008648 533 GLARTC 538 (558)
Q Consensus 533 Gla~~~ 538 (558)
|-|...
T Consensus 191 GSatt~ 196 (738)
T KOG1989|consen 191 GSATTK 196 (738)
T ss_pred cccccc
Confidence 998643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=240.74 Aligned_cols=151 Identities=36% Similarity=0.640 Sum_probs=134.6
Q ss_pred cCCcccceeecccCcccEEEEEEcC--C----cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD--G----QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
....++.+.||+|.||.||+|...+ + ..||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566777899999999999998644 3 34999999764 456778899999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 458 LLIYEFMPNKSLDYFIFDQT----NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
+|++|||++|+|..||++.. ....++..+.+.++.+||+|++||++++ +|||||.++|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997642 1456899999999999999999999988 9999999999999999999999999
Q ss_pred cceee
Q 008648 534 LARTC 538 (558)
Q Consensus 534 la~~~ 538 (558)
|||.+
T Consensus 848 lArDi 852 (1025)
T KOG1095|consen 848 LARDI 852 (1025)
T ss_pred hhHhh
Confidence 99944
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=218.55 Aligned_cols=150 Identities=22% Similarity=0.267 Sum_probs=132.2
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999964 5889999998642 2233456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998542 345889999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=211.72 Aligned_cols=149 Identities=30% Similarity=0.367 Sum_probs=134.2
Q ss_pred CCcccceeecccCcccEEEEEEcC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++++.||.|.-|+||++++.+ +..+|+|++.+. ......+.+.|.+||+.++||.++.|++.++.++..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467788999999999999999865 589999999763 2344567888999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||+||+|..+++++ ..+.+++..+.-++.+|+.||+|||-.| ||.|||||+||||.++|++.|+||.|+...
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999988765 4567899999999999999999999988 999999999999999999999999999876
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=217.81 Aligned_cols=150 Identities=21% Similarity=0.241 Sum_probs=131.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 5788999998652 2223455788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++|+|..++... ...+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998542 235788999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=222.99 Aligned_cols=151 Identities=23% Similarity=0.261 Sum_probs=132.4
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
...++|++.++||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999864 5789999998642 2233455788999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++|+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998843 24788888899999999999999988 999999999999999999999999999876
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 193 ~~ 194 (370)
T cd05596 193 DA 194 (370)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-25 Score=210.50 Aligned_cols=151 Identities=30% Similarity=0.463 Sum_probs=130.8
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-----CC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH-----GE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 455 (558)
....|...+.||+|+||.|..|.. .+++.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666678999999999999986 4589999999873 344566788999999999999999999999876 34
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..|+|+|+| +.+|...+.. ...|+...+..++.||++||+|+|+.+ |+||||||.|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 579999999 6789888843 344889999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCC
Q 008648 536 RTCGGD 541 (558)
Q Consensus 536 ~~~~~~ 541 (558)
|.....
T Consensus 173 R~~~~~ 178 (359)
T KOG0660|consen 173 RYLDKF 178 (359)
T ss_pred eecccc
Confidence 998643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=217.68 Aligned_cols=141 Identities=25% Similarity=0.324 Sum_probs=125.3
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
+.||+|+||.||++... +++.+|+|++.+. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 6889999998752 2234456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 468 SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 468 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99888854 345889999999999999999999998 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-25 Score=224.33 Aligned_cols=149 Identities=28% Similarity=0.404 Sum_probs=133.7
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..-|++.+.||.|+-|.|-.|++ .+|+.+|||++.+. .......+.+|+.+|+.|.|||++++++++++..+.|||
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35688999999999999999986 56999999999763 233456788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
.||+++|.|.+++.. .+.+++.++.+++.||+.|+.|.|..+ |+||||||+|+|||.++++||+|||||..-.
T Consensus 91 lEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999854 456899999999999999999999988 9999999999999999999999999997543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=217.96 Aligned_cols=150 Identities=22% Similarity=0.288 Sum_probs=133.2
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||++... +++.+|+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999864 58899999987532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998553 245889999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=220.27 Aligned_cols=148 Identities=26% Similarity=0.363 Sum_probs=131.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||++... +++.+|+|++... .......+++|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999875 5889999998642 2334567889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999854 345889999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=221.45 Aligned_cols=156 Identities=21% Similarity=0.245 Sum_probs=135.3
Q ss_pred hhhhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 008648 378 LATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453 (558)
Q Consensus 378 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 453 (558)
+..+....++|++.+.||+|+||.||++... +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344555689999999999999999999975 5788999998642 22334567889999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
....++||||+++++|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998843 23788888899999999999999998 9999999999999999999999999
Q ss_pred cceeeCC
Q 008648 534 LARTCGG 540 (558)
Q Consensus 534 la~~~~~ 540 (558)
+|+.+..
T Consensus 188 ~a~~~~~ 194 (371)
T cd05622 188 TCMKMNK 194 (371)
T ss_pred ceeEcCc
Confidence 9987643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=220.79 Aligned_cols=151 Identities=26% Similarity=0.399 Sum_probs=134.9
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 5889999998752 2244567889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998553 46889999999999999999999988 999999999999999999999999999877544
Q ss_pred c
Q 008648 542 K 542 (558)
Q Consensus 542 ~ 542 (558)
.
T Consensus 155 ~ 155 (350)
T cd05573 155 K 155 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=212.58 Aligned_cols=148 Identities=28% Similarity=0.454 Sum_probs=129.4
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999864 57899999886432 23345678999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 975 888887443 335788999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=191.87 Aligned_cols=148 Identities=28% Similarity=0.462 Sum_probs=128.3
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|.-.++||+|.||+||+|+.. .++.||+|+++-. ++.-.....+|+.+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999964 4788999988642 233346788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+ ..+|..+.... ...++.+....++.|+++||.|.|+++ ++||||||+|.||+.+|+.||+|||+||.++-
T Consensus 83 c-dqdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred h-hHHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9 46787776432 345888999999999999999999998 99999999999999999999999999998763
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-25 Score=220.25 Aligned_cols=167 Identities=23% Similarity=0.391 Sum_probs=142.6
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe-EEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE-KLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 461 (558)
++|..++++|+|+||.++.++.+ +++.+++|++.- ......+....|+.++++++|||||.+.+.+++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999864 577899998754 333445578899999999999999999999999888 89999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+|++||+|.+.+..++ ...++++.+..++.|++.|+.|||++. |+|||||+.||+++.+..|||.|||+||.++.+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997754 567899999999999999999999877 999999999999999999999999999999877
Q ss_pred cCccccceEEEeecccC
Q 008648 542 KTEGNTNRVWLYGTGIC 558 (558)
Q Consensus 542 ~~~~~~~~~~~~g~~~c 558 (558)
...+. .+.|+.-.+|
T Consensus 160 ~~~a~--tvvGTp~Ymc 174 (426)
T KOG0589|consen 160 DSLAS--TVVGTPYYMC 174 (426)
T ss_pred hhhhh--eecCCCcccC
Confidence 53322 3445544444
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=216.66 Aligned_cols=141 Identities=26% Similarity=0.343 Sum_probs=125.5
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 5889999998752 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 468 SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 468 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99888743 345889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=222.04 Aligned_cols=154 Identities=34% Similarity=0.491 Sum_probs=132.1
Q ss_pred hcCCcccceeecccCcccEEEEEE------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 455 (558)
..++|++.++||+|+||.||+|.. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 455799999999999999999973 235689999986432 23456788999999999 8999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCC---------------------------------------------------------
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTN--------------------------------------------------------- 478 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 478 (558)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999988854211
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 479 ---------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 479 ---------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124788899999999999999999988 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=226.08 Aligned_cols=153 Identities=18% Similarity=0.225 Sum_probs=133.5
Q ss_pred CCcccceeecccCcccEEEEEEc-C-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-D-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..|.+.+.||+|+||.||+|... + ++.||+|.+..........+++|+.+++.++||||+++++++...+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999853 3 577888877554445556788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999887543 23346889999999999999999999988 999999999999999999999999999987543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=216.73 Aligned_cols=141 Identities=24% Similarity=0.331 Sum_probs=125.1
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999998652 2234456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 468 SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 468 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99888744 335889999999999999999999988 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-25 Score=226.17 Aligned_cols=153 Identities=30% Similarity=0.442 Sum_probs=133.3
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC------eEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE------EKL 458 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 458 (558)
.|...+.||+|+||.||+++. ..|+.||||.+.+. .....+..-+|+++|++++|+|||++++.-++.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 455668999999999999995 56999999998763 3445677889999999999999999999876544 468
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCC--CeEEecccc
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--HDM--NPKISDFGL 534 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~--~~~--~~kl~DFGl 534 (558)
+|||||.+|+|...+.+.++...|++.+.+.++.++..||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988777788999999999999999999999998 99999999999994 334 379999999
Q ss_pred ceeeCCCc
Q 008648 535 ARTCGGDK 542 (558)
Q Consensus 535 a~~~~~~~ 542 (558)
||.++++.
T Consensus 171 Arel~d~s 178 (732)
T KOG4250|consen 171 ARELDDNS 178 (732)
T ss_pred cccCCCCC
Confidence 99887664
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=214.38 Aligned_cols=139 Identities=24% Similarity=0.290 Sum_probs=124.3
Q ss_pred ecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
||+|+||.||+|... +++.||+|++.+. .......+.+|+.++.+++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 4789999998642 233456788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 998854 335889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=213.80 Aligned_cols=148 Identities=30% Similarity=0.463 Sum_probs=126.9
Q ss_pred eeecccCcccEEEEEE-cCCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 392 NKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
+.||.|.||+||-|.. ++|+.||||++.+ ........+++|+.||+.++||.||.+.-.|+..+..++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 7899999999999986 4699999999976 234456889999999999999999999999999999999999996554
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CCeEEeccccceeeCCCcCc
Q 008648 469 LDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD---MNPKISDFGLARTCGGDKTE 544 (558)
Q Consensus 469 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~ 544 (558)
|+-+| ..+ ...|++.....++.||+.||.|||.++ |+|+||||+||||... ..+||+|||+||.+++...+
T Consensus 650 LEMIL-SsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 650 LEMIL-SSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHH-Hhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 54444 433 346888888889999999999999998 9999999999999643 46999999999999876543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=212.43 Aligned_cols=149 Identities=30% Similarity=0.444 Sum_probs=129.2
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.++||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 588999999865322 234567889999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 5776666432 345788899999999999999999998 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=215.79 Aligned_cols=147 Identities=23% Similarity=0.310 Sum_probs=128.7
Q ss_pred CcccceeecccCcccEEEEEE----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeE
Q 008648 387 NFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 457 (558)
+|++.+.||+|+||.||+++. .+++.+|+|++.+.. ....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999975 257899999986421 22345678899999999 599999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998854 245889999999999999999999988 99999999999999999999999999986
Q ss_pred eC
Q 008648 538 CG 539 (558)
Q Consensus 538 ~~ 539 (558)
+.
T Consensus 155 ~~ 156 (332)
T cd05614 155 FL 156 (332)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=213.49 Aligned_cols=141 Identities=25% Similarity=0.335 Sum_probs=124.3
Q ss_pred eeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 392 NKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
+.||+|+||.||++.. .+++.||+|.+.+. .......+..|++++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 46889999998752 2234456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 468 SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 468 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 99888743 3458999999999999999999997 56 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=214.39 Aligned_cols=149 Identities=19% Similarity=0.245 Sum_probs=130.6
Q ss_pred CCcccceeecccCcccEEEEEEcC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.++||+|+||.||++.... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368899999999999999999754 678999998642 2223445888999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999998542 235888899999999999999999988 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=205.38 Aligned_cols=152 Identities=30% Similarity=0.475 Sum_probs=136.0
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..++|++.+.||+|++|.||+|...+++.||+|.++.. ....+++.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 34578899999999999999999877889999998653 23457789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999986533 346899999999999999999999988 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=214.01 Aligned_cols=141 Identities=29% Similarity=0.434 Sum_probs=124.0
Q ss_pred eeecccCcccEEEEEEc----CCcEEEEEEeccc----ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+.||+|+||.||++... .++.||+|.+... .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999852 4788999998652 122345678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+++++|..++.. ...+.+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999988854 345788888899999999999999988 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=207.76 Aligned_cols=149 Identities=27% Similarity=0.457 Sum_probs=130.9
Q ss_pred cCCcccceeecccCcccEEEEEEc----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 35689999987532 2334678899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998543 245889999999999999999999988 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=219.75 Aligned_cols=151 Identities=29% Similarity=0.457 Sum_probs=133.2
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecc---cccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCe
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEE 456 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 456 (558)
....++|.+.++||+|.||+|+++..+ +++.+|||.+++ ...+..+..+.|.+|+.... ||.++.|+.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999975 478899999987 34567788899999988875 9999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+.||++..+. ....+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954333 3456899999999999999999999999 9999999999999999999999999999
Q ss_pred eeC
Q 008648 537 TCG 539 (558)
Q Consensus 537 ~~~ 539 (558)
.-.
T Consensus 517 e~m 519 (694)
T KOG0694|consen 517 EGM 519 (694)
T ss_pred ccC
Confidence 754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=209.83 Aligned_cols=149 Identities=23% Similarity=0.399 Sum_probs=130.3
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999975 57889999986532 3345678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999987765542 2345889999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=219.24 Aligned_cols=157 Identities=31% Similarity=0.444 Sum_probs=133.3
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEcC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCeeeeeeeEEE
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQ-HRNLVKLLGCCI 452 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 452 (558)
.....++|.+.++||+|+||.||+|.... ...||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 34456789999999999999999998521 3479999986532 233567899999999996 999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCC------------------------------------------------------
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTN------------------------------------------------------ 478 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 478 (558)
+....+|||||+++|+|.+++.....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999988864210
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 008648 479 ---------------------------------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 519 (558)
Q Consensus 479 ---------------------------------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NI 519 (558)
...+++.++..++.||++||+|||+.+ |+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 124778888999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeccccceeeCC
Q 008648 520 LLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 520 ll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++++.+||+|||+++.+..
T Consensus 269 ll~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMH 289 (400)
T ss_pred EEeCCCEEEEEeCCcceeccc
Confidence 999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=219.53 Aligned_cols=156 Identities=35% Similarity=0.512 Sum_probs=132.5
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCIH 453 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 453 (558)
....++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344568999999999999999999742 23579999986532 33456788999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCC-------------------------------------------------------
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTN------------------------------------------------------- 478 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 478 (558)
....++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998854210
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 479 ------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 479 ------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
...+++.++.+++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 124788889999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=212.66 Aligned_cols=143 Identities=29% Similarity=0.325 Sum_probs=125.7
Q ss_pred eeecccCcccEEEEEE----cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 392 NKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
+.||+|+||.||++.. .+++.+|+|++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999975 357899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999988843 345899999999999999999999988 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=204.85 Aligned_cols=148 Identities=28% Similarity=0.450 Sum_probs=132.2
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 467888999999999999999888889999987642 3345678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 999999885432 35889999999999999999999988 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-25 Score=201.50 Aligned_cols=157 Identities=26% Similarity=0.387 Sum_probs=134.8
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc-----c---ccHHHHHHHHHHHhcC-CCCeeeeeeeEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS-----D---QGLKELKNEVILFSKL-QHRNLVKLLGCC 451 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 451 (558)
....+.|...+.||+|..+.|-++.. .+++++|+|++.... + .-.+.-+.|+.||+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456788889999999999988875 468899999885321 1 1234567899999998 599999999999
Q ss_pred EeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEec
Q 008648 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531 (558)
Q Consensus 452 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 531 (558)
+.+...++|+|.|+.|.|.++|. ..-.++++...+|+.|+.+|++|||.++ ||||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 99999999999999999999993 3446899999999999999999999998 99999999999999999999999
Q ss_pred cccceeeCCCcCc
Q 008648 532 FGLARTCGGDKTE 544 (558)
Q Consensus 532 FGla~~~~~~~~~ 544 (558)
||+|..+.+++..
T Consensus 167 FGFa~~l~~GekL 179 (411)
T KOG0599|consen 167 FGFACQLEPGEKL 179 (411)
T ss_pred cceeeccCCchhH
Confidence 9999998776543
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=212.90 Aligned_cols=146 Identities=27% Similarity=0.381 Sum_probs=127.2
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCC-CeeeeeeeEEEeCCeEEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQH-RNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 461 (558)
+|++.+.||+|+||.||+|... +++.||+|++.+. .....+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 4678999998752 23345678889999999976 56888999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999988844 235788999999999999999999988 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=212.61 Aligned_cols=150 Identities=25% Similarity=0.308 Sum_probs=132.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999975 5788999988653 23345679999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999998543 35789999999999999999999853 39999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=212.77 Aligned_cols=144 Identities=30% Similarity=0.451 Sum_probs=124.8
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHH---hcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILF---SKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
|++.+.||+|+||.||+|... +++.||||++++.. ....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999864 58899999987532 23345667776655 567899999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||+++++|...+.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999887732 35899999999999999999999988 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=207.68 Aligned_cols=149 Identities=30% Similarity=0.400 Sum_probs=130.5
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 58899999986422 1223457789999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+++++|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999998875432 345899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=204.62 Aligned_cols=151 Identities=32% Similarity=0.487 Sum_probs=135.1
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4578999999999999999999888889999988653 334578899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999986532 345788899999999999999999988 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=214.09 Aligned_cols=152 Identities=28% Similarity=0.407 Sum_probs=135.6
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccc---cHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCe
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQ---GLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEE 456 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 456 (558)
......|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+++.+++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3455689999999999999999999765 999999999764332 4568999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CCeEEecc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD----MNPKISDF 532 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~DF 532 (558)
.++|||++.||.|.+.+... .+++.++..++.||+.+++|||+.+ |+||||||+|+|+... +.+|++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999988665 2899999999999999999999988 9999999999999632 47999999
Q ss_pred ccceeeCC
Q 008648 533 GLARTCGG 540 (558)
Q Consensus 533 Gla~~~~~ 540 (558)
|+|+....
T Consensus 184 Gla~~~~~ 191 (382)
T KOG0032|consen 184 GLAKFIKP 191 (382)
T ss_pred CCceEccC
Confidence 99999876
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=216.33 Aligned_cols=144 Identities=30% Similarity=0.431 Sum_probs=126.2
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.+|+..++||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677789999999999999864 58999999986432 23456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|... ....+..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+.
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999998543 23567778889999999999999998 9999999999999999999999999998764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=212.07 Aligned_cols=150 Identities=32% Similarity=0.573 Sum_probs=129.0
Q ss_pred CCcccceeecccCcccEEEEEEc-CCc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.+|++.+.||+|+||.||+|.+. ++. .||+|.+... .....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999853 333 4899998653 234456789999999999999999999998764 5679
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988543 335788999999999999999999988 9999999999999999999999999999775
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=203.11 Aligned_cols=149 Identities=30% Similarity=0.472 Sum_probs=132.7
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
++|++.+.||+|+||.||++...++..+|+|.+... ....+++.+|+.++++++||||+++++++.+....+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 468888999999999999998877778999988653 3345678999999999999999999999998888999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999985432 35899999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=206.61 Aligned_cols=153 Identities=32% Similarity=0.557 Sum_probs=138.4
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
...+|++.++||+|+||.||+|...++..+++|.+..........+..|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44678999999999999999999888899999998775555667899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|.+++.+.. ...+++..+..++.||+.||+|||+++ |+|+||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999996543 345899999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=206.78 Aligned_cols=150 Identities=29% Similarity=0.536 Sum_probs=131.7
Q ss_pred CCcccceeecccCcccEEEEEE-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 458 (558)
.+|++.+.||+|+||.||++.. .++..||+|.+........+.+.+|+++++.++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788899999999999999974 24788999998765555667899999999999999999999987543 4578
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 235889999999999999999999988 999999999999999999999999999976
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=212.75 Aligned_cols=150 Identities=23% Similarity=0.315 Sum_probs=131.5
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.++||+|+||.||++... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999975 5778899987653 23345678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999854 235788899999999999999999742 39999999999999999999999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=210.40 Aligned_cols=146 Identities=27% Similarity=0.375 Sum_probs=126.6
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 461 (558)
+|++.+.||+|+||.||+|... +++.+|+|.+.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999875 46799999987532 22344567788888777 5899999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||+++++|..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 999999999888443 35889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-25 Score=229.13 Aligned_cols=150 Identities=33% Similarity=0.553 Sum_probs=130.0
Q ss_pred cccceeecccCcccEEEEEE-cCC----cEEEEEEecc-cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 388 FSINNKLGEGGFGPVYKGTL-VDG----QEIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~-~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
.+..++||+|+||+||+|.+ +++ -+||+|++.. ...+...++.+|+.+|.+++|||+++|+++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34457999999999999985 343 4789998864 34456788999999999999999999999998766 78999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+||+.|.|.++++.. ...+-.+..+.|..|||+||.|||++. ++||||.++||||.+-..+||.|||+|+.+..+
T Consensus 777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999653 345788899999999999999999887 999999999999999999999999999988766
Q ss_pred cC
Q 008648 542 KT 543 (558)
Q Consensus 542 ~~ 543 (558)
..
T Consensus 852 ~~ 853 (1177)
T KOG1025|consen 852 EK 853 (1177)
T ss_pred cc
Confidence 53
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=214.49 Aligned_cols=154 Identities=29% Similarity=0.431 Sum_probs=136.1
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
......|.+..+||+|.|+.|..|+.. .+.+||+|.+.+.. ......+.+|+++|..++|||||+++.+.+.....|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 445678999999999999999999864 58999999998743 233456899999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+.+|.+.+++.+. ..+.+..+..++.|+..|++|+|+++ |+|||||++||||+.+.++||+|||++..+
T Consensus 132 lV~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 999999999999999553 34556888889999999999999998 999999999999999999999999999887
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 206 ~~~ 208 (596)
T KOG0586|consen 206 DYG 208 (596)
T ss_pred ccc
Confidence 644
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=211.37 Aligned_cols=141 Identities=26% Similarity=0.388 Sum_probs=123.6
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.+|+|++.+. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999964 5789999998753 223445678898888776 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999888743 245899999999999999999999998 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=212.22 Aligned_cols=140 Identities=26% Similarity=0.394 Sum_probs=124.1
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||++... +++.||+|++++. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999864 5789999998752 223445688899999888 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999888743 245899999999999999999999998 99999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=212.47 Aligned_cols=146 Identities=26% Similarity=0.472 Sum_probs=125.6
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----eEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-----EKL 458 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 458 (558)
+|++.++||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888899999999999999864 5889999998642 2233456889999999999999999999886533 479
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688888743 335889999999999999999999998 999999999999999999999999999865
Q ss_pred C
Q 008648 539 G 539 (558)
Q Consensus 539 ~ 539 (558)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=210.88 Aligned_cols=141 Identities=27% Similarity=0.421 Sum_probs=123.4
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|+.. +++.||+|++.+. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 4789999998752 223445677888888866 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|...+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999888844 335888999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=216.37 Aligned_cols=142 Identities=22% Similarity=0.314 Sum_probs=125.4
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
...+|++.++||+|+||.||++... .++.||+|... ...+.+|+.++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999864 57899999653 2356789999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++. ++|..++.. ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 995 678777743 235789999999999999999999988 999999999999999999999999999754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=205.41 Aligned_cols=145 Identities=32% Similarity=0.431 Sum_probs=126.0
Q ss_pred ecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
||+|+||.||++... +++.+|+|.+.... ....+.+..|+.+++.++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 58899999986522 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 470 DYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 470 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 88875432 3346899999999999999999999988 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=205.23 Aligned_cols=152 Identities=32% Similarity=0.546 Sum_probs=131.1
Q ss_pred CCcccceeecccCcccEEEEEE-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..|++.+.||+|+||.||+|.. ..+..+++|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 245789999987532 3344678899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 008648 460 IYEFMPNKSLDYFIFDQTN--------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM 525 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~ 525 (558)
+|||+++++|.+++..... ...+++.+++.++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853221 234788899999999999999999988 99999999999999999
Q ss_pred CeEEeccccceeeCC
Q 008648 526 NPKISDFGLARTCGG 540 (558)
Q Consensus 526 ~~kl~DFGla~~~~~ 540 (558)
.+||+|||+++.+..
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=209.13 Aligned_cols=141 Identities=30% Similarity=0.421 Sum_probs=121.3
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhc-CCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSK-LQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.||+|.++.. .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999874 4788999998652 22334455667777665 4899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 999988854 235889999999999999999999988 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=202.44 Aligned_cols=149 Identities=26% Similarity=0.434 Sum_probs=133.6
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999996 46789999998754444556788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999998853 235789999999999999999999988 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=227.36 Aligned_cols=150 Identities=21% Similarity=0.315 Sum_probs=131.4
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.++||+|+||.||+|... .++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 48899999986522 223467899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 462 EFMPNKSLDYFIFDQTN--------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 223567788899999999999999988 9999999999999999999999999
Q ss_pred cceee
Q 008648 534 LARTC 538 (558)
Q Consensus 534 la~~~ 538 (558)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99987
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=201.88 Aligned_cols=149 Identities=29% Similarity=0.454 Sum_probs=132.1
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.+|++.+.||+|+||.||++....+..+|+|.+.+. ......+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357888999999999999999877778999988642 2234578889999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999985432 35889999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=210.05 Aligned_cols=146 Identities=27% Similarity=0.387 Sum_probs=126.7
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 461 (558)
+|+..+.||+|+||.||+|... +++.||+|++.+. .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677799999999999999864 5889999998752 2234456778888888885 577888999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||+++++|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 99999999988844 245889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=209.16 Aligned_cols=141 Identities=28% Similarity=0.387 Sum_probs=120.8
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVI-LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.||+|++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999974 58899999986521 222344455544 56789999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999988854 345888999999999999999999998 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=202.62 Aligned_cols=145 Identities=40% Similarity=0.660 Sum_probs=126.3
Q ss_pred cceeecccCcccEEEEEEc-----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 390 INNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4579999999999999976 2568999999653 333478899999999999999999999999988889999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+++|+|.+++... ....+++..+..|+.||++||.|||+++ |+|+||+|+||++++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999999765 2345899999999999999999999988 999999999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=207.32 Aligned_cols=148 Identities=28% Similarity=0.465 Sum_probs=128.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|.+.++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999864 57889999986432 22345677899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++ +|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 777776443 345788999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=209.79 Aligned_cols=141 Identities=28% Similarity=0.387 Sum_probs=120.9
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHH-HHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVI-LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.+|+|++.+. ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 5889999998652 1223344555554 56789999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 999888743 345889999999999999999999988 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=220.75 Aligned_cols=158 Identities=21% Similarity=0.277 Sum_probs=134.2
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE- 455 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 455 (558)
+.....++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344567999999999999999999985 46899999998642 3344567889999999999999999988776433
Q ss_pred -------eEEEEEecCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCe
Q 008648 456 -------EKLLIYEFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 456 -------~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 2579999999999999886532 2456899999999999999999999988 9999999999999999999
Q ss_pred EEeccccceeeCC
Q 008648 528 KISDFGLARTCGG 540 (558)
Q Consensus 528 kl~DFGla~~~~~ 540 (558)
||+|||+++.+..
T Consensus 183 kL~DFGls~~~~~ 195 (496)
T PTZ00283 183 KLGDFGFSKMYAA 195 (496)
T ss_pred EEEecccCeeccc
Confidence 9999999987654
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=209.29 Aligned_cols=141 Identities=31% Similarity=0.474 Sum_probs=123.6
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 5789999998652 233456677888888776 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999888543 45889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=204.13 Aligned_cols=153 Identities=27% Similarity=0.495 Sum_probs=131.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
..++|++.+.||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999753 24679999886432 2344568899999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEE
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTN-------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKI 529 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 529 (558)
.++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 224678889999999999999999988 999999999999999999999
Q ss_pred eccccceeeC
Q 008648 530 SDFGLARTCG 539 (558)
Q Consensus 530 ~DFGla~~~~ 539 (558)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=201.95 Aligned_cols=149 Identities=30% Similarity=0.522 Sum_probs=131.8
Q ss_pred CCcccceeecccCcccEEEEEEcC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
++|++.+.||+|+||.||+|.... ...||+|.++... ......+.+|+.++++++||||+++++.+...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998642 4579999886532 33456788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999985432 36889999999999999999999988 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=216.81 Aligned_cols=159 Identities=29% Similarity=0.480 Sum_probs=140.4
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
+++....+..+..+||-|.||.||.|.++. .-.||||.++. +.-..++|+.|+.+|+.++|||+|+|+|+|.....+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344445566777899999999999999865 67899999976 3456789999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||+|||..|+|.+||.... ...++....+.++.||+.||+||..++ +|||||.++|+||.++..+||+||||+|.+
T Consensus 340 IiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999997643 345777788899999999999999888 999999999999999999999999999999
Q ss_pred CCCcC
Q 008648 539 GGDKT 543 (558)
Q Consensus 539 ~~~~~ 543 (558)
.++..
T Consensus 416 tgDTY 420 (1157)
T KOG4278|consen 416 TGDTY 420 (1157)
T ss_pred cCCce
Confidence 87653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=208.86 Aligned_cols=141 Identities=28% Similarity=0.378 Sum_probs=120.2
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVI-LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
++||+|+||.||+|+.. +++.+|+|++.+.. ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999974 57899999986522 222344555554 67889999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999888743 345788888999999999999999988 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-23 Score=208.32 Aligned_cols=141 Identities=26% Similarity=0.387 Sum_probs=124.2
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.+|+|++++. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 4789999998753 223455688999999888 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999888743 235899999999999999999999988 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-24 Score=194.12 Aligned_cols=157 Identities=27% Similarity=0.358 Sum_probs=138.8
Q ss_pred hhhhcCCcccceeecccCcccEEEEE-EcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC----
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE---- 455 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 455 (558)
+....++|.+.++||+|+|+-||.++ ..++..+|+|++.....+..+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34456799999999999999999998 5678899999998767778889999999999999999999998876543
Q ss_pred -eEEEEEecCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 456 -EKLLIYEFMPNKSLDYFIFDQTN-SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 456 -~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
..||+++|...|+|.+.+..... +..+++.+++.|+.+|.+||++||+.. ++++||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 48999999999999988866533 447999999999999999999999986 579999999999999999999999999
Q ss_pred cceee
Q 008648 534 LARTC 538 (558)
Q Consensus 534 la~~~ 538 (558)
-+...
T Consensus 175 S~~~a 179 (302)
T KOG2345|consen 175 SATQA 179 (302)
T ss_pred Ccccc
Confidence 98754
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=201.14 Aligned_cols=151 Identities=29% Similarity=0.484 Sum_probs=131.5
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.++|++.++||+|+||.||+|...+...||+|+++.. ....+.+.+|+.++++++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 4579999999999999999999877778999998752 234567899999999999999999999874 45679999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999998643 2345789999999999999999999988 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=201.74 Aligned_cols=151 Identities=28% Similarity=0.504 Sum_probs=131.5
Q ss_pred CCcccceeecccCcccEEEEEEc-C---CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-D---GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.+|++.+.||+|+||.||+|... . ...+|+|.++... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999863 2 3479999886522 23456789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 235789999999999999999999988 99999999999999999999999999987754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=203.67 Aligned_cols=141 Identities=19% Similarity=0.318 Sum_probs=123.9
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEeccccccc---HHHHHHHHHHHhcCCCCeeeeeeeEEEe----CCeEEEEEecC
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQG---LKELKNEVILFSKLQHRNLVKLLGCCIH----GEEKLLIYEFM 464 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~ 464 (558)
..|++|+++.||+|.. +++.||||+++...... .+.+.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999987643322 4678899999999999999999999977 34678999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+.
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 99999999854 34588999999999999999999984 5 8899999999999999999999999998654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=207.97 Aligned_cols=141 Identities=26% Similarity=0.374 Sum_probs=119.3
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHH-HHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEV-ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.+|+|++.+.. ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 46789999986522 12223444444 456789999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+.+..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999998854 334778888889999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=212.74 Aligned_cols=147 Identities=29% Similarity=0.445 Sum_probs=127.3
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----eEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-----EKL 458 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 458 (558)
+|++.++||+|+||.||++.. .+++.||+|++... .....+++.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 46899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+. ++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 577777633 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=199.75 Aligned_cols=152 Identities=32% Similarity=0.509 Sum_probs=136.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..++|.+.++||+|+||.||+|...+++.+++|.+... ....+++.+|+.++++++|+||+++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45689999999999999999999878889999998753 33457899999999999999999999999988899999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|.+++.... ...+++..+..++.+++.||.|||+++ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999985532 345899999999999999999999998 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=207.24 Aligned_cols=141 Identities=31% Similarity=0.431 Sum_probs=122.5
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.||+|.+++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999975 57899999987521 23445667788887754 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999988854 245788999999999999999999998 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=204.08 Aligned_cols=153 Identities=27% Similarity=0.494 Sum_probs=130.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
..++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997532 4579999876432 2234467889999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEE
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTN-------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKI 529 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 529 (558)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999865321 234567788899999999999999988 999999999999999999999
Q ss_pred eccccceeeC
Q 008648 530 SDFGLARTCG 539 (558)
Q Consensus 530 ~DFGla~~~~ 539 (558)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=202.80 Aligned_cols=150 Identities=27% Similarity=0.459 Sum_probs=123.1
Q ss_pred CCcccceeecccCcccEEEEEEc--CCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCeeeeeeeEEEe-----
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--DQGLKELKNEVILFSKL---QHRNLVKLLGCCIH----- 453 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 453 (558)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 36789999886422 22234566677776665 69999999999863
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
....++||||++ ++|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 58888875432 335889999999999999999999988 9999999999999999999999999
Q ss_pred cceeeCC
Q 008648 534 LARTCGG 540 (558)
Q Consensus 534 la~~~~~ 540 (558)
+|+....
T Consensus 156 ~~~~~~~ 162 (290)
T cd07862 156 LARIYSF 162 (290)
T ss_pred ceEeccC
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=207.26 Aligned_cols=141 Identities=30% Similarity=0.434 Sum_probs=122.4
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhc-CCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSK-LQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 47899999987531 2334556677778775 4899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999998854 245788999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=226.50 Aligned_cols=149 Identities=26% Similarity=0.382 Sum_probs=132.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|.+.++||+|+||.||+|... +++.||||++.... ......+..|+.++..++||||+++++.+......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999975 58899999986532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|..++... ..+++..++.|+.||+.||+|||.++ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999998542 35788899999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=201.89 Aligned_cols=144 Identities=31% Similarity=0.501 Sum_probs=122.6
Q ss_pred eeecccCcccEEEEEEcC---CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
++||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888775432 233456889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 468 SLDYFIFDQTN--SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 468 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99999866432 233567788899999999999999988 999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=199.30 Aligned_cols=143 Identities=28% Similarity=0.498 Sum_probs=126.5
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
+.||+|+||.||+|... +++.+|+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999874 6889999987643 233456799999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 9998542 335789999999999999999999988 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=203.70 Aligned_cols=153 Identities=25% Similarity=0.464 Sum_probs=136.4
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.....+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 34457899999999999999999986 46899999998765555567788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999999998843 34788999999999999999999988 99999999999999999999999999987654
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 168 ~ 168 (297)
T cd06656 168 E 168 (297)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=203.20 Aligned_cols=153 Identities=33% Similarity=0.602 Sum_probs=133.9
Q ss_pred cCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888899999999999999742 24568999887655556678999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeE
Q 008648 459 LIYEFMPNKSLDYFIFDQT----------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPK 528 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 528 (558)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986432 1235899999999999999999999988 99999999999999999999
Q ss_pred EeccccceeeCC
Q 008648 529 ISDFGLARTCGG 540 (558)
Q Consensus 529 l~DFGla~~~~~ 540 (558)
|+|||+++.+..
T Consensus 161 l~dfg~~~~~~~ 172 (288)
T cd05093 161 IGDFGMSRDVYS 172 (288)
T ss_pred eccCCccccccC
Confidence 999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=213.10 Aligned_cols=157 Identities=31% Similarity=0.457 Sum_probs=132.4
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCeeeeeeeEEE
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQ-HRNLVKLLGCCI 452 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 452 (558)
.....++|.+.++||+|+||.||+|.+. .+..||+|++.... ....+.+..|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3445567888899999999999999853 24689999997532 223457889999999997 999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCC------------------------------------------------------
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTN------------------------------------------------------ 478 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 478 (558)
.....++||||+++|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999864311
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 008648 479 -----------------------------------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 517 (558)
Q Consensus 479 -----------------------------------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~ 517 (558)
...+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 123677788899999999999999987 999999999
Q ss_pred cEEEcCCCCeEEeccccceeeCC
Q 008648 518 NVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 518 NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++.+||+|||+++.+..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccc
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=200.46 Aligned_cols=143 Identities=31% Similarity=0.423 Sum_probs=123.7
Q ss_pred ecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
||+|+||.||++... +++.+|+|.+.... ......+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 58999999986421 12234566799999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 88875432 334888999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=202.34 Aligned_cols=152 Identities=31% Similarity=0.594 Sum_probs=133.1
Q ss_pred cCCcccceeecccCcccEEEEEEcC------CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
.++|.+.+.||+|+||.||+|...+ +..||+|.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3468888999999999999998633 478999998764333 457899999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 458 LLIYEFMPNKSLDYFIFDQT-----------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
++||||+++++|.+++.... ....+++.++..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986532 1235788999999999999999999988 999999999999999999
Q ss_pred eEEeccccceeeC
Q 008648 527 PKISDFGLARTCG 539 (558)
Q Consensus 527 ~kl~DFGla~~~~ 539 (558)
+||+|||+++.+.
T Consensus 161 ~kl~d~g~~~~~~ 173 (280)
T cd05049 161 VKIGDFGMSRDVY 173 (280)
T ss_pred EEECCcccceecc
Confidence 9999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=199.69 Aligned_cols=150 Identities=29% Similarity=0.498 Sum_probs=133.0
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.+|++.++||+|+||.||+|... .++.||+|.+... ....+++.+|+++++.++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999865 4788999988653 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++++|.+++.... ...+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999985432 345899999999999999999999988 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=200.59 Aligned_cols=149 Identities=31% Similarity=0.520 Sum_probs=130.9
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|++|.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999874 5889999988642 223346788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++ ++|.+++........+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888755444456899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=205.06 Aligned_cols=152 Identities=28% Similarity=0.469 Sum_probs=130.2
Q ss_pred cCCcccceeecccCcccEEEEEEcC---------------CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeee
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD---------------GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLL 448 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 448 (558)
.++|++.+.||+|+||.||++...+ ...||+|.++.. .......+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4579999999999999999987532 235899988653 233456789999999999999999999
Q ss_pred eEEEeCCeEEEEEecCCCCChhHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 008648 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTN---------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 519 (558)
Q Consensus 449 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NI 519 (558)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999998854321 123688899999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeccccceeeC
Q 008648 520 LLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 520 ll~~~~~~kl~DFGla~~~~ 539 (558)
++++++.+||+|||+++.+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EEcCCCcEEecccccccccc
Confidence 99999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-24 Score=197.55 Aligned_cols=152 Identities=29% Similarity=0.463 Sum_probs=131.4
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEec--ccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLS--KISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..+.|++.+.||+|.|+.|+++.. +.|+.+|+|++. +......+++.+|++|.+.|+||||++|++...+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346788899999999999999975 568899998874 34455788999999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEecccccee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGLART 537 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~ 537 (558)
+|+|.|++|..-+..+ ...++..+-..+.||+++|.|.|.++ |||||+||+|+||-. .--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999996655332 45778888899999999999999999 999999999999953 33599999999999
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+++.
T Consensus 163 l~~g 166 (355)
T KOG0033|consen 163 VNDG 166 (355)
T ss_pred eCCc
Confidence 8733
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=198.61 Aligned_cols=150 Identities=32% Similarity=0.488 Sum_probs=132.7
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..+.|++.++||+|+||.||+|...+++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 346789999999999999999998888999999987533 34568899999999999999999999864 5678999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999885533 346889999999999999999999988 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=201.70 Aligned_cols=150 Identities=32% Similarity=0.488 Sum_probs=134.5
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..+.|++.++||+|+||.||+|.... ++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 34679999999999999999998754 78999999876655667788999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|+++++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 90 FCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999998877443 235889999999999999999999988 999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=202.12 Aligned_cols=150 Identities=31% Similarity=0.519 Sum_probs=130.1
Q ss_pred CCcccceeecccCcccEEEEEE-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEK 457 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 457 (558)
+.|++.+.||+|+||.||++.. .++..||+|.++... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247789999986532 33456799999999999999999999998875 567
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998543 235899999999999999999999998 99999999999999999999999999987
Q ss_pred eCC
Q 008648 538 CGG 540 (558)
Q Consensus 538 ~~~ 540 (558)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=197.98 Aligned_cols=149 Identities=31% Similarity=0.571 Sum_probs=133.7
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999874 78999999876433 5678999999999999999999999999989999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++++|.+++.... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999985532 235899999999999999999999998 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=201.78 Aligned_cols=141 Identities=24% Similarity=0.359 Sum_probs=120.4
Q ss_pred eecccCcccEEEEEEcC-------------------------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeee
Q 008648 393 KLGEGGFGPVYKGTLVD-------------------------GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKL 447 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 447 (558)
.||+|+||.||+|.... ...|++|.+.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588898865444445678899999999999999999
Q ss_pred eeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC--
Q 008648 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-- 525 (558)
Q Consensus 448 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-- 525 (558)
++++.+....++||||+++++|..++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999988542 345789999999999999999999988 99999999999997644
Q ss_pred -----CeEEeccccceee
Q 008648 526 -----NPKISDFGLARTC 538 (558)
Q Consensus 526 -----~~kl~DFGla~~~ 538 (558)
.+||+|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=204.10 Aligned_cols=148 Identities=25% Similarity=0.293 Sum_probs=130.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++.+++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999864 4778888887643 233446688999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|.+++... ..+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999998543 4588999999999999999999974 5 9999999999999999999999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=203.12 Aligned_cols=152 Identities=28% Similarity=0.484 Sum_probs=130.8
Q ss_pred cCCcccceeecccCcccEEEEEEc-----------------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeee
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-----------------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVK 446 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 446 (558)
.++|++.++||+|+||.||++... +...+|+|.+... .......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 2346899988653 2334567899999999999999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCChhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 008648 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTN--------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518 (558)
Q Consensus 447 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~N 518 (558)
+++++...+..+++|||+++++|.+++..... ...+++.++..++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 124778889999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeccccceeeC
Q 008648 519 VLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~~~ 539 (558)
||+++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEEcCCCCEEeccCccccccc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=199.06 Aligned_cols=150 Identities=29% Similarity=0.526 Sum_probs=128.3
Q ss_pred cccceeecccCcccEEEEEEcC----CcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe-----
Q 008648 388 FSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE----- 456 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 456 (558)
|++.+.||+|+||.||+|.... +..+|+|+++.. .......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 367999998642 23345678999999999999999999999876554
Q ss_pred -EEEEEecCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 457 -KLLIYEFMPNKSLDYFIFDQT---NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 457 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999998885532 2346899999999999999999999988 999999999999999999999999
Q ss_pred ccceeeCC
Q 008648 533 GLARTCGG 540 (558)
Q Consensus 533 Gla~~~~~ 540 (558)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=198.79 Aligned_cols=152 Identities=25% Similarity=0.436 Sum_probs=132.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.++||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 6889999987542 2333456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|..++.... ....+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875432 2345788999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=201.00 Aligned_cols=151 Identities=36% Similarity=0.607 Sum_probs=130.8
Q ss_pred CCcccceeecccCcccEEEEEEcC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
++|++.+.||+|+||.||+|.... ...|++|.+.... ......+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998643 2579999886432 234567899999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 008648 459 LIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM 525 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~ 525 (558)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+++ |+|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145788999999999999999999998 99999999999999999
Q ss_pred CeEEeccccceeeC
Q 008648 526 NPKISDFGLARTCG 539 (558)
Q Consensus 526 ~~kl~DFGla~~~~ 539 (558)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=202.63 Aligned_cols=151 Identities=28% Similarity=0.437 Sum_probs=135.5
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
+.++|++.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++.+......++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 4567999999999999999999874 578999999876555566789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+++++|..++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 83 FCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999988543 245899999999999999999999998 9999999999999999999999999987553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=214.36 Aligned_cols=144 Identities=25% Similarity=0.335 Sum_probs=126.5
Q ss_pred cCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
...|.+.+.||+|+||.||++.... ++.||||... ...+.+|++++++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999754 7889999542 23457899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+. ++|..++... ...+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 95 6787777432 236899999999999999999999988 99999999999999999999999999987654
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=199.98 Aligned_cols=150 Identities=29% Similarity=0.511 Sum_probs=131.3
Q ss_pred CCcccceeecccCcccEEEEEEcC-C---cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..|++.+.||+|+||.||+|.... + ..||+|.+... .....+++..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998643 2 36999998653 334457899999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|..++... ...+++.++..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 345889999999999999999999988 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=202.64 Aligned_cols=154 Identities=31% Similarity=0.522 Sum_probs=132.9
Q ss_pred hhcCCcccceeecccCcccEEEEEEcC------CcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG 454 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 454 (558)
...++|++.+.||+|+||.||++.... ...+|+|.+... ......++.+|+.++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678899999999999999998642 357999988652 233446688999999999 799999999999999
Q ss_pred CeEEEEEecCCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQ-------------TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 521 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll 521 (558)
+..+++|||+++++|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998642 22346889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeccccceeeC
Q 008648 522 DHDMNPKISDFGLARTCG 539 (558)
Q Consensus 522 ~~~~~~kl~DFGla~~~~ 539 (558)
++++.+||+|||+++.+.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~ 183 (293)
T cd05053 166 TEDHVMKIADFGLARDIH 183 (293)
T ss_pred cCCCeEEeCccccccccc
Confidence 999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=205.38 Aligned_cols=141 Identities=30% Similarity=0.429 Sum_probs=124.0
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.+|+|++.+. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998753 233455677888898887 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9998887443 35899999999999999999999988 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=201.95 Aligned_cols=150 Identities=30% Similarity=0.408 Sum_probs=133.2
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 58899999886522 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+|+||+|+||+|+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 46889999999999999999999988 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=200.51 Aligned_cols=149 Identities=27% Similarity=0.475 Sum_probs=133.2
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.++||+|+||.||+|... +++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 5889999998764444556788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999998844 335889999999999999999999998 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=199.75 Aligned_cols=150 Identities=29% Similarity=0.565 Sum_probs=125.3
Q ss_pred cccceeecccCcccEEEEEEcCCc---EEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------Ce
Q 008648 388 FSINNKLGEGGFGPVYKGTLVDGQ---EIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------EE 456 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 456 (558)
|.+.++||+|+||.||+|...+.. .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 346689999999999999875432 6899987642 234456788999999999999999999987542 24
Q ss_pred EEEEEecCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQT---NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
.+++|||+++++|..++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 2345889999999999999999999988 9999999999999999999999999
Q ss_pred cceeeCC
Q 008648 534 LARTCGG 540 (558)
Q Consensus 534 la~~~~~ 540 (558)
+++.+..
T Consensus 158 ~~~~~~~ 164 (272)
T cd05075 158 LSKKIYN 164 (272)
T ss_pred cccccCc
Confidence 9987643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=216.46 Aligned_cols=149 Identities=28% Similarity=0.430 Sum_probs=125.5
Q ss_pred ccceeecccCcccEEEEEEc-CCcEEEEEEec--c--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe--EEEEE
Q 008648 389 SINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS--K--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE--KLLIY 461 (558)
Q Consensus 389 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 461 (558)
+..++||+|+|-+||+|.+. +|.+||--.++ . ..+...++|..|+.+|+.|+||||++++..+.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44479999999999999874 47777643222 1 234456889999999999999999999999998766 67999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~ 540 (558)
|.+..|+|..|+.+. +.++.+.+..|++||++||.|||++. ++|||||||.+||+|+ ..|.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999998553 45788899999999999999999986 7899999999999998 568999999999987644
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 199 s 199 (632)
T KOG0584|consen 199 S 199 (632)
T ss_pred c
Confidence 3
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=200.55 Aligned_cols=148 Identities=28% Similarity=0.389 Sum_probs=129.3
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 58899999986522 22334578899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998875432 345899999999999999999999988 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-22 Score=196.66 Aligned_cols=152 Identities=27% Similarity=0.460 Sum_probs=134.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+||+++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 7899999988632 2334567899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|..++.... ....+++.++..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2445889999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=199.80 Aligned_cols=149 Identities=30% Similarity=0.402 Sum_probs=129.6
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.+++.++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999864 58899999886532 22234577899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999998885432 345889999999999999999999988 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=203.18 Aligned_cols=155 Identities=29% Similarity=0.521 Sum_probs=132.8
Q ss_pred hhcCCcccceeecccCcccEEEEEEc--------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCI 452 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 452 (558)
....+|.+.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888999999999999999741 2357999988643 234456789999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 519 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NI 519 (558)
.....+++|||+++++|.+++..... ...+++.++..++.||++||.|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999865321 235788899999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeccccceeeCC
Q 008648 520 LLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 520 ll~~~~~~kl~DFGla~~~~~ 540 (558)
++++++.+||+|||+|+.+..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EEcCCCcEEECCCccceeccc
Confidence 999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=197.88 Aligned_cols=150 Identities=31% Similarity=0.497 Sum_probs=131.8
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.++|++.++||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 35788899999999999999998888899999987532 34567999999999999999999999875 45689999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999986532 345789999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=203.94 Aligned_cols=149 Identities=34% Similarity=0.612 Sum_probs=128.3
Q ss_pred CCcccceeecccCcccEEEEEEcC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 460 (558)
++|++.+.||+|+||.||+|.... +. .+++|.+... .......+.+|+.++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 478888999999999999998643 43 4677776542 233456788999999999 899999999999999999999
Q ss_pred EecCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCe
Q 008648 461 YEFMPNKSLDYFIFDQT-------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
|||+++++|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986532 1235789999999999999999999988 9999999999999999999
Q ss_pred EEecccccee
Q 008648 528 KISDFGLART 537 (558)
Q Consensus 528 kl~DFGla~~ 537 (558)
||+|||+++.
T Consensus 164 kl~dfg~~~~ 173 (303)
T cd05088 164 KIADFGLSRG 173 (303)
T ss_pred EeCccccCcc
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=208.65 Aligned_cols=153 Identities=29% Similarity=0.476 Sum_probs=128.4
Q ss_pred hcCCcccceeecccCcccEEEEEE------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG- 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 454 (558)
..++|++.+.||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345799999999999999999973 346789999986532 23345788999999999 689999999988654
Q ss_pred CeEEEEEecCCCCChhHHHhhcCC--------------------------------------------------------
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTN-------------------------------------------------------- 478 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 478 (558)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999998864210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 479 --------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 479 --------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 123678888999999999999999988 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=202.44 Aligned_cols=151 Identities=24% Similarity=0.398 Sum_probs=132.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||+|+||.||++... .+..+|+|.+... .......+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888899999999999999975 6889999988642 233456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999886543334689999999999999999999974 5 9999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=197.95 Aligned_cols=154 Identities=28% Similarity=0.413 Sum_probs=127.3
Q ss_pred cCCcccceeecccCcccEEEEEEcC-----CcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CCe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIH-GEE 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 456 (558)
...|+....||+|.||.||+|...+ .+++|+|+++.... .......+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3478888999999999999996432 34789999875322 123457789999999999999999999988 778
Q ss_pred EEEEEecCCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CCeEEe
Q 008648 457 KLLIYEFMPNKSLDYFIFD--QTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD----MNPKIS 530 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~ 530 (558)
.+|++||.+. +|..+++- ....+.++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999976 56555543 233457899999999999999999999998 9999999999999866 899999
Q ss_pred ccccceeeCCCc
Q 008648 531 DFGLARTCGGDK 542 (558)
Q Consensus 531 DFGla~~~~~~~ 542 (558)
|||+||.+...-
T Consensus 179 DlGlaR~~~~pl 190 (438)
T KOG0666|consen 179 DLGLARLFNNPL 190 (438)
T ss_pred cccHHHHhhccc
Confidence 999999986553
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=208.67 Aligned_cols=153 Identities=29% Similarity=0.473 Sum_probs=128.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC-
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG- 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 454 (558)
+.++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+..|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4458999999999999999999642 24689999986432 22345678899999999 899999999988754
Q ss_pred CeEEEEEecCCCCChhHHHhhcCC--------------------------------------------------------
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTN-------------------------------------------------------- 478 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 478 (558)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 467899999999999998854221
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 479 --SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 479 --~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~ 224 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 224 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence 125789999999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=214.24 Aligned_cols=149 Identities=25% Similarity=0.430 Sum_probs=122.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-------- 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 454 (558)
...+|++.+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4467999999999999999999874 57899999885421 2345799999999999999999887542
Q ss_pred CeEEEEEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEecc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDF 532 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DF 532 (558)
...++||||+++ +|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 666655432 23456899999999999999999999998 99999999999999664 6999999
Q ss_pred ccceeeCC
Q 008648 533 GLARTCGG 540 (558)
Q Consensus 533 Gla~~~~~ 540 (558)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99987643
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=196.29 Aligned_cols=149 Identities=32% Similarity=0.490 Sum_probs=130.2
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
++|.+.++||+|++|.||+|....+..+|+|.+... ....+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 568888999999999999999877778999987653 234567889999999999999999999875 456889999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999986532 345789999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=210.36 Aligned_cols=149 Identities=25% Similarity=0.380 Sum_probs=129.9
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCC-C-----CeeeeeeeEEEeCCeEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 458 (558)
.+|.+.+.||+|+||.|.+|.+ .+++.||||+++. ......+...|+.+|..|+ | -|+|+++++|...++.+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3899999999999999999986 4589999999976 3455677788999999996 4 48999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCCeEEeccccce
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH--DMNPKISDFGLAR 536 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~ 536 (558)
||+|.+ ..+|.+++.... ...++...+..|+.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.|.
T Consensus 265 iVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999999 579999996643 445899999999999999999999988 999999999999964 3479999999998
Q ss_pred eeCC
Q 008648 537 TCGG 540 (558)
Q Consensus 537 ~~~~ 540 (558)
....
T Consensus 340 ~~~q 343 (586)
T KOG0667|consen 340 FESQ 343 (586)
T ss_pred ccCC
Confidence 6543
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=201.93 Aligned_cols=150 Identities=25% Similarity=0.472 Sum_probs=134.5
Q ss_pred hhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
....+|++.+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++.+......++||
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 3456899999999999999999986 458899999987655555677899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred cccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999998843 34788999999999999999999988 9999999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=203.56 Aligned_cols=152 Identities=31% Similarity=0.522 Sum_probs=131.6
Q ss_pred cCCcccceeecccCcccEEEEEEcC--------CcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG 454 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 454 (558)
.++|.+.+.||+|+||.||++.... ...+|+|.+... ......++..|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999997522 346999988753 233456788899999999 799999999999999
Q ss_pred CeEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 521 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll 521 (558)
+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965421 235889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeccccceeeC
Q 008648 522 DHDMNPKISDFGLARTCG 539 (558)
Q Consensus 522 ~~~~~~kl~DFGla~~~~ 539 (558)
++++.+||+|||+|+.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=201.41 Aligned_cols=152 Identities=31% Similarity=0.565 Sum_probs=132.7
Q ss_pred CCcccceeecccCcccEEEEEEc------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.+|.+.+.||+|+||.||++... +...+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999742 345689998876555556789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 460 IYEFMPNKSLDYFIFDQT-------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986532 1234789999999999999999999998 999999999999999999
Q ss_pred eEEeccccceeeCC
Q 008648 527 PKISDFGLARTCGG 540 (558)
Q Consensus 527 ~kl~DFGla~~~~~ 540 (558)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=200.02 Aligned_cols=153 Identities=29% Similarity=0.531 Sum_probs=132.8
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH-GEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 456 (558)
..++|++.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35688899999999999999999765 678999988653 23345678899999999999999999998876 467
Q ss_pred EEEEEecCCCCChhHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEec
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNS-----KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 531 (558)
.++++||+++++|..++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 46899999999999999999999988 99999999999999999999999
Q ss_pred cccceeeC
Q 008648 532 FGLARTCG 539 (558)
Q Consensus 532 FGla~~~~ 539 (558)
||+++.+.
T Consensus 161 ~g~~~~~~ 168 (280)
T cd05043 161 NALSRDLF 168 (280)
T ss_pred CCCccccc
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=198.61 Aligned_cols=145 Identities=32% Similarity=0.462 Sum_probs=123.8
Q ss_pred eeecccCcccEEEEEEcC---CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
+.||+|+||.||+|...+ +..+++|.++... ......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 4579999886533 233457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 468 SLDYFIFDQTN--SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 468 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999865322 234567788889999999999999988 9999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=197.03 Aligned_cols=153 Identities=28% Similarity=0.389 Sum_probs=131.2
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
+++.+.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3445555579999999999999864 577899998876555567789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~ 539 (558)
|+++++|..++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999865322222378888899999999999999988 999999999999986 6789999999998664
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=199.04 Aligned_cols=150 Identities=27% Similarity=0.409 Sum_probs=131.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999975 58899999886432 2234568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|++++.|..++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988887632 335899999999999999999999988 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=200.59 Aligned_cols=152 Identities=32% Similarity=0.492 Sum_probs=132.1
Q ss_pred cCCcccceeecccCcccEEEEEEcC-----------------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeee
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVK 446 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 446 (558)
.++|++.++||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999997543 2458999886532 345667899999999999999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCChhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 008648 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQT--------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518 (558)
Q Consensus 447 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~N 518 (558)
+++++......+++|||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986533 1235899999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeccccceeeC
Q 008648 519 VLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~~~ 539 (558)
|+++.++.++|+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=198.40 Aligned_cols=144 Identities=26% Similarity=0.352 Sum_probs=127.5
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
+|++.++||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999986 46789999988653 2334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999996542 3678888899999999999999988 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=205.65 Aligned_cols=139 Identities=24% Similarity=0.321 Sum_probs=118.7
Q ss_pred ecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC---CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKL---QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
||+|+||.||+|... +++.||+|++.+.. ......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 58899999986422 12233455566666655 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 999888844 345889999999999999999999998 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=200.50 Aligned_cols=150 Identities=34% Similarity=0.539 Sum_probs=128.7
Q ss_pred CcccceeecccCcccEEEEEEcC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
+|++.+.||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998532 3568888876532 2345678899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 008648 460 IYEFMPNKSLDYFIFDQT---------------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~N 518 (558)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 1235788999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeccccceeeC
Q 008648 519 VLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~~~ 539 (558)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-24 Score=200.83 Aligned_cols=148 Identities=30% Similarity=0.492 Sum_probs=134.2
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
+-|.++++||+|+||.||+|.++ .|+.+|+|.+.. ..+.+++..|+.+++..+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 35778899999999999999875 489999999864 457889999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
..|+..++++. ..+.|.+.++..++...++||+|||.-. -||||||+.||||+.+|.+||+|||.|-.+.+
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 99999999955 3467999999999999999999999865 89999999999999999999999999987754
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=199.83 Aligned_cols=149 Identities=30% Similarity=0.505 Sum_probs=125.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.+|++.+.||+|+||.||+|... +++ .+++|.+.... .....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999864 343 47778775422 233467888888999999999999999875 455789
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998543 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 161 ~ 161 (279)
T cd05111 161 P 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=197.55 Aligned_cols=142 Identities=26% Similarity=0.440 Sum_probs=122.4
Q ss_pred eeecccCcccEEEEEEcCCc-----------EEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 392 NKLGEGGFGPVYKGTLVDGQ-----------EIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999975433 5777876543322 6788999999999999999999999988 778999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-------CeEEeccc
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-------NPKISDFG 533 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-------~~kl~DFG 533 (558)
|||+++++|..++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986533 25889999999999999999999988 99999999999999887 79999999
Q ss_pred cceeeCC
Q 008648 534 LARTCGG 540 (558)
Q Consensus 534 la~~~~~ 540 (558)
+++....
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=199.56 Aligned_cols=145 Identities=32% Similarity=0.539 Sum_probs=128.3
Q ss_pred cccceeecccCcccEEEEEEcC-CcEEEEEEecccccccH--HHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 388 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGL--KELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
|++.+.||+|+||.||++.... ++.+|+|.+........ ....+|+.++++++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999999765 56899999976433222 23456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++++|.+++. ....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999996 2345799999999999999999999998 999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=194.85 Aligned_cols=143 Identities=31% Similarity=0.508 Sum_probs=126.9
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChh
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 470 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 470 (558)
++||+|+||.||+|...++..+|+|.+..... .....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37899999999999988889999998865332 23456889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 471 YFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 471 ~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 988543 235789999999999999999999988 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=199.41 Aligned_cols=150 Identities=29% Similarity=0.445 Sum_probs=131.4
Q ss_pred CCcccceeecccCcccEEEEEEc------CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
++|++.+.||+|+||.||+|+.. +.+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999853 2467999988654333 4577999999999999999999999999988999
Q ss_pred EEEecCCCCChhHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 459 LIYEFMPNKSLDYFIFDQTNS------KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654321 25899999999999999999999988 999999999999999999999999
Q ss_pred ccceee
Q 008648 533 GLARTC 538 (558)
Q Consensus 533 Gla~~~ 538 (558)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=196.84 Aligned_cols=149 Identities=31% Similarity=0.479 Sum_probs=131.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
++|++.+.||+|++|.||++... +++++++|.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 58899999876422 1234568899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 35788999999999999999999988 9999999999999999999999999998664
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=198.55 Aligned_cols=148 Identities=30% Similarity=0.472 Sum_probs=131.6
Q ss_pred CcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36778899999999999999754 67889998876555566788999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 99998887542 345899999999999999999999988 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=199.01 Aligned_cols=150 Identities=31% Similarity=0.514 Sum_probs=128.4
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.++|++.++||+|+||.||+|... ++. .||+|.+... .....+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888899999999999999853 444 4899988643 33345678899999999999999999999875 4578
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988543 345889999999999999999999988 999999999999999999999999999877
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 160 ~~ 161 (279)
T cd05109 160 DI 161 (279)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=201.78 Aligned_cols=149 Identities=30% Similarity=0.569 Sum_probs=128.3
Q ss_pred CCcccceeecccCcccEEEEEEcC-C--cEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-G--QEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 460 (558)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 3 34788887642 333456789999999999 799999999999999999999
Q ss_pred EecCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCe
Q 008648 461 YEFMPNKSLDYFIFDQT-------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
|||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986432 1135888999999999999999999988 9999999999999999999
Q ss_pred EEecccccee
Q 008648 528 KISDFGLART 537 (558)
Q Consensus 528 kl~DFGla~~ 537 (558)
||+|||+++.
T Consensus 159 kl~dfg~~~~ 168 (297)
T cd05089 159 KIADFGLSRG 168 (297)
T ss_pred EECCcCCCcc
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=199.41 Aligned_cols=153 Identities=26% Similarity=0.469 Sum_probs=132.1
Q ss_pred cCCcccceeecccCcccEEEEEEcC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
.++|++.+.||+|+||.||+|.... +..+|+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998643 3689999986532 23445788999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 458 LLIYEFMPNKSLDYFIFDQTN-------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865322 224788899999999999999999988 9999999999999999999999
Q ss_pred ccccceeeCC
Q 008648 531 DFGLARTCGG 540 (558)
Q Consensus 531 DFGla~~~~~ 540 (558)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=210.02 Aligned_cols=139 Identities=32% Similarity=0.488 Sum_probs=123.2
Q ss_pred ccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 389 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 389 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
..++-||.|+-|.||+|++ .++.||||+++... ..+|+-|++|+||||+.+.|+|....-++||||||..|.
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3456899999999999998 46899999886432 246788999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 469 LDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 469 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|..+|. ....+.......+..+||.||.|||.+. |||||||.-||||..+..|||+|||.++.....
T Consensus 199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 999994 4456888888999999999999999988 999999999999999999999999999876543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=199.34 Aligned_cols=151 Identities=30% Similarity=0.551 Sum_probs=132.7
Q ss_pred CCcccceeecccCcccEEEEEEc------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
++|+..++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999742 356789998876666667789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCe
Q 008648 460 IYEFMPNKSLDYFIFDQTN------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
+|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 135789999999999999999999988 9999999999999999999
Q ss_pred EEeccccceeeC
Q 008648 528 KISDFGLARTCG 539 (558)
Q Consensus 528 kl~DFGla~~~~ 539 (558)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=196.85 Aligned_cols=150 Identities=28% Similarity=0.534 Sum_probs=131.3
Q ss_pred CCcccceeecccCcccEEEEEEcC-C---cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
++|+..+.||+|+||.||+|.... + ..+++|.+... .....+.+..|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999998743 3 36899988653 233456789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|..++... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998542 245889999999999999999999988 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=207.37 Aligned_cols=147 Identities=31% Similarity=0.442 Sum_probs=124.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----- 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 455 (558)
..++|++.+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 5889999998642 2334567889999999999999999999987543
Q ss_pred -eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 456 -EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 456 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
..++||||+++ +|...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999976 4555542 23788889999999999999999998 99999999999999999999999999
Q ss_pred ceeeC
Q 008648 535 ARTCG 539 (558)
Q Consensus 535 a~~~~ 539 (558)
|+...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=198.77 Aligned_cols=161 Identities=25% Similarity=0.409 Sum_probs=135.7
Q ss_pred cchhhhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEE-
Q 008648 376 FELATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCI- 452 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 452 (558)
+.+..+..+.++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334556678889999999999999999999864 5789999987652 22346788899999999 6999999999885
Q ss_pred ----eCCeEEEEEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCe
Q 008648 453 ----HGEEKLLIYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 453 ----~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
.++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999887542 23346788999999999999999999988 9999999999999999999
Q ss_pred EEeccccceeeCC
Q 008648 528 KISDFGLARTCGG 540 (558)
Q Consensus 528 kl~DFGla~~~~~ 540 (558)
||+|||+++.+..
T Consensus 164 kl~dfg~~~~~~~ 176 (286)
T cd06638 164 KLVDFGVSAQLTS 176 (286)
T ss_pred EEccCCceeeccc
Confidence 9999999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=195.44 Aligned_cols=142 Identities=30% Similarity=0.525 Sum_probs=122.4
Q ss_pred eecccCcccEEEEEEc---CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 393 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
.||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 35579999886533 233467899999999999999999999875 457899999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 469 LDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 469 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccC
Confidence 99988542 346899999999999999999999988 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=194.43 Aligned_cols=151 Identities=26% Similarity=0.413 Sum_probs=133.6
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|++|.||+|... +++.+++|.+... .......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999864 5889999987642 344567789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998653 2346889999999999999999999988 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=196.87 Aligned_cols=143 Identities=24% Similarity=0.402 Sum_probs=122.4
Q ss_pred eeecccCcccEEEEEEcC-------------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 392 NKLGEGGFGPVYKGTLVD-------------GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358889876644455567889999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC-------eEEec
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN-------PKISD 531 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~-------~kl~D 531 (558)
++|||+++++|+.++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999887542 345889999999999999999999988 999999999999987664 89999
Q ss_pred cccceeeC
Q 008648 532 FGLARTCG 539 (558)
Q Consensus 532 FGla~~~~ 539 (558)
||++....
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=195.77 Aligned_cols=151 Identities=31% Similarity=0.472 Sum_probs=133.1
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..++|++.++||+|+||.||++...++..+++|.+... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 45688999999999999999999877788999988653 3345678999999999999999999999887 778999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 82 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999986532 345788899999999999999999988 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=194.16 Aligned_cols=152 Identities=23% Similarity=0.379 Sum_probs=133.8
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|+..+.||+|+||.||.+.. .+++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999985 45889999987642 344556788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999986543 346889999999999999999999988 9999999999999999999999999998774433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=197.17 Aligned_cols=152 Identities=32% Similarity=0.489 Sum_probs=131.6
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC------
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG------ 454 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 454 (558)
.+.+.|++.+.||+|+||.||+|... +++.+|+|.+... ......+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678899999999999999999864 4788999988653 34456788999999998 699999999998763
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999988653 2346889999999999999999999988 99999999999999999999999999
Q ss_pred ceeeC
Q 008648 535 ARTCG 539 (558)
Q Consensus 535 a~~~~ 539 (558)
++.+.
T Consensus 158 ~~~~~ 162 (272)
T cd06637 158 SAQLD 162 (272)
T ss_pred ceecc
Confidence 98764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=199.03 Aligned_cols=146 Identities=36% Similarity=0.537 Sum_probs=126.4
Q ss_pred cccceeecccCcccEEEEEE-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEEE
Q 008648 388 FSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKLL 459 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 459 (558)
|++.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 357789999986532 23456788999999999999999999988764 35789
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+|||+++++|.+++.. ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999844 24899999999999999999999988 9999999999999999999999999998764
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=200.67 Aligned_cols=148 Identities=29% Similarity=0.465 Sum_probs=129.3
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999864 57899999886432 23345678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888877543 335788999999999999999999988 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=195.41 Aligned_cols=150 Identities=25% Similarity=0.463 Sum_probs=134.8
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++.+......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467899999999999999999864 4788999998765555678899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|.+++... ...+++.++..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999988543 245889999999999999999999988 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=200.58 Aligned_cols=150 Identities=33% Similarity=0.524 Sum_probs=129.4
Q ss_pred CcccceeecccCcccEEEEEEcC------CcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.|++.++||+|+||.||+|...+ ++.||+|++..... ...+.+.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 57778899999999999998632 47899999875332 234668899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 460 IYEFMPNKSLDYFIFDQT-------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1234788889999999999999999988 999999999999999999
Q ss_pred eEEeccccceeeC
Q 008648 527 PKISDFGLARTCG 539 (558)
Q Consensus 527 ~kl~DFGla~~~~ 539 (558)
+||+|||+++...
T Consensus 163 ~kl~Dfg~~~~~~ 175 (283)
T cd05091 163 VKISDLGLFREVY 175 (283)
T ss_pred eEecccccccccc
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=199.87 Aligned_cols=149 Identities=34% Similarity=0.505 Sum_probs=130.9
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccccc-----cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQ-----GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
+|++.+.||+|+||.||+|... +++.|++|.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999864 5889999998653222 344577899999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985432 36899999999999999999999998 99999999999999999999999999987754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 155 ~ 155 (298)
T cd07841 155 P 155 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=198.33 Aligned_cols=152 Identities=26% Similarity=0.445 Sum_probs=133.2
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 57889999987642 2234467889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|.+++... .....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 22456899999999999999999999988 99999999999999999999999999887643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=206.05 Aligned_cols=143 Identities=22% Similarity=0.341 Sum_probs=124.5
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
...+|++.+.||+|+||.||+|... .++.||+|.... .....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4467999999999999999999975 467899997543 123568999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|+. ++|..++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 995 577777744 2346899999999999999999999988 999999999999999999999999999754
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=195.10 Aligned_cols=149 Identities=32% Similarity=0.491 Sum_probs=131.7
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999976 68899999886532 23456789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 35789999999999999999999988 99999999999999999999999999987644
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 155 ~ 155 (258)
T cd06632 155 F 155 (258)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=201.40 Aligned_cols=152 Identities=33% Similarity=0.531 Sum_probs=130.8
Q ss_pred cCCcccceeecccCcccEEEEEEc--------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG 454 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 454 (558)
..+|.+.++||+|+||.||++... ....+|+|.+... .......+..|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999742 2457899988643 233456788999999999 699999999999998
Q ss_pred CeEEEEEecCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQT-------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 521 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll 521 (558)
...+++|||+++++|.+++.... ....+++.++..++.||+.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 89999999999999999986532 1235889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeccccceeeC
Q 008648 522 DHDMNPKISDFGLARTCG 539 (558)
Q Consensus 522 ~~~~~~kl~DFGla~~~~ 539 (558)
++++.+||+|||+++.+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 168 TEDNVMKIADFGLARGVH 185 (314)
T ss_pred cCCCcEEEcccccccccc
Confidence 999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=200.74 Aligned_cols=146 Identities=21% Similarity=0.326 Sum_probs=129.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999865 47899999886532 233457889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999998543 35889999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=203.07 Aligned_cols=144 Identities=22% Similarity=0.222 Sum_probs=115.9
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc--CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCeeee-eeeEEEe
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-----SDQGLKELKNEVILFSKLQHRNLVK-LLGCCIH 453 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 453 (558)
.....+|.+.+.||+|+||.||+|... +++.+|||++... .....+.+.+|++++++++|+|++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 445578999999999999999999864 4677899986532 1223566999999999999999985 443
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEEcCCCCeEEecc
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDHDMNPKISDF 532 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl~DF 532 (558)
.+..+|||||+++++|.... .. . ...++.++++||.|||+++ |+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 24679999999999996321 10 1 1457889999999999988 999999 999999999999999999
Q ss_pred ccceeeCCCc
Q 008648 533 GLARTCGGDK 542 (558)
Q Consensus 533 Gla~~~~~~~ 542 (558)
|+|+.+....
T Consensus 157 GlA~~~~~~~ 166 (365)
T PRK09188 157 QLASVFRRRG 166 (365)
T ss_pred ccceecccCc
Confidence 9999876543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=197.68 Aligned_cols=149 Identities=31% Similarity=0.542 Sum_probs=129.4
Q ss_pred CCcccceeecccCcccEEEEEEcC-Cc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.+|++.+.||+|+||.||+|...+ +. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568888999999999999998643 32 58999876543 2345678899999999999999999999987 78899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 234899999999999999999999988 9999999999999999999999999998765
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=199.79 Aligned_cols=150 Identities=26% Similarity=0.489 Sum_probs=134.7
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
...+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 445799999999999999999985 4688999999876555556788999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 97 YLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999998843 34789999999999999999999998 99999999999999999999999999887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=196.40 Aligned_cols=146 Identities=32% Similarity=0.509 Sum_probs=129.8
Q ss_pred CcccceeecccCcccEEEEEEcCCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS------DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998788999999876421 12335688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999998543 34788999999999999999999988 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=197.24 Aligned_cols=153 Identities=29% Similarity=0.515 Sum_probs=131.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
..++|++.+.||+|++|.||+|.... +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678999999999999999998753 5678999876432 3344568999999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---CeEE
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTN----SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM---NPKI 529 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl 529 (558)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865421 235889999999999999999999988 99999999999998654 5999
Q ss_pred eccccceeeC
Q 008648 530 SDFGLARTCG 539 (558)
Q Consensus 530 ~DFGla~~~~ 539 (558)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=209.43 Aligned_cols=145 Identities=24% Similarity=0.331 Sum_probs=126.3
Q ss_pred cCCcccceeecccCcccEEEEEEc---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..+|++.+.||+|+||.||++... .+..|++|.+... +...+|+.++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3568999987542 24568999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|++. ++|..++. ....+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 57777772 2346899999999999999999999988 999999999999999999999999999876543
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=203.28 Aligned_cols=152 Identities=31% Similarity=0.528 Sum_probs=130.7
Q ss_pred CCcccceeecccCcccEEEEEEcC--------CcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGE 455 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 455 (558)
.+|++.+.||+|+||.||+|.... ...+|+|.+... .....+++.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999997421 236899987642 233456889999999999 7999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQT-------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 522 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~ 522 (558)
..+++|||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1235788999999999999999999988 99999999999999
Q ss_pred CCCCeEEeccccceeeCC
Q 008648 523 HDMNPKISDFGLARTCGG 540 (558)
Q Consensus 523 ~~~~~kl~DFGla~~~~~ 540 (558)
+++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=199.35 Aligned_cols=152 Identities=32% Similarity=0.543 Sum_probs=132.0
Q ss_pred cCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... ....+++.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999863 36789999886532 33456789999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 008648 458 LLIYEFMPNKSLDYFIFDQT-------------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~N 518 (558)
+++|||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1124788899999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeccccceeeC
Q 008648 519 VLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~~~ 539 (558)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=192.13 Aligned_cols=150 Identities=24% Similarity=0.387 Sum_probs=132.1
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
+|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999864 5889999988542 2345567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999998887543 2345788999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=195.34 Aligned_cols=147 Identities=31% Similarity=0.534 Sum_probs=129.4
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccccc---------cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQ---------GLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
+|.+...||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 5789999988643221 23568899999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.+++|||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999998442 45788899999999999999999988 9999999999999999999999999998
Q ss_pred eeC
Q 008648 537 TCG 539 (558)
Q Consensus 537 ~~~ 539 (558)
.+.
T Consensus 155 ~~~ 157 (267)
T cd06628 155 KLE 157 (267)
T ss_pred ccc
Confidence 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=205.33 Aligned_cols=149 Identities=30% Similarity=0.441 Sum_probs=127.3
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------ 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 454 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 456899999999999999999986 457899999986522 22345677899999999999999999987643
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
...++++|++ +++|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 788888763 235899999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-22 Score=192.62 Aligned_cols=148 Identities=28% Similarity=0.485 Sum_probs=128.7
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CCeEEEEEecC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH-GEEKLLIYEFM 464 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~ 464 (558)
.+|++.+.||+|+||.||++.. .+..+++|.++.. ...+.+.+|+.++++++|+|++++++++.. .+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4788889999999999999976 4778999988642 345678999999999999999999998654 45689999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999986532 335789999999999999999999988 99999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=198.11 Aligned_cols=147 Identities=31% Similarity=0.466 Sum_probs=128.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999875 578999999865322 2334577899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+++ +|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 8988875432 35789999999999999999999988 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=200.14 Aligned_cols=153 Identities=35% Similarity=0.518 Sum_probs=132.2
Q ss_pred hcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 455 (558)
..++|.+.+.||+|+||.||++... .+..+|+|.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457889999999999999999742 24579999887532 33456789999999999 7999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..+++|||+++++|.+++.... ...+++.++..++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999986432 234899999999999999999999988 999999999999999999999999999
Q ss_pred eeeCC
Q 008648 536 RTCGG 540 (558)
Q Consensus 536 ~~~~~ 540 (558)
+.+..
T Consensus 189 ~~~~~ 193 (302)
T cd05055 189 RDIMN 193 (302)
T ss_pred ccccC
Confidence 87643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=194.93 Aligned_cols=141 Identities=29% Similarity=0.401 Sum_probs=127.4
Q ss_pred eeecccCcccEEEEE-EcCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 392 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
+.||+|+|+.|--+. +.++.++|||++.+.......++.+|++++...+ |+||++|+++|+++..+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999887 5779999999999877778889999999999885 99999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---CeEEeccccceee
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM---NPKISDFGLARTC 538 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~~ 538 (558)
...|.++ ..+++.++.+++.+|+.||.|||.+| |.||||||+|||-.+.. -+||+||.++.-+
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 9888543 45899999999999999999999998 99999999999996544 3899999998654
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=194.31 Aligned_cols=142 Identities=32% Similarity=0.513 Sum_probs=123.1
Q ss_pred eecccCcccEEEEEE---cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 393 KLGEGGFGPVYKGTL---VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
+||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999974 347889999886432 234567899999999999999999999875 45678999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 468 SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 468 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999998432 35889999999999999999999988 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=196.75 Aligned_cols=143 Identities=23% Similarity=0.437 Sum_probs=120.9
Q ss_pred eeecccCcccEEEEEEcCC---cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 392 NKLGEGGFGPVYKGTLVDG---QEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
++||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 345667665432 334568999999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 468 SLDYFIFDQTN-SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 468 sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
+|.+++..... ....++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 99999865322 234667778899999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=210.29 Aligned_cols=151 Identities=30% Similarity=0.456 Sum_probs=129.2
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccccccc---HHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQG---LKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..|+.++.||.|+||.||-|+. .+.+.||||+++-...+. ...+..|++.|++++|||+|.+.|++......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4577778999999999999996 457789999997544443 356889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|||- |+-.+++.-. .+++.+.++..|..+.+.||+|||+.+ .||||||+.||||++.|.|||+|||.|....+.
T Consensus 106 EYCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9994 5666666332 356888999999999999999999998 999999999999999999999999999766543
Q ss_pred c
Q 008648 542 K 542 (558)
Q Consensus 542 ~ 542 (558)
+
T Consensus 180 n 180 (948)
T KOG0577|consen 180 N 180 (948)
T ss_pred h
Confidence 3
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=194.27 Aligned_cols=144 Identities=32% Similarity=0.455 Sum_probs=127.3
Q ss_pred eeecccCcccEEEEEEcC--C--cEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
++||+|++|.||+|.+.. + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999876544 556789999999999999999999999988 888999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++|.+++..... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999866432 46899999999999999999999988 99999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=195.08 Aligned_cols=148 Identities=29% Similarity=0.454 Sum_probs=127.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEK 457 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 457 (558)
.+|++.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999864 48899999875311 12345788999999999999999999998764 457
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988543 34788889999999999999999988 99999999999999999999999999986
Q ss_pred eC
Q 008648 538 CG 539 (558)
Q Consensus 538 ~~ 539 (558)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-22 Score=196.78 Aligned_cols=149 Identities=32% Similarity=0.444 Sum_probs=127.9
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
+.++|.+.+.||+|+||.||+|... +++.+++|.+.... ......+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 58899999986532 233346788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||++ ++|..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 6676665432 234778888899999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-22 Score=192.52 Aligned_cols=149 Identities=27% Similarity=0.498 Sum_probs=132.0
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.+|++.+.||+|+||.||++...++..+|+|.+... ......+.+|++++++++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467888999999999999998877889999988652 2345678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999988543 235788999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=205.76 Aligned_cols=148 Identities=30% Similarity=0.440 Sum_probs=125.4
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----- 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 455 (558)
..++|++.+.||+|+||.||++... .++.+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 5789999998653 2234467788999999999999999999886543
Q ss_pred -eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 456 -EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 456 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
..++||||+++ +|...+. ..+++..+..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46999999975 5655552 23788889999999999999999998 99999999999999999999999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
|+....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=196.21 Aligned_cols=149 Identities=31% Similarity=0.535 Sum_probs=131.0
Q ss_pred CCcccceeecccCcccEEEEEEc-----CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CCeE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIH--GEEK 457 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 457 (558)
+.|++.+.||+|+||.||++... .+..+|+|.+...... ..+.+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999853 3678999998764332 46789999999999999999999999887 5578
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999985432 35899999999999999999999988 99999999999999999999999999988
Q ss_pred eC
Q 008648 538 CG 539 (558)
Q Consensus 538 ~~ 539 (558)
+.
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=205.73 Aligned_cols=150 Identities=27% Similarity=0.502 Sum_probs=130.3
Q ss_pred CcccceeecccCcccEEEEEEcC---C--cEEEEEEecc-cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD---G--QEIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
...+.++||+|-||.||+|...+ | -.||||..+. ......+.|..|..+|+.++|||||+|+|+|.+ ...+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34455789999999999998533 3 3589998876 455667889999999999999999999999964 578999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||.++-|.|..||..+ ...|+......++.||..||.|||+.. +|||||.++|||+...--+||+|||++|-+..
T Consensus 469 mEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999999654 345888888999999999999999987 99999999999999999999999999998876
Q ss_pred Cc
Q 008648 541 DK 542 (558)
Q Consensus 541 ~~ 542 (558)
+.
T Consensus 544 ~~ 545 (974)
T KOG4257|consen 544 DA 545 (974)
T ss_pred cc
Confidence 54
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=195.67 Aligned_cols=151 Identities=25% Similarity=0.438 Sum_probs=129.7
Q ss_pred cCCcccceeecccCcccEEEEEEcC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.++|.+.++||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998643 2468999876543 3456689999999999999999999998865 56789
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998543 235899999999999999999999988 9999999999999999999999999998764
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 159 ~~ 160 (270)
T cd05056 159 DE 160 (270)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=193.01 Aligned_cols=147 Identities=37% Similarity=0.591 Sum_probs=130.5
Q ss_pred eeecccCcccEEEEEEcC----CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|.... +..+++|.+...... ..+.+.+|++++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999754 788999998764333 367899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 467 KSLDYFIFDQTN------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 467 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++|.+++..... ...+++.++..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||.++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 356899999999999999999999988 99999999999999999999999999998765
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=191.67 Aligned_cols=143 Identities=34% Similarity=0.555 Sum_probs=127.8
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChh
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 470 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 470 (558)
++||+|+||.||++...+++.|++|.+...... ..+.+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999988753332 4567999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 471 YFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 471 ~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++... ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998543 235788999999999999999999988 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=193.36 Aligned_cols=149 Identities=32% Similarity=0.531 Sum_probs=133.0
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|+||.||++... +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 688999999875433 3567899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++.. ...+++..+..++.+++.||+|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999854 235788999999999999999999988 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=204.74 Aligned_cols=148 Identities=30% Similarity=0.434 Sum_probs=125.5
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------ 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 454 (558)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999864 5789999998652 233456788999999999999999999987643
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346999999975 6666652 23788889999999999999999988 99999999999999999999999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
|+....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=219.35 Aligned_cols=159 Identities=25% Similarity=0.354 Sum_probs=131.0
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcC-CcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--Ce
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EE 456 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 456 (558)
....++|.+.++||+|+||.||+|.... +..+|+|.+... .......+..|+.+++.|+|||||++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4455789999999999999999999754 678899987642 233456789999999999999999999988653 46
Q ss_pred EEEEEecCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecCCCCCcEEEcC--------
Q 008648 457 KLLIYEFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSR----LRIIHRDLKASNVLLDH-------- 523 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~----~~ivHrDlkp~NIll~~-------- 523 (558)
.+|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999886532 23468999999999999999999998531 24999999999999964
Q ss_pred ---------CCCeEEeccccceeeCC
Q 008648 524 ---------DMNPKISDFGLARTCGG 540 (558)
Q Consensus 524 ---------~~~~kl~DFGla~~~~~ 540 (558)
...+||+|||+++.+..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccccCCCCceEEccCCccccccc
Confidence 23489999999987643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=194.75 Aligned_cols=149 Identities=30% Similarity=0.507 Sum_probs=130.9
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
+|++.++||+|++|.||+|... ++..||+|++..... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 588999999875332 33567788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++ +|.+++........+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88888765444456899999999999999999999988 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=195.13 Aligned_cols=148 Identities=27% Similarity=0.481 Sum_probs=129.8
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS------DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 568899999886422 1234678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccceee
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLARTC 538 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~ 538 (558)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ ++|+||+|+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998542 35788999999999999999999998 99999999999998776 5999999999876
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=226.64 Aligned_cols=142 Identities=27% Similarity=0.490 Sum_probs=121.4
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
...++..+.||+|+||.||+|.. .++..||||++...... ...|++++++++|||||++++++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577778999999999999986 56899999998653322 23468889999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
+++++|.+++. .++|.++.+|+.||++||+|||+...++|+||||||+||+++.++.+++. ||.+..
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 99999999983 27899999999999999999996655569999999999999998888875 666543
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=195.44 Aligned_cols=160 Identities=31% Similarity=0.461 Sum_probs=136.6
Q ss_pred cchhhhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 008648 376 FELATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIH 453 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 453 (558)
+...++..+.++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455666777899999999999999999999874 5789999988653 22346778899999998 79999999999876
Q ss_pred CC-----eEEEEEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCe
Q 008648 454 GE-----EKLLIYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 454 ~~-----~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
.+ ..++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 579999999999999987542 22346889999999999999999999988 9999999999999999999
Q ss_pred EEeccccceeeC
Q 008648 528 KISDFGLARTCG 539 (558)
Q Consensus 528 kl~DFGla~~~~ 539 (558)
||+|||+++.+.
T Consensus 168 kl~dfg~~~~~~ 179 (291)
T cd06639 168 KLVDFGVSAQLT 179 (291)
T ss_pred EEeecccchhcc
Confidence 999999988654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=198.23 Aligned_cols=149 Identities=30% Similarity=0.450 Sum_probs=130.9
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.++||+|+||.||+|... .++.+|+|++..... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 488999998764222 234568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|++++.|..+... ...+++.++..++.||+.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999887633 234899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=195.30 Aligned_cols=149 Identities=29% Similarity=0.468 Sum_probs=122.6
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCeeeeeeeEEEeC-----C
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKL---QHRNLVKLLGCCIHG-----E 455 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 455 (558)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888899999999999999875 58899999886422 12234556677776665 799999999988652 3
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..+++|||+++ +|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999974 7888775432 345899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCC
Q 008648 536 RTCGG 540 (558)
Q Consensus 536 ~~~~~ 540 (558)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=198.14 Aligned_cols=150 Identities=27% Similarity=0.326 Sum_probs=132.9
Q ss_pred CCcccceeecccCcccEEEEEEcC-CcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISD---QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|++|.||+|...+ ++.+|+|.+..... ...+.+..|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999998754 88999999875322 24567889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+|+.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999988543 2356899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=193.36 Aligned_cols=143 Identities=35% Similarity=0.618 Sum_probs=123.0
Q ss_pred eeecccCcccEEEEEEcC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 5688887642 234456788999999999 799999999999999999999999999
Q ss_pred CChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 467 KSLDYFIFDQT-------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 467 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234789999999999999999999988 9999999999999999999999999
Q ss_pred ccee
Q 008648 534 LART 537 (558)
Q Consensus 534 la~~ 537 (558)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=195.07 Aligned_cols=149 Identities=30% Similarity=0.468 Sum_probs=132.7
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|+||.||+|... +++.|++|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 58899999986533 33456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999885433 56899999999999999999999988 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=191.55 Aligned_cols=150 Identities=31% Similarity=0.505 Sum_probs=134.6
Q ss_pred cCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++.+......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678999999999999999999765 78999999865322 67899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+...
T Consensus 80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999998542 346899999999999999999999988 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=196.06 Aligned_cols=148 Identities=24% Similarity=0.304 Sum_probs=129.4
Q ss_pred CcccceeecccCcccEEEEEE----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeE
Q 008648 387 NFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 457 (558)
+|++.+.||+|+||.||++.. .++..||+|++.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 367899999986522 22346688899999999 599999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999988542 35788899999999999999999988 99999999999999999999999999987
Q ss_pred eCC
Q 008648 538 CGG 540 (558)
Q Consensus 538 ~~~ 540 (558)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=190.90 Aligned_cols=150 Identities=40% Similarity=0.636 Sum_probs=131.4
Q ss_pred cccceeecccCcccEEEEEEcC-----CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 388 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
+++.+.||+|+||.||++...+ +..+|+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999998754 378999998754333 5678999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854322 22899999999999999999999988 999999999999999999999999999877544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=198.70 Aligned_cols=143 Identities=26% Similarity=0.415 Sum_probs=118.3
Q ss_pred eeecccCcccEEEEEEc---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH--GEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~ 466 (558)
++||+|+||.||+|... +++.+|+|.+... .....+.+|+.++++++||||+++++++.. ....+++|||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 68999999999999864 4578999988652 233567889999999999999999999865 446789999986
Q ss_pred CChhHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCCeEEeccccce
Q 008648 467 KSLDYFIFDQT------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DHDMNPKISDFGLAR 536 (558)
Q Consensus 467 gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~ 536 (558)
++|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 47777664321 1235888999999999999999999998 9999999999999 456789999999998
Q ss_pred eeCC
Q 008648 537 TCGG 540 (558)
Q Consensus 537 ~~~~ 540 (558)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07868 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 7654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=194.41 Aligned_cols=150 Identities=28% Similarity=0.396 Sum_probs=126.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHH-HhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVIL-FSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.+.||+|+||.||++... +++.||+|++.... .....++..|+.+ ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999875 58999999986532 2233455556664 566789999999999999999999999
Q ss_pred cCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|++ ++|..++... .....+++..+..++.||+.||+|||++ + ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 6887777542 2335689999999999999999999986 6 9999999999999999999999999998664
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-23 Score=202.44 Aligned_cols=155 Identities=25% Similarity=0.430 Sum_probs=135.9
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecc-cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
...|+..+.||+|.||.||+|.+. .++.||+|++.- ......+.+++|+.++..++++||.++++.+..+...+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345777789999999999999964 578899999864 334556789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
|+.||++.+.+ .....+++..+..|+++++.||.|||.++ .+|||||+.||||..+|.+||+|||+|-.+....
T Consensus 92 y~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999988 33445588888889999999999999998 9999999999999999999999999999887655
Q ss_pred Ccc
Q 008648 543 TEG 545 (558)
Q Consensus 543 ~~~ 545 (558)
...
T Consensus 166 ~rr 168 (467)
T KOG0201|consen 166 KRR 168 (467)
T ss_pred hcc
Confidence 443
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=191.15 Aligned_cols=146 Identities=33% Similarity=0.573 Sum_probs=127.7
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
++|++.+.||+|+||.||++.. .++.+|+|.+... ...+.+.+|+.++++++||||+++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 6788999988642 2346789999999999999999999998654 5799999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999986532 345789999999999999999999988 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=194.21 Aligned_cols=149 Identities=28% Similarity=0.421 Sum_probs=132.9
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
+|++.+.||+|+||.||++... +++.+|+|.+.+.. ....+.+.+|+.++++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 48899999986532 2346789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+++++|..++... ..+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998543 46889999999999999999999988 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=190.31 Aligned_cols=153 Identities=28% Similarity=0.457 Sum_probs=134.9
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||.|+||.||+|... ++..+++|++.... ......+.+|+.+++.++|+||+++++.+...+..+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999864 57889999886422 23567899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++........+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999865433356899999999999999999999988 999999999999999999999999998766543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=198.46 Aligned_cols=144 Identities=21% Similarity=0.274 Sum_probs=124.9
Q ss_pred cceeeccc--CcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 390 INNKLGEG--GFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 390 ~~~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
+.++||+| +|++||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6789999986 468899999986532 234456888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+..
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhc
Confidence 9999999985432 234789999999999999999999988 99999999999999999999999986544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=198.57 Aligned_cols=147 Identities=29% Similarity=0.459 Sum_probs=129.6
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.|.....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444568999999999999864 588999999876555556778999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++.+..
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9999988732 34788999999999999999999988 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=191.39 Aligned_cols=148 Identities=30% Similarity=0.467 Sum_probs=127.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEK 457 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 457 (558)
.+|+..+.||+|+||.||+|... ++..+++|++.... ....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999864 58899999875421 12345688999999999999999999998763 567
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++++||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999988542 34788999999999999999999988 99999999999999999999999999986
Q ss_pred eC
Q 008648 538 CG 539 (558)
Q Consensus 538 ~~ 539 (558)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=198.81 Aligned_cols=157 Identities=25% Similarity=0.304 Sum_probs=136.6
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..-|.+.+.||+|-|+.|-+|++ -.|..||||++.+..- .....+..|++.|+.++|||||+|+++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34577889999999999999985 4799999999976433 34467889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~ 540 (558)
|+-.+|+|.+||.+.. ..+.+..+.+++.||+.|+.|.|+.. +|||||||+||.+- +-|-+||.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999996654 34889999999999999999999887 99999999999885 567899999999998877
Q ss_pred CcCccc
Q 008648 541 DKTEGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
++....
T Consensus 172 G~kL~T 177 (864)
T KOG4717|consen 172 GKKLTT 177 (864)
T ss_pred cchhhc
Confidence 665443
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=197.34 Aligned_cols=150 Identities=27% Similarity=0.424 Sum_probs=127.7
Q ss_pred CcccceeecccCcccEEEEEEc---CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKL 458 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 458 (558)
+|++.++||+|+||.||+|... .++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999974 47899999987632 33456788899999999999999999999988 7899
Q ss_pred EEEecCCCCChhHHHhhcC-C-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC----CCCeEEecc
Q 008648 459 LIYEFMPNKSLDYFIFDQT-N-SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH----DMNPKISDF 532 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~----~~~~kl~DF 532 (558)
+||||+++ +|..++.... . ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5655553322 1 236889999999999999999999988 999999999999999 899999999
Q ss_pred ccceeeCC
Q 008648 533 GLARTCGG 540 (558)
Q Consensus 533 Gla~~~~~ 540 (558)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=192.52 Aligned_cols=149 Identities=27% Similarity=0.446 Sum_probs=133.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999965 57899999886532 34456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999988432 6899999999999999999999988 999999999999999999999999999887643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=192.78 Aligned_cols=147 Identities=31% Similarity=0.463 Sum_probs=128.4
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc----------ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD----------QGLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
+|.+.+.||+|+||.||+|... +++.+|+|.++.... ...+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999864 588999998753110 12346788999999999999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 45888999999999999999999988 999999999999999999999999999
Q ss_pred eeeC
Q 008648 536 RTCG 539 (558)
Q Consensus 536 ~~~~ 539 (558)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=185.04 Aligned_cols=142 Identities=18% Similarity=0.137 Sum_probs=109.3
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccccc--c-------H-----------------HHHHHHHHHHhcCCCCee
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ--G-------L-----------------KELKNEVILFSKLQHRNL 444 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 444 (558)
...||+|+||.||+|...+|+.||||+++..... . . .....|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999878999999998653211 1 1 122359999999987776
Q ss_pred eeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCcEEEcC
Q 008648 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL-HQDSRLRIIHRDLKASNVLLDH 523 (558)
Q Consensus 445 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yL-H~~~~~~ivHrDlkp~NIll~~ 523 (558)
.....+. ....+|||||++++++...+.. ...++..+...++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 2234899999999877654322 23578899999999999999999 6777 99999999999998
Q ss_pred CCCeEEeccccceeeCCC
Q 008648 524 DMNPKISDFGLARTCGGD 541 (558)
Q Consensus 524 ~~~~kl~DFGla~~~~~~ 541 (558)
++.++|+|||+|...+..
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 478999999999866443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=189.70 Aligned_cols=151 Identities=28% Similarity=0.360 Sum_probs=135.2
Q ss_pred CCcccceeecccCcccEEEEEEcC-CcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||+|++|.||+|.... ++.+++|++..... .....+.+|+.++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999764 89999999876433 4467899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568999999999999999999999 88 9999999999999999999999999998875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=194.94 Aligned_cols=150 Identities=26% Similarity=0.475 Sum_probs=133.3
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..++|++.+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 346899999999999999999985 4578999999865444456778999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++++|.+++.. ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999998843 24788899999999999999999998 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-21 Score=188.80 Aligned_cols=150 Identities=25% Similarity=0.389 Sum_probs=131.9
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|+||.||++... +++.+++|.+... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 5789999988642 233456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|.+++.... ...+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 99999998885432 235788999999999999999999988 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=197.19 Aligned_cols=146 Identities=29% Similarity=0.445 Sum_probs=129.0
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
|+....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++.+..++..+++|||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344468999999999999864 5889999998654445567788999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 999987733 34789999999999999999999988 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=195.16 Aligned_cols=148 Identities=27% Similarity=0.461 Sum_probs=130.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++.+......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34677789999999999999864 47789999886432 33456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|.+++.. ..+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999988732 35788999999999999999999988 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=196.75 Aligned_cols=166 Identities=28% Similarity=0.368 Sum_probs=141.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecc---cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..+.|+.-++||+|+||.|+-+... +|+-+|.|++.+ ...+......+|..+|.+++.+.||.+-..++..+..+|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456777789999999999999854 588899998854 233455667899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+..|.||+|...|.+..+ ..+++..+.-++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999988866543 46899999999999999999999987 9999999999999999999999999999998
Q ss_pred CCcCccccceEEEe
Q 008648 540 GDKTEGNTNRVWLY 553 (558)
Q Consensus 540 ~~~~~~~~~~~~~~ 553 (558)
..+....-..+.||
T Consensus 339 ~g~~~~~rvGT~GY 352 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGY 352 (591)
T ss_pred CCCccccccCcccc
Confidence 77665443444444
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=194.05 Aligned_cols=151 Identities=26% Similarity=0.402 Sum_probs=131.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.++||+|+||.||+|... +++.|++|++... .....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 4789999988642 23345778999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
|++++.+..+... ...+++.++..++.||+.||.|||+++ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777766532 234889999999999999999999988 9999999999999999999999999998775543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=189.06 Aligned_cols=143 Identities=36% Similarity=0.574 Sum_probs=123.7
Q ss_pred eeecccCcccEEEEEEcC----CcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISD-QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875333 34567899999999999999999999875 5568999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 9999998543 25889999999999999999999988 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=191.36 Aligned_cols=149 Identities=27% Similarity=0.449 Sum_probs=131.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..|+..++||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++++.||||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999864 57899999886432 34456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999998843 34788899999999999999999988 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=196.15 Aligned_cols=150 Identities=33% Similarity=0.608 Sum_probs=126.4
Q ss_pred CCcccceeecccCcccEEEEEEc-CCc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
++|+..+.||+|+||.||+|... ++. .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778889999999999999863 343 47888876532 22344688999999999999999999998754 4679
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988543 335788999999999999999999988 9999999999999999999999999998765
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 161 ~~ 162 (303)
T cd05110 161 GD 162 (303)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=190.53 Aligned_cols=143 Identities=33% Similarity=0.558 Sum_probs=121.2
Q ss_pred eeecccCcccEEEEEEcC----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CCeEEEEEecCC
Q 008648 392 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH-GEEKLLIYEFMP 465 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~~ 465 (558)
+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 357999988542 23345678899999999999999999998764 445789999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999998543 234677888899999999999999988 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=187.32 Aligned_cols=150 Identities=28% Similarity=0.382 Sum_probs=129.4
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-CeEEEEEe
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-EEKLLIYE 462 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E 462 (558)
+|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|+.++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999864 4788999998642 233456788999999999999999999987644 45789999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999988653 2345899999999999999999999998 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=190.47 Aligned_cols=149 Identities=30% Similarity=0.507 Sum_probs=125.5
Q ss_pred cccceeecccCcccEEEEEEc----CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC------
Q 008648 388 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE------ 455 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 455 (558)
|.+.+.||+|+||.||+|... .++.+|+|.+... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 3678999988652 2334567889999999999999999999887543
Q ss_pred eEEEEEecCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQT---NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
..++++||+++++|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999988875321 2235788999999999999999999988 999999999999999999999999
Q ss_pred ccceeeC
Q 008648 533 GLARTCG 539 (558)
Q Consensus 533 Gla~~~~ 539 (558)
|+++...
T Consensus 158 g~~~~~~ 164 (273)
T cd05074 158 GLSKKIY 164 (273)
T ss_pred ccccccc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=190.54 Aligned_cols=147 Identities=28% Similarity=0.449 Sum_probs=129.8
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
-|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999864 57899999876422 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999988842 35789999999999999999999988 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=193.00 Aligned_cols=150 Identities=26% Similarity=0.396 Sum_probs=127.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCe-----
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEE----- 456 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 456 (558)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999964 58899999876432 223467888999999995 6999999999987665
Q ss_pred EEEEEecCCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCCeEEeccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTN--SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFG 533 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG 533 (558)
.++||||+++ +|..++..... ...+++..+..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78887754322 346899999999999999999999988 999999999999998 8899999999
Q ss_pred cceeeC
Q 008648 534 LARTCG 539 (558)
Q Consensus 534 la~~~~ 539 (558)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=195.05 Aligned_cols=143 Identities=27% Similarity=0.421 Sum_probs=117.9
Q ss_pred eeecccCcccEEEEEEcC---CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH--GEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~ 466 (558)
.+||+|+||.||+|...+ +..+|+|.+... .....+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998643 578999988653 233567889999999999999999999864 4567899999875
Q ss_pred CChhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCCeEEeccccce
Q 008648 467 KSLDYFIFDQ------TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DHDMNPKISDFGLAR 536 (558)
Q Consensus 467 gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~ 536 (558)
+|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12235788999999999999999999988 9999999999999 566789999999998
Q ss_pred eeCC
Q 008648 537 TCGG 540 (558)
Q Consensus 537 ~~~~ 540 (558)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07867 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 7754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-22 Score=193.57 Aligned_cols=144 Identities=27% Similarity=0.446 Sum_probs=123.2
Q ss_pred eeecccCcccEEEEEEcC--------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+.||+|+||.||+|.... ..++++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998632 234888887654445567788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC--------eEEeccccc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN--------PKISDFGLA 535 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~kl~DFGla 535 (558)
+++++|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999985432 35789999999999999999999988 999999999999987765 699999998
Q ss_pred eeeCC
Q 008648 536 RTCGG 540 (558)
Q Consensus 536 ~~~~~ 540 (558)
.....
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=195.03 Aligned_cols=147 Identities=27% Similarity=0.465 Sum_probs=127.7
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999974 58899999886422 22345678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++ +|..++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 974 777766432 345899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=190.76 Aligned_cols=148 Identities=28% Similarity=0.461 Sum_probs=131.1
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCC---CCeeeeeeeEEEeCCeEEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQ---HRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 461 (558)
.|++.+.||+|+||.||+|.. .+++.+++|.+... .....+++.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999996 46889999988643 3345567889999999986 999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++.+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998743 25889999999999999999999988 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=190.25 Aligned_cols=148 Identities=29% Similarity=0.476 Sum_probs=128.3
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEK 457 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 457 (558)
.+|++.+.||+|+||.||+|... +++.+++|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 5889999987431 223456788999999999999999999998764 457
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988542 34788899999999999999999988 99999999999999999999999999987
Q ss_pred eC
Q 008648 538 CG 539 (558)
Q Consensus 538 ~~ 539 (558)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=194.54 Aligned_cols=147 Identities=24% Similarity=0.330 Sum_probs=130.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.++||+|+||.||++... +++.+|+|++... .....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888899999999999999864 5788999987643 234457889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+++++|..++.. ...+++..+..++.+++.||.|||+. + |+||||||+||++++++.++|+|||+++..
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999988744 23588999999999999999999973 5 999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=193.46 Aligned_cols=150 Identities=28% Similarity=0.421 Sum_probs=129.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 460 (558)
++|++.+.||+|+||.||+|... +++.+++|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999975 47899999886432 22234567899999999999999999999887 789999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 8888875432 35899999999999999999999988 99999999999999999999999999987754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-22 Score=195.79 Aligned_cols=155 Identities=28% Similarity=0.387 Sum_probs=130.2
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecc--c-----ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CCe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--I-----SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH-GEE 456 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~--~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 456 (558)
++|-++.+||+|+|+.||+|.+ ...+.||||+-.. . .....+...+|.+|-+.|+||.||++++++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5788889999999999999985 4567889986432 1 11223456789999999999999999999875 456
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCCeEEeccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---HDMNPKISDFG 533 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFG 533 (558)
++-|+||++|.+|+.+|. ..+.+++.++..|+.||+.||.||.+.. ++|||-||||.||||- .-|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999994 3456899999999999999999999985 7899999999999995 45789999999
Q ss_pred cceeeCCCcCc
Q 008648 534 LARTCGGDKTE 544 (558)
Q Consensus 534 la~~~~~~~~~ 544 (558)
++++++++...
T Consensus 619 LSKIMdddSy~ 629 (775)
T KOG1151|consen 619 LSKIMDDDSYN 629 (775)
T ss_pred hhhhccCCccC
Confidence 99999876543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=219.17 Aligned_cols=161 Identities=23% Similarity=0.256 Sum_probs=141.4
Q ss_pred chhhhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecc---cccccHHHHHHHHHHHhcCCCCeeeeeeeEEE
Q 008648 377 ELATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452 (558)
Q Consensus 377 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 452 (558)
...++.....+|.++++||+|+||.|..++.+ .++.+|+|++.+ .......-|+.|-++|..-+.+=|+.++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34555666789999999999999999999975 478899999987 33445667999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
+..+.|+|||||+||+|-.++.+. ..+++.-+..++..|+.||.-||+-| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998432 36889988889999999999999988 999999999999999999999999
Q ss_pred ccceeeCCCcC
Q 008648 533 GLARTCGGDKT 543 (558)
Q Consensus 533 Gla~~~~~~~~ 543 (558)
|-+-.+..+.+
T Consensus 220 GsClkm~~dG~ 230 (1317)
T KOG0612|consen 220 GSCLKMDADGT 230 (1317)
T ss_pred hhHHhcCCCCc
Confidence 99988875543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=186.48 Aligned_cols=150 Identities=33% Similarity=0.511 Sum_probs=133.8
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578999999876433 4567899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998543 46899999999999999999999988 9999999999999999999999999999875443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=190.35 Aligned_cols=153 Identities=31% Similarity=0.492 Sum_probs=132.7
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCC-----
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGE----- 455 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 455 (558)
.+.++|++.+.||+|++|.||+|... +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999975 57889999886533 3456789999999999 6999999999997654
Q ss_pred -eEEEEEecCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 456 -EKLLIYEFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 456 -~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999885432 2456899999999999999999999988 9999999999999999999999999
Q ss_pred cceeeC
Q 008648 534 LARTCG 539 (558)
Q Consensus 534 la~~~~ 539 (558)
++....
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 987653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-23 Score=208.53 Aligned_cols=151 Identities=28% Similarity=0.472 Sum_probs=134.9
Q ss_pred hhcCCcccceeecccCcccEEEEEEcCCc-EEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++.+.|.|+..||.|+||.||+|..++.. ..|.|++...+....+.+..|++||...+||+||+|++.|...+.++|+.
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 34567888899999999999999876544 45677777767778899999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||.||-.+.++... ...|.+.++..++.|++.||.|||++. |||||||+.|||+.-+|.++|+|||.+...
T Consensus 109 EFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred eecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 999999999988553 456999999999999999999999998 999999999999999999999999998654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=180.04 Aligned_cols=142 Identities=20% Similarity=0.201 Sum_probs=112.5
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccccc---------------------c-----HHHHHHHHHHHhcCCCCee
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ---------------------G-----LKELKNEVILFSKLQHRNL 444 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 444 (558)
...||+|++|.||+|...+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998753211 0 1224678999999999987
Q ss_pred eeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcC
Q 008648 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDH 523 (558)
Q Consensus 445 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~ 523 (558)
.....+... ..+|||||++++++...... ...++..+...++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 555444332 34899999998865433211 2346788899999999999999999 88 99999999999998
Q ss_pred CCCeEEeccccceeeCCC
Q 008648 524 DMNPKISDFGLARTCGGD 541 (558)
Q Consensus 524 ~~~~kl~DFGla~~~~~~ 541 (558)
++.++|+|||+|+.+...
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 789999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=190.97 Aligned_cols=142 Identities=32% Similarity=0.433 Sum_probs=124.4
Q ss_pred ecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
||+|+||.||++... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 58899999886422 22345667899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
.+++..... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 998865432 45899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=187.10 Aligned_cols=151 Identities=25% Similarity=0.424 Sum_probs=131.1
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 5789999988642 233456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++.... ...+++..+..++.+++.||+|||+++ |+|+||||+||+++++ +.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999986532 345789999999999999999999988 9999999999999855 45899999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=192.74 Aligned_cols=150 Identities=29% Similarity=0.468 Sum_probs=129.2
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..+.|++.++||+|+||.||+|... +++.||+|.+.... ....+++.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4467899999999999999999864 58899999886432 2334568899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||++ ++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 93 v~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 5666665332 235899999999999999999999988 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=210.17 Aligned_cols=153 Identities=22% Similarity=0.361 Sum_probs=119.8
Q ss_pred hcCCcccceeecccCcccEEEEEEcC--CcEEEEE------------------EecccccccHHHHHHHHHHHhcCCCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD--GQEIAVK------------------RLSKISDQGLKELKNEVILFSKLQHRN 443 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 443 (558)
..++|++.++||+|+||.||++.... +...+.| .+. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999999987532 2122222 111 12223456889999999999999
Q ss_pred eeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 008648 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTN--SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 521 (558)
Q Consensus 444 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll 521 (558)
|+++++++...+..++++|++. ++|..++..... .......++..++.||+.||+|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999995 466666543211 122345667789999999999999988 9999999999999
Q ss_pred cCCCCeEEeccccceeeCCC
Q 008648 522 DHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 522 ~~~~~~kl~DFGla~~~~~~ 541 (558)
+.++.+||+|||+|+.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc
Confidence 99999999999999987543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=190.65 Aligned_cols=158 Identities=30% Similarity=0.488 Sum_probs=133.5
Q ss_pred chhhhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEe-
Q 008648 377 ELATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIH- 453 (558)
Q Consensus 377 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 453 (558)
++.++..+.+.|++.+.||+|+||.||+|... +++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455556789999999999999999999974 5788999987653 23446788899999998 69999999999863
Q ss_pred -----CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeE
Q 008648 454 -----GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPK 528 (558)
Q Consensus 454 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 528 (558)
....+++|||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 456799999999999999886532 345788888999999999999999988 99999999999999999999
Q ss_pred EeccccceeeC
Q 008648 529 ISDFGLARTCG 539 (558)
Q Consensus 529 l~DFGla~~~~ 539 (558)
|+|||+++...
T Consensus 162 l~dfg~~~~~~ 172 (282)
T cd06636 162 LVDFGVSAQLD 172 (282)
T ss_pred EeeCcchhhhh
Confidence 99999987553
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=190.79 Aligned_cols=152 Identities=29% Similarity=0.483 Sum_probs=135.9
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
....+.|+..+.||+|++|.||++... ++..+++|.+..... ..+.+.+|+++++.++|+||+++++.+......+++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 446678899999999999999999975 588999999875433 567789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999986533 36899999999999999999999988 9999999999999999999999999887554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-22 Score=215.75 Aligned_cols=151 Identities=33% Similarity=0.514 Sum_probs=123.5
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe------
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH------ 453 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 453 (558)
.+...+|+.++.||+|+||.||+++. -||+.+|||++.-. .......+.+|+.++++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34556788899999999999999995 48999999998653 34455678999999999999999987761110
Q ss_pred ------------------------------------------------------------------------C-------
Q 008648 454 ------------------------------------------------------------------------G------- 454 (558)
Q Consensus 454 ------------------------------------------------------------------------~------- 454 (558)
+
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 008648 455 ----------------------------------EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500 (558)
Q Consensus 455 ----------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~y 500 (558)
...||-||||+...|..++.+..... .....++++++|++||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 11378899999888888875432211 466778999999999999
Q ss_pred HHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 501 LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
+|+.+ ||||||||.||+||++..|||+|||+|..
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 99998 99999999999999999999999999987
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=191.43 Aligned_cols=148 Identities=30% Similarity=0.500 Sum_probs=129.1
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 58899999886422 22345788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+. ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 58888875432 345899999999999999999999988 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=183.55 Aligned_cols=151 Identities=35% Similarity=0.554 Sum_probs=135.4
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.|++.+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999975 688999999876544566789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999985432 46899999999999999999999988 9999999999999999999999999998876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-21 Score=190.13 Aligned_cols=151 Identities=26% Similarity=0.324 Sum_probs=129.6
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 461 (558)
++|+..+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999974 57889999886532 23456789999999999999999999998654 3679999
Q ss_pred ecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999887542 23445788999999999999999999988 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-21 Score=187.76 Aligned_cols=152 Identities=24% Similarity=0.470 Sum_probs=128.5
Q ss_pred CcccceeecccCcccEEEEEEcC--CcEEEEEEeccc----------ccccHHHHHHHHHHHhc-CCCCeeeeeeeEEEe
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI----------SDQGLKELKNEVILFSK-LQHRNLVKLLGCCIH 453 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 453 (558)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999755 678999987531 12234557788888865 799999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCCeEEec
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDHDMNPKISD 531 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~D 531 (558)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542 234468899999999999999999996 45 99999999999999999999999
Q ss_pred cccceeeCCC
Q 008648 532 FGLARTCGGD 541 (558)
Q Consensus 532 FGla~~~~~~ 541 (558)
||++......
T Consensus 158 fg~~~~~~~~ 167 (269)
T cd08528 158 FGLAKQKQPE 167 (269)
T ss_pred ccceeecccc
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=189.88 Aligned_cols=149 Identities=26% Similarity=0.355 Sum_probs=132.0
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||+|++|.||++... +++.+++|.+.... ....+++.+|+.++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999975 58899999886532 34556789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999985532 568889999999999999999999 77 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=186.77 Aligned_cols=153 Identities=27% Similarity=0.464 Sum_probs=130.4
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CCeEEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH--GEEKLLIY 461 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 461 (558)
+|++.+.||.|+||.||++.. .+++.+|+|.+... .....+++..|+.++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999986 45788999988642 33345678899999999999999999998764 34578999
Q ss_pred ecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 462 EFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLH-----QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 462 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH-----~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
||+++++|.+++... .....+++..++.++.||+.||+||| +.+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22456899999999999999999999 666 999999999999999999999999999
Q ss_pred eeeCCCc
Q 008648 536 RTCGGDK 542 (558)
Q Consensus 536 ~~~~~~~ 542 (558)
+.+....
T Consensus 158 ~~~~~~~ 164 (265)
T cd08217 158 KILGHDS 164 (265)
T ss_pred ccccCCc
Confidence 9875543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=187.26 Aligned_cols=142 Identities=27% Similarity=0.347 Sum_probs=126.1
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
||.|++|.||++.... ++.+++|.+.+.. ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999754 8899999986532 23456799999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
.+++.+. ..+++..+..++.||+.||+|||+++ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9998543 34889999999999999999999988 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=188.56 Aligned_cols=149 Identities=29% Similarity=0.454 Sum_probs=129.9
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEEEEEe
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKLLIYE 462 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 462 (558)
|++.++||+|++|.||+|... +++.+|+|++.... ......+.+|+.+++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999875 47899999987642 33446788999999999999999999999988 78999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
|+++ +|..++... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888877443 246899999999999999999999988 9999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=203.49 Aligned_cols=152 Identities=32% Similarity=0.488 Sum_probs=132.5
Q ss_pred CCcccceeecccCcccEEEEEEcC--C--cEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
+...+.++||+|.||.|++|.+.. | ..||||.+...... ....|++|+.+|.+|+|+|+++|+|+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 345566899999999999998743 3 36899999764443 67889999999999999999999999877 778899
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+|+++.|+|.+.|.+ .....+-......++.|||.||.||.+++ +|||||.++|+||-....|||+||||.|.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999977 34456777888899999999999999987 99999999999999999999999999998876
Q ss_pred Cc
Q 008648 541 DK 542 (558)
Q Consensus 541 ~~ 542 (558)
.+
T Consensus 265 ne 266 (1039)
T KOG0199|consen 265 NE 266 (1039)
T ss_pred CC
Confidence 54
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=191.38 Aligned_cols=152 Identities=28% Similarity=0.445 Sum_probs=129.2
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----- 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 455 (558)
..++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4568999999999999999999975 57899999986432 233456788999999999999999999987655
Q ss_pred -----eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 456 -----EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 456 -----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
..++|+||+++ ++..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 68999999986 666666332 345899999999999999999999988 9999999999999999999999
Q ss_pred ccccceeeCCC
Q 008648 531 DFGLARTCGGD 541 (558)
Q Consensus 531 DFGla~~~~~~ 541 (558)
|||+++.+...
T Consensus 159 dfg~~~~~~~~ 169 (302)
T cd07864 159 DFGLARLYNSE 169 (302)
T ss_pred cccccccccCC
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=184.13 Aligned_cols=150 Identities=30% Similarity=0.461 Sum_probs=134.1
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKLLIY 461 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 461 (558)
+|++.+.||+|++|.||+|... +++.+++|.+.... ....+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 68899999886533 24567899999999999999999999999988 8899999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985432 6899999999999999999999988 999999999999999999999999999987655
Q ss_pred c
Q 008648 542 K 542 (558)
Q Consensus 542 ~ 542 (558)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-21 Score=188.63 Aligned_cols=141 Identities=28% Similarity=0.356 Sum_probs=117.5
Q ss_pred eecccCcccEEEEEEc-CCcEEEEEEeccccc---ccHHHHHHHHHHH---hcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 393 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD---QGLKELKNEVILF---SKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..++ ...+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 578999998865221 1222344444433 34479999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 99999888542 45899999999999999999999988 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=195.30 Aligned_cols=150 Identities=28% Similarity=0.461 Sum_probs=128.6
Q ss_pred hhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC----
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE---- 455 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 455 (558)
...++|++.+.||+|+||.||++.. .++..||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999985 46889999988542 2223456889999999999999999999987654
Q ss_pred --eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 456 --EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 456 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
..++||||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7789888732 35889999999999999999999988 9999999999999999999999999
Q ss_pred cceeeCC
Q 008648 534 LARTCGG 540 (558)
Q Consensus 534 la~~~~~ 540 (558)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07880 164 LARQTDS 170 (343)
T ss_pred ccccccc
Confidence 9987644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=188.60 Aligned_cols=141 Identities=28% Similarity=0.401 Sum_probs=125.7
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISD---QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|+.++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999865332 4556789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 9998553 25899999999999999999999988 99999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=198.17 Aligned_cols=150 Identities=22% Similarity=0.339 Sum_probs=130.3
Q ss_pred hhcCCcccceeecccCcccEEEEEEcC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
....-|..++.||-|+||.|.++...| ...+|+|.+.+. ........++|-+||...+.+=||+|+-.|.+.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 344567778999999999999998654 567899998763 3345567889999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||++||++-.+|.+ ...+++..+..++..+..|+++.|.-| +|||||||+|||||.+|++||+||||+.=+
T Consensus 706 FVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999988844 356788888888889999999999887 999999999999999999999999998633
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=191.10 Aligned_cols=151 Identities=32% Similarity=0.465 Sum_probs=133.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 460 (558)
++|.+.+.||+|+||.||++... +++.+++|++... .....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999875 6889999988652 2233467889999999998 99999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998543 36899999999999999999999988 99999999999999999999999999987754
Q ss_pred Cc
Q 008648 541 DK 542 (558)
Q Consensus 541 ~~ 542 (558)
..
T Consensus 155 ~~ 156 (280)
T cd05581 155 NS 156 (280)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=191.22 Aligned_cols=151 Identities=33% Similarity=0.488 Sum_probs=128.5
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 458 (558)
..++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3468999999999999999999974 58899999886422 12233567899999999999999999998765 4679
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++ +|.+++... ...+++.++..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 787777542 245899999999999999999999998 999999999999999999999999999877
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 159 ~~ 160 (309)
T cd07845 159 GL 160 (309)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=187.62 Aligned_cols=147 Identities=28% Similarity=0.451 Sum_probs=129.8
Q ss_pred CcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 387 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344457999999999999986 4678999998865444556678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++|.+++.. ..+++.++..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||+++.+..
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 9999998844 34788999999999999999999998 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=199.39 Aligned_cols=143 Identities=32% Similarity=0.493 Sum_probs=127.8
Q ss_pred eecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChhH
Q 008648 393 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDY 471 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 471 (558)
+||+|.||+||-|++.+ ...+|||.+.....+..+.+.+|+.+-+.|+|.|||+++|.+.+++..-|.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999765 45799999987777778889999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEeccccceeeCC
Q 008648 472 FIFDQTNSKLL--DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCGG 540 (558)
Q Consensus 472 ~l~~~~~~~~l--~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~ 540 (558)
++... -+++ .+...-.+..||++||.|||++. |||||||-+||||+ -.|.+||+|||.++.+.+
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 99654 2344 67777788999999999999998 99999999999997 578999999999987754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=190.45 Aligned_cols=151 Identities=28% Similarity=0.457 Sum_probs=126.6
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe----
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE---- 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 456 (558)
..++|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999864 58899999885422 2223456789999999999999999999876543
Q ss_pred ----EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 457 ----KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 457 ----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
.++||||+++ +|..++... ...+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4999999964 777776432 235899999999999999999999988 999999999999999999999999
Q ss_pred ccceeeCC
Q 008648 533 GLARTCGG 540 (558)
Q Consensus 533 Gla~~~~~ 540 (558)
|+++.+..
T Consensus 164 g~~~~~~~ 171 (310)
T cd07865 164 GLARAFSL 171 (310)
T ss_pred CCcccccC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=189.57 Aligned_cols=143 Identities=29% Similarity=0.469 Sum_probs=127.5
Q ss_pred ceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 391 NNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
..+||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36899999999999986 46889999988654445566789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 988732 24788999999999999999999988 99999999999999999999999999887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=187.57 Aligned_cols=149 Identities=28% Similarity=0.451 Sum_probs=126.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.+.||+|.+|.||+|... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999875 58899999886432 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~ 539 (558)
|++ ++|..++.... ...+++..+..++.||+.||+|||+++ |+|+||+|+||++++ ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 47777664322 233578888899999999999999988 999999999999985 5579999999998654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=194.08 Aligned_cols=148 Identities=32% Similarity=0.452 Sum_probs=126.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------ 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 454 (558)
..++|++.+.||+|+||.||+|... +++.||+|.+.+. .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4478999999999999999999864 6889999998642 233445678899999999999999999988643
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
...++||||+++ +|...+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346999999964 77776632 2788899999999999999999988 99999999999999999999999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=182.70 Aligned_cols=152 Identities=25% Similarity=0.402 Sum_probs=134.8
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|+||.||++... +++.+++|++..... .....+.+|+++++.++|||++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999975 588999999875332 4567789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999886532 2356899999999999999999999988 999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=189.08 Aligned_cols=148 Identities=26% Similarity=0.337 Sum_probs=128.2
Q ss_pred CcccceeecccCcccEEEEEEc----CCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 457 (558)
+|++.+.||+|++|.||++... ++..+|||.+.+.. ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999742 46789999886421 22345688999999999 599999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|..++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988843 245788999999999999999999988 99999999999999999999999999987
Q ss_pred eCC
Q 008648 538 CGG 540 (558)
Q Consensus 538 ~~~ 540 (558)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=188.21 Aligned_cols=145 Identities=42% Similarity=0.604 Sum_probs=124.5
Q ss_pred eeecccCcccEEEEEEcC-------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+.||+|+||.||+|...+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2578999876532 23466788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-----CeEEecccc
Q 008648 464 MPNKSLDYFIFDQT----NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-----NPKISDFGL 534 (558)
Q Consensus 464 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-----~~kl~DFGl 534 (558)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234788999999999999999999988 99999999999999877 899999999
Q ss_pred ceeeC
Q 008648 535 ARTCG 539 (558)
Q Consensus 535 a~~~~ 539 (558)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=194.59 Aligned_cols=148 Identities=24% Similarity=0.433 Sum_probs=127.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEe----CCeEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIH----GEEKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 458 (558)
.+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68899999999999999999864 58899999987532 2345677889999999999999999998763 34679
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||++ ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 588888743 345899999999999999999999988 999999999999999999999999999876
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=187.54 Aligned_cols=147 Identities=30% Similarity=0.498 Sum_probs=128.4
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
|++.++||+|++|.||+|... ++..|++|++.... ....+.+.+|+++++.++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 68999999886432 223467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+ ++|.+++.... ...+++..+..++.|+++||+|||+++ ++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68988885433 235899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=201.37 Aligned_cols=150 Identities=24% Similarity=0.318 Sum_probs=120.1
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC------CeeeeeeeEEEe
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQH------RNLVKLLGCCIH 453 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 453 (558)
+....++|++.++||+|+||.||+|... .++.||||+++.. ....+.+..|+.+++.++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999864 4788999998642 2233456667777776654 568999998876
Q ss_pred C-CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCC------
Q 008648 454 G-EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDM------ 525 (558)
Q Consensus 454 ~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~------ 525 (558)
. ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ + ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 4678999988 67787777442 4588999999999999999999974 6 99999999999998765
Q ss_pred ----------CeEEeccccceee
Q 008648 526 ----------NPKISDFGLARTC 538 (558)
Q Consensus 526 ----------~~kl~DFGla~~~ 538 (558)
.+||+|||++...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-22 Score=217.98 Aligned_cols=153 Identities=30% Similarity=0.442 Sum_probs=133.3
Q ss_pred hhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..+-+|+-..+||.|.||.||-|.. .+|...|+|-+.. ........+.+|..++..|+|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3445677778999999999999985 4588899997653 334556778999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
.||||++|+|.+++.. ...+++.....+..|++.|+.|||++| ||||||||+||+|+.+|.+|++|||.|+.+.
T Consensus 1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999999844 344667777778899999999999999 9999999999999999999999999999986
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
+.
T Consensus 1386 ~~ 1387 (1509)
T KOG4645|consen 1386 NN 1387 (1509)
T ss_pred Cc
Confidence 65
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=193.22 Aligned_cols=148 Identities=28% Similarity=0.463 Sum_probs=126.4
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----eE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-----EK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 457 (558)
.++|++.++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999986 458899999986422 234466888999999999999999999876543 57
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++++||+++ +|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999974 7776663 235889999999999999999999998 99999999999999999999999999987
Q ss_pred eCC
Q 008648 538 CGG 540 (558)
Q Consensus 538 ~~~ 540 (558)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=185.50 Aligned_cols=141 Identities=28% Similarity=0.339 Sum_probs=117.6
Q ss_pred eecccCcccEEEEEEc-CCcEEEEEEeccccc---ccHHHHHHHH---HHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 393 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD---QGLKELKNEV---ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.||+|+||.||+|... +++.||+|.+.+... .....+..|. .+++...||+|+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 578999998865221 1122233443 34445689999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999988843 346899999999999999999999988 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=197.52 Aligned_cols=160 Identities=29% Similarity=0.493 Sum_probs=140.7
Q ss_pred cchhhhhhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 008648 376 FELATISNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIH 453 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 453 (558)
..++.+...+..|++.+.||.|.+|.||+++. .+++.+|+|++.. .....+++..|..+++.. +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44556667788899999999999999999985 5688899998765 445567888999999888 69999999999975
Q ss_pred -----CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeE
Q 008648 454 -----GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPK 528 (558)
Q Consensus 454 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 528 (558)
++.++||||||.+|+..+++.... ...+.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 567899999999999999997655 677999999999999999999999987 99999999999999999999
Q ss_pred EeccccceeeCC
Q 008648 529 ISDFGLARTCGG 540 (558)
Q Consensus 529 l~DFGla~~~~~ 540 (558)
|.|||++..+..
T Consensus 164 LvDFGvSaQlds 175 (953)
T KOG0587|consen 164 LVDFGVSAQLDS 175 (953)
T ss_pred Eeeeeeeeeeec
Confidence 999999987753
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=184.36 Aligned_cols=151 Identities=26% Similarity=0.457 Sum_probs=130.9
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999975 4788999988642 223456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999885532 335789999999999999999999988 99999999999999875 4699999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=188.57 Aligned_cols=149 Identities=29% Similarity=0.489 Sum_probs=127.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
+.|+..+.||+|+||.||++... ++..+|+|++.... ......+..|+.++++++|||++++++++.+....++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44777889999999999999864 57899999986432 223457889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++ +|.+++... ...+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99975 676666432 345899999999999999999999988 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.8e-21 Score=199.72 Aligned_cols=154 Identities=23% Similarity=0.356 Sum_probs=120.3
Q ss_pred hhcCCcccceeecccCcccEEEEEE-----------------cCCcEEEEEEecccccccHH--------------HHHH
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-----------------VDGQEIAVKRLSKISDQGLK--------------ELKN 431 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~ 431 (558)
...++|++.++||+|+||.||+|.. ..++.||||++........+ ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3567899999999999999999964 23467999998653322222 2345
Q ss_pred HHHHHhcCCCCee-----eeeeeEEEe--------CCeEEEEEecCCCCChhHHHhhcCC--------------------
Q 008648 432 EVILFSKLQHRNL-----VKLLGCCIH--------GEEKLLIYEFMPNKSLDYFIFDQTN-------------------- 478 (558)
Q Consensus 432 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~-------------------- 478 (558)
|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777776654 677777753 3467999999999999998864211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 479 -SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 479 -~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123467788899999999999999988 9999999999999999999999999997654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=195.01 Aligned_cols=148 Identities=28% Similarity=0.383 Sum_probs=126.7
Q ss_pred CCcccceeecccCcccEEEEEEcC-CcEEEEEEecccc--------cccHHHHHHHHHHHhcCC---CCeeeeeeeEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------DQGLKELKNEVILFSKLQ---HRNLVKLLGCCIH 453 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 453 (558)
..|..++.+|+|+||.|+.|.++. ..+|+||.+.+.. ....-.+-.|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999754 6789999886521 112223567999999997 9999999999999
Q ss_pred CCeEEEEEecC-CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 454 GEEKLLIYEFM-PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 454 ~~~~~lv~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
++..||+||-. ++.+|.+++ .....+++.++..|+.||+.|+++||+++ |||||||-+|++++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 567888888 33456899999999999999999999999 999999999999999999999999
Q ss_pred ccceeeC
Q 008648 533 GLARTCG 539 (558)
Q Consensus 533 Gla~~~~ 539 (558)
|-|....
T Consensus 715 gsaa~~k 721 (772)
T KOG1152|consen 715 GSAAYTK 721 (772)
T ss_pred cchhhhc
Confidence 9986543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=191.58 Aligned_cols=155 Identities=30% Similarity=0.427 Sum_probs=130.1
Q ss_pred hhhhhhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 008648 378 LATISNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG 454 (558)
Q Consensus 378 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 454 (558)
..++....++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345556778999999999999999999985 468899999986532 22345688899999999999999999988653
Q ss_pred ------CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeE
Q 008648 455 ------EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPK 528 (558)
Q Consensus 455 ------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 528 (558)
...++++|++ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2367888876 7889887732 34889999999999999999999988 99999999999999999999
Q ss_pred EeccccceeeCC
Q 008648 529 ISDFGLARTCGG 540 (558)
Q Consensus 529 l~DFGla~~~~~ 540 (558)
|+|||+++....
T Consensus 161 l~dfg~~~~~~~ 172 (345)
T cd07877 161 ILDFGLARHTDD 172 (345)
T ss_pred Eecccccccccc
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-22 Score=185.92 Aligned_cols=160 Identities=30% Similarity=0.502 Sum_probs=126.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--------
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-------- 454 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 454 (558)
..|.-..+||+|.||.||+|+.. .++.||+|++-- ..........+|+++|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666789999999999999864 477889886532 2222345577899999999999999999988642
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
..+|+|+.+++. +|.-++.+ ....++..++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 247999999964 67666632 2345888999999999999999999887 99999999999999999999999999
Q ss_pred ceeeCCCcC---ccccceEE
Q 008648 535 ARTCGGDKT---EGNTNRVW 551 (558)
Q Consensus 535 a~~~~~~~~---~~~~~~~~ 551 (558)
||.+...+. ...|+|++
T Consensus 171 ar~fs~~~n~~kprytnrvv 190 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVV 190 (376)
T ss_pred ccceecccccCCCCccccee
Confidence 987753332 33555554
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=183.25 Aligned_cols=142 Identities=27% Similarity=0.342 Sum_probs=119.7
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEeccccc---ccHHHHHHHHHHH-hcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD---QGLKELKNEVILF-SKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.||+|+||.||+|... +++.||+|.+.+... .....+..|..++ ...+|+||+++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 578999999865321 2223344555444 455899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++|..++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999998542 35789999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=192.64 Aligned_cols=150 Identities=31% Similarity=0.518 Sum_probs=127.7
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC--CeE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG--EEK 457 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 457 (558)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4468899999999999999999875 5789999988542 233445677899999999 999999999998654 367
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5888887432 6788899999999999999999988 99999999999999999999999999987
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 157 ~~~~ 160 (337)
T cd07852 157 LSEL 160 (337)
T ss_pred cccc
Confidence 6443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=189.69 Aligned_cols=151 Identities=30% Similarity=0.448 Sum_probs=128.7
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CCeE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH-GEEK 457 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 457 (558)
....++|++.+.||+|+||.||+|... +++.+|+|++.+. .....+.+..|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346678999999999999999999864 6889999987542 22345678899999999999999999999876 5578
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++++||+ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 5688887732 34778888899999999999999988 99999999999999999999999999986
Q ss_pred eCC
Q 008648 538 CGG 540 (558)
Q Consensus 538 ~~~ 540 (558)
...
T Consensus 158 ~~~ 160 (328)
T cd07856 158 QDP 160 (328)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-20 Score=181.96 Aligned_cols=149 Identities=23% Similarity=0.290 Sum_probs=121.7
Q ss_pred hhhcCCcccceee--cccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeE
Q 008648 382 SNATNNFSINNKL--GEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 382 ~~~~~~y~~~~~l--g~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 457 (558)
....++|++.+.+ |+|+||.||++... ++..+|+|.+....... . |+.....+ +||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3444677777766 99999999999864 57889999876422111 1 22222222 799999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccce
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLAR 536 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~ 536 (558)
++||||+++++|.+++... ..+++.++..++.||++||+|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999998543 36899999999999999999999988 99999999999999888 99999999998
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.....
T Consensus 159 ~~~~~ 163 (267)
T PHA03390 159 IIGTP 163 (267)
T ss_pred ecCCC
Confidence 76543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=190.99 Aligned_cols=148 Identities=27% Similarity=0.404 Sum_probs=126.6
Q ss_pred cCCccc-ceeecccCcccEEEEEEc-CCcEEEEEEeccccccc--------------HHHHHHHHHHHhcCCCCeeeeee
Q 008648 385 TNNFSI-NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQG--------------LKELKNEVILFSKLQHRNLVKLL 448 (558)
Q Consensus 385 ~~~y~~-~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 448 (558)
.++|.. .+.||+|+||.||+|... .++.||+|++....... ...+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 467999999999999864 58899999886432211 12477899999999999999999
Q ss_pred eEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeE
Q 008648 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPK 528 (558)
Q Consensus 449 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 528 (558)
+++...+..+++|||++ ++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 588888743 345889999999999999999999988 99999999999999999999
Q ss_pred EeccccceeeC
Q 008648 529 ISDFGLARTCG 539 (558)
Q Consensus 529 l~DFGla~~~~ 539 (558)
|+|||+++...
T Consensus 160 l~dfg~~~~~~ 170 (335)
T PTZ00024 160 IADFGLARRYG 170 (335)
T ss_pred ECCccceeecc
Confidence 99999998775
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=191.83 Aligned_cols=149 Identities=28% Similarity=0.475 Sum_probs=127.5
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-----Ce
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-----EE 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 456 (558)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999864 5889999988652 233455678899999999999999999988654 34
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.+++|||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 688877743 345899999999999999999999988 9999999999999999999999999998
Q ss_pred eeCC
Q 008648 537 TCGG 540 (558)
Q Consensus 537 ~~~~ 540 (558)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7644
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=184.77 Aligned_cols=146 Identities=25% Similarity=0.363 Sum_probs=123.1
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC--CeEEEEEe
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHG--EEKLLIYE 462 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E 462 (558)
|++.++||+|+||.||+|... +++.+|+|+++... .........|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999864 58899999886532 222334457888888885 99999999999987 88999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++ +|.+.+... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++.+..
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 9974 777776442 246899999999999999999999988 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=191.86 Aligned_cols=148 Identities=30% Similarity=0.495 Sum_probs=130.1
Q ss_pred CcccceeecccCcccEEEEEEcC-CcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----eEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-----EKL 458 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 458 (558)
+|++.+.||+|++|.||+|.... ++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999999754 8899999987643 345567899999999999999999999998775 789
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|||++ ++|..++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 478887743 236899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=183.04 Aligned_cols=152 Identities=29% Similarity=0.480 Sum_probs=132.6
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|++.++||+|+||.||++... +++.+++|.+... ......++.+|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 5789999988652 233456778899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|..++.+.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999886532 2346889999999999999999999988 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=186.08 Aligned_cols=151 Identities=26% Similarity=0.388 Sum_probs=126.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 460 (558)
..++|++.+.||+|+||.||+|...+ ++.+|||.+.... .....++..|+.++.+.. ||||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999865 8899999986532 223455667777776665 99999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|||++ ++|..++... ...+++..+..++.||+.||+|||+. + |+||||+|+||++++++.+||+|||+++.+.
T Consensus 93 ~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 4677766442 23689999999999999999999974 6 9999999999999999999999999998764
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 167 ~ 167 (296)
T cd06618 167 D 167 (296)
T ss_pred C
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=188.88 Aligned_cols=147 Identities=29% Similarity=0.424 Sum_probs=123.2
Q ss_pred CcccceeecccCcccEEEEEEc-C--CcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC----Ce
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-D--GQEIAVKRLSKIS--DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG----EE 456 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 456 (558)
+|++.+.||+|+||.||++... . +..+|+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999964 3 6789999886422 22355678899999999 599999999976543 35
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++++||++ ++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688999986 688888743 345889999999999999999999988 9999999999999999999999999998
Q ss_pred eeCC
Q 008648 537 TCGG 540 (558)
Q Consensus 537 ~~~~ 540 (558)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-20 Score=184.58 Aligned_cols=148 Identities=32% Similarity=0.448 Sum_probs=127.4
Q ss_pred cccceeecccCcccEEEEEEcC-CcEEEEEEeccccc-ccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEecC
Q 008648 388 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISD-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
|++.+.||+|++|.||+|...+ ++.|++|++..... .......+|+..+++++ |+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678899999999999999754 78899998865322 22334557899999999 999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++|.+++.... ...+++.++..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 788988875433 346899999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=183.98 Aligned_cols=149 Identities=33% Similarity=0.501 Sum_probs=129.5
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
|++.+.||+|++|.||++... +++.+++|.+..... .....+..|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 588899998865322 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
++ +|..++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 787777442 246899999999999999999999988 9999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=187.10 Aligned_cols=144 Identities=23% Similarity=0.237 Sum_probs=121.3
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
.+.+|.|+++.|+++.. +++.||+|++... .....+.+..|+.+++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 6899999998653 34456789999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 469 LDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 469 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+....
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999986542 235788899999999999999999988 9999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=168.12 Aligned_cols=154 Identities=27% Similarity=0.376 Sum_probs=127.2
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecc-cccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK-ISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 458 (558)
+...+...-...||+|++|.|-+-++ ..|...|+|++.. ...+..+++.+|+.+..+- ..|.+|.++|........+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 33444555667899999999988886 4689999999865 3445667788898876654 7999999999999999999
Q ss_pred EEEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 459 LIYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
+.||.| ..+|+.+-.+. .....+++..+-+|+..+.+||.|||++ +.+||||+||+||||+.+|++||+|||++-.
T Consensus 122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccccee
Confidence 999999 46787765432 3456788888999999999999999995 4699999999999999999999999999864
Q ss_pred e
Q 008648 538 C 538 (558)
Q Consensus 538 ~ 538 (558)
+
T Consensus 199 L 199 (282)
T KOG0984|consen 199 L 199 (282)
T ss_pred e
Confidence 4
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-21 Score=182.73 Aligned_cols=147 Identities=26% Similarity=0.358 Sum_probs=128.9
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|..+++||+|.||+|-+++- ..++.+|+|++++. .......-..|-++|+..+||.+..|...|...+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36788899999999999999985 46899999999873 334455567899999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
|||+.||.|...|. ....+++.....+...|+.||.|||+++ ||.||||.+|.|||++|++||+|||+++.
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh
Confidence 99999999977773 3456788777888899999999999988 99999999999999999999999999974
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=187.83 Aligned_cols=141 Identities=27% Similarity=0.365 Sum_probs=122.2
Q ss_pred eeeccc--CcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
..||+| +||+||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 88999999864 6899999998642 223356788999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++||+.+.
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 99999886532 235888999999999999999999988 9999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=180.68 Aligned_cols=149 Identities=30% Similarity=0.467 Sum_probs=124.5
Q ss_pred cccceeecccCcccEEEEEEcC-CcEEEEEEeccccc--ccHHHHHHHHHHHhcC---CCCeeeeeeeEEEeCCe-----
Q 008648 388 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISD--QGLKELKNEVILFSKL---QHRNLVKLLGCCIHGEE----- 456 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 456 (558)
|++.+.||+|+||.||+|.... ++.+|+|++..... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999764 88999999864222 2234566787776655 69999999999998776
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.+++|||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 7888775432 235899999999999999999999988 9999999999999999999999999998
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-21 Score=173.82 Aligned_cols=149 Identities=27% Similarity=0.423 Sum_probs=127.8
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCe--EEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEE--KLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~--~~l 459 (558)
..++|++.+++|+|.++.||.|.. .+++.++||++++ ...+.+.+|++||..|. ||||++|++...+... ..|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 346899999999999999999984 5678899999875 34578899999999997 9999999999887654 579
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCCeEEeccccceee
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFGLARTC 538 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~ 538 (558)
|+||+.+.+...+. ..++..++..++.++++||.|.|+.| |+|||+||.|++||. ...++|+|+|+|...
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998887664 34677788889999999999999999 999999999999995 557999999999988
Q ss_pred CCCcCc
Q 008648 539 GGDKTE 544 (558)
Q Consensus 539 ~~~~~~ 544 (558)
......
T Consensus 184 Hp~~eY 189 (338)
T KOG0668|consen 184 HPGKEY 189 (338)
T ss_pred CCCcee
Confidence 766543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=184.29 Aligned_cols=149 Identities=29% Similarity=0.394 Sum_probs=123.6
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+|+..++||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5566789999999999999864 57899999986532 234567889999999996 99999999999999999999999
Q ss_pred CCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFD--QTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++. ++..+... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 55443321 11235689999999999999999999975 5 9999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=186.47 Aligned_cols=150 Identities=33% Similarity=0.515 Sum_probs=125.7
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC------
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE------ 455 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 455 (558)
.++|++.++||+|+||.||+|... +++.+++|++.... ......+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999864 57899999885422 222346778999999999999999999876543
Q ss_pred --eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 456 --EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 456 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
..++|+||+++ +|...+.. ....+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35999999975 56665533 2346899999999999999999999988 9999999999999999999999999
Q ss_pred cceeeCC
Q 008648 534 LARTCGG 540 (558)
Q Consensus 534 la~~~~~ 540 (558)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=182.79 Aligned_cols=145 Identities=31% Similarity=0.503 Sum_probs=124.5
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
|...++||+|+||.||+|... +++.+++|++.... ......+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666678999999999999864 57899999886422 22345688899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+. ++|..++... ...+++.++..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 4666666432 345889999999999999999999988 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=184.56 Aligned_cols=150 Identities=31% Similarity=0.482 Sum_probs=127.7
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.+.|+..+.||+|+||.||+|... +++.+++|.+... ......++.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345777789999999999999964 5788999988642 223345688899999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+. ++|..++... ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 5777666432 235789999999999999999999988 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=183.11 Aligned_cols=147 Identities=33% Similarity=0.492 Sum_probs=129.3
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
|+..+.||+|.+|.||+|... +++.+++|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556789999999999999975 48899999987642 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58999885532 35899999999999999999999998 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=188.81 Aligned_cols=147 Identities=28% Similarity=0.429 Sum_probs=126.1
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC---------
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--------- 454 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 454 (558)
..+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999864 5889999998765556667889999999999999999999876543
Q ss_pred -----CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeE
Q 008648 455 -----EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPK 528 (558)
Q Consensus 455 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~k 528 (558)
...++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588777732 35789999999999999999999988 99999999999997 456789
Q ss_pred EeccccceeeC
Q 008648 529 ISDFGLARTCG 539 (558)
Q Consensus 529 l~DFGla~~~~ 539 (558)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=186.97 Aligned_cols=146 Identities=30% Similarity=0.492 Sum_probs=124.1
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC------
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE------ 455 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 455 (558)
.++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999864 6899999998652 2223456889999999999999999999987543
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 676654 234788999999999999999999988 999999999999999999999999999
Q ss_pred eeeC
Q 008648 536 RTCG 539 (558)
Q Consensus 536 ~~~~ 539 (558)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=181.53 Aligned_cols=150 Identities=19% Similarity=0.269 Sum_probs=111.3
Q ss_pred hcCCcccceeecccCcccEEEEEEcCC----cEEEEEEecccccccH-----------HHHHHHHHHHhcCCCCeeeeee
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKISDQGL-----------KELKNEVILFSKLQHRNLVKLL 448 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~ 448 (558)
..++|++.++||+|+||.||+|...++ ..+++|.......... .....+...+..++|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999986543 4556664332111110 1122333455677899999999
Q ss_pred eEEEeCC----eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 008648 449 GCCIHGE----EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD 524 (558)
Q Consensus 449 ~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~ 524 (558)
+++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9876544 3467888774 356555532 123567888899999999999999988 9999999999999999
Q ss_pred CCeEEeccccceeeCC
Q 008648 525 MNPKISDFGLARTCGG 540 (558)
Q Consensus 525 ~~~kl~DFGla~~~~~ 540 (558)
+.+||+|||+|+.+..
T Consensus 163 ~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 163 NRGYIIDYGIASHFII 178 (294)
T ss_pred CcEEEEEcCCceeecc
Confidence 9999999999998743
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=187.39 Aligned_cols=157 Identities=25% Similarity=0.343 Sum_probs=132.7
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecc--cccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 458 (558)
......|+++++||.||.+.||++...+.+.+|+|++.. .+.+....|.+|+.+|.+|+ |.+||+|++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 344567999999999999999999988888889887653 45566788999999999995 999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||||= ..+|..+|..... ....| .+..+..|++.|+.++|+++ |||.||||.|+|+- +|.+||+|||+|..+
T Consensus 437 mvmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999986 5799999855432 22334 66778899999999999999 99999999999994 568999999999999
Q ss_pred CCCcCcc
Q 008648 539 GGDKTEG 545 (558)
Q Consensus 539 ~~~~~~~ 545 (558)
..+.+..
T Consensus 510 ~~DTTsI 516 (677)
T KOG0596|consen 510 QPDTTSI 516 (677)
T ss_pred Cccccce
Confidence 8776543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.9e-21 Score=177.59 Aligned_cols=147 Identities=27% Similarity=0.341 Sum_probs=121.9
Q ss_pred hcCCcccc-eeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEe----CCe
Q 008648 384 ATNNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIH----GEE 456 (558)
Q Consensus 384 ~~~~y~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 456 (558)
.+++|++. ++||-|-.|.|..+..+ +++.+|+|++.. ....++|+++--.. .|||||.++++++. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 44566665 58999999999999864 588999998853 24567788765544 69999999999875 345
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEeccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFG 533 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFG 533 (558)
+++|||.|+||.|...+.++ ....+++.++-.|+.||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 68999999999999988664 3456899999999999999999999988 999999999999964 5569999999
Q ss_pred cceeeC
Q 008648 534 LARTCG 539 (558)
Q Consensus 534 la~~~~ 539 (558)
+|+.-.
T Consensus 210 FAK~t~ 215 (400)
T KOG0604|consen 210 FAKETQ 215 (400)
T ss_pred cccccC
Confidence 999754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-20 Score=180.27 Aligned_cols=150 Identities=30% Similarity=0.441 Sum_probs=125.1
Q ss_pred CcccceeecccCcccEEEEEEcC-CcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
+|.+.++||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998643 444555555431 222344677899999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|||+++++|..++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 23456899999999999999999999988 999999999999975 569999999998764
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=176.96 Aligned_cols=142 Identities=30% Similarity=0.388 Sum_probs=125.8
Q ss_pred ecccCcccEEEEEEc-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 394 LGEGGFGPVYKGTLV-DGQEIAVKRLSKISD---QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
||+|+||.||++... +++.+++|.+..... .....+..|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 488999998865322 2456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9998543 35899999999999999999999988 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-20 Score=188.65 Aligned_cols=149 Identities=30% Similarity=0.468 Sum_probs=128.7
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe----
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE---- 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 456 (558)
..++|++.+.||+|++|.||+|... +++.+|+|++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999975 5789999988642 22334567889999999999999999998876655
Q ss_pred --EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 457 --KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 457 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888743 35899999999999999999999988 99999999999999999999999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-21 Score=180.54 Aligned_cols=149 Identities=30% Similarity=0.459 Sum_probs=123.8
Q ss_pred ceeecccCcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----eEEEEEe
Q 008648 391 NNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-----EKLLIYE 462 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~E 462 (558)
.+.||-|+||.||.+.+ ++|+.||+|++.... -...+.+.+|+++|..++|.|++..++...-.. +.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36899999999999986 569999999986522 234567889999999999999999988765433 4578888
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
.| ..+|.+++ -....++...+.-+..||++||+|||+.+ |+||||||.|.|++.+..+||+|||+||.-+.++
T Consensus 138 Lm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 45777776 34566888888889999999999999998 9999999999999999999999999999877665
Q ss_pred Cccc
Q 008648 543 TEGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
....
T Consensus 211 ~~hM 214 (449)
T KOG0664|consen 211 RLNM 214 (449)
T ss_pred hhhh
Confidence 4433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=168.04 Aligned_cols=137 Identities=20% Similarity=0.314 Sum_probs=106.1
Q ss_pred cceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcC-----CCCeeeeeeeEEEeCC---eEE-EE
Q 008648 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL-----QHRNLVKLLGCCIHGE---EKL-LI 460 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv 460 (558)
-.+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++|++.++. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347999999999996 443333478988654444567899999999999 5799999999998874 333 78
Q ss_pred Eec--CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecCCCCCcEEEcC----CCCeEEec-c
Q 008648 461 YEF--MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL-LYLHQDSRLRIIHRDLKASNVLLDH----DMNPKISD-F 532 (558)
Q Consensus 461 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL-~yLH~~~~~~ivHrDlkp~NIll~~----~~~~kl~D-F 532 (558)
+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+| |
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5589999999442 24444 35677888888 9999998 999999999999974 33799999 5
Q ss_pred cccee
Q 008648 533 GLART 537 (558)
Q Consensus 533 Gla~~ 537 (558)
|.+..
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 54443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=196.43 Aligned_cols=159 Identities=32% Similarity=0.464 Sum_probs=134.9
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEc----C----CcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeee
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLV----D----GQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLG 449 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 449 (558)
.++...++..+.+.||+|.||.|++|... . ...||||.++.. .....+.+..|+++|..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34445556677789999999999999842 1 457999998753 334567899999999998 6999999999
Q ss_pred EEEeCCeEEEEEecCCCCChhHHHhhcC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 008648 450 CCIHGEEKLLIYEFMPNKSLDYFIFDQT-------N----S--KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 516 (558)
Q Consensus 450 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp 516 (558)
+|......++|+||++.|+|.+++.... . . ..++..+.+.++.|||.|++||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997654 0 0 23888999999999999999999987 99999999
Q ss_pred CcEEEcCCCCeEEeccccceeeCCC
Q 008648 517 SNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 517 ~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+||||.++..+||+|||+||....+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~ 471 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNK 471 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCC
Confidence 9999999999999999999965443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-20 Score=171.05 Aligned_cols=150 Identities=25% Similarity=0.370 Sum_probs=122.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 462 (558)
++.+++..||.|.-|.|++++.. .|..+|||.+.+. .....+++...++++.+-+ .|.||+.+|+|......++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34556678999999999999965 5889999999763 3445567778888776654 8999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
.|. .-++.++... ..++++..+-++...+++||.||.+++ .|+|||+||+|||+|+.|++||+|||++-.+-+
T Consensus 172 lMs-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHH-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 883 3455555432 345888888889999999999999865 599999999999999999999999999976543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.7e-21 Score=176.08 Aligned_cols=148 Identities=31% Similarity=0.407 Sum_probs=120.9
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+.+.+..||.|+||+|+|-.++ .|+..|||+++... ....++++.|.+...+- +.||||+++|.+..++..++-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 4445578999999999999864 58999999997643 35667888888876555 689999999999999999999999
Q ss_pred CCCCChhHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 464 MPNKSLDYFIFDQ--TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 464 ~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
| ..+|+.+.... .....+++...-.|....+.||.||.+.- .||||||||+||||+..|.+||+|||++-.
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHh
Confidence 9 46776654321 22345788888888888999999998753 599999999999999999999999998743
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=173.10 Aligned_cols=133 Identities=20% Similarity=0.143 Sum_probs=114.3
Q ss_pred cCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhh
Q 008648 397 GGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD 475 (558)
Q Consensus 397 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 475 (558)
|.+|.||++... +++.+|+|++.... .+..|...+....||||+++++++.+.+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999864 57899999986532 233455555566799999999999999999999999999999998854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 476 QTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 476 ~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.+..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 3 34889999999999999999999988 99999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=166.82 Aligned_cols=149 Identities=35% Similarity=0.491 Sum_probs=132.6
Q ss_pred cccceeecccCcccEEEEEEcC-CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 388 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
|++.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999865 889999998764444 56789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++|.+++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999854322 1788999999999999999999987 999999999999999999999999999988654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.2e-19 Score=190.61 Aligned_cols=149 Identities=23% Similarity=0.323 Sum_probs=105.8
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-----CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeE------EE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGC------CI 452 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 452 (558)
..++|++.++||+|+||.||+|.+.+ +..||+|++..... .+....| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999754 68999998764221 1111111 1122222222222111 23
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTNS-----------------KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 515 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlk 515 (558)
.....+|||||+++++|.+++...... .......+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999888543210 01123345678999999999999988 9999999
Q ss_pred CCcEEEcC-CCCeEEeccccceeeC
Q 008648 516 ASNVLLDH-DMNPKISDFGLARTCG 539 (558)
Q Consensus 516 p~NIll~~-~~~~kl~DFGla~~~~ 539 (558)
|+||||++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999985 5789999999998654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-20 Score=156.70 Aligned_cols=75 Identities=51% Similarity=0.792 Sum_probs=56.4
Q ss_pred ceEEec-CCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCC
Q 008648 2 RVVWSA-SLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDP 80 (558)
Q Consensus 2 ~~vWst-~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dp 80 (558)
+++|+| ++.+....+.. |+|+|+|||||++. .+.+|||||||||||+||+|+|+.+..+|.+..++||++.+||
T Consensus 39 ~~iWss~~t~~~~~~~~~-~~L~~~GNlvl~d~----~~~~lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dp 113 (114)
T PF01453_consen 39 SVIWSSNNTSGRGNSGCY-LVLQDDGNLVLYDS----SGNVLWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDP 113 (114)
T ss_dssp EEEEE--S-TTSS-SSEE-EEEETTSEEEEEET----TSEEEEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS---
T ss_pred CEEEEecccCCccccCeE-EEEeCCCCEEEEee----cceEEEeecCCCccEEEeccCcccCCCccccceEEeECCCCCC
Confidence 479999 66654223555 99999999999996 7899999999999999999999998888777789999999999
Q ss_pred C
Q 008648 81 S 81 (558)
Q Consensus 81 s 81 (558)
|
T Consensus 114 s 114 (114)
T PF01453_consen 114 S 114 (114)
T ss_dssp -
T ss_pred C
Confidence 6
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.2e-19 Score=165.66 Aligned_cols=142 Identities=12% Similarity=0.127 Sum_probs=115.9
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHH---H------HHHHHHHHhcCCCCeeeeeeeEEEeC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLK---E------LKNEVILFSKLQHRNLVKLLGCCIHG 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~~ 454 (558)
..++|++.+.||+|+||.||.+.. ++..+|+|.+.+....... . +.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999766 5778999999753322222 2 68999999999999999999886643
Q ss_pred --------CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 455 --------EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 455 --------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
...+|+|||++|.+|.++. .++. ....+++.+|..+|+.+ ++||||||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3478999999999997763 1222 24568999999999998 99999999999999988
Q ss_pred eEEeccccceeeCCC
Q 008648 527 PKISDFGLARTCGGD 541 (558)
Q Consensus 527 ~kl~DFGla~~~~~~ 541 (558)
++|+|||..+....+
T Consensus 173 i~liDfg~~~~~~e~ 187 (232)
T PRK10359 173 LRIIDLSGKRCTAQR 187 (232)
T ss_pred EEEEECCCcccccch
Confidence 999999998876433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.8e-19 Score=161.26 Aligned_cols=152 Identities=23% Similarity=0.351 Sum_probs=127.2
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH-RNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 461 (558)
....|.++++||.|+||.+|.|.. ..|.+||||.-+.. ....++..|.++.+.|+| ..|..+..+..+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 446899999999999999999984 67999999986542 233467789999999975 67888888888999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~~ 538 (558)
|.+ |-+|+++..- ....++..+++-++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+|+.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 7899888733 2345888899999999999999999998 999999999999963 346999999999988
Q ss_pred CCCcC
Q 008648 539 GGDKT 543 (558)
Q Consensus 539 ~~~~~ 543 (558)
-+..+
T Consensus 165 ~d~~t 169 (341)
T KOG1163|consen 165 RDIRT 169 (341)
T ss_pred ccccc
Confidence 65443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=176.47 Aligned_cols=148 Identities=28% Similarity=0.383 Sum_probs=126.3
Q ss_pred cCCcccceeecccCcccEEEEEEcC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 459 (558)
..+|..+.+||+|+||.|.+|..+. .+.+|||++++. ...+.+--..|-++|+.. +-|.+++++.++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3478888999999999999998654 567999999762 233455566788888776 46899999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||||+.||+|-..++.. ..+.+..+.-++..||-||-|||+++ ||.||||.+|||||.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999998888543 34667778889999999999999999 999999999999999999999999999853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=166.46 Aligned_cols=153 Identities=18% Similarity=0.149 Sum_probs=115.9
Q ss_pred hhhhhcCCcccceeecccCcccEEEEE--EcCCcEEEEEEecccccc------------------------cHHHHHHHH
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGT--LVDGQEIAVKRLSKISDQ------------------------GLKELKNEV 433 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~ 433 (558)
++......|++.+.||+|+||.||+|. ..+++.||+|++...... ....+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 334444468889999999999999998 567999999988642210 012356899
Q ss_pred HHHhcCCCC--eeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 008648 434 ILFSKLQHR--NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 511 (558)
Q Consensus 434 ~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivH 511 (558)
.++.++.+. .+.++++. ...++||||+++.+|...... ...+...+...++.||+.+|++||+.+ +|+|
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH 172 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVH 172 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence 999999753 33444443 235899999999888665422 223555667789999999999999876 4999
Q ss_pred cCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 512 RDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 512 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
|||||+||+++ ++.++|+|||.|+..+...
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccCCcc
Confidence 99999999999 8899999999998766544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.3e-18 Score=157.90 Aligned_cols=143 Identities=37% Similarity=0.586 Sum_probs=126.6
Q ss_pred ecccCcccEEEEEEcC-CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChhH
Q 008648 394 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDY 471 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 471 (558)
||+|.+|.||++.... ++++++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999998763322 35789999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCCeEEeccccceeeCCC
Q 008648 472 FIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFGLARTCGGD 541 (558)
Q Consensus 472 ~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~ 541 (558)
++.... ..+++..+..++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 985432 35789999999999999999999998 999999999999998 899999999999877544
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-19 Score=163.97 Aligned_cols=146 Identities=23% Similarity=0.399 Sum_probs=120.7
Q ss_pred CCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeE-EEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGC-CIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~E 462 (558)
+.|.+.+.||+|.||.+-+++++. ...+++|.+.+ .....++|.+|..---.| .|.||+.-++. |...+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 578899999999999999999765 66888998865 345668899998765555 58999987765 556677789999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--HDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~~~ 539 (558)
|++.|+|.+-+.. ..+-+....+++.|++.||.|+|+++ +||||||.+||||- +...+||+|||+.+..+
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999877632 34677888899999999999999998 99999999999994 34479999999998654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.4e-18 Score=156.29 Aligned_cols=133 Identities=20% Similarity=0.219 Sum_probs=105.7
Q ss_pred cceeecccCcccEEEEEEcCCcEEEEEEeccccc----ccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEecC
Q 008648 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD----QGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
+...|++|+||+||.+.. .+.+++.+.+..... .....+.+|+++|++|+ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 677888777654222 11235889999999995 5889999886 4569999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEEcCCCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+|.+|...+. . ....++.|++.+|+++|+++ |+|||| ||+|||+++++.++|+|||+|.....
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999865431 0 11346789999999999998 999999 79999999999999999999986543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-19 Score=185.16 Aligned_cols=150 Identities=31% Similarity=0.458 Sum_probs=120.0
Q ss_pred cccceeecccCcc-cEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 388 FSINNKLGEGGFG-PVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 388 y~~~~~lg~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
|.-.+.+|.|+.| .||+|.. ++++||||++-. ....-.++|+..|+.- +|||||++++.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3444678999988 4899988 678999998743 3445678999998887 5999999999988889999999999
Q ss_pred CCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---C--CCeEEeccccceeeC
Q 008648 466 NKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---D--MNPKISDFGLARTCG 539 (558)
Q Consensus 466 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~--~~~kl~DFGla~~~~ 539 (558)
..+|.+++... .......-.....+..|++.||++||+.+ ||||||||+||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 57999999653 11111121445677899999999999987 999999999999975 3 469999999999998
Q ss_pred CCcCcc
Q 008648 540 GDKTEG 545 (558)
Q Consensus 540 ~~~~~~ 545 (558)
.+++.-
T Consensus 663 ~~~sS~ 668 (903)
T KOG1027|consen 663 GGKSSF 668 (903)
T ss_pred CCcchh
Confidence 876643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=165.52 Aligned_cols=149 Identities=24% Similarity=0.373 Sum_probs=129.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecc---cccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 458 (558)
..++|.++++||+|+|++|..+++. +.+.+|+|++++ .......-.+.|..++... +||.+|.++.+|......+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468899999999999999999864 578899999876 3344556678888888776 6999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+|.||++||+|--.+++ ...++++.+..+...|..||.|||++| ||.||||..|+|||.+|.+||+|+|+.+.-
T Consensus 328 fvieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999776644 345888888888999999999999999 999999999999999999999999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-18 Score=161.90 Aligned_cols=136 Identities=20% Similarity=0.263 Sum_probs=114.1
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD--------QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..+.|++|+....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899997643211 1124578899999999999998888887778888999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++|++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988432 12 77889999999999999988 99999999999999 7889999999998643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.8e-20 Score=186.86 Aligned_cols=151 Identities=25% Similarity=0.436 Sum_probs=136.3
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++..+|++.+.+|.|.+|.|||+++. .++..|+|.++-.......-++.|+-+++..+|||||.++|-+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 56678999999999999999999964 58889999998766677788899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+.+|+|.+.-+ .-.++++.++..+.+..++||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..++
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence 9999999988763 2456889999999999999999999998 8999999999999999999999999987654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.1e-18 Score=181.97 Aligned_cols=141 Identities=20% Similarity=0.270 Sum_probs=114.0
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEE-ecccc-------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKR-LSKIS-------DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
....|...+.||+|+||.||++...... +++|+ +.+.. ....+++.+|++++..++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445566789999999999999875543 33333 22211 112356889999999999999998888888877
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ +++.++|+|||+|
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999998873 35678999999999999988 9999999999999 6778999999999
Q ss_pred eeeCC
Q 008648 536 RTCGG 540 (558)
Q Consensus 536 ~~~~~ 540 (558)
+....
T Consensus 475 ~~~~~ 479 (535)
T PRK09605 475 KYSDL 479 (535)
T ss_pred ccCCc
Confidence 87643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=160.27 Aligned_cols=147 Identities=18% Similarity=0.179 Sum_probs=113.6
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccccc----------------------ccHHHHHHHHHHHh
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD----------------------QGLKELKNEVILFS 437 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~ 437 (558)
++......|.+.+.||+|+||.||++...+++.||||++..... ........|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33444445788899999999999999988899999998653210 01123567888899
Q ss_pred cCCCCe--eeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 008648 438 KLQHRN--LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 515 (558)
Q Consensus 438 ~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlk 515 (558)
.+.|++ +++.++ ....++||||+++++|..+.. ......++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 888774 444443 245689999999999976541 0234578899999999999988 9999999
Q ss_pred CCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 516 ASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 516 p~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
|+||++++++.++|+|||+|.....+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCcc
Confidence 999999999999999999998776544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.8e-20 Score=181.63 Aligned_cols=151 Identities=25% Similarity=0.323 Sum_probs=130.5
Q ss_pred CCcccceeecccCcccEEEEEEcCCc-EEEEEEecc---cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
.+++.+..||-|+||.|=++...... .+|+|.+++ ......+.+..|-.||...+.|.||+++..|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999998865433 488888765 23445677889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|-|-||.|...+.++ ..++......++..+++|++|||.++ ||.|||||+|.|||.+|.+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999553 45777778888889999999999998 999999999999999999999999999998765
Q ss_pred c
Q 008648 542 K 542 (558)
Q Consensus 542 ~ 542 (558)
.
T Consensus 574 ~ 574 (732)
T KOG0614|consen 574 R 574 (732)
T ss_pred C
Confidence 4
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=161.64 Aligned_cols=138 Identities=30% Similarity=0.438 Sum_probs=123.4
Q ss_pred CcccEEEEEEcC-CcEEEEEEeccccccc-HHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhh
Q 008648 398 GFGPVYKGTLVD-GQEIAVKRLSKISDQG-LKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFD 475 (558)
Q Consensus 398 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 475 (558)
+||.||+|...+ ++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999987644444 68899999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 476 QTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 476 ~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
.. .+++..+..++.+++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 32 2789999999999999999999988 999999999999999999999999999987653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=157.52 Aligned_cols=132 Identities=22% Similarity=0.316 Sum_probs=107.7
Q ss_pred eecccCcccEEEEEEcCCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISD--------QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.||+|+||.||+|.. ++..+++|....... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 568899998543211 12356788999999999887766666666777789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+|++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++|+|||+++...
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999988873311 078899999999999988 99999999999999 7899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.6e-18 Score=163.18 Aligned_cols=156 Identities=24% Similarity=0.396 Sum_probs=132.0
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcC------CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEE
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 452 (558)
++.....+++....+.+|.||.||+|.+.+ .+.|.+|.++.. ++-....+..|..++..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 344455677778889999999999996543 456788887653 3445677889999999999999999999987
Q ss_pred eC-CeEEEEEecCCCCChhHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 453 HG-EEKLLIYEFMPNKSLDYFIF-----DQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 453 ~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
+. +..++++.++.-|+|+.|+. +....+.++..+...++.|++.|++|||.++ |||.||.++|++||+...
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 64 45789999999999999997 4444567888899999999999999999998 999999999999999999
Q ss_pred eEEeccccceee
Q 008648 527 PKISDFGLARTC 538 (558)
Q Consensus 527 ~kl~DFGla~~~ 538 (558)
+||+|=.++|-+
T Consensus 435 VkltDsaLSRDL 446 (563)
T KOG1024|consen 435 VKLTDSALSRDL 446 (563)
T ss_pred EEeccchhcccc
Confidence 999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-18 Score=175.23 Aligned_cols=147 Identities=27% Similarity=0.341 Sum_probs=122.9
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 461 (558)
.+..|.+...+|.|+|+.|-.+.. .+++..+||++.+.. ....+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 466788888999999999999885 458899999997642 2334566555554 7999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-cCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll-~~~~~~kl~DFGla~~~~~ 540 (558)
|++.++.|.+.+.... ....++..|+.+|+.|+.|||++| ||||||||+|||+ +..++++|+|||.++...+
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877664322 222677789999999999999998 9999999999999 5899999999999998766
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
+
T Consensus 469 ~ 469 (612)
T KOG0603|consen 469 S 469 (612)
T ss_pred h
Confidence 5
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.6e-18 Score=166.33 Aligned_cols=147 Identities=27% Similarity=0.480 Sum_probs=128.0
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc----CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCC
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGE 455 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 455 (558)
+....+.|...++||+|.|+.||++.+. ..+.||+|.+... ....++.+|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445577889999999999999999853 3678999998763 34567899999999995 899999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEecccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGL 534 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGl 534 (558)
...+|+||+++....++... ++..++..++..++.||+++|.+| ||||||||+|+|.+ ..+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999888733 567888999999999999999999 99999999999998 456789999999
Q ss_pred ceee
Q 008648 535 ARTC 538 (558)
Q Consensus 535 a~~~ 538 (558)
|...
T Consensus 180 A~~~ 183 (418)
T KOG1167|consen 180 AQRY 183 (418)
T ss_pred HHHH
Confidence 9853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=167.09 Aligned_cols=145 Identities=27% Similarity=0.381 Sum_probs=122.0
Q ss_pred CcccceeecccCcccEEEEEEcCC--cEEEEEEecccccccHHHHHHHHHHHhcCCC----CeeeeeeeEE-EeCCeEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVDG--QEIAVKRLSKISDQGLKELKNEVILFSKLQH----RNLVKLLGCC-IHGEEKLL 459 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 459 (558)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997553 4788887765333333378889999888873 5888888888 46778899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-----CCeEEecccc
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-----MNPKISDFGL 534 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~DFGl 534 (558)
||+.+ |.+|.++..... ...++....++|+.|++.+|++||+.| ++||||||.|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889998775544 567999999999999999999999999 9999999999999754 4699999999
Q ss_pred ce
Q 008648 535 AR 536 (558)
Q Consensus 535 a~ 536 (558)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-17 Score=161.33 Aligned_cols=154 Identities=22% Similarity=0.279 Sum_probs=128.5
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCC-C-C----eeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQ-H-R----NLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~ 456 (558)
..++|.+..++|+|.||.|-++.+.. +..||||+++.. ....+..+-|++++.+|. + | -+|++.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36899999999999999999998644 688999998753 345567788999999993 2 2 38889999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------------
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH------------- 523 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~------------- 523 (558)
.+||+|.+ |-++.+++..+ +..+++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 66888888543 3456889999999999999999999988 999999999999932
Q ss_pred -------CCCeEEeccccceeeCCCcC
Q 008648 524 -------DMNPKISDFGLARTCGGDKT 543 (558)
Q Consensus 524 -------~~~~kl~DFGla~~~~~~~~ 543 (558)
+..+||+|||-|+.....+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs 267 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHS 267 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcc
Confidence 23489999999998766653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=157.32 Aligned_cols=151 Identities=22% Similarity=0.375 Sum_probs=127.1
Q ss_pred cCCcccceeecccCcccEEEEE-EcCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 462 (558)
.-+|.+.++||+|.||.++.|. +-+++.||||.-.. .....+++.|.+..+.|. .++|...+-+-.++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3479999999999999999998 56789999996543 234457788888888774 6899999988888888999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-----CCeEEecccccee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-----MNPKISDFGLART 537 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~DFGla~~ 537 (558)
++ |-+|+++..- ....++.+.+.-|+.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 7899888733 3456899999999999999999999998 9999999999999643 3589999999998
Q ss_pred eCCCcC
Q 008648 538 CGGDKT 543 (558)
Q Consensus 538 ~~~~~~ 543 (558)
+.+..+
T Consensus 179 YrDp~T 184 (449)
T KOG1165|consen 179 YRDPKT 184 (449)
T ss_pred hcCccc
Confidence 866554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.9e-17 Score=154.90 Aligned_cols=146 Identities=33% Similarity=0.440 Sum_probs=119.7
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC------e
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE------E 456 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 456 (558)
.+|.-+..++.|.- .|..|.+ ..+++||+|++.. ......++..+|..++..++|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46666778888876 5555543 3578999998754 22345567889999999999999999999997543 4
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.|+|||+| ..+|...+.. .++-.....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 69999999 5688887742 3667788899999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.-+.+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 87655
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-16 Score=147.13 Aligned_cols=139 Identities=20% Similarity=0.203 Sum_probs=98.8
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccccc--cHHH----------------------HHHHHHHHhcCCCCe--e
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ--GLKE----------------------LKNEVILFSKLQHRN--L 444 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 444 (558)
.+.||+|+||.||+|...++++||||++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999987642211 1111 134555555554332 4
Q ss_pred eeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcC
Q 008648 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDH 523 (558)
Q Consensus 445 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~ 523 (558)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 245899999998544221111000 11 5677889999999999999 77 99999999999999
Q ss_pred CCCeEEeccccceeeCCC
Q 008648 524 DMNPKISDFGLARTCGGD 541 (558)
Q Consensus 524 ~~~~kl~DFGla~~~~~~ 541 (558)
++.++|+|||.|+.....
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 889999999999877653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.8e-16 Score=138.79 Aligned_cols=137 Identities=23% Similarity=0.175 Sum_probs=114.7
Q ss_pred cceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCC--CeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH--RNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
+.+.|++|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++++....+..+++|||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999754 7899998865332 5678899999999976 58999998888878899999999988
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 468 SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 468 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
.+..+ +......++.+++++|++||.....+++|+||+|+||++++.+.++++|||.++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 77433 455667788999999999998644459999999999999998999999999997543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.2e-16 Score=154.61 Aligned_cols=134 Identities=28% Similarity=0.390 Sum_probs=111.3
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----C---CeeeeeeeEEEe---
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-----H---RNLVKLLGCCIH--- 453 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--- 453 (558)
.+|.+.++||-|-|++||++.+. ..+.||+|+++. .....+....||++|+.++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999864 467899998865 4455677889999999883 3 369999999985
Q ss_pred -CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 008648 454 -GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD 524 (558)
Q Consensus 454 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~ 524 (558)
+.+.+||+|++ |.+|..+|... ..+.++...+..|+.||+.||.|||.++ +|||-||||+||||...
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45789999999 56676666543 3456899999999999999999999976 69999999999999543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-16 Score=158.69 Aligned_cols=155 Identities=20% Similarity=0.261 Sum_probs=131.9
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCC------CCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ------HRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~ 456 (558)
...+|.+....|+|-|+.|.+|... .++.||||++.. .+...+.=+.|++||++|. .-|+++|+..|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4467888888999999999999864 478999999976 3344455678999999995 3579999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CCeEEeccccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLA 535 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla 535 (558)
++||+|-+ ..+|.++|......-.|....+..++.|+..||..|...+ |+|.||||.||||++. ..+||||||-|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999988 5789999988766667888899999999999999999887 9999999999999864 56999999999
Q ss_pred eeeCCCcC
Q 008648 536 RTCGGDKT 543 (558)
Q Consensus 536 ~~~~~~~~ 543 (558)
-.++..+.
T Consensus 585 ~~~~enei 592 (752)
T KOG0670|consen 585 SFASENEI 592 (752)
T ss_pred cccccccc
Confidence 87765553
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.2e-15 Score=145.40 Aligned_cols=136 Identities=17% Similarity=0.182 Sum_probs=105.2
Q ss_pred eeec-ccCcccEEEEEEcCCcEEEEEEecccc-------------cccHHHHHHHHHHHhcCCCCee--eeeeeEEEeCC
Q 008648 392 NKLG-EGGFGPVYKGTLVDGQEIAVKRLSKIS-------------DQGLKELKNEVILFSKLQHRNL--VKLLGCCIHGE 455 (558)
Q Consensus 392 ~~lg-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 455 (558)
..|| .|+.|+||++... +..++||++.... ......+.+|+.++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999999874 6788998774310 1223567889999999998775 67777654432
Q ss_pred e----EEEEEecCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 456 E----KLLIYEFMPN-KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 456 ~----~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
. .++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 689888743 224433 3568999999999998 9999999999999988899999
Q ss_pred ccccceeeC
Q 008648 531 DFGLARTCG 539 (558)
Q Consensus 531 DFGla~~~~ 539 (558)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.8e-16 Score=117.84 Aligned_cols=66 Identities=47% Similarity=1.026 Sum_probs=57.4
Q ss_pred CCCCCceEEeccccCCCCcceeeecCCChHHHHHHhhcCCceEEEEeeccCCCCCccceeccccccc
Q 008648 234 YSRQDGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLIDM 300 (558)
Q Consensus 234 c~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~~l~~~ 300 (558)
|+.+++|+++++|++|+.....+..+.++++|++.||+||||+||+|.+.. ++++|.+|.++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 444789999999999999776665679999999999999999999997655 567899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.9e-14 Score=144.90 Aligned_cols=150 Identities=33% Similarity=0.481 Sum_probs=127.6
Q ss_pred cccceeecccCcccEEEEEEcCCcEEEEEEecccccc---cHHHHHHHHHHHhcCCCC-eeeeeeeEEEeCCeEEEEEec
Q 008648 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ---GLKELKNEVILFSKLQHR-NLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 463 (558)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999976 78899988753332 367899999999999988 799999999777778999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccceeeCCCc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLARTCGGDK 542 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~ 542 (558)
+.++++..++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643221125888999999999999999999998 99999999999999888 69999999998665543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.3e-14 Score=149.00 Aligned_cols=142 Identities=25% Similarity=0.283 Sum_probs=99.9
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccH------------------------------H----------HHHH
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGL------------------------------K----------ELKN 431 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 431 (558)
+.||.|++|.||+|++.+|+.||||+.++...... + .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865211100 0 1344
Q ss_pred HHHHHhcC----CCCeeeeeeeEE-EeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 008648 432 EVILFSKL----QHRNLVKLLGCC-IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR-GLLYLHQDS 505 (558)
Q Consensus 432 E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-gL~yLH~~~ 505 (558)
|+..+.++ +|.+-+.+-..+ ......+|||||++|++|.++...... .. .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 55544444 232222322222 224557999999999999887643211 11 23456666666 478899888
Q ss_pred CCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 506 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
++|+|+||.||++++++.++|+|||++..+...
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 999999999999999999999999999988643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2e-14 Score=158.52 Aligned_cols=146 Identities=25% Similarity=0.378 Sum_probs=114.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ---HRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 460 (558)
....|.|.+.||+|+||+||+|...+++.||+|.-++...- +|.-=.+++.+|+ -+.|..+..+..-.+.-+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 34578888999999999999999888999999987653221 1211222333333 23455566666667788999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------CCCeEEeccc
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-------DMNPKISDFG 533 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-------~~~~kl~DFG 533 (558)
+||.+.|+|.+++. ..+.+++.....++.|+++-+++||..+ |||+||||+|+||.. ...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999984 5567999999999999999999999998 999999999999942 3359999999
Q ss_pred cceee
Q 008648 534 LARTC 538 (558)
Q Consensus 534 la~~~ 538 (558)
-|--+
T Consensus 847 ~siDm 851 (974)
T KOG1166|consen 847 RSIDM 851 (974)
T ss_pred cceee
Confidence 98543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.6e-13 Score=143.81 Aligned_cols=145 Identities=21% Similarity=0.231 Sum_probs=94.1
Q ss_pred CCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccc----------------------------------cHHH--
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQ----------------------------------GLKE-- 428 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-- 428 (558)
..|+. +.||.|++|+||+|++.+ |++||||++++.... ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 999999998753110 0111
Q ss_pred ----HHHHHHHHhcC----CCCeeeeeeeEEEe-CCeEEEEEecCCCCChhHHHhhcCCC---CCCCHHHHHHHHHHHHH
Q 008648 429 ----LKNEVILFSKL----QHRNLVKLLGCCIH-GEEKLLIYEFMPNKSLDYFIFDQTNS---KLLDWSKRFHIICGTAR 496 (558)
Q Consensus 429 ----~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~i~~ 496 (558)
+.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++..-.... ..+....+..+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~------ 272 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF------ 272 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH------
Confidence 23344333333 23333443333332 45678999999999997753211111 01222222222
Q ss_pred HHHHHHhCCCCceEecCCCCCcEEEcCCC----CeEEeccccceeeCCC
Q 008648 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDM----NPKISDFGLARTCGGD 541 (558)
Q Consensus 497 gL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~~~~~ 541 (558)
+..++..| ++|+|+||.||+++.++ .++++|||++..+...
T Consensus 273 -~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 273 -FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 23344566 99999999999999888 9999999999988654
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.5e-13 Score=105.94 Aligned_cols=80 Identities=43% Similarity=0.926 Sum_probs=65.0
Q ss_pred CccCCCC---CceEEeccccCCCCcceeeecCCChHHHHHHhhcCCceEEEEeeccCCCCCccceeccccccccccCCCC
Q 008648 231 ALNYSRQ---DGFIKFTELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGDLIDMRSFPDGG 307 (558)
Q Consensus 231 ~l~c~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~~l~~~~~~~~~~ 307 (558)
+++|..+ +.|.++.++++|+..... .+.++++|++.||+||+|+||+|.+ ++++|.+|.+.+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 3567543 689999999999886643 6789999999999999999999974 3567999999998877655556
Q ss_pred cceEEeec
Q 008648 308 QDFYIRMS 315 (558)
Q Consensus 308 ~~~ylrv~ 315 (558)
..+|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999974
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.7e-12 Score=118.65 Aligned_cols=131 Identities=23% Similarity=0.148 Sum_probs=97.0
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCee-eeeeeEEEeCCeEEEEEecCCCCChh
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMPNKSLD 470 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~ 470 (558)
+.|+.|.++.||++... ++.+++|....... ....+..|+.++..+.+.++ .+++... ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999864 77899998754321 23356789999888865544 3455443 33468999999998875
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 471 YFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 471 ~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
... . ....++.+++++|+.||..+ +..++|+|++|.||+++ ++.++|+|||.|..-
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 320 1 11235678999999999876 23369999999999999 668999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.1e-13 Score=102.59 Aligned_cols=70 Identities=19% Similarity=0.266 Sum_probs=60.4
Q ss_pred CCCCceEEeccccCCCCcceeeecCCChHHHHHHhhc---CCceEEEEeeccCCCCCccceecccc-ccccccCCCCcce
Q 008648 235 SRQDGFIKFTELKLPDANFSRVSKSVNLKECREKCLE---NSSCMAYTNSDIRGGGSGCAMWFGDL-IDMRSFPDGGQDF 310 (558)
Q Consensus 235 ~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~C~~~~~~l-~~~~~~~~~~~~~ 310 (558)
...+.|+++.+|++|++.. .++++|++.|++ ||||.||+|.+. +.+|.+|.+++ .+++.+.+.+.++
T Consensus 6 ~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~L 76 (80)
T cd00129 6 KSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFDL 76 (80)
T ss_pred ecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCcee
Confidence 3467899999999998754 589999999999 999999999652 35899999999 9998887778899
Q ss_pred EEe
Q 008648 311 YIR 313 (558)
Q Consensus 311 ylr 313 (558)
|+|
T Consensus 77 y~r 79 (80)
T cd00129 77 YEN 79 (80)
T ss_pred EeE
Confidence 997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.2e-11 Score=112.50 Aligned_cols=138 Identities=14% Similarity=0.102 Sum_probs=99.8
Q ss_pred eeecccCcccEEEEEEcC-------CcEEEEEEeccc-------------c---------cccHHHHH----HHHHHHhc
Q 008648 392 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKI-------------S---------DQGLKELK----NEVILFSK 438 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~ 438 (558)
..||.|.-+.||.|...+ +..+|||+.+.. . ....+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998543 478999975321 0 01122233 79999988
Q ss_pred CCC--CeeeeeeeEEEeCCeEEEEEecCCCCChhH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCC
Q 008648 439 LQH--RNLVKLLGCCIHGEEKLLIYEFMPNKSLDY-FIFDQTNSKLLDWSKRFHIICGTARGLLYL-HQDSRLRIIHRDL 514 (558)
Q Consensus 439 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~gL~yL-H~~~~~~ivHrDl 514 (558)
+.. -++.+++++ ...+|||||+.+..+.. .+. ...++..+...+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 456666654 56789999998754422 221 11244556677889999999999 7777 999999
Q ss_pred CCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 515 KASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 515 kp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+|.|||++ ++.++|+|||.|...+..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 99999997 467999999999877644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.1e-12 Score=146.71 Aligned_cols=89 Identities=16% Similarity=0.214 Sum_probs=67.9
Q ss_pred cCCC-CeeeeeeeEE-------EeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 008648 438 KLQH-RNLVKLLGCC-------IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRI 509 (558)
Q Consensus 438 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~i 509 (558)
.++| +||+++++.+ ...+.+++++|++ +++|.+++... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4445 5777788876 2334567888987 56999998532 345899999999999999999999988 9
Q ss_pred EecCCCCCcEEEcCCCCeEEecc
Q 008648 510 IHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 510 vHrDlkp~NIll~~~~~~kl~DF 532 (558)
+||||||+||||+..+.+|++||
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~ 124 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIES 124 (793)
T ss_pred eeccCCchhEEEcccCcEEEeec
Confidence 99999999999965443333333
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-11 Score=108.25 Aligned_cols=134 Identities=19% Similarity=0.277 Sum_probs=101.8
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEE-ecccc-------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKR-LSKIS-------DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..+++|+-+.+|.+.+.+ .++++|. +++.- .-..++..+|++++.+++--.|....=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 367899999999997643 3466663 22211 11234567899999998766666666666788888999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..-..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9999999888432 2456777888889999999 99999999999997765 99999999986443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.7e-12 Score=138.89 Aligned_cols=143 Identities=26% Similarity=0.295 Sum_probs=111.0
Q ss_pred cceeecccCcccEEEEEEc-CCcEEEEEEec----c-cc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 390 INNKLGEGGFGPVYKGTLV-DGQEIAVKRLS----K-IS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~----~-~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..+.+|.|++|.|+.+... ..+..+.|... . .. .+....+..|..+-..++|||++..+....+....+-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4478999999988877643 23334444322 1 11 1112226678888888999999888887777666666699
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+++ +|..++... ..+...++..++.|++.|++|||+.| |.||||||+|+++..++.+||+|||.+..+.
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 998888432 35788889999999999999999999 9999999999999999999999999998664
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.9e-11 Score=112.16 Aligned_cols=143 Identities=20% Similarity=0.215 Sum_probs=109.6
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCC--CeeeeeeeEEEeCC---eEEEEEecCC
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD-QGLKELKNEVILFSKLQH--RNLVKLLGCCIHGE---EKLLIYEFMP 465 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~E~~~ 465 (558)
+.|+.|..+.||++...+|..+++|....... .....+..|+++++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987678999998754322 245678899999999975 44677777765532 5689999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS---------------------------------------- 505 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~---------------------------------------- 505 (558)
|.++...+.. ..++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988665421 24667777788888888888888531
Q ss_pred -------------CCceEecCCCCCcEEEcC--CCCeEEeccccceee
Q 008648 506 -------------RLRIIHRDLKASNVLLDH--DMNPKISDFGLARTC 538 (558)
Q Consensus 506 -------------~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~ 538 (558)
...++|+|++|.||+++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 235799999999999998 567899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=102.54 Aligned_cols=144 Identities=24% Similarity=0.295 Sum_probs=106.2
Q ss_pred cceeecccCcccEEEEEEcCCcEEEEEE-eccc-------ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 390 INNKLGEGGFGPVYKGTLVDGQEIAVKR-LSKI-------SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
....|-+|+-+.|+++.+ .|+..+||. +.+. ..-..++..+|++++.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999987 456656663 3221 1123456788999999887556555555677777788999
Q ss_pred ecCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---CeEEecccccee
Q 008648 462 EFMPN-KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM---NPKISDFGLART 537 (558)
Q Consensus 462 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~ 537 (558)
||+++ .++.+++........ .......++..|-+.+.-||.++ |+|+||..+||+|..++ .+.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 477888765433322 22233677888999999999999 99999999999997655 358999999865
Q ss_pred e
Q 008648 538 C 538 (558)
Q Consensus 538 ~ 538 (558)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.9e-10 Score=110.74 Aligned_cols=150 Identities=24% Similarity=0.352 Sum_probs=98.5
Q ss_pred CcccceeecccCcccEEEEEEcC-CcEEEEEEecc---cccccHHHHHHHHHHHhcCCC----------CeeeeeeeEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISDQGLKELKNEVILFSKLQH----------RNLVKLLGCCI 452 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 452 (558)
.+...+.||.|+++.||.+++.+ ++++|||+... ......+++++|.-.+..+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45566899999999999999865 89999998743 233456777777766655432 22333333222
Q ss_pred e---------CC--------eEEEEEecCCCCChhHHHh---hcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 008648 453 H---------GE--------EKLLIYEFMPNKSLDYFIF---DQTN-SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 511 (558)
Q Consensus 453 ~---------~~--------~~~lv~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivH 511 (558)
- .. ..+++|+-+ -++|..++. .... ...+....++.+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1 11 225777777 567877653 2211 223445556677799999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 512 RDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 512 rDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+||||+|++++++|.++|+||+.....+.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 99999999999999999999998876653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.1e-12 Score=129.86 Aligned_cols=143 Identities=27% Similarity=0.303 Sum_probs=115.4
Q ss_pred eecccCcccEEEEEE----cCCcEEEEEEeccccc--ccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 393 KLGEGGFGPVYKGTL----VDGQEIAVKRLSKISD--QGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
.+|+|.||.|+.++. ..+..+|+|.+++... ........|..++...+ ||.+|+++..+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999998763 3366788888765221 11125566788888887 9999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+|.|...+ ......++.....+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++.+-..
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99997665 33344566666667788999999999988 999999999999999999999999999876443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.5e-11 Score=113.03 Aligned_cols=141 Identities=26% Similarity=0.456 Sum_probs=115.5
Q ss_pred CcccceeecccCcccEEEEEEcCCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
...+..+|.+...|..|+|++. |..+++|++.. ......+.|.+|.-.|+-+.||||..+++.|.......++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3445568889999999999985 45566676643 33344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
+.|+|...++... .-..+..++.+++.+||+|++|||+..+ -|.---|....++||++.+++|+
T Consensus 270 p~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred cchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence 9999999997643 3457888999999999999999999763 23344689999999999988874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-09 Score=100.00 Aligned_cols=128 Identities=23% Similarity=0.255 Sum_probs=85.0
Q ss_pred cEEEEEEcCCcEEEEEEeccc--------------cc------------ccHHHHHHHHHHHhcCCCC--eeeeeeeEEE
Q 008648 401 PVYKGTLVDGQEIAVKRLSKI--------------SD------------QGLKELKNEVILFSKLQHR--NLVKLLGCCI 452 (558)
Q Consensus 401 ~Vy~~~~~~~~~vavK~~~~~--------------~~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 452 (558)
.||.|...++..+|||..+.. .. ......++|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 389999989999999975321 00 0123467899999999765 56666654
Q ss_pred eCCeEEEEEecCC--CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceEecCCCCCcEEEcCCCCeEE
Q 008648 453 HGEEKLLIYEFMP--NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY-LHQDSRLRIIHRDLKASNVLLDHDMNPKI 529 (558)
Q Consensus 453 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~y-LH~~~~~~ivHrDlkp~NIll~~~~~~kl 529 (558)
....|||||++ |..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 66665443111 1134456677788886665 56777 9999999999999887 8999
Q ss_pred eccccceeeCCC
Q 008648 530 SDFGLARTCGGD 541 (558)
Q Consensus 530 ~DFGla~~~~~~ 541 (558)
+|||.|......
T Consensus 148 IDf~qav~~~~p 159 (188)
T PF01163_consen 148 IDFGQAVDSSHP 159 (188)
T ss_dssp --GTTEEETTST
T ss_pred EecCcceecCCc
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.7e-11 Score=129.48 Aligned_cols=141 Identities=18% Similarity=0.252 Sum_probs=111.7
Q ss_pred CcccceeecccCcccEEEEEEcCCcEEEEEEecccc-cccHHHHH---HHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-DQGLKELK---NEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++...+.||++.|=+|.+|++++|. |+||++-+.. .-..+.+. +|++ +..++|||.+.+.-+-+...-.|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667789999999999999988877 8899875533 23334443 4444 556689999998877666666788888
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
|+. .+|.+.+ ..+..+...+...|+.|++.||...|..+ |.|+|||.+||||+.-+=+.|+||.--|
T Consensus 102 yvk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 884 4676666 33456778888899999999999999988 9999999999999988889999997655
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.99 E-value=5e-10 Score=95.28 Aligned_cols=42 Identities=55% Similarity=1.020 Sum_probs=35.5
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYP 49 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~P 49 (558)
.+||+|++.+ .....+ |+|+|+|||||++. .+.+||||||||
T Consensus 75 ~~vW~S~~~~-~~~~~~-~~L~ddGnlvl~~~----~~~~~W~Sf~~P 116 (116)
T cd00028 75 TVVWSSNTTR-VNGNYV-LVLLDDGNLVLYDS----DGNFLWQSFDYP 116 (116)
T ss_pred cEEEEecccC-CCCceE-EEEeCCCCEEEECC----CCCEEEcCCCCC
Confidence 4799999875 234555 99999999999987 689999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.4e-09 Score=100.75 Aligned_cols=140 Identities=17% Similarity=0.094 Sum_probs=98.7
Q ss_pred eecccCcccEEEEEEcCCcEEEEEEeccccc-----------ccHHHHHHHHHHHhcCCCCe--eeeeeeEEEe-----C
Q 008648 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISD-----------QGLKELKNEVILFSKLQHRN--LVKLLGCCIH-----G 454 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~ 454 (558)
.+-+-....|++... +|+.+.||....... .....+.+|...+.++...+ .+.++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445667655 677899996643210 11124778988888874333 3445555543 2
Q ss_pred CeEEEEEecCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------CCC
Q 008648 455 EEKLLIYEFMPNK-SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-------DMN 526 (558)
Q Consensus 455 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-------~~~ 526 (558)
...+||||++++. +|.+++.... ....+...+..++.+++..+.-||..| |+|+|+++.||||+. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3468999999986 8988874321 223456677789999999999999999 999999999999975 467
Q ss_pred eEEecccccee
Q 008648 527 PKISDFGLART 537 (558)
Q Consensus 527 ~kl~DFGla~~ 537 (558)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-09 Score=107.07 Aligned_cols=90 Identities=23% Similarity=0.434 Sum_probs=70.4
Q ss_pred CCCeeeeeeeEEEeC---------------------------CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHH
Q 008648 440 QHRNLVKLLGCCIHG---------------------------EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492 (558)
Q Consensus 440 ~h~niv~l~~~~~~~---------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 492 (558)
+|||||++.++|.+. ...|+||.-.+ .+|..++-.+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 599999999887642 23578888774 5788887432 345566677889
Q ss_pred HHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCC--CeEEecccccee
Q 008648 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLD--HDM--NPKISDFGLART 537 (558)
Q Consensus 493 ~i~~gL~yLH~~~~~~ivHrDlkp~NIll~--~~~--~~kl~DFGla~~ 537 (558)
|+++|+.|||.++ |.|||+|.+||||. +|+ .+.|+|||.+-.
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 9999999999999 99999999999994 343 478999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.4e-08 Score=96.12 Aligned_cols=139 Identities=20% Similarity=0.195 Sum_probs=99.9
Q ss_pred cccceeecccCcccEEEEEEcCCcEEEEEEecc----------c----------c--cccHHHHHHHHHHHhcCCCC--e
Q 008648 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK----------I----------S--DQGLKELKNEVILFSKLQHR--N 443 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~----------~----------~--~~~~~~~~~E~~~l~~l~h~--n 443 (558)
..+..+||.|.-+.||.|..+.|.++|||.-+. . + .......++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455689999999999999999999999994211 0 0 01223467899999999754 6
Q ss_pred eeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 008648 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH 523 (558)
Q Consensus 444 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~ 523 (558)
+.+.+++ +...+||||++|-.|...- ++....-.++..|++-+.-+-..| |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777765 5568999999997774332 122333344445555555444556 999999999999999
Q ss_pred CCCeEEeccccceeeCCC
Q 008648 524 DMNPKISDFGLARTCGGD 541 (558)
Q Consensus 524 ~~~~kl~DFGla~~~~~~ 541 (558)
+|.+.++||--+...+..
T Consensus 238 dg~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 238 DGDIVVIDWPQAVPISHP 255 (304)
T ss_pred CCCEEEEeCcccccCCCC
Confidence 999999999777655443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.3e-09 Score=108.01 Aligned_cols=100 Identities=32% Similarity=0.497 Sum_probs=89.7
Q ss_pred HhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 008648 436 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 515 (558)
Q Consensus 436 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlk 515 (558)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....+++.....++++|++||+|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4578999999999999999999999999999999999965 3445889999999999999999999864 23999999
Q ss_pred CCcEEEcCCCCeEEeccccceeeC
Q 008648 516 ASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 516 p~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+.|+++|....+||+|||+.....
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-09 Score=118.91 Aligned_cols=152 Identities=26% Similarity=0.340 Sum_probs=120.9
Q ss_pred cCCcccceeecccCcccEEEEEEcC--CcEEEEEEecccc--cccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKIS--DQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 459 (558)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4567888899999999998887543 3456666655432 333445566777777776 9999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCcEEEcCCC-CeEEecccccee
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH-QDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLART 537 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH-~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~ 537 (558)
++||..++++...+.. ......+......++.|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999776631 11113555666778999999999999 777 99999999999999999 999999999988
Q ss_pred eCC
Q 008648 538 CGG 540 (558)
Q Consensus 538 ~~~ 540 (558)
+..
T Consensus 175 ~~~ 177 (601)
T KOG0590|consen 175 YRN 177 (601)
T ss_pred ccc
Confidence 766
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.8e-09 Score=87.05 Aligned_cols=41 Identities=51% Similarity=0.956 Sum_probs=33.1
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDY 48 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~ 48 (558)
.+||+|++.. ..+..+ |+|+|+|||||++. .+.++||||||
T Consensus 74 ~~vW~S~t~~-~~~~~~-~~L~ddGnlvl~~~----~~~~~W~Sf~~ 114 (114)
T smart00108 74 RVVWSSNTTG-ANGNYV-LVLLDDGNLVIYDS----DGNFLWQSFDY 114 (114)
T ss_pred CEEEEecccC-CCCceE-EEEeCCCCEEEECC----CCCEEeCCCCC
Confidence 4789999872 124555 99999999999986 67899999997
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4e-08 Score=103.24 Aligned_cols=124 Identities=17% Similarity=0.233 Sum_probs=101.9
Q ss_pred EcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHH
Q 008648 407 LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSK 486 (558)
Q Consensus 407 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~ 486 (558)
..++.+|.|...+...........+.++.|+.++||||+++++..+.....|||+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 45678888888776444345567888899999999999999999999999999999884 56666643 22455
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 487 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 487 ~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
...-+.||+.||.|||+.+ .++|++|.-..|+|++.|..||++|.++....+
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 5667899999999999766 499999999999999999999999998866543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=9.5e-08 Score=90.20 Aligned_cols=108 Identities=25% Similarity=0.242 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHhcCC--CCeeeeeeeEEEeCC----eEEEEEecCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 008648 426 LKELKNEVILFSKLQ--HRNLVKLLGCCIHGE----EKLLIYEFMPNK-SLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498 (558)
Q Consensus 426 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL 498 (558)
.....+|...+..+. .-..++.+++.+... ..+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 446778888877774 334556666666532 348999999884 79988854222 56667788999999999
Q ss_pred HHHHhCCCCceEecCCCCCcEEEcCCC---CeEEeccccceeeC
Q 008648 499 LYLHQDSRLRIIHRDLKASNVLLDHDM---NPKISDFGLARTCG 539 (558)
Q Consensus 499 ~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~~~ 539 (558)
.-||+.+ |+|+|++|.|||++.+. .+.|+||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 99999999999999877 89999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.1e-08 Score=102.47 Aligned_cols=142 Identities=17% Similarity=0.193 Sum_probs=93.7
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEeccccccc----------------------------------HHH------HHH
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQG----------------------------------LKE------LKN 431 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------~~~------~~~ 431 (558)
+.|+.++-|+||+|++.+|+.||||+.++.-... .+. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999876521100 011 233
Q ss_pred HHHHHhcC----C-CCeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 008648 432 EVILFSKL----Q-HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARG-LLYLHQDS 505 (558)
Q Consensus 432 E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~g-L~yLH~~~ 505 (558)
|+.-+.++ + .+++.-..=+..-.....|+|||++|..+.+...... ...+.+. ++..++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 44444433 2 3443322223334567799999999999988753322 2234322 33333332 33333355
Q ss_pred CCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 506 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
++|.|.+|.||+++.++.+.+.|||+...++..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999887654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2e-07 Score=95.10 Aligned_cols=140 Identities=23% Similarity=0.316 Sum_probs=111.5
Q ss_pred ccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe----CCeEEEEEecCCC-CChhHHH
Q 008648 400 GPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH----GEEKLLIYEFMPN-KSLDYFI 473 (558)
Q Consensus 400 g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~-gsL~~~l 473 (558)
.+.|++.. .||..+++|+++....+.......-+++++++.|+|||++.+++.. +...++||+|.++ .+|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 46788874 5799999999955433443344556788999999999999999873 3457899999985 5665554
Q ss_pred hhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 474 FDQT------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 474 ~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+... ....+++...+.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|+...+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 2234678899999999999999999999 888999999999999999999999999888766
Q ss_pred c
Q 008648 542 K 542 (558)
Q Consensus 542 ~ 542 (558)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 5
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.4e-07 Score=83.12 Aligned_cols=140 Identities=16% Similarity=0.103 Sum_probs=102.3
Q ss_pred ecccCcccEEEEEEcCCcEEEEEEeccc------ccccHHHHHHHHHHHhcCCC--CeeeeeeeEEEeCC----eEEEEE
Q 008648 394 LGEGGFGPVYKGTLVDGQEIAVKRLSKI------SDQGLKELKNEVILFSKLQH--RNLVKLLGCCIHGE----EKLLIY 461 (558)
Q Consensus 394 lg~G~fg~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~ 461 (558)
-|+|+.+.|++..+. |+.+-+|+-... -+.....|.+|...|..+.. -.+.++........ ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 356888889987763 447888876521 13466789999999998853 23455552222211 257999
Q ss_pred ecCC-CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC--eEEeccccceee
Q 008648 462 EFMP-NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN--PKISDFGLARTC 538 (558)
Q Consensus 462 E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~~ 538 (558)
|-++ -.+|.+++.+. .....+...+..++.++++.+.-||+.+ +.|+|+-+.||+++.++. ++++||.-++..
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 9765 36888887442 2234577778899999999999999998 999999999999986666 999999877653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.3e-06 Score=83.67 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=85.4
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCe--eeeeeeEEEeCCeEEEEEecCCCCC-
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN--LVKLLGCCIHGEEKLLIYEFMPNKS- 468 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs- 468 (558)
..||+|..+.||+. .+..+++|..... .......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 2456778877542 23456788999998886433 4677778777777889999999863
Q ss_pred hhHHHh--------------h------cCCCCCCCHHHHH-HHHHH----------HHH-HHHHHHh-CCCCceEecCCC
Q 008648 469 LDYFIF--------------D------QTNSKLLDWSKRF-HIICG----------TAR-GLLYLHQ-DSRLRIIHRDLK 515 (558)
Q Consensus 469 L~~~l~--------------~------~~~~~~l~~~~~~-~i~~~----------i~~-gL~yLH~-~~~~~ivHrDlk 515 (558)
+...+. . ............. .+..+ +.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 0000000100000 00000 011 1122221 122357899999
Q ss_pred CCcEEEcCCCCeEEecccccee
Q 008648 516 ASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 516 p~NIll~~~~~~kl~DFGla~~ 537 (558)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.9e-08 Score=102.30 Aligned_cols=150 Identities=25% Similarity=0.280 Sum_probs=118.2
Q ss_pred hhhcCCcccceeecccCcccEEEEEE--cCCcEEEEEEecccccccHHH--HHHHHHHHhcC-CCCeeeeeeeEEEeCCe
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL--VDGQEIAVKRLSKISDQGLKE--LKNEVILFSKL-QHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 456 (558)
.....+|..+..||.|.|+.|++... .++..+++|.+.+.......+ -..|+.+...+ .|.++++....+..-..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 44556788899999999999999874 357788998876533332222 23455555555 48888888888888888
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CCeEEeccccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLA 535 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla 535 (558)
.|+--||++++++...+ .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||++
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 88999999999987665 23345788888999999999999999877 9999999999999876 78899999998
Q ss_pred ee
Q 008648 536 RT 537 (558)
Q Consensus 536 ~~ 537 (558)
..
T Consensus 415 t~ 416 (524)
T KOG0601|consen 415 TR 416 (524)
T ss_pred cc
Confidence 63
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=9.2e-08 Score=104.86 Aligned_cols=112 Identities=26% Similarity=0.367 Sum_probs=77.0
Q ss_pred cCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..+|..++.|..|++|.||.++++. .+.+|+|+-++ .- -+++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch----hhhc---cccccCCccee------------------
Confidence 3578888999999999999998764 57788853222 10 0111 33333444444
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+-...+ +....++. +++.+++|||+.+ |+|||+||+|.+|..-|.+|+.|||+++...
T Consensus 136 ---gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ---chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence 3333333 22222332 2278999999988 9999999999999999999999999998653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.2e-06 Score=79.85 Aligned_cols=139 Identities=15% Similarity=0.137 Sum_probs=89.5
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHH---------HHHHHHHHhcCCC---CeeeeeeeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKE---------LKNEVILFSKLQH---RNLVKLLGCC 451 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~l~~~~ 451 (558)
..++|.+.+.+-......|.+-.. +++.+++|..........+. ..+++..+.+++. ..++.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 446788878887776666665554 67889999775533222222 2233333333322 2222222222
Q ss_pred E-----eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 452 I-----HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 452 ~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
+ -....+|+|||++|..|.++. .+++ .++..+++++.-||+.| ++|+|+.|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 223456899999999886553 1222 24456778899999999 99999999999998655
Q ss_pred eEEeccccceee
Q 008648 527 PKISDFGLARTC 538 (558)
Q Consensus 527 ~kl~DFGla~~~ 538 (558)
++++||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999887654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.4e-07 Score=98.32 Aligned_cols=151 Identities=23% Similarity=0.313 Sum_probs=119.0
Q ss_pred CCcccceeecc--cCcccEEEEEE---cCCcEEEEEEecc--cccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeE
Q 008648 386 NNFSINNKLGE--GGFGPVYKGTL---VDGQEIAVKRLSK--ISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 386 ~~y~~~~~lg~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 457 (558)
..+.+...+|. |.+|.||.+.. .++..+|+|+-+. ..+.....=.+|+....++ .|+|.++.+..++.++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45566678999 99999999986 3577899987433 2223333445666666666 499999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecCCCCCcEEEcCC-CCeEEecc
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDF 532 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----gL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DF 532 (558)
++-+|++. .+|..+... ....++......+..+... ||.++|... |+|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999985 667666533 2334677777888888888 999999988 9999999999999988 88999999
Q ss_pred ccceeeCCCc
Q 008648 533 GLARTCGGDK 542 (558)
Q Consensus 533 Gla~~~~~~~ 542 (558)
|+...++...
T Consensus 268 ~~v~~i~~~~ 277 (524)
T KOG0601|consen 268 GLVSKISDGN 277 (524)
T ss_pred ceeEEccCCc
Confidence 9999987665
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.40 E-value=8.7e-07 Score=69.31 Aligned_cols=73 Identities=38% Similarity=0.793 Sum_probs=54.7
Q ss_pred CCceEEeccccCCCCcceeeecCCChHHHHHHhhc-CCceEEEEeeccCCCCCccceec-cccccccccCCCCcceEEe
Q 008648 237 QDGFIKFTELKLPDANFSRVSKSVNLKECREKCLE-NSSCMAYTNSDIRGGGSGCAMWF-GDLIDMRSFPDGGQDFYIR 313 (558)
Q Consensus 237 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~C~~~~-~~l~~~~~~~~~~~~~ylr 313 (558)
...|.+++++.+++..... ....++++|++.|+. +|+|.||.|.. +..+|.+|. +.+.+....+..+.++|.|
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 3568899999998654432 456799999999999 99999999964 356799998 7777766444445555554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.37 E-value=8.7e-07 Score=81.21 Aligned_cols=62 Identities=23% Similarity=0.191 Sum_probs=53.5
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+|.+++... ...+++.++..|+.||++||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 6888888543 345899999999999999999999864 999999999999999 9999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.7e-06 Score=89.81 Aligned_cols=140 Identities=14% Similarity=0.175 Sum_probs=89.4
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEeccccccc-------------------------------HHH------HHHHHH
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQG-------------------------------LKE------LKNEVI 434 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~------~~~E~~ 434 (558)
+.||.-+.|.||+|++++|+.||||+-++.-+.. .+. |..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999865521110 011 223333
Q ss_pred HHh----cCCCCe------eeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 008648 435 LFS----KLQHRN------LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504 (558)
Q Consensus 435 ~l~----~l~h~n------iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~ 504 (558)
-.. .+.|-+ |.+++-. -...+.|+||||+|..+.+...-.. ..++...+..-+.+.. ++-|-..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHH--HHHHHhc
Confidence 222 233444 3333322 2456799999999998866543221 2245554443333322 2233334
Q ss_pred CCCceEecCCCCCcEEEcC----CCCeEEeccccceeeCC
Q 008648 505 SRLRIIHRDLKASNVLLDH----DMNPKISDFGLARTCGG 540 (558)
Q Consensus 505 ~~~~ivHrDlkp~NIll~~----~~~~kl~DFGla~~~~~ 540 (558)
| ++|+|-+|.||++.. ++.+.+-|||+.+.+..
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 5 999999999999984 66899999999987754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.5e-06 Score=78.98 Aligned_cols=145 Identities=21% Similarity=0.167 Sum_probs=85.6
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC--eeeeeeeEEEe---CCeEEEEEecCC
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHR--NLVKLLGCCIH---GEEKLLIYEFMP 465 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~E~~~ 465 (558)
++.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3678999999999999877 69999987553 4566788898888887432 35666665433 234689999999
Q ss_pred CCChhH----------------HHh---hc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 008648 466 NKSLDY----------------FIF---DQ-TNSKLLDWSK---------RFHI------------ICGTAR-GLLYLHQ 503 (558)
Q Consensus 466 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~i~~-gL~yLH~ 503 (558)
+..+.. .+. .. .......... .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988876 111 11 0111111100 0000 011222 2333332
Q ss_pred ----CCCCceEecCCCCCcEEEc-CCCCeEEeccccceee
Q 008648 504 ----DSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTC 538 (558)
Q Consensus 504 ----~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~ 538 (558)
.....++|+|+.|.|||++ +++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2334699999999999999 5666689999988654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.1e-06 Score=80.70 Aligned_cols=141 Identities=15% Similarity=0.114 Sum_probs=85.9
Q ss_pred eecccCc-ccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEecCCCCChh
Q 008648 393 KLGEGGF-GPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 470 (558)
Q Consensus 393 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 470 (558)
.|..|.. ..||+.... +..+.+|...... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555665 688999764 4678888775432 345678888888774 344667787777666789999999998876
Q ss_pred HHHh-------------------hcCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----C
Q 008648 471 YFIF-------------------DQTN-SKLLDW--SKRFHIIC--------------------GTARGLLYLHQ----D 504 (558)
Q Consensus 471 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~i~~gL~yLH~----~ 504 (558)
.... .... ...... ...+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4320 0000 000100 00000000 01111122211 1
Q ss_pred CCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 505 ~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
..+.++|+|+.|.|||++++..+.|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.1e-06 Score=77.30 Aligned_cols=154 Identities=19% Similarity=0.204 Sum_probs=100.4
Q ss_pred cchhhhhhhcCCccccee---ecccCcccEEEEEEcCCcEEEEEEecccccc-------------------cHH-----H
Q 008648 376 FELATISNATNNFSINNK---LGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ-------------------GLK-----E 428 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~---lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~ 428 (558)
.++..+.....+..+.+. |..|.-+.||+|...++..+|||+....... ..+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345555555555555554 5567777899999888999999987541110 111 1
Q ss_pred HHHHHHHHhcCC--CCeeeeeeeEEEeCCeEEEEEecCCCCChh-HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 008648 429 LKNEVILFSKLQ--HRNLVKLLGCCIHGEEKLLIYEFMPNKSLD-YFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-D 504 (558)
Q Consensus 429 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~ 504 (558)
...|..-|.++. +-.+.+.+.+. ...|||||+....+. -.| ..-.+...+...+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 235666666653 44455555543 347999999654221 111 11122333566777888888888876 4
Q ss_pred CCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 505 ~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+ +||+||..-|||+. ++.+.|+|||-|......
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 4 99999999999998 888999999998876644
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.4e-06 Score=78.04 Aligned_cols=105 Identities=22% Similarity=0.203 Sum_probs=82.2
Q ss_pred HHHHHHHhcCCC-CeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 008648 430 KNEVILFSKLQH-RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508 (558)
Q Consensus 430 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ 508 (558)
..|.-+++.+++ +++++++|.| ..+++.||.+.+++.............+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 6999999999 34789999987765321000011123689999999999999999999865445
Q ss_pred eEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 509 IIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 509 ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+.-.|++|+|+-+++++++|++|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=8e-07 Score=85.75 Aligned_cols=97 Identities=27% Similarity=0.302 Sum_probs=80.9
Q ss_pred HHHHhcCCCCeeeeeeeEEEeCC-----eEEEEEecCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 008648 433 VILFSKLQHRNLVKLLGCCIHGE-----EKLLIYEFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSR 506 (558)
Q Consensus 433 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~ 506 (558)
..-|-.+.|.|||+++.++.+.. ...+++|||+-|+|..+|++.. ....+......+++-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34455567999999999987644 3578999999999999997643 3445777788899999999999999975
Q ss_pred CceEecCCCCCcEEEcCCCCeEEe
Q 008648 507 LRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 507 ~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
++|+|+++..+-|++..++-+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred CccccCCcchhheeecCCceEEec
Confidence 779999999999999999888874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.1e-07 Score=94.09 Aligned_cols=81 Identities=26% Similarity=0.391 Sum_probs=72.5
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..||.|++++..+|.++|.........++...+.++.|++.|++| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999876666678888999999999999999 56 999999999999999999999999999
Q ss_pred eeeCCCc
Q 008648 536 RTCGGDK 542 (558)
Q Consensus 536 ~~~~~~~ 542 (558)
.......
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8776655
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.6e-05 Score=87.88 Aligned_cols=79 Identities=15% Similarity=0.323 Sum_probs=57.4
Q ss_pred ceeecccCcccEEEEEEcCC---cEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCee--eeeeeEEEeC---CeEEEE
Q 008648 391 NNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKIS-DQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIHG---EEKLLI 460 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 460 (558)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |+++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876553 467777654322 123457889999999995 6664 7788887664 357899
Q ss_pred EecCCCCCh
Q 008648 461 YEFMPNKSL 469 (558)
Q Consensus 461 ~E~~~~gsL 469 (558)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.2e-05 Score=73.16 Aligned_cols=73 Identities=16% Similarity=0.288 Sum_probs=45.5
Q ss_pred eeecccCcc-cEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC---eeeeeeeEEEeCC---eEEEEEecC
Q 008648 392 NKLGEGGFG-PVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHR---NLVKLLGCCIHGE---EKLLIYEFM 464 (558)
Q Consensus 392 ~~lg~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~E~~ 464 (558)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+++..+... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567766666 58875 23567776543 22345788999998877532 3444444433222 347899999
Q ss_pred CCCChh
Q 008648 465 PNKSLD 470 (558)
Q Consensus 465 ~~gsL~ 470 (558)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.95 E-value=4e-05 Score=64.83 Aligned_cols=71 Identities=24% Similarity=0.457 Sum_probs=47.7
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
.+||++++......... +.|.++|||||++. .+.++|+| .|. ..
T Consensus 41 ~~vW~snt~~~~~~~~~-l~l~~dGnLvl~~~----~g~~vW~S---~t~----------------------------~~ 84 (114)
T smart00108 41 TVVWVANRDNPVSDSCT-LTLQSDGNLVLYDG----DGRVVWSS---NTT----------------------------GA 84 (114)
T ss_pred cEEEECCCCCCCCCCEE-EEEeCCCCEEEEeC----CCCEEEEe---ccc----------------------------CC
Confidence 57999998643222344 89999999999986 57889987 111 12
Q ss_pred CcceEEEEecCCCceEEEEeC-CeEEEEec
Q 008648 82 PGDFIWAVERQDNPEVVMWKG-SSKFYTTG 110 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~-~~~y~~~~ 110 (558)
.+.|.+.|+.+|...+ ++. +++.|.|.
T Consensus 85 ~~~~~~~L~ddGnlvl--~~~~~~~~W~Sf 112 (114)
T smart00108 85 NGNYVLVLLDDGNLVI--YDSDGNFLWQSF 112 (114)
T ss_pred CCceEEEEeCCCCEEE--ECCCCCEEeCCC
Confidence 3457788888887544 433 45778753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00012 Score=73.19 Aligned_cols=77 Identities=13% Similarity=0.078 Sum_probs=56.4
Q ss_pred cceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCC---CeeeeeeeEEEeC---CeEEEEEec
Q 008648 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH---RNLVKLLGCCIHG---EEKLLIYEF 463 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~E~ 463 (558)
-.+.||.|..+.||+....++ .+.+|..+. ......+..|...++.|.. ..+.++++++... +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 346899999999999976555 466666432 1134588899999988853 4678888877543 568999999
Q ss_pred CCCCCh
Q 008648 464 MPNKSL 469 (558)
Q Consensus 464 ~~~gsL 469 (558)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.95 E-value=9.1e-05 Score=68.90 Aligned_cols=133 Identities=16% Similarity=0.254 Sum_probs=90.1
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccc----------------cccHHHHHHHHHHHhcCC------CCeeeeee
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------DQGLKELKNEVILFSKLQ------HRNLVKLL 448 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 448 (558)
...||+|+.-.||. +++.....||+..... ....++.++|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35899999988884 4556677888876533 123456677776655554 88999999
Q ss_pred eEEEeCCeEEEEEecCCC------CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 008648 449 GCCIHGEEKLLIYEFMPN------KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 522 (558)
Q Consensus 449 ~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~ 522 (558)
|+.++....-+|+|.+.+ .+|.+++.+ ..++. ..... +-+-.+||-+++ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998742 356677632 23444 33323 334456677666 99999999999996
Q ss_pred CC--C--CeEEec-cccce
Q 008648 523 HD--M--NPKISD-FGLAR 536 (558)
Q Consensus 523 ~~--~--~~kl~D-FGla~ 536 (558)
.. + .+.|+| ||-..
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 32 2 466666 45433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.2e-05 Score=64.38 Aligned_cols=73 Identities=23% Similarity=0.334 Sum_probs=49.1
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
++||++++......... +.|.++|||||.+. .+.++|+|=-. .+
T Consensus 42 ~~vW~snt~~~~~~~~~-l~l~~dGnLvl~~~----~g~~vW~S~~~-------------------------------~~ 85 (116)
T cd00028 42 TVVWVANRDNPSGSSCT-LTLQSDGNLVIYDG----SGTVVWSSNTT-------------------------------RV 85 (116)
T ss_pred eEEEECCCCCCCCCCEE-EEEecCCCeEEEcC----CCcEEEEeccc-------------------------------CC
Confidence 57999998642223344 89999999999986 67889986311 02
Q ss_pred CcceEEEEecCCCceEEEEeCCeEEEEecc
Q 008648 82 PGDFIWAVERQDNPEVVMWKGSSKFYTTGP 111 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 111 (558)
.+.+.+.|+.+|...++-. ...+.|.|..
T Consensus 86 ~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~ 114 (116)
T cd00028 86 NGNYVLVLLDDGNLVLYDS-DGNFLWQSFD 114 (116)
T ss_pred CCceEEEEeCCCCEEEECC-CCCEEEcCCC
Confidence 4567888888887544322 2467787653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.92 E-value=9.8e-05 Score=68.15 Aligned_cols=125 Identities=27% Similarity=0.392 Sum_probs=90.6
Q ss_pred CCcccceeecccCc-ccEEEEEEcCCcEEEEEEecc---c---------cc---------ccHHHHHHHHHHHhcCC---
Q 008648 386 NNFSINNKLGEGGF-GPVYKGTLVDGQEIAVKRLSK---I---------SD---------QGLKELKNEVILFSKLQ--- 440 (558)
Q Consensus 386 ~~y~~~~~lg~G~f-g~Vy~~~~~~~~~vavK~~~~---~---------~~---------~~~~~~~~E~~~l~~l~--- 440 (558)
..++.++.||.|.. |.||+++. +|+.+|+|.... . .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 677999998321 0 00 11235778888888775
Q ss_pred CCee--eeeeeEEEeCC------------------eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 008648 441 HRNL--VKLLGCCIHGE------------------EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500 (558)
Q Consensus 441 h~ni--v~l~~~~~~~~------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~y 500 (558)
+.++ |+.+|+..-.. ...||.||++... .+.. .-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4456 99999875331 1257777765432 1222 235677888899
Q ss_pred HHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 501 LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
+|..+ |+-+|++++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999987 4699999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=9.9e-05 Score=65.94 Aligned_cols=131 Identities=21% Similarity=0.268 Sum_probs=87.6
Q ss_pred cccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeee-eeeeEEEeCCeEEEEEecCCC
Q 008648 388 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV-KLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~ 466 (558)
....+.|++|.+|.||++.+. +.++|+|+-.. ......+..|+++|..+.-.++- +++.+- ..++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence 344578999999999999984 45889987654 34567899999999998765543 344432 23456999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC-CCcEEEcCCCCeEEeccccceee
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK-ASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlk-p~NIll~~~~~~kl~DFGla~~~ 538 (558)
-.|.+.-.. .+.++.+. +++.---|-..| |-|..|. |..++|-.++.+.|+||.-|+.-
T Consensus 97 ~~L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 888765411 12333333 334322333334 8888875 55555555558999999999843
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00015 Score=69.81 Aligned_cols=73 Identities=19% Similarity=0.291 Sum_probs=47.4
Q ss_pred eeecccCcccEEEEEEcC--CcEEEEEEecccccccHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN-LVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
+.|..|-...+|+....+ ++.+++|+...... ......+|+.++..+...+ .+++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999998764 67888887654221 1123346888888774333 344444332 248999999877
Q ss_pred h
Q 008648 469 L 469 (558)
Q Consensus 469 L 469 (558)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 6
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00027 Score=72.89 Aligned_cols=75 Identities=15% Similarity=0.218 Sum_probs=55.0
Q ss_pred eeecccCcccEEEEEEcCC-cEEEEEEeccc-----c--cccHHHHHHHHHHHhcCC---CCeeeeeeeEEEeCCeEEEE
Q 008648 392 NKLGEGGFGPVYKGTLVDG-QEIAVKRLSKI-----S--DQGLKELKNEVILFSKLQ---HRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 460 (558)
+.||.|.+..||++...+| +.++||.-.+. . +...++...|.+.|..+. ...+++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999998776 58999974321 1 234567778888887762 3457777777 44567899
Q ss_pred EecCCCCC
Q 008648 461 YEFMPNKS 468 (558)
Q Consensus 461 ~E~~~~gs 468 (558)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00015 Score=70.89 Aligned_cols=139 Identities=17% Similarity=0.126 Sum_probs=77.8
Q ss_pred eecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCee-eeeeeEEEeCCeEEEEEecCCCCChhH
Q 008648 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMPNKSLDY 471 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~ 471 (558)
.+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .+++... . .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 455677788998873 567888887544222211235778888888854323 3344432 1 368999999876532
Q ss_pred H--------------H---hhcC-CCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCceEecCCCCCc
Q 008648 472 F--------------I---FDQT-NSKLLDWSKR-FHIICG---------TARGLLYLHQD-----SRLRIIHRDLKASN 518 (558)
Q Consensus 472 ~--------------l---~~~~-~~~~l~~~~~-~~i~~~---------i~~gL~yLH~~-----~~~~ivHrDlkp~N 518 (558)
. + +... ....++.... ..+..+ +..-++.+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1 1111 1111221111 111111 11112222111 12358999999999
Q ss_pred EEEcCCCCeEEecccccee
Q 008648 519 VLLDHDMNPKISDFGLART 537 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~ 537 (558)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 79999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00029 Score=70.52 Aligned_cols=142 Identities=20% Similarity=0.177 Sum_probs=84.5
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCe--eeeeeeE------EEeCCeEEEEEe
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN--LVKLLGC------CIHGEEKLLIYE 462 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E 462 (558)
.+.|..|....+|+....+ ..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 3567778778999987644 4788888754 33456777888887774322 4444331 123445689999
Q ss_pred cCCCCChhH----HH----------hhc----CC----CCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 008648 463 FMPNKSLDY----FI----------FDQ----TN----SKLLDWSKRF----------HIICGTARGLLYLHQ----DSR 506 (558)
Q Consensus 463 ~~~~gsL~~----~l----------~~~----~~----~~~l~~~~~~----------~i~~~i~~gL~yLH~----~~~ 506 (558)
+++|..+.. .. +.. .. .....|.... .....+..++.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 10 000 00 0111221111 011123344555543 112
Q ss_pred CceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 507 LRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 507 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999988777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00086 Score=67.31 Aligned_cols=141 Identities=26% Similarity=0.334 Sum_probs=82.2
Q ss_pred eeecccCcccEEEEEEcC-------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN-LVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~ 463 (558)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+.... ..++++.+. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456666677899888654 4788898865432 23345677888877774322 334555543 2368999
Q ss_pred CCCCChhHHH-----------------hhcCCCC------CCC--HHHHHH--------------------------HHH
Q 008648 464 MPNKSLDYFI-----------------FDQTNSK------LLD--WSKRFH--------------------------IIC 492 (558)
Q Consensus 464 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 492 (558)
++|..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764311 0110000 011 111100 111
Q ss_pred HHHHHHHHHHh------CCCCceEecCCCCCcEEEcCC----CCeEEecccccee
Q 008648 493 GTARGLLYLHQ------DSRLRIIHRDLKASNVLLDHD----MNPKISDFGLART 537 (558)
Q Consensus 493 ~i~~gL~yLH~------~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~ 537 (558)
.+..-++.|.. ..+..++|+|+.|.|||++++ +.++|+||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234568999999999999874 7899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00027 Score=69.04 Aligned_cols=141 Identities=17% Similarity=0.198 Sum_probs=94.6
Q ss_pred hhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecc--c-------cc-------c------cHHHHHHHHHHH
Q 008648 379 ATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--I-------SD-------Q------GLKELKNEVILF 436 (558)
Q Consensus 379 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~--~-------~~-------~------~~~~~~~E~~~l 436 (558)
.++.....-+.+.++||-|.-+.||.+-..+|++.++|.-.- . .. . ..-...+|...|
T Consensus 85 ktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm 164 (465)
T KOG2268|consen 85 KTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM 164 (465)
T ss_pred HHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence 333333335678899999999999999999999999884211 0 00 0 111245678888
Q ss_pred hcCC-C-CeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 008648 437 SKLQ-H-RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 514 (558)
Q Consensus 437 ~~l~-h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDl 514 (558)
+.|. | --+.+.+++ +..++|||++.+-.|...- ...+..++. ..+..-+.-|..+| +||+|.
T Consensus 165 kaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly---~~lm~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 165 KALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLY---DDLMGLIVRLANHG---LIHGDF 228 (465)
T ss_pred HHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHH---HHHHHHHHHHHHcC---ceeccc
Confidence 8774 2 234555544 4568999999988875442 122333333 33333455666677 999999
Q ss_pred CCCcEEEcCCCCeEEeccccc
Q 008648 515 KASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 515 kp~NIll~~~~~~kl~DFGla 535 (558)
.--||+|++++.++++||=-.
T Consensus 229 NEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred chheeEEecCCCEEEeechHh
Confidence 999999999999999999533
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0028 Score=64.15 Aligned_cols=141 Identities=20% Similarity=0.180 Sum_probs=75.7
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC--eeeeeee------EEEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHR--NLVKLLG------CCIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~E~ 463 (558)
+.|..|....+|+....++ .+++|+... ...+.+..|+.++..|... .+.+++. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999886555 688887752 1233444455555554311 1333332 11234567899999
Q ss_pred CCCCChh-----------HHHh---hcCC--------CCCCCH-HHHHH------------HHHH-HHHHHHHHHhC---
Q 008648 464 MPNKSLD-----------YFIF---DQTN--------SKLLDW-SKRFH------------IICG-TARGLLYLHQD--- 504 (558)
Q Consensus 464 ~~~gsL~-----------~~l~---~~~~--------~~~l~~-~~~~~------------i~~~-i~~gL~yLH~~--- 504 (558)
++|..+. ..+. .... ...+.+ ..... .+.+ +...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9987542 1111 0000 001111 11111 1111 11122333211
Q ss_pred -CCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 505 -SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 505 -~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
-+..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23359999999999999876556899999874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0017 Score=64.18 Aligned_cols=32 Identities=25% Similarity=0.476 Sum_probs=26.4
Q ss_pred CceEecCCCCCcEEEcCCCC-eEEeccccceee
Q 008648 507 LRIIHRDLKASNVLLDHDMN-PKISDFGLARTC 538 (558)
Q Consensus 507 ~~ivHrDlkp~NIll~~~~~-~kl~DFGla~~~ 538 (558)
..++|+|++|.|||+++++. .-|+||+.|..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997555 569999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0033 Score=63.28 Aligned_cols=143 Identities=24% Similarity=0.226 Sum_probs=81.2
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC--eeeeeeeE------EEeCCeEEEEEe
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHR--NLVKLLGC------CIHGEEKLLIYE 462 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~E 462 (558)
.+.++.|....+|+....++ .+++|+.... ...+.+..|..++..|... .+.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999876444 5778876542 1234556677777666322 23444331 112345689999
Q ss_pred cCCCCChhH-----------HH---hhcCCC---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 008648 463 FMPNKSLDY-----------FI---FDQTNS---------KLLDWSKRF------------HIICGTARGLLYLHQ---- 503 (558)
Q Consensus 463 ~~~~gsL~~-----------~l---~~~~~~---------~~l~~~~~~------------~i~~~i~~gL~yLH~---- 503 (558)
|++|..+.. .+ +..... ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 01 110000 001111110 001123345555543
Q ss_pred CCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 504 ~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.-+..++|+|+++.||++++++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123459999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0037 Score=63.87 Aligned_cols=142 Identities=18% Similarity=0.249 Sum_probs=79.3
Q ss_pred eeecccCcccEEEEEEcC-----CcEEEEEEecccccccHHHHHHHHHHHhcCCCCee-eeeeeEEEeCCeEEEEEecCC
Q 008648 392 NKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~ 465 (558)
+.|..|-.-.+|++...+ ++.+++|+.......... -.+|..++..+...++ .++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345556677888887532 367888877553332222 3678888877753333 3455555322 5899998
Q ss_pred CCChhHH-------H----------hhcC-C-CC-CCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 008648 466 NKSLDYF-------I----------FDQT-N-SK-LLDWSKRFHIICG-----------------TARGLLYL----HQ- 503 (558)
Q Consensus 466 ~gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~-----------------i~~gL~yL----H~- 503 (558)
+.+|... + +... . .. ...+.....+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 0 1111 0 00 1112222222211 11112222 21
Q ss_pred CCCCceEecCCCCCcEEEcC-CCCeEEeccccceee
Q 008648 504 DSRLRIIHRDLKASNVLLDH-DMNPKISDFGLARTC 538 (558)
Q Consensus 504 ~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~ 538 (558)
..+..++|+|+++.|||+++ ++.++|+||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22335899999999999986 467999999988643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.005 Score=60.93 Aligned_cols=74 Identities=19% Similarity=0.251 Sum_probs=48.4
Q ss_pred cceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcC---CCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL---QHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
-.+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.| .--.+++++++....+..+|||||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34678888889999887 577889999765 23445678888877777 345688899988888888999999987
Q ss_pred C
Q 008648 467 K 467 (558)
Q Consensus 467 g 467 (558)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.00064 Score=52.33 Aligned_cols=48 Identities=17% Similarity=0.483 Sum_probs=34.8
Q ss_pred ccccCCCCcceeeecCCChHHHHHHhhcCCceEEEEeeccCCCCCccceecc
Q 008648 244 TELKLPDANFSRVSKSVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFG 295 (558)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~ 295 (558)
++++++..+.... ...+.++|++.|+.+|+|.||.|.. +...|+++..
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 4566665554423 2568999999999999999999974 2345988655
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.005 Score=61.47 Aligned_cols=143 Identities=23% Similarity=0.220 Sum_probs=94.7
Q ss_pred cceeecccCcccEEEEEEcCCcEEEEEEecccc----------------------cccHH----HHHHHHHHHhcCCCCe
Q 008648 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------------DQGLK----ELKNEVILFSKLQHRN 443 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~----~~~~E~~~l~~l~h~n 443 (558)
+...|..|.-+.||.|.-.+|..+|||+.+... ....+ ....|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788899999999999999999999764310 00111 1335666677765444
Q ss_pred eeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 008648 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH 523 (558)
Q Consensus 444 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~ 523 (558)
|.-.--... ....|||+|+.......-. ...-.++...+..+-.+++.-|.-|-+.+ ++||.||.--|+|+ .
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence 322111111 1246999999643221111 12234667778888888999999888876 59999999999999 5
Q ss_pred CCCeEEeccccceeeCC
Q 008648 524 DMNPKISDFGLARTCGG 540 (558)
Q Consensus 524 ~~~~kl~DFGla~~~~~ 540 (558)
+|.++|+|-+-+...+.
T Consensus 300 dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred CCEEEEEEccccccCCC
Confidence 67899999887755443
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.002 Score=54.28 Aligned_cols=72 Identities=22% Similarity=0.424 Sum_probs=40.3
Q ss_pred ceEEecCCCCCC---CCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCC
Q 008648 2 RVVWSASLSKEV---QQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSAD 78 (558)
Q Consensus 2 ~~vWst~~~~~~---~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~ 78 (558)
++||..|..... .+... +.|.++|||||.+. .+.++|+| +. + .
T Consensus 3 tvvW~an~~~p~~~~s~~~~-L~l~~dGnLvl~~~----~~~~iWss----------------~~--------t-----~ 48 (114)
T PF01453_consen 3 TVVWVANRNSPLTSSSGNYT-LILQSDGNLVLYDS----NGSVIWSS----------------NN--------T-----S 48 (114)
T ss_dssp -------TTEEEEECETTEE-EEEETTSEEEEEET----TTEEEEE------------------S--------------T
T ss_pred cccccccccccccccccccc-ceECCCCeEEEEcC----CCCEEEEe----------------cc--------c-----C
Confidence 689999976422 12244 89999999999986 56789998 00 0 0
Q ss_pred CCCCcceEEEEecCCCceEEEEe-CCeEEEEe
Q 008648 79 DPSPGDFIWAVERQDNPEVVMWK-GSSKFYTT 109 (558)
Q Consensus 79 dps~g~~~~~~~~~~~~~~~~~~-~~~~y~~~ 109 (558)
......+.+.|+.+|+. ++++ .....|.|
T Consensus 49 ~~~~~~~~~~L~~~GNl--vl~d~~~~~lW~S 78 (114)
T PF01453_consen 49 GRGNSGCYLVLQDDGNL--VLYDSSGNVLWQS 78 (114)
T ss_dssp TSS-SSEEEEEETTSEE--EEEETTSEEEEES
T ss_pred CccccCeEEEEeCCCCE--EEEeecceEEEee
Confidence 00113577888877754 4455 46789987
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.005 Score=62.29 Aligned_cols=72 Identities=14% Similarity=0.155 Sum_probs=48.7
Q ss_pred eecccCcccEEEEEEcCC-cEEEEEEecc-------cccccHHHHHHHHHHHhcCC--CC-eeeeeeeEEEeCCeEEEEE
Q 008648 393 KLGEGGFGPVYKGTLVDG-QEIAVKRLSK-------ISDQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 461 (558)
.||.|....||++..+++ +.|+||.-.+ .-+-..++...|...|+... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 6899996432 11334456667777776653 23 45556554 455667999
Q ss_pred ecCCC
Q 008648 462 EFMPN 466 (558)
Q Consensus 462 E~~~~ 466 (558)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00012 Score=81.18 Aligned_cols=148 Identities=17% Similarity=0.218 Sum_probs=103.4
Q ss_pred cCCcccceeecccCcccEEEEEEcC-CcEEEEEEe---cccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL---SKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.+.+.+.+-+.+|.++.++.+.-.. +...+.|.. ........+..+.+-.++-..+||-++....-+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 3566777788899999998876432 333333322 222223334444444444445667777666656667788999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
++|+.+++|...++... ..+..-....+..+..+++|||... +.|+|++|.|+|+..++..+++|||..+..
T Consensus 883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999988875432 3444444445667889999999876 899999999999999999999999966544
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.013 Score=60.51 Aligned_cols=73 Identities=10% Similarity=0.101 Sum_probs=49.8
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEeccc----cc---ccHHHHHHHHHHHhcCC---CCeeeeeeeEEEeCCeEEEE
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SD---QGLKELKNEVILFSKLQ---HRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 460 (558)
.+.||.|....||+... +++.++||.-... .. ....+-..|...|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 36889999999999886 4567899975421 11 13344455566665553 357888888876 456789
Q ss_pred EecCCC
Q 008648 461 YEFMPN 466 (558)
Q Consensus 461 ~E~~~~ 466 (558)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.011 Score=59.01 Aligned_cols=145 Identities=15% Similarity=0.277 Sum_probs=80.3
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEec-ccccccHHHHHHHHHHHhcCCC--CeeeeeeeEEEeCC--eEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISDQGLKELKNEVILFSKLQH--RNLVKLLGCCIHGE--EKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~~~ 466 (558)
+.+..|..-.+|..... ++++++.+-. ...........+|..+|+.+.- .-+.+.++.|.++. ..+.||+|++|
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 44434443445554443 6777777221 1122344566778888887743 23445667776665 56999999988
Q ss_pred CChhH----------HHh--------h---c--------C------CCCCCCHHHHHHHH--------HHHHHHHHHHHh
Q 008648 467 KSLDY----------FIF--------D---Q--------T------NSKLLDWSKRFHII--------CGTARGLLYLHQ 503 (558)
Q Consensus 467 gsL~~----------~l~--------~---~--------~------~~~~l~~~~~~~i~--------~~i~~gL~yLH~ 503 (558)
..+.. +.. . - . ..+...|....+.+ -....-..+|++
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 43211 111 0 0 0 00001111111100 011223445544
Q ss_pred C-----CCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 504 D-----SRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 504 ~-----~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
+ ++..++|+|+.+.||+|+.+.-+-|.||+++..
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 3 234699999999999999888899999999865
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0072 Score=61.92 Aligned_cols=74 Identities=11% Similarity=0.092 Sum_probs=51.0
Q ss_pred ceeecccCcccEEEEEEcC-CcEEEEEEecc------cccccHHHHHHHHHHHhcCC--CC-eeeeeeeEEEeCCeEEEE
Q 008648 391 NNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK------ISDQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 460 (558)
.+.||.|.-.-||++...+ ++.|+||.-.. .-+-..++...|...|+... -| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3689999999999999743 56899996422 11334567777877777653 23 46666655 45566789
Q ss_pred EecCCC
Q 008648 461 YEFMPN 466 (558)
Q Consensus 461 ~E~~~~ 466 (558)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.018 Score=58.50 Aligned_cols=141 Identities=18% Similarity=0.240 Sum_probs=76.8
Q ss_pred eeecccCcccEEEEEEcC----CcEEEEEEecccccccHHHHHHHHHHHhcCCCCee-eeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~ 466 (558)
+.|..|-...+|+....+ +..+++|+....... .-.-.+|..+++.+...++ .++++++. +. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence 345556667788887543 237888877553322 2223568888877754444 34555552 22 58999987
Q ss_pred CChhHH-------H----------hhcC-C-CC-CCCHHHHHHHHHH----------------------HHH---HHHHH
Q 008648 467 KSLDYF-------I----------FDQT-N-SK-LLDWSKRFHIICG----------------------TAR---GLLYL 501 (558)
Q Consensus 467 gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~----------------------i~~---gL~yL 501 (558)
..|..- + +... . .. ..-+..+.++..+ +.+ .+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 1111 0 00 1112222222211 111 11112
Q ss_pred H-h-CCCCceEecCCCCCcEEEcC-CCCeEEecccccee
Q 008648 502 H-Q-DSRLRIIHRDLKASNVLLDH-DMNPKISDFGLART 537 (558)
Q Consensus 502 H-~-~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~ 537 (558)
. . ..+..+.|.|+.|.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1 11234799999999999974 56899999998854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.00059 Score=72.12 Aligned_cols=146 Identities=16% Similarity=0.116 Sum_probs=99.3
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCCeEEE
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN-LVKLLGCCIHGEEKLL 459 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 459 (558)
++..+.-+.....++++++++++|.+....+....+.+... ...+-++++|.+++||| .+..++-+..++..++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34455556666778999999999998644444445555332 45667889999999999 6666666666677789
Q ss_pred EEecCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 460 IYEFMPNK-SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 460 v~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+++++..+ +-.... ......+...+...+.+.-+++|++||+.. -+|+| ||+..+ +..|..||+.+..+
T Consensus 312 ~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99999776 221111 011112333344455666778999999864 48999 888765 57899999998877
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
.+.
T Consensus 382 ~~~ 384 (829)
T KOG0576|consen 382 TRT 384 (829)
T ss_pred Ccc
Confidence 654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.072 Score=53.52 Aligned_cols=29 Identities=24% Similarity=0.347 Sum_probs=25.2
Q ss_pred CceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 507 LRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 507 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.079 Score=49.79 Aligned_cols=75 Identities=16% Similarity=0.240 Sum_probs=51.2
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcC---CCCeeeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL---QHRNLVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
+++.-|..-..|.... +..++-||+-. ......|.+|+.-|..| +-..+.+++.+-.+..+.|+||||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444334444432 45678888643 33456788888766666 34567888888888999999999999877
Q ss_pred hh
Q 008648 469 LD 470 (558)
Q Consensus 469 L~ 470 (558)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.014 Score=55.15 Aligned_cols=30 Identities=33% Similarity=0.510 Sum_probs=21.4
Q ss_pred ceEecCCCCCcEEE-cCCCCeEEecccccee
Q 008648 508 RIIHRDLKASNVLL-DHDMNPKISDFGLART 537 (558)
Q Consensus 508 ~ivHrDlkp~NIll-~~~~~~kl~DFGla~~ 537 (558)
.+.|.||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 7889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.073 Score=53.72 Aligned_cols=140 Identities=23% Similarity=0.261 Sum_probs=82.0
Q ss_pred eecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCe------eeeeeeEEE--eC--CeEEEEEe
Q 008648 393 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN------LVKLLGCCI--HG--EEKLLIYE 462 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~--~~--~~~~lv~E 462 (558)
.|.+ .-..+|+....+++. ++|..... ....++..|...+..|.-.. +..+-|-.. -. ...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 456789998877766 88877653 45667777888777763111 222222111 12 36678999
Q ss_pred cCCCCChhH-HH----h--------------hcC--C---CCCCCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 008648 463 FMPNKSLDY-FI----F--------------DQT--N---SKLLDWSK-------------RFHIICGTARGLLYLHQDS 505 (558)
Q Consensus 463 ~~~~gsL~~-~l----~--------------~~~--~---~~~l~~~~-------------~~~i~~~i~~gL~yLH~~~ 505 (558)
|++|..+.. .. + +.. . .....|.. ......++...++.+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988872 10 0 000 0 11223320 0112233444555555431
Q ss_pred ----C---CceEecCCCCCcEEEcCCCC-eEEeccccce
Q 008648 506 ----R---LRIIHRDLKASNVLLDHDMN-PKISDFGLAR 536 (558)
Q Consensus 506 ----~---~~ivHrDlkp~NIll~~~~~-~kl~DFGla~ 536 (558)
+ ..+||+|+.|.||+++.+.. +.++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 22999999999999998875 8999999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 558 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 6e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 3e-95
Identities = 72/199 (36%), Positives = 107/199 (53%), Gaps = 15/199 (7%)
Query: 363 ENEDQNI-DLELPLFELATISNATNNFS------INNKLGEGGFGPVYKGTLVDGQEIAV 415
EN+ + D F + N TNNF NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 416 KRLSKI----SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDY 471
K+L+ + +++ ++ E+ + +K QH NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 472 FIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531
+ + L W R I G A G+ +LH++ IHRD+K++N+LLD KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 532 FGLARTCGGDKTEGNTNRV 550
FGLAR T+R+
Sbjct: 177 FGLARASEKFAQTVMTSRI 195
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-89
Identities = 76/170 (44%), Positives = 104/170 (61%), Gaps = 2/170 (1%)
Query: 376 FELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLK-ELKNEVI 434
F L + A++NFS N LG GGFG VYKG L DG +AVKRL + QG + + + EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 435 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL-LDWSKRFHIICG 493
+ S HRNL++L G C+ E+LL+Y +M N S+ + ++ S+ LDW KR I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+ARGL YLH +IIHRD+KA+N+LLD + + DFGLA+ T
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 4e-81
Identities = 70/192 (36%), Positives = 106/192 (55%), Gaps = 5/192 (2%)
Query: 354 RRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEI 413
+ + D + + E L + ATNNF +G G FG VYKG L DG ++
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 414 AVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI 473
A+KR + S QG++E + E+ S +H +LV L+G C E +LIY++M N +L +
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 474 FDQTNSKL-LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532
+ + + W +R I G ARGL YLH + IIHRD+K+ N+LLD + PKI+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 533 GLARTC-GGDKT 543
G+++ D+T
Sbjct: 184 GISKKGTELDQT 195
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-61
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 362 QENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI 421
+ + ++L L + + G FG V+K + + +AVK
Sbjct: 3 HHHHHHSSGVDLGTENLYF---QSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ 58
Query: 422 SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----EKLLIYEFMPNKSLDYFIFDQT 477
Q + + EV ++H N+++ +G G + LI F SL F+
Sbjct: 59 DKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 478 NSKLLDWSKRFHIICGTARGLLYLHQD-------SRLRIIHRDLKASNVLLDHDMNPKIS 530
+ W++ HI ARGL YLH+D + I HRD+K+ NVLL +++ I+
Sbjct: 118 ----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 531 DFGLARTCGGDKTEGNTNRVWLYGT 555
DFGLA K+ G+T+ GT
Sbjct: 174 DFGLALKFEAGKSAGDTHGQV--GT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-52
Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 17/174 (9%)
Query: 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN 443
+N + +G G +G VYKG+L D + +AVK S + Q K + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 444 LVKLLGCCIHGE-----EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
+ + + E LL+ E+ PN SL ++ T DW + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 499 LYLHQD------SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGN 546
YLH + + I HRDL + NVL+ +D ISDFGL+ G++
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 48/187 (25%), Positives = 83/187 (44%), Gaps = 18/187 (9%)
Query: 352 KRRRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQ 411
+ + +D +I +L +I K+G G FG V++ G
Sbjct: 17 TTENLYFQGAMDGDDMDIPWC----DL----------NIKEKIGAGSFGTVHRAEW-HGS 61
Query: 412 EIAVKRL--SKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469
++AVK L + + E EV + +L+H N+V +G ++ E++ SL
Sbjct: 62 DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKI 529
+ + LD +R + A+G+ YLH I+HR+LK+ N+L+D K+
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 530 SDFGLAR 536
DFGL+R
Sbjct: 181 CDFGLSR 187
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 6/152 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ +G G FG V K +++A+K++ S+ K E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
KL G C+ L+ E+ SL + + ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 506 RLRIIHRDLKASNVLLDHDMN-PKISDFGLAR 536
+IHRDLK N+LL KI DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 6/148 (4%)
Query: 390 INNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLL 448
LG+G FG K T G+ + +K L + ++ + EV + L+H N++K +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
G + I E++ +L I ++ WS+R A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLAR 536
IIHRDL + N L+ + N ++DFGLAR
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLAR 156
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 7/156 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISDQGLKELKNEVILFSKLQHRN 443
+ KL E G ++KG G +I VK L S + ++ E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 444 LVKLLGCCIHGEEKLL--IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
++ +LG C I +MP SL + + TN + D S+ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
H L I L + +V++D DM +IS + +
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFS 162
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-43
Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 20/180 (11%)
Query: 370 DLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQG--- 425
E P L T+++ N ++G+GGFG V+KG LV D +A+K L +G
Sbjct: 5 GSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 426 ----LKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL 481
+E + EV + S L H N+VKL G ++ EF+P L + + D+ +
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-- 118
Query: 482 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-----HDMNPKISDFGLAR 536
+ WS + ++ A G+ Y+ I+HRDL++ N+ L + K++DFGL++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ----GLKELKNEVILFSKLQHRNLV 445
+ +G GGFG VY+ G E+AVK D+ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
L G C+ L+ EF L+ + + K + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 506 RLRIIHRDLKASNVLLDHDMNP--------KISDFGLAR 536
+ IIHRDLK+SN+L+ + KI+DFGLAR
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISDQGLKELKNEVILFSKLQHRN 443
++ ++G G FG VYKG ++AVK L + + Q L+ KNEV + K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 444 LVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
++ +G +L ++ ++ SL + + + + K I TARG+ YLH
Sbjct: 82 ILLFMGYST--APQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH 137
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
IIHRDLK++N+ L D KI DFGLA
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 24/186 (12%)
Query: 353 RRRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQE 412
R ++T ++ +I E +L I +G+G FG VY G E
Sbjct: 14 FPRKASQTSIFLQEWDIPFE----QL----------EIGELIGKGRFGQVYHGRW--HGE 57
Query: 413 IAVKRL--SKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 470
+A++ + + ++ LK K EV+ + + +H N+V +G C+ +I ++L
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 471 YFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530
+ + +LD +K I +G+ YLH I+H+DLK+ NV D + I+
Sbjct: 118 SVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVIT 171
Query: 531 DFGLAR 536
DFGL
Sbjct: 172 DFGLFS 177
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 47/180 (26%), Positives = 74/180 (41%), Gaps = 25/180 (13%)
Query: 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILF--SKLQHRNLVKL 447
+ +G+G +G V++G+ G+ +AVK S + K E L+ L+H N++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 448 LGCCIHGEEK----LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+ + LI + SL ++ LD I+ A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 504 DSRLR-----IIHRDLKASNVLLDHDMNPKISDFGLART---CGGDKTEGNTNRVWLYGT 555
+ I HRDLK+ N+L+ + I+D GLA GN RV GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV---GT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 24/195 (12%)
Query: 373 LPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNE 432
LPL TI+ + ++G+G +G V+ G G+++AVK +++ + E
Sbjct: 27 LPLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT-TEEASWFRETE 81
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEK----LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF 488
+ ++H N++ + I G LI ++ N SL ++ S LD
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSML 137
Query: 489 HIICGTARGLLYLHQDSRLR-----IIHRDLKASNVLLDHDMNPKISDFGLART---CGG 540
+ + GL +LH + I HRDLK+ N+L+ + I+D GLA
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 541 DKTEGNTNRVWLYGT 555
+ RV GT
Sbjct: 198 EVDIPPNTRV---GT 209
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 28/197 (14%)
Query: 373 LPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNE 432
LPL TI+ + +G+G FG V++G G+E+AVK S + + E
Sbjct: 32 LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFRE 84
Query: 433 --VILFSKLQHRNLVKLLGCCIHGEEK----LLIYEFMPNKSLDYFIFDQTNSKLLDWSK 486
+ L+H N++ + L+ ++ + SL FD N +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140
Query: 487 RFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR---TC 538
+ TA GL +LH + + I HRDLK+ N+L+ + I+D GLA +
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 539 GGDKTEGNTNRVWLYGT 555
+RV GT
Sbjct: 201 TDTIDIAPNHRV---GT 214
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 42/158 (26%), Positives = 66/158 (41%), Gaps = 9/158 (5%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
++ KLGEGGF V L DG A+KR+ Q +E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 446 KLLGCCI----HGEEKLLIYEFMPNKSL-DYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
+L+ C+ E L+ F +L + + L + ++ G RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538
+H HRDLK +N+LL + P + D G
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 41/153 (26%), Positives = 66/153 (43%), Gaps = 7/153 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISDQGLKELKNEVILFSKLQHRN 443
+ + ++G G FG V+ G L D +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+V+L+G C + ++ E + F+ +T L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
IHRDL A N L+ KISDFG++R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKISDQGLKELKNEVILFSKL 439
+ + +LGEG FG V+ + +AVK L + S+ ++ + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYF------------IFDQTNSKLLDWSKR 487
QH+++V+ G C G L+++E+M + L+ F + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 488 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ A G++YL + L +HRDL N L+ + KI DFG++R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKISDQGLKELKNEVILFSKL 439
+ + +LGEG FG V+ + +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYF-------------IFDQTNSKLLDWSK 486
QH ++VK G C G+ ++++E+M + L+ F + L S+
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 487 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
HI A G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SDQGLKELKNEVILFSK 438
+++ +LG+G FG VY+G + +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYF-------IFDQTNSKLLDWSKRFHII 491
++V+LLG G+ L+I E M L + + + SK +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ YL + + +HRDL A N ++ D KI DFG+ R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ 440
+ +LG+G FG V G+ +AVK+L +++ L++ + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 441 HRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
H N+VK G C + LI E++P SL ++ Q + + +D K +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
YL R IHRDL N+L++++ KI DFGL + DK
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 17/165 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSK--ISDQGLKELKNEVILFSKL 439
N + LGEG FG V +G L +AVK + S + ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 440 QHRNLVKLLGCCIHGE-----EKLLIYEFMPNKSLDYFI---FDQTNSKLLDWSKRFHII 491
H N+++LLG CI + ++I FM L ++ +T K + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A G+ YL S +HRDL A N +L DM ++DFGL++
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 389 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRN 443
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 444 LVKLLGCCIHGEEKLL-IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
++ LLG C+ E L + +M + L FI + + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ + +HRDL A N +LD K++DFGLAR
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 6/156 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L G C+ L+ EFM + L ++ +T L + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
+IHRDL A N L+ + K+SDFG+ R D
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ 440
+ +LG+G FG V G+ +AVK+L +++ L++ + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 441 HRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
H N+VK G C + LI E++P SL ++ Q + + +D K +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
YL R IHRDL N+L++++ KI DFGL + DK
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 26/174 (14%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SDQGLKELKNEVILF 436
+ ++ LGEG FG V V +AVK L +++ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 437 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DY------------FIFDQTNSKLL 482
+ +H+N++ LLG C +I E+ +L +Y + ++ + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 483 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ ARG+ YL + + IHRDL A NVL+ + KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 13/165 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRL-SKISDQGLKELKNEVILFSKL 439
LGEG FG V G+++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 440 QHRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARG 497
H N+VK G C LI EF+P+ SL ++ N ++ ++ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
+ YL + +HRDL A NVL++ + KI DFGL + DK
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 365 EDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSK 420
D + L + ++ I + + +G+G FG VY G +D + A+K LS+
Sbjct: 1 RDLDSALLAEVKDVL-IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR 59
Query: 421 I-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE-KLLIYEFMPNKSLDYFIFDQTN 478
I Q ++ E +L L H N++ L+G + E ++ +M + L FI ++
Sbjct: 60 ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSP 117
Query: 479 SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ ARG+ YL + + +HRDL A N +LD K++DFGLAR
Sbjct: 118 QRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 7e-31
Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 6/151 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
++ +LG G FG V G ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
K G C ++ E++ N L ++ +++ K L+ S+ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ IHRDL A N L+D D+ K+SDFG+ R
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 47/166 (28%), Positives = 71/166 (42%), Gaps = 18/166 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK--ISDQGLKELKNEVILFSKL 439
F++ LG+G FG V + L ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 440 QHRNLVKLLGCCIHGEEK------LLIYEFMPNKSLDYFIFD---QTNSKLLDWSKRFHI 490
H ++ KL+G + K ++I FM + L F+ N L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ A G+ YL S IHRDL A N +L DM ++DFGL+R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 389 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRN 443
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 444 LVKLLGCCIHGEEKLL-IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
++ LLG C+ E L + +M + L FI + + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ + +HRDL A N +LD K++DFGLAR
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 21/169 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE---IAVKRL-SKISDQGLKELKNEVILFSKL-Q 440
N+ + +GEG FG V K + A+KR+ S ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYF-------------IFDQTNSKLLDWSKR 487
H N++ LLG C H L E+ P+ +L F + + L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 488 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H ARG+ YL S+ + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 49/179 (27%), Positives = 76/179 (42%), Gaps = 31/179 (17%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SDQGLKELKNEVILFSK 438
N + LGEG FG V K T +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL---------------------DYFIFDQT 477
+ H +++KL G C LLI E+ SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 478 NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ + L ++G+ YL + ++++HRDL A N+L+ KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 26/174 (14%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRL-SKISDQGLKELKNEVILF 436
+ ++ LGEG FG V V +AVK L +++ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 437 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DY------------FIFDQTNSKLL 482
+ +H+N++ LLG C +I E+ +L +Y + ++ + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 483 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ ARG+ YL + + IHRDL A NVL+ + KI+DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SDQGLKELKNEVILFSK 438
+ +LGE FG VYKG L Q +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYF-------------IFDQTNSKLLDWS 485
LQH N+V LLG + +I+ + + L F D+T L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 486 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H++ A G+ YL S ++H+DL NVL+ +N KISD GL R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 52/167 (31%), Positives = 70/167 (41%), Gaps = 19/167 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTL---VDGQEI--AVKRL-SKISDQGLKELKNEVILFSKL 439
LGEG FG V DG AVK L + Q K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 440 QHRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDYFIFDQ--TNSKLLDWSKRFHIICGTA 495
H +++K GCC L+ E++P SL ++ ++LL ++
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA------QQIC 144
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
G+ YLH IHRDL A NVLLD+D KI DFGLA+
Sbjct: 145 EGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 6/151 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + +LG G FG V G ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L G C +I E+M N L ++ + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ +HRDL A N L++ K+SDFGL+R
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISDQGLKELKNEVILFSKL 439
F LG G FG VYKG + E +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ----TNSKLLDWSKRFHIICGTA 495
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G ++ E
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 20/170 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ 440
+ ++LG+G FG V G +AVK+L ++ + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 441 HRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDYFIFDQ----TNSKLLDWSKRFHIICGT 494
+VK G + L+ E++P+ L F+ S+LL +S
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS------SQI 136
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+G+ YL R +HRDL A N+L++ + + KI+DFGLA+ DK
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISDQGLKELKNEVILFSKLQ 440
+ I +G G G V G L +++ A+K L + +++ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H N+++L G G +++ E+M N SLD F+ +T+ + ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
L S L +HRDL A NVL+D ++ K+SDFGL+R D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 31/179 (17%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SDQGLKELKNEVILFSK 438
NN +GEG FG V++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYF---------------------IFDQT 477
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 478 NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L +++ I A G+ YL S + +HRDL N L+ +M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 8/152 (5%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 446 KLLGCCIHGEEKLLI-YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+LLG + + L I E+M SL ++ + +L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+HRDL A NVL+ D K+SDFGL +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 19/203 (9%)
Query: 348 YLIHKRRRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTL 407
Y + K R + TD + +L + N ++ LG G FG VY+G +
Sbjct: 35 YKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR--KNITLIRGLGHGAFGEVYEGQV 92
Query: 408 VDG------QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460
++AVK L ++ S+Q + E ++ SK H+N+V+ +G + + ++
Sbjct: 93 SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152
Query: 461 YEFMPNKSLDYFI----FDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 516
E M L F+ + L H+ A G YL IHRD+ A
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAA 209
Query: 517 SNVLLD---HDMNPKISDFGLAR 536
N LL KI DFG+AR
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 53/170 (31%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISDQGLKELKNEVILFSK 438
NN LG G FG V + T + +AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-----------DYFIFDQTNSKLLDWSK 486
L QH N+V LLG C HG L+I E+ L + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 487 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H A+G+ +L + IHRD+ A NVLL + KI DFGLAR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SDQGLKELKNEVILFSK 438
N ++ LG G FG VY+G + ++AVK L ++ S+Q + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI----FDQTNSKLLDWSKRFHIICGT 494
H+N+V+ +G + + ++ E M L F+ + L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLD---HDMNPKISDFGLAR 536
A G YL IHRD+ A N LL KI DFG+AR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 20/166 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISDQGLKELKNEVILFSKL 439
LG G FG V+KG + E + +K + K Q + + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ----TNSKLLDWSKRFHIICGTA 495
H ++V+LLG C G L+ +++P SL + LL+W A
Sbjct: 73 DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIA 125
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
+G+ YL ++HR+L A NVLL +++DFG+A D
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 8/152 (5%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ +G+G FG V G G ++AVK + +D + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 249
Query: 446 KLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+LLG + + L ++ E+M SL ++ + +L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+HRDL A NVL+ D K+SDFGL +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISDQGLKELKNEVILFS 437
+ N LG+G F ++KG + E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARG 497
KL H++LV G C+ G+E +L+ EF+ SLD ++ + N ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNP--------KISDFGLART 537
+ +L +IH ++ A N+LL + + K+SD G++ T
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 17/176 (9%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISDQGLKELKNEVILFSKLQHRN 443
+F LG GGFG V++ VD A+KR+ + +++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 444 LVKLLGCCIHGEE---------KLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHII 491
+V+ + K+ +Y + ++L ++ + + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
A + +LH ++HRDLK SN+ D K+ DFGL D+ E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 36/165 (21%), Positives = 68/165 (41%), Gaps = 7/165 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISDQGLKELKNEVILFSKLQHR 442
+ K+GEG FG DG++ +K +S++S + +E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
N+V+ ++ ++ L I Q L + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH 142
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
+I+HRD+K+ N+ L D ++ DFG+AR
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 54/180 (30%), Positives = 72/180 (40%), Gaps = 38/180 (21%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SDQGLKELKNEVILFSK 438
N S LG G FG V + T + +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYF---------------------IFDQ 476
L H N+V LLG C G L+I E+ L F
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 477 TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
LL +S + + A+G+ +L + IHRDL A N+LL H KI DFGLAR
Sbjct: 143 DLEDLLSFS--YQV----AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISDQGLKELKNEVILFSKL 439
+ + +G G FG VYKG L +A+K L +++ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLL 499
H N+++L G + ++I E+M N +LD F+ + + ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
YL + + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 47/156 (30%), Positives = 81/156 (51%), Gaps = 10/156 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISDQGLKELKNEVILFSKLQ 440
N SI+ +G G FG V G L +EI A+K L +++ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H N+++L G + +++ E+M N SLD F+ + + + ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L S + +HRDL A N+L++ ++ K+SDFGL R
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISDQGLKELKNEVILFSKL 439
F LG G FG VYKG + E +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ----TNSKLLDWSKRFHIICGTA 495
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G +
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 46/173 (26%), Positives = 67/173 (38%), Gaps = 25/173 (14%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISDQGLKELKNEVILFSK 438
+ + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 439 L-QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-DY------------FIFDQTNSKLLD 483
+ H N+V LLG C L +I EF +L Y + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 484 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
A+G+ +L + + IHRDL A N+LL KI DFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 50/179 (27%), Positives = 72/179 (40%), Gaps = 31/179 (17%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISDQGLKELKNEVILFSK 438
N LG G FG V T + +AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-----------DYFIFDQTNSKLLDWSK 486
L H N+V LLG C LI+E+ L + N K L+ +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 487 RFHIICGT---------ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+++ A+G+ +L +HRDL A NVL+ H KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 26/174 (14%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SDQGLKELKNEVILF 436
+ + LGEG FG V + ++AVK L +++ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 437 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DY------------FIFDQTNSKLL 482
+ +H+N++ LLG C +I E+ +L +Y + + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 483 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
ARG+ YL + + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
V+LLG C +I EFM +L ++ + N + + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ IHRDL A N L+ + K++DFGL+R
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 10/167 (5%)
Query: 380 TISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSK 438
T+ + L EGGF VY+ + G+E A+KRL ++ + + EV K
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81
Query: 439 LQ-HRNLVKLLGCCI-------HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI 490
L H N+V+ G+ + L+ + L F+ + L I
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
T R + ++H+ + IIHRDLK N+LL + K+ DFG A T
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452
LG+G +G VY G L + IA+K + + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 453 HGEEKLLIY-EFMPNKSLDYFIFDQTNSKLLDWSKRF----HIICGTAR----GLLYLHQ 503
+ I+ E +P SL ++ L I + GL YLH
Sbjct: 90 E-NGFIKIFMEQVPGGSL--------SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 504 DSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCGGDKTEGNT 547
+ +I+HRD+K NVL++ + KISDFG ++ G T
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-28
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
V+LLG C +I EFM +L ++ + N + + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
+ IHR+L A N L+ + K++DFGL+R GD
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 25/178 (14%)
Query: 377 ELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVIL 435
+F +G GGFG V+K +DG+ +KR+ ++ + + EV
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKA 57
Query: 436 FSKLQHRNLVKLLGC---------------CIHGEEKLLIY-EFMPNKSLDYFIFDQTNS 479
+KL H N+V GC + L I EF +L+ +I ++
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRG 116
Query: 480 KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
+ LD + +G+ Y+H ++I+RDLK SN+ L KI DFGL +
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN 443
++F LG+G FG V K +D + A+K++ ++ L + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFI---------FD--QTNSKLLDWSKRFHIIC 492
+V+ + + + KS + +D + + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWL 552
L Y+H IIHRDLK N+ +D N KI DFGLA+ + L
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 553 YGTG 556
G+
Sbjct: 181 PGSS 184
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFD-----QTNSKLLDWSKRFHIICGTARGLLY 500
KL E +I EFM SL F+ Q KL+D+S A G+ +
Sbjct: 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS------AQIAEGMAF 299
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
+ + IHRDL+A+N+L+ + KI+DFGLAR ++
Sbjct: 300 I---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 390 INNKLGEGGFGPVYKGTLVDGQE---IAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLV 445
+ +LG G FG V +G ++ +A+K L + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L+G C E +L+ E L F+ + + S ++ + G+ YL
Sbjct: 74 RLIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+HRDL A NVLL + KISDFGL++ G D +
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 48/151 (31%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ +LG G FG V+ G ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L E +I E+M N SL F+ + L +K + A G+ ++
Sbjct: 72 RLYAVVT-QEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
IHRDL+A+N+L+ ++ KI+DFGLAR
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQHR 442
+ LG+GGF ++ + D + A K + K + +E + E+ + L H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 443 NLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFD--QTNSKLLDWSKRFHI--ICGTARG 497
++V G + + ++ E +SL + + L + R+++ I G
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVL---G 153
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
YLH+ R+IHRDLK N+ L+ D+ KI DFGLA
Sbjct: 154 CQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQHR 442
+ LG+GGF ++ + D + A K + K + +E + E+ + L H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 443 NLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFD--QTNSKLLDWSKRFHI--ICGTARG 497
++V G + + ++ E +SL + + L + R+++ I G
Sbjct: 76 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVL---G 127
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
YLH R R+IHRDLK N+ L+ D+ KI DFGLA
Sbjct: 128 CQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 12/183 (6%)
Query: 362 QENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RL 418
+E Q D+E + +SN + ++G G F VYKG E+A +
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 419 SKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH---GEEKLLIY-EFMPNKSLDYFIF 474
K++ + K E + LQH N+V+ G++ +++ E M + +L ++
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL- 120
Query: 475 DQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFG 533
K++ +GL +LH + IIHRDLK N+ + + KI D G
Sbjct: 121 --KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 534 LAR 536
LA
Sbjct: 178 LAT 180
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISDQGLKELKNEVILFSKLQ 440
+ +GEG FG V++G + + + A+K SD ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H ++VKL+G +I E L F+ Q LD + + L Y
Sbjct: 75 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 21/198 (10%)
Query: 350 IHKRRRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVD 409
+H + + D E+ ++S +SI ++G GG V++
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQ---------SMSVKGRIYSILKQIGSGGSSKVFQVLNEK 51
Query: 410 GQEIAVKR--LSKISDQGLKELKNEVILFSKLQHRNL--VKLLGCCIHGEEKLLIYEFMP 465
Q A+K L + +Q L +NE+ +KLQ + ++L I + ++ E
Sbjct: 52 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG- 110
Query: 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM 525
N L+ ++ K +D +R + +HQ I+H DLK +N L+ D
Sbjct: 111 NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DG 163
Query: 526 NPKISDFGLARTCGGDKT 543
K+ DFG+A D T
Sbjct: 164 MLKLIDFGIANQMQPDTT 181
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 48/170 (28%), Positives = 68/170 (40%), Gaps = 21/170 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTL--VDGQEI--AVKRL---SKISDQGLKELKNEVILFSK 438
+ + KLG+G FG V +G G+ + AVK L + + + EV
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ----TNSKLLDWSKRFHIICGT 494
L HRNL++L G + ++ E P SL + L ++
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA------VQV 130
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
A G+ YL R IHRDL A N+LL KI DFGL R +
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 23/161 (14%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQH 441
+F + N LG+G F VY+ + G E+A+K + K + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGT 494
++++L + L+ E N + L + K F H +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NR----YLKNRVKPFSENEARHFMHQI 121
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
G+LYLH I+HRDL SN+LL +MN KI+DFGLA
Sbjct: 122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKI-SDQGLKELKNEVILFSKLQ 440
+ +N LGEG FG VY+G G++I AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H ++VKL+G E +I E P L +++ + N L + + Y
Sbjct: 72 HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L + +HRD+ N+L+ K+ DFGL+R
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSR 161
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 390 INNKLGEGGFGPVYKGTL-VDGQEI--AVKRL-SKISDQGLKELKNEVILFSKLQHRNLV 445
+ +LG G FG V +G + ++I A+K L +E+ E + +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L+G C E +L+ E L F+ + + S ++ + G+ YL
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+HR+L A NVLL + KISDFGL++ G D +
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 9/163 (5%)
Query: 377 ELATISNATN---NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNE 432
E + + + I +LG+G FG VYK G A K + S++ L++ E
Sbjct: 7 EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE 66
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
+ + + H +VKLLG H + ++ EF P ++D + + L + +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCR 124
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
L +LH RIIHRDLKA NVL+ + + +++DFG++
Sbjct: 125 QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L E ++ E+M SL F+ + K L + + A G+ Y+
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
R+ +HRDL+A+N+L+ ++ K++DFGLAR ++
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 41/165 (24%), Positives = 84/165 (50%), Gaps = 14/165 (8%)
Query: 375 LFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV 433
L + ++ + ++ K+G+G G VY + GQE+A+++++ + + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 434 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--I 491
++ + ++ N+V L + G+E ++ E++ SL D +D I +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD---EGQIAAV 121
Query: 492 C-GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
C + L +LH + ++IHRD+K+ N+LL D + K++DFG
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-27
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 8/170 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISDQGLKELKNEVILFSKLQHR 442
++ + +G G +G K DG+ + K +++ + L +EV L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 443 NLVKLLGCCIHGEEKLL--IYEFMPNKSLDYFI-FDQTNSKLLDWSKRFHIICGTARGLL 499
N+V+ I L + E+ L I + LD ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 500 YLHQ--DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
H+ D ++HRDLK +NV LD N K+ DFGLAR D + T
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 9e-27
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L E ++ E+M SL F+ + K L + + A G+ Y+
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
R+ +HRDL+A+N+L+ ++ K++DFGLAR ++
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 8/162 (4%)
Query: 375 LFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV 433
L + + K+GEG G V G+++AVK + Q + L NEV
Sbjct: 34 LRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEV 93
Query: 434 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICG 493
++ QH N+V++ + GEE ++ EF+ +L D + L+ + +
Sbjct: 94 VIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEA 149
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ L YLH +IHRD+K+ ++LL D K+SDFG
Sbjct: 150 VLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-26
Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISDQGLKELKNEVILFSKLQ 440
+ +GEG FG V++G + + + A+K + SD ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H ++VKL+G +I E L F+ Q LD + + L Y
Sbjct: 450 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 10/168 (5%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISDQGLKELKNEVILFSKLQH 441
NF I K+G G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 442 RNLVKLLGCCIHGEEKLLIY-EFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLL 499
N++K I + +L I E L I +L+ + L
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
++H R++HRD+K +NV + K+ D GL R T ++
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 13/170 (7%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKL 439
S + + + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 440 QHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
H+N+VKL EF P SL + + +N+ L S+ ++
Sbjct: 65 NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLL----DHDMNPKISDFGLARTCGGDK 542
G+ +L + I+HR++K N++ D K++DFG AR D+
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 12/162 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRN 443
+SI ++G GG V++ Q A+K ++ +Q L +NE+ +KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 444 L--VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
++L I + ++ E N L+ ++ K +D +R + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
HQ I+H DLK +N L+ D K+ DFG+A D T
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 47/216 (21%), Positives = 79/216 (36%), Gaps = 33/216 (15%)
Query: 352 KRRRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDG 410
+ + + ++NE + +L + + + ++G G FG V++ G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 411 QEIAVK--RLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY-EFMPNK 467
+ AVK RL + E++ + L +V L G G + I+ E +
Sbjct: 84 FQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGG 135
Query: 468 SLDYFIFDQTNSKLLDWSKRF--HIICGTAR----GLLYLHQDSRLRIIHRDLKASNVLL 521
SL +L+ GL YLH RI+H D+KA NVLL
Sbjct: 136 SL---------GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLL 183
Query: 522 DHDMNP-KISDFGLA-RTCGGDKTEGNTNRVWLYGT 555
D + + DFG A + ++ GT
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 393 KLGEGGFGPVYKGTL-VDGQEI--AVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKL 447
+LG G FG V KG + AVK L EL E + +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 448 LGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
+G C E +L+ E L+ ++ ++ + ++ + G+ YL
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+HRDL A NVLL KISDFGL++ D+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 375 LFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISDQGLKELK 430
+ EL + FS ++G G FG VY + + + +A+K++S K S++ +++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 431 NEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI 490
EV KL+H N ++ GC + L+ E+ + D + + K L + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
G +GL YLH +IHRD+KA N+LL K+ DFG A
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 8/162 (4%)
Query: 375 LFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV 433
L E + F + KLGEG +G VYK GQ +A+K++ + L+E+ E+
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESD-LQEIIKEI 75
Query: 434 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICG 493
+ + ++VK G + ++ E+ S+ I + +K L + I+
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQS 133
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
T +GL YLH R IHRD+KA N+LL+ + + K++DFG+A
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 12/168 (7%)
Query: 380 TISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISDQGLKELKNEVILFS 437
IS +SI ++G GG V++ Q A+K L + +Q L +NE+ +
Sbjct: 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 438 KLQHRNL--VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
KLQ + ++L I + ++ E N L+ ++ K +D +R
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNML 165
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+ +HQ I+H DLK +N L+ D K+ DFG+A D T
Sbjct: 166 EAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 13/170 (7%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKL 439
S + + + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 440 QHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
H+N+VKL EF P SL + + +N+ L S+ ++
Sbjct: 65 NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLL----DHDMNPKISDFGLARTCGGDK 542
G+ +L + I+HR++K N++ D K++DFG AR D+
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 376 FELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVI 434
+L+ + + F + +G G +G VYKG + GQ A+K + ++ +E+K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 435 LFSKL-QHRNLVKLLGCCIHG-----EEKL-LIYEFMPNKSL-DYFIFDQTNSKLLDWSK 486
+ K HRN+ G I +++L L+ EF S+ D + T L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEW 130
Query: 487 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+I RGL +LHQ ++IHRD+K NVLL + K+ DFG++
Sbjct: 131 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 24/161 (14%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQH 441
+F I LG+G FG VY +A+K L K + G++ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGT 494
N+++L G H ++ LI E+ P ++ + L +F I
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTATYITEL 118
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
A L Y H R+IHRD+K N+LL KI+DFG +
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISDQGLKELKNEVILFSKLQHRNLV 445
F+ K+G+G FG V+KG + +A+K + + ++ +++++ E+ + S+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
K G + + +I E++ S D LD ++ I+ +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ IHRD+KA+NVLL K++DFG+A
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 43/188 (22%), Positives = 67/188 (35%), Gaps = 29/188 (15%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISDQGLKELKNEVILFSK 438
S T F K+G G FG V+K +DG A+KR + EV +
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIY-EFMPNKSLDYFIFDQTNS-KLLDWSKRFHIICGTA 495
L QH ++V+ + +LI E+ SL I + ++ ++
Sbjct: 67 LGQHSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP-------------------KISDFGLAR 536
RGL Y+H ++H D+K SN+ + P KI D G
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 537 TCGGDKTE 544
+ E
Sbjct: 183 RISSPQVE 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 37/202 (18%)
Query: 381 ISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKN-------- 431
+ + + + LGEG F VYK Q +A+K KI E K+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGHRSEAKDGINRTALR 61
Query: 432 EVILFSKLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF-H 489
E+ L +L H N++ LL + + L+++FM L+ I D + K +
Sbjct: 62 EIKLLQELSHPNIIGLLDA-FGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYML 119
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNR 549
+ +GL YLHQ I+HRDLK +N+LLD + K++DFGLA++ G T++
Sbjct: 120 MTL---QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQ 172
Query: 550 V---W-----------LYGTGI 557
V W +YG G+
Sbjct: 173 VVTRWYRAPELLFGARMYGVGV 194
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 40/202 (19%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG-----LKELKNEVILF 436
++++ F KLG G + VYKG G +A+K + S++G ++E+ L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 437 SKLQHRNLVKLLGCCIHGEEKL-LIYEFMPN--KSLDYFIFDQTNSKLLDWSKRFHIICG 493
+L+H N+V+L IH E KL L++EFM N K D +++
Sbjct: 58 KELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKY----MDSRTVGNTPRGLELNLVKY 112
Query: 494 TA----RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNR 549
+GL + H++ +I+HRDLK N+L++ K+ DFGLAR G ++
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSE 168
Query: 550 V---W-----------LYGTGI 557
V W Y T I
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSI 190
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 59/198 (29%), Positives = 88/198 (44%), Gaps = 43/198 (21%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISD----QGLKELKNEVILFSKL 439
+ K+GEG +G VYK G+ +A+K RL + ++E+ L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76
Query: 440 QHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDYF--IFDQTNSKLLDWSKRFHIICG 493
H N+V L+ IH E L L++EFM K LD + K+ + +
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY-----LYQLL- 129
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV--- 550
RG+ + HQ RI+HRDLK N+L++ D K++DFGLAR G T+ V
Sbjct: 130 --RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTL 183
Query: 551 W-----------LYGTGI 557
W Y T +
Sbjct: 184 WYRAPDVLMGSKKYSTSV 201
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 42/188 (22%), Positives = 77/188 (40%), Gaps = 40/188 (21%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK-----------------ISDQGL 426
N++ I L +G F + L D + A+K+ K
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 427 KELKNEVILFSKLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-DY----FIFDQTNSK 480
+ KNE+ + + +++ + G I +++ +IYE+M N S+ + F+ D+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 481 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR---- 536
+ II Y+H + I HRD+K SN+L+D + K+SDFG +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 537 -----TCG 539
+ G
Sbjct: 205 KKIKGSRG 212
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 43/193 (22%), Positives = 77/193 (39%), Gaps = 32/193 (16%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKN-----EVILFSKL 439
+ K+GEG +G V+K GQ +A+K K + + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 440 QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
+H NLV LL + +L L++E+ + ++ + + K T + +
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI--TWQTLQAV 115
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV---W---- 551
+ H+ IHRD+K N+L+ K+ DFG AR ++ + V W
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSP 171
Query: 552 -------LYGTGI 557
YG +
Sbjct: 172 ELLVGDTQYGPPV 184
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 32/164 (19%), Positives = 64/164 (39%), Gaps = 11/164 (6%)
Query: 378 LATISNATNNFSINNKLGEG--GFGPVYKGT-LVDGQEIAVKR--LSKISDQGLKELKNE 432
+++ + + +G+G V G+ + V+R L S++ + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DYFIFDQTNSKLLDWSKRFHII 491
+ + H N+V I E ++ FM S D + ++ +I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYIL 134
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
G + L Y+H +HR +KAS++L+ D +S
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 43/198 (21%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG-----LKELKNEVILFSKL 439
+ +KLGEG + VYKG + +A+K + ++G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 440 QHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDY--FIFDQTNSKLLDWSKRFHIICG 493
+H N+V L IH E+ L L++E++ + LD I + N KL +
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ-------- 108
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV--- 550
RGL Y H+ +++HRDLK N+L++ K++DFGLAR T+ N V
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVVTL 164
Query: 551 W-----------LYGTGI 557
W Y T I
Sbjct: 165 WYRPPDILLGSTDYSTQI 182
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 36/195 (18%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISD----QGLKELKNEVILFSK 438
+ K+GEG +G V+K + +A+K RL + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 439 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF-HIICGTAR 496
L+H+N+V+L +H ++KL L++EF + L + + K F + +
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLL---K 112
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV---W-- 551
GL + H ++HRDLK N+L++ + K+++FGLAR G + V W
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYR 168
Query: 552 ---------LYGTGI 557
LY T I
Sbjct: 169 PPDVLFGAKLYSTSI 183
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 41/159 (25%), Positives = 62/159 (38%), Gaps = 10/159 (6%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSK 438
S +F ++LG G +G V+K DG+ AVKR + EV K
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARG 497
+ QH V+L G L E SL + L ++ + + T
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLA 169
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
L +LH ++H D+K +N+ L K+ DFGL
Sbjct: 170 LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNL 444
+ + +LG GGFG V + G+++A+K+ + +E E+ + KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 445 VKLL------GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
V + LL E+ L ++ N L ++ + L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 499 LYLHQDSRLRIIHRDLKASNVLLD---HDMNPKISDFGLARTCGGDK 542
YLH+ RIIHRDLK N++L + KI D G A+ +
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 3e-23
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 35/194 (18%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQ------GLKELKNEVILFSKL 439
+ K+GEG +G VYK G+ A+K++ + ++E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 440 QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF-HIICGTARG 497
+H N+VKL IH +++L L++E + + L + +K F + G
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLL---NG 112
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV---W--- 551
+ Y H R++HRDLK N+L++ + KI+DFGLAR G T+ + W
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRA 168
Query: 552 --------LYGTGI 557
Y T I
Sbjct: 169 PDVLMGSKKYSTTI 182
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISDQGLKELKNEVILFSKL 439
S +++ + +G G V +++A+KR++ + + EL E+ S+
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-----DYFIFDQTNSKLLDWSKRFHIICGT 494
H N+V + +E L+ + + S+ + S +LD S I+
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
GL YLH++ IHRD+KA N+LL D + +I+DFG++
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQH 441
++F I LG+G FG VY +A+K L K + +G++ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFD--QTNSKLLDWSKRFHIICGTARGL 498
N++++ H +++ L+ EF P L + Q + + + + A L
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSAT-FMEELADAL 127
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
Y H ++IHRD+K N+L+ + KI+DFG +
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 48/193 (24%), Positives = 78/193 (40%), Gaps = 32/193 (16%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKN-----EVILFSKL 439
+ +GEG +G V K G+ +A+K K + ++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 440 QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
+H NLV LL +++ L++EF+ + LD + LD+ + G+
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGI 137
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV---W---- 551
+ H IIHRD+K N+L+ K+ DFG ART E + V W
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAP 193
Query: 552 -------LYGTGI 557
YG +
Sbjct: 194 ELLVGDVKYGKAV 206
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 29/176 (16%), Positives = 52/176 (29%), Gaps = 22/176 (12%)
Query: 380 TISNATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISDQGLKELKNEV 433
+ +++ LGEG F VY+ T D Q+ +K + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 434 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI--FDQTNSKLLDWSKRFHII 491
+K + +L+ E +L I + T K++
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLL-----------DHDMNPKISDFGLAR 536
+ +H IIH D+K N +L D + D G +
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 42/179 (23%), Positives = 81/179 (45%), Gaps = 28/179 (15%)
Query: 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
++ +G G FG V++ LV+ E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 445 VKLLGCCIH------GEEKL-LIYEFMP---NKSLDYFIFDQTNSKL-LDWSKRF-HIIC 492
V L + E L L+ E++P ++ + + + + + K + + +
Sbjct: 95 VDLK-AFFYSNGDKKDEVFLNLVLEYVPETVYRASRH--YAKLKQTMPMLLIKLYMYQLL 151
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP-KISDFGLARTCGGDKTEGNTNRV 550
R L Y+H + I HRD+K N+LLD K+ DFG A+ E N + +
Sbjct: 152 ---RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYI 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISDQGLKELKNEV-ILFSKLQHR 442
++ +LG G +G V K V GQ +AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTAR 496
V G + + E M + SLD F +++D + I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
L +LH S+L +IHRD+K SNVL++ K+ DFG++
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 54/206 (26%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISDQG-----LKELKNEVILFS 437
+ + KLGEG +G VYK V + +A+K RL ++G ++E+ L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVS----LLK 88
Query: 438 KLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF---HIICG 493
+LQHRN+++L IH +L LI+E+ + K +D + I
Sbjct: 89 ELQHRNIIELK-SVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 494 TA---RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP-----KISDFGLARTCGGDKTEG 545
G+ + H R +HRDLK N+LL KI DFGLAR G
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 546 NTNRV---W-----------LYGTGI 557
T+ + W Y T +
Sbjct: 194 FTHEIITLWYRPPEILLGSRHYSTSV 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 24/155 (15%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISDQGLKELKNEVILFSKLQHRNLVKL 447
LGEG +G V + AVK +L +I + G +K E+ L +L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPN-GEANVKKEIQLLRRLRHKNVIQL 71
Query: 448 LGCCIHGEEKLLIY---EFMPNKSLDYFIFDQ-TNSKLLDWSKR--FH-IICGTARGLLY 500
+ ++ EEK +Y E+ + + D + F +I G Y
Sbjct: 72 VDV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----Y 124
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
LH I+H+D+K N+LL KIS G+A
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 21/167 (12%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLV 445
+F + LG G G + + D +++AVKR+ + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 446 KLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
+ +++ Y E +Y + + ++ T GL +LH
Sbjct: 82 RYFCTE---KDRQFQYIAIELCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 503 QDSRLRIIHRDLKASNVLL-----DHDMNPKISDFGLARTCGGDKTE 544
L I+HRDLK N+L+ + ISDFGL + +
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 16/150 (10%)
Query: 393 KLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISDQGLKELKNEV-ILFSKLQHRNLVKLLG 449
++G G +G V K GQ +AVKR+ S + ++ K+L ++ ++ +V+ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 450 CCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTARGLLYLHQ 503
+ + E M + S D F + I T + L +L
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVL----DDVIPEEILGKITLATVKALNHLK- 142
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFG 533
L+IIHRD+K SN+LLD N K+ DFG
Sbjct: 143 -ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 38/158 (24%), Positives = 69/158 (43%), Gaps = 19/158 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS-KISDQGLKELKNEVILFSKLQHRN 443
++F ++LG G G V+K + G +A K + +I ++ E+ + +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTARG 497
+V G E + E M SLD ++L + R + +G
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIAVIKG 143
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
L YL + +I+HRD+K SN+L++ K+ DFG++
Sbjct: 144 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 42/169 (24%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 390 INNKLGEGGFGPVYKG---TLVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNL 444
K+G G +G VYK D ++ A+K++ IS +E + L +L+H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNV 80
Query: 445 VKLLGCCI-HGEEKL-LIYEFMPN---KSLDYFIFDQTNSKLLDWS----KRF-HIICGT 494
+ L + H + K+ L++++ + + + + N K + K + I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-- 138
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP----KISDFGLARTCG 539
G+ YLH + ++HRDLK +N+L+ + KI+D G AR
Sbjct: 139 -DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 50/197 (25%), Positives = 79/197 (40%), Gaps = 51/197 (25%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKG--TLVDGQEIAVK--RLSKISDQG-----------L 426
A + ++GEG +G V+K G+ +A+K R+ ++G L
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVL 65
Query: 427 KELKNEVILFSKLQHRNLVKLL----GCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKL 481
+ L+ +H N+V+L E KL L++E + DQ +
Sbjct: 66 RHLETF-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTY 108
Query: 482 LDWSKRFHIICGTA--------RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533
LD + T RGL +LH R++HRDLK N+L+ K++DFG
Sbjct: 109 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165
Query: 534 LARTCGGDKTEGNTNRV 550
LAR T+ V
Sbjct: 166 LARIYSFQMAL--TSVV 180
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 51/198 (25%), Positives = 79/198 (39%), Gaps = 51/198 (25%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG--------------- 425
S AT+ + ++G G +G VYK G +A+K + + G
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 426 LKELKNEVILFSKLQHRNLVKLLGCCIH----GEEKL-LIYEFMPNKSLDYFIFDQTNSK 480
L+ L+ +H N+V+L+ C E K+ L++E + DQ
Sbjct: 65 LRRLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRT 107
Query: 481 LLDWSKRFHIICGTA--------RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532
LD + + T RGL +LH + I+HRDLK N+L+ K++DF
Sbjct: 108 YLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADF 164
Query: 533 GLARTCGGDKTEGNTNRV 550
GLAR T V
Sbjct: 165 GLARIYSYQMA--LTPVV 180
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 24/228 (10%), Positives = 49/228 (21%), Gaps = 36/228 (15%)
Query: 345 ISGYLIHKRRRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYK 404
+ GY + + A + + +S + L G V+
Sbjct: 21 LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFL 80
Query: 405 GTLVD-GQEIAVKRLSK---ISDQGLKELKNEVILFSKLQHRNLVKLLGCC--------- 451
V+ ++ A+K + S L+ L ++L + +
Sbjct: 81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140
Query: 452 -----------------IHGEEKLLIYEFMP---NKSLDYFIFDQTNSKLLDWSKRFHII 491
LL+ F +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
R L ++H N+ + D + D G
Sbjct: 201 AQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 27/179 (15%)
Query: 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN 443
+++ +G G FG VY+ L D G+ +A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 444 LVKLLGCCIHGEEKL------LIYEFMP---NKSLDYFIFDQTNSKLLDWSKRFHI--IC 492
+V+L EK L+ +++P + ++ + L + ++ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLF 166
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP-KISDFGLARTCGGDKTEGNTNRV 550
R L Y+H I HRD+K N+LLD D K+ DFG A+ + E N + +
Sbjct: 167 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYI 217
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 39/173 (22%), Positives = 67/173 (38%), Gaps = 44/173 (25%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISDQGLKELKNEVILFS 437
+S + LG G FG V+ +E+ VK + K I D L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI----------FD--QTNSKL--LD 483
+++H N++K+ + N+ + F + +L
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131
Query: 484 WSKRFH-IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
S F ++ YL IIHRD+K N+++ D K+ DFG A
Sbjct: 132 ASYIFRQLVSAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 8e-21
Identities = 47/189 (24%), Positives = 71/189 (37%), Gaps = 27/189 (14%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEV-ILFSKLQHRNL 444
N LG G G V G+ +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 445 VKLLGCCIHGEEKL-LIYEFMPNKSLDYFI----FDQTNSKLLDWSKRFHIICGTARGLL 499
++ C + L + E N +L + N KL ++ A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 500 YLHQDSRLRIIHRDLKASNVLLDH-------------DMNPKISDFGLARTCGGDKTEGN 546
+LH L+IIHRDLK N+L+ ++ ISDFGL + ++
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 547 TNRVWLYGT 555
TN GT
Sbjct: 187 TNLNNPSGT 195
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 27/228 (11%), Positives = 59/228 (25%), Gaps = 37/228 (16%)
Query: 354 RRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQE 412
+ D + P + + LG+ + T G+
Sbjct: 41 EYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGES 100
Query: 413 IAVKRLSK---ISDQGLKELKNEVILFSKLQ-------------------------HRNL 444
V +K++K EV+ L+ + +
Sbjct: 101 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 160
Query: 445 VKLLGCCIHGEEK--LLIYEFMPNKSLDYF--IFD-QTNSKLLDWSKRFHIICGTARGLL 499
+++ +Y M + + + + K L R + R L
Sbjct: 161 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
LH ++H L+ +++LD ++ F G +
Sbjct: 221 SLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS 265
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 46/158 (29%), Positives = 66/158 (41%), Gaps = 36/158 (22%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNLVKLLGCC 451
LGEG +G V V + +AVK + E +K E+ + L H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70
Query: 452 IHGEEKLLIYEFMPNKSLDYFI---------FDQ--TNSKLLDWSKR--FH-IICGTARG 497
Y ++ Y FD+ + + + + FH ++ G
Sbjct: 71 ---------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
YLH + I HRD+K N+LLD N KISDFGLA
Sbjct: 120 --YLH---GIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 56/211 (26%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQ------GLKELKNEVILFSK 438
+ + K+G+G FG V+K GQ++A+K++ +++ L+E+K IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72
Query: 439 LQHRNLVKLLGCCIHGEEKL--------LIYEFMPNKSLDYFIFDQTNSKLLD-WSKRF- 488
L+H N+V L+ C L+++F + + LL +F
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC----------EHDLAGLLSNVLVKFT 122
Query: 489 --HIICGTA---RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
I GL Y+H++ +I+HRD+KA+NVL+ D K++DFGLAR K
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 544 EGN---TNRV---W-----------LYGTGI 557
TNRV W YG I
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPI 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL--SKISDQGLKELKNEVILFSKLQHRN 443
N+ + +G+G F V ++ G+E+A+K + ++++ L++L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 444 LVKLLGCCIHGEEKL-LIYEFMPNKSL-DYFIFDQTNSKLL-DWSKRF--HIICGTARGL 498
+VKL I E+ L LI E+ + DY + + ++ ++ I+
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQ--- 128
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
Y H + RI+HRDLKA N+LLD DMN KI+DFG +
Sbjct: 129 -YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 46/158 (29%), Positives = 66/158 (41%), Gaps = 36/158 (22%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNLVKLLGCC 451
LGEG +G V V + +AVK + E +K E+ + L H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70
Query: 452 IHGEEKLLIYEFMPNKSLDYFI---------FDQ--TNSKLLDWSKR--FH-IICGTARG 497
Y ++ Y FD+ + + + + FH ++ G
Sbjct: 71 ---------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
YLH + I HRD+K N+LLD N KISDFGLA
Sbjct: 120 --YLH---GIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 34/153 (22%), Positives = 63/153 (41%), Gaps = 8/153 (5%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISDQGLKELKNEV-ILFSKLQHR 442
N+ ++G G G V+K G IAVK++ + + K + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
+V+ G I + + E M + + + + + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
+ +IHRD+K SN+LLD K+ DFG++
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 37/159 (23%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQHRNLVKLLG 449
LGEG FG V T Q++A+K +S+ + + ++ E+ L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 450 CCIHGEEKLLIYEFMPNKSLDYFI--------FDQ--TNSKLLDWSKR--FH-IICGTAR 496
Y+ + + + FD ++ + R F IIC
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
Y H R +I+HRDLK N+LLD ++N KI+DFGL+
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 38/160 (23%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQHRNLVKLLG 449
LG G FG V G + G ++AVK L++ I + +K E+ +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 450 CCIHGEEKLLIYEFMPNKSLDYFI---------FDQ--TNSKLLDWSKR--FH-IICGTA 495
Y+ + + + + FD + ++ + R F I+
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
Y H R ++HRDLK NVLLD MN KI+DFGL+
Sbjct: 126 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 5e-20
Identities = 28/196 (14%), Positives = 54/196 (27%), Gaps = 40/196 (20%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQ--------- 440
LG+ + T G+ V +K++K EV+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 441 -------------HRNLVKLLGCCIHGEEKLLIYEF--MPNKSLDYFIF------DQTNS 479
K++ + + ++ F P + F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 480 KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539
K L R + R L LH ++H L+ +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261
Query: 540 GDKTEGNTNRVWLYGT 555
G R +
Sbjct: 262 GASAVSPIGRG--FAP 275
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 38/184 (20%), Positives = 70/184 (38%), Gaps = 31/184 (16%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKN----EVILF 436
+ F + G+G FG V G G +A+K K+ +N +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDL 73
Query: 437 SKLQHRNLVKLLGCCIHGEEK-------LLIYEFMP---NKSLDYFIFDQTNSKLLDWSK 486
+ L H N+V+L E+ ++ E++P ++ + +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY--RRQVAPPPILI 131
Query: 487 RFHI--ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP-KISDFGLARTCGGDKT 543
+ + + R + LH S + + HRD+K NVL++ K+ DFG A+ +
Sbjct: 132 KVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185
Query: 544 EGNT 547
E N
Sbjct: 186 EPNV 189
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 44/205 (21%), Positives = 78/205 (38%), Gaps = 22/205 (10%)
Query: 351 HKRRRNIAETDQENEDQNIDLELPLFELATISNATNNFS----INNKLGEGGFGPVYKGT 406
+ T N D + + + ++ I+ +LG G FG V++ T
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177
Query: 407 -LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465
G A K + + + ++ E+ S L+H LV L E ++IYEFM
Sbjct: 178 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237
Query: 466 NKSLDYFIFDQTNSKLLDWSKR-----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 520
L F++ + S+ +C GL ++H+ +H DLK N++
Sbjct: 238 GGEL----FEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHE---NNYVHLDLKPENIM 287
Query: 521 LDHDMNP--KISDFGLARTCGGDKT 543
+ K+ DFGL ++
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPKQS 312
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 51/206 (24%), Positives = 80/206 (38%), Gaps = 24/206 (11%)
Query: 350 IHKRRRNIAETDQENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT-LV 408
+H + + + ++ +F + + + + KLG G +G V V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 409 DGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466
E A+K + K +S +L EV + L H N++KL L+ E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 467 KSLDYFIFDQTNSKLLDWSKRF------HIICGTARGLLYLHQDSRLRIIHRDLKASNVL 520
L FD+ + +F II G+ YLH+ I+HRDLK N+L
Sbjct: 121 GEL----FDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLL 168
Query: 521 L---DHDMNPKISDFGLARTCGGDKT 543
L + D KI DFGL+ K
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQKK 194
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 38/160 (23%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQHRNLVKLLG 449
LG G FG V G + G ++AVK L++ I + ++ E+ +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 450 CCIHGEEKLLIYEFMPNKSLDYFI---------FDQ--TNSKLLDWSKR--FH-IICGTA 495
Y+ + S + + FD N +L + R F I+ G
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
Y H R ++HRDLK NVLLD MN KI+DFGL+
Sbjct: 131 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 50/171 (29%), Positives = 73/171 (42%), Gaps = 18/171 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQH 441
+F LGEG F V + A+K L K I + + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARG 497
VKL +EKL + N L +I + + RF+ I+
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA---- 142
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
L YLH IIHRDLK N+LL+ DM+ +I+DFG A+ + + N
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 45/204 (22%), Positives = 78/204 (38%), Gaps = 22/204 (10%)
Query: 351 HKRRRNIAETDQENEDQNIDLELPLFELATISNATNNFS----INNKLGEGGFGPVYKGT 406
K R + D+ + + + + I +LG G FG V++
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 407 -LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465
G+ K ++ +KNE+ + ++L H L+ L E +LI EF+
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 466 NKSLDYFIFDQTNSKLLDWSKR-----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 520
L FD+ ++ S+ C GL ++H+ I+H D+K N++
Sbjct: 132 GGEL----FDRIAAEDYKMSEAEVINYMRQACE---GLKHMHE---HSIVHLDIKPENIM 181
Query: 521 LDHDMNP--KISDFGLARTCGGDK 542
+ KI DFGLA D+
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDE 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 62/198 (31%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------------------------ 420
N +++ +++G+G +G V D A+K LSK
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 421 -ISDQGLKE-LKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM--PNKSLDYFI--- 473
I +G E + E+ + KL H N+VKL E + PN+ Y +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFEL 119
Query: 474 ------FDQ-TNSKLLDWSKRFH---IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH 523
+ T L + RF+ +I G + YLH +IIHRD+K SN+L+
Sbjct: 120 VNQGPVMEVPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGE 172
Query: 524 DMNPKISDFGLARTCGGD 541
D + KI+DFG++ G
Sbjct: 173 DGHIKIADFGVSNEFKGS 190
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 53/177 (29%), Positives = 76/177 (42%), Gaps = 30/177 (16%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSK 438
++I LG+G FG V K + QE AVK ++K ++ + EV L K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 439 LQHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRF------H 489
L H N++KL E+ Y E L FD+ + KRF
Sbjct: 78 LDHPNIMKLFEIL---EDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAAR 125
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKT 543
II G+ Y+H+ I+HRDLK N+LL + D + KI DFGL+ +
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 53/174 (30%), Positives = 76/174 (43%), Gaps = 30/174 (17%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQH 441
++I LG+G FG V K + QE AVK ++K ++ + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 442 RNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRF------HIIC 492
N++KL E+ Y E L FD+ + KRF II
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIK 128
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKT 543
G+ Y+H+ I+HRDLK N+LL + D + KI DFGL+ +
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 35/174 (20%), Positives = 63/174 (36%), Gaps = 45/174 (25%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISDQGLKELKNEVILFSKL 439
+ + LG GGFG VY G + D +A+K + K + EV+L K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 440 QHR--NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI----------FD--QTNSKLL-DW 484
+++L ++ I FD L +
Sbjct: 104 SSGFSGVIRL-------------LDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 485 SKRF--HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLA 535
++ F ++ + + H ++HRD+K N+L+D + K+ DFG
Sbjct: 151 ARSFFWQVLEA----VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 33/176 (18%), Positives = 62/176 (35%), Gaps = 47/176 (26%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISDQGLKELKNEV----IL 435
+ + LG+GGFG V+ G L D ++A+K + + EV +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 436 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI----------FD--QTNSKLL- 482
+ H +++L ++ + + FD L
Sbjct: 92 GAGGGHPGVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE 138
Query: 483 DWSKRF--HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP-KISDFGLA 535
S+ F ++ + + H ++HRD+K N+L+D K+ DFG
Sbjct: 139 GPSRCFFGQVVAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 43/174 (24%), Positives = 67/174 (38%), Gaps = 21/174 (12%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKL 439
+ F KLG G FG V+ G E +K ++K Q E ++ E+ + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 440 QHRNLVKLLGCCIHGEEKLLIY---EFMPNKSL-DYFIFDQTNSKLL---DWSKRFHIIC 492
H N++K+ E+ +Y E L + + Q K L ++ +
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKT 543
L Y H ++H+DLK N+L KI DFGLA D+
Sbjct: 135 N---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
S LG G FG V+K G ++A K + + +E+KNE+ + ++L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKR-----FHIICGTARGLLY 500
+L + +L+ E++ L FD+ + + ++ IC G+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICE---GIRH 202
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNP--KISDFGLARTCGGDKT 543
+HQ + I+H DLK N+L + KI DFGLAR +
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 37/169 (21%), Positives = 68/169 (40%), Gaps = 19/169 (11%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH 441
+ I LG G FG V++ + K + +K E+ + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKR-----FHIICGTAR 496
RN++ L EE ++I+EF+ + F++ N+ + ++R H +C
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCE--- 113
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNP--KISDFGLARTCGGDKT 543
L +LH I H D++ N++ + KI +FG AR
Sbjct: 114 ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 54/172 (31%), Positives = 75/172 (43%), Gaps = 25/172 (14%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQ 440
++ + LG+G FG V + GQE AVK +SK + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGT 494
H N++KL L+ E L FD+ S+ KRF II
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISR-----KRFSEVDAARIIRQV 135
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKT 543
G+ Y+H+ +I+HRDLK N+LL D N +I DFGL+ K
Sbjct: 136 LSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 55/172 (31%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQH 441
+ F LG GGFG V+ + ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIF--DQTNSKLLDWSKRF---HIICGTA 495
R +V L + L L+ M + Y I+ D+ N + F I+ G
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR--TCGGDKTEG 545
L +LHQ II+RDLK NVLLD D N +ISD GLA G KT+G
Sbjct: 302 --LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQH 441
N F LG+GGFG V + ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF---HIICGTARG 497
R +V L ++ L L+ M L + I+ + + F I CG
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
L LH R RI++RDLK N+LLD + +ISD GLA
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 41/175 (23%), Positives = 65/175 (37%), Gaps = 28/175 (16%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ 440
+ +++ N +G G +G V A K++ K + + K E+ + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 441 HRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRF------HII 491
H N+++L E+ IY E L F++ K + F I+
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVMELCTGGEL----FERVVHK-----RVFRESDAARIM 112
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKT 543
+ Y H+ L + HRDLK N L D K+ DFGLA K
Sbjct: 113 KDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 38/219 (17%), Positives = 68/219 (31%), Gaps = 56/219 (25%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISDQGLKELKNEVILFSKLQHRN 443
+F +G GGFG V++ VD A+KR+ + +++ EV +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 444 LVKLLGCCIHGE-----------EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
+V+ + P S + +D + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 493 G----TARGLLYL------HQDSRLRI--------------------------------- 509
+ + LY+ ++ + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 510 IHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
+HRDLK SN+ D K+ DFGL D+ E
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 41/200 (20%), Positives = 71/200 (35%), Gaps = 34/200 (17%)
Query: 362 QENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK 420
+ Q++ E L + A + + +G G V + G E AVK +
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 421 --------ISDQGLKELKNEV-ILFSKLQHRNLVKLLGCCIHGEEKLLIY---EFMPNKS 468
++ + + E IL H +++ L+ E ++ + M
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFMFLVFDLMRKGE 186
Query: 469 LDYFIFDQTNSKLLDWSKRF------HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 522
L FD K I+ + +LH I+HRDLK N+LLD
Sbjct: 187 L----FDYLTEK-----VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 523 HDMNPKISDFGLARTCGGDK 542
+M ++SDFG + +
Sbjct: 235 DNMQIRLSDFGFSCHLEPGE 254
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 41/176 (23%), Positives = 82/176 (46%), Gaps = 23/176 (13%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVILFS 437
+ + I + +G G +G V + ++ + +A+K++ ++ + L+E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 438 KLQHRNLVKLLGCCI-HGEEKL----LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
+L H ++VK+L I EK ++ E +T L + + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLY 163
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
G+ Y+H S I+HRDLK +N L++ D + K+ DFGLART + +
Sbjct: 164 NLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 35/205 (17%)
Query: 362 QENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK 420
+ Q I + ++ ++ KLG G +G V E A+K + K
Sbjct: 12 ENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKK 71
Query: 421 -------------ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 467
++ +E+ NE+ L L H N++KL + L+ EF
Sbjct: 72 SQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGG 131
Query: 468 SLDYFIFDQTNSKLLDWSKRF------HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 521
L F+Q ++ +F +I+ G+ YLH+ I+HRD+K N+LL
Sbjct: 132 EL----FEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILL 179
Query: 522 ---DHDMNPKISDFGLARTCGGDKT 543
+ +N KI DFGL+ D
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYK 204
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 45/180 (25%), Positives = 73/180 (40%), Gaps = 40/180 (22%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVILFS 437
+ +G G +G V G+++A+K+LS+ +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD-----YFIFD--QTN------SKLLDW 484
+QH N++ LL F P SL Y + QT+ K +
Sbjct: 79 HMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE 126
Query: 485 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
++ ++ +GL Y+H ++HRDLK N+ ++ D KI DFGLAR + T
Sbjct: 127 KIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 39/163 (23%), Positives = 75/163 (46%), Gaps = 23/163 (14%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ- 440
+++ + KLG G + V++ + + +++ VK L + K++K E+ + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89
Query: 441 HRNLVKLLGCCIHGEEK---LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--ICGTA 495
N++ L + L++E + N L D+ RF++ I
Sbjct: 90 GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL--- 140
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLART 537
+ L Y H S I+HRD+K NV++DH+ ++ D+GLA
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 4e-17
Identities = 31/161 (19%), Positives = 61/161 (37%), Gaps = 27/161 (16%)
Query: 390 INNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNLVK 446
+ + GG G +Y V+G+ + +K L D + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 447 LLGCCIH--GEE-----KLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
I E + Y E++ +SL + L ++ +
Sbjct: 144 -----IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILP 193
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
L YLH + +++ DLK N++L + K+ D G
Sbjct: 194 ALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 43/178 (24%), Positives = 61/178 (34%), Gaps = 35/178 (19%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE---------LKNEV- 433
N+ LG G V + +E AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 434 ILFSKLQHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRF-- 488
IL H N+++L E + + M L FD K
Sbjct: 76 ILRKVSGHPNIIQLKDTY---ETNTFFFLVFDLMKKGEL----FDYLTEK-----VTLSE 123
Query: 489 ----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
I+ + LH+ L I+HRDLK N+LLD DMN K++DFG + +
Sbjct: 124 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 39/225 (17%), Positives = 70/225 (31%), Gaps = 48/225 (21%)
Query: 376 FELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISDQGLKEL 429
F+ ++ + + +G+G +G V A+K ++ +I+ + ++ +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 430 KNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF- 488
K EV L KL H N+ +L + L+ E L + + +
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 489 ------------------------------------HIICGTARGLLYLHQDSRLRIIHR 512
+I+ L YLH I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHR 192
Query: 513 DLKASNVLL--DHDMNPKISDFGLARTCGGDKTEGNTNRVWLYGT 555
D+K N L + K+ DFGL++ GT
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 44/176 (25%), Positives = 72/176 (40%), Gaps = 25/176 (14%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISDQGLKELKNEVI 434
S +++ + +LG G F V K G+E A K + K +E++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 435 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL----LDWSKRFHI 490
+ +++H N++ L + + +LI E + L FD K + ++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQ 116
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP----KISDFGLARTCGGDK 542
I G+ YLH RI H DLK N++L P K+ DFG+A
Sbjct: 117 ILD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 7e-17
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKL-- 439
N+FS++ +G GGFG VY D ++ A+K L K QG NE I+ S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 440 -QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGT 494
+V + H +KL I + M L Y + + + RF+ II G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG- 304
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEG 545
L ++H +++RDLK +N+LLD + +ISD GLA K
Sbjct: 305 ---LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 18/170 (10%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSK 438
+ ++N+ + +LG+G F V + G E A K ++ +S + ++L+ E + K
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 439 LQHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
LQH N+V+L +E+ Y + + L I + D S I
Sbjct: 62 LQHPNIVRLHDSI---QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-- 116
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDK 542
+ Y H I+HR+LK N+LL K++DFGLA +
Sbjct: 117 -SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 42/176 (23%), Positives = 69/176 (39%), Gaps = 25/176 (14%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISDQGLKELKNEVILFSKLQH 441
+ + +G+G F V + GQ+ AVK + + ++LK E + L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 442 RNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLL----DWSKRFHIICGT 494
++V+LL ++Y EFM L + I + ++ + S I
Sbjct: 86 PHIVELLETY---SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKTEGNT 547
L Y H IIHRD+K VLL ++ K+ FG+A G
Sbjct: 142 --ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 29/175 (16%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISDQGLKELKNEVIL 435
+ + ++ LG G G V +++A++ +SK ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 436 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DYFI----FDQTNSKLLDWSKRFHI 490
KL H ++K+ E+ ++ E M L D + + KL F+
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQ 247
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDK 542
+ + YLH+ IIHRDLK NVLL + D KI+DFG ++ G
Sbjct: 248 MLL---AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 27/174 (15%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKE------LKNEVIL 435
+ + ++ LG G G V +++A+K +SK + +E ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 436 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ--TNSKL--LDWSKRFHII 491
KL H ++K+ E+ ++ E M L FD+ N +L F+ +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 123
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDK 542
+ YLH IIHRDLK NVLL + D KI+DFG ++ G
Sbjct: 124 LL---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 41/154 (26%), Positives = 62/154 (40%), Gaps = 23/154 (14%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCC 451
LGEG V L+ QE AVK + K + EV + + Q HRN+++L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTARGLLYLHQDS 505
+ L++E M S+ + + + F ++ A L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKR-----RHFNELEASVVVQDVASALDFLHN-- 129
Query: 506 RLRIIHRDLKASNVLL---DHDMNPKISDFGLAR 536
I HRDLK N+L + KI DF L
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 36/160 (22%), Positives = 62/160 (38%), Gaps = 40/160 (25%)
Query: 394 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRNLVKLLGCC 451
+G G FG + + +AVK + + + E ++ E+I L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 452 IHGEEKLLIYEFMPNKSLDYFI---------FD--QTNSKLL-DWSKRF--HIICGTARG 497
E + + I ++ + D ++ F ++ G +
Sbjct: 82 ---------KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS-- 130
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHD--MNPKISDFGLA 535
Y H ++I HRDLK N LLD KI DFG +
Sbjct: 131 --YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 46/191 (24%), Positives = 74/191 (38%), Gaps = 16/191 (8%)
Query: 362 QENEDQNIDLELPLFELATISNATNNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLS 419
+ +DL ++ N N + + +K LG G F V + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 420 K--ISDQGLKELKNEVILFSKLQHR-NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ 476
K E+ +E+ + + ++ L + E +LI E+ + +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 477 TNSKL--LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISD 531
+ D + I G+ YLHQ I+H DLK N+LL + KI D
Sbjct: 124 LAEMVSENDVIRLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 532 FGLARTCGGDK 542
FG++R G
Sbjct: 178 FGMSRKIGHAC 188
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 39/165 (23%), Positives = 62/165 (37%), Gaps = 30/165 (18%)
Query: 393 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV-ILFSKLQHRNLVKLLGC 450
LG G G V + GQ+ A+K L + EV + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDV 90
Query: 451 C---IHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTARGLLY 500
HG+ L +I E M L F + + + F I+ + +
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQER---GDQAFTEREAAEIMRDIGTAIQF 143
Query: 501 LHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDK 542
LH I HRD+K N+L + D K++DFG A+ +
Sbjct: 144 LHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 44/173 (25%), Positives = 67/173 (38%), Gaps = 25/173 (14%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISDQGLKELKNEVILFS 437
+ + I +LG G F V K G E A K + K +E++ EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL----LDWSKRFHIICG 493
++ H N++ L + + +LI E + L FD K + + I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP----KISDFGLARTCGGDK 542
G+ YLH +I H DLK N++L P K+ DFGLA
Sbjct: 127 ---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 28/168 (16%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ 440
+N F LG G F V+ + G+ A+K + K L+NE+ + K++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 441 HRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRF------HII 491
H N+V L E Y + + L FD+ + + +I
Sbjct: 65 HENIVTLEDIY---ESTTHYYLVMQLVSGGEL----FDRILER-----GVYTEKDASLVI 112
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLAR 536
+ YLH+ I+HRDLK N+L + + I+DFGL++
Sbjct: 113 QQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 30/183 (16%)
Query: 376 FELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNE 432
F + + ++N+ + +LG+G F V + G E A K ++ +S + ++L+ E
Sbjct: 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRF- 488
+ KLQH N+V+L +E+ Y + + L F+ ++ + +
Sbjct: 79 ARICRKLQHPNIVRLHDSI---QEESFHYLVFDLVTGGEL----FEDIVAR-----EFYS 126
Query: 489 -----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGG 540
H I + Y H I+HR+LK N+LL K++DFGLA
Sbjct: 127 EADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 541 DKT 543
+
Sbjct: 184 SEA 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 44/167 (26%), Positives = 67/167 (40%), Gaps = 25/167 (14%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------DQGLKELKNEVILFS 437
+ + I +LG G F V K G E A K + K +E++ EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL----LDWSKRFHIICG 493
++ H N++ L + + +LI E + L FD K + + I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP----KISDFGLAR 536
G+ YLH +I H DLK N++L P K+ DFGLA
Sbjct: 127 ---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 26/168 (15%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN 443
T+ + + +G G + + E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTARG 497
++ L G+ ++ E M L D+ + K F ++ +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQ-----KFFSEREASAVLFTITKT 128
Query: 498 LLYLHQDSRLRIIHRDLKASNVLL-DHDMNP---KISDFGLARTCGGD 541
+ YLH ++HRDLK SN+L D NP +I DFG A+ +
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 390 INNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISDQGLKE-LKNEVILFSKLQHRNLV 445
I +KLG GG VY + ++A+K + + + + EV S+L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 446 KLLGCCIH--GEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
+ EE Y E++ +L +I L + G+ +
Sbjct: 75 S-----MIDVDEEDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKH 126
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H +RI+HRD+K N+L+D + KI DFG+A+
Sbjct: 127 AH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 42/173 (24%), Positives = 75/173 (43%), Gaps = 23/173 (13%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG-----LKELKNEVILFSK 438
++ + +GEG +G V ++ +A+K++S Q L+E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 439 LQHRNLVKLLGCCIHGEEKL-----LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICG 493
+H N++ + + ++ + M L + Q L + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICY-FLYQ 136
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGN 546
RGL Y+H S ++HRDLK SN+LL+ + KI DFGLAR D
Sbjct: 137 ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVILFS 437
+ +G G +G V G ++A+K+L + +EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD-----YFIFD--QTN------SKLLDW 484
++H N++ LL F P+++LD Y + T+ + L
Sbjct: 80 HMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 127
Query: 485 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+ ++ +GL Y+H IIHRDLK N+ ++ D KI DFGLAR + T
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 32/182 (17%)
Query: 378 LATI--SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNE 432
+ATI + T + + +LG+G F V + ++ GQE A ++ +S + ++L+ E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRF- 488
+ L+H N+V+L E+ Y + + L F+ ++ + +
Sbjct: 61 ARICRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGEL----FEDIVAR-----EYYS 108
Query: 489 -----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGG 540
H I +L+ HQ + ++HR+LK N+LL K++DFGLA G
Sbjct: 109 EADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 541 DK 542
++
Sbjct: 166 EQ 167
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 42/211 (19%), Positives = 80/211 (37%), Gaps = 61/211 (28%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQH 441
++ +S+ LG G FG V + ++ G+ A+K++ + +EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 442 RNLVKLLGCCIHGEEKL---------------------------------------LIYE 462
N++KL+ + +I E
Sbjct: 60 VNIIKLV-DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 463 FMP---NKSLDYFIFDQTNSKLLDWSKRFHI--ICGTARGLLYLHQDSRLRIIHRDLKAS 517
++P +K L FI ++ + +I + R + ++H L I HRD+K
Sbjct: 119 YVPDTLHKVLKSFI--RSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQ 170
Query: 518 NVLLD-HDMNPKISDFGLARTCGGDKTEGNT 547
N+L++ D K+ DFG A+ +E +
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKL--IPSEPSV 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 17/172 (9%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISDQGLKELKNEVIL 435
N + + +LG G F V K G + A K + K ++++ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 436 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
++QH N++ L + + +LI E + L F+ ++ + + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN-- 125
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP----KISDFGLARTCGGDKT 543
G+ YLH L+I H DLK N++L P KI DFGLA
Sbjct: 126 -GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 34/166 (20%), Positives = 63/166 (37%), Gaps = 30/166 (18%)
Query: 393 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV-ILFSKLQHRNLVKLLGC 450
LG G G V + ++ A+K L + EV + + Q ++V+++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123
Query: 451 C---IHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTARGLLY 500
G + L ++ E + L F + + + F I+ + Y
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDR---GDQAFTEREASEIMKSIGEAIQY 176
Query: 501 LHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKT 543
LH + I HRD+K N+L + K++DFG A+ +
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 43/177 (24%), Positives = 71/177 (40%), Gaps = 30/177 (16%)
Query: 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQG---------------LKEL 429
+ +++ + G +G V G +G +A+KR+ G L+E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 430 KNEVILFSKLQHRNLVKLLGCCIHGEEKL-----LIYEFMPNKSLDYFIFDQTNSKLLDW 484
+ L + H N++ L +H EE L+ E M L I DQ +
Sbjct: 81 R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ-RIVISPQ 134
Query: 485 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
++ + GL LH+ ++HRDL N+LL + + I DF LAR D
Sbjct: 135 HIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 33/164 (20%), Positives = 58/164 (35%), Gaps = 42/164 (25%)
Query: 393 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV-ILFSKLQHRNLVKLLGC 450
LG G G V + ++ A+K L + EV + + Q ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVD- 78
Query: 451 CIHGEEKLLIYEFMPNKSLDYFI----------FDQTNSKLLDWSKRF------HIICGT 494
+YE + I F + + + F I+
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSI 126
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLA 535
+ YLH + I HRD+K N+L + K++DFG A
Sbjct: 127 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 40/177 (22%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVILFS 437
+ +G G G V V + +A+K+LS+ +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD-----YFIFD--QTN------SKLLDW 484
+ H+N++ LL F P K+L+ Y + + N +L
Sbjct: 117 CVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 164
Query: 485 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
+ ++ G+ +LH IIHRDLK SN+++ D KI DFGLART G
Sbjct: 165 RMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 43/177 (24%), Positives = 80/177 (45%), Gaps = 23/177 (12%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVILFS 437
+N+ I + +G G +G VY + +A+K+++++ + L+E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 438 KLQHRNLVKLLGCCI-----HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
+L+ +++L I +E ++ E L +T L + + I+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT-ILY 136
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNR 549
G ++H IIHRDLK +N LL+ D + K+ DFGLART +K N
Sbjct: 137 NLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 41/155 (26%), Positives = 62/155 (40%), Gaps = 26/155 (16%)
Query: 393 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGC 450
LGEG F K Q AVK IS + + E+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF------HIICGTARGLLYLHQD 504
L+ E + L F++ K K F +I+ + ++H
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKK-----KHFSETEASYIMRKLVSAVSHMHD- 124
Query: 505 SRLRIIHRDLKASNVLL---DHDMNPKISDFGLAR 536
+ ++HRDLK N+L + ++ KI DFG AR
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 51/181 (28%), Positives = 75/181 (41%), Gaps = 41/181 (22%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVILFS 437
+ + +G G +G V G +AVK+LS+ +EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD-----YFIFD--QTN-------SKLLD 483
++H N++ LL F P +SL+ Y + + KL D
Sbjct: 84 HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 484 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+F +I RGL Y+H IIHRDLK SN+ ++ D KI DFGLAR + T
Sbjct: 132 DHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 544 E 544
Sbjct: 188 G 188
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 40/177 (22%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVILFS 437
+ +G G G V + + +A+K+LS+ +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD-----YFIFD--QTN------SKLLDW 484
+ H+N++ LL F P KSL+ Y + + N +L
Sbjct: 80 CVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 485 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
+ ++ G+ +LH IIHRDLK SN+++ D KI DFGLART G
Sbjct: 128 RMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 20/156 (12%)
Query: 390 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKE-LKNEVILFSKLQHRNLV 445
+ +G GG G VY+ V + +A+K +S+ SD + ++ E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 446 KLLGCCIH--GEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
IH GE +Y + L + Q L + I+ L
Sbjct: 98 P-----IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDA 149
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H HRD+K N+L+ D + DFG+A
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIAS 182
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 41/176 (23%), Positives = 71/176 (40%), Gaps = 32/176 (18%)
Query: 382 SNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ 440
++ F + ++LG G VY+ + A+K L K D+ K ++ E+ + +L
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLS 106
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ-TNSKLLDW---SKRF------HI 490
H N++KL I+E + + + T +L D +
Sbjct: 107 HPNIIKLKE----------IFE---TPTEISLVLELVTGGELFDRIVEKGYYSERDAADA 153
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKT 543
+ + YLH+ I+HRDLK N+L D KI+DFGL++
Sbjct: 154 VKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 12/163 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQH 441
++F I +G+G FG V D +++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
LV L EE + ++ + + L Y + Q N + + + I C L Y
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFI-CELVMALDY 130
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
L RIIHRD+K N+LLD + I+DF +A +
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.4 bits (179), Expect = 2e-14
Identities = 35/197 (17%), Positives = 58/197 (29%), Gaps = 46/197 (23%)
Query: 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD--------QGLKELKNEVIL 435
T K+GEG FG V++ D +A+K ++ + +E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 436 FSKLQ---------HRNLVKLLGCCI-------------------HGEEKLLIYEFMPNK 467
+L + L G F ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 468 SLDYFIF-------DQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 520
F +Q +KL + I+ L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 521 LDHDMNPKISDFGLART 537
L K+ ++
Sbjct: 195 LKKTSLKKLHYTLNGKS 211
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 23/180 (12%)
Query: 380 TISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG-----LKELKNEV 433
+ N +++F + + LGEG +G V T G+ +A+K++ L+E+K
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK--- 61
Query: 434 ILFSKLQHRNLVKLL-----GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRF 488
+ +H N++ + + E +I E M L I Q L D ++
Sbjct: 62 -ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQY 116
Query: 489 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
I T R + LH + +IHRDLK SN+L++ + + K+ DFGLAR + +
Sbjct: 117 -FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 24/178 (13%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS--KISD--QGLKELKNEVILFSKL 439
+ + LG GG G V+ + +A+K++ L+E+K + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRL 65
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD-YFIFD--QTN-------SKLLDWSKRFH 489
H N+VK+ +L + Y + + +T+ LL+ R
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL- 124
Query: 490 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCGGDKTEGN 546
+ RGL Y+H + ++HRDLK +N+ ++ D+ KI DFGLAR +
Sbjct: 125 FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 16/156 (10%)
Query: 390 INNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISDQGLKE-LKNEVILFSKLQHRNLV 445
+ LG GG V+ L D +++AVK R D + E + L H +V
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 446 KLL--GCCIHGEEKLLIY---EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
+ G L Y E++ +L + + + + +I + L +
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNF 131
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
H + IIHRD+K +N+++ K+ DFG+AR
Sbjct: 132 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 20/200 (10%)
Query: 353 RRRNIAETDQENEDQNIDLELPLFELATISNAT-NNFSINNKLGEGGFGPVYKGTLVDGQ 411
++ + E+ +E + + L +E + + A + F LG G FG V +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 412 EI-AVKRLSKISDQGLKEL---KNEVILFSKLQHRNLVKLLGCCIHGEEKL-LIYEFMPN 466
A+K L K LK++ NE + + LVKL L ++ E++
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVAG 125
Query: 467 KSLDYFIFDQTNSKLLDWSKRF---HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH 523
+ F + + + RF I+ YLH L +I+RDLK N+L+D
Sbjct: 126 GEM--FSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQ 176
Query: 524 DMNPKISDFGLARTCGGDKT 543
+++DFG A+ +T
Sbjct: 177 QGYIQVTDFGFAKRV-KGRT 195
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVILFS 437
+ + KLG+G +G V+K G+ +AVK++ +E+ IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 438 KLQHRNLVKLLGCCI--HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
H N+V LL + + L++++M L I L K++ ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQY-VVYQLI 119
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNR 549
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL+R+ + N
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 8e-13
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISDQGLKEL---KNEVILFSKLQH 441
+F I LG G FG V+ A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARG 497
++++ G +++ +I +++ L F + + + + +F+ +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLA---- 118
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
L YLH II+RDLK N+LLD + + KI+DFG A+ D T
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT 160
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 42/167 (25%), Positives = 65/167 (38%), Gaps = 11/167 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQH 441
N F LG+G FG V A+K L K ++ + E + +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
L L ++L + E+ L + + + RF+ L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDY 263
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
LH S +++RDLK N++LD D + KI+DFGL + D T
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 21/161 (13%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNE-VILFSKLQHRNLVKLL 448
+G G + V L I A+K + K D+ + ++ E + H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 449 GCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQD 504
C E +L + E++ L + + Q KL + RF+ I L YLH+
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA----LNYLHE- 128
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLART--CGGDKT 543
II+RDLK NVLLD + + K++D+G+ + GD T
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 21/161 (13%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNE-VILFSKLQHRNLVKLL 448
+G G + V L I A++ + K D+ + ++ E + H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 449 GCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQD 504
C E +L + E++ L + + Q KL + RF+ I L YLH+
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA----LNYLHE- 171
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR--TCGGDKT 543
II+RDLK NVLLD + + K++D+G+ + GD T
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 14/165 (8%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQH 441
N+F LG+G FG V A+K L K I+ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
L L ++L + E+ L + + + RF+ L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEY 120
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART--CGGDKT 543
LH +++RD+K N++LD D + KI+DFGL + G
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 34/160 (21%), Positives = 59/160 (36%), Gaps = 19/160 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISDQG-LKELKNEVILFSK 438
+ + LG G FG V + + +AVK L + + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 439 L-QHRNLVKLLGCCI-HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
+ H N+V LLG C G ++I EF +L ++ SKR + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536
G + + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNE-VILFSKLQHRNLVKLL 448
LG+G FG V+ + A+K L K + D ++ E +L +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 449 GCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
C +E L + E++ L Y I Q+ K F+ GL +LH
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAE-IILGLQFLHS---K 137
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLART--CGGDKT 543
I++RDLK N+LLD D + KI+DFG+ + G KT
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNE-VILFSKLQ 440
+F+ LG+G FG V E+ AVK L K I D ++ E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 441 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLL 499
L +L C ++L + E++ L Y I Q + + F+ A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAE-IAIGLF 456
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART--CGGDKT 543
+L II+RDLK NV+LD + + KI+DFG+ + G T
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 20/152 (13%)
Query: 394 LGEGGFGPVY---KGTLVDGQEI-AVKRLSK--ISDQGLKELKNEVILFSKLQHRNLVKL 447
LG+G FG V+ K + D +++ A+K L K + + K E + ++ H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 448 LGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQ 503
E KL LI +F+ L + + +F+ + L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALA----LDHLHS 144
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535
L II+RDLK N+LLD + + K++DFGL+
Sbjct: 145 ---LGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNE-VILFSKLQHRNLVKLL 448
LG+G FG V + + ++ AVK L K + D ++ E IL H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 449 GCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRL 507
CC ++L + EF+ L + I Q + + + RF+ L++LH
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAE-IISALMFLHD---K 143
Query: 508 RIIHRDLKASNVLLDHDMNPKISDFGLART--CGGDKT 543
II+RDLK NVLLDH+ + K++DFG+ + C G T
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 21/161 (13%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNE-VILFSKLQHRNLVKLL 448
+G+G FG V + AVK L K + + K + +E +L ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 449 GCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF---HIICGTARGLLYLHQD 504
+KL + +++ L Y + Q L+ RF I L YLH
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASA----LGYLHS- 157
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLART--CGGDKT 543
L I++RDLK N+LLD + ++DFGL + T
Sbjct: 158 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 394 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNE-VILFSKLQHRNLVKLL 448
LG+G FG V E+ AVK L K I D ++ E +L + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 449 GCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARGLLYLHQD 504
C ++L + E++ L Y I Q + + F+ I G L +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIG----LFFLQS- 139
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLART--CGGDKT 543
II+RDLK NV+LD + + KI+DFG+ + G T
Sbjct: 140 --KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 394 LGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISDQGLKE-LKNEVILFSKLQHRNLV 445
LG+GG+G V+ K T + +I A+K L K + + K E + +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 446 KLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRF---HIICGTARGLLYL 501
L+ KL LI E++ L + + ++ + F I L +L
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMA----LGHL 137
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR--TCGGDKT 543
HQ II+RDLK N++L+H + K++DFGL + G T
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 35/166 (21%), Positives = 69/166 (41%), Gaps = 17/166 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQH 441
+F I +G G FG V L + ++ A+K L+K + + E +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARG 497
+ + L + L L+ ++ L + + +L + RF+ ++
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIA---- 187
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+ +HQ L +HRD+K N+L+D + + +++DFG D T
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 39/169 (23%), Positives = 69/169 (40%), Gaps = 23/169 (13%)
Query: 386 NNFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSK---ISDQGLKELKNEVILFSK 438
++F I +G G F V K T GQ A+K ++K + + + E +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 439 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGT 494
R + +L E L L+ E+ L + + ++ RF+ I+
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAEIVMA- 174
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+ +H+ L +HRD+K N+LLD + +++DFG D T
Sbjct: 175 ---IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 19/166 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISDQGLKELKNEVILFSKLQH 441
++ + +G G FG V +++ A+K LSK I E + +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 442 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IICGTARG 497
+V+L + L ++ E+MP L + +N + + RF+ ++
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAEVVLA---- 180
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
L +H + IHRD+K N+LLD + K++DFG +
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 25/162 (15%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH-RN 443
N + + K+G G FG +Y GT + G+E+A+K + L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--ICGTARGLL-- 499
+ + C G+ +++ E + SL+ +F+ + ++F + + A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCS-------RKFSLKTVLLLADQMISR 117
Query: 500 --YLHQDSRLRIIHRDLKASNVLLDHDMNPK---ISDFGLAR 536
Y+H + IHRD+K N L+ I DFGLA+
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 31/169 (18%), Positives = 67/169 (39%), Gaps = 22/169 (13%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
N + + K+G GGFG +Y ++ A + K+ Q L +E+ + ++ ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 445 V----KLLGCCIHGEEKLLIYEFMPNKSLDY--FIFD---QTNSKLLDWSKRFHI--ICG 493
+ + G K Y + + K+ + F +
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ 155
Query: 494 TARGLL----YLHQDSRLRIIHRDLKASNVLLDHDMNPKI--SDFGLAR 536
+L Y+H++ +H D+KA+N+LL + ++ +D+GL+
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 386 NNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSKIS----DQGLKELKNE-VILF 436
NF + LG G +G V+ K + D ++ A+K L K + + + + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 437 SKLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFH---IIC 492
Q LV L E KL LI +++ L + + + + + I+
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVL 170
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR---TCGGDKT 543
L +LH+ L II+RD+K N+LLD + + ++DFGL++ ++
Sbjct: 171 A----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 37/162 (22%), Positives = 72/162 (44%), Gaps = 25/162 (15%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
N F + K+G G FG +Y GT + +E+A+K + + L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 445 V-KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--ICGTARGLL-- 499
+ + + G+ +L+ + + SL+ +F+ + ++ + + A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCS-------RKLSLKTVLMLADQMINR 115
Query: 500 --YLHQDSRLRIIHRDLKASNVLLDHDMNPK---ISDFGLAR 536
++H S +HRD+K N L+ I DFGLA+
Sbjct: 116 VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 17/148 (11%), Positives = 43/148 (29%), Gaps = 12/148 (8%)
Query: 393 KLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISDQGLKELKNEVILFSKLQHRNLVKLL 448
G ++ +++A+ + + D L+E + + S++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508
L++ E++ SL + A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 509 IIHRDLKASNVLLDHDMNPKISDFGLAR 536
+ S V + D + ++
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 27/164 (16%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH-RN 443
NF + K+G G FG + G L + +A+K S +L E + +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--ICGTARGLL-- 499
+ ++ G+ ++ E + SL+ +FD + + F + + A L+
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCD-------RTFSLKTVLMIAIQLISR 117
Query: 500 --YLHQDSRLRIIHRDLKASNVLLDHDMNPK-----ISDFGLAR 536
Y+H + +I+RD+K N L+ N I DF LA+
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 34/164 (20%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH-RN 443
++ + ++GEG FG +++GT L++ Q++A+K + SD L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHI--ICGTARGLL-- 499
+ + G +L+ + + SL+ + D ++F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCG-------RKFSVKTVAMAAKQMLAR 118
Query: 500 --YLHQDSRLRIIHRDLKASNVLLDHDMNPK-----ISDFGLAR 536
+H+ S +++RD+K N L+ + + DFG+ +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 32/171 (18%), Positives = 62/171 (36%), Gaps = 23/171 (13%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KISDQGLKELKNEVILFSKLQHRN 443
+ + +G+GGFG +Y + + + K+ L E+ + +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 444 LV----KLLGCCIHGEEKLLIYEFMPNKSLDYFI-----FDQTNSKLLDW-SKRFHI--I 491
+ + G K Y F K+ + +KRF +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 492 CGTARGLL----YLHQDSRLRIIHRDLKASNVLLDHDMNPKI--SDFGLAR 536
+ +L Y+H+ +H D+KASN+LL++ ++ D+GLA
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 28/177 (15%), Positives = 62/177 (35%), Gaps = 35/177 (19%)
Query: 386 NNFSINNKLGEGGFGPVYKGT---------LVDGQEIAVKRLSKISDQGLKELK------ 430
+ + + G +Y+ Q+ ++K L + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 431 --NEVILFSKLQHRNLV---KLLGCCIHGEEKLLIYEFMP----NKSLDYFIFDQTNSKL 481
+V + KL L+ +G +H ++ Y F+ +SL D + +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHV 155
Query: 482 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKI--SDFGLAR 536
L + C L +LH++ +H ++ A N+ +D + ++ + +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 40/179 (22%), Positives = 68/179 (37%), Gaps = 49/179 (27%)
Query: 390 INNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISDQGLKELKNEVILFSKLQHRNLV 445
+ KLG G F V+ +V+ +A+K + ++ E+K +L ++ +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK---LL-QRVNDADNT 78
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSK------------LLDWSKRFH---- 489
K ++ K LD+F N LL K++
Sbjct: 79 KE----DSMGANHIL------KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 490 ---IICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDHDMNP------KISDFGLA 535
+ ++ GL Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 37/172 (21%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISDQGLKELKNEVILFSKLQ 440
+ + I++ +G+G FG V K V+ + +A+K +Q E++ +L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMN 108
Query: 441 HR------NLVKLLGCCIHGE------EKLLI--YEFMPNKSLDYFIFDQTNSKLLDWSK 486
+V L + E L Y+ + N + + T +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLT--------R 160
Query: 487 RF-HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP--KISDFGLA 535
+F +C LL+L L IIH DLK N+LL + KI DFG +
Sbjct: 161 KFAQQMC---TALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 43/171 (25%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISDQGLKELKNEVILFSKLQHR- 442
+ + +G+G FG V K Q +A+K + + Q +E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 443 -----NLVKLLGC-------CIHGEEKLL---IYEFMPNKSLDYFIFDQTNSKLLDWSKR 487
N++ +L C+ E LL +YE + F ++
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLV--------RK 204
Query: 488 F-HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP--KISDFGLA 535
F H I + L LH + RIIH DLK N+LL K+ DFG +
Sbjct: 205 FAHSIL---QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 44/185 (23%), Positives = 67/185 (36%), Gaps = 40/185 (21%)
Query: 385 TNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISDQGLKELKNEVILFSKLQ 440
N F + K+G+G FG V + + + AVK + K + E IL K+Q
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQ 89
Query: 441 HR-----NLVKLLGC-------CIHGEEKLL---IYEFMPNKSLDYFIFDQTNSKLLDWS 485
+ N+VK G C+ E L +YE + + + F +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDI-------- 139
Query: 486 KRF-HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
K + I + L YL ++ + H DLK N+LLD K T G
Sbjct: 140 KLYCIEIL---KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 545 GNTNR 549
T
Sbjct: 194 YRTKS 198
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 37/175 (21%), Positives = 65/175 (37%), Gaps = 42/175 (24%)
Query: 385 TNNFSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISDQGLKELKNEVILFSKL 439
+ + I + LGEG FG V + G+ +AVK + + + E++ +L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHL 68
Query: 440 QHR------NLVKLLGC-------CIHGEEKLL---IYEFMPNKSLDYFIFDQTNSKLLD 483
V++L CI E LL Y+F+ F D
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHI------ 120
Query: 484 WSKRF-HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
++ + IC + + +LH ++ H DLK N+L + + + R
Sbjct: 121 --RKMAYQIC---KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 35/190 (18%), Positives = 63/190 (33%), Gaps = 61/190 (32%)
Query: 385 TNNFSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISDQGLKELKNEVILFSKL 439
+ I LGEG FG V + ++A+K + K + E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 440 QHR------NLVKLLGC-------CIHGEEKLL---IYEFMPNKSLDYFIFDQTNSKLLD 483
+ + V + CI E LL +EF+ + +
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHV------ 125
Query: 484 WSKRF-HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP--------------- 527
+ + +C L +LH ++ H DLK N+L +
Sbjct: 126 --RHMAYQLC---HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 528 ----KISDFG 533
+++DFG
Sbjct: 178 NTSIRVADFG 187
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 39/183 (21%), Positives = 75/183 (40%), Gaps = 21/183 (11%)
Query: 385 TNNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ--- 440
+ + KLG G F V+ + + +A+K + K ++ + +E+ L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 441 -----HRNLVKLLGC-CIHGEE---KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHII 491
+V+LL I G +++E + L +I ++N + L II
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWI-IKSNYQGLPLPCVKKII 152
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCGGDKTEGNTN 548
+GL YLH ++ RIIH D+K N+LL + + ++ + G G+
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 549 RVW 551
Sbjct: 211 STA 213
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.98 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.98 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.94 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.94 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.94 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.94 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.93 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.93 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.93 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.93 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.93 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.93 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.93 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.93 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.93 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.93 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.93 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.93 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.93 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.93 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.92 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.92 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.92 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.92 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.92 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.92 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.92 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.92 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.92 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.92 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.92 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.92 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.92 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.92 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.92 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.92 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.92 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.92 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.92 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.92 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.92 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.92 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.92 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.92 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.92 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.92 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.92 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.92 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.92 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.92 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.92 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.91 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.91 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.91 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.91 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.91 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.91 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.91 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.91 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.91 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.91 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.91 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.91 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.91 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.91 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.91 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.91 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.91 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.91 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.91 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.91 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.91 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.91 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.91 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.91 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.91 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.91 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.91 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.91 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.91 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.91 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.91 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.91 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.91 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.91 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.91 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.91 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.91 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.91 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.9 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.9 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.9 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.9 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.9 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.9 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.9 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.9 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.9 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.9 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.9 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.9 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.9 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.9 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.9 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.9 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.9 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.9 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.9 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.89 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.89 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.89 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.89 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.89 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.89 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.89 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.89 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.89 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.88 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.88 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.88 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.88 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.86 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.37 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.35 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.34 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.34 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.59 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.42 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.35 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.34 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.25 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.24 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.18 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.14 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.05 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 98.01 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.01 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.01 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 97.84 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.81 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 97.69 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.57 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.43 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.42 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.4 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.35 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.04 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 96.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.88 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.48 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 86.21 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.09 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 81.13 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 81.0 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.08 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=291.05 Aligned_cols=155 Identities=32% Similarity=0.593 Sum_probs=137.4
Q ss_pred cCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.++|.+.++||+|+||.||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357888999999999999999863 36789999998766667788999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeE
Q 008648 459 LIYEFMPNKSLDYFIFDQT----------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPK 528 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 528 (558)
|||||+++|+|.++|.... ....+++.+++.|+.||++||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 2356999999999999999999999988 99999999999999999999
Q ss_pred EeccccceeeCCCc
Q 008648 529 ISDFGLARTCGGDK 542 (558)
Q Consensus 529 l~DFGla~~~~~~~ 542 (558)
|+|||+|+......
T Consensus 169 i~DFGla~~~~~~~ 182 (299)
T 4asz_A 169 IGDFGMSRDVYSTD 182 (299)
T ss_dssp ECCCSCHHHHTGGG
T ss_pred ECCcccceecCCCC
Confidence 99999999775543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.22 Aligned_cols=155 Identities=28% Similarity=0.537 Sum_probs=132.5
Q ss_pred cCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356788899999999999999864 46789999998766677788999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 459 LIYEFMPNKSLDYFIFDQTN------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
|||||+++|+|.+++..... ...+++.+++.|+.||++||+|||+++ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999975421 246899999999999999999999988 999999999999999999
Q ss_pred eEEeccccceeeCCCc
Q 008648 527 PKISDFGLARTCGGDK 542 (558)
Q Consensus 527 ~kl~DFGla~~~~~~~ 542 (558)
+||+|||+|+.+....
T Consensus 197 ~Ki~DFGla~~~~~~~ 212 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTD 212 (329)
T ss_dssp EEECCCC---------
T ss_pred EEEcccccceeccCCC
Confidence 9999999999875443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=285.62 Aligned_cols=153 Identities=29% Similarity=0.401 Sum_probs=138.4
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999964 5899999999752 3345678999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999653 45899999999999999999999998 999999999999999999999999999998655
Q ss_pred cCc
Q 008648 542 KTE 544 (558)
Q Consensus 542 ~~~ 544 (558)
...
T Consensus 186 ~~~ 188 (311)
T 4aw0_A 186 SKQ 188 (311)
T ss_dssp TTC
T ss_pred CCc
Confidence 443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=286.87 Aligned_cols=151 Identities=28% Similarity=0.440 Sum_probs=138.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
...|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999975 5899999999765556667789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999854 34899999999999999999999998 9999999999999999999999999999886543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=285.62 Aligned_cols=151 Identities=23% Similarity=0.386 Sum_probs=130.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|+++++||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999974 5899999998653 33456789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++|+|.+++... ....+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999653 3345789999999999999999999998 99999999999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=285.62 Aligned_cols=154 Identities=31% Similarity=0.513 Sum_probs=134.4
Q ss_pred CCcccceeecccCcccEEEEEEc------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..+++.++||+|+||.||+|.+. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999862 4678999999753 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 008648 459 LIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM 525 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~ 525 (558)
|||||+++|+|.++|..... ...+++.+++.|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 245899999999999999999999988 99999999999999999
Q ss_pred CeEEeccccceeeCCCc
Q 008648 526 NPKISDFGLARTCGGDK 542 (558)
Q Consensus 526 ~~kl~DFGla~~~~~~~ 542 (558)
.+||+|||+|+.+....
T Consensus 183 ~~Ki~DFGlar~~~~~~ 199 (308)
T 4gt4_A 183 NVKISDLGLFREVYAAD 199 (308)
T ss_dssp CEEECCSCCBCGGGGGG
T ss_pred CEEECCcccceeccCCC
Confidence 99999999999775443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=281.11 Aligned_cols=151 Identities=29% Similarity=0.503 Sum_probs=130.4
Q ss_pred hhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
...+++++.++||+|+||.||+|++. ..||||+++.. .....+.|.+|+.++++++|||||++++++. .+..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEE
Confidence 34567888999999999999999864 36999998642 3345678999999999999999999999875 4568999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++|+|.+++... ...+++.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999653 345899999999999999999999988 99999999999999999999999999997754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 185 ~ 185 (307)
T 3omv_A 185 W 185 (307)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=288.88 Aligned_cols=152 Identities=28% Similarity=0.438 Sum_probs=139.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..+.|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|||||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 3467999999999999999999974 589999999976656666789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
||++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 229 y~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 229 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999854 34899999999999999999999998 9999999999999999999999999999886543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=271.30 Aligned_cols=149 Identities=28% Similarity=0.473 Sum_probs=125.6
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|+. .+++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999996 45899999998652 2334567999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 67898888553 45899999999999999999999998 999999999999999999999999999877543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.31 Aligned_cols=154 Identities=25% Similarity=0.427 Sum_probs=127.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC--------
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-------- 455 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 455 (558)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999964 68999999986533 334567999999999999999999999987644
Q ss_pred ----eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEec
Q 008648 456 ----EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531 (558)
Q Consensus 456 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 531 (558)
..||||||+++|+|.+++.........++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976554445667778899999999999999998 99999999999999999999999
Q ss_pred cccceeeCCCc
Q 008648 532 FGLARTCGGDK 542 (558)
Q Consensus 532 FGla~~~~~~~ 542 (558)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=273.70 Aligned_cols=152 Identities=25% Similarity=0.380 Sum_probs=128.4
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC----eEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----EKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 461 (558)
++|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4678889999999999999987 689999999965322 2223345666777899999999999998754 579999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~-----~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
||+++|+|.+++... .+++..+.+++.|+++||+|||++. .++||||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999643 4899999999999999999999871 2359999999999999999999999999999
Q ss_pred eeCCCcC
Q 008648 537 TCGGDKT 543 (558)
Q Consensus 537 ~~~~~~~ 543 (558)
.......
T Consensus 157 ~~~~~~~ 163 (303)
T 3hmm_A 157 RHDSATD 163 (303)
T ss_dssp EEETTTT
T ss_pred cccCCCC
Confidence 8865543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-33 Score=276.86 Aligned_cols=150 Identities=27% Similarity=0.323 Sum_probs=126.9
Q ss_pred CCcccceeecccCcccEEEEEEc----CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
++|++.+.||+|+||.||+|+.. .++.||||++++. .......+.+|+.++++++|||||++++++.+.+..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 3678999998652 22334578899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||++||+|.+++.+. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 35899999999999999999999998 9999999999999999999999999999765
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 178 ~~ 179 (304)
T 3ubd_A 178 DH 179 (304)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=269.43 Aligned_cols=148 Identities=27% Similarity=0.394 Sum_probs=128.3
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe----CCeEEEE
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH----GEEKLLI 460 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 460 (558)
|++.++||+|+||.||+|... ++..||+|++... .....+.|.+|+.++++++|||||++++++.+ ....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999975 5889999998642 33445779999999999999999999999875 2457999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~ 539 (558)
|||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||||+||||+ +++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999653 45899999999999999999999875 4599999999999998 47899999999998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=274.65 Aligned_cols=147 Identities=27% Similarity=0.345 Sum_probs=129.5
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.+.|++.++||+|+||.||+|+.. +++.||||+++.... ..+|+.+++.++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888899999999999999974 589999999975321 24699999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccceeeCCCc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLARTCGGDK 542 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~ 542 (558)
++||+|.+++... ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999653 45899999999999999999999998 99999999999999987 59999999999886543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=276.94 Aligned_cols=165 Identities=28% Similarity=0.447 Sum_probs=140.6
Q ss_pred cchhhhhhhcCCcccceeecccCcccEEEEEEcC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCC-Ceeeee
Q 008648 376 FELATISNATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQH-RNLVKL 447 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l 447 (558)
++..+++...++|++.++||+|+||.||+|.+.. ++.||||++.... ....+.|.+|+.+|.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445566778899999999999999999998643 3589999997533 3345679999999999965 899999
Q ss_pred eeEEEeC-CeEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 008648 448 LGCCIHG-EEKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 513 (558)
Q Consensus 448 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrD 513 (558)
+|+|.+. +..+||||||++|+|.++|..... ...+++.+++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 568999999999999999975321 345899999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCeEEeccccceeeCCCcC
Q 008648 514 LKASNVLLDHDMNPKISDFGLARTCGGDKT 543 (558)
Q Consensus 514 lkp~NIll~~~~~~kl~DFGla~~~~~~~~ 543 (558)
|||+||||++++.+||+|||+|+.+..+..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~ 240 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPD 240 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCC
Confidence 999999999999999999999998765544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=268.34 Aligned_cols=150 Identities=26% Similarity=0.455 Sum_probs=130.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------C
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------E 455 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 455 (558)
.++|++.++||+|+||.||+|+.. +++.||||++++.. ....+.+.+|+.+|+.++|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999974 68999999997532 23456788999999999999999999997643 5
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..||||||++ |+|..++.. ...+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6899999996 679888843 456999999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCC
Q 008648 536 RTCGGD 541 (558)
Q Consensus 536 ~~~~~~ 541 (558)
+.+...
T Consensus 206 ~~~~~~ 211 (398)
T 4b99_A 206 RGLCTS 211 (398)
T ss_dssp BCC---
T ss_pred eecccC
Confidence 977543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=259.80 Aligned_cols=150 Identities=24% Similarity=0.375 Sum_probs=132.9
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc----CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCC
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGE 455 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 455 (558)
+....++|++.++||+|+||.||+|+.. .++.||+|++.+. ....++.+|+++|+.+ +|||||++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3445678999999999999999999853 3678999998653 3456788999999988 6999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CCeEEecccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGL 534 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGl 534 (558)
..+|||||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999882 3889999999999999999999998 9999999999999876 7999999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.....
T Consensus 165 a~~~~~~ 171 (361)
T 4f9c_A 165 AQGTHDT 171 (361)
T ss_dssp CEECTTC
T ss_pred CcccCCc
Confidence 9987544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=271.45 Aligned_cols=152 Identities=28% Similarity=0.352 Sum_probs=132.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHH---HHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELK---NEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
.++|++.++||+|+||.||+|+.. +++.||||++.+. .......+. .++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999975 5899999999652 122233333 446677888999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
||||||++||+|..+|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999653 45899999999999999999999998 99999999999999999999999999998
Q ss_pred eCCCc
Q 008648 538 CGGDK 542 (558)
Q Consensus 538 ~~~~~ 542 (558)
+....
T Consensus 342 ~~~~~ 346 (689)
T 3v5w_A 342 FSKKK 346 (689)
T ss_dssp CSSCC
T ss_pred cCCCC
Confidence 86543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-29 Score=268.95 Aligned_cols=152 Identities=26% Similarity=0.418 Sum_probs=137.2
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+|+.++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 358999999999999999999974 5899999999775555667899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD--MNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DFGla~~~~~~ 541 (558)
++||+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998843 2346899999999999999999999998 9999999999999854 89999999999988654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.58 Aligned_cols=163 Identities=40% Similarity=0.711 Sum_probs=145.3
Q ss_pred cchhhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 376 FELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
+.+.++....++|++.+.||+|+||.||+|...+++.||||++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33445566788999999999999999999998889999999988766667788999999999999999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTN-SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999855432 235899999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
++.....
T Consensus 186 ~~~~~~~ 192 (321)
T 2qkw_B 186 SKKGTEL 192 (321)
T ss_dssp CEECSSS
T ss_pred ccccccc
Confidence 9876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=252.74 Aligned_cols=161 Identities=19% Similarity=0.236 Sum_probs=140.8
Q ss_pred chhhhhhhcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEE
Q 008648 377 ELATISNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCI 452 (558)
Q Consensus 377 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 452 (558)
.+.++....++|++.++||+|+||.||+|+... ++.||+|++.+.. ....+.+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345566677899999999999999999999765 7889999986521 222344889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999542 345899999999999999999999998 999999999999999999999999
Q ss_pred ccceeeCCCc
Q 008648 533 GLARTCGGDK 542 (558)
Q Consensus 533 Gla~~~~~~~ 542 (558)
|+|+.+..+.
T Consensus 220 Gla~~~~~~~ 229 (437)
T 4aw2_A 220 GSCLKLMEDG 229 (437)
T ss_dssp TTCEECCTTS
T ss_pred hhhhhcccCC
Confidence 9998875543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-27 Score=233.66 Aligned_cols=152 Identities=24% Similarity=0.466 Sum_probs=138.7
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 456899999999999999999986 5688999999876556667789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
|+++++|.+++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999998543 4889999999999999999999998 9999999999999999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-27 Score=233.84 Aligned_cols=153 Identities=29% Similarity=0.484 Sum_probs=138.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|.+.++||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467899999999999999999975 5889999998776667778899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999653 345899999999999999999999998 9999999999999999999999999999875443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=234.34 Aligned_cols=162 Identities=28% Similarity=0.392 Sum_probs=141.5
Q ss_pred CCccchhhhhhhcC----------CcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC
Q 008648 373 LPLFELATISNATN----------NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQH 441 (558)
Q Consensus 373 ~~~~~~~~~~~~~~----------~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 441 (558)
.+.++.+++..+++ .|+..+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 34455655555443 3677789999999999999976 689999999977666677889999999999999
Q ss_pred CeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 008648 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 521 (558)
Q Consensus 442 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll 521 (558)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999998843 35899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceeeCCC
Q 008648 522 DHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 522 ~~~~~~kl~DFGla~~~~~~ 541 (558)
+.++.+||+|||+++.+...
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp CTTCCEEECCCTTCEECCSS
T ss_pred CCCCcEEEeeeeeeeecccC
Confidence 99999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=236.40 Aligned_cols=154 Identities=24% Similarity=0.414 Sum_probs=135.4
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe------
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE------ 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 456 (558)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999975 6899999998643 33456789999999999999999999999876542
Q ss_pred ---------------------------------------------------EEEEEecCCCCChhHHHhhcCCCCCCCHH
Q 008648 457 ---------------------------------------------------KLLIYEFMPNKSLDYFIFDQTNSKLLDWS 485 (558)
Q Consensus 457 ---------------------------------------------------~~lv~E~~~~gsL~~~l~~~~~~~~l~~~ 485 (558)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999999776555566777
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 486 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 486 ~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
.++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 89999999999999999998 999999999999999999999999999988665
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=240.16 Aligned_cols=153 Identities=29% Similarity=0.445 Sum_probs=137.2
Q ss_pred hhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
...++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456899999999999999999997 56899999998653 33455678899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999998653 34899999999999999999999998 9999999999999999999999999998765
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 166 ~~ 167 (328)
T 3fe3_A 166 VG 167 (328)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=237.15 Aligned_cols=169 Identities=44% Similarity=0.736 Sum_probs=147.3
Q ss_pred CCccchhhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEE
Q 008648 373 LPLFELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCC 451 (558)
Q Consensus 373 ~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 451 (558)
...+++.++....++|++.+.||+|+||.||+|...+++.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45678889999999999999999999999999998789999999987532 22334689999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 452 IHGEEKLLIYEFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 452 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
...+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||++...+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 23458999999999999999999999822229999999999999999999999
Q ss_pred ccccceeeCCC
Q 008648 531 DFGLARTCGGD 541 (558)
Q Consensus 531 DFGla~~~~~~ 541 (558)
|||+|+.+...
T Consensus 177 Dfg~~~~~~~~ 187 (326)
T 3uim_A 177 DFGLAKLMDYK 187 (326)
T ss_dssp CCSSCEECCSS
T ss_pred cCccccccCcc
Confidence 99999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=242.60 Aligned_cols=161 Identities=19% Similarity=0.239 Sum_probs=141.2
Q ss_pred chhhhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEE
Q 008648 377 ELATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCI 452 (558)
Q Consensus 377 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 452 (558)
.+.+.....++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555667789999999999999999999975 5899999998652 2223455889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
+.+..+|||||+++|+|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996532 35899999999999999999999998 999999999999999999999999
Q ss_pred ccceeeCCCc
Q 008648 533 GLARTCGGDK 542 (558)
Q Consensus 533 Gla~~~~~~~ 542 (558)
|+|+.+..+.
T Consensus 207 Gla~~~~~~~ 216 (412)
T 2vd5_A 207 GSCLKLRADG 216 (412)
T ss_dssp TTCEECCTTS
T ss_pred hhheeccCCC
Confidence 9999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=235.91 Aligned_cols=149 Identities=24% Similarity=0.327 Sum_probs=134.6
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999975 5899999998753 334567889999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999988543 35899999999999999999999998 9999999999999999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=243.01 Aligned_cols=157 Identities=20% Similarity=0.250 Sum_probs=138.7
Q ss_pred hhhhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 008648 378 LATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453 (558)
Q Consensus 378 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 453 (558)
+.++....++|++.++||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455567789999999999999999999975 4789999998652 22334568899999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
.+..+|||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999998542 4889999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCC
Q 008648 534 LARTCGGD 541 (558)
Q Consensus 534 la~~~~~~ 541 (558)
+|+.+...
T Consensus 214 ~a~~~~~~ 221 (410)
T 3v8s_A 214 TCMKMNKE 221 (410)
T ss_dssp TCEECCTT
T ss_pred eeEeeccC
Confidence 99987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=237.96 Aligned_cols=155 Identities=30% Similarity=0.515 Sum_probs=136.2
Q ss_pred hcCCcccceeecccCcccEEEEEEc--------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIH 453 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 453 (558)
..++|++.+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4568999999999999999999863 3457999999753 234457799999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 520 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIl 520 (558)
.+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999976432 235789999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeccccceeeCCC
Q 008648 521 LDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 521 l~~~~~~kl~DFGla~~~~~~ 541 (558)
|+.++.+||+|||+|+.+...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNI 256 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCC
T ss_pred ECCCCCEEEccccCCcccCcc
Confidence 999999999999999977544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=234.20 Aligned_cols=153 Identities=29% Similarity=0.504 Sum_probs=135.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467999999999999999999974 3456999999753 3345577999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 127 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 202 ~~~ 204 (325)
T 3kul_A 202 EDD 204 (325)
T ss_dssp C--
T ss_pred ccC
Confidence 654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=238.88 Aligned_cols=151 Identities=25% Similarity=0.393 Sum_probs=136.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|... +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999975 4789999998652 234567889999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 168 ~ 168 (384)
T 4fr4_A 168 E 168 (384)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=234.84 Aligned_cols=152 Identities=28% Similarity=0.376 Sum_probs=135.6
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD------QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
..+.|++.+.||+|+||.||+|... +++.||+|.+.+... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4467999999999999999999975 588999999875322 135789999999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----CeEEecc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM----NPKISDF 532 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DF 532 (558)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999843 346899999999999999999999998 99999999999998776 7999999
Q ss_pred ccceeeCCC
Q 008648 533 GLARTCGGD 541 (558)
Q Consensus 533 Gla~~~~~~ 541 (558)
|+|+.+...
T Consensus 164 G~a~~~~~~ 172 (361)
T 2yab_A 164 GLAHEIEDG 172 (361)
T ss_dssp SSCEECCTT
T ss_pred CCceEcCCC
Confidence 999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=236.84 Aligned_cols=150 Identities=30% Similarity=0.455 Sum_probs=133.4
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3468999999999999999999975 5889999998752 234556788999999988 7999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998653 35899999999999999999999998 999999999999999999999999999864
Q ss_pred C
Q 008648 539 G 539 (558)
Q Consensus 539 ~ 539 (558)
.
T Consensus 175 ~ 175 (353)
T 3txo_A 175 I 175 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=226.75 Aligned_cols=151 Identities=27% Similarity=0.485 Sum_probs=136.6
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..++|++.+.||+|+||.||+|...+++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 34679999999999999999999988899999999763 33457899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+....
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp CTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999998543 345899999999999999999999998 99999999999999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=229.37 Aligned_cols=165 Identities=41% Similarity=0.684 Sum_probs=146.0
Q ss_pred CCccchhhhhhhcCCcccc------eeecccCcccEEEEEEcCCcEEEEEEeccc----ccccHHHHHHHHHHHhcCCCC
Q 008648 373 LPLFELATISNATNNFSIN------NKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SDQGLKELKNEVILFSKLQHR 442 (558)
Q Consensus 373 ~~~~~~~~~~~~~~~y~~~------~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~ 442 (558)
.+.+.+.++..++++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567888888888888766 8999999999999986 6789999998642 233467899999999999999
Q ss_pred eeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 008648 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 522 (558)
Q Consensus 443 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~ 522 (558)
||+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999875444556899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceeeCCC
Q 008648 523 HDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 523 ~~~~~kl~DFGla~~~~~~ 541 (558)
+++.+||+|||+++.....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp TTCCEEECCCTTCEECCSC
T ss_pred CCCcEEEeecccccccccc
Confidence 9999999999999987543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=233.85 Aligned_cols=163 Identities=28% Similarity=0.508 Sum_probs=133.7
Q ss_pred cchhhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 008648 376 FELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 453 (558)
.+...+....++|++.+.||+|+||.||+|.. +++.||||++.... ....+++.+|+.++++++||||+++++++.+
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 33444555667899999999999999999987 68899999986532 3345678999999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
.+..++||||+++++|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+||||+.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999999965433345899999999999999999999875 349999999999999999999999999
Q ss_pred cceeeCC
Q 008648 534 LARTCGG 540 (558)
Q Consensus 534 la~~~~~ 540 (558)
+|+....
T Consensus 185 ~a~~~~~ 191 (309)
T 3p86_A 185 LSRLKAS 191 (309)
T ss_dssp -------
T ss_pred CCccccc
Confidence 9986543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.26 Aligned_cols=149 Identities=30% Similarity=0.394 Sum_probs=131.6
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 68899999986432 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 9999999998833 345899999999999999999999998 9999999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-26 Score=229.59 Aligned_cols=152 Identities=22% Similarity=0.307 Sum_probs=135.4
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..++|++.+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3468999999999999999999975 4789999998653 3445678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH--DMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~~~ 540 (558)
|+++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.+..
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999843 2345899999999999999999999998 999999999999987 78999999999998754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 157 ~ 157 (321)
T 1tki_A 157 G 157 (321)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=231.06 Aligned_cols=150 Identities=26% Similarity=0.392 Sum_probs=135.1
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999975 5899999998652 224567788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999998653 35899999999999999999999988 99999999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=239.06 Aligned_cols=154 Identities=29% Similarity=0.525 Sum_probs=128.6
Q ss_pred hcCCcccceeecccCcccEEEEEEc----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3458999999999999999999864 4678999998753 3345567999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 123 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999543 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 198 ~~~~ 201 (373)
T 2qol_A 198 EDDP 201 (373)
T ss_dssp ----
T ss_pred ccCC
Confidence 6543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=224.40 Aligned_cols=152 Identities=30% Similarity=0.467 Sum_probs=137.6
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..++|++.+.||+|+||.||+|...++..||+|++... ....+++.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 45689999999999999999999888889999998753 33457799999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999998653 235899999999999999999999998 999999999999999999999999999977544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=230.64 Aligned_cols=156 Identities=28% Similarity=0.425 Sum_probs=137.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC--eEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE--EKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 459 (558)
..++|++.++||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 34689999999999999999999754 8899999987533 345677889999999999999999999998765 6799
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCCeEEeccccc
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DHDMNPKISDFGLA 535 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFGla 535 (558)
||||+++++|.+++........+++.+++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976544445899999999999999999999998 9999999999999 77888999999999
Q ss_pred eeeCCCc
Q 008648 536 RTCGGDK 542 (558)
Q Consensus 536 ~~~~~~~ 542 (558)
+.+....
T Consensus 164 ~~~~~~~ 170 (319)
T 4euu_A 164 RELEDDE 170 (319)
T ss_dssp EECCTTC
T ss_pred eecCCCC
Confidence 9876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=229.50 Aligned_cols=153 Identities=31% Similarity=0.442 Sum_probs=133.8
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
+...++|++.++||+|+||.||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 44567899999999999999999999889999999986532 2335678899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 97 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999985 777776442 345899999999999999999999998 9999999999999999999999999999875
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 171 ~ 171 (311)
T 3niz_A 171 I 171 (311)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=231.10 Aligned_cols=151 Identities=32% Similarity=0.527 Sum_probs=132.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC----eEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----EKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 459 (558)
..++|++.++||+|+||.||+|+.. ++.||||++... .........|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4468999999999999999999875 789999998653 333455677999999999999999999998754 3699
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceEecCCCCCcEEEcCCCCeEE
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD----------SRLRIIHRDLKASNVLLDHDMNPKI 529 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~----------~~~~ivHrDlkp~NIll~~~~~~kl 529 (558)
||||+++++|.+++... .+++..+..++.||+.||+|||+. + |+||||||+||||+.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 99999999999999552 489999999999999999999988 6 999999999999999999999
Q ss_pred eccccceeeCCCcC
Q 008648 530 SDFGLARTCGGDKT 543 (558)
Q Consensus 530 ~DFGla~~~~~~~~ 543 (558)
+|||+|+.+.....
T Consensus 173 ~DFg~a~~~~~~~~ 186 (322)
T 3soc_A 173 ADFGLALKFEAGKS 186 (322)
T ss_dssp CCCTTCEEECTTSC
T ss_pred ccCCcccccccccC
Confidence 99999998765443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=228.99 Aligned_cols=151 Identities=26% Similarity=0.420 Sum_probs=134.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3468999999999999999999964 5889999998542 23345678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998653 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 163 ~ 163 (294)
T 4eqm_A 163 E 163 (294)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-26 Score=225.12 Aligned_cols=149 Identities=27% Similarity=0.439 Sum_probs=130.3
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 58899999986532 3345778899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++ +|...+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9986 454444332 345899999999999999999999998 99999999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=232.76 Aligned_cols=151 Identities=23% Similarity=0.298 Sum_probs=136.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357999999999999999999975 5899999998652 234567889999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998653 34899999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 194 ~ 194 (350)
T 1rdq_E 194 R 194 (350)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=233.13 Aligned_cols=151 Identities=28% Similarity=0.418 Sum_probs=133.8
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 457 (558)
...++|++.+.||+|+||.||+|+.. +++.||+|++++. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 35578999999999999999999975 5889999999753 234566788899999876 899999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998653 35899999999999999999999998 99999999999999999999999999986
Q ss_pred eC
Q 008648 538 CG 539 (558)
Q Consensus 538 ~~ 539 (558)
..
T Consensus 168 ~~ 169 (345)
T 1xjd_A 168 NM 169 (345)
T ss_dssp CC
T ss_pred cc
Confidence 53
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=238.13 Aligned_cols=149 Identities=25% Similarity=0.388 Sum_probs=131.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.++||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467999999999999999999975 47889999987532 23345688899999876 8999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999988653 35899999999999999999999998 999999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=238.28 Aligned_cols=154 Identities=26% Similarity=0.459 Sum_probs=136.4
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
....++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 345568999999999999999999985 68899999987532 2334568899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 190 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999998643 235889999999999999999999998 9999999999999999999999999998765
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 265 ~ 265 (377)
T 3cbl_A 265 D 265 (377)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=232.66 Aligned_cols=149 Identities=26% Similarity=0.379 Sum_probs=133.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 459 (558)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999975 47899999997532 23456688999999987 89999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999998653 35899999999999999999999998 9999999999999999999999999998643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-26 Score=229.32 Aligned_cols=151 Identities=26% Similarity=0.370 Sum_probs=134.9
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD------QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357999999999999999999975 588999999865322 2467899999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----CeEEeccc
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM----NPKISDFG 533 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFG 533 (558)
++||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999843 346899999999999999999999998 99999999999999877 79999999
Q ss_pred cceeeCCC
Q 008648 534 LARTCGGD 541 (558)
Q Consensus 534 la~~~~~~ 541 (558)
+|+.+...
T Consensus 164 ~a~~~~~~ 171 (326)
T 2y0a_A 164 LAHKIDFG 171 (326)
T ss_dssp TCEECCTT
T ss_pred CCeECCCC
Confidence 99987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=225.94 Aligned_cols=153 Identities=25% Similarity=0.419 Sum_probs=134.9
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
....++|++.+.||+|+||.||++...++..||+|++... ....+++.+|++++.+++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 4456789999999999999999999988889999999763 334578999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999998542 345899999999999999999999998 99999999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=227.01 Aligned_cols=150 Identities=28% Similarity=0.438 Sum_probs=128.2
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc--------------------------ccHHHHHHHHHHHh
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD--------------------------QGLKELKNEVILFS 437 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 437 (558)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999864 588999999865321 12356889999999
Q ss_pred cCCCCeeeeeeeEEEe--CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 008648 438 KLQHRNLVKLLGCCIH--GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 515 (558)
Q Consensus 438 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlk 515 (558)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++.++..++.||+.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999997764 2346899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeEEeccccceeeCCC
Q 008648 516 ASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 516 p~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+|||++.++.+||+|||+|+.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=236.00 Aligned_cols=164 Identities=28% Similarity=0.451 Sum_probs=140.1
Q ss_pred ccchhhhhhhcCCcccceeecccCcccEEEEEE------cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeee
Q 008648 375 LFELATISNATNNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVK 446 (558)
Q Consensus 375 ~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~ 446 (558)
.+.........++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345566677888999999999999999999974 23578999999753 233456799999999999 7999999
Q ss_pred eeeEEEeCCe-EEEEEecCCCCChhHHHhhcCC-----------------------------------------------
Q 008648 447 LLGCCIHGEE-KLLIYEFMPNKSLDYFIFDQTN----------------------------------------------- 478 (558)
Q Consensus 447 l~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------- 478 (558)
+++++.+.+. .++||||+++++|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999975432
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 479 ----------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 479 ----------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122889999999999999999999998 999999999999999999999999999877543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=244.60 Aligned_cols=156 Identities=28% Similarity=0.478 Sum_probs=139.3
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
......+|++.++||+|+||.||+|.... +..||||+++.. ....+++.+|+.++++++||||+++++++...+..+|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34455689999999999999999999865 789999999763 3456789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 294 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999996532 345899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
.+
T Consensus 370 ~~ 371 (495)
T 1opk_A 370 GD 371 (495)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=231.81 Aligned_cols=150 Identities=27% Similarity=0.395 Sum_probs=125.8
Q ss_pred hcCCcccceeecccCcccEEEEEE----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
..++|++.+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 346899999999999999999987 468899999987532 234456889999999999999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999998543 35889999999999999999999998 999999999999999999999999999
Q ss_pred eeeC
Q 008648 536 RTCG 539 (558)
Q Consensus 536 ~~~~ 539 (558)
+...
T Consensus 169 ~~~~ 172 (327)
T 3a62_A 169 KESI 172 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 8654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=234.43 Aligned_cols=152 Identities=26% Similarity=0.377 Sum_probs=135.8
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999875 5889999998765555567899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH--DMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988432 345899999999999999999999998 999999999999974 567999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=228.85 Aligned_cols=158 Identities=31% Similarity=0.489 Sum_probs=138.0
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 453 (558)
.....++|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3445678999999999999999999862 3478999998753 33455778999999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTN---------------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHr 512 (558)
.+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 9999999999999999999976432 234889999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 513 DLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 513 Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||||+|||++.++.+||+|||+++.+...
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~ 203 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEE 203 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTT
T ss_pred ccchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999999999999987544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=230.87 Aligned_cols=153 Identities=30% Similarity=0.551 Sum_probs=132.9
Q ss_pred hcCCcccceeecccCcccEEEEEE-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--Ce
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 456 (558)
..++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 346899999999999999999984 35789999999876666678899999999999999999999998653 45
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 79999999999999999654 235899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 163 ~~~~~ 167 (295)
T 3ugc_A 163 VLPQD 167 (295)
T ss_dssp -----
T ss_pred cccCC
Confidence 87544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=231.69 Aligned_cols=154 Identities=27% Similarity=0.397 Sum_probs=134.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999874 58999999986421 224678999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC---eEEecccc
Q 008648 459 LIYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN---PKISDFGL 534 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFGl 534 (558)
+||||+++++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877543 23345899999999999999999999998 999999999999986654 99999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.+...
T Consensus 180 a~~~~~~ 186 (351)
T 3c0i_A 180 AIQLGES 186 (351)
T ss_dssp CEECCTT
T ss_pred eeEecCC
Confidence 9987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=239.90 Aligned_cols=151 Identities=28% Similarity=0.471 Sum_probs=136.2
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999975 68999999986532 23456799999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 169 ~ 169 (476)
T 2y94_A 169 G 169 (476)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=231.94 Aligned_cols=150 Identities=27% Similarity=0.350 Sum_probs=134.0
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.+.||+|+||.||+|+... ++.||+|++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34689999999999999999999764 788999998753 234567788999999988 7999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998653 35899999999999999999999998 999999999999999999999999999875
Q ss_pred C
Q 008648 539 G 539 (558)
Q Consensus 539 ~ 539 (558)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=226.03 Aligned_cols=148 Identities=28% Similarity=0.450 Sum_probs=132.4
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||+|+||.||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998779999999986432 23457788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 985 888887543 345889999999999999999999998 9999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=242.73 Aligned_cols=156 Identities=30% Similarity=0.445 Sum_probs=138.2
Q ss_pred hhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 379 ATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 379 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.......++|++.+.||+|+||.||+|...++..||||+++.. ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 3445567789999999999999999999988899999999763 345788999999999999999999999986 66789
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 259 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9999999999999986431 235788999999999999999999998 999999999999999999999999999876
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 335 ~~ 336 (454)
T 1qcf_A 335 ED 336 (454)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=232.98 Aligned_cols=159 Identities=30% Similarity=0.512 Sum_probs=139.3
Q ss_pred hhhhhhcCCcccceeecccCcccEEEEEEcC------CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEE
Q 008648 379 ATISNATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCC 451 (558)
Q Consensus 379 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 451 (558)
..+....++|++.+.||+|+||.||+|.... ++.||+|+++.. .....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445567899999999999999999999753 478999998753 233457799999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCChhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 008648 452 IHGEEKLLIYEFMPNKSLDYFIFDQTN---------------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRII 510 (558)
Q Consensus 452 ~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iv 510 (558)
.+.+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999976321 256899999999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 511 HRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 511 HrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||||||+||||+.++.+||+|||+++.+..
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred cCCCCcceEEECCCCeEEEeecCCCccccc
Confidence 999999999999999999999999987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=223.32 Aligned_cols=153 Identities=24% Similarity=0.373 Sum_probs=138.0
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999754 67899999987666677889999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~~ 539 (558)
|+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999888553 34899999999999999999999998 9999999999999 788999999999999876
Q ss_pred CCc
Q 008648 540 GDK 542 (558)
Q Consensus 540 ~~~ 542 (558)
...
T Consensus 161 ~~~ 163 (277)
T 3f3z_A 161 PGK 163 (277)
T ss_dssp TTS
T ss_pred Ccc
Confidence 543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=236.32 Aligned_cols=154 Identities=19% Similarity=0.227 Sum_probs=133.9
Q ss_pred hhhhhcCCcccceeecccCcccEEEEE------EcCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCeeeeeeeE
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ---HRNLVKLLGC 450 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~ 450 (558)
++....++|.+.++||+|+||.||+|. ...++.||||++... ...++..|+.++..++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344566789999999999999999994 446889999998653 4567788888888886 9999999999
Q ss_pred EEeCCeEEEEEecCCCCChhHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----
Q 008648 451 CIHGEEKLLIYEFMPNKSLDYFIFDQT--NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH----- 523 (558)
Q Consensus 451 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~----- 523 (558)
+...+..+|||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 999999999999999999999996432 3456999999999999999999999988 999999999999998
Q ss_pred ------CCCeEEeccccceeeC
Q 008648 524 ------DMNPKISDFGLARTCG 539 (558)
Q Consensus 524 ------~~~~kl~DFGla~~~~ 539 (558)
++.+||+|||+|+.+.
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ------CTTEEECCCTTCEEGG
T ss_pred cccccccCCEEEeeCchhhhhh
Confidence 8999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=230.54 Aligned_cols=159 Identities=28% Similarity=0.483 Sum_probs=124.6
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcCC----cEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 453 (558)
++....++|++.+.||+|+||.||+|..... ..||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3445567899999999999999999986543 27999998653 34456789999999999999999999999988
Q ss_pred CCeE------EEEEecCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 008648 454 GEEK------LLIYEFMPNKSLDYFIFDQT---NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD 524 (558)
Q Consensus 454 ~~~~------~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~ 524 (558)
.... ++||||+++++|.+++.... ....+++.++..++.||+.||+|||+++ |+||||||+||||+++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7665 99999999999999986532 2225899999999999999999999998 9999999999999999
Q ss_pred CCeEEeccccceeeCCC
Q 008648 525 MNPKISDFGLARTCGGD 541 (558)
Q Consensus 525 ~~~kl~DFGla~~~~~~ 541 (558)
+.+||+|||+|+.+...
T Consensus 174 ~~~kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSG 190 (323)
T ss_dssp SCEEECCCCC-------
T ss_pred CCEEEeecccccccccc
Confidence 99999999999877544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=232.12 Aligned_cols=152 Identities=27% Similarity=0.432 Sum_probs=134.2
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999875 5889999998653 233456789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CCeEEecccccee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD---MNPKISDFGLART 537 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~ 537 (558)
|||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999988843 346899999999999999999999998 9999999999999865 4599999999988
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=234.20 Aligned_cols=157 Identities=30% Similarity=0.479 Sum_probs=137.3
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc--------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCC 451 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 451 (558)
....++|.+.++||+|+||.||+|... .+..||||++... .....+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 345578999999999999999999853 2357999998753 334457799999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 008648 452 IHGEEKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518 (558)
Q Consensus 452 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~N 518 (558)
.+.+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999976432 235899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeccccceeeCCC
Q 008648 519 VLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~~~~~ 541 (558)
|||++++.+||+|||+|+.+...
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCC
T ss_pred EEEcCCCcEEEcccCcccccccc
Confidence 99999999999999999977543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=233.09 Aligned_cols=148 Identities=24% Similarity=0.323 Sum_probs=131.0
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..++|++.+.||+|+||.||++... +++.||||++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4578999999999999999999975 6889999998753 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC--eEEeccccceee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN--PKISDFGLARTC 538 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~~ 538 (558)
|+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+|+..
T Consensus 97 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 97 YASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999998553 35899999999999999999999998 999999999999987765 999999999854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-26 Score=242.60 Aligned_cols=154 Identities=29% Similarity=0.391 Sum_probs=137.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999975 6899999998652 23455678899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999886532 335899999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 338 ~~ 339 (576)
T 2acx_A 338 EG 339 (576)
T ss_dssp TT
T ss_pred cC
Confidence 44
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=231.19 Aligned_cols=151 Identities=20% Similarity=0.271 Sum_probs=135.7
Q ss_pred hcCCcccceeeccc--CcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.++||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45689999999999 99999999975 58999999986532 334567889999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999986642 345899999999999999999999998 999999999999999999999999998765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=231.68 Aligned_cols=151 Identities=27% Similarity=0.439 Sum_probs=133.5
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346899999999999999999997 56889999998642 22334678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 67888877543 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 160 ~~ 161 (336)
T 3h4j_B 160 DG 161 (336)
T ss_dssp TS
T ss_pred CC
Confidence 43
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=229.61 Aligned_cols=158 Identities=31% Similarity=0.488 Sum_probs=135.1
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCI 452 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 452 (558)
.....++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678999999999999999999862 3568999998753 234557899999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTNS--------------------KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 512 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHr 512 (558)
..+..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+++ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999654321 34789999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 513 DLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 513 Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||||+||||+.++.+||+|||+|+.+...
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~ 225 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSD 225 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccC
Confidence 99999999999999999999999877544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=236.01 Aligned_cols=151 Identities=27% Similarity=0.468 Sum_probs=134.6
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-eEEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-EKLLI 460 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv 460 (558)
....++|++.+.||+|+||.||+|... ++.||||+++.. ...+.+.+|+.++++++||||+++++++.+.+ ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 345578999999999999999999874 789999999753 25678999999999999999999999988765 78999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 266 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999997642 334789999999999999999999998 9999999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=231.86 Aligned_cols=148 Identities=30% Similarity=0.391 Sum_probs=127.0
Q ss_pred cceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 390 INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 390 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
..+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..+|||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999864 588999999987555667789999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--cCCCCeEEeccccceeeCCCc
Q 008648 469 LDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--DHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 469 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll--~~~~~~kl~DFGla~~~~~~~ 542 (558)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 98888543 345899999999999999999999998 9999999999999 567889999999999876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=221.97 Aligned_cols=153 Identities=31% Similarity=0.524 Sum_probs=132.7
Q ss_pred cCCcccceeecccCcccEEEEEE-----cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--Ce
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EE 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 456 (558)
.+.|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45689999999999999999983 35889999998753 334567899999999999999999999999876 56
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 899999999999999985532 35899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCCc
Q 008648 537 TCGGDK 542 (558)
Q Consensus 537 ~~~~~~ 542 (558)
.+....
T Consensus 175 ~~~~~~ 180 (302)
T 4e5w_A 175 AIETDK 180 (302)
T ss_dssp ECCTTC
T ss_pred cccCCC
Confidence 876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-26 Score=224.15 Aligned_cols=150 Identities=27% Similarity=0.479 Sum_probs=134.6
Q ss_pred cCCcccceeecccCcccEEEEEEcC-C-------cEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-G-------QEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
.++|++.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999998643 3 4799999987666777889999999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC--------eE
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN--------PK 528 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~k 528 (558)
.++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999653 334899999999999999999999998 999999999999998887 99
Q ss_pred EeccccceeeC
Q 008648 529 ISDFGLARTCG 539 (558)
Q Consensus 529 l~DFGla~~~~ 539 (558)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (289)
T 4fvq_A 162 LSDPGISITVL 172 (289)
T ss_dssp ECCCCSCTTTS
T ss_pred eccCccccccc
Confidence 99999997653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=226.22 Aligned_cols=151 Identities=27% Similarity=0.293 Sum_probs=127.4
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.++||+|+||.||+|... +++.||||++.... .........|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999976 68999999886422 22333455555555554 899999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67888887654 245899999999999999999999998 99999999999999999999999999988754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 210 ~ 210 (311)
T 3p1a_A 210 A 210 (311)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=229.41 Aligned_cols=152 Identities=22% Similarity=0.356 Sum_probs=129.8
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe---
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE--- 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 456 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999996 568899999987532 2334678999999999999999999999876543
Q ss_pred -EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 457 -KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 457 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
.++||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 39999999999999998653 35899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCC
Q 008648 536 RTCGGD 541 (558)
Q Consensus 536 ~~~~~~ 541 (558)
+.+...
T Consensus 164 ~~~~~~ 169 (311)
T 3ork_A 164 RAIADS 169 (311)
T ss_dssp ------
T ss_pred cccccc
Confidence 877543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=221.91 Aligned_cols=148 Identities=28% Similarity=0.438 Sum_probs=127.0
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCeeeeeeeEEEeC----CeE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSK--LQHRNLVKLLGCCIHG----EEK 457 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 457 (558)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 456899999999999999999987 6899999998642 34555666666665 7999999999997653 457
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEEcCCCCeEE
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDHDMNPKI 529 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH--------~~~~~~ivHrDlkp~NIll~~~~~~kl 529 (558)
++||||+++++|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+||||+.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 899999999999999932 35899999999999999999999 766 999999999999999999999
Q ss_pred eccccceeeCCCc
Q 008648 530 SDFGLARTCGGDK 542 (558)
Q Consensus 530 ~DFGla~~~~~~~ 542 (558)
+|||+|+......
T Consensus 155 ~Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 155 ADLGLAVMHSQST 167 (301)
T ss_dssp CCCTTCEEEETTT
T ss_pred eeCCCeeeccccc
Confidence 9999998775443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=235.88 Aligned_cols=154 Identities=27% Similarity=0.399 Sum_probs=133.8
Q ss_pred hhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
...++|++.+.||+|+||.||+|.. .+++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3456899999999999999999986 46889999998653 23345678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCCeEEeccccce
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---HDMNPKISDFGLAR 536 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~ 536 (558)
||||+++++|.+.+... ..+++.++..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999888653 45899999999999999999999998 99999999999998 46789999999998
Q ss_pred eeCCCc
Q 008648 537 TCGGDK 542 (558)
Q Consensus 537 ~~~~~~ 542 (558)
.+....
T Consensus 162 ~~~~~~ 167 (444)
T 3soa_A 162 EVEGEQ 167 (444)
T ss_dssp CCCTTC
T ss_pred EecCCC
Confidence 876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=237.41 Aligned_cols=156 Identities=30% Similarity=0.416 Sum_probs=138.2
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|.+.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 5899999998652 22345778999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 460 IYEFMPNKSLDYFIFDQTN-SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||||+++++|..++..... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999865432 346899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 340 ~~~~ 343 (543)
T 3c4z_A 340 KAGQ 343 (543)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 6543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=233.61 Aligned_cols=156 Identities=28% Similarity=0.425 Sum_probs=136.5
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC--eEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE--EKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 459 (558)
..++|++.++||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 34689999999999999999999754 8999999987533 345677889999999999999999999998765 6799
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCCeEEeccccc
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DHDMNPKISDFGLA 535 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFGla 535 (558)
||||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999965444445899999999999999999999998 9999999999999 77788999999999
Q ss_pred eeeCCCc
Q 008648 536 RTCGGDK 542 (558)
Q Consensus 536 ~~~~~~~ 542 (558)
+.+....
T Consensus 164 ~~~~~~~ 170 (396)
T 4eut_A 164 RELEDDE 170 (396)
T ss_dssp EECCCGG
T ss_pred eEccCCC
Confidence 9876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=239.76 Aligned_cols=155 Identities=28% Similarity=0.471 Sum_probs=134.4
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
......++|++.++||+|+||.||+|...++..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 3445667899999999999999999999888889999997633 346789999999999999999999999865 67899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+.
T Consensus 256 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999999542 1235889999999999999999999998 9999999999999999999999999999775
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 332 ~ 332 (452)
T 1fmk_A 332 D 332 (452)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=226.49 Aligned_cols=157 Identities=29% Similarity=0.508 Sum_probs=136.2
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc--------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCC 451 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 451 (558)
....++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 445678999999999999999999863 4678999998753 234456789999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 008648 452 IHGEEKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518 (558)
Q Consensus 452 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~N 518 (558)
.+.+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999975432 234889999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeccccceeeCCC
Q 008648 519 VLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~~~~~ 541 (558)
|||+.++.+||+|||+++.+...
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTT
T ss_pred EEEcCCCCEEEcccccccccccc
Confidence 99999999999999999987654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-27 Score=237.38 Aligned_cols=148 Identities=23% Similarity=0.291 Sum_probs=125.0
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccc--------cccHHHHHHHHHHHhcCC---------CCeeeee
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------DQGLKELKNEVILFSKLQ---------HRNLVKL 447 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 447 (558)
.++|++.++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 78999999987532 233478899999988885 7777777
Q ss_pred eeEEE------------------------------eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 008648 448 LGCCI------------------------------HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARG 497 (558)
Q Consensus 448 ~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~g 497 (558)
.+.+. .....+|||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77653 26788999999999976555522 458999999999999999
Q ss_pred HHHHH-hCCCCceEecCCCCCcEEEcCCC--------------------CeEEeccccceeeCC
Q 008648 498 LLYLH-QDSRLRIIHRDLKASNVLLDHDM--------------------NPKISDFGLARTCGG 540 (558)
Q Consensus 498 L~yLH-~~~~~~ivHrDlkp~NIll~~~~--------------------~~kl~DFGla~~~~~ 540 (558)
|+||| +++ |+||||||+||||+.++ .+||+|||+|+....
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 888 99999999999999887 899999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=219.89 Aligned_cols=151 Identities=27% Similarity=0.472 Sum_probs=136.4
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
..++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 346899999999999999999998888899999997633 3457899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 9999999998653 245889999999999999999999998 99999999999999999999999999987643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=219.71 Aligned_cols=154 Identities=31% Similarity=0.486 Sum_probs=135.3
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
....++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.+++.++||||+++++++. .+..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 3455789999999999999999999888889999998753 345678999999999999999999999976 55689999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|.+++.... ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999984321 125899999999999999999999998 999999999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=223.01 Aligned_cols=152 Identities=30% Similarity=0.482 Sum_probs=120.1
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457999999999999999999864 58899999986532 3345778899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQT---NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988886432 2245889999999999999999999998 9999999999999999999999999999875
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=222.44 Aligned_cols=158 Identities=29% Similarity=0.494 Sum_probs=140.1
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
......++|++.+.||+|+||.||+|.... +..||+|.+.. .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 334466789999999999999999999764 78899999875 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+|+..
T Consensus 86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999998653 3356899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 162 ~~~~ 165 (288)
T 3kfa_A 162 TGDT 165 (288)
T ss_dssp CSSS
T ss_pred cCCc
Confidence 6443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=231.62 Aligned_cols=150 Identities=25% Similarity=0.337 Sum_probs=124.0
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHH-HhcCCCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVIL-FSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3468999999999999999999975 47899999987532 2234456677776 57789999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 116 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999998553 35789999999999999999999998 999999999999999999999999999864
Q ss_pred C
Q 008648 539 G 539 (558)
Q Consensus 539 ~ 539 (558)
.
T Consensus 190 ~ 190 (373)
T 2r5t_A 190 I 190 (373)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=239.65 Aligned_cols=149 Identities=25% Similarity=0.323 Sum_probs=124.5
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++.+.+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 5889999998752 334456788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|||+++++|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999988553 358999999999999999999998 77 9999999999999999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=222.26 Aligned_cols=149 Identities=27% Similarity=0.378 Sum_probs=133.2
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999975 48999999886532 2235678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999988743 345899999999999999999999998 99999999999999999999999999988754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=229.06 Aligned_cols=157 Identities=23% Similarity=0.299 Sum_probs=133.2
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG 454 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 454 (558)
+....++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3455678999999999999999999874 5789999998642 334567899999999999999999999999999
Q ss_pred CeEEEEEecCCCCChhHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQT-------------------------------------NSKLLDWSKRFHIICGTARG 497 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~g 497 (558)
+..++||||+++++|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01123567788899999999
Q ss_pred HHHHHhCCCCceEecCCCCCcEEEcCCC--CeEEeccccceeeCC
Q 008648 498 LLYLHQDSRLRIIHRDLKASNVLLDHDM--NPKISDFGLARTCGG 540 (558)
Q Consensus 498 L~yLH~~~~~~ivHrDlkp~NIll~~~~--~~kl~DFGla~~~~~ 540 (558)
|+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999998 99999999999998766 899999999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-25 Score=217.67 Aligned_cols=152 Identities=31% Similarity=0.524 Sum_probs=135.5
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 446799999999999999999997 468999999986422 2345789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998543 346899999999999999999999998 9999999999999999999999999998875
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 164 ~ 164 (278)
T 3cok_A 164 M 164 (278)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-26 Score=227.65 Aligned_cols=160 Identities=27% Similarity=0.457 Sum_probs=138.3
Q ss_pred hhhhhhhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeE
Q 008648 378 LATISNATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGC 450 (558)
Q Consensus 378 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~ 450 (558)
..++....++|++.+.||+|+||.||+|... .++.||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3445566789999999999999999999864 36789999987532 2345678999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCChhHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 008648 451 CIHGEEKLLIYEFMPNKSLDYFIFDQT-------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH 523 (558)
Q Consensus 451 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~ 523 (558)
+.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence 999999999999999999999986421 1245789999999999999999999998 999999999999999
Q ss_pred CCCeEEeccccceeeCC
Q 008648 524 DMNPKISDFGLARTCGG 540 (558)
Q Consensus 524 ~~~~kl~DFGla~~~~~ 540 (558)
++.+||+|||+++.+..
T Consensus 174 ~~~~kl~Dfg~~~~~~~ 190 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYE 190 (322)
T ss_dssp TCCEEECCTTCCCGGGG
T ss_pred CCeEEECcCcccccccc
Confidence 99999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=231.37 Aligned_cols=152 Identities=31% Similarity=0.547 Sum_probs=132.4
Q ss_pred hcCCcccceeecccCcccEEEEEEc------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
..++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3468999999999999999999843 3668999998653 34455678999999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---CeEE
Q 008648 457 KLLIYEFMPNKSLDYFIFDQT----NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM---NPKI 529 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl 529 (558)
.++||||+++++|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+||||+.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999997643 2245899999999999999999999998 99999999999999555 5999
Q ss_pred eccccceee
Q 008648 530 SDFGLARTC 538 (558)
Q Consensus 530 ~DFGla~~~ 538 (558)
+|||+|+.+
T Consensus 226 ~DFG~a~~~ 234 (367)
T 3l9p_A 226 GDFGMARDI 234 (367)
T ss_dssp CCCHHHHHH
T ss_pred CCCcccccc
Confidence 999999865
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=219.02 Aligned_cols=156 Identities=26% Similarity=0.378 Sum_probs=134.7
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... +++.||+|++... ......++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999975 6899999998752 233456788999999999 99999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--------------
Q 008648 460 IYEFMPNKSLDYFIFDQTN-SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-------------- 524 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-------------- 524 (558)
||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999865321 245899999999999999999999998 9999999999999844
Q ss_pred -----CCeEEeccccceeeCCCc
Q 008648 525 -----MNPKISDFGLARTCGGDK 542 (558)
Q Consensus 525 -----~~~kl~DFGla~~~~~~~ 542 (558)
..+||+|||+++......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC
T ss_pred ccCCceEEEEcccccccccCCcc
Confidence 479999999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=224.55 Aligned_cols=158 Identities=34% Similarity=0.501 Sum_probs=138.0
Q ss_pred hhhcCCcccceeecccCcccEEEEEE------cCCcEEEEEEeccccc-ccHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKISD-QGLKELKNEVILFSKL-QHRNLVKLLGCCIH 453 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 453 (558)
....++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 44557899999999999999999985 2467899999875332 3457799999999999 99999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTN---------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~N 518 (558)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 9999999999999999999876432 124899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeccccceeeCCCc
Q 008648 519 VLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~~~~~~ 542 (558)
||++.++.+||+|||+++.+....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCT
T ss_pred EEEcCCCCEEEccccccccccccc
Confidence 999999999999999999876553
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=224.67 Aligned_cols=153 Identities=28% Similarity=0.451 Sum_probs=136.0
Q ss_pred cCCcccceeecccCcccEEEEEE-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH--GEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 457 (558)
.++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999984 3578999999987666667789999999999999999999999874 4568
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999986532 35899999999999999999999998 99999999999999999999999999998
Q ss_pred eCCCc
Q 008648 538 CGGDK 542 (558)
Q Consensus 538 ~~~~~ 542 (558)
+....
T Consensus 177 ~~~~~ 181 (327)
T 3lxl_A 177 LPLDK 181 (327)
T ss_dssp CCTTC
T ss_pred cccCC
Confidence 75443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=225.68 Aligned_cols=162 Identities=27% Similarity=0.291 Sum_probs=140.3
Q ss_pred CCccchhhhhhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCC-----CCeeee
Q 008648 373 LPLFELATISNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-----HRNLVK 446 (558)
Q Consensus 373 ~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 446 (558)
...+.+.+.....++|++.++||+|+||.||+|.. .+++.||||++.. .....+.+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44455666666778999999999999999999997 4588999999875 2344567788999999986 999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---
Q 008648 447 LLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH--- 523 (558)
Q Consensus 447 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~--- 523 (558)
+++++...+..++||||+ +++|.+++.... ...+++.++..++.||+.||+|||+++ |+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 999999986543 335899999999999999999999998 999999999999975
Q ss_pred ----------------------CCCeEEeccccceeeCC
Q 008648 524 ----------------------DMNPKISDFGLARTCGG 540 (558)
Q Consensus 524 ----------------------~~~~kl~DFGla~~~~~ 540 (558)
++.+||+|||+|+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78899999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=228.51 Aligned_cols=149 Identities=27% Similarity=0.382 Sum_probs=121.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..++|++.+.||+|+||.||+|... +++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999975 4789999998753 244678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~~~ 539 (558)
|+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||||+. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998843 345899999999999999999999998 999999999999975 8899999999998765
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 203 ~ 203 (349)
T 2w4o_A 203 H 203 (349)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=225.21 Aligned_cols=150 Identities=22% Similarity=0.304 Sum_probs=132.6
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999996 568899999986532 234688999999999 99999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC-----eEEecccccee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN-----PKISDFGLART 537 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~DFGla~~ 537 (558)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998653 346899999999999999999999998 999999999999998887 99999999998
Q ss_pred eCCCc
Q 008648 538 CGGDK 542 (558)
Q Consensus 538 ~~~~~ 542 (558)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.7e-26 Score=228.43 Aligned_cols=159 Identities=34% Similarity=0.505 Sum_probs=137.4
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcC------CcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEE
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCC 451 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 451 (558)
......++|++.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 445567899999999999999999998643 2479999987532 33456799999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCChhHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 008648 452 IHGEEKLLIYEFMPNKSLDYFIFDQT-----------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 520 (558)
Q Consensus 452 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIl 520 (558)
.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999986532 1235789999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeccccceeeCCC
Q 008648 521 LDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 521 l~~~~~~kl~DFGla~~~~~~ 541 (558)
|+.++.+||+|||+|+.+...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMND 217 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGC
T ss_pred ECCCCeEEECccccccccccc
Confidence 999999999999999876544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=223.60 Aligned_cols=151 Identities=28% Similarity=0.385 Sum_probs=135.1
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD------QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999975 588999999865322 1367899999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----CeEEeccc
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM----NPKISDFG 533 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFG 533 (558)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999854 345899999999999999999999998 99999999999999887 79999999
Q ss_pred cceeeCCC
Q 008648 534 LARTCGGD 541 (558)
Q Consensus 534 la~~~~~~ 541 (558)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=225.61 Aligned_cols=152 Identities=31% Similarity=0.563 Sum_probs=128.1
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCc----EEEEEEecc-cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.++|++.++||+|+||.||+|... +++ +||+|.+.. ......+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357999999999999999999864 343 468888754 23355678999999999999999999999998754 78
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+|+||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999986543 45899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 168 ~~~~ 171 (327)
T 3poz_A 168 GAEE 171 (327)
T ss_dssp TTTC
T ss_pred cCCc
Confidence 6543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=219.26 Aligned_cols=155 Identities=25% Similarity=0.369 Sum_probs=133.4
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..++|.+.++||+|+||.||+|... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3357999999999999999999974 58899999986533 345678999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCCeEEecccccee
Q 008648 462 EFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLART 537 (558)
Q Consensus 462 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~ 537 (558)
||+++++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999888543 22356899999999999999999999998 9999999999999 4567899999999987
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 177 ~~~~ 180 (285)
T 3is5_A 177 FKSD 180 (285)
T ss_dssp ----
T ss_pred cCCc
Confidence 6543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=227.85 Aligned_cols=153 Identities=28% Similarity=0.361 Sum_probs=134.2
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--------DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 454 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999986 458899999986532 11334677899999999999999999999999
Q ss_pred CeEEEEEecCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 455 EEKLLIYEFMPNK-SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 455 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
+..++||||+.+| +|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999776 99998854 335899999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCCc
Q 008648 534 LARTCGGDK 542 (558)
Q Consensus 534 la~~~~~~~ 542 (558)
+|+.+....
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=222.95 Aligned_cols=155 Identities=27% Similarity=0.397 Sum_probs=134.6
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe----CCe
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH----GEE 456 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 456 (558)
....++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34557899999999999999999997 5689999999876556667889999999999999999999999873 346
Q ss_pred EEEEEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
.++||||+++++|.+++... .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 78999999999999988653 23456899999999999999999999998 999999999999999999999999998
Q ss_pred eeeC
Q 008648 536 RTCG 539 (558)
Q Consensus 536 ~~~~ 539 (558)
+...
T Consensus 182 ~~~~ 185 (317)
T 2buj_A 182 NQAC 185 (317)
T ss_dssp EESC
T ss_pred hhcc
Confidence 7653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=237.11 Aligned_cols=150 Identities=25% Similarity=0.460 Sum_probs=122.6
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-----Ce
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-----EE 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 456 (558)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999864 5889999998653 233457789999999999999999999998543 46
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+ +++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 4788888843 345899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 205 ~~~~~ 209 (458)
T 3rp9_A 205 TVDYP 209 (458)
T ss_dssp CTTSC
T ss_pred hccCc
Confidence 87543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=217.44 Aligned_cols=153 Identities=33% Similarity=0.557 Sum_probs=125.5
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3468999999999999999999974 8899999986532 2345778999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--------CCCeEEec
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH--------DMNPKISD 531 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~--------~~~~kl~D 531 (558)
||||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+|||++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999983 346899999999999999999999987555899999999999986 67899999
Q ss_pred cccceeeCCC
Q 008648 532 FGLARTCGGD 541 (558)
Q Consensus 532 FGla~~~~~~ 541 (558)
||+++.+...
T Consensus 160 fg~~~~~~~~ 169 (271)
T 3dtc_A 160 FGLAREWHRT 169 (271)
T ss_dssp CCC-------
T ss_pred CCcccccccc
Confidence 9999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=218.30 Aligned_cols=151 Identities=25% Similarity=0.368 Sum_probs=135.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|.+.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4468999999999999999999975 4788999998653 23345678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999988543 35899999999999999999999998 9999999999999999999999999999875
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 167 ~ 167 (294)
T 2rku_A 167 Y 167 (294)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=220.99 Aligned_cols=153 Identities=25% Similarity=0.406 Sum_probs=125.1
Q ss_pred hhcCCcccceeecccCcccEEEEEEcC----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
...++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCcc
Confidence 345689999999999999999998643 457999998653 234456799999999999999999999997 45678
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999998653 335899999999999999999999998 99999999999999999999999999988
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 166 ~~~~ 169 (281)
T 1mp8_A 166 MEDS 169 (281)
T ss_dssp ----
T ss_pred cCcc
Confidence 7543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=242.69 Aligned_cols=155 Identities=28% Similarity=0.471 Sum_probs=136.7
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.++...++|++.++||+|+||.||+|.+.++..||||+++... ...+++.+|+.++++++||||+++++++.+ +..+|
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3445567899999999999999999999888899999997633 346789999999999999999999999865 67899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+.
T Consensus 339 v~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999999542 1235889999999999999999999998 9999999999999999999999999998765
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 415 ~ 415 (535)
T 2h8h_A 415 D 415 (535)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=223.05 Aligned_cols=151 Identities=26% Similarity=0.379 Sum_probs=135.3
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|.+.+.||+|+||.||++...+ ++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 44689999999999999999999754 788999998653 23345678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999988543 35899999999999999999999998 9999999999999999999999999999875
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 193 ~ 193 (335)
T 2owb_A 193 Y 193 (335)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=221.82 Aligned_cols=149 Identities=27% Similarity=0.371 Sum_probs=131.4
Q ss_pred cCCcccc-eeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEE
Q 008648 385 TNNFSIN-NKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 385 ~~~y~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 461 (558)
.+.|++. +.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578875 6899999999999985 46899999999776556678899999999885 7999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC---eEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN---PKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~~ 538 (558)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998653 35899999999999999999999998 999999999999998776 999999999876
Q ss_pred C
Q 008648 539 G 539 (558)
Q Consensus 539 ~ 539 (558)
.
T Consensus 165 ~ 165 (316)
T 2ac3_A 165 K 165 (316)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=217.13 Aligned_cols=149 Identities=30% Similarity=0.394 Sum_probs=134.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357999999999999999999975 68899999986432 3445789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 9999999998833 345899999999999999999999998 9999999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=221.93 Aligned_cols=162 Identities=29% Similarity=0.511 Sum_probs=130.0
Q ss_pred chhhhhhhcCCcccceeecccCcccEEEEEEcC----CcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeE
Q 008648 377 ELATISNATNNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGC 450 (558)
Q Consensus 377 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 450 (558)
.+.++....++|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 344555567889999999999999999998642 458999998653 23345679999999999999999999999
Q ss_pred EEeCCe-----EEEEEecCCCCChhHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 008648 451 CIHGEE-----KLLIYEFMPNKSLDYFIFDQ---TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 522 (558)
Q Consensus 451 ~~~~~~-----~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~ 522 (558)
+.+... .++||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence 987653 49999999999999998543 23456899999999999999999999988 99999999999999
Q ss_pred CCCCeEEeccccceeeCCC
Q 008648 523 HDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 523 ~~~~~kl~DFGla~~~~~~ 541 (558)
.++.+||+|||+++.+...
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSG 200 (313)
T ss_dssp TTSCEEECSCSCC------
T ss_pred CCCcEEEeecCcceecccc
Confidence 9999999999999877543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=216.02 Aligned_cols=152 Identities=28% Similarity=0.403 Sum_probs=133.5
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
++|.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556999999999999996 457899999997765566788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCCeEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~ 540 (558)
++++|.+++........+++..+..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||+++.+..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999976544456788899999999999999999998 999999999999987 89999999999988754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=218.84 Aligned_cols=151 Identities=30% Similarity=0.415 Sum_probs=133.0
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4568999999999999999999875 4678999998642 22345678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999988553 34899999999999999999999988 9999999999999999999999999986654
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 161 ~ 161 (279)
T 3fdn_A 161 S 161 (279)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=232.87 Aligned_cols=151 Identities=26% Similarity=0.475 Sum_probs=131.6
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-----C
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-----E 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 455 (558)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4568999999999999999999975 4788999999753 233456789999999999999999999999876 5
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..++||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999986 599998843 345899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCC
Q 008648 536 RTCGGD 541 (558)
Q Consensus 536 ~~~~~~ 541 (558)
+.+...
T Consensus 177 ~~~~~~ 182 (432)
T 3n9x_A 177 RTINSE 182 (432)
T ss_dssp EEC---
T ss_pred cccccc
Confidence 987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=225.94 Aligned_cols=152 Identities=27% Similarity=0.476 Sum_probs=129.8
Q ss_pred cCCcccceeecccCcccEEEEEEcC-Cc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.++|++.+.||+|+||.||+|.... ++ .||+|.+... .....+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 3579999999999999999998643 43 3788877542 2334456788999999999999999999886 56688
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998543 346889999999999999999999998 999999999999999999999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 166 ~~~~ 169 (325)
T 3kex_A 166 PPDD 169 (325)
T ss_dssp CCCT
T ss_pred Cccc
Confidence 6543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=225.16 Aligned_cols=150 Identities=29% Similarity=0.466 Sum_probs=131.4
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.+.|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688999999999999999996 568899999986432 23346789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||++ |+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 5777776433 245899999999999999999999998 99999999999999999999999999987654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=229.61 Aligned_cols=150 Identities=24% Similarity=0.305 Sum_probs=133.6
Q ss_pred cCCcccceeecccCcccEEEEEE----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----DQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGE 455 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 455 (558)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 368899999986522 23456678899999999 6999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..+|||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998653 35899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCC
Q 008648 536 RTCGG 540 (558)
Q Consensus 536 ~~~~~ 540 (558)
+.+..
T Consensus 207 ~~~~~ 211 (355)
T 1vzo_A 207 KEFVA 211 (355)
T ss_dssp EECCG
T ss_pred eeccc
Confidence 97653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=217.30 Aligned_cols=153 Identities=27% Similarity=0.438 Sum_probs=134.6
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999875 5889999998653 233456788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC---eEEecccccee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN---PKISDFGLART 537 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~ 537 (558)
|||+++++|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+++.
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998888553 45899999999999999999999998 999999999999986655 99999999987
Q ss_pred eCCCc
Q 008648 538 CGGDK 542 (558)
Q Consensus 538 ~~~~~ 542 (558)
.....
T Consensus 158 ~~~~~ 162 (284)
T 3kk8_A 158 VNDSE 162 (284)
T ss_dssp CCSSC
T ss_pred cccCc
Confidence 76443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-25 Score=222.25 Aligned_cols=153 Identities=30% Similarity=0.549 Sum_probs=135.2
Q ss_pred hcCCcccceeecccCcccEEEEEE-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC--e
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE--E 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~ 456 (558)
..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346799999999999999999984 358899999998766666778999999999999999999999987654 6
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+++++|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 799999999999999996542 35899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 194 ~~~~~ 198 (326)
T 2w1i_A 194 VLPQD 198 (326)
T ss_dssp ECCSS
T ss_pred hcccc
Confidence 87654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=218.34 Aligned_cols=149 Identities=33% Similarity=0.504 Sum_probs=131.3
Q ss_pred CCc-ccceeecccCcccEEEEEE-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--Ce
Q 008648 386 NNF-SINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EE 456 (558)
Q Consensus 386 ~~y-~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 456 (558)
++| ++.++||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8999999999999999864 257899999997532 34467799999999999999999999999984 57
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+++++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 89999999999999998542 3899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 183 ~~~~~ 187 (318)
T 3lxp_A 183 AVPEG 187 (318)
T ss_dssp ECCTT
T ss_pred ccccc
Confidence 87654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=220.21 Aligned_cols=153 Identities=31% Similarity=0.524 Sum_probs=131.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcC----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CCeE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH-GEEK 457 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 457 (558)
...+|++.+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34578899999999999999998643 235899988753 23445779999999999999999999998654 4577
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999999542 345789999999999999999999998 99999999999999999999999999987
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 178 ~~~~ 181 (298)
T 3f66_A 178 MYDK 181 (298)
T ss_dssp CSCG
T ss_pred cccc
Confidence 7544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=227.23 Aligned_cols=151 Identities=26% Similarity=0.353 Sum_probs=131.7
Q ss_pred hhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCC--CeeeeeeeEEEeCCeEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQH--RNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~ 458 (558)
...++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++......+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 345689999999999999999999888999999998642 33445778999999999976 99999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||| +.+++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+ ++.+||+|||+|+.+
T Consensus 86 lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 5688999998653 45889999999999999999999998 99999999999997 578999999999887
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 158 ~~~ 160 (343)
T 3dbq_A 158 QPD 160 (343)
T ss_dssp ---
T ss_pred Ccc
Confidence 544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=216.93 Aligned_cols=152 Identities=30% Similarity=0.536 Sum_probs=132.7
Q ss_pred hcCCcccce-eecccCcccEEEEEEc---CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..++|.+.+ .||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 345677776 9999999999999853 5778999999763 334567899999999999999999999999 566789
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+
T Consensus 86 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999999853 2345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 161 ~~~ 163 (287)
T 1u59_A 161 GAD 163 (287)
T ss_dssp TTC
T ss_pred ccC
Confidence 544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=216.81 Aligned_cols=152 Identities=27% Similarity=0.444 Sum_probs=135.9
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999975 6899999998652 23345688999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998653 34889999999999999999999998 9999999999999999999999999998775
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 163 ~~ 164 (276)
T 2h6d_A 163 DG 164 (276)
T ss_dssp C-
T ss_pred CC
Confidence 43
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=222.01 Aligned_cols=163 Identities=28% Similarity=0.458 Sum_probs=138.6
Q ss_pred cchhhhhhhcCCcccceeecccCcccEEEEEE------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeee
Q 008648 376 FELATISNATNNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKL 447 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 447 (558)
+.........++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455566778999999999999999999984 246789999987532 23456789999999999 79999999
Q ss_pred eeEEEeCC-eEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 008648 448 LGCCIHGE-EKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 513 (558)
Q Consensus 448 ~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrD 513 (558)
++++...+ ..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988755 48999999999999999965432 123789999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 514 LKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 514 lkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|||+||||+.++.+||+|||+++.+...
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred CccceEEECCCCCEEECCCccccccccC
Confidence 9999999999999999999999877544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-25 Score=222.10 Aligned_cols=141 Identities=28% Similarity=0.339 Sum_probs=125.2
Q ss_pred eeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 392 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
+.||+|+||.||+|... +++.||||++.+ .....+.+|+.++..+. ||||+++++++.+....++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999975 588999999864 34567889999999997 99999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---CeEEeccccceeeCCC
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM---NPKISDFGLARTCGGD 541 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~~~~~ 541 (558)
.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9998653 45899999999999999999999998 99999999999998665 7999999999976544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-25 Score=215.79 Aligned_cols=150 Identities=26% Similarity=0.409 Sum_probs=133.2
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57899999999999999999975 58999999986522 124678999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----CeEEecccc
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM----NPKISDFGL 534 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGl 534 (558)
+||||+++++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999998543 35899999999999999999999998 99999999999998877 799999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
++.+...
T Consensus 159 ~~~~~~~ 165 (283)
T 3bhy_A 159 AHKIEAG 165 (283)
T ss_dssp CEECC--
T ss_pred ceeccCC
Confidence 9987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=222.48 Aligned_cols=150 Identities=29% Similarity=0.475 Sum_probs=129.7
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------- 454 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 454 (558)
.++|++.++||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 468999999885432 23356788999999999999999999999874
Q ss_pred -CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 455 -EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 455 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
+..++||||+++ +|...+... ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 467999999985 666666432 345899999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCC
Q 008648 534 LARTCGG 540 (558)
Q Consensus 534 la~~~~~ 540 (558)
+|+.+..
T Consensus 170 ~a~~~~~ 176 (351)
T 3mi9_A 170 LARAFSL 176 (351)
T ss_dssp TCEECCC
T ss_pred hcccccc
Confidence 9998753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=228.03 Aligned_cols=151 Identities=32% Similarity=0.536 Sum_probs=123.1
Q ss_pred CCcccceeecccCcccEEEEEEcC--C--cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe-CCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH-GEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 459 (558)
..|++.+.||+|+||.||+|...+ + ..||+|.+... .....+++.+|+.++++++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 357778999999999999998642 2 36899988653 33456789999999999999999999999765 457799
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999543 345789999999999999999999998 9999999999999999999999999998775
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 244 ~~ 245 (373)
T 3c1x_A 244 DK 245 (373)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=231.33 Aligned_cols=152 Identities=26% Similarity=0.371 Sum_probs=127.6
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------DQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 453 (558)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999874 47899999986521 112235789999999999999999999974
Q ss_pred CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CCeEEe
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD---MNPKIS 530 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~ 530 (558)
.+..++||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 5668999999999999888743 346899999999999999999999998 9999999999999754 459999
Q ss_pred ccccceeeCCC
Q 008648 531 DFGLARTCGGD 541 (558)
Q Consensus 531 DFGla~~~~~~ 541 (558)
|||+|+.+...
T Consensus 285 DFG~a~~~~~~ 295 (419)
T 3i6u_A 285 DFGHSKILGET 295 (419)
T ss_dssp CSSTTTSCC--
T ss_pred ecccceecCCC
Confidence 99999877543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=225.61 Aligned_cols=156 Identities=21% Similarity=0.373 Sum_probs=137.2
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc--------ccHHHHHHHHHHHhcC-CCCeeeeeee
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD--------QGLKELKNEVILFSKL-QHRNLVKLLG 449 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~ 449 (558)
......++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445578999999999999999999985 689999999865321 1245678999999999 7999999999
Q ss_pred EEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEE
Q 008648 450 CCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKI 529 (558)
Q Consensus 450 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 529 (558)
++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998643 35899999999999999999999998 999999999999999999999
Q ss_pred eccccceeeCCC
Q 008648 530 SDFGLARTCGGD 541 (558)
Q Consensus 530 ~DFGla~~~~~~ 541 (558)
+|||+++.+...
T Consensus 242 ~DfG~~~~~~~~ 253 (365)
T 2y7j_A 242 SDFGFSCHLEPG 253 (365)
T ss_dssp CCCTTCEECCTT
T ss_pred EecCcccccCCC
Confidence 999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-25 Score=218.71 Aligned_cols=149 Identities=30% Similarity=0.493 Sum_probs=132.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4568999999999999999999975 488999999977666677889999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
|+++++|..++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999988653 235899999999999999999999998 99999999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=214.71 Aligned_cols=151 Identities=27% Similarity=0.440 Sum_probs=135.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3457999999999999999999864 58899999986532 345678999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999999842 45899999999999999999999998 999999999999999999999999999887544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=222.47 Aligned_cols=153 Identities=29% Similarity=0.494 Sum_probs=129.4
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
...+|++.+.||+|+||.||+|.... +..||+|++... .......+.+|+.++++++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34678888999999999999998643 236999998753 233456789999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999998653 345899999999999999999999998 99999999999999999999999999998
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 197 ~~~~ 200 (333)
T 1mqb_A 197 LEDD 200 (333)
T ss_dssp ----
T ss_pred hccc
Confidence 7544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-25 Score=222.14 Aligned_cols=150 Identities=26% Similarity=0.444 Sum_probs=127.3
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcC--CCCeeeeeeeEEEeC----C
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL--QHRNLVKLLGCCIHG----E 455 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 455 (558)
....++|++.++||+|+||.||+|... ++.||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999875 899999998542 234445555555554 899999999999987 6
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceEecCCCCCcEEEcCCCCe
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD--------SRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~--------~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
..++||||+++++|.+++... .+++..++.++.|++.||+|||++ + |+||||||+||||+.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 789999999999999999543 489999999999999999999988 6 9999999999999999999
Q ss_pred EEeccccceeeCCCc
Q 008648 528 KISDFGLARTCGGDK 542 (558)
Q Consensus 528 kl~DFGla~~~~~~~ 542 (558)
||+|||+|+.+....
T Consensus 182 kl~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 182 CIADLGLAVKFISDT 196 (337)
T ss_dssp EECCCTTCEECC---
T ss_pred EEEeCCCceeecccc
Confidence 999999998775443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=241.71 Aligned_cols=151 Identities=26% Similarity=0.339 Sum_probs=134.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4468999999999999999999975 4788999998752 234556788999999988 7999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998653 35899999999999999999999998 999999999999999999999999999975
Q ss_pred CC
Q 008648 539 GG 540 (558)
Q Consensus 539 ~~ 540 (558)
..
T Consensus 493 ~~ 494 (674)
T 3pfq_A 493 IW 494 (674)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=218.69 Aligned_cols=152 Identities=20% Similarity=0.261 Sum_probs=130.6
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD---QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4478999999999999999999975 588999999875322 234678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998653 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 186 ~~ 187 (309)
T 2h34_A 186 DE 187 (309)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.7e-25 Score=221.34 Aligned_cols=150 Identities=30% Similarity=0.472 Sum_probs=129.9
Q ss_pred cCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
.++|++.+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3589999999999999999999754 8899999986532 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999887643 335899999999999999999999998 99999999999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=216.83 Aligned_cols=150 Identities=30% Similarity=0.487 Sum_probs=131.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe---------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH--------- 453 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 453 (558)
...+|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999975 68999999986532 356789999999999999999999865
Q ss_pred -------CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 454 -------GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 454 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 344789999999999999996532 346899999999999999999999998 999999999999999999
Q ss_pred eEEeccccceeeCCC
Q 008648 527 PKISDFGLARTCGGD 541 (558)
Q Consensus 527 ~kl~DFGla~~~~~~ 541 (558)
+||+|||+++.+...
T Consensus 161 ~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 161 VKIGDFGLVTSLKND 175 (284)
T ss_dssp EEECCCTTCEESSCC
T ss_pred EEECcchhheecccc
Confidence 999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=224.98 Aligned_cols=149 Identities=27% Similarity=0.530 Sum_probs=123.5
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCC--eE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGE--EK 457 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 457 (558)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999864 5889999998642 2344567889999999997 999999999998654 68
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 589888854 35889999999999999999999998 99999999999999999999999999998
Q ss_pred eCC
Q 008648 538 CGG 540 (558)
Q Consensus 538 ~~~ 540 (558)
+..
T Consensus 159 ~~~ 161 (388)
T 3oz6_A 159 FVN 161 (388)
T ss_dssp SSS
T ss_pred ccc
Confidence 753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.7e-25 Score=233.92 Aligned_cols=153 Identities=30% Similarity=0.420 Sum_probs=132.9
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc-------------ccHHHHHHHHHHHhcCCCCeeeeee
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD-------------QGLKELKNEVILFSKLQHRNLVKLL 448 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~ 448 (558)
...++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35578999999999999999999975 478999999865321 3456789999999999999999999
Q ss_pred eEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---
Q 008648 449 GCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM--- 525 (558)
Q Consensus 449 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~--- 525 (558)
+++.+....++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999998888553 35899999999999999999999998 99999999999998765
Q ss_pred CeEEeccccceeeCCC
Q 008648 526 NPKISDFGLARTCGGD 541 (558)
Q Consensus 526 ~~kl~DFGla~~~~~~ 541 (558)
.+||+|||+|+.+...
T Consensus 187 ~~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD 202 (504)
T ss_dssp SEEECCCTTCEECCTT
T ss_pred cEEEEECCCCEEcCCC
Confidence 6999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=225.59 Aligned_cols=157 Identities=25% Similarity=0.407 Sum_probs=131.4
Q ss_pred hhhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccccc-----------ccHHHHHHHHHHHhcCCCCeeee
Q 008648 378 LATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD-----------QGLKELKNEVILFSKLQHRNLVK 446 (558)
Q Consensus 378 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~ 446 (558)
..++....++|++.+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4566777899999999999999999999988899999999854221 12378999999999999999999
Q ss_pred eeeEEEeCC-----eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 008648 447 LLGCCIHGE-----EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 521 (558)
Q Consensus 447 l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll 521 (558)
+++++...+ ..++||||++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999996533 5799999998 577777753 3346899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceeeCC
Q 008648 522 DHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 522 ~~~~~~kl~DFGla~~~~~ 540 (558)
+.++.+||+|||+|+....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTA 186 (362)
T ss_dssp CTTCCEEECCTTC------
T ss_pred cCCCCEEEEecCccccccc
Confidence 9999999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-25 Score=217.16 Aligned_cols=154 Identities=28% Similarity=0.459 Sum_probs=132.6
Q ss_pred hhhcCCcccce-eecccCcccEEEEEEc---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 382 SNATNNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 382 ~~~~~~y~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
....++|.+.+ .||+|+||.||+|... .++.||||++.... ....+++.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 33456788888 9999999999999643 36789999987532 23357899999999999999999999999 667
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 789999999999999999653 35899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCc
Q 008648 536 RTCGGDK 542 (558)
Q Consensus 536 ~~~~~~~ 542 (558)
+.+....
T Consensus 165 ~~~~~~~ 171 (291)
T 1xbb_A 165 KALRADE 171 (291)
T ss_dssp EECCTTC
T ss_pred eeeccCC
Confidence 9876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=216.89 Aligned_cols=153 Identities=29% Similarity=0.456 Sum_probs=127.5
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc-----cccHHHHHHHHHHHhcCC---CCeeeeeeeEEEeC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS-----DQGLKELKNEVILFSKLQ---HRNLVKLLGCCIHG 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 454 (558)
..++|++.++||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999996 468899999986422 122356777887777664 99999999999876
Q ss_pred C-----eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEE
Q 008648 455 E-----EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKI 529 (558)
Q Consensus 455 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 529 (558)
. ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 59999886543 334899999999999999999999998 999999999999999999999
Q ss_pred eccccceeeCCC
Q 008648 530 SDFGLARTCGGD 541 (558)
Q Consensus 530 ~DFGla~~~~~~ 541 (558)
+|||+|+.+...
T Consensus 162 ~Dfg~a~~~~~~ 173 (308)
T 3g33_A 162 ADFGLARIYSYQ 173 (308)
T ss_dssp CSCSCTTTSTTC
T ss_pred eeCccccccCCC
Confidence 999999876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=215.27 Aligned_cols=151 Identities=27% Similarity=0.410 Sum_probs=134.4
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3468999999999999999999975 4778999998642 22345678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999998653 35899999999999999999999988 9999999999999999999999999998765
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 166 ~ 166 (284)
T 2vgo_A 166 S 166 (284)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=216.50 Aligned_cols=153 Identities=25% Similarity=0.334 Sum_probs=135.1
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---------cccHHHHHHHHHHHhcCC-CCeeeeeeeEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------DQGLKELKNEVILFSKLQ-HRNLVKLLGCC 451 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 451 (558)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999975 58899999986432 123456889999999995 99999999999
Q ss_pred EeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEec
Q 008648 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531 (558)
Q Consensus 452 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 531 (558)
......++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998653 35899999999999999999999998 99999999999999999999999
Q ss_pred cccceeeCCC
Q 008648 532 FGLARTCGGD 541 (558)
Q Consensus 532 FGla~~~~~~ 541 (558)
||+++.+...
T Consensus 168 fg~~~~~~~~ 177 (298)
T 1phk_A 168 FGFSCQLDPG 177 (298)
T ss_dssp CTTCEECCTT
T ss_pred ccchhhcCCC
Confidence 9999987544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=234.12 Aligned_cols=149 Identities=30% Similarity=0.440 Sum_probs=125.0
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------ 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 454 (558)
..++|++.++||+|+||.||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999864 5889999999753 334466788999999999999999999999754
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
...+|||||++++ |...+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3569999999865 555552 23889999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.....
T Consensus 211 a~~~~~~ 217 (464)
T 3ttj_A 211 ARTAGTS 217 (464)
T ss_dssp C-----C
T ss_pred eeecCCC
Confidence 9977543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.7e-25 Score=238.78 Aligned_cols=151 Identities=30% Similarity=0.529 Sum_probs=130.2
Q ss_pred cCCcccce-eecccCcccEEEEEEc---CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 385 TNNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.+++.+.+ +||+|+||.||+|... ++..||||+++... ....+++.+|+.++++++||||+++++++.. +..+|
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34455555 8999999999999864 45679999997633 3456889999999999999999999999875 56899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 413 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999998542 446899999999999999999999998 9999999999999999999999999998875
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
.+
T Consensus 488 ~~ 489 (613)
T 2ozo_A 488 AD 489 (613)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=230.94 Aligned_cols=153 Identities=18% Similarity=0.222 Sum_probs=126.0
Q ss_pred hhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecc---cccccHHHHHHHH---HHHhcCCCCeeeeee-------
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISDQGLKELKNEV---ILFSKLQHRNLVKLL------- 448 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~------- 448 (558)
...++|++.+.||+|+||.||+|.. .+++.||||++.. ......+.+.+|+ .+++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999999996 4689999999864 2334567899999 555666899999998
Q ss_pred eEEEeCCe-----------------EEEEEecCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 008648 449 GCCIHGEE-----------------KLLIYEFMPNKSLDYFIFDQTN----SKLLDWSKRFHIICGTARGLLYLHQDSRL 507 (558)
Q Consensus 449 ~~~~~~~~-----------------~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~yLH~~~~~ 507 (558)
+++.+.+. .+|||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 66665532 78999999 6899999865311 123446888899999999999999998
Q ss_pred ceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 508 RIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 508 ~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|+||||||+||||+.++.+||+|||+|+..+
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 9999999999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-25 Score=223.30 Aligned_cols=152 Identities=35% Similarity=0.494 Sum_probs=126.3
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc-----ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD-----QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
...++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 588999999864221 123468899999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+++ +|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 88888743 2345888999999999999999999998 9999999999999999999999999998
Q ss_pred eeCC
Q 008648 537 TCGG 540 (558)
Q Consensus 537 ~~~~ 540 (558)
.+..
T Consensus 161 ~~~~ 164 (346)
T 1ua2_A 161 SFGS 164 (346)
T ss_dssp TTTS
T ss_pred eccC
Confidence 7653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=223.77 Aligned_cols=150 Identities=29% Similarity=0.467 Sum_probs=125.7
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----- 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 455 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999997 45899999998542 2334567889999999999999999999998653
Q ss_pred -eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 456 -EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 456 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999854 34889999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.....
T Consensus 175 a~~~~~~ 181 (367)
T 1cm8_A 175 ARQADSE 181 (367)
T ss_dssp CEECCSS
T ss_pred ccccccc
Confidence 9987543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=222.13 Aligned_cols=152 Identities=26% Similarity=0.380 Sum_probs=134.8
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccccccc-----------------HHHHHHHHHHHhcCCCCeeee
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQG-----------------LKELKNEVILFSKLQHRNLVK 446 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 446 (558)
..++|++.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 346899999999999999999999 89999999986522111 178999999999999999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCChhHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcE
Q 008648 447 LLGCCIHGEEKLLIYEFMPNKSLDYF------IFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNV 519 (558)
Q Consensus 447 l~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NI 519 (558)
+++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||+|||+ .+ |+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 99999999999999999999999988 422 124568999999999999999999999 87 99999999999
Q ss_pred EEcCCCCeEEeccccceeeCC
Q 008648 520 LLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 520 ll~~~~~~kl~DFGla~~~~~ 540 (558)
|++.++.+||+|||+++....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp EECTTSCEEECCCTTCEECBT
T ss_pred EEcCCCcEEEecccccccccc
Confidence 999999999999999988644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-25 Score=218.45 Aligned_cols=149 Identities=31% Similarity=0.475 Sum_probs=129.3
Q ss_pred CcccceeecccCcccEEEEEEcC-C---cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE-EEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK-LLI 460 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 460 (558)
.|.+.++||+|+||.||+|...+ + ..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 56667899999999999998643 2 379999987533 34557889999999999999999999999876665 999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+.+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999854 2345889999999999999999999998 99999999999999999999999999986644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-25 Score=219.77 Aligned_cols=151 Identities=27% Similarity=0.435 Sum_probs=125.9
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.++|++.+.||+|+||.||+|.. .++.||+|++.. ....+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 35788999999999999999987 478899999864 345678999999999999999999999876 4579999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC-eEEeccccceeeCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN-PKISDFGLARTCGG 540 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~-~kl~DFGla~~~~~ 540 (558)
++++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+||||+.++. +||+|||+|+.+..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999976544445788999999999999999999932223999999999999998886 79999999986643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=218.42 Aligned_cols=150 Identities=35% Similarity=0.607 Sum_probs=129.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcE--EEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQE--IAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 460 (558)
++|++.+.||+|+||.||+|... ++.. +|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999864 4554 489988652 334556789999999999 899999999999999999999
Q ss_pred EecCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCe
Q 008648 461 YEFMPNKSLDYFIFDQT-------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
|||+++++|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeccccceee
Q 008648 528 KISDFGLARTC 538 (558)
Q Consensus 528 kl~DFGla~~~ 538 (558)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=216.31 Aligned_cols=155 Identities=25% Similarity=0.431 Sum_probs=128.5
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 446799999999999999999996 46899999998752 23445678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 460 IYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+|+.++.+||+|||+++.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999988642 22456899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 187 ~~~ 189 (310)
T 2wqm_A 187 SSK 189 (310)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-25 Score=233.45 Aligned_cols=152 Identities=30% Similarity=0.375 Sum_probs=130.2
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..++|++.++||+|+||.||+|... ++..||+|++.+.. ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999975 58899999987532 33467889999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEecccccee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGLART 537 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~ 537 (558)
|||+++++|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||+|+.
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999998888543 35899999999999999999999998 999999999999976 44599999999998
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 189 ~~~~ 192 (494)
T 3lij_A 189 FENQ 192 (494)
T ss_dssp CBTT
T ss_pred CCCC
Confidence 7654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=219.65 Aligned_cols=161 Identities=30% Similarity=0.469 Sum_probs=136.7
Q ss_pred ccchhhhhhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 008648 375 LFELATISNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCI 452 (558)
Q Consensus 375 ~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 452 (558)
.+++..+....++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 344555666788999999999999999999997 46889999998653 34457889999999998 7999999999998
Q ss_pred e------CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 453 H------GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 453 ~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
. .+..++||||+++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 7 457899999999999999986542 346889999999999999999999998 999999999999999999
Q ss_pred eEEeccccceeeCC
Q 008648 527 PKISDFGLARTCGG 540 (558)
Q Consensus 527 ~kl~DFGla~~~~~ 540 (558)
+||+|||+++.+..
T Consensus 168 ~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 168 VKLVDFGVSAQLDR 181 (326)
T ss_dssp EEECCCTTTC----
T ss_pred EEEeeCcCceecCc
Confidence 99999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=216.11 Aligned_cols=150 Identities=28% Similarity=0.492 Sum_probs=132.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe----------
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH---------- 453 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 453 (558)
.++|++.+.||+|+||.||+|... +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457999999999999999999974 689999999865 33456788999999999999999999999876
Q ss_pred ---CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 454 ---GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 454 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
....++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34578999999999999999653 245788899999999999999999998 9999999999999999999999
Q ss_pred ccccceeeCC
Q 008648 531 DFGLARTCGG 540 (558)
Q Consensus 531 DFGla~~~~~ 540 (558)
|||+++.+..
T Consensus 159 dfg~~~~~~~ 168 (303)
T 1zy4_A 159 DFGLAKNVHR 168 (303)
T ss_dssp CCCCCSCTTC
T ss_pred eCcchhhccc
Confidence 9999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-25 Score=222.28 Aligned_cols=151 Identities=30% Similarity=0.468 Sum_probs=127.4
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
....++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 445578999999999999999999864 68899999986532 223456789999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-----CCCCeEEeccc
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-----HDMNPKISDFG 533 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-----~~~~~kl~DFG 533 (558)
+||||+++ +|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+ +++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999984 999888553 34899999999999999999999998 99999999999994 45569999999
Q ss_pred cceeeC
Q 008648 534 LARTCG 539 (558)
Q Consensus 534 la~~~~ 539 (558)
+|+.+.
T Consensus 183 ~a~~~~ 188 (329)
T 3gbz_A 183 LARAFG 188 (329)
T ss_dssp HHHHHC
T ss_pred CccccC
Confidence 998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=9.1e-25 Score=216.80 Aligned_cols=151 Identities=34% Similarity=0.542 Sum_probs=124.6
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
+...++|++.++||+|+||.||+|... ..+|+|++... .....+.+.+|+.++++++||||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345678999999999999999999864 36999998643 334457799999999999999999999965 5567899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 97 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999988443 346899999999999999999999998 9999999999999999999999999998664
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 172 ~ 172 (289)
T 3og7_A 172 R 172 (289)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=231.99 Aligned_cols=152 Identities=32% Similarity=0.419 Sum_probs=135.5
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3468999999999999999999975 6899999998642 23456789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCCeEEeccccce
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLAR 536 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~ 536 (558)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999888543 45899999999999999999999998 9999999999999 467899999999998
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 178 ~~~~~ 182 (484)
T 3nyv_A 178 HFEAS 182 (484)
T ss_dssp HBCCC
T ss_pred Ecccc
Confidence 77554
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=213.22 Aligned_cols=152 Identities=32% Similarity=0.586 Sum_probs=129.5
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccc-------cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQ-------GLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
..++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 4468999999999999999999974 6889999998642221 1267899999999999999999999986544
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC-----eEEe
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN-----PKIS 530 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~ 530 (558)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 7999999999998888543 346899999999999999999999875 34999999999999988776 9999
Q ss_pred ccccceeeCC
Q 008648 531 DFGLARTCGG 540 (558)
Q Consensus 531 DFGla~~~~~ 540 (558)
|||+|+....
T Consensus 172 Dfg~~~~~~~ 181 (287)
T 4f0f_A 172 DFGLSQQSVH 181 (287)
T ss_dssp CCTTCBCCSS
T ss_pred CCCccccccc
Confidence 9999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-25 Score=222.39 Aligned_cols=148 Identities=29% Similarity=0.489 Sum_probs=127.7
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQ-GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 6889999998653221 122455799999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 97 5888887553 345899999999999999999999998 9999999999999999999999999998664
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.2e-25 Score=218.33 Aligned_cols=151 Identities=25% Similarity=0.384 Sum_probs=131.9
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
..++|.+.+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3468999999999999999999975 689999999976544455678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCCeEEeccccceeeC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTCG 539 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~~ 539 (558)
|+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988553 35889999999999999999999998 9999999999999 788899999999998654
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 161 ~ 161 (304)
T 2jam_A 161 N 161 (304)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-25 Score=226.80 Aligned_cols=149 Identities=27% Similarity=0.361 Sum_probs=130.0
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC--CCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQ--HRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999998642 3345678999999999996 59999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|| +.+++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+ ++.+||+|||+|+.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5688999998653 35788999999999999999999988 99999999999995 57899999999998754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 207 ~ 207 (390)
T 2zmd_A 207 D 207 (390)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=9.5e-25 Score=223.71 Aligned_cols=148 Identities=24% Similarity=0.323 Sum_probs=133.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999975 5889999998753 33445778999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||||+.++.+||+|||+|+.+
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999998653 3588999999999999999999985 7 999999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=217.96 Aligned_cols=150 Identities=26% Similarity=0.374 Sum_probs=127.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999875 47899999986421 122345889999999999999999999987654
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC---eEEecc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN---PKISDF 532 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DF 532 (558)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999998843 346899999999999999999999998 999999999999987654 999999
Q ss_pred ccceeeCCC
Q 008648 533 GLARTCGGD 541 (558)
Q Consensus 533 Gla~~~~~~ 541 (558)
|+++.+...
T Consensus 162 g~~~~~~~~ 170 (322)
T 2ycf_A 162 GHSKILGET 170 (322)
T ss_dssp TTCEECCCC
T ss_pred ccceecccc
Confidence 999987543
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-25 Score=215.79 Aligned_cols=157 Identities=17% Similarity=0.193 Sum_probs=111.5
Q ss_pred ceEEecCCCCCC----CCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCC
Q 008648 2 RVVWSASLSKEV----QQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSA 77 (558)
Q Consensus 2 ~~vWst~~~~~~----~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~ 77 (558)
++||+|+++..+ .++++ |+|+|+|||||++ +.+|||| ||||||||||+|+.+.++|.. | ++.
T Consensus 93 ~~vWst~~~~~~~~~~~~~~~-a~L~d~GNlVl~~------~~~lWqS--~ptdtlLpg~~~~~~l~~g~~--L---~S~ 158 (276)
T 3m7h_A 93 RRVWLTDNSTFTSNDQWNRTH-LVLQDDGNIVLVD------SLALWNG--TPAIPLVPGAIDSLLLAPGSE--L---VQG 158 (276)
T ss_dssp TEEEEECCCCCCCTTHHHHEE-EEECTTSCEEEEE------EEEEEES--CTTSCCCCSCTTCEEECSSEE--E---CTT
T ss_pred CEEEEeCCCcccccccCCceE-EEEeCCCCEEecC------CceeeCc--ccccccccccccccccccCcc--c---ccC
Confidence 479999976421 12345 9999999999996 4799999 999999999998888887765 5 578
Q ss_pred CCCCCcceEEEEecCCCceEEEEeC-CeEEEEeccCCCCCccCCCCCCCCceeeEEeecCC-eeEEEEEecCCceEEEEE
Q 008648 78 DDPSPGDFIWAVERQDNPEVVMWKG-SSKFYTTGPWNGLSFSAPTTRPNPIFNFSFVANED-ELCYTFSIKDKAVVSRIV 155 (558)
Q Consensus 78 ~dps~g~~~~~~~~~~~~~~~~~~~-~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~r~~ 155 (558)
+||++|.|+++|+++|. +++++. ..+||++++|+..... ..+.. ...+.+.++.+ ..+.++ ......+|++
T Consensus 159 ~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~-l~l~~--dGnLvl~d~~~~~vWsS~--t~~~~~~rl~ 231 (276)
T 3m7h_A 159 VVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVR-AVFQG--DGNLVVYGAGNAVLWHSH--TGGHASAVLR 231 (276)
T ss_dssp CEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCE-EEECT--TSCEEEECTTSCEEEECS--CTTCTTCEEE
T ss_pred CCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEE-EEEcC--CCeEEEEeCCCcEEEEec--CCCCCCEEEE
Confidence 99999999999999885 455654 5899999998753211 11111 23344444433 223222 2222347999
Q ss_pred EeccCCceEEEEEeCCCCCeEEEeeccC
Q 008648 156 MNQTTYLGQRFTWSNNTQTWDLYSKAPR 183 (558)
Q Consensus 156 ld~~G~~~~~~~~~~~~~~W~~~~~~~~ 183 (558)
|+.|| ++++|.| +..|...|.+|.
T Consensus 232 Ld~dG-nLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 232 LQANG-SIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp ECTTS-CEEEEEE---EEEEESSSCCTT
T ss_pred EcCCc-cEEEEcC---CCeEEccCccCC
Confidence 99999 9999998 345766666554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=213.02 Aligned_cols=143 Identities=11% Similarity=0.056 Sum_probs=127.0
Q ss_pred cCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999999754 8999999997532 23347789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
|||+++++|.+++.. . ....++.+++.||+.||+|||+++ |+||||||+||||+.++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999832 1 355678899999999999999998 999999999999999999999987765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=219.16 Aligned_cols=148 Identities=24% Similarity=0.404 Sum_probs=128.0
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..++|++.+.||+|+||.||+|... +++.||+|++.+... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999975 588999999976432 234678888777 7999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-C---CeEEecccccee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-M---NPKISDFGLART 537 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-~---~~kl~DFGla~~ 537 (558)
||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+.++ + .+||+|||+|+.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999988543 45899999999999999999999998 9999999999998543 3 499999999998
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 170 ~~~~ 173 (342)
T 2qr7_A 170 LRAE 173 (342)
T ss_dssp CBCT
T ss_pred CcCC
Confidence 7554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-25 Score=233.94 Aligned_cols=152 Identities=32% Similarity=0.442 Sum_probs=134.5
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..++|++.++||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4468999999999999999999975 6889999998642 234567899999999999999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCCeEEecccccee
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---HDMNPKISDFGLART 537 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~ 537 (558)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999998888553 35899999999999999999999998 99999999999995 456799999999987
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 174 ~~~~ 177 (486)
T 3mwu_A 174 FQQN 177 (486)
T ss_dssp BCCC
T ss_pred CCCC
Confidence 6543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=214.34 Aligned_cols=152 Identities=30% Similarity=0.483 Sum_probs=130.4
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
...++|++.+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+.++..++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999975 4889999998753 34578899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999998532 345899999999999999999999998 999999999999999999999999999887544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-25 Score=224.07 Aligned_cols=152 Identities=22% Similarity=0.313 Sum_probs=126.7
Q ss_pred hcCCcccceeecccCcccEEEEEEcC------CcEEEEEEeccccccc-----------HHHHHHHHHHHhcCCCCeeee
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISDQG-----------LKELKNEVILFSKLQHRNLVK 446 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 446 (558)
..++|++.++||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999986533211 122345666778889999999
Q ss_pred eeeEEEeC----CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 008648 447 LLGCCIHG----EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 522 (558)
Q Consensus 447 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~ 522 (558)
+++++... ...+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4479999999 99999998653 346899999999999999999999998 99999999999999
Q ss_pred --CCCCeEEeccccceeeCCC
Q 008648 523 --HDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 523 --~~~~~kl~DFGla~~~~~~ 541 (558)
.++.+||+|||+|+.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=217.18 Aligned_cols=146 Identities=23% Similarity=0.414 Sum_probs=130.3
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEe--CCeEEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIH--GEEKLLI 460 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 460 (558)
.++|++.+.||+|+||.||+|.. .+++.||||++.. ...+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999999986 5688999999864 34578899999999997 9999999999988 5678999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~ 539 (558)
|||+++++|..++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 3788999999999999999999998 99999999999999776 89999999999875
Q ss_pred CCc
Q 008648 540 GDK 542 (558)
Q Consensus 540 ~~~ 542 (558)
...
T Consensus 183 ~~~ 185 (330)
T 3nsz_A 183 PGQ 185 (330)
T ss_dssp TTC
T ss_pred CCC
Confidence 443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.7e-25 Score=218.03 Aligned_cols=156 Identities=27% Similarity=0.401 Sum_probs=121.0
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
....++|++.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34567899999999999999999985 468899999886432 3345678899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 460 IYEFMPNKSLDYFIFDQ-----TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
||||+++++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999988641 12346899999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
++.+..
T Consensus 168 ~~~~~~ 173 (303)
T 2vwi_A 168 SAFLAT 173 (303)
T ss_dssp HHHCC-
T ss_pred hheecc
Confidence 987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=219.08 Aligned_cols=151 Identities=31% Similarity=0.564 Sum_probs=126.2
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCc----EEEEEEecc-cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.++|++.++||+|+||.||+|... +++ +|++|.+.. ......+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999864 344 457777754 23456788999999999999999999999998654 78
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+|+||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998654 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 168 ~~~ 170 (327)
T 3lzb_A 168 GAE 170 (327)
T ss_dssp ---
T ss_pred cCc
Confidence 544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=213.69 Aligned_cols=151 Identities=18% Similarity=0.319 Sum_probs=133.1
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++... ...+.+.+|+.++..+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346899999999999999999996 56899999988642 2335688899999999 7999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC-----eEEeccccce
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN-----PKISDFGLAR 536 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~DFGla~ 536 (558)
||+ +++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+|+
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999653 335899999999999999999999988 999999999999987776 9999999999
Q ss_pred eeCCCc
Q 008648 537 TCGGDK 542 (558)
Q Consensus 537 ~~~~~~ 542 (558)
.+....
T Consensus 160 ~~~~~~ 165 (298)
T 1csn_A 160 FYRDPV 165 (298)
T ss_dssp ESBCTT
T ss_pred cccccc
Confidence 876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=216.84 Aligned_cols=149 Identities=28% Similarity=0.425 Sum_probs=125.2
Q ss_pred hcCCcccceeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEE----------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCI---------- 452 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 452 (558)
..++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 34689999999999999999999764 8899999987666666788999999999999999999999873
Q ss_pred ----eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCe
Q 008648 453 ----HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNP 527 (558)
Q Consensus 453 ----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~ 527 (558)
+....++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999998 699998832 45889999999999999999999998 99999999999997 56799
Q ss_pred EEeccccceeeCC
Q 008648 528 KISDFGLARTCGG 540 (558)
Q Consensus 528 kl~DFGla~~~~~ 540 (558)
||+|||+++.+..
T Consensus 161 kl~Dfg~~~~~~~ 173 (320)
T 2i6l_A 161 KIGDFGLARIMDP 173 (320)
T ss_dssp EECCCTTCBCC--
T ss_pred EEccCccccccCC
Confidence 9999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=211.00 Aligned_cols=153 Identities=25% Similarity=0.382 Sum_probs=133.1
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC--CeEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG--EEKLL 459 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 459 (558)
..++|++.+.||+|+||.||+|... ++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3457999999999999999999984 889999998753 234456799999999999999999999999887 67899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++++|.+++... ....+++.++..++.||+.||+|||+++ .+|+||||||+|||++.++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999653 2335899999999999999999999865 459999999999999999999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=224.32 Aligned_cols=147 Identities=23% Similarity=0.319 Sum_probs=124.3
Q ss_pred cCCcccc-eeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHH-hcCCCCeeeeeeeEEEe----CCeE
Q 008648 385 TNNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILF-SKLQHRNLVKLLGCCIH----GEEK 457 (558)
Q Consensus 385 ~~~y~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 457 (558)
.++|.+. +.||+|+||.||++... +++.||||++.. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3467666 68999999999999975 588999999853 24567888887 45589999999999876 5568
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEecccc
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGL 534 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGl 534 (558)
+|||||+++++|.+++.... ...+++.++..++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999986532 345899999999999999999999998 999999999999997 78899999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
|+....
T Consensus 211 a~~~~~ 216 (400)
T 1nxk_A 211 AKETTS 216 (400)
T ss_dssp CEECC-
T ss_pred ccccCC
Confidence 997654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.5e-25 Score=221.07 Aligned_cols=159 Identities=30% Similarity=0.414 Sum_probs=135.9
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEe-----
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIH----- 453 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~----- 453 (558)
+.....+|++.++||+|+||.||+|... +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3444568999999999999999999964 68899999987655566678999999999996 9999999999953
Q ss_pred ---CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 454 ---GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 454 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
....++||||++ |+|.+++........+++.+++.++.||+.||+|||+++ ++|+||||||+||||+.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence 334789999996 789888865444556999999999999999999999875 359999999999999999999999
Q ss_pred ccccceeeCCC
Q 008648 531 DFGLARTCGGD 541 (558)
Q Consensus 531 DFGla~~~~~~ 541 (558)
|||+++.+...
T Consensus 181 Dfg~~~~~~~~ 191 (337)
T 3ll6_A 181 DFGSATTISHY 191 (337)
T ss_dssp CCTTCBCCSSC
T ss_pred cCccceecccc
Confidence 99999887543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=217.95 Aligned_cols=162 Identities=26% Similarity=0.395 Sum_probs=137.3
Q ss_pred cchhhhhhhcCCcccc-eeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC-CCeeeeeeeE
Q 008648 376 FELATISNATNNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQ-HRNLVKLLGC 450 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 450 (558)
..+.......++|.+. +.||+|+||.||+|... +++.||+|++... .......+.+|+.++..+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344455566778887 89999999999999875 5899999998753 2344678999999999994 6999999999
Q ss_pred EEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCe
Q 008648 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNP 527 (558)
Q Consensus 451 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~ 527 (558)
+.+.+..++||||+++++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+||||+. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999988442 2356899999999999999999999998 999999999999987 7899
Q ss_pred EEeccccceeeCCC
Q 008648 528 KISDFGLARTCGGD 541 (558)
Q Consensus 528 kl~DFGla~~~~~~ 541 (558)
||+|||+|+.+...
T Consensus 174 kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 174 KIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCGGGCEEC---
T ss_pred EEeeCccccccCCc
Confidence 99999999987544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.5e-25 Score=216.77 Aligned_cols=154 Identities=27% Similarity=0.329 Sum_probs=122.2
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999997 468899999986532 22233455566668889999999999999999999999
Q ss_pred EecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 461 YEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||+++ +|.+++... .....+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+|+.+
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999974 887776442 2345689999999999999999999997 7 999999999999999999999999999876
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 161 ~~~ 163 (290)
T 3fme_A 161 VDD 163 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=222.90 Aligned_cols=153 Identities=24% Similarity=0.362 Sum_probs=125.6
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------ 454 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 454 (558)
....++|++.+.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 4689999999865322 234799999999999999999998543
Q ss_pred --------------------------------CeEEEEEecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 008648 455 --------------------------------EEKLLIYEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYL 501 (558)
Q Consensus 455 --------------------------------~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yL 501 (558)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 5777766532 2345689999999999999999999
Q ss_pred HhCCCCceEecCCCCCcEEEc-CCCCeEEeccccceeeCCCc
Q 008648 502 HQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 502 H~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~ 542 (558)
|+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9988 99999999999998 68899999999999875443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=225.05 Aligned_cols=150 Identities=24% Similarity=0.344 Sum_probs=125.9
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe------EE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE------KL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 458 (558)
..+|++.+.||+|+||.||+|....+..+|+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457999999999999999999988877899998864322 22369999999999999999999976443 78
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEecccccee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLART 537 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~ 537 (558)
+||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655544432233456899999999999999999999998 99999999999999 799999999999998
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 192 ~~~~ 195 (394)
T 4e7w_A 192 LIAG 195 (394)
T ss_dssp CCTT
T ss_pred ccCC
Confidence 7544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-24 Score=213.23 Aligned_cols=151 Identities=26% Similarity=0.406 Sum_probs=129.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCeeeeeeeEEE--eCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS----DQGLKELKNEVILFSKLQHRNLVKLLGCCI--HGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 457 (558)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999974 57899999986532 234678999999999999999999999985 34578
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||++++ |.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 66666543 2346899999999999999999999998 99999999999999999999999999998
Q ss_pred eCC
Q 008648 538 CGG 540 (558)
Q Consensus 538 ~~~ 540 (558)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=213.18 Aligned_cols=153 Identities=26% Similarity=0.373 Sum_probs=131.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe----CCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH----GEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 456 (558)
..+.|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3456888899999999999999874 5788999998642 33456778999999999999999999999876 345
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEeccccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLA 535 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla 535 (558)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+|
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 79999999999999999553 45889999999999999999999875 3499999999999998 7899999999999
Q ss_pred eeeCC
Q 008648 536 RTCGG 540 (558)
Q Consensus 536 ~~~~~ 540 (558)
+....
T Consensus 180 ~~~~~ 184 (290)
T 1t4h_A 180 TLKRA 184 (290)
T ss_dssp GGCCT
T ss_pred ccccc
Confidence 76543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-24 Score=212.61 Aligned_cols=150 Identities=30% Similarity=0.489 Sum_probs=130.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57999999999999999999975 68999999986532 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 997 69998886543 245889999999999999999999998 99999999999999999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=212.67 Aligned_cols=152 Identities=27% Similarity=0.436 Sum_probs=130.4
Q ss_pred hcCCcccceeecccCcccEEEEEEcC----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45689999999999999999998643 236999998753 33456789999999999999999999999764 5578
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998653 235889999999999999999999998 999999999999999999999999999876
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=215.33 Aligned_cols=147 Identities=34% Similarity=0.563 Sum_probs=123.1
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHH--HhcCCCCeeeeeeeEEEe-----CCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVIL--FSKLQHRNLVKLLGCCIH-----GEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~ 456 (558)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 456899999999999999999976 6899999998642 23344444444 456899999999986653 225
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceEecCCCCCcEEEcCCCCe
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD---------SRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~---------~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
.++||||+++++|.+++... ..++..+..++.||+.||+|||+. + |+||||||+||||+.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 68999999999999999543 348899999999999999999998 6 9999999999999999999
Q ss_pred EEeccccceeeCCC
Q 008648 528 KISDFGLARTCGGD 541 (558)
Q Consensus 528 kl~DFGla~~~~~~ 541 (558)
||+|||+|+.+...
T Consensus 160 kL~DFG~a~~~~~~ 173 (336)
T 3g2f_A 160 VISDFGLSMRLTGN 173 (336)
T ss_dssp EECCCTTCEECSSS
T ss_pred EEeeccceeecccc
Confidence 99999999987543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-24 Score=216.88 Aligned_cols=150 Identities=25% Similarity=0.429 Sum_probs=132.0
Q ss_pred hhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCeeeeeeeEEEeCC----
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSK--LQHRNLVKLLGCCIHGE---- 455 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 455 (558)
....++|++.+.||+|+||.||+|.. +++.||||++.. .....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34456899999999999999999987 589999999864 234667788888877 78999999999998876
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEEcCCCCe
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH--------~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
..++||||+++++|.+++... .+++.+++.++.||+.||+||| +.+ |+||||||+||||+.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 789999999999999999542 4899999999999999999999 666 9999999999999999999
Q ss_pred EEeccccceeeCCCc
Q 008648 528 KISDFGLARTCGGDK 542 (558)
Q Consensus 528 kl~DFGla~~~~~~~ 542 (558)
||+|||+|+......
T Consensus 187 kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 187 CIADLGLAVRHDSAT 201 (342)
T ss_dssp EECCCTTCEEEETTT
T ss_pred EEEECCCceeccccc
Confidence 999999998876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=211.96 Aligned_cols=157 Identities=28% Similarity=0.406 Sum_probs=131.7
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CCeEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH--GEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 459 (558)
.++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 5889999998642 23445679999999999999999999998865 567899
Q ss_pred EEecCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 460 IYEFMPNKSLDYFIFDQT-NSKLLDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986532 2345899999999999999999999865 1239999999999999999999999999998
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 165 ~~~~~ 169 (279)
T 2w5a_A 165 ILNHD 169 (279)
T ss_dssp HC---
T ss_pred eeccc
Confidence 76543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=237.07 Aligned_cols=144 Identities=30% Similarity=0.481 Sum_probs=125.8
Q ss_pred eeecccCcccEEEEEEc---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++|||||++++++. .+..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 35789999997532 334678999999999999999999999986 4568899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
++|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999543 45899999999999999999999998 9999999999999999999999999999875543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=216.54 Aligned_cols=153 Identities=31% Similarity=0.535 Sum_probs=130.3
Q ss_pred hcCCcccceeecccCcccEEEEEE------cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
..++|++.+.||+|+||.||+|.. .++..||||.+... ......++.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 456899999999999999999984 24678999998643 33455678999999999999999999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEE
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTN----SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKI 529 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl 529 (558)
.++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ |+||||||+||||+. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 245889999999999999999999998 999999999999984 446999
Q ss_pred eccccceeeC
Q 008648 530 SDFGLARTCG 539 (558)
Q Consensus 530 ~DFGla~~~~ 539 (558)
+|||+++.+.
T Consensus 185 ~Dfg~~~~~~ 194 (327)
T 2yfx_A 185 GDFGMARDIY 194 (327)
T ss_dssp CCCHHHHHHH
T ss_pred Cccccccccc
Confidence 9999998653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=210.19 Aligned_cols=149 Identities=23% Similarity=0.333 Sum_probs=128.9
Q ss_pred hcCCcccc-eeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHH-hcCCCCeeeeeeeEEEe----CCe
Q 008648 384 ATNNFSIN-NKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILF-SKLQHRNLVKLLGCCIH----GEE 456 (558)
Q Consensus 384 ~~~~y~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~ 456 (558)
..++|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 33567776 7899999999999997 4588999999854 24567888887 66699999999999987 667
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEeccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFG 533 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFG 533 (558)
.++||||+++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 899999999999999997642 346899999999999999999999998 999999999999997 7889999999
Q ss_pred cceeeCCC
Q 008648 534 LARTCGGD 541 (558)
Q Consensus 534 la~~~~~~ 541 (558)
+|+.....
T Consensus 166 ~a~~~~~~ 173 (299)
T 3m2w_A 166 FAKETTGE 173 (299)
T ss_dssp TCEECTTC
T ss_pred cccccccc
Confidence 99987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=213.52 Aligned_cols=150 Identities=27% Similarity=0.475 Sum_probs=126.1
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-CeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-EEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E 462 (558)
..++|++.+.||+|+||.||++.. .++.||||++... ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 456899999999999999999987 4889999998753 3567899999999999999999999997654 46899999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999986532 223788999999999999999999998 99999999999999999999999999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=220.11 Aligned_cols=148 Identities=30% Similarity=0.433 Sum_probs=124.9
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----- 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 455 (558)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3468999999999999999999864 5889999998652 2334567889999999999999999999998665
Q ss_pred -eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 456 -EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 456 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999975 6777773 23789999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
|+....
T Consensus 174 a~~~~~ 179 (371)
T 2xrw_A 174 ARTAGT 179 (371)
T ss_dssp ------
T ss_pred cccccc
Confidence 987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=209.84 Aligned_cols=153 Identities=31% Similarity=0.430 Sum_probs=134.8
Q ss_pred hhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
...++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999975 6889999998653 23456789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CCeEEeccccce
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD---MNPKISDFGLAR 536 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~ 536 (558)
||||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998888543 35899999999999999999999998 9999999999999754 469999999998
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.....
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 77544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-24 Score=218.39 Aligned_cols=151 Identities=20% Similarity=0.286 Sum_probs=123.9
Q ss_pred hcCCcccceeecccCcccEEEEEEc----CCcEEEEEEecccccc-----------cHHHHHHHHHHHhcCCCCeeeeee
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISDQ-----------GLKELKNEVILFSKLQHRNLVKLL 448 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~ 448 (558)
..++|++.+.||+|+||.||+|... .+..+|+|++...... ..+.+.+|+.++..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3468999999999999999999975 5678999988653221 123466788899999999999999
Q ss_pred eEEEe----CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 008648 449 GCCIH----GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD 524 (558)
Q Consensus 449 ~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~ 524 (558)
+++.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 99988 67889999999 99999998543 26899999999999999999999998 9999999999999987
Q ss_pred C--CeEEeccccceeeCCC
Q 008648 525 M--NPKISDFGLARTCGGD 541 (558)
Q Consensus 525 ~--~~kl~DFGla~~~~~~ 541 (558)
+ .+||+|||+|+.+...
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp STTSEEECCCTTCEESSGG
T ss_pred CCCcEEEEeCCCceecccc
Confidence 7 9999999999987543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=220.71 Aligned_cols=149 Identities=31% Similarity=0.454 Sum_probs=116.1
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------ 454 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 454 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 447899999999999999999986 45889999998652 233456788999999999999999999998754
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
...++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 4579999999 6899888743 45899999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCC
Q 008648 535 ARTCGG 540 (558)
Q Consensus 535 a~~~~~ 540 (558)
|+....
T Consensus 179 a~~~~~ 184 (367)
T 2fst_X 179 ARHTAD 184 (367)
T ss_dssp ------
T ss_pred cccccc
Confidence 987643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=211.30 Aligned_cols=152 Identities=30% Similarity=0.435 Sum_probs=124.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc--CCc--EEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV--DGQ--EIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 456 (558)
..++|++.+.||+|+||.||+|... +++ .||+|++... .....+.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3468999999999999999999853 233 6899988653 2345678899999999999999999999987654
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 88999999999999998653 245889999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 170 ~~~~~ 174 (291)
T 1u46_A 170 ALPQN 174 (291)
T ss_dssp ECCC-
T ss_pred ccccc
Confidence 87554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=232.93 Aligned_cols=141 Identities=20% Similarity=0.232 Sum_probs=110.5
Q ss_pred eecccCcccEEEEE-EcCCcEEEEEEeccc----------ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEE
Q 008648 393 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKI----------SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 393 ~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 460 (558)
..+.|++|.+..++ .--|+.+++|.+.+. .+...++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45566666666554 234788999998642 123456799999999999 799999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||++|++|.++|... ..++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999543 345554 47899999999999999 99999999999999999999999999998765
Q ss_pred Cc
Q 008648 541 DK 542 (558)
Q Consensus 541 ~~ 542 (558)
+.
T Consensus 392 ~~ 393 (569)
T 4azs_A 392 DC 393 (569)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-24 Score=223.70 Aligned_cols=148 Identities=26% Similarity=0.399 Sum_probs=121.8
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC----C--eEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG----E--EKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~ 458 (558)
.+|++.+.||+|+||.||+|... +++.||||++.... ....+|+++++.++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999975 58999999986532 2234799999999999999999998652 2 257
Q ss_pred EEEecCCCCChhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CCeEEeccccce
Q 008648 459 LIYEFMPNKSLDYFIFD-QTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLAR 536 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~ 536 (558)
+||||+++ +|..++.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 55554432 123456899999999999999999999988 9999999999999965 568999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-24 Score=217.53 Aligned_cols=150 Identities=25% Similarity=0.416 Sum_probs=131.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----e
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE-----E 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 456 (558)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4468999999999999999999864 57889999987532 334477899999999999999999999997653 5
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||++ ++|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 799999997 589888854 24899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.....
T Consensus 177 ~~~~~ 181 (364)
T 3qyz_A 177 VADPD 181 (364)
T ss_dssp ECCGG
T ss_pred ecCCC
Confidence 87543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=215.25 Aligned_cols=150 Identities=28% Similarity=0.459 Sum_probs=130.6
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-----Ce
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-----EE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 456 (558)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999975 58899999986532 33456788999999999999999999998764 56
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 589888854 35899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 161 ~~~~~ 165 (353)
T 2b9h_A 161 IIDES 165 (353)
T ss_dssp ECC--
T ss_pred ccccc
Confidence 87543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-24 Score=218.75 Aligned_cols=152 Identities=13% Similarity=0.130 Sum_probs=113.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC--CCCeeeeee-------eE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---DQGLKELKNEVILFSKL--QHRNLVKLL-------GC 450 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~ 450 (558)
....|++.+.||+|+||.||+|... +++.||||++.... ....+.+++|+.+++.+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3456999999999999999999975 68899999997633 23455677885444444 799988755 55
Q ss_pred EEeC-----------------CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 008648 451 CIHG-----------------EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKR------FHIICGTARGLLYLHQDSRL 507 (558)
Q Consensus 451 ~~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~gL~yLH~~~~~ 507 (558)
+... ...+|||||++ ++|.+++.... ..+++..+ +.++.||+.||+|||+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 5443 33799999999 89999996542 23455555 678899999999999998
Q ss_pred ceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 508 RIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 508 ~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+||||||+||||+.++.+||+|||+|+..+..
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 999999999999999999999999999977543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=218.05 Aligned_cols=159 Identities=21% Similarity=0.254 Sum_probs=119.6
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe--
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE-- 456 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 456 (558)
......++|++.+.||+|+||.||+|... +++.||||++... ........+|+..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34456679999999999999999999974 5889999988653 2334466778888899999999999999976443
Q ss_pred -----EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecCCCCCcEEEcC-CCCeE
Q 008648 457 -----KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH--QDSRLRIIHRDLKASNVLLDH-DMNPK 528 (558)
Q Consensus 457 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH--~~~~~~ivHrDlkp~NIll~~-~~~~k 528 (558)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+||||+. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987433333222234556889999999999999999999 777 999999999999996 89999
Q ss_pred EeccccceeeCCCc
Q 008648 529 ISDFGLARTCGGDK 542 (558)
Q Consensus 529 l~DFGla~~~~~~~ 542 (558)
|+|||+|+.+....
T Consensus 173 l~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE 186 (360)
T ss_dssp ECCCTTCBCCCTTS
T ss_pred EeeCCCceecCCCC
Confidence 99999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=234.96 Aligned_cols=148 Identities=18% Similarity=0.324 Sum_probs=128.4
Q ss_pred cCCcccceeecccCcccEEEEEEc--CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe-----
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE----- 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 456 (558)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 5889999988643 23445678999999999999999999999987665
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.+|||||+++++|.+++.. .+++.+++.++.||+.||+|||+++ |+||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887622 5899999999999999999999998 9999999999999886 89999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.90 E-value=5.9e-24 Score=214.46 Aligned_cols=153 Identities=27% Similarity=0.453 Sum_probs=128.2
Q ss_pred hhcCCcccceeecccCcccEEEEEE--cCCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCeeeeeeeEEE---
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTL--VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKL---QHRNLVKLLGCCI--- 452 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 452 (558)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4557899999999999999999997 357899999986422 22233566777776665 8999999999987
Q ss_pred --eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 453 --HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 453 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4556799999998 69999886543 335899999999999999999999998 9999999999999999999999
Q ss_pred ccccceeeCC
Q 008648 531 DFGLARTCGG 540 (558)
Q Consensus 531 DFGla~~~~~ 540 (558)
|||+++....
T Consensus 163 Dfg~~~~~~~ 172 (326)
T 1blx_A 163 DFGLARIYSF 172 (326)
T ss_dssp SCCSCCCCCG
T ss_pred cCcccccccC
Confidence 9999987653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=217.74 Aligned_cols=152 Identities=21% Similarity=0.281 Sum_probs=130.7
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcC------CCCeeeeeeeEEEeCCe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKL------QHRNLVKLLGCCIHGEE 456 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 456 (558)
...+|++.++||+|+||.||+|... +++.||||++.. .....+.+.+|+.+++.+ .|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4568999999999999999999875 478999999975 233456777888888776 57799999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC--eEEecccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN--PKISDFGL 534 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFGl 534 (558)
.++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 68888886543 335899999999999999999999998 999999999999999887 99999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.....
T Consensus 249 a~~~~~~ 255 (429)
T 3kvw_A 249 SCYEHQR 255 (429)
T ss_dssp CEETTCC
T ss_pred ceecCCc
Confidence 9876543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=216.72 Aligned_cols=149 Identities=28% Similarity=0.491 Sum_probs=126.6
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE---
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK--- 457 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 457 (558)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4478999999999999999999864 5889999998753 233457788999999999999999999999877655
Q ss_pred ---EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 458 ---LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 458 ---~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
++||||++ ++|.+++ ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 6787776 223899999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.....
T Consensus 191 a~~~~~~ 197 (371)
T 4exu_A 191 ARHADAE 197 (371)
T ss_dssp C------
T ss_pred ccccccC
Confidence 9876543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.8e-24 Score=214.01 Aligned_cols=158 Identities=25% Similarity=0.341 Sum_probs=134.3
Q ss_pred cchhhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC--CCeeeeeeeEE
Q 008648 376 FELATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQ--HRNLVKLLGCC 451 (558)
Q Consensus 376 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 451 (558)
+.+..+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4445556667789999999999999999999888999999998642 3345678899999999997 59999999999
Q ss_pred EeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEec
Q 008648 452 IHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISD 531 (558)
Q Consensus 452 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 531 (558)
...+..++||| +.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 5688999998653 35889999999999999999999998 999999999999965 7899999
Q ss_pred cccceeeCCC
Q 008648 532 FGLARTCGGD 541 (558)
Q Consensus 532 FGla~~~~~~ 541 (558)
||+++.+...
T Consensus 170 fg~~~~~~~~ 179 (313)
T 3cek_A 170 FGIANQMQPD 179 (313)
T ss_dssp CSSSCC----
T ss_pred ccccccccCc
Confidence 9999877544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=231.30 Aligned_cols=156 Identities=25% Similarity=0.395 Sum_probs=133.7
Q ss_pred hhhhhcCCcccceeecccCcccEEEEEEcC----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC
Q 008648 380 TISNATNNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG 454 (558)
Q Consensus 380 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 454 (558)
......++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 334455789999999999999999998643 457999988653 2334577999999999999999999999984 5
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
+..++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 6689999999999999998653 335899999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.+...
T Consensus 538 a~~~~~~ 544 (656)
T 2j0j_A 538 SRYMEDS 544 (656)
T ss_dssp CCSCCC-
T ss_pred CeecCCC
Confidence 9987543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=218.62 Aligned_cols=147 Identities=18% Similarity=0.302 Sum_probs=128.1
Q ss_pred cCCcccceeecccCcccEEEEEEcC---------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeee---------
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVK--------- 446 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 446 (558)
.++|++.+.||+|+||.||+|.... ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999753 789999998653 46789999999999999987
Q ss_pred ------eeeEEEe-CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 008648 447 ------LLGCCIH-GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 519 (558)
Q Consensus 447 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NI 519 (558)
+++++.. ....++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778776 67889999999 999999996532 356899999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEeccccceeeCCC
Q 008648 520 LLDHDM--NPKISDFGLARTCGGD 541 (558)
Q Consensus 520 ll~~~~--~~kl~DFGla~~~~~~ 541 (558)
|++.++ .+||+|||+|+.+...
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999988 8999999999877543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=207.22 Aligned_cols=151 Identities=25% Similarity=0.419 Sum_probs=125.3
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCC-IHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 461 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 568899999865422 234578899999999988766666555 6677889999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~ 538 (558)
||+ +++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998643 235899999999999999999999998 9999999999999 78899999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 6543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-23 Score=209.36 Aligned_cols=152 Identities=23% Similarity=0.375 Sum_probs=131.4
Q ss_pred hcCCcccceeecccCcccEEEEEE--cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC------eeeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL--VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHR------NLVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~ 455 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++|+ +|+++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999986 35789999998753 34457788999999888665 4999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC------------
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH------------ 523 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~------------ 523 (558)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 889999886542 345889999999999999999999998 999999999999987
Q ss_pred -------CCCeEEeccccceeeCCC
Q 008648 524 -------DMNPKISDFGLARTCGGD 541 (558)
Q Consensus 524 -------~~~~kl~DFGla~~~~~~ 541 (558)
++.+||+|||+|+.....
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC
T ss_pred cccccccCCCceEeeCcccccCccc
Confidence 668999999999876543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7e-24 Score=220.91 Aligned_cols=149 Identities=26% Similarity=0.414 Sum_probs=116.0
Q ss_pred CCccc-ceeecccCcccEEEEEEc---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CCeEEE
Q 008648 386 NNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH--GEEKLL 459 (558)
Q Consensus 386 ~~y~~-~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 459 (558)
+.|++ .++||+|+||.||+|... +++.||||++... .....+.+|+.++++++||||+++++++.. ....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44665 358999999999999965 4788999998753 234578899999999999999999999965 667899
Q ss_pred EEecCCCCChhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCCeEE
Q 008648 460 IYEFMPNKSLDYFIFDQ------TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DHDMNPKI 529 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl 529 (558)
||||+++ +|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 776666421 12234899999999999999999999998 9999999999999 67789999
Q ss_pred eccccceeeCC
Q 008648 530 SDFGLARTCGG 540 (558)
Q Consensus 530 ~DFGla~~~~~ 540 (558)
+|||+|+.+..
T Consensus 174 ~Dfg~a~~~~~ 184 (405)
T 3rgf_A 174 ADMGFARLFNS 184 (405)
T ss_dssp CCTTCCC----
T ss_pred EECCCceecCC
Confidence 99999987754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=210.28 Aligned_cols=154 Identities=26% Similarity=0.366 Sum_probs=127.0
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHH-HHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVI-LFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..++|++.+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4578999999999999999999974 68899999987532 233445556665 77888999999999999999999999
Q ss_pred EecCCCCChhHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 461 YEFMPNKSLDYFIFDQ--TNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
|||+++ +|.+++... .....+++..+..++.|++.||.|||++ + |+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 777776431 2245689999999999999999999998 7 99999999999999999999999999987
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 176 ~~~~ 179 (327)
T 3aln_A 176 LVDS 179 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 6543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-24 Score=215.16 Aligned_cols=154 Identities=30% Similarity=0.528 Sum_probs=130.1
Q ss_pred hhhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC
Q 008648 378 LATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE 455 (558)
Q Consensus 378 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 455 (558)
..+.....++|++.+.||+|+||.||+|.... .+|+|++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445566889999999999999999998754 4999988642 2334456788999999999999999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..++||||+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 999999999999999998442 345889999999999999999999998 99999999999998 679999999998
Q ss_pred eeeC
Q 008648 536 RTCG 539 (558)
Q Consensus 536 ~~~~ 539 (558)
+...
T Consensus 177 ~~~~ 180 (319)
T 2y4i_B 177 SISG 180 (319)
T ss_dssp C---
T ss_pred cccc
Confidence 7653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=216.54 Aligned_cols=135 Identities=25% Similarity=0.369 Sum_probs=113.5
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCC--------CCeeeeeeeEEE---
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ--------HRNLVKLLGCCI--- 452 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 452 (558)
.++|++.++||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5789999998753 345577889999999885 788999999988
Q ss_pred -eCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCC
Q 008648 453 -HGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDM 525 (558)
Q Consensus 453 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~ 525 (558)
.....++||||+ +++|.+.+... ....+++..+..++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 455789999999 45555555432 234589999999999999999999998 7 99999999999999775
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=213.70 Aligned_cols=147 Identities=29% Similarity=0.478 Sum_probs=126.7
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCe-----
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEE----- 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 456 (558)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999974 5889999998653 22345678899999999999999999999987654
Q ss_pred -EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 457 -KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 457 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877662 24899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCC
Q 008648 536 RTCGG 540 (558)
Q Consensus 536 ~~~~~ 540 (558)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=205.50 Aligned_cols=151 Identities=25% Similarity=0.419 Sum_probs=128.9
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEE-EeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCC-IHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 461 (558)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 356899999999999999999996 568999999886532 334688999999999988766655554 5677889999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~ 538 (558)
||+ +++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999998643 245899999999999999999999998 9999999999999 48889999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 159 ~~~~ 162 (296)
T 3uzp_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cccc
Confidence 6553
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-24 Score=213.19 Aligned_cols=155 Identities=24% Similarity=0.361 Sum_probs=124.5
Q ss_pred hhhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccc------cHHHHHHHHHHHhcC----CCCeeeeeee
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQ------GLKELKNEVILFSKL----QHRNLVKLLG 449 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~ 449 (558)
.....++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999986 45889999998653221 223456788888888 8999999999
Q ss_pred EEEeCCeEEEEEec-CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCe
Q 008648 450 CCIHGEEKLLIYEF-MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNP 527 (558)
Q Consensus 450 ~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~ 527 (558)
++...+..++|||| +++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 7899999998653 35899999999999999999999998 99999999999999 88999
Q ss_pred EEeccccceeeCCC
Q 008648 528 KISDFGLARTCGGD 541 (558)
Q Consensus 528 kl~DFGla~~~~~~ 541 (558)
||+|||+++.+...
T Consensus 180 kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 180 KLIDFGSGALLHDE 193 (312)
T ss_dssp EECCCSSCEECCSS
T ss_pred EEEEcchhhhcccC
Confidence 99999999987644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=217.97 Aligned_cols=150 Identities=25% Similarity=0.308 Sum_probs=121.1
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
+.|.+.+.||+|+||+||.+...+++.||||++.. ...+.+.+|+.++.++ +||||+++++++.+....+|||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34555688999999999877777899999999864 2345678999999876 8999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-------------CCe
Q 008648 465 PNKSLDYFIFDQTNSK----LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD-------------MNP 527 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~-------------~~~ 527 (558)
+ ++|.+++....... ..++..++.++.||+.||+|||+++ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999986543211 1234456789999999999999998 9999999999999754 479
Q ss_pred EEeccccceeeCCCc
Q 008648 528 KISDFGLARTCGGDK 542 (558)
Q Consensus 528 kl~DFGla~~~~~~~ 542 (558)
||+|||+|+.+....
T Consensus 168 kL~DFG~a~~~~~~~ 182 (434)
T 2rio_A 168 LISDFGLCKKLDSGQ 182 (434)
T ss_dssp EECCCTTCEECCC--
T ss_pred EEcccccceecCCCC
Confidence 999999999886543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-23 Score=217.23 Aligned_cols=151 Identities=25% Similarity=0.394 Sum_probs=129.7
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH-RNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 461 (558)
..++|++.++||+|+||.||+|.. .+++.||||++.... ...++..|+++++.++| ++|..+..++...+..+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 346899999999999999999996 468999999876432 23457889999999986 56667777778888999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DHDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~ 538 (558)
||+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|+.+
T Consensus 83 e~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 99999998643 345899999999999999999999998 9999999999999 68899999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 157 ~~~~ 160 (483)
T 3sv0_A 157 RDTS 160 (483)
T ss_dssp BCTT
T ss_pred cCCc
Confidence 6544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=210.23 Aligned_cols=154 Identities=25% Similarity=0.359 Sum_probs=132.6
Q ss_pred hhhcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccc------cHHHHHHHHHHHhcCC--CCeeeeeeeEEE
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQ------GLKELKNEVILFSKLQ--HRNLVKLLGCCI 452 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 452 (558)
....++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34557899999999999999999986 46889999998653211 2345678999999996 599999999999
Q ss_pred eCCeEEEEEecCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEe
Q 008648 453 HGEEKLLIYEFMPN-KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKIS 530 (558)
Q Consensus 453 ~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~ 530 (558)
..+..++|||++.+ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 8999998653 35899999999999999999999998 99999999999999 78899999
Q ss_pred ccccceeeCCC
Q 008648 531 DFGLARTCGGD 541 (558)
Q Consensus 531 DFGla~~~~~~ 541 (558)
|||+++.+...
T Consensus 193 Dfg~~~~~~~~ 203 (320)
T 3a99_A 193 DFGSGALLKDT 203 (320)
T ss_dssp CCTTCEECCSS
T ss_pred eCccccccccc
Confidence 99999987643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=205.72 Aligned_cols=150 Identities=24% Similarity=0.302 Sum_probs=121.6
Q ss_pred hcCCcccce-eecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe----CCeE
Q 008648 384 ATNNFSINN-KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH----GEEK 457 (558)
Q Consensus 384 ~~~~y~~~~-~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 457 (558)
..++|.+.+ .||+|+||.||+|... +++.||||++... .....+....++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 446788855 6999999999999975 5899999998652 1222233344667799999999999976 4457
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEecccc
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGL 534 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGl 534 (558)
++||||+++++|.+++.... ...+++.++..++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999996542 346899999999999999999999998 999999999999976 45599999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.....
T Consensus 178 ~~~~~~~ 184 (336)
T 3fhr_A 178 AKETTQN 184 (336)
T ss_dssp CEEC---
T ss_pred ceecccc
Confidence 9876543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=6e-23 Score=206.21 Aligned_cols=152 Identities=23% Similarity=0.369 Sum_probs=117.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD--QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3468999999999999999999975 688999999865322 2233455556678888999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
|||+ ++.+..+.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 55565555332 34589999999999999999999985 7 9999999999999999999999999998765
Q ss_pred CC
Q 008648 540 GD 541 (558)
Q Consensus 540 ~~ 541 (558)
..
T Consensus 177 ~~ 178 (318)
T 2dyl_A 177 DD 178 (318)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-23 Score=228.64 Aligned_cols=154 Identities=27% Similarity=0.389 Sum_probs=132.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe------CCe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH------GEE 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 456 (558)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999864 5889999998653 34456779999999999999999999998765 567
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC---eEEeccc
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN---PKISDFG 533 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFG 533 (558)
.++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999976555556899999999999999999999998 999999999999997665 9999999
Q ss_pred cceeeCCC
Q 008648 534 LARTCGGD 541 (558)
Q Consensus 534 la~~~~~~ 541 (558)
+|+.+...
T Consensus 170 ~a~~~~~~ 177 (676)
T 3qa8_A 170 YAKELDQG 177 (676)
T ss_dssp CCCBTTSC
T ss_pred cccccccc
Confidence 99887543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-23 Score=214.35 Aligned_cols=150 Identities=24% Similarity=0.342 Sum_probs=122.6
Q ss_pred hhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 461 (558)
....+|++.+.||+|+||.|+.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....+|||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34457999999999999997766566889999999865322 2356799999999 7999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----CCCeEEeccccce
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-----DMNPKISDFGLAR 536 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFGla~ 536 (558)
||++ ++|.+++.... ..+.+..+..++.||+.||+|||+++ |+||||||+||||+. ...+||+|||+|+
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 59999886532 23455567789999999999999998 999999999999953 3358899999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 172 ~~~~~ 176 (432)
T 3p23_A 172 KLAVG 176 (432)
T ss_dssp CC---
T ss_pred eccCC
Confidence 87543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-22 Score=204.92 Aligned_cols=152 Identities=21% Similarity=0.346 Sum_probs=128.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CC-cEEEEEEecccccccHHHHHHHHHHHhcCCCCe------eeeeeeEEEeCC
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DG-QEIAVKRLSKISDQGLKELKNEVILFSKLQHRN------LVKLLGCCIHGE 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 455 (558)
..++|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|+.+++.++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3478999999999999999999974 34 68999998752 344567889999999987665 999999999999
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--------------
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-------------- 521 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll-------------- 521 (558)
..++||||+ +++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+||||
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 55666666443 2345899999999999999999999988 9999999999999
Q ss_pred -----cCCCCeEEeccccceeeCCC
Q 008648 522 -----DHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 522 -----~~~~~~kl~DFGla~~~~~~ 541 (558)
+.++.+||+|||+|+.....
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~ 195 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH 195 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC
T ss_pred ccccccCCCcEEEeecCcccccccc
Confidence 56789999999999876443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-22 Score=207.51 Aligned_cols=156 Identities=24% Similarity=0.343 Sum_probs=130.1
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CC-----eeeeeeeEEEeC
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HR-----NLVKLLGCCIHG 454 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 454 (558)
....++|++.+.||+|+||.||+|... +++.||||++.. ......++..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 445679999999999999999999875 578999999975 2334567788888888874 44 499999999999
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCCeEEecc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--HDMNPKISDF 532 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DF 532 (558)
+..+|||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+||||+ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 59998886543 245899999999999999999999531 2399999999999995 5778999999
Q ss_pred ccceeeCCC
Q 008648 533 GLARTCGGD 541 (558)
Q Consensus 533 Gla~~~~~~ 541 (558)
|+|+.+...
T Consensus 206 G~a~~~~~~ 214 (382)
T 2vx3_A 206 GSSCQLGQR 214 (382)
T ss_dssp TTCEETTCC
T ss_pred cCceecccc
Confidence 999987543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=199.97 Aligned_cols=145 Identities=19% Similarity=0.187 Sum_probs=117.2
Q ss_pred hhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccccc------------------ccHHHHHHHHHHHhcCC
Q 008648 379 ATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD------------------QGLKELKNEVILFSKLQ 440 (558)
Q Consensus 379 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 440 (558)
..+......|++.+.||+|+||.||+|...+++.||+|.++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455567778899999999999999997789999999864211 13456899999999999
Q ss_pred CCeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 008648 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 520 (558)
Q Consensus 441 h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIl 520 (558)
| +++.+++.. +..++||||+++++|.+ +. ......++.||+.||+|||+.+ |+||||||+|||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 666665543 55699999999999987 41 1234579999999999999998 999999999999
Q ss_pred EcCCCCeEEeccccceeeCCC
Q 008648 521 LDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 521 l~~~~~~kl~DFGla~~~~~~ 541 (558)
|+ ++.+||+|||+|+.....
T Consensus 226 l~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EE-TTEEEECCCTTCEETTST
T ss_pred EE-CCcEEEEECCCCeECCCC
Confidence 99 999999999999977544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=208.54 Aligned_cols=151 Identities=24% Similarity=0.346 Sum_probs=128.9
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCC-----------CCeeeeeeeEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCI 452 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 452 (558)
.++|++.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 4688999999875 3334567889999998886 899999999998
Q ss_pred eCC----eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEc-----
Q 008648 453 HGE----EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 522 (558)
Q Consensus 453 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~----- 522 (558)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 679999999 899999986543 34589999999999999999999998 8 99999999999994
Q ss_pred -CCCCeEEeccccceeeCCC
Q 008648 523 -HDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 523 -~~~~~kl~DFGla~~~~~~ 541 (558)
..+.+||+|||+|+.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~ 191 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH 191 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC
T ss_pred cCcceEEEcccccccccCCC
Confidence 3447999999999877543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-22 Score=215.26 Aligned_cols=136 Identities=18% Similarity=0.235 Sum_probs=108.6
Q ss_pred ccceeecccCcccEEEEEEcCCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 389 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD--------QGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 389 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
...+.||+|+||.||++.. .++.+++|+...... ...+++.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 578889987643111 1234589999999999999999777777788888999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||++. .+||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 4578999999999999998 999999999999998 999999999998865
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 482 ~ 482 (540)
T 3en9_A 482 D 482 (540)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=187.49 Aligned_cols=146 Identities=10% Similarity=0.125 Sum_probs=100.5
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCcccc-CCCCcccccc-CCCc-----eeEEEEe
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTL-LPGMKLGWDL-KTGF-----ERRVISW 74 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTl-Lpgq~l~~~~-~~~~-----~~~l~s~ 74 (558)
++||+|++... .+..+ |+|+|+|||||++ . ++||||||||||+ ||+| +.+. .+|. +++|+
T Consensus 76 ~~vW~s~~~~~-~~~~~-~~l~d~Gnlvl~~-----~--~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~-- 142 (236)
T 1dlp_A 76 TIRWSSGTKGS-IGNYV-LVLQPDRTVTIYG-----P--GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH-- 142 (236)
T ss_dssp CCSCCCCCCCC-SSCCE-EEECSSSCEEEEC-----S--EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC--
T ss_pred cEEEeCCcccc-CCcEE-EEEeCCCCEEEec-----C--CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE--
Confidence 46899998643 23445 9999999999984 2 8999999998776 4443 3332 3333 45787
Q ss_pred cCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccC-CCCCCCCceeeEEeecCCeeEEEEEecCCceEEE
Q 008648 75 KSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTTRPNPIFNFSFVANEDELCYTFSIKDKAVVSR 153 (558)
Q Consensus 75 ~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r 153 (558)
+.+||++|.|+|+++++| +++++++..+||++++|++. ++. +.+...+.+ +.+..+.++.+.+|..... ..+|
T Consensus 143 -s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~-~~~r 216 (236)
T 1dlp_A 143 -ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSA-GRYV 216 (236)
T ss_dssp -SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCSS-SCCE
T ss_pred -cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCCC-CCEE
Confidence 478999999999999987 67788888899999999653 433 455433321 1122233344444443333 3589
Q ss_pred EEEeccCCceEEEE
Q 008648 154 IVMNQTTYLGQRFT 167 (558)
Q Consensus 154 ~~ld~~G~~~~~~~ 167 (558)
++||.|| ++++|.
T Consensus 217 l~Ld~dG-~l~ly~ 229 (236)
T 1dlp_A 217 FVLQPDR-NLAIYG 229 (236)
T ss_dssp EEECSSS-CEEEEC
T ss_pred EEEcCCC-cEEEeC
Confidence 9999999 999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.7e-21 Score=199.89 Aligned_cols=153 Identities=20% Similarity=0.232 Sum_probs=115.7
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCC-Cee--------------
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQH-RNL-------------- 444 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~ni-------------- 444 (558)
....|...+.||+|+||.||+|.+ .+++.||||++.... ....+.+++|+.+++.++| +|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 445688889999999999999996 468999999987322 2336789999999999987 211
Q ss_pred -eee------eeEEEe-----CCeEEEEEecCCCCChhHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 008648 445 -VKL------LGCCIH-----GEEKLLIYEFMPNKSLDYFIFD----QTNSKLLDWSKRFHIICGTARGLLYLHQDSRLR 508 (558)
Q Consensus 445 -v~l------~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ 508 (558)
+.+ ..+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 111 111111 12346777765 6899888742 122445788899999999999999999998
Q ss_pred eEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 509 IIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 509 ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|+||||||+||||+.++.+||+|||+|+..+.
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 99999999999999999999999999987643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=182.16 Aligned_cols=143 Identities=16% Similarity=0.147 Sum_probs=110.0
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcE--EEEEEecccccc------------------------cHHHHHHHHHHH
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQE--IAVKRLSKISDQ------------------------GLKELKNEVILF 436 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l 436 (558)
...-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 333467889999999999999997 67888 999986532111 113678999999
Q ss_pred hcCCCCee--eeeeeEEEeCCeEEEEEecCCC-C----ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCc
Q 008648 437 SKLQHRNL--VKLLGCCIHGEEKLLIYEFMPN-K----SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH-QDSRLR 508 (558)
Q Consensus 437 ~~l~h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH-~~~~~~ 508 (558)
.+++|+++ +.+++. ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+
T Consensus 125 ~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--- 191 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--- 191 (258)
T ss_dssp HHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---
T ss_pred HHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99988754 334432 356899999942 3 66665422 234567889999999999999 888
Q ss_pred eEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 509 IIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 509 ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+||||||+|||+++ .++|+|||+|......
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999999988 8999999999987544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.8e-18 Score=172.99 Aligned_cols=147 Identities=12% Similarity=0.140 Sum_probs=103.7
Q ss_pred hhhhhhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccccc--------------ccHHH--------HHHHHHHH
Q 008648 379 ATISNATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD--------------QGLKE--------LKNEVILF 436 (558)
Q Consensus 379 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l 436 (558)
..+.....-|++.+.||+|+||.||+|...+|+.||||+++.... ..... ...|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 334444445899999999999999999998999999998753100 01111 23455666
Q ss_pred hcCCCCeeeeeeeEEEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 008648 437 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 516 (558)
Q Consensus 437 ~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp 516 (558)
.++.+.++....-+.. ...+|||||++|.+|..+. .......++.||+.+|.|||+.+ ||||||||
T Consensus 168 ~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 6665444322111111 2237999999998886543 11234567899999999999998 99999999
Q ss_pred CcEEEcCCCC----------eEEeccccceeeC
Q 008648 517 SNVLLDHDMN----------PKISDFGLARTCG 539 (558)
Q Consensus 517 ~NIll~~~~~----------~kl~DFGla~~~~ 539 (558)
.||||++++. +.|+||+-+....
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999987763 8999999886654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6e-13 Score=129.43 Aligned_cols=145 Identities=16% Similarity=0.048 Sum_probs=114.0
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEe
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 462 (558)
....|++...++.|+.+.||++... ++.+++|............+.+|+.+++.+. |..+.+++++....+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456888888888889999999754 6899999886532233446889999999884 6788899999999889999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-------------------------------------- 504 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-------------------------------------- 504 (558)
|++|.+|...+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999977631 1223346788999999999981
Q ss_pred ------------------CCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 505 ------------------SRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 505 ------------------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
.+..++|+|++|.|||++++..+.|+||+.|..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998766677999998864
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.37 E-value=2.6e-12 Score=107.47 Aligned_cols=73 Identities=25% Similarity=0.518 Sum_probs=58.1
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
++||++++.+. ..... |+|+|+|||||++ .+.++||||+ +|+
T Consensus 38 ~~vW~sn~~~~-~~~~~-l~l~~~GNLvl~d-----~~~~~W~S~~-------------------------------~~~ 79 (112)
T 1xd5_A 38 RAVWASGTNGK-ASGCV-LKMQNDGNLVIYS-----GSRAIWASNT-------------------------------NRQ 79 (112)
T ss_dssp EEEEECCCTTS-CSSEE-EEECTTSCEEEEE-----TTEEEEECCC-------------------------------CCS
T ss_pred EEEEeCCCcCC-CCCEE-EEEeCCCCEEEEc-----CCEEEEECCc-------------------------------cCC
Confidence 47999998643 22345 9999999999997 3579999993 456
Q ss_pred CcceEEEEecCCCceEEEEe-CCeEEEEeccCCC
Q 008648 82 PGDFIWAVERQDNPEVVMWK-GSSKFYTTGPWNG 114 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~-~~~~y~~~~~~~~ 114 (558)
+|.|++.|+++|. +++++ ...+||++++|+|
T Consensus 80 ~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 80 NGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp CCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred CCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 7889999999987 55665 4679999999976
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=3.4e-12 Score=106.19 Aligned_cols=71 Identities=23% Similarity=0.438 Sum_probs=56.7
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
++||++++.+. ..... |+|+|+|||||++. .+.++|||| .+|+
T Consensus 39 ~~vW~sn~~~~-~~~~~-l~l~~dGNLVl~~~----~~~~~W~S~-------------------------------t~~~ 81 (110)
T 3a0c_A 39 KPVWASNTGGL-GSGCR-LTLHNNGNLVIYDQ----SNRVIWQTK-------------------------------TNGK 81 (110)
T ss_dssp EEEEECCCTTS-CSSCE-EEECTTSCEEEECT----TCCEEEECC-------------------------------CCCS
T ss_pred EEEEECCCCCC-CCcEE-EEEeCCCCEEEECC----CCcEEEecC-------------------------------CCCC
Confidence 57999998753 22345 99999999999986 578999999 3567
Q ss_pred CcceEEEEecCCCceEEEEeCCeEEEEeccCC
Q 008648 82 PGDFIWAVERQDNPEVVMWKGSSKFYTTGPWN 113 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~ 113 (558)
+|.|++.|+++|. ++++++ .||+++++.
T Consensus 82 ~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~ 109 (110)
T 3a0c_A 82 EDHYVLVLQQDRN--VVIYGP--VVWATGSGP 109 (110)
T ss_dssp SSCCEEEECTTSC--EEEECS--EEEECSCCC
T ss_pred CCCEEEEEeCCcc--EEEECC--CEecCCCcC
Confidence 7899999999887 556765 899998753
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=3.6e-12 Score=107.05 Aligned_cols=74 Identities=20% Similarity=0.448 Sum_probs=59.1
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
++||++++.+. ..... ++|+++|||||++. .+.++||||++ |+
T Consensus 39 ~~vW~sn~~~~-~~~~~-l~l~~~GnLvl~d~----~~~~vW~S~~~-------------------------------~~ 81 (115)
T 2dpf_A 39 RQIWASNTDRR-GSGCR-LTLLSDGNLVIYDH----NNNDVWGSACW-------------------------------GD 81 (115)
T ss_dssp EEEEECSCTTS-CSSCE-EEECTTSCEEEECT----TCCEEEECCCC-------------------------------CS
T ss_pred EEEEeCCCCCC-CCceE-EEECCCCcEEEECC----CceEEEEcCCC-------------------------------CC
Confidence 57999998653 22345 99999999999986 57899999997 35
Q ss_pred CcceEEEEecCCCceEEEEeCCeEEEEeccCCCCC
Q 008648 82 PGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLS 116 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~ 116 (558)
+|.|++.++++|. +++++. .||+|++|....
T Consensus 82 ~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~~ 112 (115)
T 2dpf_A 82 NGKYALVLQKDGR--FVIYGP--VLWSLGPNGCRR 112 (115)
T ss_dssp SSCCEEEECTTSC--EEEECS--EEECSSTTCBCC
T ss_pred CCCEEEEEeCCCe--EEEECC--CEEECCCCCCcC
Confidence 6789999999987 556765 899999997543
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.9e-12 Score=107.28 Aligned_cols=69 Identities=19% Similarity=0.338 Sum_probs=55.7
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
++||++++.+. ..... |+|+|+|||||++. .+.++|||| .+|+
T Consensus 49 ~~vW~sn~~~~-~~~~~-l~l~~dGNLVl~d~----~~~~lW~S~-------------------------------~~~~ 91 (119)
T 1b2p_A 49 NPIWATNTGGL-GNGCR-AVLQPDGVLVVITN----ENVTVWQSP-------------------------------VAGK 91 (119)
T ss_dssp EEEEECCCTTS-CSSCE-EEECTTSCEEEECT----TCCEEEECS-------------------------------CCCC
T ss_pred EEEEeCCCccC-CCceE-EEEccCCEEEEEeC----CCcEEEcCC-------------------------------CCCC
Confidence 57999998653 22355 99999999999986 678999999 4567
Q ss_pred CcceEEEEecCCCceEEEEeCCeEEEEecc
Q 008648 82 PGDFIWAVERQDNPEVVMWKGSSKFYTTGP 111 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 111 (558)
+|.|++.|+++|. +++++ .+||++|+
T Consensus 92 ~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 92 AGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp SSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred CCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 8999999999987 55566 38999886
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=7.7e-12 Score=121.10 Aligned_cols=141 Identities=16% Similarity=0.129 Sum_probs=103.0
Q ss_pred hcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCe--eeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN--LVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~ 461 (558)
....+.+....+.|..+.||++...++..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 33455553333456668999998777788999987543 2345788999988885444 566888888777889999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS------------------------------------ 505 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~------------------------------------ 505 (558)
||++|.+|. .. . .+ ...++.++++.|..||+..
T Consensus 95 e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 21 0 11 2356777888888888643
Q ss_pred -------------------CCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 506 -------------------RLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 506 -------------------~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+..++|+|++|.|||++++..++|+||+.|..-
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766779999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.8e-10 Score=117.26 Aligned_cols=141 Identities=17% Similarity=0.209 Sum_probs=106.0
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEec--ccc-cccHHHHHHHHHHHhcCC--CCeeeeeeeEEEeC---CeEEEEEe
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KIS-DQGLKELKNEVILFSKLQ--HRNLVKLLGCCIHG---EEKLLIYE 462 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~E 462 (558)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 468999999999999875 4678888765 321 122456888999999886 45688889888766 34799999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS------------------------------------- 505 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~------------------------------------- 505 (558)
|++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998874321 123678888899999999999999731
Q ss_pred ------------------CCceEecCCCCCcEEEcCCCC--eEEecccccee
Q 008648 506 ------------------RLRIIHRDLKASNVLLDHDMN--PKISDFGLART 537 (558)
Q Consensus 506 ------------------~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~ 537 (558)
+..++|+|++|.|||++.++. +.|+||+.|..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=5.6e-08 Score=96.33 Aligned_cols=137 Identities=20% Similarity=0.212 Sum_probs=99.1
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCe--eeeeeeEEEeCC---eEEEEEecCC
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRN--LVKLLGCCIHGE---EKLLIYEFMP 465 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~~ 465 (558)
+.++.|....||+.. ..+++|.... ......+.+|..+++.+. +.. +.+++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999763 5688887643 234567899999998873 332 444544433333 2478999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD----------------------------------------- 504 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~----------------------------------------- 504 (558)
|..|..... ..++..++..++.++++.|..||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 998865432 2366777788888888888888861
Q ss_pred --------------CCCceEecCCCCCcEEEcC--CCCeEEeccccceeeC
Q 008648 505 --------------SRLRIIHRDLKASNVLLDH--DMNPKISDFGLARTCG 539 (558)
Q Consensus 505 --------------~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~~ 539 (558)
.+..++|+|++|.||++++ ...+.|+||+.+..-.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 1235899999999999998 4568899999987643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=3.8e-07 Score=90.43 Aligned_cols=136 Identities=21% Similarity=0.149 Sum_probs=94.9
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC---eeeeeeeEEE-eCCeEEEEEecCCCC
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHR---NLVKLLGCCI-HGEEKLLIYEFMPNK 467 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~g 467 (558)
+.++.|....||+. +..+++|+... ......+..|..+|+.+.+. .+.+++.+.. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56788888899987 56788887532 23456789999999998642 3566676664 344578999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 008648 468 SLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD------------------------------------------- 504 (558)
Q Consensus 468 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~------------------------------------------- 504 (558)
.|...... .++..+...++.++++.|..||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88663211 134445555555555555555542
Q ss_pred --------------CCCceEecCCCCCcEEEcC---CCC-eEEeccccceee
Q 008648 505 --------------SRLRIIHRDLKASNVLLDH---DMN-PKISDFGLARTC 538 (558)
Q Consensus 505 --------------~~~~ivHrDlkp~NIll~~---~~~-~kl~DFGla~~~ 538 (558)
.+..++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234799999999999987 455 489999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=7.4e-07 Score=86.44 Aligned_cols=137 Identities=16% Similarity=0.130 Sum_probs=98.5
Q ss_pred eeecccCcc-cEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 392 NKLGEGGFG-PVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 392 ~~lg~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
+.+..|..+ .||+.... ++..+++|+-.. .....+.+|..+|+.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 58988754 456788887643 23457888999888774 4447788999999999999999999988
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 008648 469 LDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS------------------------------------------- 505 (558)
Q Consensus 469 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~------------------------------------------- 505 (558)
+.+.... .......+..+++..|.-||...
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8765422 11233345666666677776421
Q ss_pred ------------CCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 506 ------------RLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 506 ------------~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
...++|+|+.|.|||+++++.+-|+||+.|..-
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 113799999999999998777789999998653
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.42 E-value=8.1e-07 Score=73.83 Aligned_cols=69 Identities=17% Similarity=0.332 Sum_probs=48.4
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
++||++++.+. ..... ++|+|+|||||++. .+.++|||=.+ + .
T Consensus 45 ~~vWssnt~~~-~~~~~-l~l~~dGNLVl~d~----~~~~iW~S~t~-------------~------------------~ 87 (113)
T 3mez_B 45 NIVWESGTSGR-GQHCF-MRLGHSGELDITDD----RLNTVFVSNTV-------------G------------------Q 87 (113)
T ss_dssp EEEEECCCTTS-CSSCE-EEECTTSCEEEECT----TSCEEEECSCC-------------C------------------S
T ss_pred EEEEECCcccC-CcCEE-EEEeCCCcEEEECC----CCCEEEECCCc-------------C------------------C
Confidence 47999998653 12345 89999999999986 56789997321 0 1
Q ss_pred CcceEEEEecCCCceEEEEeCCeEEEEecc
Q 008648 82 PGDFIWAVERQDNPEVVMWKGSSKFYTTGP 111 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 111 (558)
.|.|.+.++.+|... +++ .+.|.+++
T Consensus 88 ~~~~~~~L~~dGnlv--ly~--~~~W~s~~ 113 (113)
T 3mez_B 88 EGDYVLILQINGQAV--VYG--PAVWSTAA 113 (113)
T ss_dssp SSCCEEEECTTSCEE--EEC--SEEEESCC
T ss_pred CCCEEEEEcCCceEE--Eec--CCEecCCC
Confidence 245788898888754 444 58898874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=4.6e-07 Score=91.80 Aligned_cols=80 Identities=6% Similarity=-0.014 Sum_probs=55.3
Q ss_pred ceee-cccCcccEEEEEEc-------CCcEEEEEEecccc---cccHHHHHHHHHHHhcCC-C--CeeeeeeeEEEeC--
Q 008648 391 NNKL-GEGGFGPVYKGTLV-------DGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQ-H--RNLVKLLGCCIHG-- 454 (558)
Q Consensus 391 ~~~l-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 454 (558)
.+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3577 88888999998764 26678888765422 111245778888888774 2 3577788777554
Q ss_pred -CeEEEEEecCCCCChh
Q 008648 455 -EEKLLIYEFMPNKSLD 470 (558)
Q Consensus 455 -~~~~lv~E~~~~gsL~ 470 (558)
...++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.35 E-value=9.8e-07 Score=73.04 Aligned_cols=69 Identities=12% Similarity=0.218 Sum_probs=49.2
Q ss_pred EEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCC-ceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCCC
Q 008648 4 VWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSG-TYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPSP 82 (558)
Q Consensus 4 vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~-~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~ 82 (558)
+|++++.+. ..... ++|+|+|||||++. .+ .++|||..+ .....
T Consensus 40 vW~snt~~~-~~~~~-l~l~~dGNLVl~~~----~~~~~vW~S~t~-----------------------------~~~~~ 84 (111)
T 3mez_A 40 GFQSNTHGR-GVDCT-LRLNNRGQLEIHSA----NSNTPVWVYPRS-----------------------------VNTVR 84 (111)
T ss_dssp CEECCCTTS-CSSCE-EEECTTSCEEEECS----SCSSCSEEESSS-----------------------------CCCCS
T ss_pred EEECCcccC-CcCEE-EEEcCCCcEEEEeC----CCCEEEEEeccc-----------------------------cCCCC
Confidence 899998753 22345 89999999999986 34 469999721 01134
Q ss_pred cceEEEEecCCCceEEEEeCCeEEEEecc
Q 008648 83 GDFIWAVERQDNPEVVMWKGSSKFYTTGP 111 (558)
Q Consensus 83 g~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 111 (558)
|.|.+.++.+|...+ +. .++|.+++
T Consensus 85 ~~~~l~Lq~dGNlvl--y~--~~~W~s~t 109 (111)
T 3mez_A 85 GNYAATLGPDQHVTI--YG--PAIWSTPA 109 (111)
T ss_dssp SCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred cCEEEEECCCCeEEE--ec--cCEEccCC
Confidence 678999999887544 44 68999874
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=6.2e-07 Score=85.19 Aligned_cols=70 Identities=19% Similarity=0.303 Sum_probs=51.4
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
++||.+|+.+. .... ++|.++|||||.+. .+.++|+|+.+. +
T Consensus 45 ~~vW~an~~~~--~~~~-l~l~~dGnLvl~d~----~~~~vW~s~~~~-------------------------------~ 86 (236)
T 1dlp_A 45 VRVWASNTAGA--TGCR-AVLQSDGLLVILTA----QNTIRWSSGTKG-------------------------------S 86 (236)
T ss_dssp SEEECCCCCSC--SCCB-CCBCSSSCBCCBCT----TTCCSCCCCCCC-------------------------------C
T ss_pred EEEEECCCCCC--CCeE-EEEcCCCcEEEEcC----CCcEEEeCCccc-------------------------------c
Confidence 58999998653 3455 89999999999986 678999998750 2
Q ss_pred CcceEEEEecCCCceEEEEeCCeEEEEeccCC
Q 008648 82 PGDFIWAVERQDNPEVVMWKGSSKFYTTGPWN 113 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~ 113 (558)
+|.|.+.|+.+|+..+ ++. .+|.+..+.
T Consensus 87 ~~~~~~~l~d~Gnlvl--~~~--~~W~S~~~p 114 (236)
T 1dlp_A 87 IGNYVLVLQPDRTVTI--YGP--GLWDSGTSN 114 (236)
T ss_dssp SSCCEEEECSSSCEEE--ECS--EEEECSCCC
T ss_pred CCcEEEEEeCCCCEEE--ecC--CEEECCCCC
Confidence 3457788887777443 332 788887664
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=2.9e-06 Score=70.03 Aligned_cols=69 Identities=17% Similarity=0.389 Sum_probs=47.2
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
++||++++.+. ..... ++|+|+|||||++. .+.++|||.... .
T Consensus 38 ~~vW~snt~~~-~~~~~-l~l~~dGNLvl~~~----~~~~~W~S~t~~-------------------------------~ 80 (109)
T 3dzw_A 38 KPIWATNTGGL-DRRCH-LSMQSDGNLVVYSP----RNNPIWASNTGG-------------------------------E 80 (109)
T ss_dssp EEEEECCCTTS-SSSCE-EEECTTSCEEEECT----TSCEEEECCCCC-------------------------------S
T ss_pred EEEEECCcccC-CCCEE-EEEeCCCCEEEECC----CCCEEEECCCCC-------------------------------C
Confidence 47999998753 22345 89999999999986 568999985321 1
Q ss_pred CcceEEEEecCCCceEEEEeCCeEEEEecc
Q 008648 82 PGDFIWAVERQDNPEVVMWKGSSKFYTTGP 111 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 111 (558)
.+.|.+.++.+|+.. +++. +.|.++.
T Consensus 81 ~~~~~~~L~ddGNlv--ly~~--~~W~s~t 106 (109)
T 3dzw_A 81 NGNYVCVLQKDRNVV--IYGT--ARWATGT 106 (109)
T ss_dssp SSCEEEEECTTSCEE--EEES--CCCCCCC
T ss_pred CCCEEEEEeCCCEEE--EECC--CEEeCCC
Confidence 245778888888754 3442 5666553
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.24 E-value=2.6e-06 Score=70.31 Aligned_cols=67 Identities=13% Similarity=0.362 Sum_probs=47.3
Q ss_pred eEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCCC
Q 008648 3 VVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPSP 82 (558)
Q Consensus 3 ~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~ 82 (558)
++|++++.+. ..... ++|+|+|||||++. .+.++|||-.+- ..
T Consensus 43 ~vW~snt~~~-~~~~~-l~l~~dGNLvl~d~----~~~~iW~S~t~~-------------------------------~~ 85 (110)
T 3r0e_B 43 YGWQSNTHGN-GEHCF-LRLNHKGELIIKDD----DFKTIWSSRSSS-------------------------------KQ 85 (110)
T ss_dssp SCEECCCTTS-SSSCE-EEECTTSCEEEECT----TCCEEEECCCCC-------------------------------SS
T ss_pred EEEECCCcCC-CcCEE-EEEeCCCcEEEEeC----CCCEEEEcCCcC-------------------------------CC
Confidence 6899998753 12345 89999999999986 568999985310 12
Q ss_pred cceEEEEecCCCceEEEEeCCeEEEEec
Q 008648 83 GDFIWAVERQDNPEVVMWKGSSKFYTTG 110 (558)
Q Consensus 83 g~~~~~~~~~~~~~~~~~~~~~~y~~~~ 110 (558)
|.|.+.++.+|... +++ .+.|.++
T Consensus 86 ~~~~~~L~~dGNlv--ly~--~~~W~t~ 109 (110)
T 3r0e_B 86 GEYVLILQDDGFGV--IYG--PAIFETS 109 (110)
T ss_dssp SCCEEEECTTSCEE--EEC--SEEEESC
T ss_pred CCEEEEEcCCccEE--Eec--CCEecCC
Confidence 34778888888754 444 3788876
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.18 E-value=2.3e-06 Score=70.48 Aligned_cols=94 Identities=15% Similarity=0.127 Sum_probs=57.1
Q ss_pred ccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccC-CCCCCCCce
Q 008648 50 SDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTTRPNPIF 128 (558)
Q Consensus 50 TDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~-~~~~~~~~~ 128 (558)
+|||||||.|..+. .| +.|.|.|.|+.+|+. +++++ ||.++..... ... ..+.. ..
T Consensus 3 ~dtL~~gq~L~~g~------~L---------~~g~~~L~~q~dGNL--vl~~~---~Wssnt~~~~-~~~~l~l~~--dG 59 (109)
T 3r0e_A 3 TNYLLSGQTLDTEG------HL---------KNGDFDLVMQDDCNL--VLYNG---NWQSNTANNG-RDCKLTLTD--YG 59 (109)
T ss_dssp CSEEETTCEECTTC------EE---------EETTEEEEECTTSCE--EEETT---TEECCCTTSC-SSCEEEECT--TS
T ss_pred cCCcCCCCCcCCCC------Ee---------ECCCEEEEEecCCeE--EEEeC---eEEcCCCCCC-CcEEEEEcC--CC
Confidence 79999999998884 46 458999999988864 34553 7887654311 001 11111 12
Q ss_pred eeEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEEE
Q 008648 129 NFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFT 167 (558)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~~ 167 (558)
.+.+.+..+....+..........+++|+.|| ++++|.
T Consensus 60 nLvl~d~~~~~vWss~t~~~~~~~~~~L~~dG-Nlvly~ 97 (109)
T 3r0e_A 60 ELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDG-RLVVFG 97 (109)
T ss_dssp CEEEECTTSCEEEECCCCCSSSCCEEEEETTT-EEEEEC
T ss_pred eEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCC-eEEEEe
Confidence 23333333333333222222345689999999 999995
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.16 E-value=3.1e-06 Score=69.88 Aligned_cols=96 Identities=10% Similarity=0.081 Sum_probs=58.5
Q ss_pred ccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccC-CCCCCCCce
Q 008648 50 SDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTTRPNPIF 128 (558)
Q Consensus 50 TDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~-~~~~~~~~~ 128 (558)
+|||+|||.|..+. .|+| |.|.|.|+.+|.. ++++. .+||.++..... ... ..+.. ..
T Consensus 6 ~dtL~~gq~L~~g~------~L~s---------g~~~L~~q~dGnL--vl~~~-~~vW~snt~~~~-~~~~l~l~~--dG 64 (110)
T 3r0e_B 6 NNLLFSGQVLYGDG------RLTA---------KNHQLVMQGDCNL--VLYGG-KYGWQSNTHGNG-EHCFLRLNH--KG 64 (110)
T ss_dssp TTEEETTCEEETTE------EEEC---------SSCEEEECTTSCE--EEECS-SSCEECCCTTSS-SSCEEEECT--TS
T ss_pred cCEECCCCEecCCC------EEEe---------CCEEEEEcCCCeE--EEECC-eEEEECCCcCCC-cCEEEEEeC--CC
Confidence 79999999999884 5763 6799999988864 44665 589987654311 000 11111 12
Q ss_pred eeEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEEE
Q 008648 129 NFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFT 167 (558)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~~ 167 (558)
.+.+.+..+.............-.+++|+.|| ++++|.
T Consensus 65 NLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dG-Nlvly~ 102 (110)
T 3r0e_B 65 ELIIKDDDFKTIWSSRSSSKQGEYVLILQDDG-FGVIYG 102 (110)
T ss_dssp CEEEECTTCCEEEECCCCCSSSCCEEEECTTS-CEEEEC
T ss_pred cEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCc-cEEEec
Confidence 33333433333333322222223689999999 999985
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=7.7e-06 Score=81.94 Aligned_cols=141 Identities=18% Similarity=0.243 Sum_probs=79.7
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCeeeeeee------EEEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ--HRNLVKLLG------CCIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~E~ 463 (558)
+.|+.|..+.||+....++ .+++|+.... ...+..|..+++.|. .-.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987544 5889988651 234445555555442 112333332 22346678999999
Q ss_pred CCCCChh-----------HH---Hhhc-CC---C-------CCCCHHHHH------------------------------
Q 008648 464 MPNKSLD-----------YF---IFDQ-TN---S-------KLLDWSKRF------------------------------ 488 (558)
Q Consensus 464 ~~~gsL~-----------~~---l~~~-~~---~-------~~l~~~~~~------------------------------ 488 (558)
++|..+. .. ++.. .. . ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 01 1110 00 0 011222110
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 489 -HIICGTARGLLYLHQ----------DSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 489 -~i~~~i~~gL~yLH~----------~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
.+...+..++++|++ ..+..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223446667763 1234599999999999998888899999998854
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.14 E-value=5.3e-06 Score=68.32 Aligned_cols=69 Identities=20% Similarity=0.481 Sum_probs=48.8
Q ss_pred EEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCCCc
Q 008648 4 VWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPSPG 83 (558)
Q Consensus 4 vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g 83 (558)
+|+|++.+. ..... ++|+++|||||++. .+.++|+|- | ....+
T Consensus 39 ~Wssnt~~~-~~~~~-l~l~~dGnLvl~d~----~~~~vWss~-----t--------------------------~~~~~ 81 (109)
T 3r0e_A 39 NWQSNTANN-GRDCK-LTLTDYGELVIKNG----DGSTVWKSG-----A--------------------------QSVKG 81 (109)
T ss_dssp TEECCCTTS-CSSCE-EEECTTSCEEEECT----TSCEEEECC-----C--------------------------CCSSS
T ss_pred eEEcCCCCC-CCcEE-EEEcCCCeEEEEeC----CCCEEEcCC-----C--------------------------cCCCc
Confidence 599998753 22345 89999999999986 567899762 1 00234
Q ss_pred ceEEEEecCCCceEEEEeCCeEEEEeccCC
Q 008648 84 DFIWAVERQDNPEVVMWKGSSKFYTTGPWN 113 (558)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~ 113 (558)
.|.+.++++|+.. +++ .+.|.+++|-
T Consensus 82 ~~~~~L~~dGNlv--ly~--~~~W~s~t~~ 107 (109)
T 3r0e_A 82 NYAAVVHPDGRLV--VFG--PSVFKIDPWV 107 (109)
T ss_dssp CCEEEEETTTEEE--EEC--SEEEEECTTS
T ss_pred CEEEEEcCCCeEE--EEe--cCEECCCCcc
Confidence 6788999888644 444 5889999873
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=7.6e-06 Score=84.10 Aligned_cols=75 Identities=9% Similarity=0.134 Sum_probs=50.0
Q ss_pred ceeecccCcccEEEEEEc-CCcEEEEEEeccccc-------ccHHHHHHHHHHHhcCCC--C-eeeeeeeEEEeCCeEEE
Q 008648 391 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISD-------QGLKELKNEVILFSKLQH--R-NLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 459 (558)
.+.||.|..+.||++... +++.++||....... ...+++..|.++++.+.+ + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 368999999999999754 467899997643211 223456788888887632 3 34455544 4556789
Q ss_pred EEecCCCC
Q 008648 460 IYEFMPNK 467 (558)
Q Consensus 460 v~E~~~~g 467 (558)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1.2e-05 Score=66.26 Aligned_cols=96 Identities=9% Similarity=0.048 Sum_probs=60.2
Q ss_pred cccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccC-CCCCCCCcee
Q 008648 51 DTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTTRPNPIFN 129 (558)
Q Consensus 51 DTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~-~~~~~~~~~~ 129 (558)
+||+|||.|..+. .|+ .|.|.|.|+.+|.. ++++...++|.++..... ... ..+.. ...
T Consensus 2 ntL~~gq~L~~g~------~L~---------~g~~~L~~q~dGnL--vly~~~~~vW~snt~~~~-~~~~l~l~~--dGN 61 (109)
T 3dzw_A 2 NILYSGETLSPGE------FLN---------NGRYVFIMQEDCNL--VLYDVDKPIWATNTGGLD-RRCHLSMQS--DGN 61 (109)
T ss_dssp CEEETTEEECTTC------EEE---------ETTEEEEECTTSCE--EEEETTEEEEECCCTTSS-SSCEEEECT--TSC
T ss_pred CCcCCCCEeCCCC------EEE---------CCCEEEEEcCCCcE--EEEeCCEEEEECCcccCC-CCEEEEEeC--CCC
Confidence 6999999998874 463 58999999988864 456777899998754311 001 11111 123
Q ss_pred eEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEEE
Q 008648 130 FSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFT 167 (558)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~~ 167 (558)
+.+.+..+...............+++|+.|| ++++|.
T Consensus 62 Lvl~~~~~~~~W~S~t~~~~~~~~~~L~ddG-Nlvly~ 98 (109)
T 3dzw_A 62 LVVYSPRNNPIWASNTGGENGNYVCVLQKDR-NVVIYG 98 (109)
T ss_dssp EEEECTTSCEEEECCCCCSSSCEEEEECTTS-CEEEEE
T ss_pred EEEECCCCCEEEECCCCCCCCCEEEEEeCCC-EEEEEC
Confidence 3333433333333322223345689999999 999985
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=6.3e-06 Score=68.06 Aligned_cols=40 Identities=28% Similarity=0.538 Sum_probs=31.4
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCc
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPS 50 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PT 50 (558)
.++|+|++... .+..+ ++|+|+|||||++. ++||||+||.
T Consensus 71 ~~~W~S~t~~~-~g~~~-l~l~~dGnlvl~~~-------~~W~S~~~~~ 110 (110)
T 3a0c_A 71 RVIWQTKTNGK-EDHYV-LVLQQDRNVVIYGP-------VVWATGSGPA 110 (110)
T ss_dssp CEEEECCCCCS-SSCCE-EEECTTSCEEEECS-------EEEECSCCC-
T ss_pred cEEEecCCCCC-CCCEE-EEEeCCccEEEECC-------CEecCCCcCC
Confidence 47999998753 23445 99999999999751 7999999984
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.01 E-value=1.2e-05 Score=66.67 Aligned_cols=97 Identities=7% Similarity=0.047 Sum_probs=59.3
Q ss_pred ccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeC--CeEEEEeccCCCCCccC-CCCCCCC
Q 008648 50 SDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKG--SSKFYTTGPWNGLSFSA-PTTRPNP 126 (558)
Q Consensus 50 TDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~--~~~y~~~~~~~~~~~~~-~~~~~~~ 126 (558)
.|||+|||.|..+. .|+ .|.|.|.|+.+|.. ++++. ...||.++..... ... ..+..
T Consensus 6 ~~tL~~gq~L~~g~------~L~---------~g~~~L~~q~dGNL--vL~~~~~~~~vWssnt~~~~-~~~~l~l~~-- 65 (113)
T 3mez_B 6 RNVLFSSQVMYDNA------QLA---------TRDYSLVMRDDCNL--VLTKGSKTNIVWESGTSGRG-QHCFMRLGH-- 65 (113)
T ss_dssp SSEEETTCEEETTC------EEE---------ETTEEEEECTTSCE--EEEETTTTEEEEECCCTTSC-SSCEEEECT--
T ss_pred CCEeCCCCEECCCC------EeE---------cCCEEEEEcCCCEE--EEEECCCCEEEEECCcccCC-cCEEEEEeC--
Confidence 69999999999884 474 48899999988864 45554 5799998754211 000 11111
Q ss_pred ceeeEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEEE
Q 008648 127 IFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFT 167 (558)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~~ 167 (558)
...+.+.+..+...............+++|+.|| ++++|.
T Consensus 66 dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dG-nlvly~ 105 (113)
T 3mez_B 66 SGELDITDDRLNTVFVSNTVGQEGDYVLILQING-QAVVYG 105 (113)
T ss_dssp TSCEEEECTTSCEEEECSCCCSSSCCEEEECTTS-CEEEEC
T ss_pred CCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCc-eEEEec
Confidence 1233333333333333222222223689999999 999994
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.5e-05 Score=63.76 Aligned_cols=96 Identities=8% Similarity=0.034 Sum_probs=61.6
Q ss_pred cccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccC-CCCCCCCcee
Q 008648 51 DTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTTRPNPIFN 129 (558)
Q Consensus 51 DTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~-~~~~~~~~~~ 129 (558)
|||+|||.|..+. +|+| |.|+|.|+.+++ +++|++..+.|.+...+...... ..+... ..
T Consensus 2 n~L~~g~~L~~g~------~L~s---------g~y~l~~q~DgN--Lvly~~~~~vW~ant~~~~~~~~~L~l~~d--Gn 62 (105)
T 4h3o_A 2 NILDNNEGLYAGQ------SLDV---------EPYHFIMQDDCN--LVLYDHSTSTWASNTEIGGKSGCSAVLQSD--GN 62 (105)
T ss_dssp CEECTTEEECTTC------EEEE---------TTEEEEECTTSC--EEEEETTEEEEECCCCCTTCCSCEEEECTT--SC
T ss_pred CCcCCCCEEcCCC------EEEE---------CCEEEEECCCCe--EEEEECCEEEEEecCCCCCCccEEEEEeCC--cc
Confidence 8999999998884 6764 889999998876 45678888999976543211111 112222 23
Q ss_pred eEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEE
Q 008648 130 FSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRF 166 (558)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~ 166 (558)
+...+..+...++........-.+++|..|| ++.+|
T Consensus 63 LvL~d~~~~~vWss~t~~~~~~~~l~L~ddG-NlVly 98 (105)
T 4h3o_A 63 FVVYDSSGRSLWASHSTRGSGNYILILQDDG-NVIIY 98 (105)
T ss_dssp EEEECTTCCEEEECCCCCCSSCEEEEECTTS-CEEEE
T ss_pred EEEECCCcEEEEEecCCCCCCCEEEEEeCCC-eEEEE
Confidence 3334444444444433333344689999999 99998
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.00 E-value=2.6e-05 Score=63.64 Aligned_cols=39 Identities=23% Similarity=0.403 Sum_probs=24.4
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeee
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQS 45 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqS 45 (558)
++||++++......... +.|.++|||||.|. .++++|.|
T Consensus 38 ~~vW~ant~~~~~~~~~-L~l~~dGnLvL~d~----~~~~vWss 76 (105)
T 4h3o_A 38 TSTWASNTEIGGKSGCS-AVLQSDGNFVVYDS----SGRSLWAS 76 (105)
T ss_dssp EEEEECCCCCTTCCSCE-EEECTTSCEEEECT----TCCEEEEC
T ss_pred EEEEEecCCCCCCccEE-EEEeCCccEEEECC----CcEEEEEe
Confidence 35777776543222334 77777777777765 56677765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=5.9e-05 Score=74.51 Aligned_cols=138 Identities=17% Similarity=0.143 Sum_probs=92.4
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCeeeeeeeEEEeCCeEEEEEecCCCC
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ---HRNLVKLLGCCIHGEEKLLIYEFMPNK 467 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~g 467 (558)
.+.|+.|....+|+... ++..+++|+... .....+..|...|+.|. ...+++++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46899999999999986 567888987653 23567889998888873 367888998888888899999999988
Q ss_pred ChhH--------H---HhhcCC-CC------------------CCCHHHHH---HHHH----------------HHHHHH
Q 008648 468 SLDY--------F---IFDQTN-SK------------------LLDWSKRF---HIIC----------------GTARGL 498 (558)
Q Consensus 468 sL~~--------~---l~~~~~-~~------------------~l~~~~~~---~i~~----------------~i~~gL 498 (558)
.+.. . |+.... .. .-+|...+ ++.. .++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1 111111 00 11344322 1111 111122
Q ss_pred -HHHHh-CCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 499 -LYLHQ-DSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 499 -~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
..|.. ..++.++|+|+.+.|++++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23422 2346799999999999999887 9999984
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=97.92 E-value=1.2e-05 Score=66.72 Aligned_cols=42 Identities=19% Similarity=0.430 Sum_probs=33.3
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYP 49 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~P 49 (558)
.++|+|.+... .+... ++|+++|||||++. .+.++||||++.
T Consensus 69 ~~~W~S~~~~~-~g~~~-l~l~~dGnlvl~~~----~~~~~W~S~~~~ 110 (112)
T 1xd5_A 69 RAIWASNTNRQ-NGNYY-LILQRDRNVVIYDN----SNNAIWATHTNV 110 (112)
T ss_dssp EEEEECCCCCS-CCCCE-EEECTTSCEEEECT----TSCEEEECCCCC
T ss_pred EEEEECCccCC-CCCEE-EEEeCCCcEEEECC----CCceEEECCCcc
Confidence 47999987653 23445 99999999999974 467999999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.91 E-value=4.1e-05 Score=74.84 Aligned_cols=79 Identities=16% Similarity=0.204 Sum_probs=57.7
Q ss_pred CcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCC---CeeeeeeeEEEeCCeEEEEEec
Q 008648 387 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH---RNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~E~ 463 (558)
...-.+.+|.|..+.||+.+..+|+.+.+|+...........+..|+..|+.|.- --+++++++ . ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 3444578999999999999999999999998765444444568889998887742 234455544 2 34789999
Q ss_pred CCCCCh
Q 008648 464 MPNKSL 469 (558)
Q Consensus 464 ~~~gsL 469 (558)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=97.84 E-value=1.8e-05 Score=65.32 Aligned_cols=97 Identities=7% Similarity=0.032 Sum_probs=57.9
Q ss_pred ccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccCCCCCCCCcee
Q 008648 50 SDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPTTRPNPIFN 129 (558)
Q Consensus 50 TDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~ 129 (558)
+|||+|||.|..+. .| +.|.|.|.|+.+|.. ++++... +|.++......-....+... ..
T Consensus 2 ~~~l~~gq~L~~g~------~L---------~~g~~~L~~q~dGnL--vl~~~~~-vW~snt~~~~~~~~l~l~~d--GN 61 (111)
T 3mez_A 2 NNVLLTGDVIHTDN------QL---------SYESAAFVMQGDCNL--VLYNEAG-GFQSNTHGRGVDCTLRLNNR--GQ 61 (111)
T ss_dssp TTEEETTCEECTTC------EE---------EETTEEEEECTTSCE--EEECSSC-CEECCCTTSCSSCEEEECTT--SC
T ss_pred cCEeCCCCEeCCCC------EE---------ecCCEEEEEccCCeE--EEECCCC-EEECCcccCCcCEEEEEcCC--Cc
Confidence 69999999999884 46 358999999988764 4466555 99976542110000111111 22
Q ss_pred eEEeecCC-eeEEEEEe--cCCceEEEEEEeccCCceEEEE
Q 008648 130 FSFVANED-ELCYTFSI--KDKAVVSRIVMNQTTYLGQRFT 167 (558)
Q Consensus 130 ~~~~~~~~-~~~~~~~~--~~~~~~~r~~ld~~G~~~~~~~ 167 (558)
+.+.+..+ ........ .......+++|+.|| ++++|.
T Consensus 62 LVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dG-Nlvly~ 101 (111)
T 3mez_A 62 LEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQ-HVTIYG 101 (111)
T ss_dssp EEEECSSCSSCSEEESSSCCCCSSCCEEEECTTS-CEEEEC
T ss_pred EEEEeCCCCEEEEEeccccCCCCcCEEEEECCCC-eEEEec
Confidence 33333332 21333221 122345689999999 999995
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.0001 Score=76.25 Aligned_cols=73 Identities=10% Similarity=0.163 Sum_probs=45.3
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEeccc----cc-----ccHHHHHHHHHHHh-cCCCCeeeeeeeEEEeCCeEEEE
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SD-----QGLKELKNEVILFS-KLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~----~~-----~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 460 (558)
.+.||.|....||++.. +++.++||..... .. .....+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 36789999999999964 5678999943210 11 12233444443332 22234566777664 5667999
Q ss_pred EecC-CC
Q 008648 461 YEFM-PN 466 (558)
Q Consensus 461 ~E~~-~~ 466 (558)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00014 Score=60.47 Aligned_cols=96 Identities=11% Similarity=0.115 Sum_probs=57.5
Q ss_pred ccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccC-CCCCCCCce
Q 008648 50 SDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTTRPNPIF 128 (558)
Q Consensus 50 TDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~-~~~~~~~~~ 128 (558)
.|||+|||.|..+. .|+ .|.|.|.++.+|.. ++++...++|.+...... .+. ..+... .
T Consensus 2 ~dtl~~gq~L~~g~------~L~---------~g~~~L~~~~dgnl--vly~~~~~vW~sn~~~~~-~~~~l~l~~~--G 61 (115)
T 2dpf_A 2 DNVLLSGQTLHADH------SLQ---------AGAYTLTIQNKCNL--VKYQNGRQIWASNTDRRG-SGCRLTLLSD--G 61 (115)
T ss_dssp CCEEETTCEEETTE------EEE---------ETTEEEEECTTSCE--EEEETTEEEEECSCTTSC-SSCEEEECTT--S
T ss_pred CCEeCCCCEECCCC------EEE---------CCCEEEEEcCCCcE--EEEeCCEEEEeCCCCCCC-CceEEEECCC--C
Confidence 59999999998874 464 58999999888764 345677899998754321 111 112111 2
Q ss_pred eeEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEE
Q 008648 129 NFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRF 166 (558)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~ 166 (558)
.+.+.+..+...............+++|+.|| ++++|
T Consensus 62 nLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dG-nlvl~ 98 (115)
T 2dpf_A 62 NLVIYDHNNNDVWGSACWGDNGKYALVLQKDG-RFVIY 98 (115)
T ss_dssp CEEEECTTCCEEEECCCCCSSSCCEEEECTTS-CEEEE
T ss_pred cEEEECCCceEEEEcCCCCCCCCEEEEEeCCC-eEEEE
Confidence 23333333332222211112234579999999 88887
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00029 Score=69.74 Aligned_cols=143 Identities=16% Similarity=0.126 Sum_probs=79.0
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC--eeeeeeeE------EEeCCeEEEEEec
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHR--NLVKLLGC------CIHGEEKLLIYEF 463 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~E~ 463 (558)
+.|+.|....+|+....++ .+++|..... ...+.+..|+.++..+... .+.+++.. ....+..+++|||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4677788889999987555 6888887642 1223456677777665321 13333321 1234567899999
Q ss_pred CCCCChhH----H----------HhhcC-C---C--CCC---CHHHHHH------------HHHHHHHHHHHHHhC----
Q 008648 464 MPNKSLDY----F----------IFDQT-N---S--KLL---DWSKRFH------------IICGTARGLLYLHQD---- 504 (558)
Q Consensus 464 ~~~gsL~~----~----------l~~~~-~---~--~~l---~~~~~~~------------i~~~i~~gL~yLH~~---- 504 (558)
++|..+.. . ++... . . ... .|...+. +...+.+.++.+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 0 11110 0 0 001 1221110 001234455555532
Q ss_pred CCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 505 ~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234599999999999998876568999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.001 Score=65.92 Aligned_cols=143 Identities=14% Similarity=0.111 Sum_probs=81.7
Q ss_pred eeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCC--CeeeeeeeE-----EEeCCeEEEEEecC
Q 008648 392 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQH--RNLVKLLGC-----CIHGEEKLLIYEFM 464 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~-----~~~~~~~~lv~E~~ 464 (558)
..++ |....||+....+|+.+++|..... ......+..|..++..+.. -.+++++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 7778999987767778999987632 1234567778887777642 124444432 22345668899999
Q ss_pred CCCChh-----HH---------Hhh--c--CC--CCCCCHHHH----------------------HHHHHHHHHHHHHHH
Q 008648 465 PNKSLD-----YF---------IFD--Q--TN--SKLLDWSKR----------------------FHIICGTARGLLYLH 502 (558)
Q Consensus 465 ~~gsL~-----~~---------l~~--~--~~--~~~l~~~~~----------------------~~i~~~i~~gL~yLH 502 (558)
+|..+. .. ++. . .. ....++... ...+..++..++-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885542 11 111 0 00 011121110 011112222222221
Q ss_pred h-CCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 503 Q-DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 503 ~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
. ..+..++|+|++|.|||++ + .+.|+||+.+..-
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1 1234589999999999998 4 8999999887643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00078 Score=67.05 Aligned_cols=142 Identities=15% Similarity=0.077 Sum_probs=71.9
Q ss_pred eeecccCccc-EEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCeeeeeeeEEEeCCeEEEEEecCCCCC
Q 008648 392 NKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ--HRNLVKLLGCCIHGEEKLLIYEFMPNKS 468 (558)
Q Consensus 392 ~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gs 468 (558)
+.|+.|.... +|+....++..+++|....... +.+..|+.+++.+. .-.+.+++.+.. +..+++||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 3565554444 6677654467777776543211 23445666666553 233556666532 22378999998766
Q ss_pred hhHHHhhc---------------------CCC--CCCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 008648 469 LDYFIFDQ---------------------TNS--KLLDWSKRF-------H-I------------ICGTARGLLYLH--- 502 (558)
Q Consensus 469 L~~~l~~~---------------------~~~--~~l~~~~~~-------~-i------------~~~i~~gL~yLH--- 502 (558)
+...+... ... ...+..... . + ...+...++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64433210 000 011111000 0 0 001112222221
Q ss_pred hCCCCceEecCCCCCcEEEcCC----CCeEEeccccceee
Q 008648 503 QDSRLRIIHRDLKASNVLLDHD----MNPKISDFGLARTC 538 (558)
Q Consensus 503 ~~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~~ 538 (558)
...+..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999874 67999999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00025 Score=73.48 Aligned_cols=72 Identities=18% Similarity=0.281 Sum_probs=48.5
Q ss_pred eeecccCcccEEEEEEcC--------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCCeEEEEEe
Q 008648 392 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN-LVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E 462 (558)
+.|+.|....+|++...+ +..+++|+.... ...+.+..|..+++.+...+ ..++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 578888888999998753 478889887431 12255667888888774323 356666543 2 38999
Q ss_pred cCCCCCh
Q 008648 463 FMPNKSL 469 (558)
Q Consensus 463 ~~~~gsL 469 (558)
|++|..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0013 Score=68.54 Aligned_cols=73 Identities=16% Similarity=0.098 Sum_probs=46.8
Q ss_pred eeecccCcccEEEEEEcC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCee-eeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 392 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
+.|+.|-...+|+....+ +..+++|+........ -...+|..++..|...++ .++++.+ .+ .+||||++|..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 578888888999998765 4788888764322111 112578888888864444 5677665 23 359999987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00036 Score=68.46 Aligned_cols=71 Identities=8% Similarity=0.160 Sum_probs=43.6
Q ss_pred ceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCee-eeeeeEEEeCCeEEEEEecC-CCCC
Q 008648 391 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFM-PNKS 468 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~gs 468 (558)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+....+ .++++. +.+..++++||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578989999999998 56888876542111 1123457777666632222 455543 344467899999 6655
Q ss_pred h
Q 008648 469 L 469 (558)
Q Consensus 469 L 469 (558)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00055 Score=69.43 Aligned_cols=141 Identities=18% Similarity=0.232 Sum_probs=81.6
Q ss_pred eeecccCcccEEEEEEc--------CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEe
Q 008648 392 NKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 462 (558)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+. +.-..++++.+. + .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 56777778889998864 2478889876332 234556678999888774 222356666553 3 29999
Q ss_pred cCCCCChhHH--------------H---hhcC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 008648 463 FMPNKSLDYF--------------I---FDQT--NSKLLD--WSKRFHIICGTAR-------------------GLLYL- 501 (558)
Q Consensus 463 ~~~~gsL~~~--------------l---~~~~--~~~~l~--~~~~~~i~~~i~~-------------------gL~yL- 501 (558)
|++|..|..- | +... ...... +.++.++..++.. .++.|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 0 1110 011112 3444444433321 22333
Q ss_pred ---HhC-CCCceEecCCCCCcEEEcCC----CCeEEecccccee
Q 008648 502 ---HQD-SRLRIIHRDLKASNVLLDHD----MNPKISDFGLART 537 (558)
Q Consensus 502 ---H~~-~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~ 537 (558)
... .+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 23458999999999999876 7899999998864
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0043 Score=51.56 Aligned_cols=98 Identities=9% Similarity=0.009 Sum_probs=59.1
Q ss_pred ccccCCCCccccccCCCceeEEE--EecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccC-CCCCCCC
Q 008648 50 SDTLLPGMKLGWDLKTGFERRVI--SWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTTRPNP 126 (558)
Q Consensus 50 TDTlLpgq~l~~~~~~~~~~~l~--s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~-~~~~~~~ 126 (558)
+|||.|||.|..+. .|+ | ..|.|.|.++.+|. +++++...+.|.+...... .+. ..+...
T Consensus 8 ~~~l~~g~~L~~g~------~l~~~S-------~~g~~~L~~~~dgn--lvly~~~~~vW~sn~~~~~-~~~~l~l~~d- 70 (119)
T 1b2p_A 8 QPDDNHPQILHATE------SLEILF-------GTHVYRFIMQTDCN--LVLYDNNNPIWATNTGGLG-NGCRAVLQPD- 70 (119)
T ss_dssp CSSSCCCCEEETTC------EEEEEE-------TTEEEEEEECTTSC--EEEEETTEEEEECCCTTSC-SSCEEEECTT-
T ss_pred CcccCCCCEEcCCC------EEEEeC-------CCCCEEEEEecCCC--EEEEECCEEEEeCCCccCC-CceEEEEccC-
Confidence 78999999998874 577 4 57899999998876 4456777899998754211 111 112211
Q ss_pred ceeeEEeecCCeeEEE-EEecCCceEEEEEEeccCCceEEEE
Q 008648 127 IFNFSFVANEDELCYT-FSIKDKAVVSRIVMNQTTYLGQRFT 167 (558)
Q Consensus 127 ~~~~~~~~~~~~~~~~-~~~~~~~~~~r~~ld~~G~~~~~~~ 167 (558)
..+-..+..+...+. +.... .-..++.|+.+| ++.+|.
T Consensus 71 -GNLVl~d~~~~~lW~S~~~~~-~g~~~l~l~~~G-nlvl~~ 109 (119)
T 1b2p_A 71 -GVLVVITNENVTVWQSPVAGK-AGHYVLVLQPDR-NVVIYG 109 (119)
T ss_dssp -SCEEEECTTCCEEEECSCCCC-SSCEEEEECTTS-CEEEEE
T ss_pred -CEEEEEeCCCcEEEcCCCCCC-CCCEEEEEECCC-cEEEEC
Confidence 223333333332222 22221 223578999999 888864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00077 Score=68.20 Aligned_cols=73 Identities=15% Similarity=0.178 Sum_probs=42.8
Q ss_pred eeecccCcccEEEEEEcC---------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCCeEEEEE
Q 008648 392 NKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN-LVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 461 (558)
+.|+.|....+|+....+ +..+++|+...... .......|..+++.+...+ ..++++.. . .++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467778888999998643 26788887654221 1112356777777764223 34566543 2 36899
Q ss_pred ecCCCCCh
Q 008648 462 EFMPNKSL 469 (558)
Q Consensus 462 E~~~~gsL 469 (558)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998644
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00074 Score=65.22 Aligned_cols=41 Identities=22% Similarity=0.400 Sum_probs=27.0
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYP 49 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~P 49 (558)
.++|++++.+. +... +.|.++||||+.+. .+.++|+|+...
T Consensus 184 ~~yW~Sgt~~~--~~~~-l~l~~dGnLvl~d~----~~~~vWsS~t~~ 224 (276)
T 3m7h_A 184 AATWNAGTQGK--GAVR-AVFQGDGNLVVYGA----GNAVLWHSHTGG 224 (276)
T ss_dssp SEEEECCCTTT--TCCE-EEECTTSCEEEECT----TSCEEEECSCTT
T ss_pred eEEEECCCCCC--ccEE-EEEcCCCeEEEEeC----CCcEEEEecCCC
Confidence 35788776543 2234 77777888888764 446778887653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0032 Score=62.82 Aligned_cols=32 Identities=25% Similarity=0.347 Sum_probs=28.2
Q ss_pred CceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 507 LRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 507 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
..++|+|+.|.||++++++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 45999999999999998888999999887654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.30 E-value=0.05 Score=55.75 Aligned_cols=73 Identities=16% Similarity=0.163 Sum_probs=45.9
Q ss_pred eeecccCcccEEEEEEcC--------CcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEe
Q 008648 392 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 462 (558)
+.|..|-...+|+....+ ++.+++|+...... ..-...+|..+++.+. +.-..++++.+ . .++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 567777788899998753 57888888644221 1122356777777764 22234555432 2 378999
Q ss_pred cCCCCCh
Q 008648 463 FMPNKSL 469 (558)
Q Consensus 463 ~~~~gsL 469 (558)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.48 E-value=0.19 Score=51.15 Aligned_cols=29 Identities=24% Similarity=0.399 Sum_probs=25.1
Q ss_pred eEecCCCCCcEEE------cCCCCeEEecccccee
Q 008648 509 IIHRDLKASNVLL------DHDMNPKISDFGLART 537 (558)
Q Consensus 509 ivHrDlkp~NIll------~~~~~~kl~DFGla~~ 537 (558)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999999864
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=86.21 E-value=0.74 Score=34.80 Aligned_cols=34 Identities=29% Similarity=0.560 Sum_probs=27.2
Q ss_pred CCChHHHHHHhhcCCceEEEEeeccCCCCCccceecc
Q 008648 259 SVNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFG 295 (558)
Q Consensus 259 ~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~ 295 (558)
..++++|+..|+.+=.|.||.|.. ....|++..+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 568999999999999999999964 2234887544
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.80 E-value=1.8 Score=39.60 Aligned_cols=86 Identities=6% Similarity=0.040 Sum_probs=62.3
Q ss_pred CCCeeeeeeeEEEeCCeEEEEEecCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceEecCCCCC
Q 008648 440 QHRNLVKLLGCCIHGEEKLLIYEFMPN-KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLL-YLHQDSRLRIIHRDLKAS 517 (558)
Q Consensus 440 ~h~niv~l~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~-yLH~~~~~~ivHrDlkp~ 517 (558)
.||++ -...-.+.+...+.++.-++ .++..+ ..++..++++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 33444667777777776533 334333 23678899999988887776 5554 578889999
Q ss_pred cEEEcCCCCeEEeccccceeeC
Q 008648 518 NVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 518 NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++.++.++|.-.|+-..+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lp 135 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLP 135 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBS
T ss_pred eEEEeCCCcEEEEEcCCcccCC
Confidence 9999999999999999865553
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.09 E-value=1.9 Score=39.30 Aligned_cols=89 Identities=10% Similarity=0.063 Sum_probs=64.6
Q ss_pred CCCCeeeeeeeEEEeCCeEEEEEecCC-CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 008648 439 LQHRNLVKLLGCCIHGEEKLLIYEFMP-NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 517 (558)
Q Consensus 439 l~h~niv~l~~~~~~~~~~~lv~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~ 517 (558)
..||+++.. .+-.+.+...+.++.-+ ..++.. + ..++...+++++.+|+....+++. =+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 368888766 45556666666666544 223332 2 346788999999999988866664 478889999
Q ss_pred cEEEcCCCCeEEeccccceeeCC
Q 008648 518 NVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 518 NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++.++.++|.--|+-..+.+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P 131 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDP 131 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSC
T ss_pred eEEEcCCCCEEEEEccCccCCCC
Confidence 99999999999999988655443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=81.13 E-value=0.25 Score=32.30 Aligned_cols=27 Identities=22% Similarity=0.504 Sum_probs=11.0
Q ss_pred EEEeehhHHHHHHHHHHHhhhhhhccc
Q 008648 329 IVVLVISAVALLAVVLISGYLIHKRRR 355 (558)
Q Consensus 329 ivv~vv~~~~~l~~~~i~~~~~~~~r~ 355 (558)
++..++++++++++.++.+++++||+.
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 444444433333333344444444443
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=81.00 E-value=0.37 Score=30.61 Aligned_cols=29 Identities=34% Similarity=0.676 Sum_probs=22.6
Q ss_pred CCCCcCccCCCcccccCC-CCCcccccCCce
Q 008648 184 DECDTYGLCGAYGVCIIS-KSPVCQCLKGFK 213 (558)
Q Consensus 184 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~ 213 (558)
++|. ...|-..|.|... ..-.|.|++||.
T Consensus 4 d~C~-~~pC~ngg~C~~~~~~~~C~C~~G~~ 33 (39)
T 1edm_B 4 DQCE-SNPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CTTT-TCCCCTTCEEEEETTEEEEECCTTCC
T ss_pred ccCC-CCCCCCCCEeEcCCCceEeECCCCCc
Confidence 5676 5789999999643 356799999996
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.08 E-value=0.25 Score=51.25 Aligned_cols=62 Identities=15% Similarity=0.209 Sum_probs=18.9
Q ss_pred ccceeecccCcccEEEEEEcC-CcEEEE------EEecc--cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 008648 389 SINNKLGEGGFGPVYKGTLVD-GQEIAV------KRLSK--ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453 (558)
Q Consensus 389 ~~~~~lg~G~fg~Vy~~~~~~-~~~vav------K~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 453 (558)
.+.++|| ||.||++.+.. ..+||| |.... ...+....+.+|..++..++|||+++.+++-..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3345676 99999998754 357888 65543 122334567889999999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 558 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-36 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-19 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-46
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 6/165 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
++ ++G G FG VYKG + + ++ + Q L+ KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+G + ++ ++ SL + + + K I TA+G+ YLH S
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
IIHRDLK++N+ L D+ KI DFGLA ++
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-45
Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 6/172 (3%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQH 441
N + + I +LG+G FG VYK + A K + S++ L++ E+ + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
N+VKLL + ++ EF ++D + + + L S+ + T L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLY 553
H +IIHRDLKA N+L D + K++DFG++ ++ Y
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY 175
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 35/162 (21%), Positives = 65/162 (40%), Gaps = 7/162 (4%)
Query: 384 ATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGL-KELKNEVILFSKLQH 441
++F ++LG G G V+K + G +A K + + ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
+V G E + E M SLD + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYL 120
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+ +I+HRD+K SN+L++ K+ DFG++
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 2e-44
Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 10/171 (5%)
Query: 377 ELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISDQGLKELKNE 432
EL + FS ++G G FG VY + + + +A+K++S S++ +++ E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 433 VILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIIC 492
V KL+H N ++ GC + L+ E+ + D + K L + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTH 122
Query: 493 GTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
G +GL YLH +IHRD+KA N+LL K+ DFG A +
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-44
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 6/165 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ +LG G FG V+ G ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L E +I E+M N SL F+ + K L +K + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
IHRDL+A+N+L+ ++ KI+DFGLAR ++
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-43
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 6/165 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + +LG G FG V G ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L G C +I E+M N L ++ + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
+ +HRDL A N L++ K+SDFGL+R D+ +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 7e-43
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 6/158 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L G C+ L++EFM + L ++ Q L + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+IHRDL A N L+ + K+SDFG+ R D+
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (385), Expect = 8e-43
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 6/170 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
+ ++ +KLG G +G VY+G +AVK L + ++E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
V+LLG C +I EFM +L ++ + N + + ++ + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYG 554
+ IHRDL A N L+ + K++DFGL+R GD + +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (384), Expect = 2e-42
Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 19/189 (10%)
Query: 376 FELATISNATNNFS---------INNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK-I 421
F + A F+ I +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 422 SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL 481
+++ ++ +E + + H N++ L G ++I EFM N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 482 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541
+ ++ G A G+ YL + +HRDL A N+L++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 542 KTEGNTNRV 550
++
Sbjct: 182 TSDPTYTSA 190
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-42
Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 8/175 (4%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRN 443
++ + +G G +G K DG+ + K L +++ + L +EV L +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 444 LVKLLGCCIHGEEKLL--IYEFMPNKSLDYFIFDQTNSK-LLDWSKRFHIICGTARGLLY 500
+V+ I L + E+ L I T + LD ++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 501 LHQ--DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLY 553
H+ D ++HRDLK +NV LD N K+ DFGLAR D + Y
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY 179
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-42
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ +G+G FG V G G ++AVK + D + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 446 KLLGCCIHGEEKL-LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+LLG + + L ++ E+M SL ++ + +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 505 SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVW 551
+HRDL A NVL+ D K+SDFGL + + G W
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW 166
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-42
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 6/165 (3%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ + KLG+G FG V+ GT +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+L E ++ E+M SL F+ +T K L + + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
+ +HRDL+A+N+L+ ++ K++DFGLAR ++
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 175
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-41
Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 11/172 (6%)
Query: 384 ATNNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISDQG-LKELKNEVILFSK 438
+N I + +LG G FG V +G ++A+K L + +++ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
L + +V+L+G C E +L+ E L F+ + + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
YL + +HRDL A NVLL + KISDFGL++ G D +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 5e-41
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 31/202 (15%)
Query: 377 ELATISNATNNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKISDQGL-KEL 429
+L ++ NN +GEG FG V++ +AVK L + + + +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 430 KNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQT------------ 477
+ E L ++ + N+VKLLG C G+ L++E+M L+ F+ +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 478 ---------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPK 528
L +++ I A G+ YL + + +HRDL N L+ +M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 529 ISDFGLARTCGGDKTEGNTNRV 550
I+DFGL+R
Sbjct: 181 IADFGLSRNIYSADYYKADGND 202
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 55/189 (29%), Positives = 73/189 (38%), Gaps = 26/189 (13%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISDQG-LKELKNEVILFSK 438
N S LG G FG V + T +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL---------------L 482
L H N+V LLG C G L+I E+ L F+ + +S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 483 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
D A+G+ +L IHRDL A N+LL H KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 543 TEGNTNRVW 551
Sbjct: 200 NYVVKGNAR 208
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 3e-40
Identities = 38/172 (22%), Positives = 87/172 (50%), Gaps = 8/172 (4%)
Query: 377 ELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVIL 435
+ ++ + ++ K+G+G G VY + GQE+A+++++ + + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 436 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
+ ++ N+V L + G+E ++ E++ SL + + D + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
+ L +LH ++IHRD+K+ N+LL D + K++DFG ++++ +T
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-40
Identities = 48/167 (28%), Positives = 70/167 (41%), Gaps = 8/167 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKE-LKNEVILFSKLQHRN 443
++ + LGEG +G V V + +AVK + E +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+VK G G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
+ I HRD+K N+LLD N KISDFGLA + E N++
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 8e-40
Identities = 46/162 (28%), Positives = 68/162 (41%), Gaps = 10/162 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQH 441
+F I LG+G FG VY +A+K L K +L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
N+++L G LI E+ P ++ + D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
H R+IHRD+K N+LL KI+DFG + +
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 15/175 (8%)
Query: 390 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLG 449
+ +G+G FG V++G G+E+AVK S ++ + E+ L+H N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64
Query: 450 CCIHGEEKL----LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD- 504
L+ ++ + SL ++ N + + TA GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 505 ----SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYGT 555
+ I HRDLK+ N+L+ + I+D GLA + GT
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 21/176 (11%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SDQGLKELKNEVILFSKL-Q 440
N+ + +GEG FG V K + + A+KR+ + S ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFI-------------FDQTNSKLLDWSKR 487
H N++ LLG C H L E+ P+ +L F+ + + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 488 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
H ARG+ YL Q + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-39
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 13/175 (7%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISDQG-LKELKNEVILFSKLQH 441
+F N +G G FG VY GTL+D AVK L++I+D G + + E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 442 RNLVKLLGCCIHGEEK-LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
N++ LLG C+ E L++ +M + L FI ++T++ + F +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYGT 555
+ + + +HRDL A N +LD K++DFGLAR + + N+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 49/186 (26%), Positives = 73/186 (39%), Gaps = 31/186 (16%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISDQG-LKELKNEVILFSK 438
N LG G FG V T ++AVK L + +D + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 439 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQ--------------------T 477
L H N+V LLG C LI+E+ L ++ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 478 NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
+ +L + A+G+ +L +HRDL A NVL+ H KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 538 CGGDKT 543
D
Sbjct: 214 IMSDSN 219
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (361), Expect = 9e-39
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 8/171 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
+++ I+ +LG G FG V++ T G A K + + + ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
V L E ++IYEFM L + D+ N + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 505 SRLRIIHRDLKASNVLLDHDMNP--KISDFGLARTCGGDKTEGNTNRVWLY 553
+H DLK N++ + K+ DFGL ++ T +
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF 191
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-37
Identities = 48/169 (28%), Positives = 68/169 (40%), Gaps = 10/169 (5%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQHR 442
+F LGEG F V L +E A+K L K I + + + E + S+L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
VKL E+ + N L +I D + L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLH 125
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVW 551
IIHRDLK N+LL+ DM+ +I+DFG A+ + + N
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-37
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 12/163 (7%)
Query: 391 NNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISDQG--LKELKNEVILFSKLQHRNLV 445
+ +LG G FG V KG + +AVK L ++ EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
+++G C E +L+ E L+ ++ + + ++ + G+ YL +
Sbjct: 72 RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
+HRDL A NVLL KISDFGL++ D+
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 37/171 (21%), Positives = 74/171 (43%), Gaps = 5/171 (2%)
Query: 380 TISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG-LKELKNEVILFS 437
+ + ++ + +GEG +G V V+ +A+K++S Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 438 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARG 497
+ +H N++ + + + ++ + ++ ++ L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 498 LLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTN 548
L Y+H ++HRDLK SN+LL+ + KI DFGLAR D
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-37
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 12/171 (7%)
Query: 381 ISNATNNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISDQGLKELKNEVILFS 437
+SN + ++G G F VYKG + E+A L ++ + K E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 438 KLQHRNLVKLLGCCIHGEEK----LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICG 493
LQH N+V+ + +L+ E M + +L ++ K++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQ 120
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLL-DHDMNPKISDFGLARTCGGDKT 543
+GL +LH + IIHRDLK N+ + + KI D GLA
Sbjct: 121 ILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (350), Expect = 4e-37
Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 13/165 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISDQGLKELKNEVI---LFSK 438
N+FS++ +G GGFG VY D G+ A+K L K QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
+V + ++ I + M L Y + + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
++H +++RDLK +N+LLD + +ISD GLA K
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (348), Expect = 6e-37
Identities = 40/171 (23%), Positives = 70/171 (40%), Gaps = 8/171 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
+ + I +LG G FG V++ G+ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+ L E +LI EF+ L I + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 505 SRLRIIHRDLKASNVLLDHDMNP--KISDFGLARTCGGDKTEGNTNRVWLY 553
I+H D+K N++ + KI DFGLA D+ T +
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 194
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 6e-37
Identities = 50/171 (29%), Positives = 69/171 (40%), Gaps = 13/171 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISDQGLKELKNEVILFSK 438
+ + KLG+G FG V +G +AVK L + + + EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
L HRNL++L G + K+ + E P SL + LL R+ + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGM 124
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNR 549
YL R IHRDL A N+LL KI DFGL R +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 17/181 (9%)
Query: 386 NNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKISDQG-LKELKNEVILFSK 438
+++ +LG+G FG VY+G +A+K +++ + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIF-------DQTNSKLLDWSKRFHII 491
++V+LLG G+ L+I E M L ++ + SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVW 551
A G+ YL+ + + +HRDL A N ++ D KI DFG+ R +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 552 L 552
L
Sbjct: 197 L 197
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-36
Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 12/169 (7%)
Query: 388 FSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSKI-SDQGLKELKNEVILFSKLQH 441
F LG G FG VYKG + E +A+K L + S + KE+ +E + + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
++ +LLG C+ LI + MP L ++ + ++ + A+G+ YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
R++HRDL A NVL+ + KI+DFGLA+ G ++ E +
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-35
Identities = 40/170 (23%), Positives = 67/170 (39%), Gaps = 11/170 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISDQGLKE-LKNEVILFSKLQ 440
+ +GEG FG V++G + +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H ++VKL+G +I E L F+ + S LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRV 550
L R +HRD+ A NVL+ + K+ DFGL+R +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-35
Identities = 46/187 (24%), Positives = 66/187 (35%), Gaps = 25/187 (13%)
Query: 386 NNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISDQGLKE--LKNEVILFS 437
+ + LG G FG V + + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 438 KLQHRNLVKLLGCCIHGEEKLLI-YEFMPNKSLDYFIFDQTN-------------SKLLD 483
H N+V LLG C L++ EF +L ++ + N L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 484 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
A+G+ +L + IHRDL A N+LL KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 544 EGNTNRV 550
Sbjct: 190 YVRKGDA 196
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 11/168 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISDQGLKELKNEVILFSKL 439
+ + +G G FG VYKG L +A+K L +++ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 440 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLL 499
H N+++L G + ++I E+M N +LD F+ ++ + ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMK 124
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
YL + +HRDL A N+L++ ++ K+SDFGL+R D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (325), Expect = 4e-34
Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 10/162 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQH 441
+F I LG G FG V+ +G+ A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
++++ G ++ +I +++ L + +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
II+RDLK N+LLD + + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (320), Expect = 9e-34
Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 8/170 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISDQGLKELKNEVILFSKLQHRN 443
+ K+GEG +G VYK G+ A+K RL K + E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLY 553
R++HRDLK N+L++ + KI+DFGLAR G + V L+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 37/170 (21%), Positives = 67/170 (39%), Gaps = 9/170 (5%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+ I LG G FG V++ + K + K+ +K E+ + + +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
L EE ++I+EF+ + I T++ L+ + + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 506 RLRIIHRDLKASNVLLDHDMNP--KISDFGLARTCGGDKTEGNTNRVWLY 553
I H D++ N++ + KI +FG AR Y
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-33
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 15/175 (8%)
Query: 387 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLV 445
+++ +G G FG VY+ L D G+ +A+K++ + + E+ + KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 446 KLLGCCIHGEEK------LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLL 499
+L EK L+ +++P + L + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 500 YLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLARTCGGDKTEGNTNRVWLY 553
Y+H I HRD+K N+LLD D K+ DFG A+ + + Y
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 26/189 (13%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSK-ISDQGLKELKNEVILF 436
+ + LGEG FG V + ++AVK L +++ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 437 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKL-------------L 482
+ +H+N++ LLG C +I E+ +L ++ + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 483 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542
ARG+ YL + IHRDL A NVL+ D KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 543 TEGNTNRVW 551
T
Sbjct: 190 YYKKTTNGR 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-32
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 8/170 (4%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHRN 443
NF K+GEG +G VYK + G+ +A+K++ ++ E+ L +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 444 LVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ 503
+VKLL + L++EF+ + D + + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 504 DSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLY 553
R++HRDLK N+L++ + K++DFGLAR G V L+
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 121 bits (304), Expect = 1e-31
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 17/168 (10%)
Query: 387 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGL---------KELKNEVILF 436
N+ LG G V + +E AVK + + EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 437 SKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
K+ H N+++L L+++ M L ++ ++ L + I+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
+ LH +L I+HRDLK N+LLD DMN K++DFG + +
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 165
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 5e-31
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 11/167 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISDQGLKELKNEV-ILFSKLQ 440
+F ++ LG+G FG V+ Q A+K L K + D ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H L + E + E++ L Y I D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQF 118
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNT 547
LH I++RDLK N+LLD D + KI+DFG+ + + NT
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 9e-31
Identities = 34/163 (20%), Positives = 62/163 (38%), Gaps = 5/163 (3%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG-LKELKNEVILFSKLQ 440
+ + + + LG G F V + +A+K ++K + +G ++NE+ + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 441 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLY 500
H N+V L G LI + + L I ++ +I + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKY 122
Query: 501 LHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
LH + + LD D ISDFGL++
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 17/181 (9%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHR 442
+ + K+G+G FG V+K GQ++A+K++ + E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 443 NLVKLLGCCIHGEEK--------LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGT 494
N+V L+ C L+++F + L + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 495 ARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYG 554
L L+ R +I+HRD+KA+NVL+ D K++DFGLAR K
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 555 T 555
T
Sbjct: 184 T 184
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-30
Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 392 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-----ISDQGLKELKNEVILFSKLQHRNLV 445
+ LGEG F VYK Q +A+K++ D + E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 446 KLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS 505
LL H L+++FM + NS +L S + T +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 506 RLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
I+HRDLK +N+LLD + K++DFGLA++ G
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (290), Expect = 1e-29
Identities = 35/173 (20%), Positives = 68/173 (39%), Gaps = 14/173 (8%)
Query: 380 TISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISDQGLKELKNEVIL 435
T S+ ++ + + LG GG V+ L +++AVK L + E
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 436 FSKLQHRNLVKLLGCCIH----GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHII 491
+ L H +V + G ++ E++ +L + + + + +I
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVI 117
Query: 492 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+ L + H + IIHRD+K +N+++ K+ DFG+AR
Sbjct: 118 ADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-29
Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 13/168 (7%)
Query: 381 ISNATNNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK--ISDQGLKELKNEVILF 436
+ A + ++GEG +G V+K + G+ +A+KR+ + EV +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 437 SKL---QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD---YFIFDQTNSKLLDWSKRFHI 490
L +H N+V+L C + + +D D+ + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 491 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538
+ RGL +LH R++HRDLK N+L+ K++DFGLAR
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 9/172 (5%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHR 442
+ K+GEG +G V+K + +A+KR+ + E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 443 NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH 502
N+V+L ++ L++EF YF + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 503 QDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYG 554
++HRDLK N+L++ + K+++FGLAR G + V L+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (285), Expect = 2e-28
Identities = 41/186 (22%), Positives = 65/186 (34%), Gaps = 14/186 (7%)
Query: 362 QENEDQNIDLELPLFELATISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK 420
+ ED E P A + + F LG G FG V G A+K L K
Sbjct: 21 KAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 421 ---ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQT 477
+ + ++ NE + + LVKL ++ E++ + +
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI- 135
Query: 478 NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
YLH L +I+RDLK N+L+D +++DFG A+
Sbjct: 136 --GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 538 CGGDKT 543
G
Sbjct: 191 VKGRTW 196
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 38/174 (21%), Positives = 65/174 (37%), Gaps = 14/174 (8%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISDQGLKELKNEVILFSKLQH 441
N+F LG+G FG V G+ A+K L K I+ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 442 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
L L + + E+ L + + + ++ + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVWLYGT 555
+++RD+K N++LD D + KI+DFGL + D GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----GATMKTFCGT 168
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 4e-28
Identities = 34/178 (19%), Positives = 70/178 (39%), Gaps = 19/178 (10%)
Query: 386 NNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEV-ILFSKLQHR 442
+++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 443 NLVKLLGCCIHGEEK----LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
++V+++ + L++ E + L I D+ + + + I+ +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAI 124
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNP---KISDFGLARTCGGDKTEGNTNRVWLY 553
YLH + I HRD+K N+L K++DFG A+ + Y
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 8e-28
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 7/170 (4%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHR 442
+ +G G +G V G ++A+K+L + S+ K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 443 NLVKLLGCCIHGEEKLLIYEF-MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
N++ LL E +F + + + + L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 502 HQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVW 551
H IIHRDLK N+ ++ D KI DFGLAR + T R +
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWY 184
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 5e-27
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 15/168 (8%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKN------EVILFSK 438
+ + + LG GGFG VY G + D +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 439 LQ--HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
+ +++LL + +LI E + + + L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLARTCGGDKT 543
+ + H ++HRD+K N+L+D + K+ DFG
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (269), Expect = 9e-27
Identities = 28/169 (16%), Positives = 68/169 (40%), Gaps = 13/169 (7%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
++ + ++GEG FG +++GT L++ Q++A+K + SD +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+ + ++ + SL+ + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 505 SRLRIIHRDLKASNVLLDHDMNP-----KISDFGLARTCGGDKTEGNTN 548
+++RD+K N L+ + + DFG+ + T+ +
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-26
Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 17/182 (9%)
Query: 383 NATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQG------LKELKNEVIL 435
N + + +LG G F V K G + A K + K + ++++ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 436 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
++QH N++ L + + +LI E + L F+ ++ + L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQIL 123
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP----KISDFGLARTCGGDKTEGNTNRVW 551
G+ YLH L+I H DLK N++L P KI DFGLA N
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 552 LY 553
+
Sbjct: 181 EF 182
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (265), Expect = 4e-26
Identities = 36/170 (21%), Positives = 64/170 (37%), Gaps = 11/170 (6%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL 444
N + + K+G G FG +Y GT + G+E+A+K + +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 445 VKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD 504
+ + C + ++ + SL+ S+ + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYIH-- 120
Query: 505 SRLRIIHRDLKASNVL---LDHDMNPKISDFGLARTCGGDKTEGNTNRVW 551
IHRD+K N L I DFGLA+ +T +
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-25
Identities = 39/168 (23%), Positives = 71/168 (42%), Gaps = 15/168 (8%)
Query: 386 NNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----DQGLKELKNEVILFS 437
NF + LG G +G V+ + G+ A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 438 KLQHR-NLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
++ LV L + LI +++ L + + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTE 544
+L L +L II+RD+K N+LLD + + ++DFGL++ D+TE
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.9 bits (248), Expect = 7e-25
Identities = 31/159 (19%), Positives = 54/159 (33%), Gaps = 20/159 (12%)
Query: 389 SINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKIS--------DQGLKELKNEVILFSK 438
+I +GEG V+ E VK ++ S D G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 439 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGL 498
+ R L KL G + +Y + N L I + ++ + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 499 LYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537
+ I+H DL NVL+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVE 151
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (256), Expect = 9e-25
Identities = 34/163 (20%), Positives = 71/163 (43%), Gaps = 17/163 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRN 443
+++ + KLG G + V++ + + +++ VK L + K++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 444 LVKLLGCCIHGEEKL--LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYL 501
++ L + L++E + N + L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 502 HQDSRLRIIHRDLKASNVLLDHD-MNPKISDFGLARTCGGDKT 543
H + I+HRD+K NV++DH+ ++ D+GLA +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-24
Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 18/167 (10%)
Query: 386 NNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILFSKLQHR 442
+ +G G G V V + +A+K+LS+ + K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 443 NLVKLLGCCIH------GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTAR 496
N++ LL ++ L+ E M + D + +++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 497 GLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543
G+ +LH IIHRDLK SN+++ D KI DFGLART G
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 5e-24
Identities = 47/176 (26%), Positives = 73/176 (41%), Gaps = 7/176 (3%)
Query: 380 TISNATNNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISDQGLKELKNEVILF 436
TI + + +G G +G V G +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 437 SKLQHRNLVKLLGCCIHGEE-KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTA 495
++H N++ LL + ++ + + + + L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 496 RGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKTEGNTNRVW 551
RGL Y+H IIHRDLK SN+ ++ D KI DFGLAR + T R +
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWY 184
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (211), Expect = 9e-19
Identities = 37/179 (20%), Positives = 67/179 (37%), Gaps = 18/179 (10%)
Query: 388 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVK 446
+ + KLG G F V+ +V+ +A+K + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 447 LLGCCIHGEEKLLIY--EFMPNKSLDYFIFDQTNSKLLDWSKRF-----------HIICG 493
+ KLL + PN +F+ LL K++ I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 494 TARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCGGDKTEGNTNRVW 551
GL Y+H+ R IIH D+K NVL++ D + +A + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 36.1 bits (83), Expect = 0.002
Identities = 11/48 (22%), Positives = 20/48 (41%), Gaps = 9/48 (18%)
Query: 1 MRVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDY 48
R +W++ + VL L + GN+V+ G+ W + Y
Sbjct: 70 GRSLWASHSVRG--NGNYVLVLQEDGNVVIY-------GSDIWSTGTY 108
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.98 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.98 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.98 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.95 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.93 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.93 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.86 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.87 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.83 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.75 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.74 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.5 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.46 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.34 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.06 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.01 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.21 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 97.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.66 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.02 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 92.6 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 91.45 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 89.14 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 88.92 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.82 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.39 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.69 | |
| d1dx5i2 | 35 | Thrombomodulin, different EGF-like domains {Human | 86.6 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 86.34 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.84 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 83.8 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 83.67 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 82.95 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 82.72 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 81.14 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-33 Score=276.63 Aligned_cols=159 Identities=29% Similarity=0.474 Sum_probs=141.6
Q ss_pred hhhhhhcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 379 ATISNATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 379 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
++++...++|++.++||+|+||.||+|.+. +++.||||+++.. ....+++.+|+.++++++|||||++++++.+.+..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 344455678999999999999999999975 4889999998753 44567899999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
+|||||+++|+|..++... ....+++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999998654 3456899999999999999999999998 99999999999999999999999999998
Q ss_pred eCCCc
Q 008648 538 CGGDK 542 (558)
Q Consensus 538 ~~~~~ 542 (558)
...+.
T Consensus 165 ~~~~~ 169 (287)
T d1opja_ 165 MTGDT 169 (287)
T ss_dssp CCSSS
T ss_pred cCCCC
Confidence 76543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-33 Score=272.83 Aligned_cols=151 Identities=29% Similarity=0.384 Sum_probs=133.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999974 58999999986532 2345678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999998843 346899999999999999999999998 999999999999999999999999999987544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-32 Score=270.73 Aligned_cols=151 Identities=25% Similarity=0.469 Sum_probs=138.2
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.++||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 45899999999999999999996 46899999999765556678899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+++|+|.+++.+ ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998754 34899999999999999999999998 9999999999999999999999999999886543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-32 Score=267.66 Aligned_cols=151 Identities=28% Similarity=0.506 Sum_probs=131.7
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.++|++.++||+|+||.||+|++.+++.||||+++. .....+++.+|++++++++|||||+++|++.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 357899999999999999999998888999999976 3445678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 83 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred CCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999988543 346899999999999999999999998 999999999999999999999999999987544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.3e-33 Score=269.39 Aligned_cols=154 Identities=31% Similarity=0.488 Sum_probs=136.0
Q ss_pred hhcCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
...++|++.++||+|+||.||+|.+.+++.||||+++.. ....++|.+|+.++++++|||||++++++. .+..+||||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEE
Confidence 345689999999999999999999988889999999753 345678999999999999999999999875 456799999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
|+++|+|.+++.... ...+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 88 y~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999998874432 235899999999999999999999988 9999999999999999999999999999886543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.1e-32 Score=268.75 Aligned_cols=150 Identities=30% Similarity=0.453 Sum_probs=137.1
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.+.|++.++||+|+||.||+|+.. +++.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357899999999999999999974 5889999999876666778899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
+++|+|..++.+. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 91 ~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 91 CAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence 9999999987543 345899999999999999999999998 9999999999999999999999999998653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.6e-32 Score=263.40 Aligned_cols=150 Identities=30% Similarity=0.417 Sum_probs=135.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999975 5889999998642 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998543 35899999999999999999999998 999999999999999999999999999877544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2.6e-32 Score=269.74 Aligned_cols=154 Identities=30% Similarity=0.500 Sum_probs=126.8
Q ss_pred cCCcccceeecccCcccEEEEEEcC-C---cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.++|++.++||+|+||.||+|.... + ..||||++... .....++|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999998743 2 35899988653 34456789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++|+|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999988543 345899999999999999999999988 9999999999999999999999999999886
Q ss_pred CCcC
Q 008648 540 GDKT 543 (558)
Q Consensus 540 ~~~~ 543 (558)
....
T Consensus 180 ~~~~ 183 (299)
T d1jpaa_ 180 DDTS 183 (299)
T ss_dssp ----
T ss_pred CCCC
Confidence 5543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-32 Score=267.77 Aligned_cols=151 Identities=33% Similarity=0.518 Sum_probs=130.5
Q ss_pred hhcCCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 460 (558)
...++|++.++||+|+||.||+|+.. ..||||+++.. .....+.|++|+.++++++|||||++++++. .+..+||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 34578999999999999999999864 46999998642 3456678999999999999999999999875 4568999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++|+|.+++... ...+++.+++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999998543 345899999999999999999999988 99999999999999999999999999987754
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 157 ~ 157 (276)
T d1uwha_ 157 W 157 (276)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.5e-32 Score=266.16 Aligned_cols=151 Identities=30% Similarity=0.403 Sum_probs=135.1
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999974 6899999998642 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988543 45899999999999999999999998 999999999999999999999999999988654
Q ss_pred c
Q 008648 542 K 542 (558)
Q Consensus 542 ~ 542 (558)
.
T Consensus 162 ~ 162 (288)
T d1uu3a_ 162 S 162 (288)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=258.55 Aligned_cols=151 Identities=26% Similarity=0.444 Sum_probs=137.3
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 465 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 465 (558)
++|++.++||+|+||.||+|+.+++++||||++++. ....+++.+|+.++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 688999999999999999999988889999999763 3456789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 466 NKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 466 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+|+|..++... ...+++..+.+++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999987543 345889999999999999999999988 9999999999999999999999999998775443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=2e-31 Score=268.96 Aligned_cols=153 Identities=26% Similarity=0.382 Sum_probs=137.2
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.++||+|+||.||+|.. .+++.||||+++.......+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999997 46899999999765555567889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--HDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~~~~~ 541 (558)
+++|+|.+++.. ....+++.++..|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+..+
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887633 3346899999999999999999999998 99999999999998 6789999999999988654
Q ss_pred c
Q 008648 542 K 542 (558)
Q Consensus 542 ~ 542 (558)
.
T Consensus 183 ~ 183 (352)
T d1koba_ 183 E 183 (352)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.7e-32 Score=270.99 Aligned_cols=150 Identities=23% Similarity=0.307 Sum_probs=135.1
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..++|++.++||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3568999999999999999999974 5889999998753 3344577999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++ + |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999653 3589999999999999999999974 7 9999999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=2e-31 Score=268.76 Aligned_cols=153 Identities=25% Similarity=0.422 Sum_probs=137.6
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999974 5899999999776556677899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--HDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~~~~~ 541 (558)
+++|+|.+++... ...+++.++..|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999988432 345999999999999999999999998 99999999999996 4678999999999988654
Q ss_pred c
Q 008648 542 K 542 (558)
Q Consensus 542 ~ 542 (558)
.
T Consensus 180 ~ 180 (350)
T d1koaa2 180 Q 180 (350)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.2e-31 Score=265.77 Aligned_cols=149 Identities=30% Similarity=0.485 Sum_probs=133.0
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..|++.++||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4699999999999999999986 458899999987532 234467899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999877643 245899999999999999999999998 99999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=262.37 Aligned_cols=152 Identities=30% Similarity=0.505 Sum_probs=132.3
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
.++|++.+.||+|+||.||+|++.+++.||||+++. .....+.|.+|+.++++++|||||++++++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc-ccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 468999999999999999999998888999999975 3445678999999999999999999999985 56689999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
++|+|..++.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999998885532 235899999999999999999999998 9999999999999999999999999999875443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=261.23 Aligned_cols=156 Identities=28% Similarity=0.404 Sum_probs=126.5
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe--CCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH--GEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 460 (558)
++|++.+.||+|+||.||+|+.. +++.||||++... .+...+.+.+|++++++++|||||++++++.+ ....+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999874 5889999998653 33345678999999999999999999999875 4457999
Q ss_pred EecCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 461 YEFMPNKSLDYFIFDQ-TNSKLLDWSKRFHIICGTARGLLYLHQDSR--LRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~--~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+.+. .+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643 224568999999999999999999998541 2499999999999999999999999999998
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+..+
T Consensus 164 ~~~~ 167 (269)
T d2java1 164 LNHD 167 (269)
T ss_dssp C---
T ss_pred cccC
Confidence 7654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.9e-31 Score=259.13 Aligned_cols=152 Identities=30% Similarity=0.528 Sum_probs=131.4
Q ss_pred cCCcccce-eecccCcccEEEEEEc---CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 385 TNNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 385 ~~~y~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.++|.+.+ +||+|+||.||+|.+. ++..||||+++.. .....++|.+|++++++++|||||++++++.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35677777 4999999999999763 3557999999753 33456789999999999999999999999864 56899
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998743 2346899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCc
Q 008648 540 GDK 542 (558)
Q Consensus 540 ~~~ 542 (558)
...
T Consensus 161 ~~~ 163 (285)
T d1u59a_ 161 ADD 163 (285)
T ss_dssp TCS
T ss_pred ccc
Confidence 543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.9e-31 Score=264.25 Aligned_cols=152 Identities=26% Similarity=0.366 Sum_probs=123.8
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
..+.|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4467999999999999999999975 58899999987532 233456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCCeEEeccccceee
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---HDMNPKISDFGLARTC 538 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~~ 538 (558)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999854 346899999999999999999999998 99999999999994 5789999999999977
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 161 ~~~ 163 (307)
T d1a06a_ 161 DPG 163 (307)
T ss_dssp ---
T ss_pred cCC
Confidence 544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.7e-31 Score=264.03 Aligned_cols=158 Identities=31% Similarity=0.494 Sum_probs=133.6
Q ss_pred hhcCCcccceeecccCcccEEEEEEcC-C-----cEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeC
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVD-G-----QEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHG 454 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 454 (558)
...++|++.++||+|+||.||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 355789999999999999999998643 2 36999988652 334556789999999998 899999999999999
Q ss_pred CeEEEEEecCCCCChhHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTN--------------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 514 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDl 514 (558)
+..+|||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ ||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999965421 235899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCCeEEeccccceeeCCCcC
Q 008648 515 KASNVLLDHDMNPKISDFGLARTCGGDKT 543 (558)
Q Consensus 515 kp~NIll~~~~~~kl~DFGla~~~~~~~~ 543 (558)
||+|||++.++.+||+|||+|+.......
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~ 219 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN 219 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT
T ss_pred chhccccccCCeEEEeeccccccccCCCc
Confidence 99999999999999999999998765443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.1e-31 Score=263.55 Aligned_cols=150 Identities=25% Similarity=0.342 Sum_probs=136.0
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.+.||+|+||.||+|+. .+++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999997 46899999999752 2345678899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998553 45889999999999999999999998 999999999999999999999999999977544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=9.4e-31 Score=260.29 Aligned_cols=150 Identities=26% Similarity=0.389 Sum_probs=135.1
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|++.++||+|+||.||+|+. .+++.||||++++. .....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4799999999999999999997 45899999998642 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999888543 45788889999999999999999998 999999999999999999999999999987544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=7.2e-31 Score=256.16 Aligned_cols=151 Identities=26% Similarity=0.348 Sum_probs=135.1
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccccc---------ccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISD---------QGLKELKNEVILFSKLQ-HRNLVKLLGCCIHG 454 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 454 (558)
++|++.+.||+|+||+||+|+. .+++.||||++++... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999997 4688999999865321 12346889999999997 99999999999999
Q ss_pred CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 455 EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 455 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
+..+|||||+++|+|.+++... ..+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999653 35899999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCc
Q 008648 535 ARTCGGDK 542 (558)
Q Consensus 535 a~~~~~~~ 542 (558)
|+.+....
T Consensus 157 a~~~~~~~ 164 (277)
T d1phka_ 157 SCQLDPGE 164 (277)
T ss_dssp CEECCTTC
T ss_pred eeEccCCC
Confidence 99886543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-30 Score=257.86 Aligned_cols=152 Identities=26% Similarity=0.374 Sum_probs=135.4
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS------DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
.++|++.+.||+|+||.||+|+. .+++.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999997 468999999986421 22467899999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----CeEEeccc
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM----NPKISDFG 533 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFG 533 (558)
+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998653 35899999999999999999999998 99999999999998776 49999999
Q ss_pred cceeeCCCc
Q 008648 534 LARTCGGDK 542 (558)
Q Consensus 534 la~~~~~~~ 542 (558)
+|+.+....
T Consensus 163 ~a~~~~~~~ 171 (293)
T d1jksa_ 163 LAHKIDFGN 171 (293)
T ss_dssp TCEECTTSC
T ss_pred hhhhcCCCc
Confidence 999886543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.2e-31 Score=254.44 Aligned_cols=149 Identities=27% Similarity=0.392 Sum_probs=128.5
Q ss_pred cccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe----CCeEEEE
Q 008648 388 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH----GEEKLLI 460 (558)
Q Consensus 388 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 460 (558)
|++.++||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++|||||++++++.+ ....+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 466779999999999999975 5789999998653 33445679999999999999999999999876 3457999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCCeEEeccccceeeC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-HDMNPKISDFGLARTCG 539 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~ 539 (558)
|||+++|+|.+++... ..+++..+..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998553 45899999999999999999999875 4599999999999996 57899999999998654
Q ss_pred C
Q 008648 540 G 540 (558)
Q Consensus 540 ~ 540 (558)
.
T Consensus 167 ~ 167 (270)
T d1t4ha_ 167 A 167 (270)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.2e-31 Score=257.11 Aligned_cols=153 Identities=29% Similarity=0.497 Sum_probs=128.6
Q ss_pred cCCcccceeecccCcccEEEEEEcCC-----cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
.+.|++.++||+|+||.||+|.+... ..||||++... ......+|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999987542 37999998653 3334567899999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+.++++.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999998887553 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 161 ~~~~ 164 (283)
T d1mqba_ 161 EDDP 164 (283)
T ss_dssp ----
T ss_pred cCCC
Confidence 6543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.9e-31 Score=256.13 Aligned_cols=145 Identities=30% Similarity=0.477 Sum_probs=125.6
Q ss_pred eeecccCcccEEEEEEcC---CcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecCCC
Q 008648 392 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 466 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 466 (558)
++||+|+||.||+|.+.+ ++.||||+++.. .....+++.+|++++++++|||||++++++. .+..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 479999999999998643 468999998652 2334567999999999999999999999985 4567899999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCcC
Q 008648 467 KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543 (558)
Q Consensus 467 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 543 (558)
|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 9999998543 45899999999999999999999998 99999999999999999999999999998765443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=6e-31 Score=260.52 Aligned_cols=161 Identities=30% Similarity=0.512 Sum_probs=139.7
Q ss_pred hhhhhhhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeE
Q 008648 378 LATISNATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGC 450 (558)
Q Consensus 378 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~ 450 (558)
+.+++.+.++|++.++||+|+||.||+|+.. +++.||||+++... .+..+++.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445667789999999999999999999864 35689999987533 3345679999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCChhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 008648 451 CIHGEEKLLIYEFMPNKSLDYFIFDQT---------------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRI 509 (558)
Q Consensus 451 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~i 509 (558)
+.+.+..+++|||+++|+|.+++.... ....+++.+++.|+.||+.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999986432 1234889999999999999999999988 9
Q ss_pred EecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 510 IHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 510 vHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|||||||+||||+.++.+||+|||+|+.+...
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~ 193 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCC
Confidence 99999999999999999999999999877544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.9e-30 Score=256.48 Aligned_cols=151 Identities=23% Similarity=0.308 Sum_probs=134.1
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
.++|++.+.||+|+||.||+|... +++.||||.++.. ......+.+|+++|+.++|||||++++++.+.+..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999975 5889999999763 33445688999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHD--MNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DFGla~~~~~~ 541 (558)
+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+|+.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998432 335899999999999999999999998 9999999999999854 57999999999987544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=4.2e-30 Score=259.13 Aligned_cols=150 Identities=23% Similarity=0.303 Sum_probs=136.0
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 461 (558)
++|+++++||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999974 6899999998642 2345677899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
||+.+|+|..++... ..+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998654 35899999999999999999999998 999999999999999999999999999988643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.8e-30 Score=252.55 Aligned_cols=151 Identities=28% Similarity=0.473 Sum_probs=130.1
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|++.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999997 468999999986432 2346789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
|+.++.+.... . .....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765454333 2 23456899999999999999999999998 999999999999999999999999999877543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=9.8e-30 Score=257.78 Aligned_cols=151 Identities=28% Similarity=0.356 Sum_probs=131.0
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHH---HHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELK---NEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
++|++.++||+|+||.||+|+.. +++.||||++.+. .......+. +|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999975 5899999998642 122233333 4477788889999999999999999999
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
|||||+++|+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999998653 45789999999999999999999998 999999999999999999999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 158 ~~~~ 161 (364)
T d1omwa3 158 SKKK 161 (364)
T ss_dssp SSSC
T ss_pred CCCc
Confidence 6543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.96 E-value=7.1e-30 Score=251.04 Aligned_cols=149 Identities=27% Similarity=0.427 Sum_probs=134.8
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.++||+|+||+||+|+..+++.||||++... .....+.+.+|+.++++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999988999999998653 333467899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|.....
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 9888777766 23456999999999999999999999988 99999999999999999999999999987654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.5e-30 Score=252.49 Aligned_cols=160 Identities=28% Similarity=0.462 Sum_probs=137.9
Q ss_pred hhhhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEe
Q 008648 381 ISNATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIH 453 (558)
Q Consensus 381 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 453 (558)
++...++|++.++||+|+||.||+|.+. ++..||||+++.. .......+.+|+.++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445578999999999999999999863 2578999999753 33344578999999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCC
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQ-------TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMN 526 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~ 526 (558)
.+..++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+||||+++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999988642 22335789999999999999999999988 999999999999999999
Q ss_pred eEEeccccceeeCCCcC
Q 008648 527 PKISDFGLARTCGGDKT 543 (558)
Q Consensus 527 ~kl~DFGla~~~~~~~~ 543 (558)
+||+|||+|+.+.....
T Consensus 172 ~Kl~DFGla~~~~~~~~ 188 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY 188 (308)
T ss_dssp EEECCTTCCCGGGGGGC
T ss_pred EEEeecccceeccCCcc
Confidence 99999999997755443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.9e-30 Score=249.74 Aligned_cols=152 Identities=26% Similarity=0.414 Sum_probs=124.5
Q ss_pred hcCCcccceeecccCcccEEEEEEcC----CcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKL 458 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 458 (558)
..++|++.+.||+|+||.||+|.+.. +..||||.++.. .....+.+.+|+.++++++|||||++++++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35689999999999999999998643 356899988653 3334567999999999999999999999985 56789
Q ss_pred EEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceee
Q 008648 459 LIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTC 538 (558)
Q Consensus 459 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 538 (558)
+||||+++|+|..++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+
T Consensus 84 iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999987543 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 008648 539 GGD 541 (558)
Q Consensus 539 ~~~ 541 (558)
...
T Consensus 159 ~~~ 161 (273)
T d1mp8a_ 159 EDS 161 (273)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.6e-30 Score=252.04 Aligned_cols=165 Identities=28% Similarity=0.436 Sum_probs=128.6
Q ss_pred chhhhhhhcCCcccceeecccCcccEEEEEEcC------CcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeee
Q 008648 377 ELATISNATNNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLL 448 (558)
Q Consensus 377 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~ 448 (558)
+...++...++|++.++||+|+||.||+|.... ++.||||+++.. .....+.+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 444555566789999999999999999998632 468999998753 233456677888877776 689999999
Q ss_pred eEEEeCC-eEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 008648 449 GCCIHGE-EKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 514 (558)
Q Consensus 449 ~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDl 514 (558)
+++.+.+ ..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 9987654 57999999999999999965321 235899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCCeEEeccccceeeCCCcCc
Q 008648 515 KASNVLLDHDMNPKISDFGLARTCGGDKTE 544 (558)
Q Consensus 515 kp~NIll~~~~~~kl~DFGla~~~~~~~~~ 544 (558)
||+||||++++.+||+|||+|+........
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 190 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDY 190 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTS
T ss_pred CccceeECCCCcEEEccCcchhhccccccc
Confidence 999999999999999999999987655443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-29 Score=253.33 Aligned_cols=153 Identities=31% Similarity=0.567 Sum_probs=129.9
Q ss_pred CCcccceeecccCcccEEEEEEc-CCc----EEEEEEecc-cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLL 459 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 459 (558)
.+|++.++||+|+||.||+|.+. +++ +||+|+++. ...+..+++.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 689998865 3445678899999999999999999999999764 5678
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeC
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCG 539 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 539 (558)
++||+.+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999998887553 456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcCc
Q 008648 540 GDKTE 544 (558)
Q Consensus 540 ~~~~~ 544 (558)
.....
T Consensus 163 ~~~~~ 167 (317)
T d1xkka_ 163 AEEKE 167 (317)
T ss_dssp TTCC-
T ss_pred ccccc
Confidence 55443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.3e-29 Score=250.62 Aligned_cols=150 Identities=29% Similarity=0.425 Sum_probs=132.2
Q ss_pred CCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc---ccccHHHHHHHHHHHh-cCCCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SDQGLKELKNEVILFS-KLQHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 460 (558)
++|++.++||+|+||+||+|... +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 5889999999752 2344566777777665 68999999999999999999999
Q ss_pred EecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCC
Q 008648 461 YEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGG 540 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 540 (558)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999998543 35889999999999999999999998 99999999999999999999999999997654
Q ss_pred C
Q 008648 541 D 541 (558)
Q Consensus 541 ~ 541 (558)
.
T Consensus 156 ~ 156 (320)
T d1xjda_ 156 G 156 (320)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-29 Score=246.82 Aligned_cols=153 Identities=30% Similarity=0.427 Sum_probs=125.1
Q ss_pred cCCcccceeecccCcccEEEEEEcC--C--cEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeE
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI---SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEK 457 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 457 (558)
.++|++.+.||+|+||.||+|+... + .+||||++.+. .....++|.+|+.++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3579999999999999999998632 2 37899988652 23445789999999999999999999999965 567
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++||||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999887553 345899999999999999999999988 99999999999999999999999999998
Q ss_pred eCCCcC
Q 008648 538 CGGDKT 543 (558)
Q Consensus 538 ~~~~~~ 543 (558)
+.....
T Consensus 161 ~~~~~~ 166 (273)
T d1u46a_ 161 LPQNDD 166 (273)
T ss_dssp CCC-CC
T ss_pred cccCCC
Confidence 865543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=249.30 Aligned_cols=151 Identities=34% Similarity=0.601 Sum_probs=130.9
Q ss_pred CCcccceeecccCcccEEEEEEcC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCeeeeeeeEEEeCCeEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SDQGLKELKNEVILFSKL-QHRNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 460 (558)
++|++.++||+|+||.||+|.+.+ +. .||||++... .....+.+.+|+++|.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999998754 43 5788887543 334566899999999999 799999999999999999999
Q ss_pred EecCCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCe
Q 008648 461 YEFMPNKSLDYFIFDQ-------------TNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNP 527 (558)
Q Consensus 461 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 527 (558)
|||+++|+|.+++... .....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23457899999999999999999999998 9999999999999999999
Q ss_pred EEeccccceeeC
Q 008648 528 KISDFGLARTCG 539 (558)
Q Consensus 528 kl~DFGla~~~~ 539 (558)
||+|||+|+...
T Consensus 167 kl~DfG~a~~~~ 178 (309)
T d1fvra_ 167 KIADFGLSRGQE 178 (309)
T ss_dssp EECCTTCEESSC
T ss_pred EEcccccccccc
Confidence 999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-29 Score=248.38 Aligned_cols=148 Identities=31% Similarity=0.534 Sum_probs=128.3
Q ss_pred ceeecccCcccEEEEEEcCC----cEEEEEEecc-cccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-CeEEEEEecC
Q 008648 391 NNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK-ISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-EEKLLIYEFM 464 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~ 464 (558)
.++||+|+||+||+|.+.++ ..||||+++. ......++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 3689999875 3444567899999999999999999999998764 5789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCcC
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDKT 543 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 543 (558)
++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999988543 345778899999999999999999988 99999999999999999999999999998765443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.9e-30 Score=246.64 Aligned_cols=150 Identities=28% Similarity=0.495 Sum_probs=126.4
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-CeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-EEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 463 (558)
.++|++.++||+|+||.||+|.+ .+.+||||+++. ....+.+.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45788899999999999999998 578899999965 34557899999999999999999999998654 567999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGD 541 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 541 (558)
+++|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999986532 235899999999999999999999988 999999999999999999999999999976543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-29 Score=249.67 Aligned_cols=146 Identities=34% Similarity=0.456 Sum_probs=125.4
Q ss_pred ceeecccCcccEEEEEEc-CCcEEEEEEecccccc-----cHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEecC
Q 008648 391 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQ-----GLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 464 (558)
Q Consensus 391 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 464 (558)
+++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 579999999999999964 5899999998653221 2346889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 465 PNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 465 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
+++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 988777665 33456889999999999999999999998 9999999999999999999999999998775543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=249.74 Aligned_cols=159 Identities=34% Similarity=0.493 Sum_probs=137.8
Q ss_pred hhhcCCcccceeecccCcccEEEEEEc------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEEe
Q 008648 382 SNATNNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCIH 453 (558)
Q Consensus 382 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 453 (558)
+...++|++.++||+|+||.||+|++. .++.||||+++... .....++.+|+.+++++ +|||||++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 345578999999999999999999852 35689999997533 33456789999999999 69999999999999
Q ss_pred CCeEEEEEecCCCCChhHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 008648 454 GEEKLLIYEFMPNKSLDYFIFDQT---------------NSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 518 (558)
Q Consensus 454 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~N 518 (558)
.+..+|||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 999999999999999999987542 2235899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeccccceeeCCCcC
Q 008648 519 VLLDHDMNPKISDFGLARTCGGDKT 543 (558)
Q Consensus 519 Ill~~~~~~kl~DFGla~~~~~~~~ 543 (558)
||++.++.+||+|||+|+.+.....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~ 200 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN 200 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT
T ss_pred ccccccCcccccccchheeccCCCc
Confidence 9999999999999999998765543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.3e-29 Score=245.38 Aligned_cols=151 Identities=25% Similarity=0.380 Sum_probs=125.9
Q ss_pred CCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC----eEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----EKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 461 (558)
++|.+.+.||+|+||.||+|++ +|+.||||+++... ......+.|+..+..++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4678889999999999999986 68899999986422 22222334555666789999999999998754 578999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~-----~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
||+++|+|..++.+. .+++.+++.++.|++.||+|||+.. .++|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999653 4899999999999999999999741 2349999999999999999999999999999
Q ss_pred eeCCCc
Q 008648 537 TCGGDK 542 (558)
Q Consensus 537 ~~~~~~ 542 (558)
.+....
T Consensus 157 ~~~~~~ 162 (303)
T d1vjya_ 157 RHDSAT 162 (303)
T ss_dssp EEETTT
T ss_pred cccCCC
Confidence 886543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.96 E-value=5.6e-29 Score=243.34 Aligned_cols=151 Identities=21% Similarity=0.337 Sum_probs=132.4
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC----e
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS---DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----E 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 456 (558)
.++|++.+.||+|+||.||+|+. .+++.||||++++.. ....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 468999999997532 234567899999999999999999999998754 3
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.||||||+++++|..++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.++|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999888553 35899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.....
T Consensus 160 ~~~~~ 164 (277)
T d1o6ya_ 160 AIADS 164 (277)
T ss_dssp ECC--
T ss_pred hhccc
Confidence 76544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.8e-29 Score=245.82 Aligned_cols=158 Identities=30% Similarity=0.472 Sum_probs=132.0
Q ss_pred hhcCCcccceeecccCcccEEEEEEcC--------CcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCeeeeeeeEEE
Q 008648 383 NATNNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKIS-DQGLKELKNEVILFSKL-QHRNLVKLLGCCI 452 (558)
Q Consensus 383 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 452 (558)
...++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 455789999999999999999998532 2479999997633 34457788999998888 7999999999999
Q ss_pred eCCeEEEEEecCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 008648 453 HGEEKLLIYEFMPNKSLDYFIFDQTN-------------SKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 519 (558)
Q Consensus 453 ~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NI 519 (558)
+++..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+++ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999965431 245899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeccccceeeCCCcC
Q 008648 520 LLDHDMNPKISDFGLARTCGGDKT 543 (558)
Q Consensus 520 ll~~~~~~kl~DFGla~~~~~~~~ 543 (558)
|++.++.+||+|||+++.......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~ 190 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDY 190 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCT
T ss_pred eecCCCCeEeccchhhcccccccc
Confidence 999999999999999998765543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-28 Score=246.98 Aligned_cols=149 Identities=23% Similarity=0.321 Sum_probs=127.4
Q ss_pred cCCcccce-eecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhc-CCCCeeeeeeeEEEe----CCeE
Q 008648 385 TNNFSINN-KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSK-LQHRNLVKLLGCCIH----GEEK 457 (558)
Q Consensus 385 ~~~y~~~~-~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 457 (558)
.++|++.. .||+|+||.||+|.. .+++.||||+++. ...+.+|+.++.+ .+|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788875 599999999999996 4689999999864 2467789988655 589999999999876 3567
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEecccc
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGL 534 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGl 534 (558)
||||||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999653 2346899999999999999999999998 999999999999985 55799999999
Q ss_pred ceeeCCCc
Q 008648 535 ARTCGGDK 542 (558)
Q Consensus 535 a~~~~~~~ 542 (558)
|+......
T Consensus 161 a~~~~~~~ 168 (335)
T d2ozaa1 161 AKETTSHN 168 (335)
T ss_dssp CEECCCCC
T ss_pred eeeccCCC
Confidence 99876544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4e-28 Score=239.16 Aligned_cols=151 Identities=27% Similarity=0.426 Sum_probs=135.2
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCCeEEEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 462 (558)
++|+++++||+|+||+||+|+. .+++.||||+++.. .....+++.+|+.+++.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999997 46889999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccceeeCCCc
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLARTCGGDK 542 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 542 (558)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999887743 345789999999999999999999998 9999999999999999999999999999876543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.3e-28 Score=247.11 Aligned_cols=149 Identities=26% Similarity=0.378 Sum_probs=124.8
Q ss_pred CcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC------eEEE
Q 008648 387 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE------EKLL 459 (558)
Q Consensus 387 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 459 (558)
+|+..++||+|+||+||+|+.. +++.||||++..... ...+|+.+|++++||||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999975 589999999865332 2347999999999999999999986532 4689
Q ss_pred EEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccceee
Q 008648 460 IYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLARTC 538 (558)
Q Consensus 460 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~ 538 (558)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755554433334556899999999999999999999988 99999999999999775 8999999999987
Q ss_pred CCCc
Q 008648 539 GGDK 542 (558)
Q Consensus 539 ~~~~ 542 (558)
....
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-28 Score=239.26 Aligned_cols=150 Identities=25% Similarity=0.365 Sum_probs=128.4
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEeccccc------ccHHHHHHHHHHHhcCC--CCeeeeeeeEEEeCCe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISD------QGLKELKNEVILFSKLQ--HRNLVKLLGCCIHGEE 456 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 456 (558)
++|++.++||+|+||.||+|+. .+++.||||++.+... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999997 4689999999865211 12234678999999986 8999999999999999
Q ss_pred EEEEEecCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCCeEEecccc
Q 008648 457 KLLIYEFMPN-KSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-DMNPKISDFGL 534 (558)
Q Consensus 457 ~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGl 534 (558)
.++||||+.+ +++.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777777443 45899999999999999999999998 999999999999985 47899999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.....
T Consensus 158 a~~~~~~ 164 (273)
T d1xwsa_ 158 GALLKDT 164 (273)
T ss_dssp CEECCSS
T ss_pred ceecccc
Confidence 9876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=9.9e-28 Score=240.35 Aligned_cols=145 Identities=23% Similarity=0.422 Sum_probs=127.5
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeC--CeEEEEE
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHG--EEKLLIY 461 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 461 (558)
++|++.++||+|+||+||+|+. .+++.||||+++. ...+++.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 4689999999865 33567899999999995 99999999999854 4589999
Q ss_pred ecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-CeEEeccccceeeCC
Q 008648 462 EFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDM-NPKISDFGLARTCGG 540 (558)
Q Consensus 462 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~ 540 (558)
||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 34899999999999999999999998 99999999999998655 599999999998765
Q ss_pred Cc
Q 008648 541 DK 542 (558)
Q Consensus 541 ~~ 542 (558)
..
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.9e-28 Score=243.51 Aligned_cols=151 Identities=25% Similarity=0.409 Sum_probs=127.3
Q ss_pred hcCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC----eE
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS-DQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----EK 457 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 457 (558)
...+|+++++||+|+||+||+|.. .+++.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 345799999999999999999986 568999999997533 334567899999999999999999999987653 23
Q ss_pred EEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 458 LLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 458 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
++++||+.+++|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5556667799999998542 4899999999999999999999998 99999999999999999999999999987
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
....
T Consensus 159 ~~~~ 162 (345)
T d1pmea_ 159 ADPD 162 (345)
T ss_dssp CCGG
T ss_pred ccCC
Confidence 7544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9.9e-28 Score=239.28 Aligned_cols=152 Identities=28% Similarity=0.458 Sum_probs=128.4
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-------
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------- 454 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 454 (558)
.++|++.++||+|+||+||+|+. .+++.||||++... .....+++.+|+.+|++++||||+++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999997 46899999998542 334567789999999999999999999998653
Q ss_pred -CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccc
Q 008648 455 -EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFG 533 (558)
Q Consensus 455 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG 533 (558)
...++||||++++.+..+. .....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 3578999999888776554 33456889999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCCc
Q 008648 534 LARTCGGDK 542 (558)
Q Consensus 534 la~~~~~~~ 542 (558)
+|+.+....
T Consensus 163 ~~~~~~~~~ 171 (318)
T d3blha1 163 LARAFSLAK 171 (318)
T ss_dssp TCEECCC--
T ss_pred eeeeccccc
Confidence 998876443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1e-27 Score=242.04 Aligned_cols=150 Identities=29% Similarity=0.464 Sum_probs=125.3
Q ss_pred hcCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeCC-----
Q 008648 384 ATNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHGE----- 455 (558)
Q Consensus 384 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 455 (558)
..++|++.++||+|+||.||+|... +++.||||++++. .....+.+.+|+++|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3568999999999999999999974 5899999999752 2334567899999999999999999999998655
Q ss_pred -eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecccc
Q 008648 456 -EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGL 534 (558)
Q Consensus 456 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl 534 (558)
..++||||+ +.+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 5677777643 35899999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCC
Q 008648 535 ARTCGGD 541 (558)
Q Consensus 535 a~~~~~~ 541 (558)
|+.....
T Consensus 168 a~~~~~~ 174 (346)
T d1cm8a_ 168 ARQADSE 174 (346)
T ss_dssp CEECCSS
T ss_pred eeccCCc
Confidence 9987654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.3e-28 Score=239.62 Aligned_cols=150 Identities=24% Similarity=0.327 Sum_probs=132.3
Q ss_pred CCcccceeecccCcccEEEEEEc----CCcEEEEEEeccc----ccccHHHHHHHHHHHhcCCC-CeeeeeeeEEEeCCe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SDQGLKELKNEVILFSKLQH-RNLVKLLGCCIHGEE 456 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 456 (558)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999852 4789999998642 22345678899999999966 899999999999999
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.+++|||+.+++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998554 34678889999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 008648 537 TCGGD 541 (558)
Q Consensus 537 ~~~~~ 541 (558)
.+...
T Consensus 178 ~~~~~ 182 (322)
T d1vzoa_ 178 EFVAD 182 (322)
T ss_dssp ECCGG
T ss_pred hhccc
Confidence 87543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.6e-27 Score=233.77 Aligned_cols=152 Identities=26% Similarity=0.447 Sum_probs=124.3
Q ss_pred cCCcccceeecccCcccEEEEEEc-C-CcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCeeeeeeeEEEeC---
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-D-GQEIAVKRLSKIS--DQGLKELKNEVILFSKL---QHRNLVKLLGCCIHG--- 454 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~--- 454 (558)
.++|+++++||+|+||.||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999973 4 5679999986422 22233466777776655 899999999998642
Q ss_pred --CeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEecc
Q 008648 455 --EEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDF 532 (558)
Q Consensus 455 --~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF 532 (558)
...+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 35789999999887765543 23456899999999999999999999998 999999999999999999999999
Q ss_pred ccceeeCCC
Q 008648 533 GLARTCGGD 541 (558)
Q Consensus 533 Gla~~~~~~ 541 (558)
|+++.....
T Consensus 161 g~~~~~~~~ 169 (305)
T d1blxa_ 161 GLARIYSFQ 169 (305)
T ss_dssp CSCCCCCGG
T ss_pred hhhhhhccc
Confidence 999876433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.93 E-value=2.3e-26 Score=226.25 Aligned_cols=149 Identities=19% Similarity=0.327 Sum_probs=129.0
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CeeeeeeeEEEeCCeEEEEEe
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISDQGLKELKNEVILFSKLQH-RNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 462 (558)
.++|++.++||+|+||.||+|+.. +++.||||++.... ..+.+++|+++++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999965 58899999886532 23457788999999975 899999999999999999999
Q ss_pred cCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----CCCeEEecccccee
Q 008648 463 FMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH-----DMNPKISDFGLART 537 (558)
Q Consensus 463 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFGla~~ 537 (558)
|+ +++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 68998887543 345899999999999999999999998 999999999999974 56799999999998
Q ss_pred eCCC
Q 008648 538 CGGD 541 (558)
Q Consensus 538 ~~~~ 541 (558)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred cccC
Confidence 7644
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.4e-27 Score=235.51 Aligned_cols=149 Identities=29% Similarity=0.414 Sum_probs=125.7
Q ss_pred cCCcccceeecccCcccEEEEEE-cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC-----Ce
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS--DQGLKELKNEVILFSKLQHRNLVKLLGCCIHG-----EE 456 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 456 (558)
.++|++.++||+|+||+||+|+. .+++.||||++++.. ....+++.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999996 468999999997532 23456788999999999999999999998643 23
Q ss_pred EEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 457 KLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 457 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
.++++||+.+++|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677788889999999843 35899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCC
Q 008648 537 TCGG 540 (558)
Q Consensus 537 ~~~~ 540 (558)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 6643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=7.9e-26 Score=223.30 Aligned_cols=149 Identities=25% Similarity=0.413 Sum_probs=122.7
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCe-eeeeeeEEEeCCeEEEEEec
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRN-LVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~ 463 (558)
++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++..|+++++.++|+| |+.+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999986 458899999876532 2345788999999998766 55556666778889999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCCeEEeccccceeeCC
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDH---DMNPKISDFGLARTCGG 540 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~~~~ 540 (558)
++ ++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 556555533 2346899999999999999999999998 999999999999863 55799999999998865
Q ss_pred Cc
Q 008648 541 DK 542 (558)
Q Consensus 541 ~~ 542 (558)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.3e-26 Score=231.52 Aligned_cols=148 Identities=29% Similarity=0.430 Sum_probs=121.5
Q ss_pred cCCcccceeecccCcccEEEEEEc-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCeeeeeeeEEEeC------C
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SDQGLKELKNEVILFSKLQHRNLVKLLGCCIHG------E 455 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 455 (558)
.++|++.++||+|+||+||+|.+. +++.||||++... ......++.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999975 5899999999753 233456789999999999999999999999643 5
Q ss_pred eEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEeccccc
Q 008648 456 EKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKISDFGLA 535 (558)
Q Consensus 456 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla 535 (558)
..++||||+.++.+..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 789999999776554432 34789999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCC
Q 008648 536 RTCGGD 541 (558)
Q Consensus 536 ~~~~~~ 541 (558)
+.....
T Consensus 167 ~~~~~~ 172 (355)
T d2b1pa1 167 RTAGTS 172 (355)
T ss_dssp ------
T ss_pred hccccc
Confidence 876543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=4.8e-23 Score=189.19 Aligned_cols=135 Identities=21% Similarity=0.203 Sum_probs=107.7
Q ss_pred ccceeecccCcccEEEEEEcCCcEEEEEEeccccc------------------ccHHHHHHHHHHHhcCCCCeeeeeeeE
Q 008648 389 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISD------------------QGLKELKNEVILFSKLQHRNLVKLLGC 450 (558)
Q Consensus 389 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 450 (558)
.+.++||+|+||.||+|...+|++||||+++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999988899999998643100 012335578889999999999988765
Q ss_pred EEeCCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCCeEEe
Q 008648 451 CIHGEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDHDMNPKIS 530 (558)
Q Consensus 451 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 530 (558)
. ..+++|||+++..+.. ++......++.|++++|+|||+++ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 2379999998865532 334456678999999999999998 99999999999998654 9999
Q ss_pred ccccceeeCCC
Q 008648 531 DFGLARTCGGD 541 (558)
Q Consensus 531 DFGla~~~~~~ 541 (558)
|||+|+.....
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999887544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.86 E-value=6.8e-22 Score=200.17 Aligned_cols=152 Identities=22% Similarity=0.257 Sum_probs=121.6
Q ss_pred CCcccceeecccCcccEEEEEE-cCCcEEEEEEecccccccHHHHHHHHHHHhcCC-----------CCeeeeeeeEEEe
Q 008648 386 NNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIH 453 (558)
Q Consensus 386 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 453 (558)
++|++.++||+|+||+||+|+. .+++.||||++++. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999997 46899999999753 233467788999888775 5789999988865
Q ss_pred --CCeEEEEEecCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCC----
Q 008648 454 --GEEKLLIYEFMPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDHDMN---- 526 (558)
Q Consensus 454 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~ivHrDlkp~NIll~~~~~---- 526 (558)
....+++|++..................+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34566777776655544443334455678999999999999999999998 66 999999999999986553
Q ss_pred --eEEeccccceeeCCC
Q 008648 527 --PKISDFGLARTCGGD 541 (558)
Q Consensus 527 --~kl~DFGla~~~~~~ 541 (558)
+||+|||.|+.....
T Consensus 169 ~~~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH 185 (362)
T ss_dssp EEEEECCCTTCEETTBC
T ss_pred ceeeEeecccccccccc
Confidence 999999999876543
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.87 E-value=6.1e-10 Score=90.70 Aligned_cols=34 Identities=15% Similarity=0.534 Sum_probs=24.7
Q ss_pred ecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEecc
Q 008648 74 WKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGP 111 (558)
Q Consensus 74 ~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 111 (558)
|.+.++.++|.|.|.|+++|.. +++ ..++|.+|.
T Consensus 79 WsS~t~~~~g~y~l~Lq~DGNl--vlY--~~~~Wssgt 112 (115)
T d1dlpa1 79 WSSGTKGSIGNYVLVLQPDRTV--TIY--GPGLWDSGT 112 (115)
T ss_dssp CCCCCCCCSSCCEEEECSSSCE--EEE--CSEEEECSC
T ss_pred EEcCCCCCCCCEEEEECCCCcE--EEe--CCCeecCCC
Confidence 3334456789999999999885 445 348999875
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.83 E-value=2.3e-09 Score=88.14 Aligned_cols=111 Identities=16% Similarity=0.162 Sum_probs=69.7
Q ss_pred EEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEE
Q 008648 20 LQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVM 99 (558)
Q Consensus 20 ~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~ 99 (558)
+.++|+||+||.+. +|+|.|++||.++|.|. .|.|+|.|+.+|.+ ++
T Consensus 3 ~v~~~~~n~il~~~----------~~~~~~~~~l~~~q~l~---------------------~g~y~L~~q~DGNL--vL 49 (120)
T d1dlpa2 3 VVVANNGNSILYST----------QGNDNHPQTLHATQSLQ---------------------LSPYRLSMETDCNL--VL 49 (120)
T ss_dssp CCCSSCCCEECCCC------------CCCCCCEECSSCCCB---------------------CSSCEEEEETTTEE--EE
T ss_pred EEEEeCCCeEEEcC----------CCCCCcccEEcCCCeeE---------------------cCCEEEEEcCCCcE--EE
Confidence 34677777777754 77899999999999884 35699999988864 56
Q ss_pred EeCCeEEEEeccCCCCCccCCCCCCCCceeeEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEE
Q 008648 100 WKGSSKFYTTGPWNGLSFSAPTTRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRF 166 (558)
Q Consensus 100 ~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~ 166 (558)
++....+|.+............+... ..+.+.+..++..+...........+++|+.|| ++++|
T Consensus 50 ~~~~~~vW~s~t~~~~~~~~~~l~~~--GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DG-nlvlY 113 (120)
T d1dlpa2 50 FDRDDRVWSTNTAGKGTGCRAVLQPN--GRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDR-NLAIY 113 (120)
T ss_dssp EBTTBCCSCCCCCSSCSSCEEEEETT--TEEEEEETTTEEEEECCCCCSSSCCEEEECSSS-CEEEE
T ss_pred ecCCcEEEEEccccCCCcEEEEEeCC--eeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCC-cEEEe
Confidence 77788888876422110000122222 233344445554444333233334589999999 99998
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.75 E-value=3.9e-09 Score=86.66 Aligned_cols=59 Identities=17% Similarity=0.325 Sum_probs=45.8
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
+++|++++.+. ..... |+|+++|||||++. .++++||||. +.+
T Consensus 54 ~~vW~s~t~~~-~~~~~-~~l~~~GnLvl~d~----~~~~lW~S~t-------------------------------~~~ 96 (120)
T d1dlpa2 54 DRVWSTNTAGK-GTGCR-AVLQPNGRMDVLTN----QNIAVWTSGN-------------------------------SRS 96 (120)
T ss_dssp BCCSCCCCCSS-CSSCE-EEEETTTEEEEEET----TTEEEEECCC-------------------------------CCS
T ss_pred cEEEEEccccC-CCcEE-EEEeCCeeEEEEcC----CCCEEEEeCC-------------------------------CCC
Confidence 36799998754 22455 99999999999986 6789999983 346
Q ss_pred CcceEEEEecCCCceE
Q 008648 82 PGDFIWAVERQDNPEV 97 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~ 97 (558)
+|.|.+.|+++|...+
T Consensus 97 ~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 97 AGRYVFVLQPDRNLAI 112 (120)
T ss_dssp SSCCEEEECSSSCEEE
T ss_pred CCcEEEEECCCCcEEE
Confidence 7789999999987544
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.74 E-value=2.6e-08 Score=80.88 Aligned_cols=111 Identities=10% Similarity=0.152 Sum_probs=70.5
Q ss_pred ccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccCCCCCCCCcee
Q 008648 50 SDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPTTRPNPIFN 129 (558)
Q Consensus 50 TDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~ 129 (558)
||||+|||.|..+. .|+ .|+|+|.|+.+|. ++++....++|.++..+...-....+.... .
T Consensus 1 tDtL~~gq~L~~g~------~l~---------~g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~~~l~l~~dG--n 61 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG------SLA---------EGGYLFIIQNDCN--LVLYDNNRAVWASGTNGKASGCVLKMQNDG--N 61 (112)
T ss_dssp CCEEETTEEECTTC------EEE---------ETTEEEEECTTSC--EEEEETTEEEEECCCTTSCSSEEEEECTTS--C
T ss_pred CCEecCCCEecCCC------EEE---------ECCEEEEEcCCCC--EEEEcCCcEEEEccCccCCCCcEEEEeccc--c
Confidence 89999999999985 474 3999999998887 456778889998875432111011122222 2
Q ss_pred eEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEEEEeCCCCCeEEEeeccCCCC
Q 008648 130 FSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFTWSNNTQTWDLYSKAPRDEC 186 (558)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~~~~~~~~~W~~~~~~~~~~C 186 (558)
+...+. ....+...........+++|+.|| +|++|. ......|+...+.|
T Consensus 62 Lvl~~~-~~~~w~s~t~~~~~~~~l~L~ddG-Nlvly~-----~~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 62 LVIYSG-SRAIWASNTNRQNGNYYLILQRDR-NVVIYD-----NSNNAIWATHTNVG 111 (112)
T ss_dssp EEEEET-TEEEEECCCCCSCCCCEEEECTTS-CEEEEC-----TTSCEEEECCCCCC
T ss_pred EEEEec-CCeEEEEeeccCCCceEEEEcCCC-CEEEEC-----CCCcEEecCCCccC
Confidence 222232 333333333333345689999999 999983 22357788877765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=5.3e-08 Score=91.76 Aligned_cols=144 Identities=16% Similarity=0.063 Sum_probs=99.2
Q ss_pred cCCcccceeecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEec
Q 008648 385 TNNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEF 463 (558)
Q Consensus 385 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 463 (558)
...|+..+..+.++...||+... +++.+++|+...........+.+|..++..+. +--+.+++.+...++..++|||+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34666555544444568998864 56678888876544444556778888877664 44467788888888899999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 008648 464 MPNKSLDYFIFDQTNSKLLDWSKRFHIICGTARGLLYLHQDS-------------------------------------- 505 (558)
Q Consensus 464 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~-------------------------------------- 505 (558)
++|..+...... ......++.++++.|..||+..
T Consensus 92 l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred cccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999888654411 1122334555666666666421
Q ss_pred ------------------CCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 506 ------------------RLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 506 ------------------~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999999877677999998864
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.50 E-value=6e-08 Score=78.65 Aligned_cols=44 Identities=18% Similarity=0.430 Sum_probs=35.5
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCcc
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSD 51 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTD 51 (558)
..+|++++.+. .+... |+|+|+|||||++. .+.++|||+.+|++
T Consensus 69 ~~~w~s~t~~~-~~~~~-l~L~ddGNlvly~~----~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 69 RAIWASNTNRQ-NGNYY-LILQRDRNVVIYDN----SNNAIWATHTNVGN 112 (112)
T ss_dssp EEEEECCCCCS-CCCCE-EEECTTSCEEEECT----TSCEEEECCCCCCC
T ss_pred CeEEEEeeccC-CCceE-EEEcCCCCEEEECC----CCcEEecCCCccCC
Confidence 36788887653 23455 99999999999986 67899999999986
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.46 E-value=1.9e-07 Score=76.07 Aligned_cols=104 Identities=13% Similarity=0.051 Sum_probs=68.4
Q ss_pred EeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccCCC
Q 008648 42 FWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPT 121 (558)
Q Consensus 42 lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~ 121 (558)
-||++|.|.+||-++|.|... + +.|+|+|.|+.+|++ +++++..++|.+.......-....
T Consensus 6 s~~~~~~~~~~l~~~q~l~~~----------~-------~~~~y~l~mQ~DGNL--VLy~~~~~vWssnt~~~~~~~~l~ 66 (119)
T d1b2pa_ 6 SKQPDDNHPQILHATESLEIL----------F-------GTHVYRFIMQTDCNL--VLYDNNNPIWATNTGGLGNGCRAV 66 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEE----------E-------TTEEEEEEECTTSCE--EEEETTEEEEECCCTTSCSSCEEE
T ss_pred eeecCCCCCCEEeCCCeEEEe----------c-------CCceEEEEECCCCcE--EEEECCeEEEEecCCCCCcceEEE
Confidence 489999999999999987421 1 589999999999874 457888899998754311100012
Q ss_pred CCCCCceeeEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEEE
Q 008648 122 TRPNPIFNFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFT 167 (558)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~~ 167 (558)
+... ..+.+.+..+...++..........+++|+.|| ++++|.
T Consensus 67 l~~d--GnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DG-NlvlYg 109 (119)
T d1b2pa_ 67 LQPD--GVLVVITNENVTVWQSPVAGKAGHYVLVLQPDR-NVVIYG 109 (119)
T ss_dssp ECTT--SCEEEECTTCCEEEECSCCCCSSCEEEEECTTS-CEEEEE
T ss_pred EEeC--CCEEEECCCCcEEEECCCcCCCCceEEEEcCCC-CEEEEC
Confidence 2222 233344455555444433333344689999999 999983
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.34 E-value=1.1e-06 Score=70.31 Aligned_cols=71 Identities=20% Similarity=0.433 Sum_probs=47.8
Q ss_pred ceEEecCCCCCCCCCceEEEEecCCCeEEecCCCCCCCceEeeecCCCccccCCCCccccccCCCceeEEEEecCCCCCC
Q 008648 2 RVVWSASLSKEVQQTPVVLQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDTLLPGMKLGWDLKTGFERRVISWKSADDPS 81 (558)
Q Consensus 2 ~~vWst~~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps 81 (558)
.+||++++......... +.|.++|||||+++ .++++|+| ....+
T Consensus 38 ~~vW~ant~~~~~~~~~-l~l~~dGnLvl~~~----~g~~vW~s-------------------------------~t~~~ 81 (109)
T d1kj1a_ 38 TSVWASNTGILGKKGCK-AVLQSDGNFVVYDA----EGRSLWAS-------------------------------HSVRG 81 (109)
T ss_dssp EEEEECCCCCTTCCCCE-EEECTTSCEEEECS----SSCEEEEC-------------------------------CCCCC
T ss_pred EEEEEeCCCCCCceeEE-EEEcCCceEEEEeC----CCcEEEEE-------------------------------eeECC
Confidence 36788887653333444 78888888888876 67788876 11223
Q ss_pred CcceEEEEecCCCceEEEEeCCeEEEEeccC
Q 008648 82 PGDFIWAVERQDNPEVVMWKGSSKFYTTGPW 112 (558)
Q Consensus 82 ~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 112 (558)
.|.|.+.|+++|+.. +++ .+.|.|+.+
T Consensus 82 ~~~~~l~L~ddGNlv--ly~--~~~W~S~t~ 108 (109)
T d1kj1a_ 82 NGNYVLVLQEDGNVV--IYG--SDIWSTGTY 108 (109)
T ss_dssp SSCCEEEECTTSCEE--EEC--CEEEECCCC
T ss_pred CCCEEEEEeCCCcEE--EEC--CCEecCCCc
Confidence 567889999888754 443 468887653
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.19 E-value=1.7e-06 Score=69.14 Aligned_cols=97 Identities=9% Similarity=0.061 Sum_probs=62.5
Q ss_pred cccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccCCCCCCCCceee
Q 008648 51 DTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPTTRPNPIFNF 130 (558)
Q Consensus 51 DTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 130 (558)
|||+|||.|..+. .|. .|+|+|.|+.+|+ +++|++..++|.+...+........+.. ...+
T Consensus 2 ~~L~~g~~L~~G~------~l~---------ng~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~~~l~l~~--~Gnl 62 (108)
T d1jpca_ 2 NILYSGETLSTGE------FLN---------YGSFVFIMQEDCN--LVLYDVDKPIWATNTGGLSRSCFLSMQT--DGNL 62 (108)
T ss_dssp CEEETTEEECTTC------EEE---------ETTEEEEECTTSC--EEEEETTEEEEECCCTTSCSSCEEEECT--TSCE
T ss_pred CCccCCCEecCCC------EEE---------cCCEEEEECCCCe--EEEEeCCceeeEeCCCCCCCccEEEEec--cceE
Confidence 8999999998774 463 4899999999887 4568888999997754321100011221 1233
Q ss_pred EEeecCCeeEEEEEecCCceEEEEEEeccCCceEEEE
Q 008648 131 SFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRFT 167 (558)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~~ 167 (558)
.+....+...++..........+++|++|| +|++|.
T Consensus 63 vl~~~~g~~vWsS~t~~~~~~~~l~L~ddG-NlVly~ 98 (108)
T d1jpca_ 63 VVYNPSNKPIWASNTGGQNGNYVCILQKDR-NVVIYG 98 (108)
T ss_dssp EEECTTCCEEEECCCCCSCSCEEEEECTTS-CEEEEE
T ss_pred EEECCCccceEEccccCCCCcEEEEEcCCC-CEEEeC
Confidence 334444555555433333445689999999 999983
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=4.9e-06 Score=77.35 Aligned_cols=131 Identities=18% Similarity=0.150 Sum_probs=85.2
Q ss_pred eecccCc-ccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCeeeeeeeEEEeCCeEEEEEecCCCCCh
Q 008648 393 KLGEGGF-GPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQ--HRNLVKLLGCCIHGEEKLLIYEFMPNKSL 469 (558)
Q Consensus 393 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL 469 (558)
.+..|.. +.||+....++..+++|...... ...+..|...++.+. .-.+.+++.+..+.+..++|||+++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 57899988778888889765432 234667777776653 33467788888888888999999998766
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 008648 470 DYFIFDQTNSKLLDWSKRFHIICGTARGLLYLH----------------------------------------------- 502 (558)
Q Consensus 470 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~yLH----------------------------------------------- 502 (558)
.... .... .++.++++.|.-||
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 0100 11122222222222
Q ss_pred ----hC----CCCceEecCCCCCcEEEcCCCCeEEecccccee
Q 008648 503 ----QD----SRLRIIHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 503 ----~~----~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
.. .++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112379999999999999877678999998865
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.06 E-value=8.2e-06 Score=66.11 Aligned_cols=79 Identities=15% Similarity=0.183 Sum_probs=41.9
Q ss_pred EEEecCCCeEEecCCCCCCCceEeeecCCCcc--ccCCCCc---cccccCCCceeEEEEecCCCCCCCcceEEEEecCCC
Q 008648 20 LQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSD--TLLPGMK---LGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDN 94 (558)
Q Consensus 20 ~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTD--TlLpgq~---l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~ 94 (558)
+.|+.+|||||.+ .+.++|+|..+... +-|--|. |..- .+... +=|.+...-+.|.|.+.|+++|.
T Consensus 34 l~mQ~DGNLVLy~-----~~~~vWssnt~~~~~~~~l~l~~dGnLvL~--d~~g~--~vWsS~t~~~~~~~~l~Lq~DGN 104 (119)
T d1b2pa_ 34 FIMQTDCNLVLYD-----NNNPIWATNTGGLGNGCRAVLQPDGVLVVI--TNENV--TVWQSPVAGKAGHYVLVLQPDRN 104 (119)
T ss_dssp EEECTTSCEEEEE-----TTEEEEECCCTTSCSSCEEEECTTSCEEEE--CTTCC--EEEECSCCCCSSCEEEEECTTSC
T ss_pred EEECCCCcEEEEE-----CCeEEEEecCCCCCcceEEEEEeCCCEEEE--CCCCc--EEEECCCcCCCCceEEEEcCCCC
Confidence 5666666666664 24566666655431 1111111 1100 01111 22555555566789999999887
Q ss_pred ceEEEEeCCeEEEEecc
Q 008648 95 PEVVMWKGSSKFYTTGP 111 (558)
Q Consensus 95 ~~~~~~~~~~~y~~~~~ 111 (558)
..+ +. .+.|.|+.
T Consensus 105 lvl--Yg--~~~W~S~T 117 (119)
T d1b2pa_ 105 VVI--YG--DALWATQT 117 (119)
T ss_dssp EEE--EE--SEEEECCC
T ss_pred EEE--EC--CCEeccCC
Confidence 544 43 47888764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.01 E-value=6.4e-06 Score=65.72 Aligned_cols=78 Identities=15% Similarity=0.255 Sum_probs=41.0
Q ss_pred EEEecCCCeEEecCCCCCCCceEeeecCCCccc-----cCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCC
Q 008648 20 LQLLDSGNLVLRGEQEGDSGTYFWQSFDYPSDT-----LLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDN 94 (558)
Q Consensus 20 ~~LldsGNlVl~~~~~~~~~~~lWqSFd~PTDT-----lLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~ 94 (558)
+.|+++|||||.+ .+.++|+|..++..+ |.+.-.|.. ..+... +-|.|......+.|.+.|+++|.
T Consensus 23 l~~q~DGNLvly~-----~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl--~~~~g~--~vWsS~t~~~~~~~~l~L~ddGN 93 (108)
T d1jpca_ 23 FIMQEDCNLVLYD-----VDKPIWATNTGGLSRSCFLSMQTDGNLVV--YNPSNK--PIWASNTGGQNGNYVCILQKDRN 93 (108)
T ss_dssp EEECTTSCEEEEE-----TTEEEEECCCTTSCSSCEEEECTTSCEEE--ECTTCC--EEEECCCCCSCSCEEEEECTTSC
T ss_pred EEECCCCeEEEEe-----CCceeeEeCCCCCCCccEEEEeccceEEE--ECCCcc--ceEEccccCCCCcEEEEEcCCCC
Confidence 6667777777765 345677776665321 001111110 011111 22555655677888999998887
Q ss_pred ceEEEEeCCeEEEEec
Q 008648 95 PEVVMWKGSSKFYTTG 110 (558)
Q Consensus 95 ~~~~~~~~~~~y~~~~ 110 (558)
.. ++.. +.|.|+
T Consensus 94 lV--ly~~--~~W~S~ 105 (108)
T d1jpca_ 94 VV--IYGT--DRWATG 105 (108)
T ss_dssp EE--EEEC--CCCCCC
T ss_pred EE--EeCC--CcccCC
Confidence 54 3432 356554
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.00 E-value=1.2e-05 Score=64.07 Aligned_cols=96 Identities=10% Similarity=0.035 Sum_probs=59.7
Q ss_pred cccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccC-CCCCCCCcee
Q 008648 51 DTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSA-PTTRPNPIFN 129 (558)
Q Consensus 51 DTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~-~~~~~~~~~~ 129 (558)
|||+|||.|..+. .|+ .|.|+|.|+.+|. ++++.+..++|.+..-....-.. ..+... ..
T Consensus 2 ~~L~~g~~L~~g~------~l~---------~g~~~l~~q~dgn--Lvl~~~~~~vW~ant~~~~~~~~~l~l~~d--Gn 62 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQ------SLD---------VEPYHFIMQEDCN--LVLYDHSTSVWASNTGILGKKGCKAVLQSD--GN 62 (109)
T ss_dssp CEEETTCEEETTC------EEE---------ETTEEEEECTTSC--EEEEETTEEEEECCCCCTTCCCCEEEECTT--SC
T ss_pred CCccCCCEEeCCC------EEE---------eCCEEEEecCCCe--EEEEeCCEEEEEeCCCCCCceeEEEEEcCC--ce
Confidence 8999999998874 464 3889999998877 45677888999875421110000 112222 22
Q ss_pred eEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEE
Q 008648 130 FSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRF 166 (558)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~ 166 (558)
+...+..+...+...........+++|.+|| ++++|
T Consensus 63 Lvl~~~~g~~vW~s~t~~~~~~~~l~L~ddG-Nlvly 98 (109)
T d1kj1a_ 63 FVVYDAEGRSLWASHSVRGNGNYVLVLQEDG-NVVIY 98 (109)
T ss_dssp EEEECSSSCEEEECCCCCCSSCCEEEECTTS-CEEEE
T ss_pred EEEEeCCCcEEEEEeeECCCCCEEEEEeCCC-cEEEE
Confidence 3333444444444333323334589999999 99998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.75 E-value=3.4e-05 Score=76.59 Aligned_cols=76 Identities=11% Similarity=0.169 Sum_probs=49.4
Q ss_pred eeecccCcccEEEEEEcC-CcEEEEEEeccc-------ccccHHHHHHHHHHHhcCC-C--CeeeeeeeEEEeCCeEEEE
Q 008648 392 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-------SDQGLKELKNEVILFSKLQ-H--RNLVKLLGCCIHGEEKLLI 460 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 460 (558)
+.||.|....||++...+ ++.++||.-... -+....+...|.+.|+.+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998654 678999964321 1123345566877776652 2 345666654 55667899
Q ss_pred EecCCCCCh
Q 008648 461 YEFMPNKSL 469 (558)
Q Consensus 461 ~E~~~~gsL 469 (558)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.21 E-value=0.00096 Score=63.87 Aligned_cols=135 Identities=16% Similarity=0.161 Sum_probs=77.4
Q ss_pred ccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCee-----eee--eeEEEeCCeEEEEEecCCCCChh--
Q 008648 400 GPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHRNL-----VKL--LGCCIHGEEKLLIYEFMPNKSLD-- 470 (558)
Q Consensus 400 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l--~~~~~~~~~~~lv~E~~~~gsL~-- 470 (558)
-.||++...+|..+++|..... ....+++..|...+..|....| +.. -......+..+.++++++|..++
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999989999999987652 3356778888888877642221 111 11223456678999999875431
Q ss_pred ---HH------H---hh----c--CCCCCCC-------------------HHHHHHHHHHHHHHHHHHH----hCCCCce
Q 008648 471 ---YF------I---FD----Q--TNSKLLD-------------------WSKRFHIICGTARGLLYLH----QDSRLRI 509 (558)
Q Consensus 471 ---~~------l---~~----~--~~~~~l~-------------------~~~~~~i~~~i~~gL~yLH----~~~~~~i 509 (558)
.+ + +. . .....++ ......+...+.+.++.+. +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 0 00 0 0001111 1111112212222233332 2223458
Q ss_pred EecCCCCCcEEEcCCCCeEEecccccee
Q 008648 510 IHRDLKASNVLLDHDMNPKISDFGLART 537 (558)
Q Consensus 510 vHrDlkp~NIll~~~~~~kl~DFGla~~ 537 (558)
||+|+.|.|||++++ ..|+||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 56899998864
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.18 E-value=0.00026 Score=56.49 Aligned_cols=91 Identities=9% Similarity=0.165 Sum_probs=52.9
Q ss_pred CccccCCCCccccccCCCceeEEEEecCCCCCCCcceEEEEecCCCceEEEEeCCeEEEEeccCCCCCccCCCCCCCCce
Q 008648 49 PSDTLLPGMKLGWDLKTGFERRVISWKSADDPSPGDFIWAVERQDNPEVVMWKGSSKFYTTGPWNGLSFSAPTTRPNPIF 128 (558)
Q Consensus 49 PTDTlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~ 128 (558)
+++||-++|.| ..|.|+|.|+.+|.+ +++++...+|.+..-.... ....+...+
T Consensus 13 ~~~tl~~~~~l---------------------~~g~~~l~~q~DGNL--vL~~~~~~vW~s~t~~~~~-~~l~l~~dG-- 66 (115)
T d1dlpa1 13 HPQTLHAAQSL---------------------ELSSFRFTMQSDCNL--VLFDSDVRVWASNTAGATG-CRAVLQSDG-- 66 (115)
T ss_dssp SCSCCCTTCEE---------------------CSTTEEEEECTTSCE--EEEESSSEEECCCCCSCSC-CBCCBCSSS--
T ss_pred CcceecCCCcE---------------------EcCCEEEEECCCCeE--EEEcCCeeEEEcccCCCCc-eEEEEeccC--
Confidence 35888888865 347799999999874 5577888999976432111 012222222
Q ss_pred eeEEeecCCeeEEEEEecCCceEEEEEEeccCCceEEE
Q 008648 129 NFSFVANEDELCYTFSIKDKAVVSRIVMNQTTYLGQRF 166 (558)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~r~~ld~~G~~~~~~ 166 (558)
.+.+.+..+...+...........+++|+.|| ++++|
T Consensus 67 NLvl~d~~~~~vWsS~t~~~~g~y~l~Lq~DG-NlvlY 103 (115)
T d1dlpa1 67 LLVILTAQNTIRWSSGTKGSIGNYVLVLQPDR-TVTIY 103 (115)
T ss_dssp CBCCBCTTTCCSCCCCCCCCSSCCEEEECSSS-CEEEE
T ss_pred CEEEEccCCCEEEEcCCCCCCCCEEEEECCCC-cEEEe
Confidence 22223333333332222222333579999999 99998
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.94 E-value=0.00098 Score=65.70 Aligned_cols=72 Identities=17% Similarity=0.249 Sum_probs=48.1
Q ss_pred eeecccCcccEEEEEEcC--------CcEEEEEEecccccccHHHHHHHHHHHhcCC-CCeeeeeeeEEEeCCeEEEEEe
Q 008648 392 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISDQGLKELKNEVILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 462 (558)
Q Consensus 392 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 462 (558)
+.|+.|-.-.+|++...+ .+.|.+++... ........+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 578888888999998654 24566666542 223345667888888774 3334567777632 68999
Q ss_pred cCCCCCh
Q 008648 463 FMPNKSL 469 (558)
Q Consensus 463 ~~~~gsL 469 (558)
|++|..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.66 E-value=0.043 Score=51.39 Aligned_cols=156 Identities=13% Similarity=0.012 Sum_probs=78.0
Q ss_pred hhhhhhhcCCcccce-----eecccCcccEEEEEEcCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC-----eeeee
Q 008648 378 LATISNATNNFSINN-----KLGEGGFGPVYKGTLVDGQEIAVKRLSKISDQGLKELKNEVILFSKLQHR-----NLVKL 447 (558)
Q Consensus 378 ~~~~~~~~~~y~~~~-----~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-----niv~l 447 (558)
.+++.....+|.+.+ .|..|---+.|+....++ .+++|+.... ...+++..|+.++..|.+. ..+..
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccccee
Confidence 344455555665533 345666677899887655 5888987542 1234555566666665322 11111
Q ss_pred e---eEEEeCCeEEEEEecCCCCChhHH-----------H---hh--c--C--CCCC------------------CCHHH
Q 008648 448 L---GCCIHGEEKLLIYEFMPNKSLDYF-----------I---FD--Q--T--NSKL------------------LDWSK 486 (558)
Q Consensus 448 ~---~~~~~~~~~~lv~E~~~~gsL~~~-----------l---~~--~--~--~~~~------------------l~~~~ 486 (558)
. .+.........++.++.+...... + +. . . .... .....
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 0 012224455677777765433110 0 00 0 0 0000 00011
Q ss_pred HHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCCeEEeccccce
Q 008648 487 RFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDHDMNPKISDFGLAR 536 (558)
Q Consensus 487 ~~~i~~~i~~gL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 536 (558)
....+..+...+.-.+.. -+.++||+|+.+.||+++.+...-|+||+.|.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222222223222221 22359999999999999988777899999885
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.02 E-value=0.018 Score=33.72 Aligned_cols=33 Identities=33% Similarity=0.741 Sum_probs=26.4
Q ss_pred CCCCCcCccCCCcccccCC-CCCcccccCCceecC
Q 008648 183 RDECDTYGLCGAYGVCIIS-KSPVCQCLKGFKTKS 216 (558)
Q Consensus 183 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~~ 216 (558)
.|+|.+-..||. |.|+.- ..-.|.|-.||+|..
T Consensus 1 tdECsignpCGn-GTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSSS-SCEEECSSSEEECCSSSSCCCS
T ss_pred CCccccCCccCC-ceeeecccceEEeecCCcCCCc
Confidence 378999999996 889643 356799999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.60 E-value=0.022 Score=35.76 Aligned_cols=30 Identities=43% Similarity=0.889 Sum_probs=24.5
Q ss_pred CCCCc-CccCCCcccccCC-CCCcccccCCce
Q 008648 184 DECDT-YGLCGAYGVCIIS-KSPVCQCLKGFK 213 (558)
Q Consensus 184 ~~C~~-~~~CG~~g~C~~~-~~~~C~C~~gf~ 213 (558)
|+|.. ...|..+|.|... ..-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 56875 5789999999754 357899999997
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.45 E-value=0.054 Score=33.24 Aligned_cols=30 Identities=33% Similarity=0.823 Sum_probs=23.6
Q ss_pred CCCCcCccCCCcccccCC-CCCcccccCCcee
Q 008648 184 DECDTYGLCGAYGVCIIS-KSPVCQCLKGFKT 214 (558)
Q Consensus 184 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 214 (558)
|+|. +..|...|.|... ..-.|.|++||+-
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 4565 4789999999754 4678999999974
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.14 E-value=0.071 Score=32.68 Aligned_cols=30 Identities=23% Similarity=0.646 Sum_probs=23.3
Q ss_pred CCCCcCccCCCcccccCC-CCCcccccCCcee
Q 008648 184 DECDTYGLCGAYGVCIIS-KSPVCQCLKGFKT 214 (558)
Q Consensus 184 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 214 (558)
|+|. +..|...|.|... ..-.|.|++||+-
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEG 32 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEES
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCcc
Confidence 4564 4779999999754 4678999999974
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.92 E-value=0.18 Score=31.14 Aligned_cols=31 Identities=32% Similarity=0.775 Sum_probs=23.7
Q ss_pred CCCCcCccCCCcccccCC-CCCcccccCCceecC
Q 008648 184 DECDTYGLCGAYGVCIIS-KSPVCQCLKGFKTKS 216 (558)
Q Consensus 184 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~~ 216 (558)
|+|..++.|. .+|... .+-.|.|++||+...
T Consensus 2 dEC~~~~~C~--~~C~n~~Gsy~C~C~~Gy~L~~ 33 (41)
T d1i0ua2 2 DECQDPDTCS--QLCVNLEGGYKCQCEEGFQLDP 33 (41)
T ss_dssp CTTTTTTSCS--SCEECSSSCCEECCCTTEEECT
T ss_pred ccCCCCCCCC--CEeECCCCCEEeECCCCCeECC
Confidence 6788777774 589755 367899999999753
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.82 E-value=0.2 Score=31.26 Aligned_cols=31 Identities=32% Similarity=0.577 Sum_probs=24.0
Q ss_pred CCCCCcCccCCCcccccCC-CCCcccccCCcee
Q 008648 183 RDECDTYGLCGAYGVCIIS-KSPVCQCLKGFKT 214 (558)
Q Consensus 183 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 214 (558)
.|+|..+. |+..+.|... .+-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47898654 5578999765 3678999999986
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.39 E-value=0.076 Score=33.36 Aligned_cols=32 Identities=28% Similarity=0.678 Sum_probs=24.6
Q ss_pred CCCCcCccCCCcccccCCC-CCcccccCCceecC
Q 008648 184 DECDTYGLCGAYGVCIISK-SPVCQCLKGFKTKS 216 (558)
Q Consensus 184 ~~C~~~~~CG~~g~C~~~~-~~~C~C~~gf~~~~ 216 (558)
|+|..+..| -.++|.... +-.|.|++||+...
T Consensus 4 dEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~~ 36 (43)
T d1uzka1 4 NECLDPTTC-ISGNCVNTPGSYICDCPPDFELNP 36 (43)
T ss_dssp CGGGSTTSS-BTSEEEEETTEEEEECCTTCEECT
T ss_pred cccCCCCcC-cCCEeECCCCCEEEecCCCCEECC
Confidence 678887766 468997553 66899999998753
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.69 E-value=0.13 Score=30.62 Aligned_cols=30 Identities=33% Similarity=0.740 Sum_probs=22.7
Q ss_pred CCCCcCccCCCcccccCC-CCCcccccCCcee
Q 008648 184 DECDTYGLCGAYGVCIIS-KSPVCQCLKGFKT 214 (558)
Q Consensus 184 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 214 (558)
|+|. +..|-..|.|... ..-+|.|++||.-
T Consensus 1 d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 31 (35)
T d2vj3a3 1 DECA-SSPCLHNGRCLDKINEFQCECPTGFTG 31 (35)
T ss_dssp CTTT-TCCSTTTCEEEECSSCEEEECCTTEES
T ss_pred CCCC-CCCCCCCcEEECCCCCeEEECCCCCCC
Confidence 3453 5789999999754 4678999999973
|
| >d1dx5i2 g.3.11.1 (I:388-422) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.60 E-value=0.11 Score=29.72 Aligned_cols=19 Identities=21% Similarity=0.616 Sum_probs=14.8
Q ss_pred cccCCCCCcccccCCceec
Q 008648 197 VCIISKSPVCQCLKGFKTK 215 (558)
Q Consensus 197 ~C~~~~~~~C~C~~gf~~~ 215 (558)
.|+.++...|+||.||-..
T Consensus 11 dCdP~~p~~C~CPeGyIld 29 (35)
T d1dx5i2 11 DCDPNTQASCECPEGYILD 29 (35)
T ss_dssp EECTTSTTCEECCTTEEEE
T ss_pred ccCCCCCCcccCCCceEec
Confidence 4666678899999999653
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.34 E-value=0.078 Score=32.51 Aligned_cols=31 Identities=32% Similarity=0.610 Sum_probs=24.6
Q ss_pred CCCCCcCccCCCcccccCC-CCCcccccCCcee
Q 008648 183 RDECDTYGLCGAYGVCIIS-KSPVCQCLKGFKT 214 (558)
Q Consensus 183 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 214 (558)
.|+|. +..|-..|.|... ...+|.|++||+-
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 34 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCC
Confidence 46787 5889999999754 4678999999963
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.84 E-value=0.19 Score=31.61 Aligned_cols=32 Identities=31% Similarity=0.787 Sum_probs=23.6
Q ss_pred CCCCcC-ccCCCcccccCC-CCCcccccCCceecC
Q 008648 184 DECDTY-GLCGAYGVCIIS-KSPVCQCLKGFKTKS 216 (558)
Q Consensus 184 ~~C~~~-~~CG~~g~C~~~-~~~~C~C~~gf~~~~ 216 (558)
|+|... ..| .++.|... .+-.|.|++||+...
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYESGF 37 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECT
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCC
Confidence 678764 456 47899754 467899999998753
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=83.80 E-value=0.22 Score=32.70 Aligned_cols=28 Identities=32% Similarity=0.698 Sum_probs=22.2
Q ss_pred CcCccCCCcccccC---CCCCcccccCCcee
Q 008648 187 DTYGLCGAYGVCII---SKSPVCQCLKGFKT 214 (558)
Q Consensus 187 ~~~~~CG~~g~C~~---~~~~~C~C~~gf~~ 214 (558)
...+.|-..|.|.. .....|.|++||.-
T Consensus 9 c~~~~C~NgG~C~~~~~~~~~~C~C~~gy~G 39 (53)
T d3egfa_ 9 SYDGYCLNGGVCMHIESLDSYTCNCVIGYSG 39 (53)
T ss_dssp TSSCCSCSSCEEEEESSSSCEEEECCTTCCS
T ss_pred CCCCCCCCCcEeeccCCCCCeEeECCCCCcC
Confidence 34689999999963 24789999999964
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=83.67 E-value=0.098 Score=31.60 Aligned_cols=30 Identities=33% Similarity=0.739 Sum_probs=23.3
Q ss_pred CCCCcCccCCCcccccCC-CCCcccccCCcee
Q 008648 184 DECDTYGLCGAYGVCIIS-KSPVCQCLKGFKT 214 (558)
Q Consensus 184 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 214 (558)
|+|. ...|-..|.|... ..-.|.|++||+-
T Consensus 3 d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 33 (37)
T d2c4fl1 3 DQCA-SSPCQNGGSCKDQLQSYICFCLPAFEG 33 (37)
T ss_dssp CGGG-GCCCCTTCEEEEETTEEEEECCTTEES
T ss_pred ccCC-CCCCCCCCEEECCCCCeEEECCCCCcC
Confidence 5564 5789999999754 4678999999974
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.95 E-value=0.087 Score=32.27 Aligned_cols=30 Identities=27% Similarity=0.733 Sum_probs=23.0
Q ss_pred CCCCcCccCCCcccccCC-CCCcccccCCcee
Q 008648 184 DECDTYGLCGAYGVCIIS-KSPVCQCLKGFKT 214 (558)
Q Consensus 184 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 214 (558)
+.|. +..|...|.|... ....|.|++||.-
T Consensus 2 ~~C~-~~pC~ngg~C~~~~~~~~C~C~~g~~G 32 (39)
T d1g1ta2 2 AACT-NTSCSGHGECVETINNYTCKCDPGFSG 32 (39)
T ss_dssp CCCC-TTGGGGSEEEEEETTEEEEEECTTEES
T ss_pred Cccc-CCcCCCCcEEECCCCCEEEeCCCCCcC
Confidence 3465 4789999999754 4678999999974
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.72 E-value=0.75 Score=33.83 Aligned_cols=53 Identities=19% Similarity=0.395 Sum_probs=33.3
Q ss_pred CceEEeccccCCCCc---ceeeecCCChHHHHHHhhcC----CceEEEEeeccCCCCCcccee
Q 008648 238 DGFIKFTELKLPDAN---FSRVSKSVNLKECREKCLEN----SSCMAYTNSDIRGGGSGCAMW 293 (558)
Q Consensus 238 ~~f~~~~~~~~~~~~---~~~~~~~~~~~~C~~~Cl~n----CsC~a~~~~~~~~~~~~C~~~ 293 (558)
+.|.+..+..+...+ ........+.++|...|+++ -.|.+|.|.. ....|.+-
T Consensus 5 ~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~---~~~~C~Ls 64 (91)
T d2qj2a1 5 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDK---ARKQCLWF 64 (91)
T ss_dssp GGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEET---TTTEEEEE
T ss_pred HhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEEC---CCCeEEEc
Confidence 466666665542221 22222345899999999873 5699999964 23458764
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.14 E-value=0.47 Score=30.28 Aligned_cols=31 Identities=32% Similarity=0.744 Sum_probs=23.9
Q ss_pred cCCCCCcCccCCCcccccCC-CCCcccccCCcee
Q 008648 182 PRDECDTYGLCGAYGVCIIS-KSPVCQCLKGFKT 214 (558)
Q Consensus 182 ~~~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 214 (558)
+.++|+- ..|.. |.|... ..-.|.|++||.-
T Consensus 7 ~~~~C~~-~PC~n-G~C~~~~~~y~C~C~~G~~G 38 (48)
T d1autl1 7 LEHPCAS-LCCGH-GTCIDGIGSFSCDCRSGWEG 38 (48)
T ss_dssp SCCSSSS-TTTTS-EEECCCSSCCCEEECTTEES
T ss_pred CCCcccC-CCCCC-CEEECCCCCCeEeCCCCCcC
Confidence 4567875 88975 999754 4678999999973
|